Ligand source activities (1 row/activity)





Ligands (move mouse cursor over ligand name to see structure) Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb
ID
#Vendors

Reference
ligand
Fold
selectivity
# Tested
GPCRs
Species

p-value
(-log)
Activity
Type
Activity
Relation
Activity
Value
AssayType

Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

3658 4107 53 None 1 18 Human 9.5 pAC50 = 9.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
517 4107 53 None 1 18 Human 9.5 pAC50 = 9.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
5709 4107 53 None 1 18 Human 9.5 pAC50 = 9.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
CHEMBL312448 4107 53 None 1 18 Human 9.5 pAC50 = 9.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
DB06694 4107 53 None 1 18 Human 9.5 pAC50 = 9.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
11079 2733 63 None 5 7 Human 9.2 pAC50 = 9.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
3369 2733 63 None 5 7 Human 9.2 pAC50 = 9.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
4436 2733 63 None 5 7 Human 9.2 pAC50 = 9.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
5509 2733 63 None 5 7 Human 9.2 pAC50 = 9.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL761 2733 63 None 5 7 Human 9.2 pAC50 = 9.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
DB06711 2733 63 None 5 7 Human 9.2 pAC50 = 9.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
2142 3096 58 None -1 18 Human 9.1 pAC50 = 9.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
4920903 3096 58 None -1 18 Human 9.1 pAC50 = 9.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
502 3096 58 None -1 18 Human 9.1 pAC50 = 9.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
5775 3096 58 None -1 18 Human 9.1 pAC50 = 9.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
CHEMBL597 3096 58 None -1 18 Human 9.1 pAC50 = 9.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
DB00692 3096 58 None -1 18 Human 9.1 pAC50 = 9.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
1960 2857 67 None -2 18 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
439260 2857 67 None -2 18 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
505 2857 67 None -2 18 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
CHEMBL1437 2857 67 None -2 18 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
DB00368 2857 67 None -2 18 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
11079 2733 63 None 5 7 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
3369 2733 63 None 5 7 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
4436 2733 63 None 5 7 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
5509 2733 63 None 5 7 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL761 2733 63 None 5 7 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
DB06711 2733 63 None 5 7 Human 8.9 pAC50 = 8.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1038/s41467-023-40064-9
46780481 107531 20 None -7 15 Human 8.9 pAC50 = 8.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 10.1038/s41467-023-40064-9
9903970 107531 20 None -7 15 Human 8.9 pAC50 = 8.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 10.1038/s41467-023-40064-9
CHEMBL3187365 107531 20 None -7 15 Human 8.9 pAC50 = 8.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 10.1038/s41467-023-40064-9
CHEMBL3544974 107531 20 None -7 15 Human 8.9 pAC50 = 8.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 10.1038/s41467-023-40064-9
2803 955 58 None -3 14 Human 8.8 pAC50 = 8.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
516 955 58 None -3 14 Human 8.8 pAC50 = 8.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
704 955 58 None -3 14 Human 8.8 pAC50 = 8.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
CHEMBL134 955 58 None -3 14 Human 8.8 pAC50 = 8.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
DB00575 955 58 None -3 14 Human 8.8 pAC50 = 8.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
1960 2857 67 None -2 18 Human 8.8 pAC50 = 8.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
439260 2857 67 None -2 18 Human 8.8 pAC50 = 8.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
505 2857 67 None -2 18 Human 8.8 pAC50 = 8.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
CHEMBL1437 2857 67 None -2 18 Human 8.8 pAC50 = 8.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
DB00368 2857 67 None -2 18 Human 8.8 pAC50 = 8.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
129211 3749 78 None -1 14 Human 8.8 pAC50 = 8.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1038/s41467-023-40064-9
2562 3749 78 None -1 14 Human 8.8 pAC50 = 8.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1038/s41467-023-40064-9
488 3749 78 None -1 14 Human 8.8 pAC50 = 8.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1038/s41467-023-40064-9
CHEMBL836 3749 78 None -1 14 Human 8.8 pAC50 = 8.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1038/s41467-023-40064-9
DB00706 3749 78 None -1 14 Human 8.8 pAC50 = 8.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1038/s41467-023-40064-9
124 2981 47 None -8 24 Human 8.7 pAC50 = 8.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1038/s41467-023-40064-9
2032 2981 47 None -8 24 Human 8.7 pAC50 = 8.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1038/s41467-023-40064-9
4636 2981 47 None -8 24 Human 8.7 pAC50 = 8.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1038/s41467-023-40064-9
CHEMBL762 2981 47 None -8 24 Human 8.7 pAC50 = 8.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1038/s41467-023-40064-9
DB00935 2981 47 None -8 24 Human 8.7 pAC50 = 8.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1038/s41467-023-40064-9
16351 102730 47 None -17 17 Human 8.0 pAC50 = 8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 343 0 0 4 4.1 CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1038/s41467-023-40064-9
CHEMBL304902 102730 47 None -17 17 Human 8.0 pAC50 = 8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 343 0 0 4 4.1 CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1038/s41467-023-40064-9
9429 202133 58 None -5 18 Human 6.0 pAC50 = 6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 446 6 0 6 3.2 CN1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1 10.1038/s41467-023-40064-9
CHEMBL609109 202133 58 None -5 18 Human 6.0 pAC50 = 6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 446 6 0 6 3.2 CN1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1 10.1038/s41467-023-40064-9
3599 16879 88 None 1 3 Human 5.0 pAC50 = 5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 407 20 0 4 5.7 CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C 10.1038/s41467-023-40064-9
CHEMBL125 16879 88 None 1 3 Human 5.0 pAC50 = 5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 407 20 0 4 5.7 CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C 10.1038/s41467-023-40064-9
3062316 33575 121 None -1 10 Human 5.0 pAC50 = 5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 487 7 3 9 3.3 Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1 10.1038/s41467-023-40064-9
CHEMBL1421 33575 121 None -1 10 Human 5.0 pAC50 = 5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 487 7 3 9 3.3 Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1 10.1038/s41467-023-40064-9
54676537 152854 72 None - 1 Human 5.0 pAC50 = 5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 353 5 1 6 3.5 CC(=O)CC(c1ccc([N+](=O)[O-])cc1)c1c(O)c2ccccc2oc1=O 10.1038/s41467-023-40064-9
CHEMBL397420 152854 72 None - 1 Human 5.0 pAC50 = 5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 353 5 1 6 3.5 CC(=O)CC(c1ccc([N+](=O)[O-])cc1)c1c(O)c2ccccc2oc1=O 10.1038/s41467-023-40064-9
2162 41514 100 None -5 22 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1038/s41467-023-40064-9
CHEMBL1491 41514 100 None -5 22 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1038/s41467-023-40064-9
3783 14005 23 None -27 6 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 301 7 3 4 2.9 CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL1197051 14005 23 None -27 6 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 301 7 3 4 2.9 CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
6989215 1485 80 None - 1 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 213 3 5 5 -0.5 OC(=O)[C@H]([C@@H](c1ccc(c(c1)O)O)O)N 10.1038/s41467-023-40064-9
7391 1485 80 None - 1 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 213 3 5 5 -0.5 OC(=O)[C@H]([C@@H](c1ccc(c(c1)O)O)O)N 10.1038/s41467-023-40064-9
92974 1485 80 None - 1 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 213 3 5 5 -0.5 OC(=O)[C@H]([C@@H](c1ccc(c(c1)O)O)O)N 10.1038/s41467-023-40064-9
971 1485 80 None - 1 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 213 3 5 5 -0.5 OC(=O)[C@H]([C@@H](c1ccc(c(c1)O)O)O)N 10.1038/s41467-023-40064-9
CHEMBL2103827 1485 80 None - 1 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 213 3 5 5 -0.5 OC(=O)[C@H]([C@@H](c1ccc(c(c1)O)O)O)N 10.1038/s41467-023-40064-9
DB06262 1485 80 None - 1 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 213 3 5 5 -0.5 OC(=O)[C@H]([C@@H](c1ccc(c(c1)O)O)O)N 10.1038/s41467-023-40064-9
242 470 124 None -120 33 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
34 470 124 None -120 33 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
60795 470 124 None -120 33 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
CHEMBL1112 470 124 None -120 33 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
DB01238 470 124 None -120 33 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
2683 102888 25 None -812 24 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 10.1038/s41467-023-40064-9
CHEMBL305906 102888 25 None -812 24 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 10.1038/s41467-023-40064-9
CHEMBL334255 102888 25 None -812 24 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 10.1038/s41467-023-40064-9
31101 729 40 None -199 29 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
35 729 40 None -199 29 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
403 729 40 None -199 29 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
CHEMBL493 729 40 None -199 29 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
DB01200 729 40 None -199 29 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
9417 133512 54 None -33 15 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 363 6 1 4 3.3 OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 10.1038/s41467-023-40064-9
CHEMBL1524185 133512 54 None -33 15 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 363 6 1 4 3.3 OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 10.1038/s41467-023-40064-9
CHEMBL370753 133512 54 None -33 15 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 363 6 1 4 3.3 OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 10.1038/s41467-023-40064-9
22530 56130 58 None -3 9 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 2 0 2 3.7 CN1CCc2c(c3ccccc3n2Cc2ccccc2)C1 10.1038/s41467-023-40064-9
CHEMBL1600878 56130 58 None -3 9 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 2 0 2 3.7 CN1CCc2c(c3ccccc3n2Cc2ccccc2)C1 10.1038/s41467-023-40064-9
CHEMBL1625607 56130 58 None -3 9 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 2 0 2 3.7 CN1CCc2c(c3ccccc3n2Cc2ccccc2)C1 10.1038/s41467-023-40064-9
60860 205639 30 None -21 6 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 275 2 3 1 1.3 N=C(N)NCc1cccc(I)c1 10.1038/s41467-023-40064-9
CHEMBL1615777 205639 30 None -21 6 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 275 2 3 1 1.3 N=C(N)NCc1cccc(I)c1 10.1038/s41467-023-40064-9
CHEMBL818 205639 30 None -21 6 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 275 2 3 1 1.3 N=C(N)NCc1cccc(I)c1 10.1038/s41467-023-40064-9
5354 155656 21 None -51 10 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 337 12 2 3 5.6 CCCCCCCCNC(C)C(O)c1ccc(SC(C)C)cc1 10.1038/s41467-023-40064-9
CHEMBL404849 155656 21 None -51 10 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 337 12 2 3 5.6 CCCCCCCCNC(C)C(O)c1ccc(SC(C)C)cc1 10.1038/s41467-023-40064-9
2441 98625 24 None - 1 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 315 1 1 3 2.6 O=C1CN=C(c2ccccn2)c2cc(Br)ccc2N1 10.1038/s41467-023-40064-9
CHEMBL277062 98625 24 None - 1 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 315 1 1 3 2.6 O=C1CN=C(c2ccccn2)c2cc(Br)ccc2N1 10.1038/s41467-023-40064-9
104850 3330 96 None -1071 27 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
4150 3330 96 None -1071 27 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
743 3330 96 None -1071 27 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
CHEMBL111 3330 96 None -1071 27 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
DB06155 3330 96 None -1071 27 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
1056 3371 116 None -19 10 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 6 2.5 O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN(c1ccccn1)C 10.1038/s41467-023-40064-9
2405 3371 116 None -19 10 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 6 2.5 O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN(c1ccccn1)C 10.1038/s41467-023-40064-9
77999 3371 116 None -19 10 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 6 2.5 O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN(c1ccccn1)C 10.1038/s41467-023-40064-9
CHEMBL121 3371 116 None -19 10 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 6 2.5 O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN(c1ccccn1)C 10.1038/s41467-023-40064-9
DB00412 3371 116 None -19 10 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 6 2.5 O=C1NC(=O)C(S1)Cc1ccc(cc1)OCCN(c1ccccn1)C 10.1038/s41467-023-40064-9
4499 59775 99 None -6 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 388 6 1 7 3.2 COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-] 10.1038/s41467-023-40064-9
CHEMBL1726 59775 99 None -6 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 388 6 1 7 3.2 COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-] 10.1038/s41467-023-40064-9
103 4153 61 None 1 22 Human 8.0 pAC50 = 8.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
2875 4153 61 None 1 22 Human 8.0 pAC50 = 8.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
5736 4153 61 None 1 22 Human 8.0 pAC50 = 8.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
CHEMBL285802 4153 61 None 1 22 Human 8.0 pAC50 = 8.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
DB09225 4153 61 None 1 22 Human 8.0 pAC50 = 8.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
10184665 3991 51 None -645 10 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1038/s41467-023-40064-9
4799 3991 51 None -645 10 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1038/s41467-023-40064-9
7353 3991 51 None -645 10 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1038/s41467-023-40064-9
CHEMBL1198857 3991 51 None -645 10 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1038/s41467-023-40064-9
DB09082 3991 51 None -645 10 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 485 16 4 6 4.6 OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O 10.1038/s41467-023-40064-9
2267 559 71 None -45 14 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
271 559 71 None -45 14 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
7121 559 71 None -45 14 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
CHEMBL639 559 71 None -45 14 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
DB00972 559 71 None -45 14 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
2274 3173 58 None -24 36 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
4917 3173 58 None -24 36 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
7279 3173 58 None -24 36 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
CHEMBL728 3173 58 None -24 36 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
DB00433 3173 58 None -24 36 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
2601 3780 33 None -354 17 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
443951 3780 33 None -354 17 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
56 3780 33 None -354 17 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
CHEMBL73151 3780 33 None -354 17 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
DB13399 3780 33 None -354 17 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
11626560 200937 94 None -1 14 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 449 5 2 6 5.0 C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl 10.1038/s41467-023-40064-9
CHEMBL601719 200937 94 None -1 14 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 449 5 2 6 5.0 C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl 10.1038/s41467-023-40064-9
10071196 3124 79 None -831 9 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.1038/s41467-023-40064-9
5142 3124 79 None -831 9 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.1038/s41467-023-40064-9
8423 3124 79 None -831 9 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.1038/s41467-023-40064-9
CHEMBL2111101 3124 79 None -831 9 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.1038/s41467-023-40064-9
DB05316 3124 79 None -831 9 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.1038/s41467-023-40064-9
3675 7734 68 None -91 4 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 136 3 2 2 0.7 NNCCc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1089 7734 68 None -91 4 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 136 3 2 2 0.7 NNCCc1ccccc1 10.1038/s41467-023-40064-9
135409453 3773 41 None -363 35 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
226 3773 41 None -363 35 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
CHEMBL76370 3773 41 None -363 35 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
2470 3653 50 None -13803 23 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
3300 3653 50 None -13803 23 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
5265 3653 50 None -13803 23 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
99 3653 50 None -13803 23 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL267930 3653 50 None -13803 23 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
180 401 56 None -63 38 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
200 401 56 None -63 38 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
2160 401 56 None -63 38 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL629 401 56 None -63 38 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00321 401 56 None -63 38 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
4822 45032 47 None -16 10 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 293 0 0 2 4.7 CN1CCC(=C2c3ccccc3Sc3ccccc32)CC1 10.1038/s41467-023-40064-9
CHEMBL152408 45032 47 None -16 10 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 293 0 0 2 4.7 CN1CCC(=C2c3ccccc3Sc3ccccc32)CC1 10.1038/s41467-023-40064-9
16351 102730 47 None -17 17 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 343 0 0 4 4.1 CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1038/s41467-023-40064-9
CHEMBL304902 102730 47 None -17 17 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 343 0 0 4 4.1 CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1038/s41467-023-40064-9
37264 189422 24 None 8 3 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 435 6 2 10 1.3 COc1cc2c(N)nc(N3CCN(C(=O)OCC(C)(C)O)CC3)nc2c(OC)c1OC 10.1038/s41467-023-40064-9
CHEMBL513301 189422 24 None 8 3 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 435 6 2 10 1.3 COc1cc2c(N)nc(N3CCN(C(=O)OCC(C)(C)O)CC3)nc2c(OC)c1OC 10.1038/s41467-023-40064-9
643976 14518 30 None -2 3 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 456 7 6 10 -1.6 Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O)c2cc1C 10.1038/s41467-023-40064-9
CHEMBL1201794 14518 30 None -2 3 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 456 7 6 10 -1.6 Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O)c2cc1C 10.1038/s41467-023-40064-9
72093 35061 9 None -10 28 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 483 16 1 4 6.3 CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1 10.1038/s41467-023-40064-9
CHEMBL1433361 35061 9 None -10 28 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 483 16 1 4 6.3 CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1 10.1038/s41467-023-40064-9
CHEMBL2103773 35061 9 None -10 28 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 483 16 1 4 6.3 CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1 10.1038/s41467-023-40064-9
65016 10209 86 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 505 11 3 7 2.4 CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1 10.1038/s41467-023-40064-9
CHEMBL116 10209 86 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 505 11 3 7 2.4 CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1 10.1038/s41467-023-40064-9
22323 15299 32 None -3 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 2 5 2 2.9 CC(C)NC(=N)NC(=N)Nc1ccc(Cl)c(Cl)c1 10.1038/s41467-023-40064-9
9571037 15299 32 None -3 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 2 5 2 2.9 CC(C)NC(=N)NC(=N)Nc1ccc(Cl)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1213553 15299 32 None -3 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 2 5 2 2.9 CC(C)NC(=N)NC(=N)Nc1ccc(Cl)c(Cl)c1 10.1038/s41467-023-40064-9
47319 26464 35 None -4 6 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 929 24 0 12 8.1 COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC 10.1038/s41467-023-40064-9
CHEMBL1360 26464 35 None -4 6 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 929 24 0 12 8.1 COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC 10.1038/s41467-023-40064-9
3191 102858 97 None -660 33 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 10.1038/s41467-023-40064-9
CHEMBL305660 102858 97 None -660 33 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 10.1038/s41467-023-40064-9
2372 106468 40 None -144 6 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 345 10 2 5 2.6 COc1ccc(CCNCC(O)COc2cccc(C)c2)cc1OC 10.1038/s41467-023-40064-9
CHEMBL314010 106468 40 None -144 6 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 345 10 2 5 2.6 COc1ccc(CCNCC(O)COc2cccc(C)c2)cc1OC 10.1038/s41467-023-40064-9
216416 111581 48 None -141 23 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 413 6 1 3 5.7 Oc1ccc2c(c1)CC[C@H](c1ccccc1)[C@@H]2c1ccc(OCCN2CCCC2)cc1 10.1038/s41467-023-40064-9
CHEMBL328190 111581 48 None -141 23 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 413 6 1 3 5.7 Oc1ccc2c(c1)CC[C@H](c1ccccc1)[C@@H]2c1ccc(OCCN2CCCC2)cc1 10.1038/s41467-023-40064-9
23480 124090 23 None -15 7 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 5 1 1 5.0 CC(CC(c1ccccc1)c1ccccc1)NC(C)(C)C 10.1038/s41467-023-40064-9
CHEMBL363295 124090 23 None -15 7 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 5 1 1 5.0 CC(CC(c1ccccc1)c1ccccc1)NC(C)(C)C 10.1038/s41467-023-40064-9
135412795 44751 23 None -7 4 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 296 1 1 3 3.4 O=C1CN=C(c2ccccc2)c2c(sc3c2CCCC3)N1 10.1038/s41467-023-40064-9
CHEMBL1521495 44751 23 None -7 4 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 296 1 1 3 3.4 O=C1CN=C(c2ccccc2)c2c(sc3c2CCCC3)N1 10.1038/s41467-023-40064-9
2805 161890 38 None -3 9 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 329 6 0 2 4.9 Clc1ccc(C(OCCN2CCCCC2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL415087 161890 38 None -3 9 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 329 6 0 2 4.9 Clc1ccc(C(OCCN2CCCCC2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
3053 205134 95 None 1 7 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 393 16 5 8 -2.7 O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O 10.1038/s41467-023-40064-9
CHEMBL780 205134 95 None 1 7 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 393 16 5 8 -2.7 O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O 10.1038/s41467-023-40064-9
1024 1571 27 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 165 3 2 2 1.3 CN[C@H]([C@@H](c1ccccc1)O)C 10.1038/s41467-023-40064-9
556 1571 27 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 165 3 2 2 1.3 CN[C@H]([C@@H](c1ccccc1)O)C 10.1038/s41467-023-40064-9
9294 1571 27 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 165 3 2 2 1.3 CN[C@H]([C@@H](c1ccccc1)O)C 10.1038/s41467-023-40064-9
CHEMBL211456 1571 27 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 165 3 2 2 1.3 CN[C@H]([C@@H](c1ccccc1)O)C 10.1038/s41467-023-40064-9
DB01364 1571 27 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 165 3 2 2 1.3 CN[C@H]([C@@H](c1ccccc1)O)C 10.1038/s41467-023-40064-9
119570 3159 96 None -10000 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N 10.1038/s41467-023-40064-9
2233 3159 96 None -10000 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N 10.1038/s41467-023-40064-9
953 3159 96 None -10000 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N 10.1038/s41467-023-40064-9
CHEMBL301265 3159 96 None -10000 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N 10.1038/s41467-023-40064-9
DB00413 3159 96 None -10000 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 211 3 2 4 1.6 CCCN[C@H]1CCc2c(C1)sc(n2)N 10.1038/s41467-023-40064-9
2782 32000 67 None -3801 8 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 4 0 3 4.3 Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc32)cc1 10.1038/s41467-023-40064-9
CHEMBL1407943 32000 67 None -3801 8 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 4 0 3 4.3 Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc32)cc1 10.1038/s41467-023-40064-9
CHEMBL3216363 32000 67 None -3801 8 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 4 0 3 4.3 Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc32)cc1 10.1038/s41467-023-40064-9
4528 98126 80 None -5 4 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 238 1 1 2 2.8 CN1Cc2c(N)cccc2C(c2ccccc2)C1 10.1038/s41467-023-40064-9
CHEMBL273575 98126 80 None -5 4 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 238 1 1 2 2.8 CN1Cc2c(N)cccc2C(c2ccccc2)C1 10.1038/s41467-023-40064-9
5311017 120604 11 None -13 5 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 239 5 0 1 3.8 C[C@@H](Cc1ccccc1)N(C)Cc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL3545985 120604 11 None -13 5 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 239 5 0 1 3.8 C[C@@H](Cc1ccccc1)N(C)Cc1ccccc1 10.1038/s41467-023-40064-9
26248 161539 102 None -1 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 368 3 1 7 2.0 CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O 10.1038/s41467-023-40064-9
CHEMBL41286 161539 102 None -1 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 368 3 1 7 2.0 CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O 10.1038/s41467-023-40064-9
CHEMBL1630575 56343 0 None -2 6 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 1093 23 16 18 -3.3 CC[C@H](C)C[C@H](C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@H]([C@H](O)CCN)NC(=O)[C@H]([C@H](O)[C@@H](O)c2ccc(O)cc2)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H]([C@@H](C)O)NC1=O 10.1038/s41467-023-40064-9
443869 78141 45 None 1 10 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 491 7 1 8 3.8 COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@H]2CCN(Cc3ccccc3)C2)[C@H]1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
CHEMBL2103761 78141 45 None 1 10 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 491 7 1 8 3.8 COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@H]2CCN(Cc3ccccc3)C2)[C@H]1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
68555 103112 21 None -3 7 Human 6.9 pAC50 = 6.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 307 7 1 5 2.6 CNCCc1ccc(OC(=O)C(C)C)c(OC(=O)C(C)C)c1 10.1038/s41467-023-40064-9
CHEMBL307739 103112 21 None -3 7 Human 6.9 pAC50 = 6.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 307 7 1 5 2.6 CNCCc1ccc(OC(=O)C(C)C)c(OC(=O)C(C)C)c1 10.1038/s41467-023-40064-9
15942715 78193 19 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 446 5 1 5 4.0 CCCCOC(=O)C(=O)[C@H]1[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C 10.1038/s41467-023-40064-9
CHEMBL2105087 78193 19 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 446 5 1 5 4.0 CCCCOC(=O)C(=O)[C@H]1[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C 10.1038/s41467-023-40064-9
6918178 14445 44 None 1 3 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 484 4 1 5 4.1 CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C 10.1038/s41467-023-40064-9
CHEMBL1200908 14445 44 None 1 3 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 484 4 1 5 4.1 CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C 10.1038/s41467-023-40064-9
667492 43905 43 None 1 4 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 234 1 2 3 0.2 CN1C(=O)/C(=N\NC(N)=S)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1512080 43905 43 None 1 4 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 234 1 2 3 0.2 CN1C(=O)/C(=N\NC(N)=S)c2ccccc21 10.1038/s41467-023-40064-9
3652 4097 79 None -2089 15 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 281 7 0 5 3.2 CCCCCCOc1nsnc1C1=CCCN(C1)C 10.1038/s41467-023-40064-9
57 4097 79 None -2089 15 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 281 7 0 5 3.2 CCCCCCOc1nsnc1C1=CCCN(C1)C 10.1038/s41467-023-40064-9
60809 4097 79 None -2089 15 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 281 7 0 5 3.2 CCCCCCOc1nsnc1C1=CCCN(C1)C 10.1038/s41467-023-40064-9
CHEMBL21536 4097 79 None -2089 15 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 281 7 0 5 3.2 CCCCCCOc1nsnc1C1=CCCN(C1)C 10.1038/s41467-023-40064-9
DB15357 4097 79 None -2089 15 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 281 7 0 5 3.2 CCCCCCOc1nsnc1C1=CCCN(C1)C 10.1038/s41467-023-40064-9
213046 2385 59 None -6 17 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
4168 2385 59 None -6 17 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
7461 2385 59 None -6 17 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
CHEMBL1237021 2385 59 None -6 17 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
DB08815 2385 59 None -6 17 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
3351 95002 52 None -2 6 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 388 5 0 5 2.8 O=C(COc1ccc(Cl)cc1)N1CCN(Cc2ccc3c(c2)OCO3)CC1 10.1038/s41467-023-40064-9
CHEMBL254857 95002 52 None -2 6 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 388 5 0 5 2.8 O=C(COc1ccc(Cl)cc1)N1CCN(Cc2ccc3c(c2)OCO3)CC1 10.1038/s41467-023-40064-9
6917906 67773 21 None -6 5 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 887 35 10 12 1.7 CCCCCCCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O)C(N)=O)C(=O)O 10.1038/s41467-023-40064-9
CHEMBL1908331 67773 21 None -6 5 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 887 35 10 12 1.7 CCCCCCCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O)C(N)=O)C(=O)O 10.1038/s41467-023-40064-9
98941 46950 17 None -66 11 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 457 7 0 4 6.3 COc1ccc2c(c1)OC(C)(C)C(c1ccccc1)C2c1ccc(OCCN2CCCC2)cc1 10.1038/s41467-023-40064-9
CHEMBL154126 46950 17 None -66 11 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 457 7 0 4 6.3 COc1ccc2c(c1)OC(C)(C)C(c1ccccc1)C2c1ccc(OCCN2CCCC2)cc1 10.1038/s41467-023-40064-9
CHEMBL4743867 214033 14 None -4466 15 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL None None None OCCN1CCN(CCC=C2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1 10.1038/s41467-023-40064-9
3474 38101 57 None -4 8 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 372 6 3 6 3.1 O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12 10.1038/s41467-023-40064-9
CHEMBL146095 38101 57 None -4 8 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 372 6 3 6 3.1 O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12 10.1038/s41467-023-40064-9
49843517 78294 41 None -40 8 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 590 13 2 6 8.5 CCCCCCO[C@@H](C)c1cccc(-c2csc(NC(=O)c3cc(Cl)c(/C=C(\C)C(=O)O)c(Cl)c3)n2)c1OC 10.1038/s41467-023-40064-9
CHEMBL2107831 78294 41 None -40 8 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 590 13 2 6 8.5 CCCCCCO[C@@H](C)c1cccc(-c2csc(NC(=O)c3cc(Cl)c(/C=C(\C)C(=O)O)c(Cl)c3)n2)c1OC 10.1038/s41467-023-40064-9
3103 41658 49 None -138 9 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 0 2 3.9 CN1CCC(OC(c2ccccc2)c2ccccc2)CC1 10.1038/s41467-023-40064-9
CHEMBL1492 41658 49 None -138 9 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 0 2 3.9 CN1CCC(OC(c2ccccc2)c2ccccc2)CC1 10.1038/s41467-023-40064-9
16222096 80483 67 None -50 7 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 531 4 3 4 3.8 O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1 10.1038/s41467-023-40064-9
CHEMBL2146883 80483 67 None -50 7 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 531 4 3 4 3.8 O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1 10.1038/s41467-023-40064-9
2580 78395 18 None -660 10 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 446 6 1 4 4.1 NC(=O)C1(N2CCCCC2)CCN(CCCN2c3ccccc3CCc3ccccc32)CC1 10.1038/s41467-023-40064-9
CHEMBL2110775 78395 18 None -660 10 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 446 6 1 4 4.1 NC(=O)C1(N2CCCCC2)CCN(CCCN2c3ccccc3CCc3ccccc32)CC1 10.1038/s41467-023-40064-9
448537 160250 89 None -54 31 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL411 160250 89 None -54 31 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 10.1038/s41467-023-40064-9
16362 3125 71 None -14 35 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
2172 3125 71 None -14 35 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
90 3125 71 None -14 35 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL1423 3125 71 None -14 35 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
DB01100 3125 71 None -14 35 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
3634 84108 51 None 1 9 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 356 7 2 5 3.7 CCN(CC)CCNc1ccc(CO)c2sc3ccccc3c(=O)c12 10.1038/s41467-023-40064-9
CHEMBL22077 84108 51 None 1 9 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 356 7 2 5 3.7 CCN(CC)CCNc1ccc(CO)c2sc3ccccc3c(=O)c12 10.1038/s41467-023-40064-9
3478 5426 103 None -758 4 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 445 7 3 6 2.1 Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1 10.1038/s41467-023-40064-9
CHEMBL1073 5426 103 None -758 4 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 445 7 3 6 2.1 Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1 10.1038/s41467-023-40064-9
72287 61061 38 None 1 9 Human 7.9 pAC50 = 7.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 328 5 0 4 4.5 COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL1764 61061 38 None 1 9 Human 7.9 pAC50 = 7.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 328 5 0 4 4.5 COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2 10.1038/s41467-023-40064-9
19675 51670 43 None -12 15 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 7 1 5 5.0 CC(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL1584 51670 43 None -12 15 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 7 1 5 5.0 CC(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
2284 3182 33 None -3 34 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
4926 3182 33 None -3 34 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
7281 3182 33 None -3 34 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL564 3182 33 None -3 34 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00420 3182 33 None -3 34 Human 6.9 pAC50 = 6.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
2398 954 62 None -72 36 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
2801 954 62 None -72 36 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
701 954 62 None -72 36 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
CHEMBL415 954 62 None -72 36 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
DB01242 954 62 None -72 36 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
55483 205097 40 None -8 11 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 356 13 4 4 3.6 Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O 10.1038/s41467-023-40064-9
CHEMBL77622 205097 40 None -8 11 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 356 13 4 4 3.6 Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O 10.1038/s41467-023-40064-9
2869 4152 89 None -5011 5 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 287 5 2 3 1.9 CN(CCc1c[nH]c2c1cc(C[C@H]1COC(=O)N1)cc2)C 10.1038/s41467-023-40064-9
60 4152 89 None -5011 5 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 287 5 2 3 1.9 CN(CCc1c[nH]c2c1cc(C[C@H]1COC(=O)N1)cc2)C 10.1038/s41467-023-40064-9
60857 4152 89 None -5011 5 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 287 5 2 3 1.9 CN(CCc1c[nH]c2c1cc(C[C@H]1COC(=O)N1)cc2)C 10.1038/s41467-023-40064-9
CHEMBL1185 4152 89 None -5011 5 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 287 5 2 3 1.9 CN(CCc1c[nH]c2c1cc(C[C@H]1COC(=O)N1)cc2)C 10.1038/s41467-023-40064-9
DB00315 4152 89 None -5011 5 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 287 5 2 3 1.9 CN(CCc1c[nH]c2c1cc(C[C@H]1COC(=O)N1)cc2)C 10.1038/s41467-023-40064-9
4762 14469 27 None 1 2 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 177 1 1 2 1.7 CC1NCCOC1c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1201208 14469 27 None 1 2 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 177 1 1 2 1.7 CC1NCCOC1c1ccccc1 10.1038/s41467-023-40064-9
5556 203260 27 None -33 5 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 342 1 0 4 4.2 Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2 10.1038/s41467-023-40064-9
CHEMBL646 203260 27 None -33 5 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 342 1 0 4 4.2 Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2 10.1038/s41467-023-40064-9
2218 15283 23 None -5 12 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 322 8 0 2 4.4 CCN(CC)CCCN(c1ccccc1)C1Cc2ccccc2C1 10.1038/s41467-023-40064-9
CHEMBL1213033 15283 23 None -5 12 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 322 8 0 2 4.4 CCN(CC)CCCN(c1ccccc1)C1Cc2ccccc2C1 10.1038/s41467-023-40064-9
2780 110529 36 None -1479 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 373 5 2 4 3.3 COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1 10.1038/s41467-023-40064-9
CHEMBL325109 110529 36 None -1479 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 373 5 2 4 3.3 COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1 10.1038/s41467-023-40064-9
9417 133512 54 None -33 15 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 363 6 1 4 3.3 OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 10.1038/s41467-023-40064-9
CHEMBL1524185 133512 54 None -33 15 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 363 6 1 4 3.3 OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 10.1038/s41467-023-40064-9
CHEMBL370753 133512 54 None -33 15 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 363 6 1 4 3.3 OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 10.1038/s41467-023-40064-9
5365247 138429 33 None -100 10 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 316 4 0 2 3.8 CN(C)C/C=C(/c1ccc(Br)cc1)c1cccnc1 10.1038/s41467-023-40064-9
CHEMBL37744 138429 33 None -100 10 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 316 4 0 2 3.8 CN(C)C/C=C(/c1ccc(Br)cc1)c1cccnc1 10.1038/s41467-023-40064-9
2318 154856 29 None -20 15 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 351 7 1 3 4.1 CC(Cc1cccc(C(F)(F)F)c1)NCCOC(=O)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL400599 154856 29 None -20 15 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 351 7 1 3 4.1 CC(Cc1cccc(C(F)(F)F)c1)NCCOC(=O)c1ccccc1 10.1038/s41467-023-40064-9
2771 195017 74 None -46 16 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
CHEMBL1200781 195017 74 None -46 16 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
CHEMBL549 195017 74 None -46 16 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
3950 189508 109 None -4 2 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 233 4 1 3 2.3 O=NN(CCCl)C(=O)NC1CCCCC1 10.1038/s41467-023-40064-9
CHEMBL514 189508 109 None -4 2 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 233 4 1 3 2.3 O=NN(CCCl)C(=O)NC1CCCCC1 10.1038/s41467-023-40064-9
37 778 60 None -141 12 Human 6.9 pAC50 = 6.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
460 778 60 None -141 12 Human 6.9 pAC50 = 6.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
54746 778 60 None -141 12 Human 6.9 pAC50 = 6.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
CHEMBL1201087 778 60 None -141 12 Human 6.9 pAC50 = 6.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
DB00248 778 60 None -141 12 Human 6.9 pAC50 = 6.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
1599 2341 50 None -7585 21 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
3955 2341 50 None -7585 21 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
7215 2341 50 None -7585 21 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL841 2341 50 None -7585 21 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
DB00836 2341 50 None -7585 21 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
2723 154046 108 None -7 4 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 156 0 1 1 2.7 Cc1cc(O)cc(C)c1Cl 10.1038/s41467-023-40064-9
CHEMBL398440 154046 108 None -7 4 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 156 0 1 1 2.7 Cc1cc(O)cc(C)c1Cl 10.1038/s41467-023-40064-9
135398737 958 93 None -17 43 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
38 958 93 None -17 43 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
722 958 93 None -17 43 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL42 958 93 None -17 43 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
DB00363 958 93 None -17 43 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
5351322 94791 38 None 1 9 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 398 4 4 8 1.8 C(=N/NC1=NCCN1)\c1c2ccccc2c(/C=N/NC2=NCCN2)c2ccccc12 10.1038/s41467-023-40064-9
CHEMBL25336 94791 38 None 1 9 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 398 4 4 8 1.8 C(=N/NC1=NCCN1)\c1c2ccccc2c(/C=N/NC2=NCCN2)c2ccccc12 10.1038/s41467-023-40064-9
3117 207841 103 None -20 24 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC 10.1038/s41467-023-40064-9
CHEMBL964 207841 103 None -20 24 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC 10.1038/s41467-023-40064-9
9818306 14419 15 None -2 5 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 1 1 3 3.8 CC(=O)Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12 10.1038/s41467-023-40064-9
CHEMBL1200430 14419 15 None -2 5 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 1 1 3 3.8 CC(=O)Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12 10.1038/s41467-023-40064-9
2398 954 62 None -72 36 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
2801 954 62 None -72 36 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
701 954 62 None -72 36 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
CHEMBL415 954 62 None -72 36 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
DB01242 954 62 None -72 36 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
2337 3256 77 None -4 29 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
50 3256 77 None -4 29 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
5002 3256 77 None -4 29 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL716 3256 77 None -4 29 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
DB01224 3256 77 None -4 29 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
1530 2182 50 None -912 25 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
3827 2182 50 None -912 25 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
7206 2182 50 None -912 25 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
CHEMBL534 2182 50 None -912 25 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
DB00920 2182 50 None -912 25 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
243 3202 91 None -1288 5 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N 10.1038/s41467-023-40064-9
3052762 3202 91 None -1288 5 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N 10.1038/s41467-023-40064-9
3502 3202 91 None -1288 5 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N 10.1038/s41467-023-40064-9
CHEMBL117287 3202 91 None -1288 5 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N 10.1038/s41467-023-40064-9
DB06480 3202 91 None -1288 5 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N 10.1038/s41467-023-40064-9
2351 4300 49 None -3 22 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 366 10 0 3 4.8 CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1 10.1038/s41467-023-40064-9
CHEMBL1008 4300 49 None -3 22 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 366 10 0 3 4.8 CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1 10.1038/s41467-023-40064-9
CHEMBL1257078 4300 49 None -3 22 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 366 10 0 3 4.8 CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1 10.1038/s41467-023-40064-9
21772 78399 31 None -1000 10 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 293 4 0 1 4.5 CC(CC1c2ccccc2CCc2ccccc21)CN(C)C 10.1038/s41467-023-40064-9
CHEMBL2110816 78399 31 None -1000 10 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 293 4 0 1 4.5 CC(CC1c2ccccc2CCc2ccccc21)CN(C)C 10.1038/s41467-023-40064-9
4413 98073 57 None -4 15 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 347 4 5 4 2.6 N=C(N)Nc1ccc(C(=O)Oc2ccc3cc(C(=N)N)ccc3c2)cc1 10.1038/s41467-023-40064-9
CHEMBL273264 98073 57 None -4 15 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 347 4 5 4 2.6 N=C(N)Nc1ccc(C(=O)Oc2ccc3cc(C(=N)N)ccc3c2)cc1 10.1038/s41467-023-40064-9
60151560 167442 39 None -1 5 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 439 11 1 5 5.3 CCO[C@@H](Cc1ccc(OCCn2c(C)ccc2-c2ccc(SC)cc2)cc1)C(=O)O 10.1038/s41467-023-40064-9
CHEMBL4297530 167442 39 None -1 5 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 439 11 1 5 5.3 CCO[C@@H](Cc1ccc(OCCn2c(C)ccc2-c2ccc(SC)cc2)cc1)C(=O)O 10.1038/s41467-023-40064-9
216239 23795 118 None -8 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 464 5 3 4 5.6 CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1 10.1038/s41467-023-40064-9
CHEMBL1200485 23795 118 None -8 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 464 5 3 4 5.6 CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1 10.1038/s41467-023-40064-9
CHEMBL1336 23795 118 None -8 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 464 5 3 4 5.6 CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1 10.1038/s41467-023-40064-9
1830 2590 44 None -416 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
207 2590 44 None -416 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
23897 2590 44 None -416 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
CHEMBL460 2590 44 None -416 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
DB01618 2590 44 None -416 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
196122 112588 55 None -1 4 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 478 13 1 6 4.5 CCOC1O[C@H]([C@@H](COCc2ccccc2)OCc2ccccc2)[C@H](OCc2ccccc2)[C@H]1O 10.1038/s41467-023-40064-9
CHEMBL3301681 112588 55 None -1 4 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 478 13 1 6 4.5 CCOC1O[C@H]([C@@H](COCc2ccccc2)OCc2ccccc2)[C@H](OCc2ccccc2)[C@H]1O 10.1038/s41467-023-40064-9
392622 56312 95 None -8 20 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 720 17 4 9 5.9 CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1 10.1038/s41467-023-40064-9
CHEMBL163 56312 95 None -8 20 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 720 17 4 9 5.9 CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1 10.1038/s41467-023-40064-9
1570 57299 97 None 2 3 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 127 0 1 3 1.5 On1ccccc1=S 10.1038/s41467-023-40064-9
CHEMBL1650619 57299 97 None 2 3 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 127 0 1 3 1.5 On1ccccc1=S 10.1038/s41467-023-40064-9
1548955 88581 20 None -43 11 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 405 9 0 2 6.6 CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
2800 88581 20 None -43 11 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 405 9 0 2 6.6 CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL2355051 88581 20 None -43 11 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 405 9 0 2 6.6 CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
1155 1629 53 None -257 11 Human 5.8 pAC50 = 5.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
3343 1629 53 None -257 11 Human 5.8 pAC50 = 5.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
557 1629 53 None -257 11 Human 5.8 pAC50 = 5.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL32800 1629 53 None -257 11 Human 5.8 pAC50 = 5.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
DB01288 1629 53 None -257 11 Human 5.8 pAC50 = 5.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
9270 14430 66 None -5 3 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 384 2 0 4 4.4 C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C[C@@H](OC(C)=O)CC[C@@H]4[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
CHEMBL1200624 14430 66 None -5 3 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 384 2 0 4 4.4 C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C[C@@H](OC(C)=O)CC[C@@H]4[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
3158 56267 27 None -125 28 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1628227 56267 27 None -125 28 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1038/s41467-023-40064-9
60663 175669 42 None -8 12 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
CHEMBL1421212 175669 42 None -8 12 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
CHEMBL1534525 175669 42 None -8 12 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
CHEMBL45816 175669 42 None -8 12 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
5994 4641 88 None -5 10 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 1 0 2 4.7 CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C 10.1038/s41467-023-40064-9
CHEMBL103 4641 88 None -5 10 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 1 0 2 4.7 CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C 10.1038/s41467-023-40064-9
4034 55822 55 None -12 18 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 5 0 2 5.6 Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1 10.1038/s41467-023-40064-9
CHEMBL1623 55822 55 None -12 18 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 5 0 2 5.6 Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1 10.1038/s41467-023-40064-9
441383 20333 57 None -165 19 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 10.1038/s41467-023-40064-9
CHEMBL1306 20333 57 None -165 19 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 10.1038/s41467-023-40064-9
2470 3653 50 None -13803 23 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
3300 3653 50 None -13803 23 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
5265 3653 50 None -13803 23 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
99 3653 50 None -13803 23 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL267930 3653 50 None -13803 23 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
5440 28724 37 None -1995 16 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 399 6 0 5 5.0 CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL1378 28724 37 None -1995 16 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 399 6 0 5 5.0 CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
3926 207241 40 None -2 18 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 491 9 1 3 5.8 Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1038/s41467-023-40064-9
CHEMBL92870 207241 40 None -2 18 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 491 9 1 3 5.8 Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1038/s41467-023-40064-9
31703 194717 63 None -25 8 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 543 5 6 12 0.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
CHEMBL359744 194717 63 None -25 8 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 543 5 6 12 0.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
CHEMBL53463 194717 63 None -25 8 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 543 5 6 12 0.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
24826799 10798 104 None -50 20 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 532 4 1 6 4.5 Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12 10.1038/s41467-023-40064-9
CHEMBL1171837 10798 104 None -50 20 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 532 4 1 6 4.5 Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12 10.1038/s41467-023-40064-9
2162 41514 100 None -5 22 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1038/s41467-023-40064-9
CHEMBL1491 41514 100 None -5 22 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1038/s41467-023-40064-9
5584 203211 44 None -9 9 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 294 4 0 2 4.1 CC(CN(C)C)CN1c2ccccc2CCc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL644 203211 44 None -9 9 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 294 4 0 2 4.1 CC(CN(C)C)CN1c2ccccc2CCc2ccccc21 10.1038/s41467-023-40064-9
4735 195115 96 None -199 14 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL361506 195115 96 None -199 14 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL55 195115 96 None -199 14 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL508338 188966 0 None -181 15 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL None None None None 10.1038/s41467-023-40064-9
1712 2492 43 None 1 8 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 4 0 4 4.9 CN1CCCCC1CCN1c2ccccc2Sc2c1cc(cc2)S(=O)C 10.1038/s41467-023-40064-9
4078 2492 43 None 1 8 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 4 0 4 4.9 CN1CCCCC1CCN1c2ccccc2Sc2c1cc(cc2)S(=O)C 10.1038/s41467-023-40064-9
7227 2492 43 None 1 8 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 4 0 4 4.9 CN1CCCCC1CCN1c2ccccc2Sc2c1cc(cc2)S(=O)C 10.1038/s41467-023-40064-9
CHEMBL1088 2492 43 None 1 8 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 4 0 4 4.9 CN1CCCCC1CCN1c2ccccc2Sc2c1cc(cc2)S(=O)C 10.1038/s41467-023-40064-9
DB00933 2492 43 None 1 8 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 4 0 4 4.9 CN1CCCCC1CCN1c2ccccc2Sc2c1cc(cc2)S(=O)C 10.1038/s41467-023-40064-9
2865 4143 73 None -23 20 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
59 4143 73 None -23 20 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
60854 4143 73 None -23 20 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL708 4143 73 None -23 20 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
DB00246 4143 73 None -23 20 Human 7.8 pAC50 = 7.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
10531 1420 21 None -301 25 Human 5.8 pAC50 = 5.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
121 1420 21 None -301 25 Human 5.8 pAC50 = 5.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
888 1420 21 None -301 25 Human 5.8 pAC50 = 5.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
CHEMBL1732 1420 21 None -301 25 Human 5.8 pAC50 = 5.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
DB00320 1420 21 None -301 25 Human 5.8 pAC50 = 5.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
2286 3183 51 None -37 28 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
4927 3183 51 None -37 28 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
7282 3183 51 None -37 28 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
CHEMBL643 3183 51 None -37 28 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
DB01069 3183 51 None -37 28 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
56959 31556 103 None -3 9 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 9 2 6 2.3 COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1 10.1038/s41467-023-40064-9
CHEMBL1404 31556 103 None -3 9 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 9 2 6 2.3 COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1 10.1038/s41467-023-40064-9
CHEMBL1526084 31556 103 None -3 9 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 9 2 6 2.3 COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1 10.1038/s41467-023-40064-9
213 3853 55 None -18 22 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
2717 3853 55 None -18 22 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
5533 3853 55 None -18 22 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
CHEMBL621 3853 55 None -18 22 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
DB00656 3853 55 None -18 22 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
6231 29770 33 None -6 4 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 0 1 2 3.6 C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
CHEMBL1387 29770 33 None -6 4 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 0 1 2 3.6 C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
2247 505 81 None -26 42 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
249 505 81 None -26 42 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
2603 505 81 None -26 42 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
CHEMBL296419 505 81 None -26 42 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
DB00637 505 81 None -26 42 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
10180 98869 47 None -33 11 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 340 6 1 4 4.5 CCN(CC)CCNc1ccc(C)c2sc3ccccc3c(=O)c12 10.1038/s41467-023-40064-9
CHEMBL279014 98869 47 None -33 11 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 340 6 1 4 4.5 CCN(CC)CCNc1ccc(C)c2sc3ccccc3c(=O)c12 10.1038/s41467-023-40064-9
9324 9238 60 None -3 6 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 2 0 4 4.8 CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
CHEMBL110691 9238 60 None -3 6 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 2 0 4 4.8 CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
1662 188705 80 None -1 3 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 162 4 3 3 -0.3 CC(O)(CC(=O)O)CC(=O)O 10.1038/s41467-023-40064-9
CHEMBL50444 188705 80 None -1 3 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 162 4 3 3 -0.3 CC(O)(CC(=O)O)CC(=O)O 10.1038/s41467-023-40064-9
25151352 140606 67 None -4 11 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 417 5 2 4 5.2 FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1 10.1038/s41467-023-40064-9
CHEMBL3813873 140606 67 None -4 11 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 417 5 2 4 5.2 FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1 10.1038/s41467-023-40064-9
4046 2483 33 None -35 17 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
4252 2483 33 None -35 17 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
CHEMBL416956 2483 33 None -35 17 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
DB00358 2483 33 None -35 17 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
54454 5258 88 None -7 14 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 418 6 1 5 4.6 CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21 10.1038/s41467-023-40064-9
CHEMBL1064 5258 88 None -7 14 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 418 6 1 5 4.6 CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21 10.1038/s41467-023-40064-9
9822750 78409 65 None -4 8 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)[C@@H]1c1ccccc1Cl 10.1038/s41467-023-40064-9
CHEMBL2111097 78409 65 None -4 8 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)[C@@H]1c1ccccc1Cl 10.1038/s41467-023-40064-9
119369 2606 74 None -602 7 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 10.1038/s41467-023-40064-9
2197 2606 74 None -602 7 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 10.1038/s41467-023-40064-9
4004 2606 74 None -602 7 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 10.1038/s41467-023-40064-9
CHEMBL420762 2606 74 None -602 7 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 4 1 3 5.3 O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C 10.1038/s41467-023-40064-9
2005 78230 91 None - 1 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 173 6 2 2 0.8 CC(=O)NCCCCCC(=O)O 10.1038/s41467-023-40064-9
CHEMBL2105922 78230 91 None - 1 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 173 6 2 2 0.8 CC(=O)NCCCCCC(=O)O 10.1038/s41467-023-40064-9
2162 41514 100 None -5 22 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1038/s41467-023-40064-9
CHEMBL1491 41514 100 None -5 22 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1038/s41467-023-40064-9
12555 17961 53 None -38 9 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 7 0 4 3.4 CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12 10.1038/s41467-023-40064-9
CHEMBL12610 17961 53 None -38 9 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 7 0 4 3.4 CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12 10.1038/s41467-023-40064-9
10133 910 78 None -6 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 4 3 3 4.5 O[C@@H]1CC[C@]2([C@@H](C1)C[C@H]([C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)O)C 10.1038/s41467-023-40064-9
145714624 910 78 None -6 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 4 3 3 4.5 O[C@@H]1CC[C@]2([C@@H](C1)C[C@H]([C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)O)C 10.1038/s41467-023-40064-9
4361 910 78 None -6 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 4 3 3 4.5 O[C@@H]1CC[C@]2([C@@H](C1)C[C@H]([C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)O)C 10.1038/s41467-023-40064-9
608 910 78 None -6 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 4 3 3 4.5 O[C@@H]1CC[C@]2([C@@H](C1)C[C@H]([C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)O)C 10.1038/s41467-023-40064-9
CHEMBL240597 910 78 None -6 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 4 3 3 4.5 O[C@@H]1CC[C@]2([C@@H](C1)C[C@H]([C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)O)C 10.1038/s41467-023-40064-9
DB06777 910 78 None -6 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 4 3 3 4.5 O[C@@H]1CC[C@]2([C@@H](C1)C[C@H]([C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)O)C 10.1038/s41467-023-40064-9
657202 12530 6 None -524 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 282 6 0 2 3.5 CCCC(CCC)C(=O)O[C@H]1C[C@H]2CC[C@@H](C1)[N+]2(C)C 10.1038/s41467-023-40064-9
CHEMBL1186610 12530 6 None -524 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 282 6 0 2 3.5 CCCC(CCC)C(=O)O[C@H]1C[C@H]2CC[C@@H](C1)[N+]2(C)C 10.1038/s41467-023-40064-9
9911830 19148 100 None 1 2 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 454 6 2 7 5.6 COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC 10.1038/s41467-023-40064-9
CHEMBL1289494 19148 100 None 1 2 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 454 6 2 7 5.6 COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC 10.1038/s41467-023-40064-9
5281718 34250 84 None - 1 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 5 6 8 0.4 OC[C@H]1O[C@@H](Oc2cc(O)cc(/C=C/c3ccc(O)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O 10.1038/s41467-023-40064-9
CHEMBL142652 34250 84 None - 1 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 5 6 8 0.4 OC[C@H]1O[C@@H](Oc2cc(O)cc(/C=C/c3ccc(O)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O 10.1038/s41467-023-40064-9
4041 99511 18 None -19 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 270 1 0 2 3.6 CN1CCN=C(c2ccccc2)c2cc(Cl)ccc21 10.1038/s41467-023-40064-9
CHEMBL28333 99511 18 None -19 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 270 1 0 2 3.6 CN1CCN=C(c2ccccc2)c2cc(Cl)ccc21 10.1038/s41467-023-40064-9
2695 3841 81 None -2 6 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 10.1038/s41467-023-40064-9
5504 3841 81 None -2 6 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 10.1038/s41467-023-40064-9
7310 3841 81 None -2 6 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 10.1038/s41467-023-40064-9
CHEMBL770 3841 81 None -2 6 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 10.1038/s41467-023-40064-9
DB00797 3841 81 None -2 6 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 10.1038/s41467-023-40064-9
45138674 16646 50 None 1 6 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 572 6 1 7 5.7 COc1cccc(N2CCN(C3=Nc4c(F)cccc4[C@H](CC(=O)O)N3c3cc(C(F)(F)F)ccc3OC)CC2)c1 10.1038/s41467-023-40064-9
CHEMBL1241951 16646 50 None 1 6 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 572 6 1 7 5.7 COc1cccc(N2CCN(C3=Nc4c(F)cccc4[C@H](CC(=O)O)N3c3cc(C(F)(F)F)ccc3OC)CC2)c1 10.1038/s41467-023-40064-9
8569 22643 91 None -1 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 244 3 2 4 2.3 COc1ccc(C(=O)c2ccccc2O)c(O)c1 10.1038/s41467-023-40064-9
CHEMBL1326877 22643 91 None -1 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 244 3 2 4 2.3 COc1ccc(C(=O)c2ccccc2O)c(O)c1 10.1038/s41467-023-40064-9
24821094 67094 93 None -6 8 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 440 5 1 7 4.2 C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1 10.1038/s41467-023-40064-9
CHEMBL1873475 67094 93 None -6 8 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 440 5 1 7 4.2 C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1 10.1038/s41467-023-40064-9
3658 4107 53 None 1 18 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
517 4107 53 None 1 18 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
5709 4107 53 None 1 18 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
CHEMBL312448 4107 53 None 1 18 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
DB06694 4107 53 None 1 18 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
1028 291 71 None 1 19 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
139148732 291 71 None 1 19 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
479 291 71 None 1 19 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
5816 291 71 None 1 19 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
CHEMBL679 291 71 None 1 19 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
DB00668 291 71 None 1 19 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
2146 3100 67 None -20 14 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
485 3100 67 None -20 14 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
6041 3100 67 None -20 14 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL1215 3100 67 None -20 14 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
DB00388 3100 67 None -20 14 Human 8.6 pAC50 = 8.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
4151 3607 89 None 1 10 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1038/s41467-023-40064-9
493 3607 89 None 1 10 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1038/s41467-023-40064-9
5312125 3607 89 None 1 10 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1038/s41467-023-40064-9
CHEMBL24778 3607 89 None 1 10 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1038/s41467-023-40064-9
DB06207 3607 89 None 1 10 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1038/s41467-023-40064-9
150 2509 21 None -194 17 Human 7.7 pAC50 = 7.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
1764 2509 21 None -194 17 Human 7.7 pAC50 = 7.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
8226 2509 21 None -194 17 Human 7.7 pAC50 = 7.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
CHEMBL1201356 2509 21 None -194 17 Human 7.7 pAC50 = 7.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
DB00353 2509 21 None -194 17 Human 7.7 pAC50 = 7.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
135398737 958 93 None -17 43 Human 7.7 pAC50 = 7.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
38 958 93 None -17 43 Human 7.7 pAC50 = 7.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
722 958 93 None -17 43 Human 7.7 pAC50 = 7.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL42 958 93 None -17 43 Human 7.7 pAC50 = 7.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
DB00363 958 93 None -17 43 Human 7.7 pAC50 = 7.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
31729 205784 10 None -131 7 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 6 4 4 2.4 CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL83063 205784 10 None -131 7 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 6 4 4 2.4 CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
202 1508 77 None -3 17 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
60835 1508 77 None -3 17 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
972 1508 77 None -3 17 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL1175 1508 77 None -3 17 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
DB00476 1508 77 None -3 17 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
448537 160250 89 None -54 31 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL411 160250 89 None -54 31 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 10.1038/s41467-023-40064-9
3035016 12594 50 None -1 3 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 483 3 5 10 0.6 CC(=O)[C@]1(N)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](O)[C@H](O)CO2)C1)C(=O)c1ccccc1C3=O 10.1038/s41467-023-40064-9
CHEMBL1186894 12594 50 None -1 3 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 483 3 5 10 0.6 CC(=O)[C@]1(N)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](O)[C@H](O)CO2)C1)C(=O)c1ccccc1C3=O 10.1038/s41467-023-40064-9
89683805 154433 67 None -6760 6 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 473 6 3 8 4.3 CC(C)(O)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1 10.1038/s41467-023-40064-9
CHEMBL3989908 154433 67 None -6760 6 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 473 6 3 8 4.3 CC(C)(O)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1 10.1038/s41467-023-40064-9
44439 165687 19 None -63 2 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 377 9 3 5 2.8 COc1ccc(CCC(C)NCC(O)c2ccc(O)c([S+](C)[O-])c2)cc1 10.1038/s41467-023-40064-9
CHEMBL424518 165687 19 None -63 2 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 377 9 3 5 2.8 COc1ccc(CCC(C)NCC(O)c2ccc(O)c([S+](C)[O-])c2)cc1 10.1038/s41467-023-40064-9
444795 139999 105 None -57 6 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 300 5 1 1 5.6 CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1 10.1038/s41467-023-40064-9
CHEMBL38 139999 105 None -57 6 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 300 5 1 1 5.6 CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1 10.1038/s41467-023-40064-9
5489013 57405 32 None -21 6 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 313 8 2 4 3.0 COc1cccc(C(=O)CCN[C@@H](C)[C@H](O)c2ccccc2)c1 10.1038/s41467-023-40064-9
CHEMBL1651913 57405 32 None -21 6 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 313 8 2 4 3.0 COc1cccc(C(=O)CCN[C@@H](C)[C@H](O)c2ccccc2)c1 10.1038/s41467-023-40064-9
1923 104724 136 None -3 3 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 145 0 1 2 1.9 Oc1cccc2cccnc12 10.1038/s41467-023-40064-9
CHEMBL310555 104724 136 None -3 3 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 145 0 1 2 1.9 Oc1cccc2cccnc12 10.1038/s41467-023-40064-9
1753 2504 28 None 2 4 Human 7.7 pAC50 = 7.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10.1038/s41467-023-40064-9
483 2504 28 None 2 4 Human 7.7 pAC50 = 7.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10.1038/s41467-023-40064-9
6082 2504 28 None 2 4 Human 7.7 pAC50 = 7.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10.1038/s41467-023-40064-9
CHEMBL524 2504 28 None 2 4 Human 7.7 pAC50 = 7.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10.1038/s41467-023-40064-9
DB00723 2504 28 None 2 4 Human 7.7 pAC50 = 7.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10.1038/s41467-023-40064-9
2726 919 68 None -29 42 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
621 919 68 None -29 42 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
83 919 68 None -29 42 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
CHEMBL71 919 68 None -29 42 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
DB00477 919 68 None -29 42 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
135409453 3773 41 None -363 35 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
226 3773 41 None -363 35 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
CHEMBL76370 3773 41 None -363 35 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
214 3860 58 None -22 28 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
2740 3860 58 None -22 28 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
5566 3860 58 None -22 28 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
66064 3860 58 None -22 28 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL422 3860 58 None -22 28 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
DB00831 3860 58 None -22 28 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
26248 161539 102 None -1 11 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 368 3 1 7 2.0 CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O 10.1038/s41467-023-40064-9
CHEMBL41286 161539 102 None -1 11 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 368 3 1 7 2.0 CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O 10.1038/s41467-023-40064-9
11289 14438 67 None -2 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 380 6 0 3 5.9 COc1ccc(C(Cl)=C(c2ccc(OC)cc2)c2ccc(OC)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL1200761 14438 67 None -2 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 380 6 0 3 5.9 COc1ccc(C(Cl)=C(c2ccc(OC)cc2)c2ccc(OC)cc2)cc1 10.1038/s41467-023-40064-9
2880 98008 49 None -13 9 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 5 0 3 4.6 C=C(c1ccccc1OCc1cccc(Cl)c1)n1ccnc1 10.1038/s41467-023-40064-9
CHEMBL27289 98008 49 None -13 9 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 5 0 3 4.6 C=C(c1ccccc1OCc1cccc(Cl)c1)n1ccnc1 10.1038/s41467-023-40064-9
3356 203368 81 None -33 3 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 414 7 2 4 3.4 O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL1200822 203368 81 None -33 3 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 414 7 2 4 3.4 O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL652 203368 81 None -33 3 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 414 7 2 4 3.4 O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F 10.1038/s41467-023-40064-9
54684141 208000 82 None 1 2 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 270 2 2 3 3.0 C/C(O)=C(\C#N)C(=O)Nc1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
CHEMBL973 208000 82 None 1 2 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 270 2 2 3 3.0 C/C(O)=C(\C#N)C(=O)Nc1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
1499 2091 47 None -44668 38 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
3779 2091 47 None -44668 38 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
536 2091 47 None -44668 38 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
CHEMBL434 2091 47 None -44668 38 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
DB01064 2091 47 None -44668 38 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
16564 204995 32 None -144 6 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 207 2 3 3 0.3 N=C(N)NCC1COc2ccccc2O1 10.1038/s41467-023-40064-9
CHEMBL76725 204995 32 None -144 6 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 207 2 3 3 0.3 N=C(N)NCC1COc2ccccc2O1 10.1038/s41467-023-40064-9
2028 2979 80 None -10715 14 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 4 3.3 CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC 10.1038/s41467-023-40064-9
359 2979 80 None -10715 14 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 4 3.3 CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC 10.1038/s41467-023-40064-9
4634 2979 80 None -10715 14 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 4 3.3 CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC 10.1038/s41467-023-40064-9
CHEMBL1231 2979 80 None -10715 14 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 4 3.3 CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC 10.1038/s41467-023-40064-9
DB01062 2979 80 None -10715 14 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 4 3.3 CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC 10.1038/s41467-023-40064-9
34040 28085 72 None -7244 11 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 483 4 0 6 3.9 CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13 10.1038/s41467-023-40064-9
CHEMBL1372950 28085 72 None -7244 11 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 483 4 0 6 3.9 CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13 10.1038/s41467-023-40064-9
3081361 93934 123 None -35 14 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 474 5 1 5 4.4 COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1 10.1038/s41467-023-40064-9
CHEMBL24828 93934 123 None -35 14 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 474 5 1 5 4.4 COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1 10.1038/s41467-023-40064-9
5344 173473 101 None -3981 6 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 267 3 2 5 1.7 Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C 10.1038/s41467-023-40064-9
CHEMBL453 173473 101 None -3981 6 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 267 3 2 5 1.7 Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C 10.1038/s41467-023-40064-9
3157 1470 71 None -38 21 Human 7.7 pAC50 = 7.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
7170 1470 71 None -38 21 Human 7.7 pAC50 = 7.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
954 1470 71 None -38 21 Human 7.7 pAC50 = 7.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
CHEMBL707 1470 71 None -38 21 Human 7.7 pAC50 = 7.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
DB00590 1470 71 None -38 21 Human 7.7 pAC50 = 7.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
2142 3096 58 None -1 18 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
4920903 3096 58 None -1 18 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
502 3096 58 None -1 18 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
5775 3096 58 None -1 18 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
CHEMBL597 3096 58 None -1 18 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
DB00692 3096 58 None -1 18 Human 6.7 pAC50 = 6.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
1890 2759 49 None -4 24 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
4449 2759 49 None -4 24 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
7247 2759 49 None -4 24 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
CHEMBL623 2759 49 None -4 24 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
DB01149 2759 49 None -4 24 Human 5.7 pAC50 = 5.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
10453870 73662 62 None -1 2 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 4 4 6 2.1 OC[C@H]1O[C@@H](c2ccc(F)c(Cc3cc4ccccc4s3)c2)[C@H](O)[C@@H](O)[C@@H]1O 10.1038/s41467-023-40064-9
CHEMBL2018096 73662 62 None -1 2 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 4 4 6 2.1 OC[C@H]1O[C@@H](c2ccc(F)c(Cc3cc4ccccc4s3)c2)[C@H](O)[C@@H](O)[C@@H]1O 10.1038/s41467-023-40064-9
9419 35922 35 None -72 7 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 295 3 0 3 3.0 CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1442422 35922 35 None -72 7 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 295 3 0 3 3.0 CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21 10.1038/s41467-023-40064-9
4601 206747 35 None -1148 19 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1201023 206747 35 None -1148 19 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL900 206747 35 None -1148 19 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 269 6 0 2 3.7 Cc1ccccc1C(OCCN(C)C)c1ccccc1 10.1038/s41467-023-40064-9
8609 14444 66 None -1 4 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 229 2 2 4 2.2 Nc1ccc(C(=O)Oc2ccccc2)c(O)c1 10.1038/s41467-023-40064-9
CHEMBL1200868 14444 66 None -1 4 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 229 2 2 4 2.2 Nc1ccc(C(=O)Oc2ccccc2)c(O)c1 10.1038/s41467-023-40064-9
5205 78187 58 None -2 8 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 261 0 0 1 3.8 CN1CCC2=C(C1)c1ccccc1Cc1ccccc12 10.1038/s41467-023-40064-9
CHEMBL2104895 78187 58 None -2 8 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 261 0 0 1 3.8 CN1CCC2=C(C1)c1ccccc1Cc1ccccc12 10.1038/s41467-023-40064-9
1209 1658 75 None -91 20 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
203 1658 75 None -91 20 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
3386 1658 75 None -91 20 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL41 1658 75 None -91 20 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
DB00472 1658 75 None -91 20 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
2202 3132 96 None -389 10 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 10.1038/s41467-023-40064-9
4850 3132 96 None -389 10 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 10.1038/s41467-023-40064-9
49 3132 96 None -389 10 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 10.1038/s41467-023-40064-9
CHEMBL1371770 3132 96 None -389 10 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 10.1038/s41467-023-40064-9
DB12478 3132 96 None -389 10 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 10.1038/s41467-023-40064-9
39941 118306 54 None - 1 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 301 3 1 3 4.3 CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1 10.1038/s41467-023-40064-9
CHEMBL340978 118306 54 None - 1 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 301 3 1 3 4.3 CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1 10.1038/s41467-023-40064-9
5280453 205971 74 None -5 8 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 416 6 3 3 5.7 C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O 10.1038/s41467-023-40064-9
CHEMBL846 205971 74 None -5 8 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 416 6 3 3 5.7 C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O 10.1038/s41467-023-40064-9
2749 32643 101 None 1 3 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 207 1 1 3 2.4 Cc1cc(C2CCCCC2)n(O)c(=O)c1 10.1038/s41467-023-40064-9
CHEMBL1413 32643 101 None 1 3 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 207 1 1 3 2.4 Cc1cc(C2CCCCC2)n(O)c(=O)c1 10.1038/s41467-023-40064-9
9846332 52059 37 None -1 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 444 2 3 5 2.4 C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C(Cl)=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO 10.1038/s41467-023-40064-9
CHEMBL1587228 52059 37 None -1 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 444 2 3 5 2.4 C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C(Cl)=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO 10.1038/s41467-023-40064-9
3157 1470 71 None -38 21 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
7170 1470 71 None -38 21 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
954 1470 71 None -38 21 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
CHEMBL707 1470 71 None -38 21 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
DB00590 1470 71 None -38 21 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
27901 78207 22 None -33 8 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 286 4 0 3 3.8 CN1CCC(N(Cc2cccs2)c2ccccc2)CC1 10.1038/s41467-023-40064-9
CHEMBL2105458 78207 22 None -33 8 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 286 4 0 3 3.8 CN1CCC(N(Cc2cccs2)c2ccccc2)CC1 10.1038/s41467-023-40064-9
2993 114692 24 None -177 13 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 456 11 2 2 6.2 Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL121663 114692 24 None -177 13 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 456 11 2 2 6.2 Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL333826 114692 24 None -177 13 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 456 11 2 2 6.2 Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21 10.1038/s41467-023-40064-9
1343 1889 62 None -9 12 Human 7.6 pAC50 = 7.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
3519 1889 62 None -9 12 Human 7.6 pAC50 = 7.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
522 1889 62 None -9 12 Human 7.6 pAC50 = 7.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
CHEMBL862 1889 62 None -9 12 Human 7.6 pAC50 = 7.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
DB01018 1889 62 None -9 12 Human 7.6 pAC50 = 7.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
2169 44847 35 None -4 12 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 380 9 3 6 1.4 COc1ccccc1OCCNCC(O)c1ccc(C)c(S(N)(=O)=O)c1 10.1038/s41467-023-40064-9
CHEMBL152231 44847 35 None -4 12 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 380 9 3 6 1.4 COc1ccccc1OCCNCC(O)c1ccc(C)c(S(N)(=O)=O)c1 10.1038/s41467-023-40064-9
9853053 120519 74 None -1 9 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 693 10 2 3 8.4 O=C(NC1CCN(CCCCC2(C(=O)NCC(F)(F)F)c3ccccc3-c3ccccc32)CC1)c1ccccc1-c1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
CHEMBL354541 120519 74 None -1 9 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 693 10 2 3 8.4 O=C(NC1CCN(CCCCC2(C(=O)NCC(F)(F)F)c3ccccc3-c3ccccc32)CC1)c1ccccc1-c1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
93154 5436 29 None -316 8 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 304 1 0 2 4.0 c1ccc2c(c1)CCc1ccccc1N2C1CN2CCC1CC2 10.1038/s41467-023-40064-9
CHEMBL107360 5436 29 None -316 8 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 304 1 0 2 4.0 c1ccc2c(c1)CCc1ccccc1N2C1CN2CCC1CC2 10.1038/s41467-023-40064-9
3735 206231 76 None -1 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 571 4 2 2 3.7 CCC(Cc1c(I)cc(I)c(N)c1I)C(=O)O 10.1038/s41467-023-40064-9
CHEMBL867 206231 76 None -1 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 571 4 2 2 3.7 CCC(Cc1c(I)cc(I)c(N)c1I)C(=O)O 10.1038/s41467-023-40064-9
65863 14465 57 None -14 11 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 436 6 0 4 7.0 Clc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1201196 14465 57 None -14 11 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 436 6 0 4 7.0 Clc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1 10.1038/s41467-023-40064-9
7547 5504 94 None -3 4 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 2 2 1 5.3 O=C(Nc1ccc(Cl)cc1)Nc1ccc(Cl)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1076347 5504 94 None -3 4 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 2 2 1 5.3 O=C(Nc1ccc(Cl)cc1)Nc1ccc(Cl)c(Cl)c1 10.1038/s41467-023-40064-9
65646 121301 26 None -2 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 6 2 9 0.8 Cc1oc(=O)oc1COC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1(C)C 10.1038/s41467-023-40064-9
CHEMBL3580454 121301 26 None -2 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 6 2 9 0.8 Cc1oc(=O)oc1COC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1(C)C 10.1038/s41467-023-40064-9
71743 78267 62 None -1 4 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 353 3 0 4 3.6 O=C(Oc1ccc2c(c1)CCCN2C(=O)C(Cl)Cl)c1ccco1 10.1038/s41467-023-40064-9
CHEMBL2107014 78267 62 None -1 4 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 353 3 0 4 3.6 O=C(Oc1ccc2c(c1)CCCN2C(=O)C(Cl)Cl)c1ccco1 10.1038/s41467-023-40064-9
5440 28724 37 None -1995 16 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 399 6 0 5 5.0 CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL1378 28724 37 None -1995 16 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 399 6 0 5 5.0 CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
2705 3842 64 None -1288 9 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.1038/s41467-023-40064-9
360 3842 64 None -1288 9 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.1038/s41467-023-40064-9
443879 3842 64 None -1288 9 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.1038/s41467-023-40064-9
CHEMBL1382 3842 64 None -1288 9 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.1038/s41467-023-40064-9
DB01036 3842 64 None -1288 9 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.1038/s41467-023-40064-9
104870 98880 47 None -8 10 Human 5.6 pAC50 = 5.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 10.1038/s41467-023-40064-9
5374 98880 47 None -8 10 Human 5.6 pAC50 = 5.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 10.1038/s41467-023-40064-9
CHEMBL279085 98880 47 None -8 10 Human 5.6 pAC50 = 5.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 209 2 1 4 1.3 C=CCN1CCc2nc(N)sc2CC1 10.1038/s41467-023-40064-9
21722 17992 31 None -16 21 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 4 0 2 4.3 CN(C)CCCn1c2c(c3ccccc31)CCCCCC2 10.1038/s41467-023-40064-9
CHEMBL126224 17992 31 None -16 21 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 284 4 0 2 4.3 CN(C)CCCn1c2c(c3ccccc31)CCCCCC2 10.1038/s41467-023-40064-9
5282219 35869 63 None -4 9 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 450 12 1 5 5.7 CC(C)=CCOc1ccc(/C=C/C(=O)c2ccc(OCC=C(C)C)cc2OCC(=O)O)cc1 10.1038/s41467-023-40064-9
CHEMBL1441961 35869 63 None -4 9 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 450 12 1 5 5.7 CC(C)=CCOc1ccc(/C=C/C(=O)c2ccc(OCC=C(C)C)cc2OCC(=O)O)cc1 10.1038/s41467-023-40064-9
16678941 78153 109 None -1 2 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 452 5 2 5 4.7 Cc1ccc(NC(=O)C2(c3ccc4c(c3)OC(F)(F)O4)CC2)nc1-c1cccc(C(=O)O)c1 10.1038/s41467-023-40064-9
CHEMBL2103870 78153 109 None -1 2 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 452 5 2 5 4.7 Cc1ccc(NC(=O)C2(c3ccc4c(c3)OC(F)(F)O4)CC2)nc1-c1cccc(C(=O)O)c1 10.1038/s41467-023-40064-9
71927 78403 18 None -2 2 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 202 2 1 3 0.9 COc1cc(N)cn[n+]1-c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL2106667 78403 18 None -2 2 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 202 2 1 3 0.9 COc1cc(N)cn[n+]1-c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL2110922 78403 18 None -2 2 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 202 2 1 3 0.9 COc1cc(N)cn[n+]1-c1ccccc1 10.1038/s41467-023-40064-9
1549120 196486 85 None -16 19 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 319 4 1 4 2.9 CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL56337 196486 85 None -16 19 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 319 4 1 4 2.9 CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1 10.1038/s41467-023-40064-9
24821094 67094 93 None -6 8 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 440 5 1 7 4.2 C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1 10.1038/s41467-023-40064-9
CHEMBL1873475 67094 93 None -6 8 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 440 5 1 7 4.2 C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1 10.1038/s41467-023-40064-9
446156 39825 29 None -1 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 459 11 3 5 4.9 COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1 10.1038/s41467-023-40064-9
CHEMBL1477 39825 29 None -1 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 459 11 3 5 4.9 COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1 10.1038/s41467-023-40064-9
1027 1576 73 None -676 7 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 0 2 1 2.7 N=C1NCC2N1c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
3241 1576 73 None -676 7 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 0 2 1 2.7 N=C1NCC2N1c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
7176 1576 73 None -676 7 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 0 2 1 2.7 N=C1NCC2N1c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
CHEMBL1106 1576 73 None -676 7 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 0 2 1 2.7 N=C1NCC2N1c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
DB00751 1576 73 None -676 7 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 0 2 1 2.7 N=C1NCC2N1c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
37464 19221 26 None -707 8 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 291 6 2 3 3.5 CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1 10.1038/s41467-023-40064-9
CHEMBL1290 19221 26 None -707 8 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 291 6 2 3 3.5 CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1 10.1038/s41467-023-40064-9
37907 35398 88 None -2 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 292 4 0 4 3.7 CC(C)(C)C(=O)C(Oc1ccc(Cl)cc1)n1ccnc1 10.1038/s41467-023-40064-9
CHEMBL1437764 35398 88 None -2 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 292 4 0 4 3.7 CC(C)(C)C(=O)C(Oc1ccc(Cl)cc1)n1ccnc1 10.1038/s41467-023-40064-9
3336 95001 30 None -5248 14 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 315 7 1 1 5.6 CC(NCCC(c1ccccc1)c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1405922 95001 30 None -5248 14 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 315 7 1 1 5.6 CC(NCCC(c1ccccc1)c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL254832 95001 30 None -5248 14 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 315 7 1 1 5.6 CC(NCCC(c1ccccc1)c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
6989 100952 115 None -2 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 150 1 1 1 2.8 Cc1ccc(C(C)C)c(O)c1 10.1038/s41467-023-40064-9
CHEMBL29411 100952 115 None -2 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 150 1 1 1 2.8 Cc1ccc(C(C)C)c(O)c1 10.1038/s41467-023-40064-9
60663 175669 42 None -8 12 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
CHEMBL1421212 175669 42 None -8 12 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
CHEMBL1534525 175669 42 None -8 12 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
CHEMBL45816 175669 42 None -8 12 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
3606 203488 60 None -3 8 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 270 5 2 2 4.8 CCC(c1ccc(O)cc1)C(CC)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL6615 203488 60 None -3 8 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 270 5 2 2 4.8 CCC(c1ccc(O)cc1)C(CC)c1ccc(O)cc1 10.1038/s41467-023-40064-9
65948 18556 109 None -12 6 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 582 9 2 9 4.7 CC1=C(C(=O)OC(C)C)C(c2cccc([N+](=O)[O-])c2)C(C(=O)OC2CN(C(c3ccccc3)c3ccccc3)C2)=C(N)N1 10.1038/s41467-023-40064-9
CHEMBL1275868 18556 109 None -12 6 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 582 9 2 9 4.7 CC1=C(C(=O)OC(C)C)C(c2cccc([N+](=O)[O-])c2)C(C(=O)OC2CN(C(c3ccccc3)c3ccccc3)C2)=C(N)N1 10.1038/s41467-023-40064-9
54679224 59903 113 None - 1 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 145 0 2 3 1.1 Oc1cc(O)c(Cl)cn1 10.1038/s41467-023-40064-9
CHEMBL1730601 59903 113 None - 1 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 145 0 2 3 1.1 Oc1cc(O)c(Cl)cn1 10.1038/s41467-023-40064-9
180 401 56 None -63 38 Human 7.6 pAC50 = 7.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
200 401 56 None -63 38 Human 7.6 pAC50 = 7.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
2160 401 56 None -63 38 Human 7.6 pAC50 = 7.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL629 401 56 None -63 38 Human 7.6 pAC50 = 7.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00321 401 56 None -63 38 Human 7.6 pAC50 = 7.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
2389 3331 118 None -13 29 Human 7.6 pAC50 = 7.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
5073 3331 118 None -13 29 Human 7.6 pAC50 = 7.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
96 3331 118 None -13 29 Human 7.6 pAC50 = 7.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
CHEMBL85 3331 118 None -13 29 Human 7.6 pAC50 = 7.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
DB00734 3331 118 None -13 29 Human 7.6 pAC50 = 7.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
2337 3256 77 None -4 29 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
50 3256 77 None -4 29 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
5002 3256 77 None -4 29 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL716 3256 77 None -4 29 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
DB01224 3256 77 None -4 29 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
135 2532 43 None -72 33 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
1796 2532 43 None -72 33 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
4184 2532 43 None -72 33 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
CHEMBL6437 2532 43 None -72 33 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
DB06148 2532 43 None -72 33 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
2333 142335 97 None -2 14 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 422 3 1 3 5.5 CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1 10.1038/s41467-023-40064-9
CHEMBL388590 142335 97 None -2 14 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 422 3 1 3 5.5 CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1 10.1038/s41467-023-40064-9
135 2532 43 None -72 33 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
1796 2532 43 None -72 33 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
4184 2532 43 None -72 33 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
CHEMBL6437 2532 43 None -72 33 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
DB06148 2532 43 None -72 33 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
135400189 44575 73 None -26 4 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 488 8 1 8 2.1 CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12 10.1038/s41467-023-40064-9
CHEMBL1520 44575 73 None -26 4 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 488 8 1 8 2.1 CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12 10.1038/s41467-023-40064-9
1155 1629 53 None -257 11 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
3343 1629 53 None -257 11 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
557 1629 53 None -257 11 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL32800 1629 53 None -257 11 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
DB01288 1629 53 None -257 11 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
65981 18454 102 None -2 3 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 452 10 2 4 5.2 CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O 10.1038/s41467-023-40064-9
CHEMBL1272 18454 102 None -2 3 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 452 10 2 4 5.2 CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O 10.1038/s41467-023-40064-9
6010 30698 44 None -1 2 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 302 0 1 2 4.3 C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O 10.1038/s41467-023-40064-9
CHEMBL1395 30698 44 None -1 2 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 302 0 1 2 4.3 C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O 10.1038/s41467-023-40064-9
5328940 100216 107 None -3 23 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 529 9 1 8 5.2 COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl 10.1038/s41467-023-40064-9
CHEMBL288441 100216 107 None -3 23 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 529 9 1 8 5.2 COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl 10.1038/s41467-023-40064-9
1960 2857 67 None -2 18 Human 6.6 pAC50 = 6.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
439260 2857 67 None -2 18 Human 6.6 pAC50 = 6.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
505 2857 67 None -2 18 Human 6.6 pAC50 = 6.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
CHEMBL1437 2857 67 None -2 18 Human 6.6 pAC50 = 6.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
DB00368 2857 67 None -2 18 Human 6.6 pAC50 = 6.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
2448 99323 70 None -12 15 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 419 6 1 3 4.5 O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1 10.1038/s41467-023-40064-9
CHEMBL28218 99323 70 None -12 15 Human 6.6 pAC50 = 6.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 419 6 1 3 4.5 O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1 10.1038/s41467-023-40064-9
3151 1462 97 None -223 24 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
945 1462 97 None -223 24 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
965 1462 97 None -223 24 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL219916 1462 97 None -223 24 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
DB01184 1462 97 None -223 24 Human 5.6 pAC50 = 5.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
6256 9671 86 None - 1 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 296 2 3 6 -0.8 O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1C(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL1129 9671 86 None - 1 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 296 2 3 6 -0.8 O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1C(F)(F)F 10.1038/s41467-023-40064-9
4006 59109 94 None - 1 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 288 4 0 6 3.1 CC(C)OC(=O)C(C(=O)OC(C)C)=C1SC=CS1 10.1038/s41467-023-40064-9
CHEMBL1697754 59109 94 None - 1 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 288 4 0 6 3.1 CC(C)OC(=O)C(C(=O)OC(C)C)=C1SC=CS1 10.1038/s41467-023-40064-9
14052 172578 51 None -5495 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 204 9 4 4 -0.3 CC[C@@H](CO)NCCN[C@@H](CC)CO 10.1038/s41467-023-40064-9
CHEMBL44884 172578 51 None -5495 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 204 9 4 4 -0.3 CC[C@@H](CO)NCCN[C@@H](CC)CO 10.1038/s41467-023-40064-9
1046 202652 116 None -1412 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 123 1 1 3 -0.4 NC(=O)c1cnccn1 10.1038/s41467-023-40064-9
CHEMBL614 202652 116 None -1412 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 123 1 1 3 -0.4 NC(=O)c1cnccn1 10.1038/s41467-023-40064-9
43082 60283 37 None -72 10 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 357 6 0 2 5.5 CC(OCCN1CCCCCC1)(c1ccccc1)c1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL1742452 60283 37 None -72 10 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 357 6 0 2 5.5 CC(OCCN1CCCCCC1)(c1ccccc1)c1ccc(Cl)cc1 10.1038/s41467-023-40064-9
219024 3300 65 None -6456 5 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 390 4 5 12 -2.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(nc2N)n1ncc(c1)C(=O)NC 10.1038/s41467-023-40064-9
2362 3300 65 None -6456 5 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 390 4 5 12 -2.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(nc2N)n1ncc(c1)C(=O)NC 10.1038/s41467-023-40064-9
5596 3300 65 None -6456 5 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 390 4 5 12 -2.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(nc2N)n1ncc(c1)C(=O)NC 10.1038/s41467-023-40064-9
CHEMBL317052 3300 65 None -6456 5 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 390 4 5 12 -2.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(nc2N)n1ncc(c1)C(=O)NC 10.1038/s41467-023-40064-9
DB06213 3300 65 None -6456 5 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 390 4 5 12 -2.4 OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1nc(nc2N)n1ncc(c1)C(=O)NC 10.1038/s41467-023-40064-9
2520 204008 70 None -50 20 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
CHEMBL1280 204008 70 None -50 20 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
CHEMBL6966 204008 70 None -50 20 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
11154555 800 62 None -1096 10 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 5 1 3 4.3 O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
5037 800 62 None -1096 10 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 5 1 3 4.3 O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
7671 800 62 None -1096 10 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 5 1 3 4.3 O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
CHEMBL2028019 800 62 None -1096 10 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 5 1 3 4.3 O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
CHEMBL3085826 800 62 None -1096 10 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 5 1 3 4.3 O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
DB06016 800 62 None -1096 10 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 5 1 3 4.3 O=C(N(C)C)N[C@@H]1CC[C@H](CC1)CCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
2406 100404 89 None -16 17 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 354 2 2 3 5.9 Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O 10.1038/s41467-023-40064-9
CHEMBL290106 100404 89 None -16 17 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 354 2 2 3 5.9 Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O 10.1038/s41467-023-40064-9
3627 44129 18 None -39 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 3 0 2 4.1 CN1CCCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1 10.1038/s41467-023-40064-9
CHEMBL1515447 44129 18 None -39 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 3 0 2 4.1 CN1CCCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1 10.1038/s41467-023-40064-9
2247 505 81 None -26 42 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
249 505 81 None -26 42 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
2603 505 81 None -26 42 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
CHEMBL296419 505 81 None -26 42 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
DB00637 505 81 None -26 42 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
2749 344 40 None -1 10 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 4 0 3 4.5 CN(CC(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
5574 344 40 None -1 10 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 4 0 3 4.5 CN(CC(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
7237 344 40 None -1 10 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 4 0 3 4.5 CN(CC(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
CHEMBL829 344 40 None -1 10 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 4 0 3 4.5 CN(CC(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
DB01246 344 40 None -1 10 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 4 0 3 4.5 CN(CC(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
2142 3096 58 None -1 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
4920903 3096 58 None -1 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
502 3096 58 None -1 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
5775 3096 58 None -1 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
CHEMBL597 3096 58 None -1 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
DB00692 3096 58 None -1 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
6337614 12996 54 None -26 6 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 296 1 0 2 2.7 O=C1c2cccc3c2[C@H](CCC3)CN1[C@@H]1CN2CCC1CC2 10.1038/s41467-023-40064-9
CHEMBL1189679 12996 54 None -26 6 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 296 1 0 2 2.7 O=C1c2cccc3c2[C@H](CCC3)CN1[C@@H]1CN2CCC1CC2 10.1038/s41467-023-40064-9
242 470 124 None -120 33 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
34 470 124 None -120 33 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
60795 470 124 None -120 33 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
CHEMBL1112 470 124 None -120 33 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
DB01238 470 124 None -120 33 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
9051 14442 67 None -5 3 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 1 0 2 4.5 CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C 10.1038/s41467-023-40064-9
CHEMBL1200853 14442 67 None -5 3 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 1 0 2 4.5 CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C 10.1038/s41467-023-40064-9
4121 50835 62 None -1 2 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 359 2 2 5 0.6 CN1C(CCl)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O 10.1038/s41467-023-40064-9
CHEMBL1577 50835 62 None -1 2 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 359 2 2 5 0.6 CN1C(CCl)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O 10.1038/s41467-023-40064-9
24765256 173297 23 None -2 4 Human 4.5 pAC50 = 4.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 757 6 3 9 3.9 CC[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H](C(C)(C)C)NC(=O)OCC(C)(C)CCCCc1cccc3c1CN(C3)C(=O)O2)C(=O)NS(=O)(=O)C1CC1 10.1038/s41467-023-40064-9
CHEMBL4525964 173297 23 None -2 4 Human 4.5 pAC50 = 4.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 757 6 3 9 3.9 CC[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H](C(C)(C)C)NC(=O)OCC(C)(C)CCCCc1cccc3c1CN(C3)C(=O)O2)C(=O)NS(=O)(=O)C1CC1 10.1038/s41467-023-40064-9
15387 45822 55 None 1 8 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 263 5 0 2 3.5 CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1 10.1038/s41467-023-40064-9
CHEMBL1531134 45822 55 None 1 8 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 263 5 0 2 3.5 CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1 10.1038/s41467-023-40064-9
5748845 78231 12 None - 1 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 522 9 4 13 -3.2 CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccc(N)n3CCO)CS[C@H]12)c1csc(N)n1 10.1038/s41467-023-40064-9
CHEMBL2105940 78231 12 None - 1 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 522 9 4 13 -3.2 CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccc(N)n3CCO)CS[C@H]12)c1csc(N)n1 10.1038/s41467-023-40064-9
68818 78268 28 None 3 3 Human 8.5 pAC50 = 8.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 217 1 2 3 2.2 c1ccc2c(SC3=NCCN3)c[nH]c2c1 10.1038/s41467-023-40064-9
CHEMBL2107015 78268 28 None 3 3 Human 8.5 pAC50 = 8.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 217 1 2 3 2.2 c1ccc2c(SC3=NCCN3)c[nH]c2c1 10.1038/s41467-023-40064-9
3294 2006 111 None -3 23 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
71360 2006 111 None -3 23 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
87 2006 111 None -3 23 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
CHEMBL14376 2006 111 None -3 23 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
DB04946 2006 111 None -3 23 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
115368 3056 47 None -1 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 6 0 6 3.4 O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1CCCC2 10.1038/s41467-023-40064-9
2112 3056 47 None -1 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 6 0 6 3.4 O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1CCCC2 10.1038/s41467-023-40064-9
7556 3056 47 None -1 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 6 0 6 3.4 O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1CCCC2 10.1038/s41467-023-40064-9
CHEMBL1472975 3056 47 None -1 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 6 0 6 3.4 O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1CCCC2 10.1038/s41467-023-40064-9
DB08922 3056 47 None -1 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 6 0 6 3.4 O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1CCCC2 10.1038/s41467-023-40064-9
4151 3607 89 None 1 10 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1038/s41467-023-40064-9
493 3607 89 None 1 10 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1038/s41467-023-40064-9
5312125 3607 89 None 1 10 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1038/s41467-023-40064-9
CHEMBL24778 3607 89 None 1 10 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1038/s41467-023-40064-9
DB06207 3607 89 None 1 10 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1038/s41467-023-40064-9
6077 150698 31 None 3 11 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 5 0 4 4.4 CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL39560 150698 31 None 3 11 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 5 0 4 4.4 CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2 10.1038/s41467-023-40064-9
2107 3055 50 None 2 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 365 4 1 5 4.0 N#Cc1ccc2c(c1)N(CCCN1CCC(CC1)O)c1c(S2)cccc1 10.1038/s41467-023-40064-9
4747 3055 50 None 2 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 365 4 1 5 4.0 N#Cc1ccc2c(c1)N(CCCN1CCC(CC1)O)c1c(S2)cccc1 10.1038/s41467-023-40064-9
9216 3055 50 None 2 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 365 4 1 5 4.0 N#Cc1ccc2c(c1)N(CCCN1CCC(CC1)O)c1c(S2)cccc1 10.1038/s41467-023-40064-9
CHEMBL251940 3055 50 None 2 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 365 4 1 5 4.0 N#Cc1ccc2c(c1)N(CCCN1CCC(CC1)O)c1c(S2)cccc1 10.1038/s41467-023-40064-9
DB01608 3055 50 None 2 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 365 4 1 5 4.0 N#Cc1ccc2c(c1)N(CCCN1CCC(CC1)O)c1c(S2)cccc1 10.1038/s41467-023-40064-9
62867 3129 35 None -1 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 475 8 1 6 4.0 OCCC1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
7557 3129 35 None -1 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 475 8 1 6 4.0 OCCC1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
CHEMBL398880 3129 35 None -1 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 475 8 1 6 4.0 OCCC1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
DB01621 3129 35 None -1 9 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 475 8 1 6 4.0 OCCC1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
2407 3372 76 None 1 17 Human 8.5 pAC50 = 8.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 315 6 1 3 4.3 CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1 10.1038/s41467-023-40064-9
59227 3372 76 None 1 17 Human 8.5 pAC50 = 8.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 315 6 1 3 4.3 CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1 10.1038/s41467-023-40064-9
941 3372 76 None 1 17 Human 8.5 pAC50 = 8.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 315 6 1 3 4.3 CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1 10.1038/s41467-023-40064-9
CHEMBL1303 3372 76 None 1 17 Human 8.5 pAC50 = 8.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 315 6 1 3 4.3 CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1 10.1038/s41467-023-40064-9
DB05271 3372 76 None 1 17 Human 8.5 pAC50 = 8.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 315 6 1 3 4.3 CCCN([C@H]1CCc2c(C1)cccc2O)CCc1cccs1 10.1038/s41467-023-40064-9
5568 197500 29 None -1 13 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 352 4 0 3 5.3 CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21 10.1038/s41467-023-40064-9
66069 197500 29 None -1 13 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 352 4 0 3 5.3 CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21 10.1038/s41467-023-40064-9
CHEMBL1201102 197500 29 None -1 13 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 352 4 0 3 5.3 CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21 10.1038/s41467-023-40064-9
CHEMBL570 197500 29 None -1 13 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 352 4 0 3 5.3 CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21 10.1038/s41467-023-40064-9
11976 920 59 None -1 16 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 315 3 0 2 5.2 CN(C)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)Cl 10.1038/s41467-023-40064-9
667467 920 59 None -1 16 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 315 3 0 2 5.2 CN(C)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)Cl 10.1038/s41467-023-40064-9
CHEMBL908 920 59 None -1 16 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 315 3 0 2 5.2 CN(C)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)Cl 10.1038/s41467-023-40064-9
DB01239 920 59 None -1 16 Human 8.5 pAC50 = 8.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 315 3 0 2 5.2 CN(C)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)Cl 10.1038/s41467-023-40064-9
2585 803 103 None -50 33 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
522 803 103 None -50 33 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
551 803 103 None -50 33 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
CHEMBL723 803 103 None -50 33 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
DB01136 803 103 None -50 33 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
1524 2181 96 None -23 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
197 2181 96 None -23 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
3822 2181 96 None -23 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
88 2181 96 None -23 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
CHEMBL51 2181 96 None -23 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
DB12465 2181 96 None -23 18 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
2583 3776 118 None -3019 16 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
592 3776 118 None -3019 16 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
65999 3776 118 None -3019 16 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
CHEMBL1017 3776 118 None -3019 16 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
DB00966 3776 118 None -3019 16 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
3601 14503 9 None -45 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 502 9 0 0 8.2 C[N+](C)(CCCCCC[N+](C)(C)C1c2ccccc2-c2ccccc21)C1c2ccccc2-c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1201349 14503 9 None -45 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 502 9 0 0 8.2 C[N+](C)(CCCCCC[N+](C)(C)C1c2ccccc2-c2ccccc21)C1c2ccccc2-c2ccccc21 10.1038/s41467-023-40064-9
212 3806 47 None -28 22 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
2639 3806 47 None -28 22 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
941651 3806 47 None -28 22 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
CHEMBL1201 3806 47 None -28 22 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
DB01623 3806 47 None -28 22 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
1043 1582 14 None -15488 22 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
149 1582 14 None -15488 22 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
8223 1582 14 None -15488 22 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
CHEMBL442 1582 14 None -15488 22 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
DB00696 1582 14 None -15488 22 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
118422671 2757 65 None -1023 23 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
1887 2757 65 None -1023 23 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
71301 2757 65 None -1023 23 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
7246 2757 65 None -1023 23 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
CHEMBL434394 2757 65 None -1023 23 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
DB04861 2757 65 None -1023 23 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 405 6 3 5 2.4 OC(C1CCc2c(O1)ccc(c2)F)CNCC(C1CCc2c(O1)ccc(c2)F)O 10.1038/s41467-023-40064-9
4452 2762 19 None -10232 21 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 6 2 4 3.8 COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl 10.1038/s41467-023-40064-9
983 2762 19 None -10232 21 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 6 2 4 3.8 COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl 10.1038/s41467-023-40064-9
CHEMBL20734 2762 19 None -10232 21 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 6 2 4 3.8 COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl 10.1038/s41467-023-40064-9
1720 2957 38 None - 1 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 211 4 4 4 1.1 OC(c1cc(O)cc(c1)O)CNC(C)C 10.1038/s41467-023-40064-9
4086 2957 38 None - 1 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 211 4 4 4 1.1 OC(c1cc(O)cc(c1)O)CNC(C)C 10.1038/s41467-023-40064-9
7250 2957 38 None - 1 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 211 4 4 4 1.1 OC(c1cc(O)cc(c1)O)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL776 2957 38 None - 1 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 211 4 4 4 1.1 OC(c1cc(O)cc(c1)O)CNC(C)C 10.1038/s41467-023-40064-9
DB00816 2957 38 None - 1 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 211 4 4 4 1.1 OC(c1cc(O)cc(c1)O)CNC(C)C 10.1038/s41467-023-40064-9
2389 3331 118 None -13 29 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
5073 3331 118 None -13 29 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
96 3331 118 None -13 29 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
CHEMBL85 3331 118 None -13 29 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
DB00734 3331 118 None -13 29 Human 7.5 pAC50 = 7.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
228 445 28 None -75 20 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 10.1038/s41467-023-40064-9
33 445 28 None -75 20 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 10.1038/s41467-023-40064-9
6005 445 28 None -75 20 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 10.1038/s41467-023-40064-9
CHEMBL53 445 28 None -75 20 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 10.1038/s41467-023-40064-9
DB00714 445 28 None -75 20 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O 10.1038/s41467-023-40064-9
2169 44847 35 None -4 12 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 380 9 3 6 1.4 COc1ccccc1OCCNCC(O)c1ccc(C)c(S(N)(=O)=O)c1 10.1038/s41467-023-40064-9
CHEMBL152231 44847 35 None -4 12 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 380 9 3 6 1.4 COc1ccccc1OCCNCC(O)c1ccc(C)c(S(N)(=O)=O)c1 10.1038/s41467-023-40064-9
3584 3777 64 None -69 11 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
5401 3777 64 None -69 11 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
7302 3777 64 None -69 11 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
CHEMBL611 3777 64 None -69 11 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
DB01162 3777 64 None -69 11 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
5482 14420 80 None -3 13 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 6 0 4 5.9 Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1200438 14420 80 None -3 13 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 6 0 4 5.9 Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
2993 114692 24 None -177 13 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 456 11 2 2 6.2 Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL121663 114692 24 None -177 13 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 456 11 2 2 6.2 Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL333826 114692 24 None -177 13 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 456 11 2 2 6.2 Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21 10.1038/s41467-023-40064-9
681 1465 72 None -162 15 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
940 1465 72 None -162 15 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
947 1465 72 None -162 15 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL59 1465 72 None -162 15 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
DB00988 1465 72 None -162 15 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 153 2 3 3 0.6 NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
2105 3054 37 None -158 25 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
47811 3054 37 None -158 25 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
48 3054 37 None -158 25 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
CHEMBL531 3054 37 None -158 25 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
DB01186 3054 37 None -158 25 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
2220 3134 82 None -269 17 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
27400 3134 82 None -269 17 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
93 3134 82 None -269 17 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
CHEMBL294951 3134 82 None -269 17 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
DB06153 3134 82 None -269 17 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
1086 1590 27 None -91 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 5 0 3 5.0 CCN(C(CN1c2ccccc2Sc2c1cccc2)C)CC 10.1038/s41467-023-40064-9
3290 1590 27 None -91 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 5 0 3 5.0 CCN(C(CN1c2ccccc2Sc2c1cccc2)C)CC 10.1038/s41467-023-40064-9
7181 1590 27 None -91 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 5 0 3 5.0 CCN(C(CN1c2ccccc2Sc2c1cccc2)C)CC 10.1038/s41467-023-40064-9
CHEMBL1206 1590 27 None -91 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 5 0 3 5.0 CCN(C(CN1c2ccccc2Sc2c1cccc2)C)CC 10.1038/s41467-023-40064-9
DB00392 1590 27 None -91 9 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 5 0 3 5.0 CCN(C(CN1c2ccccc2Sc2c1cccc2)C)CC 10.1038/s41467-023-40064-9
2200 20203 61 None 1 12 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 265 5 1 3 2.7 c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL1256819 20203 61 None 1 12 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 265 5 1 3 2.7 c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL1305 20203 61 None 1 12 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 265 5 1 3 2.7 c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
2136 3095 30 None 1 21 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 10.1038/s41467-023-40064-9
4768 3095 30 None 1 21 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 10.1038/s41467-023-40064-9
7268 3095 30 None 1 21 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL753 3095 30 None 1 21 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 10.1038/s41467-023-40064-9
DB00925 3095 30 None 1 21 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 10.1038/s41467-023-40064-9
68712 100338 60 None -4 7 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1038/s41467-023-40064-9
CHEMBL289480 100338 60 None -4 7 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1038/s41467-023-40064-9
65700 78260 28 None -10 8 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 238 1 1 2 3.3 CNC1Cc2ccccc2N(C)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL2106919 78260 28 None -10 8 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 238 1 1 2 3.3 CNC1Cc2ccccc2N(C)c2ccccc21 10.1038/s41467-023-40064-9
4066 204626 78 None -21 16 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 322 2 0 3 4.6 c1ccc2c(c1)Sc1ccccc1N2CC1CN2CCC1CC2 10.1038/s41467-023-40064-9
CHEMBL73451 204626 78 None -21 16 Human 6.5 pAC50 = 6.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 322 2 0 3 4.6 c1ccc2c(c1)Sc1ccccc1N2CC1CN2CCC1CC2 10.1038/s41467-023-40064-9
3108 207287 116 None -1 7 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 504 12 4 12 -0.0 OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1 10.1038/s41467-023-40064-9
CHEMBL932 207287 116 None -1 7 Human 5.5 pAC50 = 5.5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 504 12 4 12 -0.0 OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1 10.1038/s41467-023-40064-9
47936 193422 88 None -74 6 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 2 3 7 1.5 C=C[C@@]1(C)CC(=O)[C@@]2(O)[C@](C)(O1)[C@@H](OC(C)=O)[C@@H](O)[C@H]1C(C)(C)CC[C@H](O)[C@@]12C 10.1038/s41467-023-40064-9
CHEMBL52606 193422 88 None -74 6 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 410 2 3 7 1.5 C=C[C@@]1(C)CC(=O)[C@@]2(O)[C@](C)(O1)[C@@H](OC(C)=O)[C@@H](O)[C@H]1C(C)(C)CC[C@H](O)[C@@]12C 10.1038/s41467-023-40064-9
3158 56267 27 None -125 28 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1628227 56267 27 None -125 28 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1038/s41467-023-40064-9
1971 2866 38 None -89 32 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
2404 2866 38 None -89 32 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
4543 2866 38 None -89 32 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL445 2866 38 None -89 32 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
DB00540 2866 38 None -89 32 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
3584 3777 64 None -69 11 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
5401 3777 64 None -69 11 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
7302 3777 64 None -69 11 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
CHEMBL611 3777 64 None -69 11 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
DB01162 3777 64 None -69 11 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
124087 1389 114 None -112 27 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
7157 1389 114 None -112 27 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
814 1389 114 None -112 27 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
CHEMBL1172 1389 114 None -112 27 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
DB00967 1389 114 None -112 27 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
441074 19414 82 None -1 11 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 4 1 4 3.2 C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12 10.1038/s41467-023-40064-9
CHEMBL1294 19414 82 None -1 11 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 4 1 4 3.2 C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12 10.1038/s41467-023-40064-9
115 343 71 None 14 5 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
2092 343 71 None 14 5 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
7109 343 71 None 14 5 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
CHEMBL709 343 71 None 14 5 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
DB00346 343 71 None 14 5 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
4260 52558 31 None -3 9 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 279 6 0 4 3.0 CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C 10.1038/s41467-023-40064-9
CHEMBL159226 52558 31 None -3 9 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 279 6 0 4 3.0 CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C 10.1038/s41467-023-40064-9
1353 1911 93 None -22 39 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
3559 1911 93 None -22 39 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
86 1911 93 None -22 39 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
CHEMBL54 1911 93 None -22 39 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
DB00502 1911 93 None -22 39 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
5022 1651 76 None -8 9 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 4 1 4 3.2 O=c1[nH]c2c(n1CCN1CCN(CC1)c1cccc(c1)C(F)(F)F)cccc2 10.1038/s41467-023-40064-9
6918248 1651 76 None -8 9 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 4 1 4 3.2 O=c1[nH]c2c(n1CCN1CCN(CC1)c1cccc(c1)C(F)(F)F)cccc2 10.1038/s41467-023-40064-9
8182 1651 76 None -8 9 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 4 1 4 3.2 O=c1[nH]c2c(n1CCN1CCN(CC1)c1cccc(c1)C(F)(F)F)cccc2 10.1038/s41467-023-40064-9
CHEMBL231068 1651 76 None -8 9 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 4 1 4 3.2 O=c1[nH]c2c(n1CCN1CCN(CC1)c1cccc(c1)C(F)(F)F)cccc2 10.1038/s41467-023-40064-9
DB04908 1651 76 None -8 9 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 4 1 4 3.2 O=c1[nH]c2c(n1CCN1CCN(CC1)c1cccc(c1)C(F)(F)F)cccc2 10.1038/s41467-023-40064-9
6075 150108 42 None -14 20 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 10.1038/s41467-023-40064-9
CHEMBL395110 150108 42 None -14 20 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 10.1038/s41467-023-40064-9
5591 157531 90 None -4 17 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 441 5 2 6 4.4 Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2 10.1038/s41467-023-40064-9
CHEMBL408 157531 90 None -4 17 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 441 5 2 6 4.4 Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2 10.1038/s41467-023-40064-9
2181 3128 46 None -1 7 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N 10.1038/s41467-023-40064-9
4830 3128 46 None -1 7 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N 10.1038/s41467-023-40064-9
92 3128 46 None -1 7 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N 10.1038/s41467-023-40064-9
CHEMBL440294 3128 46 None -1 7 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N 10.1038/s41467-023-40064-9
DB09286 3128 46 None -1 7 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N 10.1038/s41467-023-40064-9
2146 3100 67 None -20 14 Human 8.4 pAC50 = 8.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
485 3100 67 None -20 14 Human 8.4 pAC50 = 8.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
6041 3100 67 None -20 14 Human 8.4 pAC50 = 8.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL1215 3100 67 None -20 14 Human 8.4 pAC50 = 8.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
DB00388 3100 67 None -20 14 Human 8.4 pAC50 = 8.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
17676 7072 29 None -1 13 Human 8.4 pAC50 = 8.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 411 7 1 6 3.5 CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
5281082 7072 29 None -1 13 Human 8.4 pAC50 = 8.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 411 7 1 6 3.5 CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL1085 7072 29 None -1 13 Human 8.4 pAC50 = 8.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 411 7 1 6 3.5 CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
1427 2013 54 None -112 30 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
357 2013 54 None -112 30 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
3696 2013 54 None -112 30 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL11 2013 54 None -112 30 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00458 2013 54 None -112 30 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
1385580 29276 76 None -478 19 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 7 1 4 4.1 O=c1[nH]c2ccccc2n1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1 10.1038/s41467-023-40064-9
4615 29276 76 None -478 19 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 7 1 4 4.1 O=c1[nH]c2ccccc2n1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1 10.1038/s41467-023-40064-9
CHEMBL13828 29276 76 None -478 19 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 7 1 4 4.1 O=c1[nH]c2ccccc2n1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1 10.1038/s41467-023-40064-9
3952 1888 38 None -4 21 Human 7.4 pAC50 = 7.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
5353646 1888 38 None -4 21 Human 7.4 pAC50 = 7.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
5443 1888 38 None -4 21 Human 7.4 pAC50 = 7.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
5702063 1888 38 None -4 21 Human 7.4 pAC50 = 7.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
CHEMBL1331786 1888 38 None -4 21 Human 7.4 pAC50 = 7.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
CHEMBL420 1888 38 None -4 21 Human 7.4 pAC50 = 7.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
4209 3163 75 None -24 17 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
4893 3163 75 None -24 17 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
503 3163 75 None -24 17 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
5385 3163 75 None -24 17 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
CHEMBL2 3163 75 None -24 17 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
DB00457 3163 75 None -24 17 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
5329102 194726 86 None -3 37 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 398 7 3 3 3.3 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C 10.1038/s41467-023-40064-9
CHEMBL535 194726 86 None -3 37 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 398 7 3 3 3.3 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C 10.1038/s41467-023-40064-9
5803 162227 84 None 1 8 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 622 4 2 3 4.6 O=C(O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1 10.1038/s41467-023-40064-9
CHEMBL41632 162227 84 None 1 8 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 622 4 2 3 4.6 O=C(O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1 10.1038/s41467-023-40064-9
71897 78248 19 None -141 7 Human 6.4 pAC50 = 6.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 304 4 1 3 2.7 Cc1cc(CCN2CCN(c3cccc(Cl)c3)CC2)n[nH]1 10.1038/s41467-023-40064-9
CHEMBL2106537 78248 19 None -141 7 Human 6.4 pAC50 = 6.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 304 4 1 3 2.7 Cc1cc(CCN2CCN(c3cccc(Cl)c3)CC2)n[nH]1 10.1038/s41467-023-40064-9
44591583 184536 96 None 3 2 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 251 2 1 4 1.6 N#Cc1ccc(Oc2ccc3c(c2)COB3O)cc1 10.1038/s41467-023-40064-9
CHEMBL484785 184536 96 None 3 2 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 251 2 1 4 1.6 N#Cc1ccc(Oc2ccc3c(c2)COB3O)cc1 10.1038/s41467-023-40064-9
5453 203619 102 None 1 14 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 189 3 0 1 0.2 S=P(N1CC1)(N1CC1)N1CC1 10.1038/s41467-023-40064-9
CHEMBL671 203619 102 None 1 14 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 189 3 0 1 0.2 S=P(N1CC1)(N1CC1)N1CC1 10.1038/s41467-023-40064-9
1613 2348 53 None -16 34 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
205 2348 53 None -16 34 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
3964 2348 53 None -16 34 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
CHEMBL831 2348 53 None -16 34 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
DB00408 2348 53 None -16 34 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
3947 206395 53 None -6 16 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 418 7 0 3 5.8 CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL87708 206395 53 None -6 16 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 418 7 0 3 5.8 CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1 10.1038/s41467-023-40064-9
3152 188411 103 None -9 10 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 379 6 0 4 4.4 COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2 10.1038/s41467-023-40064-9
CHEMBL502 188411 103 None -9 10 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 379 6 0 4 4.4 COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2 10.1038/s41467-023-40064-9
55645 84370 8 None -1258 11 Human 6.4 pAC50 = 6.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 395 7 2 4 2.1 CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21 10.1038/s41467-023-40064-9
CHEMBL2218861 84370 8 None -1258 11 Human 6.4 pAC50 = 6.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 395 7 2 4 2.1 CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21 10.1038/s41467-023-40064-9
3689 102771 55 None -64 16 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 5 2 3 3.8 CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1038/s41467-023-40064-9
CHEMBL1372983 102771 55 None -64 16 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 5 2 3 3.8 CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1038/s41467-023-40064-9
CHEMBL305187 102771 55 None -64 16 Human 6.4 pAC50 = 6.4 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 5 2 3 3.8 CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1038/s41467-023-40064-9
60065 84369 6 None -2 11 Human 5.4 pAC50 = 5.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 505 7 1 8 4.2 COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@@H]2CCCN(Cc3ccccc3)C2)C1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
CHEMBL2218858 84369 6 None -2 11 Human 5.4 pAC50 = 5.4 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 505 7 1 8 4.2 COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@@H]2CCCN(Cc3ccccc3)C2)C1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
4418 34222 85 None -4 18 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1038/s41467-023-40064-9
CHEMBL142635 34222 85 None -4 18 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1038/s41467-023-40064-9
100 3805 58 None -8 38 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
2637 3805 58 None -8 38 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
5452 3805 58 None -8 38 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
CHEMBL479 3805 58 None -8 38 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
DB00679 3805 58 None -8 38 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
2335 11848 22 None -38 34 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
8478 11848 22 None -38 34 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL1182210 11848 22 None -38 34 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL221753 11848 22 None -38 34 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
2895 203592 41 None -16 15 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 275 3 0 1 4.6 CN(C)CCC=C1c2ccccc2C=Cc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL669 203592 41 None -16 15 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 275 3 0 1 4.6 CN(C)CCC=C1c2ccccc2C=Cc2ccccc21 10.1038/s41467-023-40064-9
54682461 84686 62 None 1 12 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 602 11 2 6 7.3 CCC[C@@]1(CCc2ccccc2)CC(O)=C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1 10.1038/s41467-023-40064-9
CHEMBL222559 84686 62 None 1 12 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 602 11 2 6 7.3 CCC[C@@]1(CCc2ccccc2)CC(O)=C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1 10.1038/s41467-023-40064-9
82153 43901 45 None 11 3 Human 7.3 pAC50 = 7.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 434 2 2 6 2.3 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1 10.1038/s41467-023-40064-9
CHEMBL1512 43901 45 None 11 3 Human 7.3 pAC50 = 7.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 434 2 2 6 2.3 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1 10.1038/s41467-023-40064-9
4011 82408 49 None -8 26 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 10.1038/s41467-023-40064-9
CHEMBL21731 82408 49 None -8 26 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 10.1038/s41467-023-40064-9
2710 84308 31 None -10 9 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 300 3 0 2 3.7 CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1 10.1038/s41467-023-40064-9
CHEMBL22150 84308 31 None -10 9 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 300 3 0 2 3.7 CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1 10.1038/s41467-023-40064-9
54758501 139067 58 None -1621 11 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 486 7 2 8 5.1 C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccsc23)c1 10.1038/s41467-023-40064-9
CHEMBL3786343 139067 58 None -1621 11 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 486 7 2 8 5.1 C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccsc23)c1 10.1038/s41467-023-40064-9
6719 32668 39 None -6 4 Human 5.3 pAC50 = 5.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 340 4 0 3 4.1 O=C1c2ccccc2C(=O)C1C(=O)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1413199 32668 39 None -6 4 Human 5.3 pAC50 = 5.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 340 4 0 3 4.1 O=C1c2ccccc2C(=O)C1C(=O)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
4195 14471 44 None 2 2 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 254 6 3 5 -0.2 COc1ccc(OC)c(C(O)CNC(=O)CN)c1 10.1038/s41467-023-40064-9
CHEMBL1201212 14471 44 None 2 2 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 254 6 3 5 -0.2 COc1ccc(OC)c(C(O)CNC(=O)CN)c1 10.1038/s41467-023-40064-9
36811 1454 37 None -1 17 Human 8.3 pAC50 = 8.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
535 1454 37 None -1 17 Human 8.3 pAC50 = 8.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
937 1454 37 None -1 17 Human 8.3 pAC50 = 8.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL926 1454 37 None -1 17 Human 8.3 pAC50 = 8.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
DB00841 1454 37 None -1 17 Human 8.3 pAC50 = 8.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
3083544 26809 51 None -407 6 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
CHEMBL1200811 26809 51 None -407 6 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
CHEMBL1363 26809 51 None -407 6 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
CHEMBL1951071 26809 51 None -407 6 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
CHEMBL605993 26809 51 None -407 6 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
643976 14518 30 None -2 3 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 456 7 6 10 -1.6 Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O)c2cc1C 10.1038/s41467-023-40064-9
CHEMBL1201794 14518 30 None -2 3 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 456 7 6 10 -1.6 Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)COP(=O)(O)O)c2cc1C 10.1038/s41467-023-40064-9
133 2496 52 None -131 27 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C 10.1038/s41467-023-40064-9
1723 2496 52 None -131 27 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C 10.1038/s41467-023-40064-9
28693 2496 52 None -131 27 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C 10.1038/s41467-023-40064-9
CHEMBL19215 2496 52 None -131 27 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C 10.1038/s41467-023-40064-9
DB13520 2496 52 None -131 27 Human 7.3 pAC50 = 7.3 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C 10.1038/s41467-023-40064-9
3033538 1319 39 None -63 13 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 10.1038/s41467-023-40064-9
7155 1319 39 None -63 13 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 10.1038/s41467-023-40064-9
781 1319 39 None -63 13 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 10.1038/s41467-023-40064-9
CHEMBL1201216 1319 39 None -63 13 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 10.1038/s41467-023-40064-9
DB00298 1319 39 None -63 13 Human 6.3 pAC50 = 6.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 10.1038/s41467-023-40064-9
2771 195017 74 None -46 16 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
CHEMBL1200781 195017 74 None -46 16 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
CHEMBL549 195017 74 None -46 16 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
191 403 98 None -67 36 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
201 403 98 None -67 36 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
2170 403 98 None -67 36 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
CHEMBL1113 403 98 None -67 36 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
DB00543 403 98 None -67 36 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
107641 61143 78 None -2 2 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 4 1 2 3.4 CCC(C(=O)O)c1ccc(N2Cc3ccccc3C2=O)cc1 10.1038/s41467-023-40064-9
CHEMBL1765292 61143 78 None -2 2 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 4 1 2 3.4 CCC(C(=O)O)c1ccc(N2Cc3ccccc3C2=O)cc1 10.1038/s41467-023-40064-9
2540 4401 111 None -1047 28 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 610 10 1 11 6.3 CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1 10.1038/s41467-023-40064-9
CHEMBL1014 4401 111 None -1047 28 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 610 10 1 11 6.3 CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1 10.1038/s41467-023-40064-9
11504295 2923 47 None -416 8 Human 7.3 pAC50 = 7.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1038/s41467-023-40064-9
4814 2923 47 None -416 8 Human 7.3 pAC50 = 7.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1038/s41467-023-40064-9
7543 2923 47 None -416 8 Human 7.3 pAC50 = 7.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1038/s41467-023-40064-9
CHEMBL605846 2923 47 None -416 8 Human 7.3 pAC50 = 7.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1038/s41467-023-40064-9
DB09080 2923 47 None -416 8 Human 7.3 pAC50 = 7.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 386 7 4 6 2.4 COc1ccc(cc1)CC(NC[C@@H](c1cc(O)cc2c1OCC(=O)N2)O)(C)C 10.1038/s41467-023-40064-9
1547484 940 74 None -50 26 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
654 940 74 None -50 26 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
9072 940 74 None -50 26 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL43064 940 74 None -50 26 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
DB00568 940 74 None -50 26 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
5639 98895 75 None 7 13 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 7 1 8 0.7 COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1038/s41467-023-40064-9
CHEMBL279229 98895 75 None 7 13 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 387 7 1 8 0.7 COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1038/s41467-023-40064-9
2995 204405 53 None -213 18 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1696 204405 53 None -213 18 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL72 204405 53 None -213 18 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1038/s41467-023-40064-9
114948 60297 14 None -457 6 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 577 5 3 6 2.5 CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 10.1038/s41467-023-40064-9
CHEMBL1743263 60297 14 None -457 6 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 577 5 3 6 2.5 CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 10.1038/s41467-023-40064-9
146570 43454 67 None -1 7 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 5 0 3 3.8 CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
CHEMBL1508 43454 67 None -1 7 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 5 0 3 3.8 CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
4167 14500 43 None -109 10 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 2 0 2 5.0 CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1 10.1038/s41467-023-40064-9
CHEMBL1201342 14500 43 None -109 10 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 2 0 2 5.0 CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1 10.1038/s41467-023-40064-9
2855 4132 104 None -2951 12 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 575 8 2 7 5.7 COc1cc(ccc1Cc1cn(c2c1cc(cc2)NC(=O)OC1CCCC1)C)C(=O)NS(=O)(=O)c1ccccc1C 10.1038/s41467-023-40064-9
3322 4132 104 None -2951 12 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 575 8 2 7 5.7 COc1cc(ccc1Cc1cn(c2c1cc(cc2)NC(=O)OC1CCCC1)C)C(=O)NS(=O)(=O)c1ccccc1C 10.1038/s41467-023-40064-9
5717 4132 104 None -2951 12 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 575 8 2 7 5.7 COc1cc(ccc1Cc1cn(c2c1cc(cc2)NC(=O)OC1CCCC1)C)C(=O)NS(=O)(=O)c1ccccc1C 10.1038/s41467-023-40064-9
CHEMBL603 4132 104 None -2951 12 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 575 8 2 7 5.7 COc1cc(ccc1Cc1cn(c2c1cc(cc2)NC(=O)OC1CCCC1)C)C(=O)NS(=O)(=O)c1ccccc1C 10.1038/s41467-023-40064-9
DB00549 4132 104 None -2951 12 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 575 8 2 7 5.7 COc1cc(ccc1Cc1cn(c2c1cc(cc2)NC(=O)OC1CCCC1)C)C(=O)NS(=O)(=O)c1ccccc1C 10.1038/s41467-023-40064-9
2335 11848 22 None -38 34 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
8478 11848 22 None -38 34 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL1182210 11848 22 None -38 34 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL221753 11848 22 None -38 34 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 11 0 2 6.1 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 10.1038/s41467-023-40064-9
5832 14460 54 None -7 5 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 1 0 3 4.1 C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
CHEMBL1201146 14460 54 None -7 5 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 1 0 3 4.1 C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
208898 66199 78 None -9 11 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 556 18 1 6 7.0 CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1 10.1038/s41467-023-40064-9
CHEMBL184412 66199 78 None -9 11 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 556 18 1 6 7.0 CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1 10.1038/s41467-023-40064-9
37 778 60 None -141 12 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
460 778 60 None -141 12 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
54746 778 60 None -141 12 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
CHEMBL1201087 778 60 None -141 12 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
DB00248 778 60 None -141 12 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
5419 18060 57 None 10 5 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 200 1 1 2 2.1 c1ccc2c(c1)CCCC2C1=NCCN1 10.1038/s41467-023-40064-9
CHEMBL1200413 18060 57 None 10 5 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 200 1 1 2 2.1 c1ccc2c(c1)CCCC2C1=NCCN1 10.1038/s41467-023-40064-9
CHEMBL1266 18060 57 None 10 5 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 200 1 1 2 2.1 c1ccc2c(c1)CCCC2C1=NCCN1 10.1038/s41467-023-40064-9
1028 291 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
139148732 291 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
479 291 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
5816 291 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
CHEMBL679 291 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
DB00668 291 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
1028 291 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
139148732 291 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
479 291 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
5816 291 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
CHEMBL679 291 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
DB00668 291 71 None 1 19 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1038/s41467-023-40064-9
1524 2181 96 None -23 18 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
197 2181 96 None -23 18 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
3822 2181 96 None -23 18 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
88 2181 96 None -23 18 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
CHEMBL51 2181 96 None -23 18 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
DB12465 2181 96 None -23 18 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
2713 205271 82 None -1 27 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
5353524 205271 82 None -1 27 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
5360566 205271 82 None -1 27 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
88536661 205271 82 None -1 27 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
9552079 205271 82 None -1 27 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL1330113 205271 82 None -1 27 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL790 205271 82 None -1 27 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
5324346 205582 59 None 2 3 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 318 9 1 4 3.2 COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
CHEMBL1409 205582 59 None 2 3 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 318 9 1 4 3.2 COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
CHEMBL814 205582 59 None 2 3 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 318 9 1 4 3.2 COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
1353 1911 93 None -22 39 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
3559 1911 93 None -22 39 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
86 1911 93 None -22 39 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
CHEMBL54 1911 93 None -22 39 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
DB00502 1911 93 None -22 39 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
102 4127 48 None -380 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
3659 4127 48 None -380 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
8969 4127 48 None -380 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
CHEMBL15245 4127 48 None -380 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
DB01392 4127 48 None -380 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
392622 56312 95 None -8 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 720 17 4 9 5.9 CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1 10.1038/s41467-023-40064-9
CHEMBL163 56312 95 None -8 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 720 17 4 9 5.9 CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1 10.1038/s41467-023-40064-9
3354 41784 50 None -7 9 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 391 5 0 5 4.4 Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O 10.1038/s41467-023-40064-9
CHEMBL1493 41784 50 None -7 9 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 391 5 0 5 4.4 Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O 10.1038/s41467-023-40064-9
447715 196927 68 None -10 7 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 420 5 3 3 5.1 CC[C@@H]1[C@@H]2C[C@H](O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@H]3[C@H](C)CCC(=O)O)[C@@H]2[C@@H]1O 10.1038/s41467-023-40064-9
CHEMBL566315 196927 68 None -10 7 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 420 5 3 3 5.1 CC[C@@H]1[C@@H]2C[C@H](O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@H]3[C@H](C)CCC(=O)O)[C@@H]2[C@@H]1O 10.1038/s41467-023-40064-9
25382 9157 37 None -16 21 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 291 3 0 1 4.7 CN(C)CCC=C1c2ccccc2C(C)(C)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL110094 9157 37 None -16 21 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 291 3 0 1 4.7 CN(C)CCC=C1c2ccccc2C(C)(C)c2ccccc21 10.1038/s41467-023-40064-9
2435 3590 83 None -25 21 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
60149 3590 83 None -25 21 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
98 3590 83 None -25 21 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
CHEMBL12713 3590 83 None -25 21 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
DB06144 3590 83 None -25 21 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
2683 102888 25 None -812 24 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 10.1038/s41467-023-40064-9
CHEMBL305906 102888 25 None -812 24 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 10.1038/s41467-023-40064-9
CHEMBL334255 102888 25 None -812 24 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 10.1038/s41467-023-40064-9
2435 722 100 None -199 10 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1038/s41467-023-40064-9
395 722 100 None -199 10 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1038/s41467-023-40064-9
520 722 100 None -199 10 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1038/s41467-023-40064-9
5386 722 100 None -199 10 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1038/s41467-023-40064-9
CHEMBL844 722 100 None -199 10 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1038/s41467-023-40064-9
DB00484 722 100 None -199 10 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1038/s41467-023-40064-9
25295 13620 37 None -4 8 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 289 6 0 3 3.3 CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1 10.1038/s41467-023-40064-9
CHEMBL1194287 13620 37 None -4 8 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 289 6 0 3 3.3 CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1 10.1038/s41467-023-40064-9
10607 202247 100 None - 1 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 414 4 1 8 2.4 COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC 10.1038/s41467-023-40064-9
CHEMBL61 202247 100 None - 1 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 414 4 1 8 2.4 COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC 10.1038/s41467-023-40064-9
73417116 154431 0 None -11 5 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 266 2 2 2 3.0 N[C@@H]1C[C@H]1c1ccccc1.N[C@H]1C[C@@H]1c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL3989843 154431 0 None -11 5 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 266 2 2 2 3.0 N[C@@H]1C[C@H]1c1ccccc1.N[C@H]1C[C@@H]1c1ccccc1 10.1038/s41467-023-40064-9
5314 204108 23 None 25 2 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 290 9 0 4 0.3 C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C 10.1038/s41467-023-40064-9
CHEMBL703 204108 23 None 25 2 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 290 9 0 4 0.3 C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C 10.1038/s41467-023-40064-9
20628 96548 28 None -17 13 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 6 1 5 3.7 CN(C)CCCNc1c2ccccc2nc2cccc([N+](=O)[O-])c12 10.1038/s41467-023-40064-9
CHEMBL26291 96548 28 None -17 13 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 324 6 1 5 3.7 CN(C)CCCNc1c2ccccc2nc2cccc([N+](=O)[O-])c12 10.1038/s41467-023-40064-9
2865 4143 73 None -23 20 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
59 4143 73 None -23 20 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
60854 4143 73 None -23 20 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL708 4143 73 None -23 20 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
DB00246 4143 73 None -23 20 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
5353853 17986 47 None -39 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
9556529 17986 47 None -39 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1262 17986 47 None -39 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
2402 3370 62 None -354 17 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O 10.1038/s41467-023-40064-9
5095 3370 62 None -354 17 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O 10.1038/s41467-023-40064-9
7295 3370 62 None -354 17 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O 10.1038/s41467-023-40064-9
CHEMBL589 3370 62 None -354 17 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O 10.1038/s41467-023-40064-9
DB00268 3370 62 None -354 17 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 260 7 1 2 3.5 CCCN(CCC)CCc1cccc2c1CC(=N2)O 10.1038/s41467-023-40064-9
1593 2340 66 None -3 6 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
30668 2340 66 None -3 6 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
9868 2340 66 None -3 6 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
CHEMBL17860 2340 66 None -3 6 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
DB04948 2340 66 None -3 6 Human 8.2 pAC50 = 8.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
4567 9948 34 None 2 12 Human 7.2 pAC50 = 7.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 299 7 3 3 3.4 CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL114655 9948 34 None 2 12 Human 7.2 pAC50 = 7.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 299 7 3 3 3.4 CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
16363 596 53 None -13 21 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 381 6 1 4 3.8 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
312 596 53 None -13 21 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 381 6 1 4 3.8 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
9215 596 53 None -13 21 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 381 6 1 4 3.8 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL297302 596 53 None -13 21 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 381 6 1 4 3.8 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
DB12867 596 53 None -13 21 Human 7.2 pAC50 = 7.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 381 6 1 4 3.8 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
168871 89130 14 None -53 13 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 563 4 3 6 2.1 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 10.1038/s41467-023-40064-9
CHEMBL2365712 89130 14 None -53 13 Human 6.2 pAC50 = 6.2 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 563 4 3 6 2.1 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 10.1038/s41467-023-40064-9
3598 187821 76 None 1 17 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 2 2 2 6.6 Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl 10.1038/s41467-023-40064-9
CHEMBL496 187821 76 None 1 17 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 2 2 2 6.6 Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl 10.1038/s41467-023-40064-9
2247 505 81 None -26 42 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
249 505 81 None -26 42 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
2603 505 81 None -26 42 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
CHEMBL296419 505 81 None -26 42 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
DB00637 505 81 None -26 42 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
40466858 16155 67 None -20 4 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 348 6 1 3 4.0 Cc1ccc(/C(=C\CN2CCCC2)c2cccc(/C=C/C(=O)O)n2)cc1 10.1038/s41467-023-40064-9
5284514 16155 67 None -20 4 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 348 6 1 3 4.0 Cc1ccc(/C(=C\CN2CCCC2)c2cccc(/C=C/C(=O)O)n2)cc1 10.1038/s41467-023-40064-9
CHEMBL1224 16155 67 None -20 4 Human 6.2 pAC50 = 6.2 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 348 6 1 3 4.0 Cc1ccc(/C(=C\CN2CCCC2)c2cccc(/C=C/C(=O)O)n2)cc1 10.1038/s41467-023-40064-9
5077 3578 79 None -275 13 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 496 12 1 7 3.9 O=C(NS(=O)(=O)C)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C 10.1038/s41467-023-40064-9
7552 3578 79 None -275 13 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 496 12 1 7 3.9 O=C(NS(=O)(=O)C)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C 10.1038/s41467-023-40064-9
9913767 3578 79 None -275 13 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 496 12 1 7 3.9 O=C(NS(=O)(=O)C)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C 10.1038/s41467-023-40064-9
CHEMBL238804 3578 79 None -275 13 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 496 12 1 7 3.9 O=C(NS(=O)(=O)C)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C 10.1038/s41467-023-40064-9
DB11362 3578 79 None -275 13 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 496 12 1 7 3.9 O=C(NS(=O)(=O)C)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C 10.1038/s41467-023-40064-9
1613 2348 53 None -16 34 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
205 2348 53 None -16 34 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
3964 2348 53 None -16 34 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
CHEMBL831 2348 53 None -16 34 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
DB00408 2348 53 None -16 34 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
4195 14471 44 None 2 2 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 254 6 3 5 -0.2 COc1ccc(OC)c(C(O)CNC(=O)CN)c1 10.1038/s41467-023-40064-9
CHEMBL1201212 14471 44 None 2 2 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 254 6 3 5 -0.2 COc1ccc(OC)c(C(O)CNC(=O)CN)c1 10.1038/s41467-023-40064-9
12488 1657 56 None -19 28 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F 10.1038/s41467-023-40064-9
941361 1657 56 None -19 28 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F 10.1038/s41467-023-40064-9
CHEMBL30008 1657 56 None -19 28 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F 10.1038/s41467-023-40064-9
DB04841 1657 56 None -19 28 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F 10.1038/s41467-023-40064-9
1909 2822 64 None -1 11 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 479 9 1 8 3.7 COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C 10.1038/s41467-023-40064-9
2559 2822 64 None -1 11 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 479 9 1 8 3.7 COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C 10.1038/s41467-023-40064-9
4474 2822 64 None -1 11 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 479 9 1 8 3.7 COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C 10.1038/s41467-023-40064-9
CHEMBL1484 2822 64 None -1 11 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 479 9 1 8 3.7 COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C 10.1038/s41467-023-40064-9
CHEMBL3302409 2822 64 None -1 11 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 479 9 1 8 3.7 COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C 10.1038/s41467-023-40064-9
DB00622 2822 64 None -1 11 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 479 9 1 8 3.7 COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C 10.1038/s41467-023-40064-9
82146 4530 113 None 1 8 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 348 3 1 1 6.1 C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C 10.1038/s41467-023-40064-9
CHEMBL1023 4530 113 None 1 8 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 348 3 1 1 6.1 C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C 10.1038/s41467-023-40064-9
213046 2385 59 None -6 17 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
4168 2385 59 None -6 17 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
7461 2385 59 None -6 17 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
CHEMBL1237021 2385 59 None -6 17 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
DB08815 2385 59 None -6 17 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
137 370 52 None -3467 8 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
2119 370 52 None -3467 8 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
563 370 52 None -3467 8 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
66368 370 52 None -3467 8 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
CHEMBL266195 370 52 None -3467 8 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
DB00866 370 52 None -3467 8 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 249 8 2 3 2.2 C=CCc1ccccc1OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
68617 205527 62 None -14 30 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1709 205527 62 None -14 30 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL809 205527 62 None -14 30 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 10.1038/s41467-023-40064-9
11823027 192616 37 None -436 3 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 5 4 5 0.6 CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2 10.1038/s41467-023-40064-9
4411 192616 37 None -436 3 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 5 4 5 0.6 CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2 10.1038/s41467-023-40064-9
CHEMBL521606 192616 37 None -436 3 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 309 5 4 5 0.6 CC(C)(C)NCC(O)COc1cccc2c1CC(O)C(O)C2 10.1038/s41467-023-40064-9
1690 3058 19 None -2 4 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
4058 3058 19 None -2 4 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
5750 3058 19 None -2 4 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
7221 3058 19 None -2 4 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL607 3058 19 None -2 4 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
DB00454 3058 19 None -2 4 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
2291 3184 58 None -147 13 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O 10.1038/s41467-023-40064-9
2561 3184 58 None -147 13 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O 10.1038/s41467-023-40064-9
4932 3184 58 None -147 13 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O 10.1038/s41467-023-40064-9
CHEMBL631 3184 58 None -147 13 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O 10.1038/s41467-023-40064-9
DB01182 3184 58 None -147 13 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O 10.1038/s41467-023-40064-9
1588 2325 27 None -467 23 Human 7.1 pAC50 = 7.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
28864 2325 27 None -467 23 Human 7.1 pAC50 = 7.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
43 2325 27 None -467 23 Human 7.1 pAC50 = 7.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
CHEMBL157138 2325 27 None -467 23 Human 7.1 pAC50 = 7.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
DB00589 2325 27 None -467 23 Human 7.1 pAC50 = 7.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 10.1038/s41467-023-40064-9
82146 4530 113 None 1 8 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 348 3 1 1 6.1 C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C 10.1038/s41467-023-40064-9
CHEMBL1023 4530 113 None 1 8 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 348 3 1 1 6.1 C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C 10.1038/s41467-023-40064-9
2803 955 58 None -3 14 Human 8.1 pAC50 = 8.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
516 955 58 None -3 14 Human 8.1 pAC50 = 8.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
704 955 58 None -3 14 Human 8.1 pAC50 = 8.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
CHEMBL134 955 58 None -3 14 Human 8.1 pAC50 = 8.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
DB00575 955 58 None -3 14 Human 8.1 pAC50 = 8.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
2470 3653 50 None -13803 23 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
3300 3653 50 None -13803 23 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
5265 3653 50 None -13803 23 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
99 3653 50 None -13803 23 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL267930 3653 50 None -13803 23 Human 7.1 pAC50 = 7.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
154257 178619 67 None -13 19 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 470 7 2 5 6.3 Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12 10.1038/s41467-023-40064-9
CHEMBL46740 178619 67 None -13 19 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 470 7 2 5 6.3 Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12 10.1038/s41467-023-40064-9
6324616 168824 25 None 1 3 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 697 2 6 12 4.8 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(cc(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
CHEMBL437765 168824 25 None 1 3 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 697 2 6 12 4.8 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(cc(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
3949 100614 50 None -8 16 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 468 8 0 5 4.9 COc1ccc(CN2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)c(OC)c1OC 10.1038/s41467-023-40064-9
CHEMBL29188 100614 50 None -8 16 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 468 8 0 5 4.9 COc1ccc(CN2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)c(OC)c1OC 10.1038/s41467-023-40064-9
444029 167757 10 None -1 2 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 509 6 2 9 2.0 C=C[C@@]1(C)CC(=O)[C@]2(O)[C@@]3(C)[C@@H](O)CCC(C)(C)[C@@H]3[C@H](OC(=O)CCN(C)C)[C@H](OC(C)=O)[C@@]2(C)O1 10.1038/s41467-023-40064-9
CHEMBL4303178 167757 10 None -1 2 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 509 6 2 9 2.0 C=C[C@@]1(C)CC(=O)[C@]2(O)[C@@]3(C)[C@@H](O)CCC(C)(C)[C@@H]3[C@H](OC(=O)CCN(C)C)[C@H](OC(C)=O)[C@@]2(C)O1 10.1038/s41467-023-40064-9
4631 194972 29 None -1071 5 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 265 9 2 4 2.0 C=CCOc1ccccc1OCC(O)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL546 194972 29 None -1071 5 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 265 9 2 4 2.0 C=CCOc1ccccc1OCC(O)CNC(C)C 10.1038/s41467-023-40064-9
71398 106439 44 None -1174 14 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 302 5 4 4 3.6 C[C@@H](Cc1ccc(O)c(O)c1)[C@H](C)Cc1ccc(O)c(O)c1 10.1038/s41467-023-40064-9
CHEMBL313972 106439 44 None -1174 14 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 302 5 4 4 3.6 C[C@@H](Cc1ccc(O)c(O)c1)[C@H](C)Cc1ccc(O)c(O)c1 10.1038/s41467-023-40064-9
31101 729 40 None -199 29 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
35 729 40 None -199 29 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
403 729 40 None -199 29 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
CHEMBL493 729 40 None -199 29 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
DB01200 729 40 None -199 29 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
11057 176149 23 None -1 25 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 10.1038/s41467-023-40064-9
3468 176149 23 None -1 25 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL459265 176149 23 None -1 25 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL64894 176149 23 None -1 25 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 10.1038/s41467-023-40064-9
636403 188268 22 None -3 7 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 570 5 2 5 6.8 CC1(C)[C@@H](OC(=O)CCC(=O)O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12 10.1038/s41467-023-40064-9
CHEMBL499915 188268 22 None -3 7 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 570 5 2 5 6.8 CC1(C)[C@@H](OC(=O)CCC(=O)O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12 10.1038/s41467-023-40064-9
124087 1389 114 None -112 27 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
7157 1389 114 None -112 27 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
814 1389 114 None -112 27 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
CHEMBL1172 1389 114 None -112 27 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
DB00967 1389 114 None -112 27 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
41684 31221 105 None -19 32 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 307 4 1 7 2.2 CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1 10.1038/s41467-023-40064-9
CHEMBL1401 31221 105 None -19 32 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 307 4 1 7 2.2 CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1 10.1038/s41467-023-40064-9
5284550 41721 15 None -87 16 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 3 0 2 4.7 CN(C)CC/C=C1\c2ccccc2CSc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1492500 41721 15 None -87 16 Human 6.1 pAC50 = 6.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 3 0 2 4.7 CN(C)CC/C=C1\c2ccccc2CSc2ccccc21 10.1038/s41467-023-40064-9
21855 84246 42 None -112 9 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 292 5 0 2 4.1 CC(C1=C(CCN(C)C)Cc2ccccc21)c1ccccn1 10.1038/s41467-023-40064-9
CHEMBL22108 84246 42 None -112 9 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 292 5 0 2 4.1 CC(C1=C(CCN(C)C)Cc2ccccc21)c1ccccn1 10.1038/s41467-023-40064-9
134 2514 24 None -457 18 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO 10.1038/s41467-023-40064-9
1775 2514 24 None -457 18 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO 10.1038/s41467-023-40064-9
9681 2514 24 None -457 18 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO 10.1038/s41467-023-40064-9
CHEMBL1065 2514 24 None -457 18 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO 10.1038/s41467-023-40064-9
DB00247 2514 24 None -457 18 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO 10.1038/s41467-023-40064-9
2391 207453 92 None -9 5 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 361 5 0 5 4.1 CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1 10.1038/s41467-023-40064-9
CHEMBL942 207453 92 None -9 5 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 361 5 0 5 4.1 CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1 10.1038/s41467-023-40064-9
151537 162664 49 None -1 4 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 543 5 6 12 0.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
41867 162664 49 None -1 4 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 543 5 6 12 0.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
CHEMBL417 162664 49 None -1 4 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 543 5 6 12 0.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
3294 2006 111 None -3 23 Human 8.0 pAC50 = 8.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
71360 2006 111 None -3 23 Human 8.0 pAC50 = 8.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
87 2006 111 None -3 23 Human 8.0 pAC50 = 8.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
CHEMBL14376 2006 111 None -3 23 Human 8.0 pAC50 = 8.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
DB04946 2006 111 None -3 23 Human 8.0 pAC50 = 8.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
1343 1889 62 None -9 12 Human 8.0 pAC50 = 8.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
3519 1889 62 None -9 12 Human 8.0 pAC50 = 8.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
522 1889 62 None -9 12 Human 8.0 pAC50 = 8.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
CHEMBL862 1889 62 None -9 12 Human 8.0 pAC50 = 8.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
DB01018 1889 62 None -9 12 Human 8.0 pAC50 = 8.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
2683 3834 60 None -10 6 Human 8.0 pAC50 = 8.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
5487 3834 60 None -10 6 Human 8.0 pAC50 = 8.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
7308 3834 60 None -10 6 Human 8.0 pAC50 = 8.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
CHEMBL1079 3834 60 None -10 6 Human 8.0 pAC50 = 8.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
DB00697 3834 60 None -10 6 Human 8.0 pAC50 = 8.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
4209 3163 75 None -24 17 Human 8.0 pAC50 = 8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
4893 3163 75 None -24 17 Human 8.0 pAC50 = 8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
503 3163 75 None -24 17 Human 8.0 pAC50 = 8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
5385 3163 75 None -24 17 Human 8.0 pAC50 = 8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
CHEMBL2 3163 75 None -24 17 Human 8.0 pAC50 = 8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
DB00457 3163 75 None -24 17 Human 8.0 pAC50 = 8 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
12574 2605 88 None -1 8 Human 7.1 pAC50 = 7.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 10.1038/s41467-023-40064-9
4810 2605 88 None -1 8 Human 7.1 pAC50 = 7.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 10.1038/s41467-023-40064-9
CHEMBL19236 2605 88 None -1 8 Human 7.1 pAC50 = 7.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 10.1038/s41467-023-40064-9
DB09242 2605 88 None -1 8 Human 7.1 pAC50 = 7.1 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 241 2 2 6 0.8 CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC 10.1038/s41467-023-40064-9
2419 3463 84 None -3019 14 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
5152 3463 84 None -3019 14 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
559 3463 84 None -3019 14 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
CHEMBL1263 3463 84 None -3019 14 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
DB00938 3463 84 None -3019 14 Human 6.0 pAC50 = 6.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate readerAgonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
25102847 78221 93 None -7 10 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 501 8 2 6 5.5 COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC 10.1038/s41467-023-40064-9
CHEMBL2105717 78221 93 None -7 10 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 501 8 2 6 5.5 COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC 10.1038/s41467-023-40064-9
3397 205488 112 None -1 7 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 3 1 3 3.2 CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1 10.1038/s41467-023-40064-9
CHEMBL806 205488 112 None -1 7 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 3 1 3 3.2 CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1 10.1038/s41467-023-40064-9
135398745 2914 112 None -14 33 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
47 2914 112 None -14 33 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
CHEMBL715 2914 112 None -14 33 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
DB00334 2914 112 None -14 33 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
277 1301 62 None -954 29 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 10.1038/s41467-023-40064-9
2913 1301 62 None -954 29 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 10.1038/s41467-023-40064-9
765 1301 62 None -954 29 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 10.1038/s41467-023-40064-9
CHEMBL516 1301 62 None -954 29 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 10.1038/s41467-023-40064-9
DB00434 1301 62 None -954 29 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 10.1038/s41467-023-40064-9
610479 15500 90 None 1 5 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 261 3 2 2 4.1 Cc1c(Cl)cccc1Nc1ccccc1C(=O)O 10.1038/s41467-023-40064-9
CHEMBL121626 15500 90 None 1 5 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 261 3 2 2 4.1 Cc1c(Cl)cccc1Nc1ccccc1C(=O)O 10.1038/s41467-023-40064-9
3280 48449 28 None -5 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 10 0 5 5.4 CCOc1ccc(Cc2nccc3cc(OCC)c(OCC)cc23)cc1OCC 10.1038/s41467-023-40064-9
CHEMBL1555736 48449 28 None -5 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 10 0 5 5.4 CCOc1ccc(Cc2nccc3cc(OCC)c(OCC)cc23)cc1OCC 10.1038/s41467-023-40064-9
3166 169420 23 None -1230 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 317 8 0 3 4.2 CCN(CC)CCOC(=O)C(c1ccccc1)C1CCCCC1 10.1038/s41467-023-40064-9
CHEMBL442444 169420 23 None -1230 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 317 8 0 3 4.2 CCN(CC)CCOC(=O)C(c1ccccc1)C1CCCCC1 10.1038/s41467-023-40064-9
2583 3776 118 None -3019 16 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
592 3776 118 None -3019 16 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
65999 3776 118 None -3019 16 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
CHEMBL1017 3776 118 None -3019 16 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
DB00966 3776 118 None -3019 16 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
1201549 597 24 None -138 26 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
333 597 24 None -138 26 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
7601 597 24 None -138 26 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1201203 597 24 None -138 26 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL438151 597 24 None -138 26 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
DB00245 597 24 None -138 26 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
2600 3779 74 None -151 32 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
2608 3779 74 None -151 32 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
5405 3779 74 None -151 32 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
CHEMBL17157 3779 74 None -151 32 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
DB00342 3779 74 None -151 32 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
1400 1957 70 None -15 16 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
3658 1957 70 None -15 16 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
7199 1957 70 None -15 16 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
91513 1957 70 None -15 16 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL896 1957 70 None -15 16 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
DB00557 1957 70 None -15 16 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
3678 94792 57 None -33 8 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 9 0 1 4.6 CCN(CCCc1ccccc1)CCCc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL253371 94792 57 None -33 8 Human 6.0 pAC50 = 6.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 281 9 0 1 4.6 CCN(CCCc1ccccc1)CCCc1ccccc1 10.1038/s41467-023-40064-9
7019 167976 106 None -2 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 194 0 1 2 3.0 Nc1c2ccccc2nc2ccccc12 10.1038/s41467-023-40064-9
CHEMBL1308088 167976 106 None -2 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 194 0 1 2 3.0 Nc1c2ccccc2nc2ccccc12 10.1038/s41467-023-40064-9
CHEMBL43184 167976 106 None -2 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 194 0 1 2 3.0 Nc1c2ccccc2nc2ccccc12 10.1038/s41467-023-40064-9
150311 9812 102 None -2 7 Human 5.0 pAC50 = 5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 409 6 2 3 4.9 O=C1[C@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1 10.1038/s41467-023-40064-9
CHEMBL1138 9812 102 None -2 7 Human 5.0 pAC50 = 5 Functional
Agonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human ADRA1A in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 409 6 2 3 4.9 O=C1[C@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1 10.1038/s41467-023-40064-9
10934575 204486 0 None 3 5 Human 10.0 pEC50 = 10.0 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 235 4 2 4 2.1 CSc1ccc(C)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL72441 204486 0 None 3 5 Human 10.0 pEC50 = 10.0 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 235 4 2 4 2.1 CSc1ccc(C)cc1NCC1=NCCN1 10.1021/jm000542r
44362146 164934 1 None 50 3 Human 9.6 pEC50 = 9.6 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 258 4 1 4 2.8 c1ccc(-c2ccsc2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL422477 164934 1 None 50 3 Human 9.6 pEC50 = 9.6 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 258 4 1 4 2.8 c1ccc(-c2ccsc2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
44574074 189469 0 None 977 2 Human 9.4 pEC50 = 9.4 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 262 2 0 4 2.7 c1ccc([C@@H]2Cc3nccn3C2)c(-c2cncnc2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL513691 189469 0 None 977 2 Human 9.4 pEC50 = 9.4 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 262 2 0 4 2.7 c1ccc([C@@H]2Cc3nccn3C2)c(-c2cncnc2)c1 10.1016/j.bmcl.2009.03.166
11109088 204180 0 None 1 5 Human 9.4 pEC50 = 9.4 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 255 4 2 4 2.5 CSc1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70751 204180 0 None 1 5 Human 9.4 pEC50 = 9.4 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 255 4 2 4 2.5 CSc1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
22493318 44757 0 None 13 3 Human 9.3 pEC50 = 9.3 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 241 4 2 4 2.4 c1coc(-c2ccccc2NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
CHEMBL152155 44757 0 None 13 3 Human 9.3 pEC50 = 9.3 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 241 4 2 4 2.4 c1coc(-c2ccccc2NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
44362194 34382 1 None 10 3 Human 9.3 pEC50 = 9.3 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 242 4 1 4 2.3 c1ccc(-c2ccoc2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL142784 34382 1 None 10 3 Human 9.3 pEC50 = 9.3 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 242 4 1 4 2.3 c1ccc(-c2ccoc2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
22493352 48274 0 None 2 3 Human 9.2 pEC50 = 9.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 242 4 2 5 1.8 c1ccc(-c2ncco2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
CHEMBL155326 48274 0 None 2 3 Human 9.2 pEC50 = 9.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 242 4 2 5 1.8 c1ccc(-c2ncco2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
22493236 60396 0 None 5 3 Human 9.1 pEC50 = 9.1 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 242 4 3 5 0.9 c1ccc(-c2nc[nH]n2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(03)00050-7
CHEMBL17491 60396 0 None 5 3 Human 9.1 pEC50 = 9.1 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 242 4 3 5 0.9 c1ccc(-c2nc[nH]n2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(03)00050-7
44271661 161796 0 None -1 3 Human 9.1 pEC50 = 9.1 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 233 4 2 5 0.9 COC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL414185 161796 0 None -1 3 Human 9.1 pEC50 = 9.1 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 233 4 2 5 0.9 COC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
44271661 161796 0 None -1 3 Human 9.1 pEC50 = 9.1 Functional
Effective concentration showing agonistic activity towards Human alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cells was determinedEffective concentration showing agonistic activity towards Human alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cells was determined
ChEMBL 233 4 2 5 0.9 COC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL414185 161796 0 None -1 3 Human 9.1 pEC50 = 9.1 Functional
Effective concentration showing agonistic activity towards Human alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cells was determinedEffective concentration showing agonistic activity towards Human alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cells was determined
ChEMBL 233 4 2 5 0.9 COC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
22493280 48275 0 None 1 3 Human 9.1 pEC50 = 9.1 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 242 4 2 5 1.8 c1ccc(-c2ccno2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
CHEMBL155327 48275 0 None 1 3 Human 9.1 pEC50 = 9.1 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 242 4 2 5 1.8 c1ccc(-c2ccno2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
44271661 161796 0 None -1 3 Human 9.1 pEC50 = 9.1 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 233 4 2 5 0.9 COC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL414185 161796 0 None -1 3 Human 9.1 pEC50 = 9.1 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 233 4 2 5 0.9 COC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
44369431 45355 0 None 57 3 Human 9.1 pEC50 = 9.1 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 271 4 2 4 3.1 Cc1ccsc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL152693 45355 0 None 57 3 Human 9.1 pEC50 = 9.1 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 271 4 2 4 3.1 Cc1ccsc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
44362208 35433 1 None 3 3 Human 9.0 pEC50 = 9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 258 4 1 4 2.8 c1csc(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL143801 35433 1 None 3 3 Human 9.0 pEC50 = 9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 258 4 1 4 2.8 c1csc(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
22493258 98664 0 None 5 3 Human 9.0 pEC50 = 9 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 241 4 3 4 1.5 c1ccc(-c2cc[nH]n2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(03)00050-7
CHEMBL277375 98664 0 None 5 3 Human 9.0 pEC50 = 9 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 241 4 3 4 1.5 c1ccc(-c2cc[nH]n2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(03)00050-7
44574078 178761 0 None 120 3 Human 9.0 pEC50 = 9 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 261 2 0 3 3.3 c1cncc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL468711 178761 0 None 120 3 Human 9.0 pEC50 = 9 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 261 2 0 3 3.3 c1cncc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
44219718 188846 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 280 2 0 4 2.8 Fc1ccc(-c2cncnc2)c(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL506744 188846 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 280 2 0 4 2.8 Fc1ccc(-c2cncnc2)c(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
44362286 98886 1 None 7 2 Human 8.9 pEC50 = 8.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 242 4 1 4 2.3 c1coc(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL279136 98886 1 None 7 2 Human 8.9 pEC50 = 8.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 242 4 1 4 2.3 c1coc(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
44362195 121089 0 None 2 3 Human 8.9 pEC50 = 8.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 241 4 2 3 2.1 c1c[nH]c(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL357129 121089 0 None 2 3 Human 8.9 pEC50 = 8.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 241 4 2 3 2.1 c1c[nH]c(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
22493263 98084 0 None 50 3 Human 8.9 pEC50 = 8.9 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 270 5 2 6 1.4 CCn1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL273316 98084 0 None 50 3 Human 8.9 pEC50 = 8.9 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 270 5 2 6 1.4 CCn1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
22493365 98464 0 None 15 3 Human 8.9 pEC50 = 8.9 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 241 4 3 4 1.5 c1ccc(-c2cn[nH]c2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(03)00050-7
CHEMBL275844 98464 0 None 15 3 Human 8.9 pEC50 = 8.9 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 241 4 3 4 1.5 c1ccc(-c2cn[nH]c2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(03)00050-7
44329788 208102 0 None - 1 Human 8.9 pEC50 = 8.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 275 6 2 5 2.1 CCC(C)OC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL97859 208102 0 None - 1 Human 8.9 pEC50 = 8.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 275 6 2 5 2.1 CCC(C)OC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
11098175 204170 0 None 2 4 Human 8.8 pEC50 = 8.8 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 251 5 2 5 1.8 COc1ccc(SC)c(NCC2=NCCN2)c1 10.1021/jm000542r
CHEMBL70691 204170 0 None 2 4 Human 8.8 pEC50 = 8.8 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 251 5 2 5 1.8 COc1ccc(SC)c(NCC2=NCCN2)c1 10.1021/jm000542r
10221005 204322 0 None 72 3 Human 8.7 pEC50 = 8.7 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 267 4 2 5 0.8 Cc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
CHEMBL71479 204322 0 None 72 3 Human 8.7 pEC50 = 8.7 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 267 4 2 5 0.8 Cc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
44362185 121029 0 None 19 3 Human 8.7 pEC50 = 8.7 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 253 4 1 4 2.1 c1cncc(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL356605 121029 0 None 19 3 Human 8.7 pEC50 = 8.7 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 253 4 1 4 2.1 c1cncc(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
22493343 63971 0 None 19 3 Human 8.7 pEC50 = 8.7 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 256 4 2 6 0.9 Cn1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL18069 63971 0 None 19 3 Human 8.7 pEC50 = 8.7 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 256 4 2 6 0.9 Cn1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
44343410 11555 2 None -1 3 Human 8.0 pEC50 = 8 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 219 4 2 3 2.7 CSc1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
CHEMBL118055 11555 2 None -1 3 Human 8.0 pEC50 = 8 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 219 4 2 3 2.7 CSc1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
9837963 62971 0 None 8 3 Human 8.0 pEC50 = 8 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 255 4 2 5 1.5 Cn1nccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL17851 62971 0 None 8 3 Human 8.0 pEC50 = 8 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 255 4 2 5 1.5 Cn1nccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
44329796 208379 0 None 1 3 Human 8.0 pEC50 = 8 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 275 7 2 5 2.1 CCCCOC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL99559 208379 0 None 1 3 Human 8.0 pEC50 = 8 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 275 7 2 5 2.1 CCCCOC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
22493289 49688 0 None 4 3 Human 8.0 pEC50 = 8 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 253 4 2 5 1.6 c1cnc(-c2ccccc2NCC2=NCCN2)nc1 10.1016/s0960-894x(01)00822-8
CHEMBL156661 49688 0 None 4 3 Human 8.0 pEC50 = 8 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 253 4 2 5 1.6 c1cnc(-c2ccccc2NCC2=NCCN2)nc1 10.1016/s0960-894x(01)00822-8
11034737 204528 0 None -1 4 Human 8.0 pEC50 = 8.0 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 289 4 2 4 2.8 CSc1ccc(C(F)(F)F)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL72724 204528 0 None -1 4 Human 8.0 pEC50 = 8.0 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 289 4 2 4 2.8 CSc1ccc(C(F)(F)F)cc1NCC1=NCCN1 10.1021/jm000542r
44362145 34483 3 None - 1 Human 7.0 pEC50 = 7 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 242 4 2 4 1.5 c1ccc(-c2ncc[nH]2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL142864 34483 3 None - 1 Human 7.0 pEC50 = 7 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 242 4 2 4 1.5 c1ccc(-c2ncc[nH]2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
22493401 208249 0 None - 1 Human 7.0 pEC50 = 7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 288 7 2 4 2.0 CCCN(CC)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL98769 208249 0 None - 1 Human 7.0 pEC50 = 7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 288 7 2 4 2.0 CCCN(CC)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
22493225 62512 0 None - 1 Human 6.0 pEC50 = 6 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 270 4 2 6 1.2 Cc1nc(-c2ccccc2NCC2=NCCN2)n(C)n1 10.1016/s0960-894x(03)00050-7
CHEMBL17819 62512 0 None - 1 Human 6.0 pEC50 = 6 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 270 4 2 6 1.2 Cc1nc(-c2ccccc2NCC2=NCCN2)n(C)n1 10.1016/s0960-894x(03)00050-7
44574878 178547 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 228 2 1 2 2.7 COc1cccc(C2CCc3nc[nH]c3C2)c1 10.1016/j.bmcl.2009.03.162
CHEMBL466916 178547 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 228 2 1 2 2.7 COc1cccc(C2CCc3nc[nH]c3C2)c1 10.1016/j.bmcl.2009.03.162
22493372 120238 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 256 4 2 5 2.1 Cc1ncc(-c2ccccc2NCC2=NCCN2)o1 10.1016/s0960-894x(01)00822-8
CHEMBL352225 120238 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 256 4 2 5 2.1 Cc1ncc(-c2ccccc2NCC2=NCCN2)o1 10.1016/s0960-894x(01)00822-8
11059195 102172 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 321 4 2 5 1.5 CS(=O)(=O)c1ccc(C(F)(F)F)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL302698 102172 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 321 4 2 5 1.5 CS(=O)(=O)c1ccc(C(F)(F)F)cc1NCC1=NCCN1 10.1021/jm000542r
44574987 178677 0 None - 1 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 250 3 0 3 2.8 FC(F)Oc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
CHEMBL467915 178677 0 None - 1 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 250 3 0 3 2.8 FC(F)Oc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
76632 100050 51 None -5 2 Human 5.0 pEC50 = 5.0 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 181 4 1 3 1.2 COc1ccc(OC)c(CCN)c1 10.1021/jm00144a012
CHEMBL287047 100050 51 None -5 2 Human 5.0 pEC50 = 5.0 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 181 4 1 3 1.2 COc1ccc(OC)c(CCN)c1 10.1021/jm00144a012
44449657 96066 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 265 2 1 3 3.5 Cc1oncc1-c1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL260009 96066 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 265 2 1 3 3.5 Cc1oncc1-c1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44571891 170016 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 280 3 1 4 2.8 Cc1noc(Cc2cccc3c2CC[C@H]3c2ncc[nH]2)n1 10.1016/j.bmcl.2008.10.066
CHEMBL444252 170016 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 280 3 1 4 2.8 Cc1noc(Cc2cccc3c2CC[C@H]3c2ncc[nH]2)n1 10.1016/j.bmcl.2008.10.066
2435 722 100 None -25 10 Bovine 6.0 pEC50 = 6.0 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
395 722 100 None -25 10 Bovine 6.0 pEC50 = 6.0 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
520 722 100 None -25 10 Bovine 6.0 pEC50 = 6.0 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
5386 722 100 None -25 10 Bovine 6.0 pEC50 = 6.0 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
CHEMBL844 722 100 None -25 10 Bovine 6.0 pEC50 = 6.0 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
DB00484 722 100 None -25 10 Bovine 6.0 pEC50 = 6.0 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
44449690 96161 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 261 2 1 2 3.6 c1ccc(-c2cccc3c2CCC3c2ncc[nH]2)nc1 10.1016/j.bmcl.2008.03.070
CHEMBL260575 96161 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 261 2 1 2 3.6 c1ccc(-c2cccc3c2CCC3c2ncc[nH]2)nc1 10.1016/j.bmcl.2008.03.070
1960 2857 67 None -93 18 Rat 5.9 pEC50 = 5.9 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
439260 2857 67 None -93 18 Rat 5.9 pEC50 = 5.9 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
505 2857 67 None -93 18 Rat 5.9 pEC50 = 5.9 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
CHEMBL1437 2857 67 None -93 18 Rat 5.9 pEC50 = 5.9 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
DB00368 2857 67 None -93 18 Rat 5.9 pEC50 = 5.9 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
44574105 178808 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 305 5 1 4 1.3 CNS(=O)(=O)CCc1ccccc1[C@@H]1Cc2nccn2C1 10.1016/j.bmcl.2009.03.166
CHEMBL469127 178808 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 305 5 1 4 1.3 CNS(=O)(=O)CCc1ccccc1[C@@H]1Cc2nccn2C1 10.1016/j.bmcl.2009.03.166
44574045 189286 0 None 60 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 260 2 0 2 3.9 c1ccc(-c2ccccc2[C@@H]2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.166
CHEMBL512062 189286 0 None 60 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 260 2 0 2 3.9 c1ccc(-c2ccccc2[C@@H]2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.166
2765 943 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(02)00753-9
515 943 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(02)00753-9
CHEMBL13852 943 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(02)00753-9
DB09202 943 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(02)00753-9
22493274 11038 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 258 4 2 4 2.1 c1ccc(N2CCCCC2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(02)00753-9
CHEMBL117581 11038 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 258 4 2 4 2.1 c1ccc(N2CCCCC2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(02)00753-9
10015132 163869 1 None 29 3 Human 7.9 pEC50 = 7.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 253 4 1 4 2.1 c1ccc(-c2ccccc2OCC2=NCCN2)nc1 10.1016/s0960-894x(02)00753-9
CHEMBL420683 163869 1 None 29 3 Human 7.9 pEC50 = 7.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 253 4 1 4 2.1 c1ccc(-c2ccccc2OCC2=NCCN2)nc1 10.1016/s0960-894x(02)00753-9
9817256 204238 0 None 251 2 Human 7.9 pEC50 = 7.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 283 5 2 6 0.5 COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1016/s0960-894x(02)00753-9
CHEMBL71001 204238 0 None 251 2 Human 7.9 pEC50 = 7.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 283 5 2 6 0.5 COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1016/s0960-894x(02)00753-9
2765 943 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00764-8
515 943 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00764-8
CHEMBL13852 943 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00764-8
DB09202 943 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00764-8
10038958 118725 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 273 4 1 5 2.5 Cc1cnsc1-c1ccccc1OCC1=NCCN1 10.1016/s0960-894x(01)00764-8
CHEMBL341747 118725 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 273 4 1 5 2.5 Cc1cnsc1-c1ccccc1OCC1=NCCN1 10.1016/s0960-894x(01)00764-8
10015132 163869 1 None 29 3 Human 7.9 pEC50 = 7.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 253 4 1 4 2.1 c1ccc(-c2ccccc2OCC2=NCCN2)nc1 10.1016/s0960-894x(01)00764-8
CHEMBL420683 163869 1 None 29 3 Human 7.9 pEC50 = 7.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 253 4 1 4 2.1 c1ccc(-c2ccccc2OCC2=NCCN2)nc1 10.1016/s0960-894x(01)00764-8
22493265 62134 0 None 19 3 Human 7.9 pEC50 = 7.9 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 284 6 2 6 1.8 CCCn1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL17776 62134 0 None 19 3 Human 7.9 pEC50 = 7.9 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 284 6 2 6 1.8 CCCn1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
2765 943 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00569-8
515 943 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00569-8
CHEMBL13852 943 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00569-8
DB09202 943 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00569-8
44329790 112546 0 None 5 3 Human 7.9 pEC50 = 7.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 247 5 2 5 1.3 CCOC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL329928 112546 0 None 5 3 Human 7.9 pEC50 = 7.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 247 5 2 5 1.3 CCOC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
22493224 208345 4 None 6 3 Human 7.9 pEC50 = 7.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 246 5 3 4 0.9 CCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL99362 208345 4 None 6 3 Human 7.9 pEC50 = 7.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 246 5 3 4 0.9 CCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
2765 943 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00822-8
515 943 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00822-8
CHEMBL13852 943 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00822-8
DB09202 943 19 None 4 7 Human 7.9 pEC50 = 7.9 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 10.1016/s0960-894x(01)00822-8
12924821 102897 7 None - 1 Human 6.9 pEC50 = 6.9 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 207 2 1 3 1.5 COc1ccc(OC)c2c1CCC(N)C2 10.1021/jm00144a012
CHEMBL30596 102897 7 None - 1 Human 6.9 pEC50 = 6.9 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 207 2 1 3 1.5 COc1ccc(OC)c2c1CCC(N)C2 10.1021/jm00144a012
44593577 178464 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 198 1 1 1 2.7 c1ccc(C2CCc3nc[nH]c3C2)cc1 10.1016/j.bmcl.2009.03.162
CHEMBL466296 178464 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 198 1 1 1 2.7 c1ccc(C2CCc3nc[nH]c3C2)cc1 10.1016/j.bmcl.2009.03.162
44343251 10520 2 None - 1 Human 6.9 pEC50 = 6.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 251 4 2 4 1.4 CS(=O)(=O)c1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
CHEMBL116843 10520 2 None - 1 Human 6.9 pEC50 = 6.9 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 251 4 2 4 1.4 CS(=O)(=O)c1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
44362510 118933 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 267 4 1 4 2.4 Cc1cccc(-c2ccccc2OCC2=NCCN2)n1 10.1016/s0960-894x(01)00764-8
CHEMBL342324 118933 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 267 4 1 4 2.4 Cc1cccc(-c2ccccc2OCC2=NCCN2)n1 10.1016/s0960-894x(01)00764-8
22493257 207646 3 None 2 2 Human 6.9 pEC50 = 6.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 272 4 2 4 1.3 O=C(c1ccccc1NCC1=NCCN1)N1CCCC1 10.1016/s0960-894x(01)00569-8
CHEMBL95245 207646 3 None 2 2 Human 6.9 pEC50 = 6.9 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 272 4 2 4 1.3 O=C(c1ccccc1NCC1=NCCN1)N1CCCC1 10.1016/s0960-894x(01)00569-8
44362289 121697 1 None - 1 Human 5.9 pEC50 = 5.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 254 4 1 5 1.5 c1cnc(-c2ccccc2OCC2=NCCN2)nc1 10.1016/s0960-894x(01)00764-8
CHEMBL358802 121697 1 None - 1 Human 5.9 pEC50 = 5.9 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 254 4 1 5 1.5 c1cnc(-c2ccccc2OCC2=NCCN2)nc1 10.1016/s0960-894x(01)00764-8
44449306 95606 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 305 5 2 3 2.6 CCCS(=O)(=O)Nc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL257801 95606 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 305 5 2 3 2.6 CCCS(=O)(=O)Nc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44449730 156108 0 None 22 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 250 2 2 2 2.9 c1cc(-c2cn[nH]c2)c2c(c1)C(c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.03.070
CHEMBL406316 156108 0 None 22 2 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 250 2 2 2 2.9 c1cc(-c2cn[nH]c2)c2c(c1)C(c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.03.070
9817256 204238 0 None 251 2 Human 7.9 pEC50 = 7.9 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 283 5 2 6 0.5 COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
CHEMBL71001 204238 0 None 251 2 Human 7.9 pEC50 = 7.9 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 283 5 2 6 0.5 COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
44449278 95652 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL257977 95652 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44574877 178541 0 None 23 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 228 2 1 2 2.7 COc1ccccc1C1CCc2nc[nH]c2C1 10.1016/j.bmcl.2009.03.162
CHEMBL466869 178541 0 None 23 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 228 2 1 2 2.7 COc1ccccc1C1CCc2nc[nH]c2C1 10.1016/j.bmcl.2009.03.162
44574135 189178 0 None 18 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 268 2 1 3 2.8 Fc1ccc(C2Cc3nccn3C2)c(-c2ccn[nH]2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL511211 189178 0 None 18 2 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 268 2 1 3 2.8 Fc1ccc(C2Cc3nccn3C2)c(-c2ccn[nH]2)c1 10.1016/j.bmcl.2009.03.166
22493269 46826 0 None 6 3 Human 7.8 pEC50 = 7.8 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 256 4 2 5 2.1 Cc1ncoc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL154023 46826 0 None 6 3 Human 7.8 pEC50 = 7.8 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 256 4 2 5 2.1 Cc1ncoc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
44343257 10500 0 None 13 3 Human 7.8 pEC50 = 7.8 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 250 4 1 2 3.7 c1ccc(-c2ccccc2OCc2c[nH]cn2)cc1 10.1016/s0960-894x(02)00753-9
CHEMBL116700 10500 0 None 13 3 Human 7.8 pEC50 = 7.8 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 250 4 1 2 3.7 c1ccc(-c2ccccc2OCc2c[nH]cn2)cc1 10.1016/s0960-894x(02)00753-9
10199052 207954 0 None 5 3 Human 7.8 pEC50 = 7.8 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 258 5 3 4 1.0 O=C(NC1CC1)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL97044 207954 0 None 5 3 Human 7.8 pEC50 = 7.8 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 258 5 3 4 1.0 O=C(NC1CC1)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
619552 102698 3 None - 1 Rat 5.8 pEC50 = 5.8 Functional
Vasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contractionVasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contraction
ChEMBL 250 2 0 3 2.5 Cn1nc(Cc2ccccc2)c2ccccc2c1=O 10.1016/j.bmcl.2006.02.003
CHEMBL304747 102698 3 None - 1 Rat 5.8 pEC50 = 5.8 Functional
Vasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contractionVasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contraction
ChEMBL 250 2 0 3 2.5 Cn1nc(Cc2ccccc2)c2ccccc2c1=O 10.1016/j.bmcl.2006.02.003
45280075 122363 0 None -91 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 430 10 4 6 2.5 CS(=O)(=O)Nc1cccc([C@@H](O)CNCCOc2ccc3c(C4CC4)n[nH]c3c2)c1 10.1021/acs.jmedchem.5b00638
CHEMBL3600395 122363 0 None -91 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 430 10 4 6 2.5 CS(=O)(=O)Nc1cccc([C@@H](O)CNCCOc2ccc3c(C4CC4)n[nH]c3c2)c1 10.1021/acs.jmedchem.5b00638
44343235 10197 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 241 4 1 4 2.6 c1ccc(-c2ccno2)c(OCc2c[nH]cn2)c1 10.1016/s0960-894x(02)00753-9
CHEMBL115977 10197 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 241 4 1 4 2.6 c1ccc(-c2ccno2)c(OCc2c[nH]cn2)c1 10.1016/s0960-894x(02)00753-9
44362013 35383 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 273 4 1 5 2.5 Cc1cc(-c2ccccc2OCC2=NCCN2)sn1 10.1016/s0960-894x(01)00764-8
CHEMBL143766 35383 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 273 4 1 5 2.5 Cc1cc(-c2ccccc2OCC2=NCCN2)sn1 10.1016/s0960-894x(01)00764-8
481 2892 7 None 8 2 Human 6.8 pEC50 = 6.8 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 10.1021/jm000542r
9838763 2892 7 None 8 2 Human 6.8 pEC50 = 6.8 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 10.1021/jm000542r
CHEMBL72958 2892 7 None 8 2 Human 6.8 pEC50 = 6.8 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 10.1021/jm000542r
10199335 204747 0 None 120 2 Human 7.8 pEC50 = 7.8 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL74467 204747 0 None 120 2 Human 7.8 pEC50 = 7.8 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
44574834 172621 1 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 1 1 2.3 c1ccc2c(c1)CC(c1ncc[nH]1)C2 10.1016/j.bmcl.2009.03.162
CHEMBL449279 172621 1 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 1 1 2.3 c1ccc2c(c1)CC(c1ncc[nH]1)C2 10.1016/j.bmcl.2009.03.162
2146 3100 67 None -186 14 Rat 5.8 pEC50 = 5.8 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
485 3100 67 None -186 14 Rat 5.8 pEC50 = 5.8 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
6041 3100 67 None -186 14 Rat 5.8 pEC50 = 5.8 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
CHEMBL1215 3100 67 None -186 14 Rat 5.8 pEC50 = 5.8 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
DB00388 3100 67 None -186 14 Rat 5.8 pEC50 = 5.8 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
44449247 95414 0 None 1 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 228 2 1 2 2.8 COc1c(C)ccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL256984 95414 0 None 1 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 228 2 1 2 2.8 COc1c(C)ccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44571843 179321 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 242 4 1 2 2.7 COCCc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL473425 179321 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 242 4 1 2 2.7 COCCc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
44571937 189550 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 282 3 1 3 2.9 Fc1ccn(Cc2cccc3c2CCC3c2ncc[nH]2)n1 10.1016/j.bmcl.2008.10.066
CHEMBL514333 189550 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 282 3 1 3 2.9 Fc1ccn(Cc2cccc3c2CCC3c2ncc[nH]2)n1 10.1016/j.bmcl.2008.10.066
9794803 11006 2 None 4 3 Human 7.8 pEC50 = 7.8 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 242 4 2 5 1.8 c1ccc(-c2cnco2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
CHEMBL117381 11006 2 None 4 3 Human 7.8 pEC50 = 7.8 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 242 4 2 5 1.8 c1ccc(-c2cnco2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
44449692 156985 0 None 8 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 251 2 1 3 3.1 c1cc(-c2ncco2)c2c(c1)C(c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.03.070
CHEMBL407308 156985 0 None 8 2 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 251 2 1 3 3.1 c1cc(-c2ncco2)c2c(c1)C(c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.03.070
44281493 99996 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 247 2 1 3 2.5 COc1ccc(OC)c2c1CC[C@H]1NCCCC21 10.1021/jm00144a012
CHEMBL286702 99996 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 247 2 1 3 2.5 COc1ccc(OC)c2c1CC[C@H]1NCCCC21 10.1021/jm00144a012
44574106 178426 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 317 3 1 3 3.3 CNC(=O)c1cccc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL466012 178426 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 317 3 1 3 3.3 CNC(=O)c1cccc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
44574107 188760 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 280 2 0 4 2.8 Fc1ccc(C2Cc3nccn3C2)c(-c2cncnc2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL505414 188760 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 280 2 0 4 2.8 Fc1ccc(C2Cc3nccn3C2)c(-c2cncnc2)c1 10.1016/j.bmcl.2009.03.166
44574935 172622 0 None 19 3 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 218 1 0 2 2.9 Clc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
CHEMBL449284 172622 0 None 19 3 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 218 1 0 2 2.9 Clc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
9794803 11006 2 None 4 3 Human 7.7 pEC50 = 7.7 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 242 4 2 5 1.8 c1ccc(-c2cnco2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(02)00753-9
CHEMBL117381 11006 2 None 4 3 Human 7.7 pEC50 = 7.7 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 242 4 2 5 1.8 c1ccc(-c2cnco2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(02)00753-9
9859855 60397 0 None 12 2 Human 7.7 pEC50 = 7.7 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 254 4 2 4 2.1 Cn1cccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL17492 60397 0 None 12 2 Human 7.7 pEC50 = 7.7 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 254 4 2 4 2.1 Cn1cccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
124 2981 47 None -8 24 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/s0960-894x(01)00569-8
2032 2981 47 None -8 24 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/s0960-894x(01)00569-8
4636 2981 47 None -8 24 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/s0960-894x(01)00569-8
CHEMBL762 2981 47 None -8 24 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/s0960-894x(01)00569-8
DB00935 2981 47 None -8 24 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/s0960-894x(01)00569-8
22493320 4204 0 None 3 3 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 246 4 2 4 0.8 CN(C)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL100198 4204 0 None 3 3 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 246 4 2 4 0.8 CN(C)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
44329481 4232 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 289 7 2 5 2.4 CCC(CC)OC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL100383 4232 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 289 7 2 5 2.4 CCC(CC)OC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
10378649 108593 0 None 15 3 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 274 7 3 4 1.6 CCCCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL320419 108593 0 None 15 3 Human 7.7 pEC50 = 7.7 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 274 7 3 4 1.6 CCCCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
124 2981 47 None -8 24 Human 7.7 pEC50 = 7.7 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/s0960-894x(01)00822-8
2032 2981 47 None -8 24 Human 7.7 pEC50 = 7.7 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/s0960-894x(01)00822-8
4636 2981 47 None -8 24 Human 7.7 pEC50 = 7.7 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/s0960-894x(01)00822-8
CHEMBL762 2981 47 None -8 24 Human 7.7 pEC50 = 7.7 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/s0960-894x(01)00822-8
DB00935 2981 47 None -8 24 Human 7.7 pEC50 = 7.7 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1016/s0960-894x(01)00822-8
11811395 204701 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 281 5 2 5 1.3 CC(C)S(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL74071 204701 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 281 5 2 5 1.3 CC(C)S(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
44571844 172555 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 295 4 2 2 3.1 FC(F)(F)CNCc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL448510 172555 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 295 4 2 2 3.1 FC(F)(F)CNCc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
22493367 66185 0 None 1 3 Human 6.7 pEC50 = 6.7 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 298 7 2 6 2.2 CCCCn1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL18436 66185 0 None 1 3 Human 6.7 pEC50 = 6.7 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 298 7 2 6 2.2 CCCCn1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
44574075 172576 0 None 72 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 251 2 0 4 2.9 c1ccc([C@@H]2Cc3nccn3C2)c(-c2ncco2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL448802 172576 0 None 72 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 251 2 0 4 2.9 c1ccc([C@@H]2Cc3nccn3C2)c(-c2ncco2)c1 10.1016/j.bmcl.2009.03.166
44369351 119602 0 None 2 3 Human 8.7 pEC50 = 8.7 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 257 4 2 4 2.8 c1csc(-c2ccccc2NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
CHEMBL346380 119602 0 None 2 3 Human 8.7 pEC50 = 8.7 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 257 4 2 4 2.8 c1csc(-c2ccccc2NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
11140347 204533 1 None -1 5 Human 8.6 pEC50 = 8.6 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 239 4 2 4 2.0 CSc1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL72768 204533 1 None -1 5 Human 8.6 pEC50 = 8.6 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 239 4 2 4 2.0 CSc1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
44362196 34488 1 None 7 3 Human 8.6 pEC50 = 8.6 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 259 4 1 5 2.2 c1ccc(-c2nccs2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL142871 34488 1 None 7 3 Human 8.6 pEC50 = 8.6 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 259 4 1 5 2.2 c1ccc(-c2nccs2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
44362288 35629 1 None 251 2 Human 8.6 pEC50 = 8.6 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 254 4 1 5 1.5 c1ccc(-c2cnccn2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL143973 35629 1 None 251 2 Human 8.6 pEC50 = 8.6 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 254 4 1 5 1.5 c1ccc(-c2cnccn2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
9881853 98474 0 None - 1 Human 8.6 pEC50 = 8.6 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 268 5 2 4 2.6 CCn1cccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL275902 98474 0 None - 1 Human 8.6 pEC50 = 8.6 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 268 5 2 4 2.6 CCn1cccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
10198532 207696 0 None 1 3 Human 8.6 pEC50 = 8.6 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 232 4 3 4 0.5 CNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL95523 207696 0 None 1 3 Human 8.6 pEC50 = 8.6 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 232 4 3 4 0.5 CNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
44369434 45381 0 None 17 2 Human 8.6 pEC50 = 8.6 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 255 4 2 4 2.7 Cc1ccc(-c2ccccc2NCC2=NCCN2)o1 10.1016/s0960-894x(01)00822-8
CHEMBL152725 45381 0 None 17 2 Human 8.6 pEC50 = 8.6 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 255 4 2 4 2.7 Cc1ccc(-c2ccccc2NCC2=NCCN2)o1 10.1016/s0960-894x(01)00822-8
9947861 204162 0 None 21 3 Human 8.6 pEC50 = 8.6 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 287 4 2 5 1.2 CS(=O)(=O)c1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70634 204162 0 None 21 3 Human 8.6 pEC50 = 8.6 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 287 4 2 5 1.2 CS(=O)(=O)c1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
124 2981 47 None -8 24 Human 7.7 pEC50 = 7.7 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
2032 2981 47 None -8 24 Human 7.7 pEC50 = 7.7 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
4636 2981 47 None -8 24 Human 7.7 pEC50 = 7.7 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
CHEMBL762 2981 47 None -8 24 Human 7.7 pEC50 = 7.7 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
DB00935 2981 47 None -8 24 Human 7.7 pEC50 = 7.7 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
10422033 120975 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 246 5 2 5 1.5 CO/N=C(\C)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL356195 120975 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 246 5 2 5 1.5 CO/N=C(\C)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
44281250 114806 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 247 2 1 3 2.5 COc1ccc(OC)c2c1CC[C@@H]1NCCCC21 10.1021/jm00144a012
CHEMBL33405 114806 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 247 2 1 3 2.5 COc1ccc(OC)c2c1CC[C@@H]1NCCCC21 10.1021/jm00144a012
44449691 96162 0 None 2 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 261 2 1 2 3.6 c1cncc(-c2cccc3c2CCC3c2ncc[nH]2)c1 10.1016/j.bmcl.2008.03.070
CHEMBL260576 96162 0 None 2 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 261 2 1 2 3.6 c1cncc(-c2cccc3c2CCC3c2ncc[nH]2)c1 10.1016/j.bmcl.2008.03.070
4038180 204 14 None -1 5 Human 7.7 pEC50 = 7.7 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
480 204 14 None -1 5 Human 7.7 pEC50 = 7.7 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
CHEMBL109783 204 14 None -1 5 Human 7.7 pEC50 = 7.7 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
44449278 95652 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL257977 95652 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
1960 2857 67 None -2 18 Human 5.7 pEC50 = 5.7 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
439260 2857 67 None -2 18 Human 5.7 pEC50 = 5.7 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
505 2857 67 None -2 18 Human 5.7 pEC50 = 5.7 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
CHEMBL1437 2857 67 None -2 18 Human 5.7 pEC50 = 5.7 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
DB00368 2857 67 None -2 18 Human 5.7 pEC50 = 5.7 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
10135864 122518 0 None -10 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 404 9 4 6 1.9 Cc1n[nH]c2cc(OCCNC[C@H](O)c3cccc(NS(C)(=O)=O)c3)ccc12 10.1021/acs.jmedchem.5b00638
CHEMBL3601200 122518 0 None -10 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 404 9 4 6 1.9 Cc1n[nH]c2cc(OCCNC[C@H](O)c3cccc(NS(C)(=O)=O)c3)ccc12 10.1021/acs.jmedchem.5b00638
44574937 178661 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 214 2 0 3 2.2 COc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
CHEMBL467688 178661 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 214 2 0 3 2.2 COc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
44449276 95651 0 None 1 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 241 2 2 2 1.8 CNC(=O)c1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL257976 95651 0 None 1 2 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 241 2 2 2 1.8 CNC(=O)c1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
11090351 163391 0 None 20 2 Human 7.6 pEC50 = 7.6 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL419448 163391 0 None 20 2 Human 7.6 pEC50 = 7.6 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
44449278 95652 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL257977 95652 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44593577 178464 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 198 1 1 1 2.7 c1ccc(C2CCc3nc[nH]c3C2)cc1 10.1016/j.bmcl.2009.03.162
CHEMBL466296 178464 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 198 1 1 1 2.7 c1ccc(C2CCc3nc[nH]c3C2)cc1 10.1016/j.bmcl.2009.03.162
10221004 204231 0 None 20 2 Human 6.6 pEC50 = 6.6 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 267 5 2 5 0.9 CCS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70973 204231 0 None 20 2 Human 6.6 pEC50 = 6.6 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 267 5 2 5 0.9 CCS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
22493356 47011 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 266 4 2 4 2.5 Cc1cccnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL154170 47011 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 266 4 2 4 2.5 Cc1cccnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
10804826 23615 2 None 1 2 Human 4.6 pEC50 = 4.6 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@@H]2C1=NCCN1 10.1021/jm960354u
CHEMBL133451 23615 2 None 1 2 Human 4.6 pEC50 = 4.6 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@@H]2C1=NCCN1 10.1021/jm960354u
216249 1305 51 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 317 5 2 5 1.4 Clc1ccc(c(c1NS(=O)(=O)C)C)OCC1=NCCN1 10.1016/j.bmcl.2008.03.070
3469 1305 51 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 317 5 2 5 1.4 Clc1ccc(c(c1NS(=O)(=O)C)C)OCC1=NCCN1 10.1016/j.bmcl.2008.03.070
CHEMBL257978 1305 51 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 317 5 2 5 1.4 Clc1ccc(c(c1NS(=O)(=O)C)C)OCC1=NCCN1 10.1016/j.bmcl.2008.03.070
10423384 34596 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 272 4 1 4 3.1 Cc1ccc(-c2ccccc2OCC2=NCCN2)s1 10.1016/s0960-894x(01)00764-8
CHEMBL142958 34596 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 272 4 1 4 3.1 Cc1ccc(-c2ccccc2OCC2=NCCN2)s1 10.1016/s0960-894x(01)00764-8
10084685 119436 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 273 4 1 5 2.5 Cc1csc(-c2ccccc2OCC2=NCCN2)n1 10.1016/s0960-894x(01)00764-8
CHEMBL344957 119436 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 273 4 1 5 2.5 Cc1csc(-c2ccccc2OCC2=NCCN2)n1 10.1016/s0960-894x(01)00764-8
10221066 163162 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 269 5 2 5 2.0 CCn1ccc(-c2ccccc2NCC2=NCCN2)n1 10.1016/s0960-894x(03)00050-7
CHEMBL417999 163162 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 269 5 2 5 2.0 CCn1ccc(-c2ccccc2NCC2=NCCN2)n1 10.1016/s0960-894x(03)00050-7
44271931 98393 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 283 6 2 5 2.4 CCCn1nccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL275386 98393 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 283 6 2 5 2.4 CCCn1nccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
10180440 122519 0 None -6 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 420 10 4 7 1.6 COc1n[nH]c2cc(OCCNC[C@H](O)c3cccc(NS(C)(=O)=O)c3)ccc12 10.1021/acs.jmedchem.5b00638
CHEMBL3601201 122519 0 None -6 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 420 10 4 7 1.6 COc1n[nH]c2cc(OCCNC[C@H](O)c3cccc(NS(C)(=O)=O)c3)ccc12 10.1021/acs.jmedchem.5b00638
2683 3834 60 None 1 6 Bovine 6.6 pEC50 = 6.6 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 nan
5487 3834 60 None 1 6 Bovine 6.6 pEC50 = 6.6 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 nan
7308 3834 60 None 1 6 Bovine 6.6 pEC50 = 6.6 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 nan
CHEMBL1079 3834 60 None 1 6 Bovine 6.6 pEC50 = 6.6 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 nan
DB00697 3834 60 None 1 6 Bovine 6.6 pEC50 = 6.6 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 nan
44574138 178505 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 268 2 0 4 2.5 Fc1ccc(C2Cc3nccn3C2)c(-n2cccn2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL466635 178505 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 268 2 0 4 2.5 Fc1ccc(C2Cc3nccn3C2)c(-n2cccn2)c1 10.1016/j.bmcl.2009.03.166
44593557 183918 11 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 262 3 1 2 3.3 COCc1c(Cl)ccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2009.03.162
CHEMBL481322 183918 11 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 262 3 1 2 3.3 COCc1c(Cl)ccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2009.03.162
44574874 178393 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 232 1 1 1 3.3 Clc1ccccc1C1CCc2nc[nH]c2C1 10.1016/j.bmcl.2009.03.162
CHEMBL465599 178393 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 232 1 1 1 3.3 Clc1ccccc1C1CCc2nc[nH]c2C1 10.1016/j.bmcl.2009.03.162
122184771 122520 0 None -3 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 434 11 4 7 2.0 CCOc1n[nH]c2cc(OCCNC[C@H](O)c3cccc(NS(C)(=O)=O)c3)ccc12 10.1021/acs.jmedchem.5b00638
CHEMBL3601202 122520 0 None -3 2 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 434 11 4 7 2.0 CCOc1n[nH]c2cc(OCCNC[C@H](O)c3cccc(NS(C)(=O)=O)c3)ccc12 10.1021/acs.jmedchem.5b00638
44449723 156134 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 264 2 1 3 2.9 Cn1nccc1-c1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL406348 156134 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 264 2 1 3 2.9 Cn1nccc1-c1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
124 2981 47 None -52 24 Rat 6.5 pEC50 = 6.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
2032 2981 47 None -52 24 Rat 6.5 pEC50 = 6.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
4636 2981 47 None -52 24 Rat 6.5 pEC50 = 6.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
CHEMBL762 2981 47 None -52 24 Rat 6.5 pEC50 = 6.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
DB00935 2981 47 None -52 24 Rat 6.5 pEC50 = 6.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
2146 3100 67 None -20 14 Human 5.5 pEC50 = 5.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
485 3100 67 None -20 14 Human 5.5 pEC50 = 5.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
6041 3100 67 None -20 14 Human 5.5 pEC50 = 5.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
CHEMBL1215 3100 67 None -20 14 Human 5.5 pEC50 = 5.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
DB00388 3100 67 None -20 14 Human 5.5 pEC50 = 5.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
44574134 178504 0 None 91 3 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 269 2 0 4 3.0 Fc1ccc(-c2ncco2)c(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL466634 178504 0 None 91 3 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 269 2 0 4 3.0 Fc1ccc(-c2ncco2)c(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
44574077 178760 0 None - 1 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 267 2 0 4 3.3 c1ccc([C@@H]2Cc3nccn3C2)c(-c2nccs2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL468710 178760 0 None - 1 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 267 2 0 4 3.3 c1ccc([C@@H]2Cc3nccn3C2)c(-c2nccs2)c1 10.1016/j.bmcl.2009.03.166
44574136 189041 0 None - 1 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 268 2 1 3 2.8 Fc1ccc(-c2ccn[nH]2)c(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL509350 189041 0 None - 1 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 268 2 1 3 2.8 Fc1ccc(-c2ccn[nH]2)c(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
44449725 96190 0 None 208 3 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 264 2 2 2 3.2 Cc1n[nH]cc1-c1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL260720 96190 0 None 208 3 Human 8.5 pEC50 = 8.5 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 264 2 2 2 3.2 Cc1n[nH]cc1-c1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44269124 28818 1 None 23 3 Human 8.5 pEC50 = 8.5 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 252 4 1 3 2.7 c1ccc(-c2ccccc2OCC2=NCCN2)cc1 10.1016/s0960-894x(02)00753-9
CHEMBL13789 28818 1 None 23 3 Human 8.5 pEC50 = 8.5 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 252 4 1 3 2.7 c1ccc(-c2ccccc2OCC2=NCCN2)cc1 10.1016/s0960-894x(02)00753-9
44269124 28818 1 None 23 3 Human 8.5 pEC50 = 8.5 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 252 4 1 3 2.7 c1ccc(-c2ccccc2OCC2=NCCN2)cc1 10.1016/s0960-894x(01)00764-8
CHEMBL13789 28818 1 None 23 3 Human 8.5 pEC50 = 8.5 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 252 4 1 3 2.7 c1ccc(-c2ccccc2OCC2=NCCN2)cc1 10.1016/s0960-894x(01)00764-8
10060965 35234 1 None 39 3 Human 8.5 pEC50 = 8.5 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 256 4 1 4 2.6 Cc1ccoc1-c1ccccc1OCC1=NCCN1 10.1016/s0960-894x(01)00764-8
CHEMBL143562 35234 1 None 39 3 Human 8.5 pEC50 = 8.5 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 256 4 1 4 2.6 Cc1ccoc1-c1ccccc1OCC1=NCCN1 10.1016/s0960-894x(01)00764-8
9816515 62978 0 None 5 3 Human 8.5 pEC50 = 8.5 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 255 4 2 5 1.5 Cn1ccc(-c2ccccc2NCC2=NCCN2)n1 10.1016/s0960-894x(03)00050-7
CHEMBL17856 62978 0 None 5 3 Human 8.5 pEC50 = 8.5 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 255 4 2 5 1.5 Cn1ccc(-c2ccccc2NCC2=NCCN2)n1 10.1016/s0960-894x(03)00050-7
44329797 108106 0 None 67 3 Human 8.5 pEC50 = 8.5 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 261 5 2 5 1.7 CC(C)OC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL319553 108106 0 None 67 3 Human 8.5 pEC50 = 8.5 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 261 5 2 5 1.7 CC(C)OC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
10244367 50043 0 None - 1 Human 8.5 pEC50 = 8.5 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 6 2 5 1.9 CC/C(=N\OC)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL156950 50043 0 None - 1 Human 8.5 pEC50 = 8.5 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 6 2 5 1.9 CC/C(=N\OC)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
11000184 13052 0 None 4 5 Human 8.5 pEC50 = 8.5 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1190038 13052 0 None 4 5 Human 8.5 pEC50 = 8.5 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL540035 13052 0 None 4 5 Human 8.5 pEC50 = 8.5 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
44343247 110635 0 None 15 3 Human 8.4 pEC50 = 8.4 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 258 6 3 3 2.2 CCCNC(=O)c1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
CHEMBL325745 110635 0 None 15 3 Human 8.4 pEC50 = 8.4 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 258 6 3 3 2.2 CCCNC(=O)c1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
15959112 203532 0 None - 1 Rat 5.5 pEC50 = 5.5 Functional
Vasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contractionVasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contraction
ChEMBL 280 2 1 5 2.7 Oc1nnc(Cc2ccc3c(c2)OCO3)c2ccccc12 10.1016/j.bmcl.2006.02.003
CHEMBL66433 203532 0 None - 1 Rat 5.5 pEC50 = 5.5 Functional
Vasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contractionVasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contraction
ChEMBL 280 2 1 5 2.7 Oc1nnc(Cc2ccc3c(c2)OCO3)c2ccccc12 10.1016/j.bmcl.2006.02.003
11264016 99646 2 None - 1 Human 4.5 pEC50 = 4.5 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 193 2 1 3 1.1 COc1ccc(OC)c2c1CC(N)C2 10.1021/jm00144a012
CHEMBL284307 99646 2 None - 1 Human 4.5 pEC50 = 4.5 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 193 2 1 3 1.1 COc1ccc(OC)c2c1CC(N)C2 10.1021/jm00144a012
44281507 99927 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 233 2 1 3 2.4 COc1ccc(OC)c2c1C1CCC2[C@@H](N)C1 10.1021/jm00144a012
CHEMBL286226 99927 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 233 2 1 3 2.4 COc1ccc(OC)c2c1C1CCC2[C@@H](N)C1 10.1021/jm00144a012
44280965 99983 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 233 2 1 3 2.4 COc1ccc(OC)c2c1C1CCC2[C@H](N)C1 10.1021/jm00144a012
CHEMBL286609 99983 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 233 2 1 3 2.4 COc1ccc(OC)c2c1C1CCC2[C@H](N)C1 10.1021/jm00144a012
10804826 23615 2 None -1 2 Rat 4.5 pEC50 = 4.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@@H]2C1=NCCN1 10.1021/jm960354u
CHEMBL133451 23615 2 None -1 2 Rat 4.5 pEC50 = 4.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@@H]2C1=NCCN1 10.1021/jm960354u
44593557 183918 11 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 262 3 1 2 3.3 COCc1c(Cl)ccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2009.03.166
CHEMBL481322 183918 11 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 262 3 1 2 3.3 COCc1c(Cl)ccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2009.03.166
44593557 183918 11 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 262 3 1 2 3.3 COCc1c(Cl)ccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL481322 183918 11 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 262 3 1 2 3.3 COCc1c(Cl)ccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
9816986 164139 0 None 21 3 Human 7.5 pEC50 = 7.5 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 274 6 2 4 1.6 CCN(CC)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
CHEMBL421011 164139 0 None 21 3 Human 7.5 pEC50 = 7.5 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 274 6 2 4 1.6 CCN(CC)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
9816986 164139 0 None 21 3 Human 7.5 pEC50 = 7.5 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 274 6 2 4 1.6 CCN(CC)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00764-8
CHEMBL421011 164139 0 None 21 3 Human 7.5 pEC50 = 7.5 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 274 6 2 4 1.6 CCN(CC)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00764-8
9816986 164139 0 None 21 3 Human 7.5 pEC50 = 7.5 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 274 6 2 4 1.6 CCN(CC)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL421011 164139 0 None 21 3 Human 7.5 pEC50 = 7.5 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 274 6 2 4 1.6 CCN(CC)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
44593577 178464 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 198 1 1 1 2.7 c1ccc(C2CCc3nc[nH]c3C2)cc1 10.1016/j.bmcl.2009.03.162
CHEMBL466296 178464 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 198 1 1 1 2.7 c1ccc(C2CCc3nc[nH]c3C2)cc1 10.1016/j.bmcl.2009.03.162
481 2892 7 None 8 2 Human 6.5 pEC50 = 6.5 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 10.1016/s0960-894x(01)00764-8
9838763 2892 7 None 8 2 Human 6.5 pEC50 = 6.5 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 10.1016/s0960-894x(01)00764-8
CHEMBL72958 2892 7 None 8 2 Human 6.5 pEC50 = 6.5 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 10.1016/s0960-894x(01)00764-8
22493344 98662 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 323 5 2 5 2.5 FC(F)(F)Cn1nccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL277361 98662 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 323 5 2 5 2.5 FC(F)(F)Cn1nccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
44449277 155183 2 None -1 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 214 2 1 2 2.5 COc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL402388 155183 2 None -1 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 214 2 1 2 2.5 COc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44449305 155610 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 291 4 2 3 2.2 CCS(=O)(=O)Nc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL404566 155610 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 291 4 2 3 2.2 CCS(=O)(=O)Nc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44571889 184029 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 264 3 1 3 2.7 c1cc(Cn2cccn2)c2c(c1)[C@H](c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.10.066
CHEMBL482148 184029 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 264 3 1 3 2.7 c1cc(Cn2cccn2)c2c(c1)[C@H](c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.10.066
44449337 155116 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 284 2 2 2 3.5 Clc1ccc2c(c1-c1ccn[nH]1)CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL402003 155116 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 284 2 2 2 3.5 Clc1ccc2c(c1-c1ccn[nH]1)CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
22493272 44755 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 256 4 2 5 2.1 Cc1nc(-c2ccccc2NCC2=NCCN2)co1 10.1016/s0960-894x(01)00822-8
CHEMBL152154 44755 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 256 4 2 5 2.1 Cc1nc(-c2ccccc2NCC2=NCCN2)co1 10.1016/s0960-894x(01)00822-8
44574133 188376 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 269 2 0 4 3.0 Fc1ccc(C2Cc3nccn3C2)c(-c2ncco2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL501404 188376 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 269 2 0 4 3.0 Fc1ccc(C2Cc3nccn3C2)c(-c2ncco2)c1 10.1016/j.bmcl.2009.03.166
122184835 122541 0 None 3 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 420 10 5 7 1.1 CS(=O)(=O)Nc1cccc([C@@H](O)CNCCOc2ccc3c(CO)n[nH]c3c2)c1 10.1021/acs.jmedchem.5b00638
CHEMBL3601310 122541 0 None 3 2 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 420 10 5 7 1.1 CS(=O)(=O)Nc1cccc([C@@H](O)CNCCOc2ccc3c(CO)n[nH]c3c2)c1 10.1021/acs.jmedchem.5b00638
44449249 95198 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 291 3 2 3 2.2 Cc1ccc2c(c1NS(C)(=O)=O)CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL255938 95198 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 291 3 2 3 2.2 Cc1ccc2c(c1NS(C)(=O)=O)CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
10420352 168740 10 None -83 2 Human 5.5 pEC50 = 5.5 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 201 3 4 4 0.5 CNCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
CHEMBL43711 168740 10 None -83 2 Human 5.5 pEC50 = 5.5 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 201 3 4 4 0.5 CNCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
44280982 99764 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 205 2 1 3 1.3 COc1ccc(OC)c2c1CC1C2[C@@H]1N 10.1021/jm00144a012
CHEMBL285082 99764 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 205 2 1 3 1.3 COc1ccc(OC)c2c1CC1C2[C@@H]1N 10.1021/jm00144a012
124 2981 47 None -8 24 Human 6.5 pEC50 = 6.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
2032 2981 47 None -8 24 Human 6.5 pEC50 = 6.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
4636 2981 47 None -8 24 Human 6.5 pEC50 = 6.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
CHEMBL762 2981 47 None -8 24 Human 6.5 pEC50 = 6.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
DB00935 2981 47 None -8 24 Human 6.5 pEC50 = 6.5 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
44574936 178630 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 218 1 0 2 2.9 Clc1ccc(C2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
CHEMBL467495 178630 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 218 1 0 2 2.9 Clc1ccc(C2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
44369646 120163 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 271 4 2 4 3.1 Cc1ccc(-c2ccccc2NCC2=NCCN2)s1 10.1016/s0960-894x(01)00822-8
CHEMBL351543 120163 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 271 4 2 4 3.1 Cc1ccc(-c2ccccc2NCC2=NCCN2)s1 10.1016/s0960-894x(01)00822-8
44571841 179320 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 228 3 1 2 2.6 COCc1cccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL473424 179320 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 228 3 1 2 2.6 COCc1cccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
44574988 189229 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 227 2 1 3 1.3 NC(=O)c1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
CHEMBL511576 189229 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 227 2 1 3 1.3 NC(=O)c1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
521 1404 69 None -501 5 Bovine 6.4 pEC50 = 6.4 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C nan
5311068 1404 69 None -501 5 Bovine 6.4 pEC50 = 6.4 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C nan
835 1404 69 None -501 5 Bovine 6.4 pEC50 = 6.4 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C nan
CHEMBL778 1404 69 None -501 5 Bovine 6.4 pEC50 = 6.4 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C nan
DB00633 1404 69 None -501 5 Bovine 6.4 pEC50 = 6.4 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C nan
22493349 119687 0 None 2 2 Human 7.4 pEC50 = 7.4 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 256 4 2 5 2.1 Cc1cc(-c2ccccc2NCC2=NCCN2)on1 10.1016/s0960-894x(01)00822-8
CHEMBL347268 119687 0 None 2 2 Human 7.4 pEC50 = 7.4 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 256 4 2 5 2.1 Cc1cc(-c2ccccc2NCC2=NCCN2)on1 10.1016/s0960-894x(01)00822-8
17804479 95660 19 None -1 4 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 198 1 1 1 2.9 c1ccc2c(c1)CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL258007 95660 19 None -1 4 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 198 1 1 1 2.9 c1ccc2c(c1)CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
10083742 34606 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 256 4 1 5 1.5 Cn1nccc1-c1ccccc1OCC1=NCCN1 10.1016/s0960-894x(01)00764-8
CHEMBL142967 34606 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 256 4 1 5 1.5 Cn1nccc1-c1ccccc1OCC1=NCCN1 10.1016/s0960-894x(01)00764-8
44329739 112324 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 287 5 2 5 2.2 O=C(OC1CCCC1)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL329272 112324 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 287 5 2 5 2.2 O=C(OC1CCCC1)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
104452 203101 73 None - 1 Rat 5.4 pEC50 = 5.4 Functional
Vasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contractionVasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contraction
ChEMBL 270 2 1 3 3.6 Oc1nnc(Cc2ccc(Cl)cc2)c2ccccc12 10.1016/j.bmcl.2006.02.003
CHEMBL63976 203101 73 None - 1 Rat 5.4 pEC50 = 5.4 Functional
Vasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contractionVasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contraction
ChEMBL 270 2 1 3 3.6 Oc1nnc(Cc2ccc(Cl)cc2)c2ccccc12 10.1016/j.bmcl.2006.02.003
22493381 98082 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 255 4 2 5 1.5 Cn1cc(-c2ccccc2NCC2=NCCN2)cn1 10.1016/s0960-894x(03)00050-7
CHEMBL273312 98082 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 255 4 2 5 1.5 Cn1cc(-c2ccccc2NCC2=NCCN2)cn1 10.1016/s0960-894x(03)00050-7
22493231 207665 0 None -5 3 Human 6.4 pEC50 = 6.4 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 286 4 2 4 1.7 O=C(c1ccccc1NCC1=NCCN1)N1CCCCC1 10.1016/s0960-894x(01)00569-8
CHEMBL95333 207665 0 None -5 3 Human 6.4 pEC50 = 6.4 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 286 4 2 4 1.7 O=C(c1ccccc1NCC1=NCCN1)N1CCCCC1 10.1016/s0960-894x(01)00569-8
44574104 189489 0 None - 1 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 353 4 1 4 3.3 CS(=O)(=O)Nc1cccc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL513871 189489 0 None - 1 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 353 4 1 4 3.3 CS(=O)(=O)Nc1cccc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
9838376 168300 0 None 15 2 Human 8.4 pEC50 = 8.4 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 272 4 2 5 2.5 Cc1nc(-c2ccccc2NCC2=NCCN2)cs1 10.1016/s0960-894x(01)00822-8
CHEMBL434074 168300 0 None 15 2 Human 8.4 pEC50 = 8.4 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 272 4 2 5 2.5 Cc1nc(-c2ccccc2NCC2=NCCN2)cs1 10.1016/s0960-894x(01)00822-8
11108001 10872 2 None -2 5 Human 8.3 pEC50 = 8.3 Functional
Agonist potency at Alpha-1A adrenoceptors assayed in rat-1 fibroblasts expressing human Alpha-1AAgonist potency at Alpha-1A adrenoceptors assayed in rat-1 fibroblasts expressing human Alpha-1A
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL117248 10872 2 None -2 5 Human 8.3 pEC50 = 8.3 Functional
Agonist potency at Alpha-1A adrenoceptors assayed in rat-1 fibroblasts expressing human Alpha-1AAgonist potency at Alpha-1A adrenoceptors assayed in rat-1 fibroblasts expressing human Alpha-1A
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL540542 10872 2 None -2 5 Human 8.3 pEC50 = 8.3 Functional
Agonist potency at Alpha-1A adrenoceptors assayed in rat-1 fibroblasts expressing human Alpha-1AAgonist potency at Alpha-1A adrenoceptors assayed in rat-1 fibroblasts expressing human Alpha-1A
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
9816460 119893 0 None 39 3 Human 8.3 pEC50 = 8.3 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 253 4 2 5 1.6 c1ccc(-c2cnccn2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
CHEMBL349082 119893 0 None 39 3 Human 8.3 pEC50 = 8.3 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 253 4 2 5 1.6 c1ccc(-c2cnccn2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
1028 291 71 None 1 19 Human 6.4 pEC50 = 6.4 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
139148732 291 71 None 1 19 Human 6.4 pEC50 = 6.4 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
479 291 71 None 1 19 Human 6.4 pEC50 = 6.4 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
5816 291 71 None 1 19 Human 6.4 pEC50 = 6.4 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
CHEMBL679 291 71 None 1 19 Human 6.4 pEC50 = 6.4 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
DB00668 291 71 None 1 19 Human 6.4 pEC50 = 6.4 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
11058166 204705 0 None 10 2 Human 7.4 pEC50 = 7.4 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cccc(F)c1NCC1=NCCN1 10.1021/jm000542r
CHEMBL74114 204705 0 None 10 2 Human 7.4 pEC50 = 7.4 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cccc(F)c1NCC1=NCCN1 10.1021/jm000542r
44574986 189210 0 None 7 3 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 202 1 0 2 2.4 Fc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
CHEMBL511411 189210 0 None 7 3 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 202 1 0 2 2.4 Fc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
22493415 49973 0 None -1 2 Human 7.4 pEC50 = 7.4 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 268 4 3 6 1.1 Nc1nccc(-c2ccccc2NCC2=NCCN2)n1 10.1016/s0960-894x(01)00822-8
CHEMBL156893 49973 0 None -1 2 Human 7.4 pEC50 = 7.4 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 268 4 3 6 1.1 Nc1nccc(-c2ccccc2NCC2=NCCN2)n1 10.1016/s0960-894x(01)00822-8
44449686 96084 0 None 7 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 267 2 1 3 3.6 c1cc(-c2nccs2)c2c(c1)C(c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.03.070
CHEMBL260116 96084 0 None 7 2 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 267 2 1 3 3.6 c1cc(-c2nccs2)c2c(c1)C(c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.03.070
25066019 95412 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 325 3 2 3 2.9 CS(=O)(=O)Nc1c(Cl)ccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL256982 95412 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 325 3 2 3 2.9 CS(=O)(=O)Nc1c(Cl)ccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
25066019 95412 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 325 3 2 3 2.9 CS(=O)(=O)Nc1c(Cl)ccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2009.03.162
CHEMBL256982 95412 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 325 3 2 3 2.9 CS(=O)(=O)Nc1c(Cl)ccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2009.03.162
25066019 95412 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 325 3 2 3 2.9 CS(=O)(=O)Nc1c(Cl)ccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL256982 95412 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 325 3 2 3 2.9 CS(=O)(=O)Nc1c(Cl)ccc2c1CCCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
11079593 204115 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70326 204115 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
15959119 77056 0 None - 1 Rat 5.4 pEC50 = 5.4 Functional
Vasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contractionVasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contraction
ChEMBL 310 4 0 3 3.8 C=CCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1016/j.bmcl.2006.02.003
CHEMBL207277 77056 0 None - 1 Rat 5.4 pEC50 = 5.4 Functional
Vasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contractionVasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contraction
ChEMBL 310 4 0 3 3.8 C=CCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1016/j.bmcl.2006.02.003
44369647 47207 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 242 4 2 5 1.8 c1ccc(-c2cnoc2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
CHEMBL154346 47207 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 242 4 2 5 1.8 c1ccc(-c2cnoc2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
44449248 95197 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 248 2 1 2 3.2 COc1c(Cl)ccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL255937 95197 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 248 2 1 2 3.2 COc1c(Cl)ccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44449338 95691 1 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 1 1 2.5 c1ccc2c(c1)CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL258178 95691 1 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 1 1 2.5 c1ccc2c(c1)CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44449338 95691 1 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 1 1 2.5 c1ccc2c(c1)CCC2c1ncc[nH]1 10.1016/j.bmcl.2009.03.162
CHEMBL258178 95691 1 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 1 1 2.5 c1ccc2c(c1)CCC2c1ncc[nH]1 10.1016/j.bmcl.2009.03.162
44593580 178542 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 242 3 1 2 2.8 COCc1ccccc1C1CCc2nc[nH]c2C1 10.1016/j.bmcl.2009.03.162
CHEMBL466876 178542 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 242 3 1 2 2.8 COCc1ccccc1C1CCc2nc[nH]c2C1 10.1016/j.bmcl.2009.03.162
11747739 13235 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1AAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1A
ChEMBL 237 4 2 4 0.8 C[S+]([O-])c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1191324 13235 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1AAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1A
ChEMBL 237 4 2 4 0.8 C[S+]([O-])c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL542402 13235 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1AAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1A
ChEMBL 237 4 2 4 0.8 C[S+]([O-])c1ccccc1NCC1=NCCN1 10.1021/jm000542r
44574103 172588 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 250 2 0 4 2.4 c1ccc(-n2cccn2)c([C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL448908 172588 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 250 2 0 4 2.4 c1ccc(-n2cccn2)c([C@@H]2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
44574137 189090 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 268 2 0 4 2.5 Fc1ccc(-n2cccn2)c(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL510023 189090 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 268 2 0 4 2.5 Fc1ccc(-n2cccn2)c(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.166
11108001 10872 2 None -2 5 Human 8.3 pEC50 = 8.3 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
CHEMBL117248 10872 2 None -2 5 Human 8.3 pEC50 = 8.3 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
CHEMBL540542 10872 2 None -2 5 Human 8.3 pEC50 = 8.3 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
44362149 33932 0 None 2 3 Human 8.3 pEC50 = 8.3 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 259 4 1 5 2.2 c1ccc(-c2ccns2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL142387 33932 0 None 2 3 Human 8.3 pEC50 = 8.3 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 259 4 1 5 2.2 c1ccc(-c2ccns2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
44362150 119390 0 None 15 2 Human 8.3 pEC50 = 8.3 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 242 4 2 4 1.5 c1ccc(-c2cc[nH]n2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL344551 119390 0 None 15 2 Human 8.3 pEC50 = 8.3 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 242 4 2 4 1.5 c1ccc(-c2cc[nH]n2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
10859076 13682 0 None 5 4 Human 8.3 pEC50 = 8.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1194763 13682 0 None 5 4 Human 8.3 pEC50 = 8.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL553276 13682 0 None 5 4 Human 8.3 pEC50 = 8.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
6604803 116518 2 None 1 3 Rat 8.3 pEC50 = 8.3 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@H]2C1=NCCN1 10.1021/jm960354u
CHEMBL336161 116518 2 None 1 3 Rat 8.3 pEC50 = 8.3 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@H]2C1=NCCN1 10.1021/jm960354u
6604803 116518 2 None -1 3 Human 8.3 pEC50 = 8.3 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@H]2C1=NCCN1 10.1021/jm960354u
CHEMBL336161 116518 2 None -1 3 Human 8.3 pEC50 = 8.3 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostateIn vitro agonist potency towards Alpha-1A adrenergic receptor in canine prostate
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@H]2C1=NCCN1 10.1021/jm960354u
4038180 204 14 None 1 5 Rat 8.2 pEC50 = 8.2 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
480 204 14 None 1 5 Rat 8.2 pEC50 = 8.2 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
CHEMBL109783 204 14 None 1 5 Rat 8.2 pEC50 = 8.2 Functional
In vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferensIn vitro agonist potency towards Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
9816461 10719 7 None 60 2 Human 7.3 pEC50 = 7.3 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
CHEMBL117094 10719 7 None 60 2 Human 7.3 pEC50 = 7.3 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
CHEMBL544290 10719 7 None 60 2 Human 7.3 pEC50 = 7.3 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
44343245 110615 2 None - 1 Human 7.3 pEC50 = 7.3 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 256 4 2 3 3.0 c1ccc(N2CCCCC2)c(NCc2c[nH]cn2)c1 10.1016/s0960-894x(02)00753-9
CHEMBL325648 110615 2 None - 1 Human 7.3 pEC50 = 7.3 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 256 4 2 3 3.0 c1ccc(N2CCCCC2)c(NCc2c[nH]cn2)c1 10.1016/s0960-894x(02)00753-9
44343275 110774 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 240 4 2 4 2.7 c1ccc(-c2cnco2)c(NCc2c[nH]cn2)c1 10.1016/s0960-894x(02)00753-9
CHEMBL326067 110774 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 240 4 2 4 2.7 c1ccc(-c2cnco2)c(NCc2c[nH]cn2)c1 10.1016/s0960-894x(02)00753-9
22493233 169287 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 268 4 2 4 2.4 Cc1ccc(-c2ccccc2NCC2=NCCN2)n1C 10.1016/s0960-894x(03)00050-7
CHEMBL441412 169287 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 268 4 2 4 2.4 Cc1ccc(-c2ccccc2NCC2=NCCN2)n1C 10.1016/s0960-894x(03)00050-7
9903313 172678 0 None 5 3 Human 7.3 pEC50 = 7.3 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 5 2 4 1.2 CCN(C)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL450018 172678 0 None 5 3 Human 7.3 pEC50 = 7.3 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 5 2 4 1.2 CCN(C)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
22493379 208126 0 None 2 3 Human 7.3 pEC50 = 7.3 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 5 3 4 1.2 CC(C)NC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL98016 208126 0 None 2 3 Human 7.3 pEC50 = 7.3 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 5 3 4 1.2 CC(C)NC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
22493411 168030 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 274 6 3 4 1.6 CCC(C)NC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL432192 168030 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 274 6 3 4 1.6 CCC(C)NC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
44329701 207678 0 None -6 3 Human 6.3 pEC50 = 6.3 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 275 6 2 5 1.9 CC(C)COC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL95398 207678 0 None -6 3 Human 6.3 pEC50 = 6.3 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 275 6 2 5 1.9 CC(C)COC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
44574044 178431 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 209 1 0 3 2.1 N#Cc1ccccc1[C@@H]1Cc2nccn2C1 10.1016/j.bmcl.2009.03.166
CHEMBL466046 178431 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 209 1 0 3 2.1 N#Cc1ccccc1[C@@H]1Cc2nccn2C1 10.1016/j.bmcl.2009.03.166
44219719 178678 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 209 1 0 3 2.1 N#Cc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
CHEMBL467916 178678 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 209 1 0 3 2.1 N#Cc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
10399043 120162 0 None -2 3 Human 7.3 pEC50 = 7.3 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 232 5 2 5 1.1 CO/N=C/c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL351542 120162 0 None -2 3 Human 7.3 pEC50 = 7.3 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 232 5 2 5 1.1 CO/N=C/c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
10916464 204153 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 287 4 2 5 1.2 CS(=O)(=O)c1cc(Cl)ccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70563 204153 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 287 4 2 5 1.2 CS(=O)(=O)c1cc(Cl)ccc1NCC1=NCCN1 10.1021/jm000542r
44574875 188643 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 232 1 1 1 3.3 Clc1cccc(C2CCc3nc[nH]c3C2)c1 10.1016/j.bmcl.2009.03.162
CHEMBL503269 188643 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 232 1 1 1 3.3 Clc1cccc(C2CCc3nc[nH]c3C2)c1 10.1016/j.bmcl.2009.03.162
44449245 95413 0 None 6 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 250 2 2 2 2.9 c1cc(-c2ccn[nH]2)c2c(c1)C(c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.03.070
CHEMBL256983 95413 0 None 6 3 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 250 2 2 2 2.9 c1cc(-c2ccn[nH]2)c2c(c1)C(c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.03.070
22493347 119612 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 6 2 5 1.9 CCO/N=C(\C)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL346465 119612 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 6 2 5 1.9 CCO/N=C(\C)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
44281057 99675 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 221 2 1 3 1.9 COc1ccc(OC)c2c1CCCC(N)C2 10.1021/jm00144a012
CHEMBL284486 99675 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 221 2 1 3 1.9 COc1ccc(OC)c2c1CCCC(N)C2 10.1021/jm00144a012
9816461 10719 7 None 60 2 Human 7.3 pEC50 = 7.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1AAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1A
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL117094 10719 7 None 60 2 Human 7.3 pEC50 = 7.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1AAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1A
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL544290 10719 7 None 60 2 Human 7.3 pEC50 = 7.3 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1AAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1A
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
44574938 188914 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 214 2 0 3 2.2 COc1cccc(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.162
CHEMBL507755 188914 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 214 2 0 3 2.2 COc1cccc(C2Cc3nccn3C2)c1 10.1016/j.bmcl.2009.03.162
44571888 183917 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 246 3 1 2 2.8 COCc1cc(F)cc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL481321 183917 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 246 3 1 2 2.8 COCc1cc(F)cc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
44343244 9952 0 None 5 2 Human 8.2 pEC50 = 8.2 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 241 3 3 4 2.0 Oc1ccc2cccc(NCC3=NCCN3)c2c1 10.1016/s0960-894x(02)00753-9
CHEMBL114669 9952 0 None 5 2 Human 8.2 pEC50 = 8.2 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 241 3 3 4 2.0 Oc1ccc2cccc(NCC3=NCCN3)c2c1 10.1016/s0960-894x(02)00753-9
44343236 111364 0 None 15 3 Human 8.2 pEC50 = 8.2 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 243 4 1 5 1.7 c1ccc(-c2ccno2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(02)00753-9
CHEMBL327005 111364 0 None 15 3 Human 8.2 pEC50 = 8.2 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 243 4 1 5 1.7 c1ccc(-c2ccno2)c(OCC2=NCCN2)c1 10.1016/s0960-894x(02)00753-9
9903932 59510 0 None 501 2 Human 8.2 pEC50 = 8.2 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 284 5 2 6 1.9 CC(C)n1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL17151 59510 0 None 501 2 Human 8.2 pEC50 = 8.2 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 284 5 2 6 1.9 CC(C)n1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
44271932 65211 0 None 6 3 Human 8.2 pEC50 = 8.2 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 255 4 2 5 1.5 Cn1ccnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL18256 65211 0 None 6 3 Human 8.2 pEC50 = 8.2 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 255 4 2 5 1.5 Cn1ccnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
22493392 47155 0 None 3 3 Human 8.2 pEC50 = 8.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 252 4 2 4 2.2 c1ccc(-c2ccccc2NCC2=NCCN2)nc1 10.1016/s0960-894x(01)00822-8
CHEMBL154298 47155 0 None 3 3 Human 8.2 pEC50 = 8.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 252 4 2 4 2.2 c1ccc(-c2ccccc2NCC2=NCCN2)nc1 10.1016/s0960-894x(01)00822-8
9838192 111312 18 None -2 3 Rabbit 7.2 pEC50 = 7.2 Functional
Agonist activity at rabbit urethra adrenergic alpha1A receptorAgonist activity at rabbit urethra adrenergic alpha1A receptor
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1016/j.bmc.2008.02.091
CHEMBL326702 111312 18 None -2 3 Rabbit 7.2 pEC50 = 7.2 Functional
Agonist activity at rabbit urethra adrenergic alpha1A receptorAgonist activity at rabbit urethra adrenergic alpha1A receptor
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1016/j.bmc.2008.02.091
122184772 122521 0 None -1 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 424 9 4 6 2.3 CS(=O)(=O)Nc1cccc([C@@H](O)CNCCOc2ccc3c(Cl)n[nH]c3c2)c1 10.1021/acs.jmedchem.5b00638
CHEMBL3601203 122521 0 None -1 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 424 9 4 6 2.3 CS(=O)(=O)Nc1cccc([C@@H](O)CNCCOc2ccc3c(Cl)n[nH]c3c2)c1 10.1021/acs.jmedchem.5b00638
44574132 178589 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 280 2 0 4 2.8 Fc1cccc(-c2cncnc2)c1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.166
CHEMBL467259 178589 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 280 2 0 4 2.8 Fc1cccc(-c2cncnc2)c1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.166
44571842 179272 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 242 4 1 2 3.0 CCOCc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL473043 179272 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 242 4 1 2 3.0 CCOCc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
44571887 188416 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 246 3 1 2 2.8 COCc1c(F)ccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL502078 188416 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 246 3 1 2 2.8 COCc1c(F)ccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
44343243 9845 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 239 3 3 3 2.9 Oc1ccc2cccc(NCc3c[nH]cn3)c2c1 10.1016/s0960-894x(02)00753-9
CHEMBL114054 9845 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 239 3 3 3 2.9 Oc1ccc2cccc(NCc3c[nH]cn3)c2c1 10.1016/s0960-894x(02)00753-9
44343173 11021 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 272 6 2 3 2.5 CCN(CC)C(=O)c1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
CHEMBL117482 11021 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 272 6 2 3 2.5 CCN(CC)C(=O)c1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
9838294 59673 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 269 5 2 5 2.0 CCn1nccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL17221 59673 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 269 5 2 5 2.0 CCn1nccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
11079 2733 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00569-8
3369 2733 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00569-8
4436 2733 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00569-8
5509 2733 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00569-8
CHEMBL761 2733 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00569-8
DB06711 2733 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00569-8
11079 2733 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00822-8
3369 2733 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00822-8
4436 2733 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00822-8
5509 2733 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00822-8
CHEMBL761 2733 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00822-8
DB06711 2733 63 None 5 7 Human 7.2 pEC50 = 7.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 10.1016/s0960-894x(01)00822-8
25154770 183652 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 246 3 1 2 2.8 COCc1ccc(F)c2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL480272 183652 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 246 3 1 2 2.8 COCc1ccc(F)c2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
22493325 119762 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 257 4 2 6 1.5 Cc1noc(-c2ccccc2NCC2=NCCN2)n1 10.1016/s0960-894x(01)00822-8
CHEMBL347920 119762 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 257 4 2 6 1.5 Cc1noc(-c2ccccc2NCC2=NCCN2)n1 10.1016/s0960-894x(01)00822-8
22493287 120093 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 320 4 2 4 3.2 FC(F)(F)c1cccnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL350906 120093 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 320 4 2 4 3.2 FC(F)(F)c1cccnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
11097789 102998 1 None -1 5 Human 8.1 pEC50 = 8.1 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 239 4 2 4 2.0 CSc1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL306792 102998 1 None -1 5 Human 8.1 pEC50 = 8.1 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 239 4 2 4 2.0 CSc1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
11140345 204171 0 None 2 5 Human 8.1 pEC50 = 8.1 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 239 4 2 4 2.0 CSc1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70692 204171 0 None 2 5 Human 8.1 pEC50 = 8.1 Functional
Agonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptorAgonist potency at Alpha-1 adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor
ChEMBL 239 4 2 4 2.0 CSc1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
9795167 107494 0 None 6 3 Human 8.1 pEC50 = 8.1 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 260 6 3 4 1.2 CCCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
CHEMBL318544 107494 0 None 6 3 Human 8.1 pEC50 = 8.1 Functional
Activation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblastsActivation of human alpha-1A adrenergic receptor expressed in rat-1 fibroblasts
ChEMBL 260 6 3 4 1.2 CCCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
44352155 116808 0 None 7 5 Human 8.1 pEC50 = 8.1 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 251 4 2 3 2.8 c1ccc(-c2ccccc2NCC2=NCCN2)cc1 10.1016/s0960-894x(01)00764-8
CHEMBL337862 116808 0 None 7 5 Human 8.1 pEC50 = 8.1 Functional
Activation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathwayActivation of recombinant human adrenergic,alpha-1A receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway
ChEMBL 251 4 2 3 2.8 c1ccc(-c2ccccc2NCC2=NCCN2)cc1 10.1016/s0960-894x(01)00764-8
9795167 107494 0 None 6 3 Human 8.1 pEC50 = 8.1 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 6 3 4 1.2 CCCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL318544 107494 0 None 6 3 Human 8.1 pEC50 = 8.1 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 260 6 3 4 1.2 CCCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
44329703 208162 0 None 7 2 Human 8.1 pEC50 = 8.1 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 275 4 2 5 2.1 CC(C)(C)OC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL98243 208162 0 None 7 2 Human 8.1 pEC50 = 8.1 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 275 4 2 5 2.1 CC(C)(C)OC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
44449304 95605 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 277 3 2 3 1.9 CS(=O)(=O)Nc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL257800 95605 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 277 3 2 3 1.9 CS(=O)(=O)Nc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
12764879 178423 0 None 100 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 0 2 2.2 c1ccc(C2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
CHEMBL465963 178423 0 None 100 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 0 2 2.2 c1ccc(C2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
172745 100123 7 None -234 2 Human 4.2 pEC50 = 4.2 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 187 2 4 4 0.2 NCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
CHEMBL287587 100123 7 None -234 2 Human 4.2 pEC50 = 4.2 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 187 2 4 4 0.2 NCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
1753 2504 28 None 2 4 Human 6.1 pEC50 = 6.1 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10.1021/jm00144a012
483 2504 28 None 2 4 Human 6.1 pEC50 = 6.1 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10.1021/jm00144a012
6082 2504 28 None 2 4 Human 6.1 pEC50 = 6.1 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10.1021/jm00144a012
CHEMBL524 2504 28 None 2 4 Human 6.1 pEC50 = 6.1 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10.1021/jm00144a012
DB00723 2504 28 None 2 4 Human 6.1 pEC50 = 6.1 Functional
Alpha-1 adrenergic receptor agonist activity in rabbit ear arteryAlpha-1 adrenergic receptor agonist activity in rabbit ear artery
ChEMBL 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10.1021/jm00144a012
12764880 178546 1 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 198 1 0 2 2.6 c1ccc(C2CCc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
CHEMBL466914 178546 1 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 198 1 0 2 2.6 c1ccc(C2CCc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
22493359 121688 0 None -1 2 Human 6.1 pEC50 = 6.1 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 257 4 2 6 1.5 Cc1nc(-c2ccccc2NCC2=NCCN2)no1 10.1016/s0960-894x(01)00822-8
CHEMBL358685 121688 0 None -1 2 Human 6.1 pEC50 = 6.1 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 257 4 2 6 1.5 Cc1nc(-c2ccccc2NCC2=NCCN2)no1 10.1016/s0960-894x(01)00822-8
12764879 178423 0 None 100 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 0 2 2.2 c1ccc(C2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
CHEMBL465963 178423 0 None 100 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 0 2 2.2 c1ccc(C2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
44593580 178542 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 242 3 1 2 2.8 COCc1ccccc1C1CCc2nc[nH]c2C1 10.1016/j.bmcl.2009.03.162
CHEMBL466876 178542 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 242 3 1 2 2.8 COCc1ccccc1C1CCc2nc[nH]c2C1 10.1016/j.bmcl.2009.03.162
44449303 95604 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 284 2 2 2 3.5 Clc1ccc2c(c1-c1cn[nH]c1)CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
CHEMBL257799 95604 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 284 2 2 2 3.5 Clc1ccc2c(c1-c1cn[nH]c1)CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.03.070
44449303 95604 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 284 2 2 2 3.5 Clc1ccc2c(c1-c1cn[nH]c1)CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL257799 95604 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 284 2 2 2 3.5 Clc1ccc2c(c1-c1cn[nH]c1)CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
9840212 62121 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 324 5 2 6 1.9 FC(F)(F)Cn1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL17764 62121 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 324 5 2 6 1.9 FC(F)(F)Cn1ncnc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
44329133 207701 0 None -6 3 Human 7.1 pEC50 = 7.1 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 274 6 3 4 1.5 CC(C)CNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL95565 207701 0 None -6 3 Human 7.1 pEC50 = 7.1 Functional
Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.Agonist potency against cloned human alpha 1A adrenoceptor expressed in rat-1 fibroblasts.
ChEMBL 274 6 3 4 1.5 CC(C)CNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
22493408 61199 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 256 4 3 5 1.2 Cc1n[nH]c(-c2ccccc2NCC2=NCCN2)n1 10.1016/s0960-894x(03)00050-7
CHEMBL17657 61199 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cellsAgonism of human alpha-1A adrenergic receptor expressed in rat 1 fibroblast cells
ChEMBL 256 4 3 5 1.2 Cc1n[nH]c(-c2ccccc2NCC2=NCCN2)n1 10.1016/s0960-894x(03)00050-7
541604 165339 10 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 201 3 4 4 0.5 CNCC(O)c1cc(O)c(O)cc1F 10.1021/jm00118a019
CHEMBL42359 165339 10 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortexAgonistic potency at alpha-1 adrenergic receptor for the amine-induced increase of phosphatidylinositol breakdown in synaptoneurosomes from guinea pig cerebral cortex
ChEMBL 201 3 4 4 0.5 CNCC(O)c1cc(O)c(O)cc1F 10.1021/jm00118a019
44574079 189309 0 None 8 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 261 2 0 3 3.3 c1ccc([C@@H]2Cc3nccn3C2)c(-c2ccncc2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL512289 189309 0 None 8 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 261 2 0 3 3.3 c1ccc([C@@H]2Cc3nccn3C2)c(-c2ccncc2)c1 10.1016/j.bmcl.2009.03.166
11522042 203679 1 None - 1 Rat 6.1 pEC50 = 6.1 Functional
Vasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contractionVasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contraction
ChEMBL 284 2 0 3 3.2 Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1016/j.bmcl.2006.02.003
CHEMBL67457 203679 1 None - 1 Rat 6.1 pEC50 = 6.1 Functional
Vasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contractionVasorelaxation of noradrenaline-stimulated Wistar rat vas deferens contraction
ChEMBL 284 2 0 3 3.2 Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1016/j.bmcl.2006.02.003
45381933 122539 0 None -12 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 458 9 4 6 2.7 CS(=O)(=O)Nc1cccc([C@@H](O)CNCCOc2ccc3c(C(F)(F)F)n[nH]c3c2)c1 10.1021/acs.jmedchem.5b00638
CHEMBL3601308 122539 0 None -12 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 458 9 4 6 2.7 CS(=O)(=O)Nc1cccc([C@@H](O)CNCCOc2ccc3c(C(F)(F)F)n[nH]c3c2)c1 10.1021/acs.jmedchem.5b00638
44574989 189230 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 228 3 0 3 2.4 COCc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
CHEMBL511577 189230 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 228 3 0 3 2.4 COCc1ccccc1C1Cc2nccn2C1 10.1016/j.bmcl.2009.03.162
12764879 178423 0 None 100 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 0 2 2.2 c1ccc(C2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
CHEMBL465963 178423 0 None 100 2 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 184 1 0 2 2.2 c1ccc(C2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
44571840 188214 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 276 3 1 3 2.0 CS(=O)(=O)Cc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL499180 188214 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 276 3 1 3 2.0 CS(=O)(=O)Cc1cccc2c1CCC2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
45381852 122522 0 None -60 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 418 10 4 6 2.2 CCc1n[nH]c2cc(OCCNC[C@H](O)c3cccc(NS(C)(=O)=O)c3)ccc12 10.1021/acs.jmedchem.5b00638
CHEMBL3601204 122522 0 None -60 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 418 10 4 6 2.2 CCc1n[nH]c2cc(OCCNC[C@H](O)c3cccc(NS(C)(=O)=O)c3)ccc12 10.1021/acs.jmedchem.5b00638
22493254 169088 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 6 2 5 1.9 CC/C(=N/OC)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL439822 169088 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
In vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assayIn vitro activation of human alpha-1A receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay
ChEMBL 260 6 2 5 1.9 CC/C(=N/OC)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
44571845 189134 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 289 3 1 2 2.9 FC1(F)CN(Cc2cccc3c2CCC3c2ncc[nH]2)C1 10.1016/j.bmcl.2008.10.066
CHEMBL510613 189134 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 289 3 1 2 2.9 FC1(F)CN(Cc2cccc3c2CCC3c2ncc[nH]2)C1 10.1016/j.bmcl.2008.10.066
2803 955 58 None -6 14 Bovine 7.1 pEC50 = 7.1 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
516 955 58 None -6 14 Bovine 7.1 pEC50 = 7.1 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
704 955 58 None -6 14 Bovine 7.1 pEC50 = 7.1 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
CHEMBL134 955 58 None -6 14 Bovine 7.1 pEC50 = 7.1 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
DB00575 955 58 None -6 14 Bovine 7.1 pEC50 = 7.1 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
2146 3100 67 None 1 14 Bovine 8.1 pEC50 = 8.1 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O nan
485 3100 67 None 1 14 Bovine 8.1 pEC50 = 8.1 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O nan
6041 3100 67 None 1 14 Bovine 8.1 pEC50 = 8.1 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O nan
CHEMBL1215 3100 67 None 1 14 Bovine 8.1 pEC50 = 8.1 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O nan
DB00388 3100 67 None 1 14 Bovine 8.1 pEC50 = 8.1 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O nan
44574080 188946 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 264 2 0 4 2.6 Cn1cc(-c2ccccc2[C@@H]2Cc3nccn3C2)cn1 10.1016/j.bmcl.2009.03.166
CHEMBL508084 188946 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 264 2 0 4 2.6 Cn1cc(-c2ccccc2[C@@H]2Cc3nccn3C2)cn1 10.1016/j.bmcl.2009.03.166
9838192 111312 18 None 2 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1016/j.bmcl.2008.03.070
CHEMBL326702 111312 18 None 2 3 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha-1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1016/j.bmcl.2008.03.070
44571938 180073 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 300 3 1 3 3.0 Fc1ccn(Cc2c(F)ccc3c2CC[C@H]3c2ncc[nH]2)n1 10.1016/j.bmcl.2008.10.066
CHEMBL474796 180073 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 300 3 1 3 3.0 Fc1ccn(Cc2c(F)ccc3c2CC[C@H]3c2ncc[nH]2)n1 10.1016/j.bmcl.2008.10.066
1960 2857 67 None -2 18 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/acs.jmedchem.5b00638
439260 2857 67 None -2 18 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/acs.jmedchem.5b00638
505 2857 67 None -2 18 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/acs.jmedchem.5b00638
CHEMBL1437 2857 67 None -2 18 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/acs.jmedchem.5b00638
DB00368 2857 67 None -2 18 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assayAgonist activity at human alpha1A-adrenergic receptor expressed in HEK293 cells assessed as calcium flux by fluorescence assay
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/acs.jmedchem.5b00638
44571890 191976 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 265 3 1 4 2.1 c1cc(Cn2ccnn2)c2c(c1)C(c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.10.066
CHEMBL520117 191976 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assayAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells by calcium mobilization-based fluorescence assay
ChEMBL 265 3 1 4 2.1 c1cc(Cn2ccnn2)c2c(c1)C(c1ncc[nH]1)CC2 10.1016/j.bmcl.2008.10.066
44574076 172461 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 251 2 0 4 2.9 c1ccc([C@H]2Cc3nccn3C2)c(-c2ncco2)c1 10.1016/j.bmcl.2009.03.166
CHEMBL448147 172461 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 251 2 0 4 2.9 c1ccc([C@H]2Cc3nccn3C2)c(-c2ncco2)c1 10.1016/j.bmcl.2009.03.166
44574985 188407 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 214 2 0 3 2.2 COc1ccc(C2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
CHEMBL501920 188407 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPRAgonist activity at human cloned adrenergic alpha1A receptor expressed in CHO cells assessed as calcium mobilization by FLIPR
ChEMBL 214 2 0 3 2.2 COc1ccc(C2Cc3nccn3C2)cc1 10.1016/j.bmcl.2009.03.162
123562321 140511 0 None 1 3 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 443 12 3 6 2.9 COc1ccc(F)cc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3810110 140511 0 None 1 3 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 443 12 3 6 2.9 COc1ccc(F)cc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
129211 3749 78 None -1 14 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assayAntagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2020.112616
2562 3749 78 None -1 14 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assayAntagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2020.112616
488 3749 78 None -1 14 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assayAntagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2020.112616
CHEMBL836 3749 78 None -1 14 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assayAntagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2020.112616
DB00706 3749 78 None -1 14 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assayAntagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2020.112616
499 4077 18 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity against human recombinant alpha1 receptor expressed in CHOK1 cells assessed as reduction in epinephrine-induced increase in intracellular Ca2+ levelsAntagonist activity against human recombinant alpha1 receptor expressed in CHOK1 cells assessed as reduction in epinephrine-induced increase in intracellular Ca2+ levels
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1016/j.ejmech.2014.12.045
5685 4077 18 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity against human recombinant alpha1 receptor expressed in CHOK1 cells assessed as reduction in epinephrine-induced increase in intracellular Ca2+ levelsAntagonist activity against human recombinant alpha1 receptor expressed in CHOK1 cells assessed as reduction in epinephrine-induced increase in intracellular Ca2+ levels
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1016/j.ejmech.2014.12.045
CHEMBL25554 4077 18 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity against human recombinant alpha1 receptor expressed in CHOK1 cells assessed as reduction in epinephrine-induced increase in intracellular Ca2+ levelsAntagonist activity against human recombinant alpha1 receptor expressed in CHOK1 cells assessed as reduction in epinephrine-induced increase in intracellular Ca2+ levels
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1016/j.ejmech.2014.12.045
499 4077 18 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human recombinant alpha1A adrenoceptor assessed as inhibition of epinephrine-induced intracellular Ca2+ releaseAntagonist activity at human recombinant alpha1A adrenoceptor assessed as inhibition of epinephrine-induced intracellular Ca2+ release
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm401895u
5685 4077 18 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human recombinant alpha1A adrenoceptor assessed as inhibition of epinephrine-induced intracellular Ca2+ releaseAntagonist activity at human recombinant alpha1A adrenoceptor assessed as inhibition of epinephrine-induced intracellular Ca2+ release
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm401895u
CHEMBL25554 4077 18 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human recombinant alpha1A adrenoceptor assessed as inhibition of epinephrine-induced intracellular Ca2+ releaseAntagonist activity at human recombinant alpha1A adrenoceptor assessed as inhibition of epinephrine-induced intracellular Ca2+ release
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm401895u
123854385 140516 0 None 72 3 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 527 13 3 6 4.3 CC(Cc1cc(C(N)=O)c2c(ccn2CCCO)c1)NCCOc1cc(Cl)ccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
CHEMBL3810145 140516 0 None 72 3 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 527 13 3 6 4.3 CC(Cc1cc(C(N)=O)c2c(ccn2CCCO)c1)NCCOc1cc(Cl)ccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
4151 3607 89 None 1 10 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.6b01217
493 3607 89 None 1 10 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.6b01217
5312125 3607 89 None 1 10 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.6b01217
CHEMBL24778 3607 89 None 1 10 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.6b01217
DB06207 3607 89 None 1 10 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.6b01217
4151 3607 89 None 1 10 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.5b02023
493 3607 89 None 1 10 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.5b02023
5312125 3607 89 None 1 10 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.5b02023
CHEMBL24778 3607 89 None 1 10 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.5b02023
DB06207 3607 89 None 1 10 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.5b02023
9913616 140383 6 None 8 3 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 493 13 3 6 3.7 CC(Cc1cc(C(N)=O)c2c(ccn2CCCO)c1)NCCOc1ccccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
CHEMBL3808572 140383 6 None 8 3 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 493 13 3 6 3.7 CC(Cc1cc(C(N)=O)c2c(ccn2CCCO)c1)NCCOc1ccccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
10160408 140440 0 None 1 3 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 439 13 3 6 3.1 CCOc1ccccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3809248 140440 0 None 1 3 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 439 13 3 6 3.1 CCOc1ccccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
86344174 140468 0 None 251 3 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 507 13 3 6 4.0 Cc1ccc(OCC(F)(F)F)c(OCCN[C@H](C)Cc2cc(C(N)=O)c3c(ccn3CCCO)c2)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3809490 140468 0 None 251 3 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 507 13 3 6 4.0 Cc1ccc(OCC(F)(F)F)c(OCCN[C@H](C)Cc2cc(C(N)=O)c3c(ccn3CCCO)c2)c1 10.1021/acs.jmedchem.5b02023
2389 3331 118 None -13 29 Human 8.0 pIC50 = 8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2018.01.038
5073 3331 118 None -13 29 Human 8.0 pIC50 = 8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2018.01.038
96 3331 118 None -13 29 Human 8.0 pIC50 = 8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2018.01.038
CHEMBL85 3331 118 None -13 29 Human 8.0 pIC50 = 8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2018.01.038
DB00734 3331 118 None -13 29 Human 8.0 pIC50 = 8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2018.01.038
2389 3331 118 None -13 29 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.ejmech.2017.12.099
5073 3331 118 None -13 29 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.ejmech.2017.12.099
96 3331 118 None -13 29 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.ejmech.2017.12.099
CHEMBL85 3331 118 None -13 29 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.ejmech.2017.12.099
DB00734 3331 118 None -13 29 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.ejmech.2017.12.099
145946682 167574 0 None -10 3 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 444 7 0 3 5.6 Fc1ccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)cc1 10.1016/j.bmcl.2018.03.070
CHEMBL4225239 167574 0 None -10 3 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 444 7 0 3 5.6 Fc1ccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)cc1 10.1016/j.bmcl.2018.03.070
CHEMBL4300633 167574 0 None -10 3 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 444 7 0 3 5.6 Fc1ccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)cc1 10.1016/j.bmcl.2018.03.070
145964299 164132 0 None -1 6 Human 8.0 pIC50 = 8.0 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 426 8 1 6 3.8 CNC(=O)c1cc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccn1 10.1016/j.bmcl.2018.01.038
CHEMBL4210030 164132 0 None -1 6 Human 8.0 pIC50 = 8.0 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 426 8 1 6 3.8 CNC(=O)c1cc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccn1 10.1016/j.bmcl.2018.01.038
76071739 142797 0 None -25 3 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 348 1 1 4 3.6 COc1ccc2[nH]c3c(c2c1)C[C@H]1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3892879 142797 0 None -25 3 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 348 1 1 4 3.6 COc1ccc2[nH]c3c(c2c1)C[C@H]1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
145946986 167605 0 None -4 3 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 460 7 0 3 6.2 Clc1cccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)c1 10.1016/j.bmcl.2018.03.070
CHEMBL4227241 167605 0 None -4 3 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 460 7 0 3 6.2 Clc1cccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)c1 10.1016/j.bmcl.2018.03.070
CHEMBL4300995 167605 0 None -4 3 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 460 7 0 3 6.2 Clc1cccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)c1 10.1016/j.bmcl.2018.03.070
145990794 166800 0 None -19 6 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 437 6 0 5 3.8 O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1 10.1016/j.ejmech.2017.12.099
CHEMBL4284346 166800 0 None -19 6 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 437 6 0 5 3.8 O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1 10.1016/j.ejmech.2017.12.099
131978695 150861 0 None 5 3 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 440 5 1 4 5.4 COc1ccc2[nH]c3c(c2c1)CC1c2cc(OCc4ccccc4)c(OC)cc2CCN1C3 10.1021/acs.jmedchem.6b01217
CHEMBL3957222 150861 0 None 5 3 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 440 5 1 4 5.4 COc1ccc2[nH]c3c(c2c1)CC1c2cc(OCc4ccccc4)c(OC)cc2CCN1C3 10.1021/acs.jmedchem.6b01217
134138882 147728 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 318 0 1 3 3.6 c1ccc2c3c([nH]c2c1)CN1CCc2cc4c(cc2C1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3932187 147728 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 318 0 1 3 3.6 c1ccc2c3c([nH]c2c1)CN1CCc2cc4c(cc2C1C3)OCO4 10.1021/acs.jmedchem.6b01217
44575544 173998 0 None -3 4 Human 7.9 pIC50 = 7.9 Functional
Inhibition of adrenergic receptor 1a expressed in HEK293 cells assessed as inhibition of calcium influx after 10 mins by Fluo-4-AM based fluorimetryInhibition of adrenergic receptor 1a expressed in HEK293 cells assessed as inhibition of calcium influx after 10 mins by Fluo-4-AM based fluorimetry
ChEMBL 794 5 5 13 3.0 CC(C)CC(=O)O[C@H]1/C=C/C=C/C(=O)O[C@H]2[C@@H](C)C[C@@H]3[C@]2(O)[C@H](O)[C@@]2(CO)O[C@H]2[C@H]2[C@H]4OC5(c6ccccc6)O[C@@H]([C@@H](C)[C@@]23O5)[C@@]4(O)[C@](C)(O)C[C@H]2CC[C@H]1[C@H]2C 10.1021/np3000359
CHEMBL454246 173998 0 None -3 4 Human 7.9 pIC50 = 7.9 Functional
Inhibition of adrenergic receptor 1a expressed in HEK293 cells assessed as inhibition of calcium influx after 10 mins by Fluo-4-AM based fluorimetryInhibition of adrenergic receptor 1a expressed in HEK293 cells assessed as inhibition of calcium influx after 10 mins by Fluo-4-AM based fluorimetry
ChEMBL 794 5 5 13 3.0 CC(C)CC(=O)O[C@H]1/C=C/C=C/C(=O)O[C@H]2[C@@H](C)C[C@@H]3[C@]2(O)[C@H](O)[C@@]2(CO)O[C@H]2[C@H]2[C@H]4OC5(c6ccccc6)O[C@@H]([C@@H](C)[C@@]23O5)[C@@]4(O)[C@](C)(O)C[C@H]2CC[C@H]1[C@H]2C 10.1021/np3000359
127044893 140408 0 None 2 3 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 411 11 3 5 2.4 Cc1ccccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
CHEMBL3808878 140408 0 None 2 3 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 411 11 3 5 2.4 Cc1ccccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
134157118 154202 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 332 0 0 4 3.6 Cn1c2c(c3ccccc31)CC1c3cc4c(cc3CCN1C2)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3985901 154202 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 332 0 0 4 3.6 Cn1c2c(c3ccccc31)CC1c3cc4c(cc3CCN1C2)OCO4 10.1021/acs.jmedchem.6b01217
123141715 140535 0 None 2 3 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 459 12 3 6 3.4 COc1cc(Cl)ccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3810401 140535 0 None 2 3 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 459 12 3 6 3.4 COc1cc(Cl)ccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
44347716 16308 0 None 4 2 Rat 4.8 pIC50 = 4.8 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 590 27 4 8 6.3 COc1cccc(CNCCCCCCNCCSSCCNCCCCCCNCc2ccccc2OC)c1 10.1021/jm000995w
CHEMBL122621 16308 0 None 4 2 Rat 4.8 pIC50 = 4.8 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 590 27 4 8 6.3 COc1cccc(CNCCCCCCNCCSSCCNCCCCCCNCc2ccccc2OC)c1 10.1021/jm000995w
145966333 164060 0 None -134 6 Human 6.8 pIC50 = 6.8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 424 8 1 6 3.6 CNC(=O)c1cc(OCCCCN2CCN(c3cccc4sccc34)CC2)ccn1 10.1016/j.bmcl.2018.01.038
CHEMBL4209188 164060 0 None -134 6 Human 6.8 pIC50 = 6.8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 424 8 1 6 3.6 CNC(=O)c1cc(OCCCCN2CCN(c3cccc4sccc34)CC2)ccn1 10.1016/j.bmcl.2018.01.038
123986550 140398 0 None 223 3 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 521 14 3 6 4.2 CCc1ccc(OCC(F)(F)F)c(OCCNC(C)Cc2cc(C(N)=O)c3c(ccn3CCCO)c2)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3808717 140398 0 None 223 3 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 521 14 3 6 4.2 CCc1ccc(OCC(F)(F)F)c(OCCNC(C)Cc2cc(C(N)=O)c3c(ccn3CCCO)c2)c1 10.1021/acs.jmedchem.5b02023
134142282 145690 0 None 2 3 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 348 1 1 4 3.6 COc1ccc2[nH]c3c(c2c1)CC1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3916182 145690 0 None 2 3 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 348 1 1 4 3.6 COc1ccc2[nH]c3c(c2c1)CC1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
242 470 124 None -120 33 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.ejmech.2017.12.099
34 470 124 None -120 33 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.ejmech.2017.12.099
60795 470 124 None -120 33 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.ejmech.2017.12.099
CHEMBL1112 470 124 None -120 33 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.ejmech.2017.12.099
DB01238 470 124 None -120 33 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.ejmech.2017.12.099
242 470 124 None -120 33 Human 6.8 pIC50 = 6.8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.bmcl.2018.01.038
34 470 124 None -120 33 Human 6.8 pIC50 = 6.8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.bmcl.2018.01.038
60795 470 124 None -120 33 Human 6.8 pIC50 = 6.8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.bmcl.2018.01.038
CHEMBL1112 470 124 None -120 33 Human 6.8 pIC50 = 6.8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.bmcl.2018.01.038
DB01238 470 124 None -120 33 Human 6.8 pIC50 = 6.8 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.bmcl.2018.01.038
145983928 166412 0 None -48 6 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 435 6 0 5 3.6 O=C1[C@H]2[C@@H]3C=C[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1 10.1016/j.ejmech.2017.12.099
CHEMBL4277101 166412 0 None -48 6 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 435 6 0 5 3.6 O=C1[C@H]2[C@@H]3C=C[C@@H](C3)[C@H]2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1 10.1016/j.ejmech.2017.12.099
10820251 96622 0 None -1 2 Rat 5.7 pIC50 = 5.7 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1277 47 6 20 10.9 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3CNCCCCCCNCCSSCCNCCCCCCNCc3ccccc3C(=O)N(C)CCCCCCN(C)c3nc(N)c4cc(OC)c(OC)cc4n3)nc(N)c2cc1OC 10.1021/jm000995w
CHEMBL1203233 96622 0 None -1 2 Rat 5.7 pIC50 = 5.7 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1277 47 6 20 10.9 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3CNCCCCCCNCCSSCCNCCCCCCNCc3ccccc3C(=O)N(C)CCCCCCN(C)c3nc(N)c4cc(OC)c(OC)cc4n3)nc(N)c2cc1OC 10.1021/jm000995w
CHEMBL263434 96622 0 None -1 2 Rat 5.7 pIC50 = 5.7 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1277 47 6 20 10.9 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3CNCCCCCCNCCSSCCNCCCCCCNCc3ccccc3C(=O)N(C)CCCCCCN(C)c3nc(N)c4cc(OC)c(OC)cc4n3)nc(N)c2cc1OC 10.1021/jm000995w
10606263 141551 0 None 20 2 Rat 5.7 pIC50 = 5.7 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1161 33 6 20 7.3 COc1cc2nc(N3CCN(C(=O)c4ccc(CNCCCCCCNCCSSCCNCCCCCCNCc5ccc(C(=O)N6CCN(c7nc(N)c8cc(OC)c(OC)cc8n7)CC6)cc5)cc4)CC3)nc(N)c2cc1OC 10.1021/jm000995w
CHEMBL384790 141551 0 None 20 2 Rat 5.7 pIC50 = 5.7 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1161 33 6 20 7.3 COc1cc2nc(N3CCN(C(=O)c4ccc(CNCCCCCCNCCSSCCNCCCCCCNCc5ccc(C(=O)N6CCN(c7nc(N)c8cc(OC)c(OC)cc8n7)CC6)cc5)cc4)CC3)nc(N)c2cc1OC 10.1021/jm000995w
123472560 140494 0 None 616 3 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 507 13 3 6 4.0 Cc1ccc(OCC(F)(F)F)c(OCCNC(C)Cc2cc(C(N)=O)c3c(ccn3CCCO)c2)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3809840 140494 0 None 616 3 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 507 13 3 6 4.0 Cc1ccc(OCC(F)(F)F)c(OCCNC(C)Cc2cc(C(N)=O)c3c(ccn3CCCO)c2)c1 10.1021/acs.jmedchem.5b02023
129211 3749 78 None -1 14 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/acs.jmedchem.6b01217
2562 3749 78 None -1 14 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/acs.jmedchem.6b01217
488 3749 78 None -1 14 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/acs.jmedchem.6b01217
CHEMBL836 3749 78 None -1 14 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/acs.jmedchem.6b01217
DB00706 3749 78 None -1 14 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/acs.jmedchem.6b01217
123415538 140377 0 None 8 3 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 491 11 3 5 3.6 CC(Cc1cc(C(N)=O)c2c(ccn2CCCO)c1)NCCOc1ccc(F)cc1Br 10.1021/acs.jmedchem.5b02023
CHEMBL3808511 140377 0 None 8 3 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 491 11 3 5 3.6 CC(Cc1cc(C(N)=O)c2c(ccn2CCCO)c1)NCCOc1ccc(F)cc1Br 10.1021/acs.jmedchem.5b02023
123667086 140399 0 None -8 3 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 573 13 3 6 3.8 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1cc(Br)ccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
CHEMBL3808726 140399 0 None -8 3 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 573 13 3 6 3.8 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1cc(Br)ccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
127044912 140428 0 None -26 3 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 501 14 3 6 4.3 CC(Cc1cc(C(N)=O)c2c(ccn2CCCO)c1)NCCOc1ccccc1OCc1ccccc1 10.1021/acs.jmedchem.5b02023
CHEMBL3809093 140428 0 None -26 3 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 501 14 3 6 4.3 CC(Cc1cc(C(N)=O)c2c(ccn2CCCO)c1)NCCOc1ccccc1OCc1ccccc1 10.1021/acs.jmedchem.5b02023
117839022 140531 0 None 407 3 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 529 13 3 6 3.7 C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1cc(Cl)ccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
CHEMBL3810346 140531 0 None 407 3 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 529 13 3 6 3.7 C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1cc(Cl)ccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
124018870 140411 0 None -7 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 445 12 3 6 2.3 COc1ccc(F)cc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
CHEMBL3808896 140411 0 None -7 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 445 12 3 6 2.3 COc1ccc(F)cc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
123368349 140433 0 None 95 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 505 12 3 6 2.9 COc1cc(Br)ccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
CHEMBL3809175 140433 0 None 95 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 505 12 3 6 2.9 COc1cc(Br)ccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
123387804 140421 0 None -52 3 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 423 12 3 5 3.3 CCc1ccccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3808999 140421 0 None -52 3 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 423 12 3 5 3.3 CCc1ccccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
156767236 182957 0 None 9 2 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assayAntagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assay
ChEMBL 449 11 1 5 4.7 COc1ccccc1N1CCN(CCCCn2cc(CCCC(=O)O)c3ccccc32)CC1 10.1016/j.ejmech.2020.112616
CHEMBL4792905 182957 0 None 9 2 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assayAntagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assay
ChEMBL 449 11 1 5 4.7 COc1ccccc1N1CCN(CCCCn2cc(CCCC(=O)O)c3ccccc32)CC1 10.1016/j.ejmech.2020.112616
134157566 154026 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 348 1 1 4 3.6 COc1cccc2[nH]c3c(c12)CC1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3984249 154026 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 348 1 1 4 3.6 COc1cccc2[nH]c3c(c12)CC1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
134137522 143098 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 336 0 1 3 3.7 Fc1ccc2c3c([nH]c2c1)CN1CCc2cc4c(cc2C1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3895460 143098 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 336 0 1 3 3.7 Fc1ccc2c3c([nH]c2c1)CN1CCc2cc4c(cc2C1C3)OCO4 10.1021/acs.jmedchem.6b01217
123204312 140472 0 None 74 3 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 425 11 3 5 2.7 Cc1cccc(C)c1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
CHEMBL3809532 140472 0 None 74 3 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 425 11 3 5 2.7 Cc1cccc(C)c1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
134150827 152167 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 392 5 1 4 4.6 CCCOc1cc2c(cc1OC)CCN1Cc3[nH]c4ccc(OC)cc4c3CC21 10.1021/acs.jmedchem.6b01217
CHEMBL3968227 152167 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 392 5 1 4 4.6 CCCOc1cc2c(cc1OC)CCN1Cc3[nH]c4ccc(OC)cc4c3CC21 10.1021/acs.jmedchem.6b01217
134155537 150985 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 406 6 1 4 5.0 CCCCOc1cc2c(cc1OC)CCN1Cc3[nH]c4ccc(OC)cc4c3CC21 10.1021/acs.jmedchem.6b01217
CHEMBL3958316 150985 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 406 6 1 4 5.0 CCCCOc1cc2c(cc1OC)CCN1Cc3[nH]c4ccc(OC)cc4c3CC21 10.1021/acs.jmedchem.6b01217
123322716 140523 0 None 17 3 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 425 12 3 5 2.7 CCc1ccccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
CHEMBL3810198 140523 0 None 17 3 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 425 12 3 5 2.7 CCc1ccccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
134149598 148477 0 None 33 2 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 336 0 1 3 3.7 Fc1ccc2[nH]c3c(c2c1)CC1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3938121 148477 0 None 33 2 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 336 0 1 3 3.7 Fc1ccc2[nH]c3c(c2c1)CC1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
123801568 140489 0 None 100 3 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 441 11 3 7 1.9 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccc2c(c1)OCO2 10.1021/acs.jmedchem.5b02023
CHEMBL3809781 140489 0 None 100 3 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 441 11 3 7 1.9 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccc2c(c1)OCO2 10.1021/acs.jmedchem.5b02023
134150128 152100 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 424 3 1 4 5.1 c1ccc(COc2ccc3[nH]c4c(c3c2)CC2c3cc5c(cc3CCN2C4)OCO5)cc1 10.1021/acs.jmedchem.6b01217
CHEMBL3967696 152100 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 424 3 1 4 5.1 c1ccc(COc2ccc3[nH]c4c(c3c2)CC2c3cc5c(cc3CCN2C4)OCO5)cc1 10.1021/acs.jmedchem.6b01217
9891967 107525 34 None 4 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 495 13 3 6 3.1 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
CHEMBL3187195 107525 34 None 4 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 495 13 3 6 3.1 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
123644751 140503 0 None 125 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 529 13 3 6 3.7 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1cc(Cl)ccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
CHEMBL3810005 140503 0 None 125 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 529 13 3 6 3.7 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1cc(Cl)ccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
123475619 140491 0 None 43 3 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 503 12 3 6 3.5 COc1cc(Br)ccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3809794 140491 0 None 43 3 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 503 12 3 6 3.5 COc1cc(Br)ccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
76071859 150353 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 348 1 1 4 3.6 COc1ccc2[nH]c3c(c2c1)C[C@@H]1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3953156 150353 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 348 1 1 4 3.6 COc1ccc2[nH]c3c(c2c1)C[C@@H]1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
156767234 182596 0 None 10 2 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assayAntagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assay
ChEMBL 467 11 1 4 5.7 O=C(O)CCCc1cn(CCCCCN2CCN(c3ccccc3Cl)CC2)c2ccccc12 10.1016/j.ejmech.2020.112616
CHEMBL4788144 182596 0 None 10 2 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assayAntagonist activity at human alpha1A receptor transfected in HEK293 cells co-transfected with Galpha16 assessed as reduction in intracellular calcium release incubated for 40 mins by Fluo-4AM dye based fluorescence assay
ChEMBL 467 11 1 4 5.7 O=C(O)CCCc1cn(CCCCCN2CCN(c3ccccc3Cl)CC2)c2ccccc12 10.1016/j.ejmech.2020.112616
123393714 140474 0 None 3 3 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 439 11 3 5 3.1 Cc1ccc(C)c(OCCNC(C)Cc2cc3c(c(C(N)=O)c2)N(CCCO)CC3)c1C 10.1021/acs.jmedchem.5b02023
CHEMBL3809543 140474 0 None 3 3 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 439 11 3 5 3.1 Cc1ccc(C)c(OCCNC(C)Cc2cc3c(c(C(N)=O)c2)N(CCCO)CC3)c1C 10.1021/acs.jmedchem.5b02023
145993493 167357 0 None -47 6 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 439 6 0 5 4.5 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1 10.1016/j.ejmech.2017.12.099
CHEMBL4294617 167357 0 None -47 6 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 439 6 0 5 4.5 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1 10.1016/j.ejmech.2017.12.099
145993117 166921 0 None -309 6 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 427 7 0 5 4.4 CCC1(C)CC(=O)N(CCCCN2CCN(c3cccc4sccc34)CC2)C(=O)C1 10.1016/j.ejmech.2017.12.099
CHEMBL4286717 166921 0 None -309 6 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) after 10 mins by calcium 5 dye based FLIPR assay
ChEMBL 427 7 0 5 4.4 CCC1(C)CC(=O)N(CCCCN2CCN(c3cccc4sccc34)CC2)C(=O)C1 10.1016/j.ejmech.2017.12.099
123311113 140521 0 None 91 3 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 523 14 3 6 3.6 CCc1ccc(OCC(F)(F)F)c(OCCNC(C)Cc2cc3c(c(C(N)=O)c2)N(CCCO)CC3)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3810187 140521 0 None 91 3 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 523 14 3 6 3.6 CCc1ccc(OCC(F)(F)F)c(OCCNC(C)Cc2cc3c(c(C(N)=O)c2)N(CCCO)CC3)c1 10.1021/acs.jmedchem.5b02023
10582125 81834 0 None 14 2 Rat 5.4 pIC50 = 5.4 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1161 33 6 20 7.3 COc1cc2nc(N3CCN(C(=O)c4cccc(CNCCCCCCNCCSSCCNCCCCCCNCc5cccc(C(=O)N6CCN(c7nc(N)c8cc(OC)c(OC)cc8n7)CC6)c5)c4)CC3)nc(N)c2cc1OC 10.1021/jm000995w
CHEMBL216443 81834 0 None 14 2 Rat 5.4 pIC50 = 5.4 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1161 33 6 20 7.3 COc1cc2nc(N3CCN(C(=O)c4cccc(CNCCCCCCNCCSSCCNCCCCCCNCc5cccc(C(=O)N6CCN(c7nc(N)c8cc(OC)c(OC)cc8n7)CC6)c5)c4)CC3)nc(N)c2cc1OC 10.1021/jm000995w
123688273 140481 0 None 36 3 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 513 13 3 6 3.2 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccc(F)cc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
CHEMBL3809630 140481 0 None 36 3 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 513 13 3 6 3.2 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccc(F)cc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
127044911 140448 0 None -10 3 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 425 12 3 6 2.7 COc1ccccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3809319 140448 0 None -10 3 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 425 12 3 6 2.7 COc1ccccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
123183757 140477 0 None 10 3 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 445 12 3 6 2.3 COc1cc(F)ccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
CHEMBL3809600 140477 0 None 10 3 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 445 12 3 6 2.3 COc1cc(F)ccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
127044894 140367 0 None 3 3 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 427 12 3 6 2.1 COc1ccccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
CHEMBL3808408 140367 0 None 3 3 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 427 12 3 6 2.1 COc1ccccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
134147190 149798 0 None 3 3 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 334 0 2 4 3.3 Oc1ccc2[nH]c3c(c2c1)CC1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3948551 149798 0 None 3 3 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 334 0 2 4 3.3 Oc1ccc2[nH]c3c(c2c1)CC1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
10034370 156992 0 None 38 2 Rat 7.3 pIC50 = 7.3 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1277 47 6 20 10.9 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CNCCCCCCNCCSSCCNCCCCCCNCc4cccc(C(=O)N(C)CCCCCCN(C)c5nc(N)c6cc(OC)c(OC)cc6n5)c4)c3)nc(N)c2cc1OC 10.1021/jm000995w
CHEMBL1203232 156992 0 None 38 2 Rat 7.3 pIC50 = 7.3 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1277 47 6 20 10.9 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CNCCCCCCNCCSSCCNCCCCCCNCc4cccc(C(=O)N(C)CCCCCCN(C)c5nc(N)c6cc(OC)c(OC)cc6n5)c4)c3)nc(N)c2cc1OC 10.1021/jm000995w
CHEMBL407315 156992 0 None 38 2 Rat 7.3 pIC50 = 7.3 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1277 47 6 20 10.9 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CNCCCCCCNCCSSCCNCCCCCCNCc4cccc(C(=O)N(C)CCCCCCN(C)c5nc(N)c6cc(OC)c(OC)cc6n5)c4)c3)nc(N)c2cc1OC 10.1021/jm000995w
127043026 140447 0 None 8 2 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 507 13 3 6 4.0 Cc1ccc(OCC(F)(F)F)c(OCCN[C@@H](C)Cc2cc(C(N)=O)c3c(ccn3CCCO)c2)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3809314 140447 0 None 8 2 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 507 13 3 6 4.0 Cc1ccc(OCC(F)(F)F)c(OCCN[C@@H](C)Cc2cc(C(N)=O)c3c(ccn3CCCO)c2)c1 10.1021/acs.jmedchem.5b02023
16638286 149600 1 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 323 0 0 5 2.8 c1c2c(cc3c1OCO3)CN1CCc3cc4c(cc3C1C2)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3946997 149600 1 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 323 0 0 5 2.8 c1c2c(cc3c1OCO3)CN1CCc3cc4c(cc3C1C2)OCO4 10.1021/acs.jmedchem.6b01217
10034371 165980 0 None -2 2 Rat 5.3 pIC50 = 5.3 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1277 47 6 20 10.9 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CNCCCCCCNCCSSCCNCCCCCCNCc4ccc(C(=O)N(C)CCCCCCN(C)c5nc(N)c6cc(OC)c(OC)cc6n5)cc4)cc3)nc(N)c2cc1OC 10.1021/jm000995w
CHEMBL1203235 165980 0 None -2 2 Rat 5.3 pIC50 = 5.3 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1277 47 6 20 10.9 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CNCCCCCCNCCSSCCNCCCCCCNCc4ccc(C(=O)N(C)CCCCCCN(C)c5nc(N)c6cc(OC)c(OC)cc6n5)cc4)cc3)nc(N)c2cc1OC 10.1021/jm000995w
CHEMBL425267 165980 0 None -2 2 Rat 5.3 pIC50 = 5.3 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1277 47 6 20 10.9 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CNCCCCCCNCCSSCCNCCCCCCNCc4ccc(C(=O)N(C)CCCCCCN(C)c5nc(N)c6cc(OC)c(OC)cc6n5)cc4)cc3)nc(N)c2cc1OC 10.1021/jm000995w
10630100 96601 0 None 1 2 Rat 5.3 pIC50 = 5.3 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1161 33 6 20 7.3 COc1cc2nc(N3CCN(C(=O)c4ccccc4CNCCCCCCNCCSSCCNCCCCCCNCc4ccccc4C(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)CC3)nc(N)c2cc1OC 10.1021/jm000995w
CHEMBL263289 96601 0 None 1 2 Rat 5.3 pIC50 = 5.3 Functional
Antagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from ratAntagonist affinity [non competitive (irreversible)] at alpha-1A-adrenoceptors on isolated prostatic Vas deferens from rat
ChEMBL 1161 33 6 20 7.3 COc1cc2nc(N3CCN(C(=O)c4ccccc4CNCCCCCCNCCSSCCNCCCCCCNCc4ccccc4C(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)CC3)nc(N)c2cc1OC 10.1021/jm000995w
145947950 167733 0 None 1 3 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 440 7 0 3 5.8 Cc1cccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)c1 10.1016/j.bmcl.2018.03.070
CHEMBL4224703 167733 0 None 1 3 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 440 7 0 3 5.8 Cc1cccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)c1 10.1016/j.bmcl.2018.03.070
CHEMBL4302771 167733 0 None 1 3 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 440 7 0 3 5.8 Cc1cccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)c1 10.1016/j.bmcl.2018.03.070
21171 186976 33 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 339 2 0 5 3.1 COc1ccc2c(c1OC)CN1CCc3cc4c(cc3[C@@H]1C2)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL490533 186976 33 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 339 2 0 5 3.1 COc1ccc2c(c1OC)CN1CCc3cc4c(cc3[C@@H]1C2)OCO4 10.1021/acs.jmedchem.6b01217
21823379 144726 2 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 304 1 1 2 3.8 COc1ccc2c(c1)CCN1Cc3[nH]c4ccccc4c3CC21 10.1021/acs.jmedchem.6b01217
CHEMBL3908813 144726 2 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 304 1 1 2 3.8 COc1ccc2c(c1)CCN1Cc3[nH]c4ccccc4c3CC21 10.1021/acs.jmedchem.6b01217
4418 34222 85 None -4 18 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmcl.2018.03.070
CHEMBL142635 34222 85 None -4 18 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmcl.2018.03.070
145947047 167635 0 None -1 3 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 425 7 0 2 6.6 c1ccc(C2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)cc1 10.1016/j.bmcl.2018.03.070
CHEMBL4227513 167635 0 None -1 3 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 425 7 0 2 6.6 c1ccc(C2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)cc1 10.1016/j.bmcl.2018.03.070
CHEMBL4301557 167635 0 None -1 3 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 425 7 0 2 6.6 c1ccc(C2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)cc1 10.1016/j.bmcl.2018.03.070
123576734 140424 0 None 15 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 455 13 3 6 2.7 CCc1ccc(OCCNC(C)Cc2cc3c(c(C(N)=O)c2)N(CCCO)CC3)c(OC)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3809032 140424 0 None 15 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 455 13 3 6 2.7 CCc1ccc(OCCNC(C)Cc2cc3c(c(C(N)=O)c2)N(CCCO)CC3)c(OC)c1 10.1021/acs.jmedchem.5b02023
76071738 148329 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 318 0 1 3 3.6 c1ccc2c3c([nH]c2c1)CN1CCc2cc4c(cc2[C@@H]1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3937032 148329 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 318 0 1 3 3.6 c1ccc2c3c([nH]c2c1)CN1CCc2cc4c(cc2[C@@H]1C3)OCO4 10.1021/acs.jmedchem.6b01217
145946630 167573 0 None 12 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 456 8 0 4 5.5 COc1ccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)cc1 10.1016/j.bmcl.2018.03.070
CHEMBL4224794 167573 0 None 12 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 456 8 0 4 5.5 COc1ccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)cc1 10.1016/j.bmcl.2018.03.070
CHEMBL4300618 167573 0 None 12 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assayAntagonist activity at alpha 1A adrenergic receptor (unknown origin) by luciferase reporter gene assay
ChEMBL 456 8 0 4 5.5 COc1ccc(N2CCN(CCc3ccc(COc4ccc5c(c4)CCCC5)cc3)CC2)cc1 10.1016/j.bmcl.2018.03.070
123752717 140470 0 None 26 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 439 11 3 5 3.1 Cc1cc(C)c(OCCNC(C)Cc2cc3c(c(C(N)=O)c2)N(CCCO)CC3)c(C)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3809500 140470 0 None 26 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 439 11 3 5 3.1 Cc1cc(C)c(OCCNC(C)Cc2cc3c(c(C(N)=O)c2)N(CCCO)CC3)c(C)c1 10.1021/acs.jmedchem.5b02023
134145079 150222 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 348 1 1 4 3.6 COc1ccc2c3c([nH]c2c1)CN1CCc2cc4c(cc2C1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3952204 150222 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 348 1 1 4 3.6 COc1ccc2c3c([nH]c2c1)CN1CCc2cc4c(cc2C1C3)OCO4 10.1021/acs.jmedchem.6b01217
127044906 140418 0 None 7 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 529 13 3 6 3.7 C[C@@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1cc(Cl)ccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
CHEMBL3808981 140418 0 None 7 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 529 13 3 6 3.7 C[C@@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1cc(Cl)ccc1OCC(F)(F)F 10.1021/acs.jmedchem.5b02023
123183788 140526 0 None 7 3 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 441 12 3 6 2.4 COc1cc(C)ccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
CHEMBL3810220 140526 0 None 7 3 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 441 12 3 6 2.4 COc1cc(C)ccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
123378354 140387 0 None 6 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 493 11 3 5 3.0 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccc(F)cc1Br 10.1021/acs.jmedchem.5b02023
CHEMBL3808595 140387 0 None 6 3 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 493 11 3 5 3.0 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccc(F)cc1Br 10.1021/acs.jmedchem.5b02023
145963961 164403 0 None -32 6 Human 7.2 pIC50 = 7.2 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 425 8 1 7 3.0 CNC(=O)c1cc(OCCCCN2CCN(c3nsc4ccccc34)CC2)ccn1 10.1016/j.bmcl.2018.01.038
CHEMBL4213342 164403 0 None -32 6 Human 7.2 pIC50 = 7.2 Functional
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 425 8 1 7 3.0 CNC(=O)c1cc(OCCCCN2CCN(c3nsc4ccccc34)CC2)ccn1 10.1016/j.bmcl.2018.01.038
134157568 154459 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 352 4 0 4 3.1 COc1cc2cc[n+]3c(c2cc1OC)Cc1ccc(OC)c(OC)c1C3 10.1021/acs.jmedchem.6b01217
CHEMBL3984336 154459 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 352 4 0 4 3.1 COc1cc2cc[n+]3c(c2cc1OC)Cc1ccc(OC)c(OC)c1C3 10.1021/acs.jmedchem.6b01217
CHEMBL3990197 154459 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 352 4 0 4 3.1 COc1cc2cc[n+]3c(c2cc1OC)Cc1ccc(OC)c(OC)c1C3 10.1021/acs.jmedchem.6b01217
127044916 140482 0 None 1 3 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 443 12 3 6 2.9 COc1cc(F)ccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
CHEMBL3809676 140482 0 None 1 3 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 443 12 3 6 2.9 COc1cc(F)ccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1 10.1021/acs.jmedchem.5b02023
123437117 140369 0 None 23 3 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 461 12 3 6 2.8 COc1cc(Cl)ccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
CHEMBL3808417 140369 0 None 23 3 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 461 12 3 6 2.8 COc1cc(Cl)ccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2 10.1021/acs.jmedchem.5b02023
127045050 140393 0 None -5 3 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 503 14 3 6 3.7 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCc1ccccc1 10.1021/acs.jmedchem.5b02023
CHEMBL3808632 140393 0 None -5 3 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 minsAntagonist activity at human alpha-1A adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins
ChEMBL 503 14 3 6 3.7 CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCc1ccccc1 10.1021/acs.jmedchem.5b02023
118167692 164209 10 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at alpha1A adrenergic receptor (unknown origin)Antagonist activity at alpha1A adrenergic receptor (unknown origin)
ChEMBL 521 7 1 7 3.0 Cn1cnc(-c2cnc(O[C@H]3CCN(C(=O)Cc4ccc(OC(F)(F)F)cc4)C[C@H]3F)c(C(N)=O)c2)c1 10.1021/acs.jmedchem.8b00633
CHEMBL4210892 164209 10 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at alpha1A adrenergic receptor (unknown origin)Antagonist activity at alpha1A adrenergic receptor (unknown origin)
ChEMBL 521 7 1 7 3.0 Cn1cnc(-c2cnc(O[C@H]3CCN(C(=O)Cc4ccc(OC(F)(F)F)cc4)C[C@H]3F)c(C(N)=O)c2)c1 10.1021/acs.jmedchem.8b00633
134134752 144209 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 318 1 1 2 4.4 COc1ccc2c(c1)CCN1C(C)c3[nH]c4ccccc4c3CC21 10.1021/acs.jmedchem.6b01217
CHEMBL3904395 144209 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assayAntagonist activity at human full-length N-terminal SNAP-tagged alpha1A adrenoceptor expressed in HEK293 cells assessed as inhibition of agonist-induced calcium mobilization preincubated for 10 mins followed by agonist addition by fluo-4 AM dye-based assay
ChEMBL 318 1 1 2 4.4 COc1ccc2c(c1)CCN1C(C)c3[nH]c4ccccc4c3CC21 10.1021/acs.jmedchem.6b01217
10813278 106940 0 None - 0 Rabbit 10.7 pKd = 10.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 446 8 1 6 3.5 Cc1ccc(N2CCN(CCCNc3ncccc3C(=O)N(C)C)CC2)c(-n2cccc2)c1 10.1021/jm970166j
CHEMBL314880 106940 0 None - 0 Rabbit 10.7 pKd = 10.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 446 8 1 6 3.5 Cc1ccc(N2CCN(CCCNc3ncccc3C(=O)N(C)C)CC2)c(-n2cccc2)c1 10.1021/jm970166j
10697270 106178 0 None - 0 Rabbit 10.0 pKd = 10 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 519 9 2 8 3.2 CNC(=O)c1cnc2c(c(C)nn2C)c1NCCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
CHEMBL313775 106178 0 None - 0 Rabbit 10.0 pKd = 10 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 519 9 2 8 3.2 CNC(=O)c1cnc2c(c(C)nn2C)c1NCCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
10552132 112788 0 None - 0 Rabbit 10.0 pKd = 10 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 465 9 1 6 3.3 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
CHEMBL330579 112788 0 None - 0 Rabbit 10.0 pKd = 10 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 465 9 1 6 3.3 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
13305910 11836 1 None - 0 Rat 10.0 pKd = 10.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182155 11836 1 None - 0 Rat 10.0 pKd = 10.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL215421 11836 1 None - 0 Rat 10.0 pKd = 10.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL3741808 11836 1 None - 0 Rat 10.0 pKd = 10.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
13305910 11836 1 None - 0 Rat 10.0 pKd = 10.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL1182155 11836 1 None - 0 Rat 10.0 pKd = 10.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL215421 11836 1 None - 0 Rat 10.0 pKd = 10.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL3741808 11836 1 None - 0 Rat 10.0 pKd = 10.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
10506159 111400 0 None - 0 Rabbit 9.9 pKd = 9.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 520 8 1 9 3.4 Cc1nn(C)c2ncc(C(=O)N(C)C)c(NCCCN3CCN(c4ccc(F)cc4-c4ncco4)CC3)c12 10.1021/jm970166j
CHEMBL327231 111400 0 None - 0 Rabbit 9.9 pKd = 9.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 520 8 1 9 3.4 Cc1nn(C)c2ncc(C(=O)N(C)C)c(NCCCN3CCN(c4ccc(F)cc4-c4ncco4)CC3)c12 10.1021/jm970166j
10693231 202762 0 None - 0 Human 9.8 pKd = 9.8 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 416 4 1 6 2.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(C#N)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL62033 202762 0 None - 0 Human 9.8 pKd = 9.8 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 416 4 1 6 2.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(C#N)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
129211 3749 78 None - 14 Rabbit 9.8 pKd = 9.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970166j
2562 3749 78 None - 14 Rabbit 9.8 pKd = 9.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970166j
488 3749 78 None - 14 Rabbit 9.8 pKd = 9.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970166j
CHEMBL836 3749 78 None - 14 Rabbit 9.8 pKd = 9.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970166j
DB00706 3749 78 None - 14 Rabbit 9.8 pKd = 9.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970166j
10526964 206965 0 None - 0 Rabbit 9.8 pKd = 9.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 437 10 1 6 3.2 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2OCC2CC2)CC1 10.1021/jm970166j
CHEMBL91278 206965 0 None - 0 Rabbit 9.8 pKd = 9.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 437 10 1 6 3.2 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2OCC2CC2)CC1 10.1021/jm970166j
10764021 206991 0 None - 0 Rabbit 9.7 pKd = 9.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 409 9 1 5 3.4 CCCc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL91400 206991 0 None - 0 Rabbit 9.7 pKd = 9.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 409 9 1 5 3.4 CCCc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
24897950 56352 0 None - 0 Rat 9.6 pKd = 9.6 Functional
Antagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 mins
ChEMBL 462 11 2 6 2.9 COc1ccc(C[C@@H](C)NCCOc2ccccc2OCC(F)(F)F)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
CHEMBL1630940 56352 0 None - 0 Rat 9.6 pKd = 9.6 Functional
Antagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 mins
ChEMBL 462 11 2 6 2.9 COc1ccc(C[C@@H](C)NCCOc2ccccc2OCC(F)(F)F)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
71462043 84568 0 None - 0 Rat 9.6 pKd = 9.6 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153555 84568 0 None - 0 Rat 9.6 pKd = 9.6 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220895 84568 0 None - 0 Rat 9.6 pKd = 9.6 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
129211 3749 78 None -1 14 Human 9.5 pKd = 9.5 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
2562 3749 78 None -1 14 Human 9.5 pKd = 9.5 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
488 3749 78 None -1 14 Human 9.5 pKd = 9.5 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
CHEMBL836 3749 78 None -1 14 Human 9.5 pKd = 9.5 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
DB00706 3749 78 None -1 14 Human 9.5 pKd = 9.5 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
129211 3749 78 None -1 14 Human 9.5 pKd = 9.5 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm000541z
2562 3749 78 None -1 14 Human 9.5 pKd = 9.5 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm000541z
488 3749 78 None -1 14 Human 9.5 pKd = 9.5 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm000541z
CHEMBL836 3749 78 None -1 14 Human 9.5 pKd = 9.5 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm000541z
DB00706 3749 78 None -1 14 Human 9.5 pKd = 9.5 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm000541z
499 4077 18 None - 1 Rat 9.5 pKd = 9.5 Functional
Antagonistic activity at ADRA1A in isolated rat prostatic vas deferensAntagonistic activity at ADRA1A in isolated rat prostatic vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1016/j.bmcl.2005.09.027
5685 4077 18 None - 1 Rat 9.5 pKd = 9.5 Functional
Antagonistic activity at ADRA1A in isolated rat prostatic vas deferensAntagonistic activity at ADRA1A in isolated rat prostatic vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1016/j.bmcl.2005.09.027
CHEMBL25554 4077 18 None - 1 Rat 9.5 pKd = 9.5 Functional
Antagonistic activity at ADRA1A in isolated rat prostatic vas deferensAntagonistic activity at ADRA1A in isolated rat prostatic vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1016/j.bmcl.2005.09.027
499 4077 18 None - 1 Rat 9.5 pKd = 9.5 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm011066n
5685 4077 18 None - 1 Rat 9.5 pKd = 9.5 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm011066n
CHEMBL25554 4077 18 None - 1 Rat 9.5 pKd = 9.5 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm011066n
10526831 111389 0 None - 0 Rabbit 9.5 pKd = 9.5 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 434 8 1 7 3.1 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2-c2ncco2)CC1 10.1021/jm970166j
CHEMBL327168 111389 0 None - 0 Rabbit 9.5 pKd = 9.5 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 434 8 1 7 3.1 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2-c2ncco2)CC1 10.1021/jm970166j
13305910 11836 1 None - 0 Rat 9.5 pKd = 9.5 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182155 11836 1 None - 0 Rat 9.5 pKd = 9.5 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL215421 11836 1 None - 0 Rat 9.5 pKd = 9.5 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL3741808 11836 1 None - 0 Rat 9.5 pKd = 9.5 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
13305910 11836 1 None - 0 Rat 9.5 pKd = 9.5 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL1182155 11836 1 None - 0 Rat 9.5 pKd = 9.5 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL215421 11836 1 None - 0 Rat 9.5 pKd = 9.5 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL3741808 11836 1 None - 0 Rat 9.5 pKd = 9.5 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
129211 3749 78 None - 14 Rat 9.5 pKd = 9.5 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
2562 3749 78 None - 14 Rat 9.5 pKd = 9.5 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
488 3749 78 None - 14 Rat 9.5 pKd = 9.5 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
CHEMBL836 3749 78 None - 14 Rat 9.5 pKd = 9.5 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
DB00706 3749 78 None - 14 Rat 9.5 pKd = 9.5 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
129211 3749 78 None - 14 Rat 9.5 pKd = 9.5 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm000541z
2562 3749 78 None - 14 Rat 9.5 pKd = 9.5 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm000541z
488 3749 78 None - 14 Rat 9.5 pKd = 9.5 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm000541z
CHEMBL836 3749 78 None - 14 Rat 9.5 pKd = 9.5 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm000541z
DB00706 3749 78 None - 14 Rat 9.5 pKd = 9.5 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm000541z
44289437 169863 0 None - 0 Rat 9.5 pKd = 9.5 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 431 9 1 5 4.7 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2C1=O 10.1021/jm011066n
CHEMBL44403 169863 0 None - 0 Rat 9.5 pKd = 9.5 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 431 9 1 5 4.7 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2C1=O 10.1021/jm011066n
10789770 100885 0 None - 0 Human 9.5 pKd = 9.5 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 451 6 1 7 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(OC)c(OC)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL293695 100885 0 None - 0 Human 9.5 pKd = 9.5 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 451 6 1 7 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(OC)c(OC)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
10645210 206479 0 None - 0 Rabbit 9.4 pKd = 9.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 409 8 1 5 3.5 CC(C)c1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL88211 206479 0 None - 0 Rabbit 9.4 pKd = 9.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 409 8 1 5 3.5 CC(C)c1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
499 4077 18 None - 1 Rat 9.4 pKd = 9.4 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm060358r
5685 4077 18 None - 1 Rat 9.4 pKd = 9.4 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm060358r
CHEMBL25554 4077 18 None - 1 Rat 9.4 pKd = 9.4 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm060358r
499 4077 18 None - 1 Rat 9.4 pKd = 9.4 Functional
Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (Alpha-1A adrenergic receptor )Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (Alpha-1A adrenergic receptor )
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm021078o
5685 4077 18 None - 1 Rat 9.4 pKd = 9.4 Functional
Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (Alpha-1A adrenergic receptor )Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (Alpha-1A adrenergic receptor )
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm021078o
CHEMBL25554 4077 18 None - 1 Rat 9.4 pKd = 9.4 Functional
Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (Alpha-1A adrenergic receptor )Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (Alpha-1A adrenergic receptor )
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm021078o
44289437 169863 0 None - 0 Rat 9.4 pKd = 9.4 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 431 9 1 5 4.7 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2C1=O 10.1021/jm011066n
CHEMBL44403 169863 0 None - 0 Rat 9.4 pKd = 9.4 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 431 9 1 5 4.7 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2C1=O 10.1021/jm011066n
10787790 105990 0 None - 0 Rabbit 9.3 pKd = 9.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 411 9 1 6 2.8 CCOc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL313157 105990 0 None - 0 Rabbit 9.3 pKd = 9.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 411 9 1 6 2.8 CCOc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10744240 107034 0 None - 0 Rabbit 9.3 pKd = 9.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 508 9 2 7 2.8 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3c(C(N)=O)cccc23)CC1 10.1021/jm970166j
CHEMBL315496 107034 0 None - 0 Rabbit 9.3 pKd = 9.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 508 9 2 7 2.8 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3c(C(N)=O)cccc23)CC1 10.1021/jm970166j
10763212 168196 0 None - 0 Rabbit 9.3 pKd = 9.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 394 9 1 6 3.3 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)C2CC2)CC1 10.1021/jm970166j
CHEMBL433348 168196 0 None - 0 Rabbit 9.3 pKd = 9.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 394 9 1 6 3.3 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)C2CC2)CC1 10.1021/jm970166j
9893282 206469 0 None - 0 Rabbit 9.3 pKd = 9.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 533 9 1 8 3.5 Cc1nn(C)c2ncc(C(=O)N(C)C)c(NCCCN3CCN(c4ccccc4OCC(F)(F)F)CC3)c12 10.1021/jm970166j
CHEMBL88160 206469 0 None - 0 Rabbit 9.3 pKd = 9.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 533 9 1 8 3.5 Cc1nn(C)c2ncc(C(=O)N(C)C)c(NCCCN3CCN(c4ccccc4OCC(F)(F)F)CC3)c12 10.1021/jm970166j
44323795 206608 0 None - 0 Rabbit 9.3 pKd = 9.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 410 8 1 5 3.3 COc1ccccc1N1CCN(CCCNc2cc(C)ccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL89030 206608 0 None - 0 Rabbit 9.3 pKd = 9.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 410 8 1 5 3.3 COc1ccccc1N1CCN(CCCNc2cc(C)ccc2C(=O)N(C)C)CC1 10.1021/jm970166j
499 4077 18 None - 1 Rat 9.3 pKd = 9.3 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm011066n
5685 4077 18 None - 1 Rat 9.3 pKd = 9.3 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm011066n
CHEMBL25554 4077 18 None - 1 Rat 9.3 pKd = 9.3 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm011066n
9824384 118787 1 None - 0 Rat 9.2 pKd = 9.2 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL342062 118787 1 None - 0 Rat 9.2 pKd = 9.2 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
10478121 170802 0 None - 0 Human 9.2 pKd = 9.2 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 435 6 0 7 3.1 COc1cc2ncn(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
CHEMBL445325 170802 0 None - 0 Human 9.2 pKd = 9.2 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 435 6 0 7 3.1 COc1cc2ncn(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
10743446 107071 0 None - 0 Rabbit 9.2 pKd = 9.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 483 8 1 8 2.8 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3c2nc(C)n3C)CC1 10.1021/jm970166j
CHEMBL315785 107071 0 None - 0 Rabbit 9.2 pKd = 9.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 483 8 1 8 2.8 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3c2nc(C)n3C)CC1 10.1021/jm970166j
10549680 112384 0 None - 0 Rabbit 9.2 pKd = 9.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 413 8 1 6 3.1 CSc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL329601 112384 0 None - 0 Rabbit 9.2 pKd = 9.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 413 8 1 6 3.1 CSc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10647512 207025 0 None - 0 Rabbit 9.2 pKd = 9.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 456 8 2 6 1.6 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)c[nH]c3ccn[n+]2-3)CC1 10.1021/jm970166j
CHEMBL91547 207025 0 None - 0 Rabbit 9.2 pKd = 9.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 456 8 2 6 1.6 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)c[nH]c3ccn[n+]2-3)CC1 10.1021/jm970166j
10621397 207092 0 None - 0 Rabbit 9.2 pKd = 9.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 407 8 1 5 3.3 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2C2CC2)CC1 10.1021/jm970166j
CHEMBL91951 207092 0 None - 0 Rabbit 9.2 pKd = 9.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 407 8 1 5 3.3 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2C2CC2)CC1 10.1021/jm970166j
499 4077 18 None - 1 Rat 9.2 pKd = 9.2 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm060358r
5685 4077 18 None - 1 Rat 9.2 pKd = 9.2 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm060358r
CHEMBL25554 4077 18 None - 1 Rat 9.2 pKd = 9.2 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm060358r
10574245 111522 0 None - 0 Rabbit 9.1 pKd = 9.1 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 422 8 1 7 2.3 COc1ccccc1N1CCN(CCCNc2ncc(C#N)cc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL327872 111522 0 None - 0 Rabbit 9.1 pKd = 9.1 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 422 8 1 7 2.3 COc1ccccc1N1CCN(CCCNc2ncc(C#N)cc2C(=O)N(C)C)CC1 10.1021/jm970166j
10577066 112412 0 None - 0 Rabbit 9.1 pKd = 9.1 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 490 8 2 6 2.3 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)c[nH]c3c(Cl)cn[n+]2-3)CC1 10.1021/jm970166j
CHEMBL329773 112412 0 None - 0 Rabbit 9.1 pKd = 9.1 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 490 8 2 6 2.3 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)c[nH]c3c(Cl)cn[n+]2-3)CC1 10.1021/jm970166j
10530686 206903 0 None - 0 Rabbit 9.1 pKd = 9.1 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 549 9 1 6 5.2 CN(C)C(=O)c1cnc2c(Cl)cccc2c1NCCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
CHEMBL90878 206903 0 None - 0 Rabbit 9.1 pKd = 9.1 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 549 9 1 6 5.2 CN(C)C(=O)c1cnc2c(Cl)cccc2c1NCCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
11795906 207066 0 None - 0 Rabbit 9.1 pKd = 9.1 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 411 8 1 6 2.7 COc1cc(C)ccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL91785 207066 0 None - 0 Rabbit 9.1 pKd = 9.1 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 411 8 1 6 2.7 COc1cc(C)ccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
14423371 97454 1 None - 0 Rat 9.0 pKd = 9.0 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 441 11 1 8 3.6 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL27013 97454 1 None - 0 Rat 9.0 pKd = 9.0 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 441 11 1 8 3.6 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1021/jm9810654
71462043 84568 0 None - 0 Rat 9.0 pKd = 9.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153555 84568 0 None - 0 Rat 9.0 pKd = 9.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220895 84568 0 None - 0 Rat 9.0 pKd = 9.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
14423371 97454 1 None - 0 Rat 9.0 pKd = 9.0 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 441 11 1 8 3.6 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1016/s0960-894x(98)00217-0
CHEMBL27013 97454 1 None - 0 Rat 9.0 pKd = 9.0 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 441 11 1 8 3.6 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1016/s0960-894x(98)00217-0
10456471 100533 0 None - 0 Human 9.0 pKd = 9.0 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 451 6 1 7 2.4 COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
CHEMBL291303 100533 0 None - 0 Human 9.0 pKd = 9.0 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 451 6 1 7 2.4 COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
10572854 112566 0 None - 0 Rabbit 9.0 pKd = 9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 396 8 1 5 3.0 COc1ccccc1N1CCN(CCCNc2ccccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL330060 112566 0 None - 0 Rabbit 9.0 pKd = 9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 396 8 1 5 3.0 COc1ccccc1N1CCN(CCCNc2ccccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10786203 207269 0 None - 0 Rabbit 9.0 pKd = 9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 383 8 2 6 2.1 CNC(=O)c1cccnc1NCCCN1CCN(c2ccccc2OC)CC1 10.1021/jm970166j
CHEMBL93054 207269 0 None - 0 Rabbit 9.0 pKd = 9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 383 8 2 6 2.1 CNC(=O)c1cccnc1NCCCN1CCN(c2ccccc2OC)CC1 10.1021/jm970166j
11430491 63001 0 None - 0 Rat 9.0 pKd = 9 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 435 5 1 9 2.4 COc1cc2nc(N3CCN(C(=O)CC4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
CHEMBL178673 63001 0 None - 0 Rat 9.0 pKd = 9 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 435 5 1 9 2.4 COc1cc2nc(N3CCN(C(=O)CC4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
10527469 156265 3 None - 0 Human 9.0 pKd = 9 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm970364a
CHEMBL40650 156265 3 None - 0 Human 9.0 pKd = 9 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm970364a
4209 3163 75 None -1 17 Rat 9.0 pKd = 9.0 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
4893 3163 75 None -1 17 Rat 9.0 pKd = 9.0 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
503 3163 75 None -1 17 Rat 9.0 pKd = 9.0 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
5385 3163 75 None -1 17 Rat 9.0 pKd = 9.0 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
CHEMBL2 3163 75 None -1 17 Rat 9.0 pKd = 9.0 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
DB00457 3163 75 None -1 17 Rat 9.0 pKd = 9.0 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
10478121 170802 0 None - 0 Rat 9.0 pKd = 9.0 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 435 6 0 7 3.1 COc1cc2ncn(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
CHEMBL445325 170802 0 None - 0 Rat 9.0 pKd = 9.0 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 435 6 0 7 3.1 COc1cc2ncn(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
16121006 11841 0 None - 0 Rat 9.0 pKd = 9.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182182 11841 0 None - 0 Rat 9.0 pKd = 9.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL217469 11841 0 None - 0 Rat 9.0 pKd = 9.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
11742834 165770 0 None - 0 Rat 9.0 pKd = 9.0 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 419 9 1 5 4.7 COc1cccc(OC)c1OCCNC[C@@H]1C[C@H](c2ccccc2)c2ccccc2O1 10.1021/jm011066n
CHEMBL42472 165770 0 None - 0 Rat 9.0 pKd = 9.0 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 419 9 1 5 4.7 COc1cccc(OC)c1OCCNC[C@@H]1C[C@H](c2ccccc2)c2ccccc2O1 10.1021/jm011066n
10527469 156265 3 None - 0 Rat 8.9 pKd = 8.9 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm970364a
CHEMBL40650 156265 3 None - 0 Rat 8.9 pKd = 8.9 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm970364a
10834793 84579 0 None - 0 Rat 8.9 pKd = 8.9 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153557 84579 0 None - 0 Rat 8.9 pKd = 8.9 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220925 84579 0 None - 0 Rat 8.9 pKd = 8.9 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
132266 1278 12 None - 0 Rat 8.9 pKd = 8.9 Functional
Antagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deferenceAntagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deference
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm8016046
486 1278 12 None - 0 Rat 8.9 pKd = 8.9 Functional
Antagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deferenceAntagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deference
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm8016046
CHEMBL423294 1278 12 None - 0 Rat 8.9 pKd = 8.9 Functional
Antagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deferenceAntagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deference
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm8016046
10505222 206665 0 None - 0 Rabbit 8.9 pKd = 8.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 490 8 1 7 3.6 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3c(C#N)cccc23)CC1 10.1021/jm970166j
CHEMBL89397 206665 0 None - 0 Rabbit 8.9 pKd = 8.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 490 8 1 7 3.6 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3c(C#N)cccc23)CC1 10.1021/jm970166j
10575254 206883 0 None - 0 Rabbit 8.9 pKd = 8.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 443 8 1 5 4.1 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2-c2ccccc2)CC1 10.1021/jm970166j
CHEMBL90746 206883 0 None - 0 Rabbit 8.9 pKd = 8.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 443 8 1 5 4.1 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2-c2ccccc2)CC1 10.1021/jm970166j
10814587 206892 0 None - 0 Rabbit 8.9 pKd = 8.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 480 8 1 7 3.4 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3nc(C)ccc23)CC1 10.1021/jm970166j
CHEMBL90810 206892 0 None - 0 Rabbit 8.9 pKd = 8.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 480 8 1 7 3.4 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3nc(C)ccc23)CC1 10.1021/jm970166j
10646065 206902 0 None - 0 Rabbit 8.9 pKd = 8.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 425 8 2 6 3.2 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)NC(C)(C)C)CC1 10.1021/jm970166j
CHEMBL90874 206902 0 None - 0 Rabbit 8.9 pKd = 8.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 425 8 2 6 3.2 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)NC(C)(C)C)CC1 10.1021/jm970166j
10624682 207038 0 None - 0 Rabbit 8.9 pKd = 8.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 483 8 1 8 2.8 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3c2c(C)nn3C)CC1 10.1021/jm970166j
CHEMBL91605 207038 0 None - 0 Rabbit 8.9 pKd = 8.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 483 8 1 8 2.8 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3c2c(C)nn3C)CC1 10.1021/jm970166j
10789770 100885 0 None - 0 Rat 8.9 pKd = 8.9 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 451 6 1 7 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(OC)c(OC)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL293695 100885 0 None - 0 Rat 8.9 pKd = 8.9 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 451 6 1 7 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(OC)c(OC)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
11742834 165770 0 None - 0 Rat 8.9 pKd = 8.9 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 419 9 1 5 4.7 COc1cccc(OC)c1OCCNC[C@@H]1C[C@H](c2ccccc2)c2ccccc2O1 10.1021/jm011066n
CHEMBL42472 165770 0 None - 0 Rat 8.9 pKd = 8.9 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 419 9 1 5 4.7 COc1cccc(OC)c1OCCNC[C@@H]1C[C@H](c2ccccc2)c2ccccc2O1 10.1021/jm011066n
10693231 202762 0 None - 0 Rat 8.8 pKd = 8.8 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 416 4 1 6 2.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(C#N)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL62033 202762 0 None - 0 Rat 8.8 pKd = 8.8 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 416 4 1 6 2.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(C#N)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
9865577 112309 2 None - 0 Rabbit 8.8 pKd = 8.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 397 8 1 6 2.4 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL329160 112309 2 None - 0 Rabbit 8.8 pKd = 8.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 397 8 1 6 2.4 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10621790 163816 0 None - 0 Rabbit 8.8 pKd = 8.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 415 8 1 6 2.6 COc1cc(F)ccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL420620 163816 0 None - 0 Rabbit 8.8 pKd = 8.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 415 8 1 6 2.6 COc1cc(F)ccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10839699 206751 0 None - 0 Rabbit 8.8 pKd = 8.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 520 9 1 8 3.8 Cc1noc2ncc(C(=O)N(C)C)c(NCCCN3CCN(c4ccccc4OCC(F)(F)F)CC3)c12 10.1021/jm970166j
CHEMBL90022 206751 0 None - 0 Rabbit 8.8 pKd = 8.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 520 9 1 8 3.8 Cc1noc2ncc(C(=O)N(C)C)c(NCCCN3CCN(c4ccccc4OCC(F)(F)F)CC3)c12 10.1021/jm970166j
10552164 206900 0 None - 0 Rabbit 8.8 pKd = 8.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 466 9 1 6 3.4 CN(C)C(=O)c1cccnc1N1CCC(NCCOc2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
CHEMBL90869 206900 0 None - 0 Rabbit 8.8 pKd = 8.8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 466 9 1 6 3.4 CN(C)C(=O)c1cccnc1N1CCC(NCCOc2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
10549596 84605 1 None - 0 Rat 8.8 pKd = 8.8 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153553 84605 1 None - 0 Rat 8.8 pKd = 8.8 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2221147 84605 1 None - 0 Rat 8.8 pKd = 8.8 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
10501886 111401 0 None - 0 Rabbit 8.7 pKd = 8.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 413 8 2 7 2.1 COc1ccccc1N1CCN(CCCNc2ncc(O)cc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL327232 111401 0 None - 0 Rabbit 8.7 pKd = 8.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 413 8 2 7 2.1 COc1ccccc1N1CCN(CCCNc2ncc(O)cc2C(=O)N(C)C)CC1 10.1021/jm970166j
10693071 206474 0 None - 0 Rabbit 8.7 pKd = 8.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 413 8 0 5 3.7 COc1ccccc1N1CCN(CCCSc2ccccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL88181 206474 0 None - 0 Rabbit 8.7 pKd = 8.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 413 8 0 5 3.7 COc1ccccc1N1CCN(CCCSc2ccccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10833725 206511 0 None - 0 Rabbit 8.7 pKd = 8.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 381 7 1 5 2.7 Cc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL88435 206511 0 None - 0 Rabbit 8.7 pKd = 8.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 381 7 1 5 2.7 Cc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10500734 206579 0 None - 0 Rabbit 8.7 pKd = 8.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 392 7 1 6 2.3 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2C#N)CC1 10.1021/jm970166j
CHEMBL88856 206579 0 None - 0 Rabbit 8.7 pKd = 8.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 392 7 1 6 2.3 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2C#N)CC1 10.1021/jm970166j
44324012 207249 0 None - 0 Rabbit 8.0 pKd = 8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 397 8 2 6 2.4 COc1ccccc1N1CCN(CCCNc2nc(C)cc(C)c2C(N)=O)CC1 10.1021/jm970166j
CHEMBL92901 207249 0 None - 0 Rabbit 8.0 pKd = 8 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 397 8 2 6 2.4 COc1ccccc1N1CCN(CCCNc2nc(C)cc(C)c2C(N)=O)CC1 10.1021/jm970166j
11994673 12316 0 None - 0 Rat 8.0 pKd = 8.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL1185036 12316 0 None - 0 Rat 8.0 pKd = 8.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL385371 12316 0 None - 0 Rat 8.0 pKd = 8.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
10745791 36509 0 None - 0 Rat 8.0 pKd = 8.0 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 579 19 3 9 4.6 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3CNCCCCCCN)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL144776 36509 0 None - 0 Rat 8.0 pKd = 8.0 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 579 19 3 9 4.6 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3CNCCCCCCN)nc(N)c2cc1OC 10.1021/jm9810654
10394346 16963 0 None - 0 Rat 8.0 pKd = 8.0 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 638 11 2 10 3.0 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C(N)=O)CC3)cccc2c1=O 10.1021/jm030825u
CHEMBL125365 16963 0 None - 0 Rat 8.0 pKd = 8.0 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 638 11 2 10 3.0 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C(N)=O)CC3)cccc2c1=O 10.1021/jm030825u
52945071 17643 0 None - 0 Rat 6.0 pKd = 6.0 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 470 7 2 5 2.7 O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1CC(O)CN1CCN(c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL1258344 17643 0 None - 0 Rat 6.0 pKd = 6.0 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 470 7 2 5 2.7 O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1CC(O)CN1CCN(c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
11133868 155342 0 None - 0 Rat 7.0 pKd = 7.0 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNC[C@H]1C[C@H](c2ccccc2)c2ccccc2S1 10.1021/jm011066n
CHEMBL40325 155342 0 None - 0 Rat 7.0 pKd = 7.0 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNC[C@H]1C[C@H](c2ccccc2)c2ccccc2S1 10.1021/jm011066n
2419 695 28 None - 3 Rat 6.9 pKd = 6.9 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm9810654
9 695 28 None - 3 Rat 6.9 pKd = 6.9 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm9810654
CHEMBL13647 695 28 None - 3 Rat 6.9 pKd = 6.9 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm9810654
2419 695 28 None - 3 Rat 6.9 pKd = 6.9 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(98)00217-0
9 695 28 None - 3 Rat 6.9 pKd = 6.9 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(98)00217-0
CHEMBL13647 695 28 None - 3 Rat 6.9 pKd = 6.9 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(98)00217-0
3584 3777 64 None -25 11 Rat 7.9 pKd = 7.9 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmcl.2018.01.068
5401 3777 64 None -25 11 Rat 7.9 pKd = 7.9 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmcl.2018.01.068
7302 3777 64 None -25 11 Rat 7.9 pKd = 7.9 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmcl.2018.01.068
CHEMBL611 3777 64 None -25 11 Rat 7.9 pKd = 7.9 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmcl.2018.01.068
DB01162 3777 64 None -25 11 Rat 7.9 pKd = 7.9 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmcl.2018.01.068
10574889 106546 0 None - 0 Rabbit 7.9 pKd = 7.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 435 7 1 5 3.4 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2C(F)(F)F)CC1 10.1021/jm970166j
CHEMBL314114 106546 0 None - 0 Rabbit 7.9 pKd = 7.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 435 7 1 5 3.4 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2C(F)(F)F)CC1 10.1021/jm970166j
10787895 111420 0 None - 0 Rabbit 7.9 pKd = 7.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 413 8 2 7 2.1 COc1cc(O)ccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL327351 111420 0 None - 0 Rabbit 7.9 pKd = 7.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 413 8 2 7 2.1 COc1cc(O)ccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10524875 207372 0 None - 0 Rabbit 7.9 pKd = 7.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 397 8 1 6 2.4 COc1ccccc1N1CCN(CCCNc2ccncc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL93736 207372 0 None - 0 Rabbit 7.9 pKd = 7.9 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 397 8 1 6 2.4 COc1ccccc1N1CCN(CCCNc2ccncc2C(=O)N(C)C)CC1 10.1021/jm970166j
52942664 17644 0 None - 0 Rat 6.9 pKd = 6.9 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 500 8 2 6 2.7 COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL1258345 17644 0 None - 0 Rat 6.9 pKd = 6.9 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 500 8 2 6 2.7 COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
52942591 17612 0 None - 0 Rat 5.9 pKd = 5.9 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 542 9 1 7 2.6 COC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL1258228 17612 0 None - 0 Rat 5.9 pKd = 5.9 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 542 9 1 7 2.6 COC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
44428846 92189 0 None - 0 Rat 6.9 pKd = 6.9 Functional
Antagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionAntagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contraction
ChEMBL 467 5 1 9 3.1 COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@@H]3CCCC[C@@H]32)o1 10.1016/j.bmc.2007.01.028
CHEMBL242508 92189 0 None - 0 Rat 6.9 pKd = 6.9 Functional
Antagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionAntagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contraction
ChEMBL 467 5 1 9 3.1 COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@@H]3CCCC[C@@H]32)o1 10.1016/j.bmc.2007.01.028
145971621 164605 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 414 9 1 7 2.0 COC(=O)Cc1ccc(OCC(O)CN2CCN(c3ccccc3OC)CC2)cc1 10.1016/j.bmcl.2018.01.068
CHEMBL4215889 164605 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 414 9 1 7 2.0 COC(=O)Cc1ccc(OCC(O)CN2CCN(c3ccccc3OC)CC2)cc1 10.1016/j.bmcl.2018.01.068
10506915 40239 0 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 552 13 1 9 4.5 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CN4CCSC4)c3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL148061 40239 0 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 552 13 1 9 4.5 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CN4CCSC4)c3)nc(N)c2cc1OC 10.1021/jm9810654
69782867 161583 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 549 8 1 9 4.4 COc1cc2nc(N3CCN(C(=O)COc4c(OC)cccc4C(C)C)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4129291 161583 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 549 8 1 9 4.4 COc1cc2nc(N3CCN(C(=O)COc4c(OC)cccc4C(C)C)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
25022505 188291 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 586 10 1 8 2.9 COC(=O)C(C)N1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL500266 188291 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 586 10 1 8 2.9 COC(=O)C(C)N1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
44586483 172467 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 600 11 1 8 3.3 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)N(C(C)C(=O)OC)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL448198 172467 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 600 11 1 8 3.3 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)N(C(C)C(=O)OC)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
44586429 184297 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 514 8 1 6 3.0 COc1ccccc1N1CCN(CC(O)CN2C(=O)N(C)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL484102 184297 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 514 8 1 6 3.0 COc1ccccc1N1CCN(CC(O)CN2C(=O)N(C)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
6603808 127522 3 None - 2 Rat 7.8 pKd = 7.8 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL214986 127522 3 None - 2 Rat 7.8 pKd = 7.8 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL36622 127522 3 None - 2 Rat 7.8 pKd = 7.8 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL3740374 127522 3 None - 2 Rat 7.8 pKd = 7.8 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
9891213 161502 0 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 477 5 1 8 4.0 COc1cc2nc(N3CCN(C(=O)OCc4ccccc4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4128084 161502 0 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 477 5 1 8 4.0 COc1cc2nc(N3CCN(C(=O)OCc4ccccc4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
50905589 56354 0 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 mins
ChEMBL 406 7 2 6 2.1 COc1ccc(C[C@@H](C)NC[C@@H]2Oc3ccccc3O[C@@H]2C)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
CHEMBL1630942 56354 0 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 mins
ChEMBL 406 7 2 6 2.1 COc1ccc(C[C@@H](C)NC[C@@H]2Oc3ccccc3O[C@@H]2C)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
10530133 37016 1 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 525 12 1 10 4.2 COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccc(CCl)o3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL145181 37016 1 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 525 12 1 10 4.2 COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccc(CCl)o3)nc(N)c2cc1OC 10.1021/jm9810654
132266 1278 12 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionAntagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contraction
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2007.01.028
486 1278 12 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionAntagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contraction
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2007.01.028
CHEMBL423294 1278 12 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionAntagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contraction
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2007.01.028
132266 1278 12 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2018.05.023
486 1278 12 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2018.05.023
CHEMBL423294 1278 12 None - 0 Rat 7.8 pKd = 7.8 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2018.05.023
71454865 84603 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153551 84603 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2221145 84603 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
44289261 164912 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 417 9 1 4 5.1 COc1cccc(OC)c1OCCNCC1Cc2ccccc2C(c2ccccc2)C1 10.1021/jm011066n
CHEMBL42231 164912 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 417 9 1 4 5.1 COc1cccc(OC)c1OCCNCC1Cc2ccccc2C(c2ccccc2)C1 10.1021/jm011066n
44277158 101645 0 None - 0 Rat 5.8 pKd = 5.8 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 449 11 3 10 3.0 COc1cc2nc(NCCSSCCNC(=O)c3ccco3)nc(N)c2cc1OC 10.1016/s0960-894x(98)00217-0
CHEMBL29907 101645 0 None - 0 Rat 5.8 pKd = 5.8 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 449 11 3 10 3.0 COc1cc2nc(NCCSSCCNC(=O)c3ccco3)nc(N)c2cc1OC 10.1016/s0960-894x(98)00217-0
11430126 60563 0 None - 0 Rat 7.7 pKd = 7.7 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 421 4 1 9 2.0 COc1cc2nc(N3CCN(C(=O)C4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
CHEMBL175934 60563 0 None - 0 Rat 7.7 pKd = 7.7 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 421 4 1 9 2.0 COc1cc2nc(N3CCN(C(=O)C4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
6603808 127522 3 None - 2 Rat 7.7 pKd = 7.7 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL214986 127522 3 None - 2 Rat 7.7 pKd = 7.7 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL36622 127522 3 None - 2 Rat 7.7 pKd = 7.7 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL3740374 127522 3 None - 2 Rat 7.7 pKd = 7.7 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
3584 3777 64 None - 11 Rabbit 7.7 pKd = 7.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970166j
5401 3777 64 None - 11 Rabbit 7.7 pKd = 7.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970166j
7302 3777 64 None - 11 Rabbit 7.7 pKd = 7.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970166j
CHEMBL611 3777 64 None - 11 Rabbit 7.7 pKd = 7.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970166j
DB01162 3777 64 None - 11 Rabbit 7.7 pKd = 7.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970166j
44323554 206459 0 None - 0 Rabbit 7.7 pKd = 7.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 446 8 1 7 2.9 CN(C)C(=O)c1cccnc1N1CCC(NCCOc2ccccc2-c2cncnc2)CC1 10.1021/jm970166j
CHEMBL88109 206459 0 None - 0 Rabbit 7.7 pKd = 7.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 446 8 1 7 2.9 CN(C)C(=O)c1cccnc1N1CCC(NCCOc2ccccc2-c2cncnc2)CC1 10.1021/jm970166j
10651334 29751 0 None - 0 Rat 6.7 pKd = 6.7 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 607 20 2 9 5.2 CNCCCCCCN(C)Cc1ccc(C(=O)N(C)CCCCCCN(C)c2nc(N)c3cc(OC)c(OC)cc3n2)cc1 10.1021/jm9810654
CHEMBL138681 29751 0 None - 0 Rat 6.7 pKd = 6.7 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 607 20 2 9 5.2 CNCCCCCCN(C)Cc1ccc(C(=O)N(C)CCCCCCN(C)c2nc(N)c3cc(OC)c(OC)cc3n2)cc1 10.1021/jm9810654
10673882 38725 0 None - 0 Rat 6.7 pKd = 6.7 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 534 13 1 11 3.5 COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccc(CN(C)C)o3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL146601 38725 0 None - 0 Rat 6.7 pKd = 6.7 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 534 13 1 11 3.5 COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccc(CN(C)C)o3)nc(N)c2cc1OC 10.1021/jm9810654
45268939 196660 0 None - 0 Rat 6.7 pKd = 6.7 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 505 4 1 9 3.0 COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL564481 196660 0 None - 0 Rat 6.7 pKd = 6.7 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 505 4 1 9 3.0 COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
10786159 206640 1 None - 0 Rabbit 6.7 pKd = 6.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 382 7 1 6 2.1 Cc1cnccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL89222 206640 1 None - 0 Rabbit 6.7 pKd = 6.7 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 382 7 1 6 2.1 Cc1cnccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
3157 1470 71 None -2 21 Rat 8.7 pKd = 8.7 Functional
Antagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deferenceAntagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deference
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm8016046
7170 1470 71 None -2 21 Rat 8.7 pKd = 8.7 Functional
Antagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deferenceAntagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deference
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm8016046
954 1470 71 None -2 21 Rat 8.7 pKd = 8.7 Functional
Antagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deferenceAntagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deference
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm8016046
CHEMBL707 1470 71 None -2 21 Rat 8.7 pKd = 8.7 Functional
Antagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deferenceAntagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deference
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm8016046
DB00590 1470 71 None -2 21 Rat 8.7 pKd = 8.7 Functional
Antagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deferenceAntagonist activity at rat alpha1A adrenoceptor assessed as inhibition if norepinephrine-induced contraction of vas deference
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm8016046
3157 1470 71 None -2 21 Rat 8.7 pKd = 8.7 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm000541z
7170 1470 71 None -2 21 Rat 8.7 pKd = 8.7 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm000541z
954 1470 71 None -2 21 Rat 8.7 pKd = 8.7 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm000541z
CHEMBL707 1470 71 None -2 21 Rat 8.7 pKd = 8.7 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm000541z
DB00590 1470 71 None -2 21 Rat 8.7 pKd = 8.7 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm000541z
11039289 116840 0 None - 0 Rat 8.6 pKd = 8.6 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 600 13 1 9 4.7 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCCCO[N+](=O)[O-])CC3)cccc2c1=O 10.1021/jm030825u
CHEMBL338029 116840 0 None - 0 Rat 8.6 pKd = 8.6 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 600 13 1 9 4.7 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCCCO[N+](=O)[O-])CC3)cccc2c1=O 10.1021/jm030825u
4209 3163 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
4893 3163 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
503 3163 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
5385 3163 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
CHEMBL2 3163 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
DB00457 3163 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
10555166 206718 0 None - 0 Rabbit 8.6 pKd = 8.6 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 575 9 1 8 4.5 CN(C)C(=O)c1cnc2c(c(C(C)(C)C)nn2C)c1NCCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
CHEMBL89822 206718 0 None - 0 Rabbit 8.6 pKd = 8.6 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 575 9 1 8 4.5 CN(C)C(=O)c1cnc2c(c(C(C)(C)C)nn2C)c1NCCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
4209 3163 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(98)00217-0
4893 3163 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(98)00217-0
503 3163 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(98)00217-0
5385 3163 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(98)00217-0
CHEMBL2 3163 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(98)00217-0
DB00457 3163 75 None -1 17 Rat 8.6 pKd = 8.6 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(98)00217-0
10549596 84605 1 None - 0 Rat 8.6 pKd = 8.6 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153553 84605 1 None - 0 Rat 8.6 pKd = 8.6 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2221147 84605 1 None - 0 Rat 8.6 pKd = 8.6 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
10456471 100533 0 None - 0 Rat 8.5 pKd = 8.5 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 451 6 1 7 2.4 COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
CHEMBL291303 100533 0 None - 0 Rat 8.5 pKd = 8.5 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 451 6 1 7 2.4 COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
11133868 155342 0 None - 0 Rat 6.7 pKd = 6.7 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNC[C@H]1C[C@H](c2ccccc2)c2ccccc2S1 10.1021/jm011066n
CHEMBL40325 155342 0 None - 0 Rat 6.7 pKd = 6.7 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNC[C@H]1C[C@H](c2ccccc2)c2ccccc2S1 10.1021/jm011066n
115 343 71 None 14 5 Human 6.7 pKd = 6.7 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm000541z
2092 343 71 None 14 5 Human 6.7 pKd = 6.7 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm000541z
7109 343 71 None 14 5 Human 6.7 pKd = 6.7 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm000541z
CHEMBL709 343 71 None 14 5 Human 6.7 pKd = 6.7 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm000541z
DB00346 343 71 None 14 5 Human 6.7 pKd = 6.7 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm000541z
11751173 63426 0 None - 0 Rat 7.6 pKd = 7.6 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 445 4 1 9 2.3 COc1cc2nc(N3CCN(C4=CC(=O)c5ccccc5C4=O)CC3)nc(N)c2cc1OC 10.1021/jm049153d
CHEMBL179743 63426 0 None - 0 Rat 7.6 pKd = 7.6 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 445 4 1 9 2.3 COc1cc2nc(N3CCN(C4=CC(=O)c5ccccc5C4=O)CC3)nc(N)c2cc1OC 10.1021/jm049153d
44586479 188627 0 None - 0 Rat 6.7 pKd = 6.7 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 572 10 1 8 2.6 COC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL503007 188627 0 None - 0 Rat 6.7 pKd = 6.7 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 572 10 1 8 2.6 COC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
115 343 71 None - 5 Rat 7.6 pKd = 7.6 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm000541z
2092 343 71 None - 5 Rat 7.6 pKd = 7.6 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm000541z
7109 343 71 None - 5 Rat 7.6 pKd = 7.6 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm000541z
CHEMBL709 343 71 None - 5 Rat 7.6 pKd = 7.6 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm000541z
DB00346 343 71 None - 5 Rat 7.6 pKd = 7.6 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm000541z
10620831 206887 0 None - 0 Rabbit 7.6 pKd = 7.6 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 397 8 1 6 2.4 COc1ccccc1N1CCN(CCCNc2ccc(C(=O)N(C)C)cn2)CC1 10.1021/jm970166j
CHEMBL90778 206887 0 None - 0 Rabbit 7.6 pKd = 7.6 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 397 8 1 6 2.4 COc1ccccc1N1CCN(CCCNc2ccc(C(=O)N(C)C)cn2)CC1 10.1021/jm970166j
44586430 187030 0 None - 0 Rat 7.6 pKd = 7.6 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 528 9 1 6 3.4 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)N(C)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL490865 187030 0 None - 0 Rat 7.6 pKd = 7.6 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 528 9 1 6 3.4 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)N(C)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
3157 1470 71 None -38 21 Human 7.6 pKd = 7.6 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm000541z
7170 1470 71 None -38 21 Human 7.6 pKd = 7.6 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm000541z
954 1470 71 None -38 21 Human 7.6 pKd = 7.6 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm000541z
CHEMBL707 1470 71 None -38 21 Human 7.6 pKd = 7.6 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm000541z
DB00590 1470 71 None -38 21 Human 7.6 pKd = 7.6 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm000541z
135 2532 43 None -72 33 Human 6.6 pKd = 6.6 Functional
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00370a011
1796 2532 43 None -72 33 Human 6.6 pKd = 6.6 Functional
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00370a011
4184 2532 43 None -72 33 Human 6.6 pKd = 6.6 Functional
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00370a011
CHEMBL6437 2532 43 None -72 33 Human 6.6 pKd = 6.6 Functional
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00370a011
DB06148 2532 43 None -72 33 Human 6.6 pKd = 6.6 Functional
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00370a011
11273296 170296 0 None - 0 Rat 6.6 pKd = 6.6 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 586 11 1 8 2.9 CCOC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL444648 170296 0 None - 0 Rat 6.6 pKd = 6.6 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 586 11 1 8 2.9 CCOC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
10834793 84579 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153557 84579 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220925 84579 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
44289261 164912 0 None - 0 Rat 6.5 pKd = 6.5 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 417 9 1 4 5.1 COc1cccc(OC)c1OCCNCC1Cc2ccccc2C(c2ccccc2)C1 10.1021/jm011066n
CHEMBL42231 164912 0 None - 0 Rat 6.5 pKd = 6.5 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 417 9 1 4 5.1 COc1cccc(OC)c1OCCNCC1Cc2ccccc2C(c2ccccc2)C1 10.1021/jm011066n
10344976 101215 2 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 477 11 1 10 3.4 COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL29591 101215 2 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 477 11 1 10 3.4 COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1021/jm9810654
10363912 6538 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (alpha1A receptor)Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (alpha1A receptor)
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
CHEMBL1082862 6538 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (alpha1A receptor)Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (alpha1A receptor)
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
CHEMBL286003 6538 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (alpha1A receptor)Antagonistic activity against (-)-noradrenaline-induced contraction of rat prostatic vas deferens (alpha1A receptor)
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
10344976 101215 2 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 477 11 1 10 3.4 COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1016/s0960-894x(98)00217-0
CHEMBL29591 101215 2 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 477 11 1 10 3.4 COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1016/s0960-894x(98)00217-0
10671310 206925 0 None - 0 Rabbit 8.5 pKd = 8.5 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 451 8 1 6 3.3 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2OC(F)(F)F)CC1 10.1021/jm970166j
CHEMBL91036 206925 0 None - 0 Rabbit 8.5 pKd = 8.5 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 451 8 1 6 3.3 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2OC(F)(F)F)CC1 10.1021/jm970166j
21473427 206977 0 None - 0 Rabbit 8.5 pKd = 8.5 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 410 8 1 5 3.3 COc1ccccc1N1CCN(CCCNc2c(C)cccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL91326 206977 0 None - 0 Rabbit 8.5 pKd = 8.5 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 410 8 1 5 3.3 COc1ccccc1N1CCN(CCCNc2c(C)cccc2C(=O)N(C)C)CC1 10.1021/jm970166j
148842 3946 27 None 12 2 Rat 8.4 pKd = 8.4 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm030825u
496 3946 27 None 12 2 Rat 8.4 pKd = 8.4 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm030825u
CHEMBL278865 3946 27 None 12 2 Rat 8.4 pKd = 8.4 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm030825u
489 145 28 None - 1 Rabbit 8.4 pKd = 8.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm970166j
5640 145 28 None - 1 Rabbit 8.4 pKd = 8.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm970166j
CHEMBL420060 145 28 None - 1 Rabbit 8.4 pKd = 8.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm970166j
44323803 206547 0 None - 0 Rabbit 8.4 pKd = 8.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 398 8 1 7 1.8 COc1ccccc1N1CCN(CCCNc2cncnc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL88633 206547 0 None - 0 Rabbit 8.4 pKd = 8.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 398 8 1 7 1.8 COc1ccccc1N1CCN(CCCNc2cncnc2C(=O)N(C)C)CC1 10.1021/jm970166j
10596968 206978 0 None - 0 Rabbit 8.4 pKd = 8.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 397 8 0 5 3.0 COc1ccccc1N1CCN(CCCOc2ccccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL91338 206978 0 None - 0 Rabbit 8.4 pKd = 8.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 397 8 0 5 3.0 COc1ccccc1N1CCN(CCCOc2ccccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10815708 207098 0 None - 0 Rabbit 8.4 pKd = 8.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 515 9 1 6 4.5 CN(C)C(=O)c1cnc2ccccc2c1NCCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
CHEMBL91989 207098 0 None - 0 Rabbit 8.4 pKd = 8.4 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 515 9 1 6 4.5 CN(C)C(=O)c1cnc2ccccc2c1NCCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
50905588 56353 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 mins
ChEMBL 406 7 2 6 2.1 COc1ccc(C[C@@H](C)NC[C@H]2Oc3ccccc3O[C@H]2C)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
CHEMBL1630941 56353 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar rat vas deferens assessed as noradrenaline induced contractions after 30 mins
ChEMBL 406 7 2 6 2.1 COc1ccc(C[C@@H](C)NC[C@H]2Oc3ccccc3O[C@H]2C)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
145971816 164532 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 412 8 1 6 2.6 COC(=O)Cc1ccc(OC[C@@H](O)CN2CCN(c3cc(C)ccc3C)CC2)cc1 10.1016/j.bmcl.2018.01.068
CHEMBL4214992 164532 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 412 8 1 6 2.6 COC(=O)Cc1ccc(OC[C@@H](O)CN2CCN(c3cc(C)ccc3C)CC2)cc1 10.1016/j.bmcl.2018.01.068
44428851 92318 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionAntagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contraction
ChEMBL 447 4 1 7 3.5 COc1cc2nc(N3CCN(C(=O)c4ccccc4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
CHEMBL242934 92318 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionAntagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contraction
ChEMBL 447 4 1 7 3.5 COc1cc2nc(N3CCN(C(=O)c4ccccc4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
145962817 161519 0 None - 0 Rat 5.5 pKd = 5.5 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 385 3 1 7 2.2 COc1cc2nc(N3CCN(C(C)=O)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4128311 161519 0 None - 0 Rat 5.5 pKd = 5.5 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 385 3 1 7 2.2 COc1cc2nc(N3CCN(C(C)=O)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
10788615 207016 0 None - 0 Rabbit 7.5 pKd = 7.5 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 427 9 1 7 2.4 COc1ccc(N2CCN(CCCNc3ncccc3C(=O)N(C)C)CC2)c(OC)c1 10.1021/jm970166j
CHEMBL91480 207016 0 None - 0 Rabbit 7.5 pKd = 7.5 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 427 9 1 7 2.4 COc1ccc(N2CCN(CCCNc3ncccc3C(=O)N(C)C)CC2)c(OC)c1 10.1021/jm970166j
10598692 207144 0 None - 0 Rabbit 7.5 pKd = 7.5 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 429 9 1 5 4.6 COc1ccccc1N1CCN(CCCNc2ccccc2C(=O)c2ccccc2)CC1 10.1021/jm970166j
CHEMBL92259 207144 0 None - 0 Rabbit 7.5 pKd = 7.5 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 429 9 1 5 4.6 COc1ccccc1N1CCN(CCCNc2ccccc2C(=O)c2ccccc2)CC1 10.1021/jm970166j
4418 34222 85 None - 18 Rat 7.5 pKd = 7.5 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmcl.2018.01.068
CHEMBL142635 34222 85 None - 18 Rat 7.5 pKd = 7.5 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmcl.2018.01.068
132266 1278 12 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/s0960-894x(98)00217-0
486 1278 12 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/s0960-894x(98)00217-0
CHEMBL423294 1278 12 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from ratAntagonistic affinity against Alpha-1A adrenergic receptor was determined in isolated prostatic vas deferens tissue from rat
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/s0960-894x(98)00217-0
11133288 166033 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 407 12 1 5 4.3 COc1cccc(OC)c1OCCNCCOc1ccccc1Cc1ccccc1 10.1021/jm011066n
CHEMBL42558 166033 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 407 12 1 5 4.3 COc1cccc(OC)c1OCCNCCOc1ccccc1Cc1ccccc1 10.1021/jm011066n
16721032 92188 0 None - 0 Rat 6.5 pKd = 6.5 Functional
Antagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionAntagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contraction
ChEMBL 451 4 1 8 3.4 COc1cc2nc(N3CCN(C(=O)c4ccc(C)o4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
CHEMBL242507 92188 0 None - 0 Rat 6.5 pKd = 6.5 Functional
Antagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionAntagonist activity against adrenergic alpha-1A receptor in rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contraction
ChEMBL 451 4 1 8 3.4 COc1cc2nc(N3CCN(C(=O)c4ccc(C)o4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
10348924 17945 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 620 10 1 10 3.8 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C#N)CC3)cccc2c1=O 10.1021/jm030825u
CHEMBL125989 17945 0 None - 0 Rat 7.5 pKd = 7.5 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 620 10 1 10 3.8 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C#N)CC3)cccc2c1=O 10.1021/jm030825u
44417706 11835 0 None - 0 Rat 5.5 pKd = 5.5 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3ccccc3cc2O1 10.1021/jm060358r
CHEMBL1182152 11835 0 None - 0 Rat 5.5 pKd = 5.5 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3ccccc3cc2O1 10.1021/jm060358r
CHEMBL215188 11835 0 None - 0 Rat 5.5 pKd = 5.5 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3ccccc3cc2O1 10.1021/jm060358r
3584 3777 64 None -69 11 Human 7.4 pKd = 7.4 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
5401 3777 64 None -69 11 Human 7.4 pKd = 7.4 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
7302 3777 64 None -69 11 Human 7.4 pKd = 7.4 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
CHEMBL611 3777 64 None -69 11 Human 7.4 pKd = 7.4 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
DB01162 3777 64 None -69 11 Human 7.4 pKd = 7.4 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostateIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in dog prostate
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
3584 3777 64 None -69 11 Human 7.4 pKd = 7.4 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm000541z
5401 3777 64 None -69 11 Human 7.4 pKd = 7.4 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm000541z
7302 3777 64 None -69 11 Human 7.4 pKd = 7.4 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm000541z
CHEMBL611 3777 64 None -69 11 Human 7.4 pKd = 7.4 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm000541z
DB01162 3777 64 None -69 11 Human 7.4 pKd = 7.4 Functional
In vitro antagonistic activity against alpha-1A receptor in dog prostate.In vitro antagonistic activity against alpha-1A receptor in dog prostate.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm000541z
10072518 35905 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 451 11 1 7 4.0 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL144224 35905 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 451 11 1 7 4.0 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3)nc(N)c2cc1OC 10.1021/jm9810654
10553385 119165 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 498 13 1 9 3.7 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CN(C)C)o3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL342997 119165 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 498 13 1 9 3.7 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CN(C)C)o3)nc(N)c2cc1OC 10.1021/jm9810654
145964162 164336 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 412 8 1 6 2.6 COC(=O)Cc1ccc(OCC(O)CN2CCN(c3cc(C)ccc3C)CC2)cc1 10.1016/j.bmcl.2018.01.068
CHEMBL4212528 164336 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 412 8 1 6 2.6 COC(=O)Cc1ccc(OCC(O)CN2CCN(c3cc(C)ccc3C)CC2)cc1 10.1016/j.bmcl.2018.01.068
10621592 84571 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153559 84571 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220898 84571 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
9838192 111312 18 None - 3 Rat 5.4 pKd = 5.4 Functional
Antagonist activity at rat spleen adrenergic alpha1A receptorAntagonist activity at rat spleen adrenergic alpha1A receptor
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1016/j.bmc.2008.02.091
CHEMBL326702 111312 18 None - 3 Rat 5.4 pKd = 5.4 Functional
Antagonist activity at rat spleen adrenergic alpha1A receptorAntagonist activity at rat spleen adrenergic alpha1A receptor
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1016/j.bmc.2008.02.091
44289248 168976 0 None - 0 Rat 8.3 pKd = 8.3 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2S1 10.1021/jm011066n
CHEMBL43905 168976 0 None - 0 Rat 8.3 pKd = 8.3 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2S1 10.1021/jm011066n
10767688 36385 0 None - 0 Rat 6.4 pKd = 6.4 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 499 12 1 7 4.7 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3CCl)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL144677 36385 0 None - 0 Rat 6.4 pKd = 6.4 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 499 12 1 7 4.7 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3CCl)nc(N)c2cc1OC 10.1021/jm9810654
11994673 12316 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL1185036 12316 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL385371 12316 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostateActivity at adrenergic alpha 1A receptor assessed as antagonsim of noradrenaline-induced contraction of Sprague-Dawley rat prostate
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
10430193 161598 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 385 3 1 7 2.2 COc1cc2nc(N3CCN(C(C)=O)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4129461 161598 0 None - 0 Rat 7.4 pKd = 7.4 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 385 3 1 7 2.2 COc1cc2nc(N3CCN(C(C)=O)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
10719536 121143 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 480 12 2 8 3.5 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CN)c3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL357669 121143 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 480 12 2 8 3.5 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CN)c3)nc(N)c2cc1OC 10.1021/jm9810654
145978803 163838 0 None - 0 Rat 6.3 pKd = 6.3 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 398 8 1 6 2.3 COC(=O)Cc1ccc(OCC(O)CN2CCN(c3ccccc3C)CC2)cc1 10.1016/j.bmcl.2018.01.068
CHEMBL4206435 163838 0 None - 0 Rat 6.3 pKd = 6.3 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 398 8 1 6 2.3 COC(=O)Cc1ccc(OCC(O)CN2CCN(c3ccccc3C)CC2)cc1 10.1016/j.bmcl.2018.01.068
4209 3163 75 None - 17 Rabbit 8.3 pKd = 8.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
4893 3163 75 None - 17 Rabbit 8.3 pKd = 8.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
503 3163 75 None - 17 Rabbit 8.3 pKd = 8.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
5385 3163 75 None - 17 Rabbit 8.3 pKd = 8.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
CHEMBL2 3163 75 None - 17 Rabbit 8.3 pKd = 8.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
DB00457 3163 75 None - 17 Rabbit 8.3 pKd = 8.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
10643699 206551 0 None - 0 Rabbit 8.3 pKd = 8.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 383 7 2 6 2.1 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2O)CC1 10.1021/jm970166j
CHEMBL88664 206551 0 None - 0 Rabbit 8.3 pKd = 8.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 383 7 2 6 2.1 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2O)CC1 10.1021/jm970166j
44289262 101374 2 None - 0 Rat 8.2 pKd = 8.2 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 421 9 1 6 4.3 COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccccc1 10.1021/jm011066n
CHEMBL297106 101374 2 None - 0 Rat 8.2 pKd = 8.2 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 421 9 1 6 4.3 COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccccc1 10.1021/jm011066n
44289262 101374 2 None - 0 Rat 8.2 pKd = 8.2 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 421 9 1 6 4.3 COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccccc1 10.1021/jm011066n
CHEMBL297106 101374 2 None - 0 Rat 8.2 pKd = 8.2 Functional
Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor
ChEMBL 421 9 1 6 4.3 COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccccc1 10.1021/jm011066n
71454865 84603 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153551 84603 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2221145 84603 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
3894573 3393 6 None - 0 Rabbit 7.3 pKd = 7.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1021/jm970166j
495 3393 6 None - 0 Rabbit 7.3 pKd = 7.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1021/jm970166j
CHEMBL88272 3393 6 None - 0 Rabbit 7.3 pKd = 7.3 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1021/jm970166j
10621592 84571 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153559 84571 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220898 84571 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions after 30 mins
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
10097792 118589 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 508 13 1 8 4.1 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CN(C)C)c3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL341665 118589 0 None - 0 Rat 7.3 pKd = 7.3 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 508 13 1 8 4.1 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CN(C)C)c3)nc(N)c2cc1OC 10.1021/jm9810654
44417713 12422 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1185884 12422 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL439346 12422 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
10602797 36500 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 552 13 1 9 4.5 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CN4CCSC4)cc3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL144768 36500 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 552 13 1 9 4.5 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CN4CCSC4)cc3)nc(N)c2cc1OC 10.1021/jm9810654
11133288 166033 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 407 12 1 5 4.3 COc1cccc(OC)c1OCCNCCOc1ccccc1Cc1ccccc1 10.1021/jm011066n
CHEMBL42558 166033 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 407 12 1 5 4.3 COc1cccc(OC)c1OCCNCCOc1ccccc1Cc1ccccc1 10.1021/jm011066n
11994665 11834 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 391 8 1 5 4.2 COc1cccc(-c2ccccc2)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182151 11834 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 391 8 1 5 4.2 COc1cccc(-c2ccccc2)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL215151 11834 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 391 8 1 5 4.2 COc1cccc(-c2ccccc2)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
44289248 168976 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2S1 10.1021/jm011066n
CHEMBL43905 168976 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2S1 10.1021/jm011066n
10974101 116953 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 609 10 1 9 4.2 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C)CC3)cccc2c1=O 10.1021/jm030825u
CHEMBL338608 116953 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Functional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferensFunctional Alpha-1A adrenergic receptor antagonistic activity of noradrenaline induced contractions in prostatic portion of rat vas deferens
ChEMBL 609 10 1 9 4.2 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C)CC3)cccc2c1=O 10.1021/jm030825u
2142 3096 58 None - 18 Rabbit 8.2 pKd = 8.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
4920903 3096 58 None - 18 Rabbit 8.2 pKd = 8.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
502 3096 58 None - 18 Rabbit 8.2 pKd = 8.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
5775 3096 58 None - 18 Rabbit 8.2 pKd = 8.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
CHEMBL597 3096 58 None - 18 Rabbit 8.2 pKd = 8.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
DB00692 3096 58 None - 18 Rabbit 8.2 pKd = 8.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
10766280 111639 0 None - 0 Rabbit 8.2 pKd = 8.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 457 9 1 5 4.0 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2Cc2ccccc2)CC1 10.1021/jm970166j
CHEMBL328545 111639 0 None - 0 Rabbit 8.2 pKd = 8.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 457 9 1 5 4.0 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2Cc2ccccc2)CC1 10.1021/jm970166j
10642742 206795 0 None - 0 Rabbit 8.2 pKd = 8.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 367 7 1 5 2.4 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2)CC1 10.1021/jm970166j
CHEMBL90287 206795 0 None - 0 Rabbit 8.2 pKd = 8.2 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 367 7 1 5 2.4 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2)CC1 10.1021/jm970166j
10814913 35918 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 489 12 1 8 4.3 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CCl)o3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL144238 35918 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 489 12 1 8 4.3 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CCl)o3)nc(N)c2cc1OC 10.1021/jm9810654
145975903 163821 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 412 8 1 6 2.6 COC(=O)Cc1ccc(OC[C@H](O)CN2CCN(c3cc(C)ccc3C)CC2)cc1 10.1016/j.bmcl.2018.01.068
CHEMBL4206260 163821 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of (-)-noradrenaline-induced contractile response
ChEMBL 412 8 1 6 2.6 COC(=O)Cc1ccc(OC[C@H](O)CN2CCN(c3cc(C)ccc3C)CC2)cc1 10.1016/j.bmcl.2018.01.068
11169638 17194 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 600 11 1 8 3.3 CCOC(=O)C(C)N1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL1256344 17194 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 600 11 1 8 3.3 CCOC(=O)C(C)N1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
11454386 63107 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 477 8 1 9 3.6 COc1cc2nc(N3CCN(C(=O)CCCCC4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
CHEMBL178923 63107 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)
ChEMBL 477 8 1 9 3.6 COc1cc2nc(N3CCN(C(=O)CCCCC4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
10552704 163449 0 None - 0 Rabbit 8.1 pKd = 8.1 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 479 8 1 6 4.0 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3c(C)cccc23)CC1 10.1021/jm970166j
CHEMBL419867 163449 0 None - 0 Rabbit 8.1 pKd = 8.1 Functional
Antagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assayAntagonistic activity against alpha 1A/1L receptor was assessed in a rabbit bladder neck functional assay
ChEMBL 479 8 1 6 4.0 COc1cc(F)ccc1N1CCN(CCCNc2c(C(=O)N(C)C)cnc3c(C)cccc23)CC1 10.1021/jm970166j
10767948 35949 0 None - 0 Rat 7.1 pKd = 7.1 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 508 13 1 8 4.1 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CN(C)C)cc3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL144263 35949 0 None - 0 Rat 7.1 pKd = 7.1 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 508 13 1 8 4.1 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CN(C)C)cc3)nc(N)c2cc1OC 10.1021/jm9810654
11994915 11832 0 None - 0 Rat 6.1 pKd = 6.1 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 391 8 1 5 4.2 COc1cc(-c2ccccc2)ccc1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182145 11832 0 None - 0 Rat 6.1 pKd = 6.1 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 391 8 1 5 4.2 COc1cc(-c2ccccc2)ccc1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL214762 11832 0 None - 0 Rat 6.1 pKd = 6.1 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 391 8 1 5 4.2 COc1cc(-c2ccccc2)ccc1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
10743978 121303 0 None - 0 Rat 7.1 pKd = 7.1 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 499 12 1 7 4.7 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CCl)cc3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL358060 121303 0 None - 0 Rat 7.1 pKd = 7.1 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 499 12 1 7 4.7 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccc(CCl)cc3)nc(N)c2cc1OC 10.1021/jm9810654
69781970 161351 0 None - 0 Rat 6.1 pKd = 6.1 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 477 5 1 8 4.0 COc1cc2nc(N3CCN(C(=O)OCc4ccccc4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4125981 161351 0 None - 0 Rat 6.1 pKd = 6.1 Functional
Antagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochlorideAntagonist activity at alpha1A adrenergic receptor in Wistar rat prostatic rat vas deferens assessed as inhibition of noradrenaline-induced contraction preincubated for 30 mins followed by noradrenaline addition measured after 45 mins in presence of cocaine hydrochloride
ChEMBL 477 5 1 8 4.0 COc1cc2nc(N3CCN(C(=O)OCc4ccccc4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
10815228 37268 0 None - 0 Rat 7.1 pKd = 7.1 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 499 12 1 7 4.7 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CCl)c3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL145384 37268 0 None - 0 Rat 7.1 pKd = 7.1 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 499 12 1 7 4.7 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CCl)c3)nc(N)c2cc1OC 10.1021/jm9810654
10531768 35652 0 None - 0 Rat 8.1 pKd = 8.1 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 607 20 2 9 5.2 CNCCCCCCN(C)Cc1cccc(C(=O)N(C)CCCCCCN(C)c2nc(N)c3cc(OC)c(OC)cc3n2)c1 10.1021/jm9810654
CHEMBL144000 35652 0 None - 0 Rat 8.1 pKd = 8.1 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 607 20 2 9 5.2 CNCCCCCCN(C)Cc1cccc(C(=O)N(C)CCCCCCN(C)c2nc(N)c3cc(OC)c(OC)cc3n2)c1 10.1021/jm9810654
52941981 17516 0 None - 0 Rat 6.1 pKd = 6.1 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 502 7 1 5 3.1 CN1C(=O)N(CC(O)CN2CCN(c3ccccc3F)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL1257883 17516 0 None - 0 Rat 6.1 pKd = 6.1 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 502 7 1 5 3.1 CN1C(=O)N(CC(O)CN2CCN(c3ccccc3F)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
3584 3777 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of phenylephrine-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of phenylephrine-induced contractile response
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmcl.2018.01.068
5401 3777 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of phenylephrine-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of phenylephrine-induced contractile response
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmcl.2018.01.068
7302 3777 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of phenylephrine-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of phenylephrine-induced contractile response
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmcl.2018.01.068
CHEMBL611 3777 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of phenylephrine-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of phenylephrine-induced contractile response
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmcl.2018.01.068
DB01162 3777 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
Antagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of phenylephrine-induced contractile responseAntagonist activity at alpha1A-adrenoreceptor in Sprague-Dawley rat vas deferens assessed as relaxation of phenylephrine-induced contractile response
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmcl.2018.01.068
3584 3777 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
5401 3777 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
7302 3777 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
CHEMBL611 3777 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
DB01162 3777 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
In vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferensIn vitro antagonism against Alpha-1A adrenergic receptor using phenylephrine (PE) challenge in rat vas deferens
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
3584 3777 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm000541z
5401 3777 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm000541z
7302 3777 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm000541z
CHEMBL611 3777 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm000541z
DB01162 3777 64 None -25 11 Rat 8.0 pKd = 8.0 Functional
In vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferensIn vitro antagonistic activity towards alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm000541z
11994797 12314 0 None - 0 Rat 7.0 pKd = 7.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 369 7 1 5 3.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)CCCC2 10.1021/jm060358r
CHEMBL1185017 12314 0 None - 0 Rat 7.0 pKd = 7.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 369 7 1 5 3.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)CCCC2 10.1021/jm060358r
CHEMBL383938 12314 0 None - 0 Rat 7.0 pKd = 7.0 Functional
Activity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferensActivity at adrenergic alpha 1A receptor assessed as antagonism of noradrenaline-induced contraction of Sprague-Dawley rat vas deferens
ChEMBL 369 7 1 5 3.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)CCCC2 10.1021/jm060358r
10553687 38881 0 None - 0 Rat 7.0 pKd = 7.0 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 508 13 1 8 4.1 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3CN(C)C)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL146724 38881 0 None - 0 Rat 7.0 pKd = 7.0 Functional
Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.Antagonism of the norepinephrine induced contraction of rat isolated prostatic vas deferens.
ChEMBL 508 13 1 8 4.1 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccccc3CN(C)C)nc(N)c2cc1OC 10.1021/jm9810654
49800167 17681 0 None - 0 Rat 7.0 pKd = 7.0 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 514 9 2 6 3.1 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)NC(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL1258457 17681 0 None - 0 Rat 7.0 pKd = 7.0 Functional
Antagonist activity at adrenergic alpha1A receptor in rat tail arteryAntagonist activity at adrenergic alpha1A receptor in rat tail artery
ChEMBL 514 9 2 6 3.1 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)NC(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
2419 695 28 None - 3 Rat 7.0 pKd = 7.0 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm011066n
9 695 28 None - 3 Rat 7.0 pKd = 7.0 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm011066n
CHEMBL13647 695 28 None - 3 Rat 7.0 pKd = 7.0 Functional
Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm011066n
9827677 168422 0 None - 0 Human 9.7 pKi = 9.7 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 510 7 2 4 4.2 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL43491 168422 0 None - 0 Human 9.7 pKi = 9.7 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 510 7 2 4 4.2 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
44288945 168915 0 None - 0 Human 9.4 pKi = 9.4 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 485 7 2 3 4.4 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL43860 168915 0 None - 0 Human 9.4 pKi = 9.4 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 485 7 2 3 4.4 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
499 4077 18 None - 1 Human 9.4 pKi = 9.4 Functional
Antagonistic affinity tested against isolated Human recombinant Thoracic Aorta Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Human recombinant Thoracic Aorta Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm011066n
5685 4077 18 None - 1 Human 9.4 pKi = 9.4 Functional
Antagonistic affinity tested against isolated Human recombinant Thoracic Aorta Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Human recombinant Thoracic Aorta Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm011066n
CHEMBL25554 4077 18 None - 1 Human 9.4 pKi = 9.4 Functional
Antagonistic affinity tested against isolated Human recombinant Thoracic Aorta Alpha-1A adrenergic receptorAntagonistic affinity tested against isolated Human recombinant Thoracic Aorta Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm011066n
44289100 100149 0 None - 0 Human 9.2 pKi = 9.2 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 499 7 1 3 4.7 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL287791 100149 0 None - 0 Human 9.2 pKi = 9.2 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 499 7 1 3 4.7 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
10436842 100256 0 None - 0 Human 9.1 pKi = 9.1 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 524 7 1 4 4.6 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL288772 100256 0 None - 0 Human 9.1 pKi = 9.1 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 524 7 1 4 4.6 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
44288874 101095 0 None - 0 Human 9.0 pKi = 9 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 528 7 2 4 4.2 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3F)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL295001 101095 0 None - 0 Human 9.0 pKi = 9 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 528 7 2 4 4.2 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3F)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
44289107 166180 0 None - 0 Human 9.0 pKi = 9 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 492 7 2 4 4.1 CC1=C(C(=O)NCCCN2CCC(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL42640 166180 0 None - 0 Human 9.0 pKi = 9 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 492 7 2 4 4.1 CC1=C(C(=O)NCCCN2CCC(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
44288769 101148 0 None - 0 Human 9.0 pKi = 9.0 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 542 7 1 4 4.5 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3F)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL295395 101148 0 None - 0 Human 9.0 pKi = 9.0 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 542 7 1 4 4.5 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3F)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
44288847 165309 0 None - 0 Human 8.9 pKi = 8.9 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 535 7 2 5 3.9 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL42335 165309 0 None - 0 Human 8.9 pKi = 8.9 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 535 7 2 5 3.9 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
44288917 100255 0 None - 0 Human 8.7 pKi = 8.7 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 510 7 2 4 4.0 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL288768 100255 0 None - 0 Human 8.7 pKi = 8.7 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 510 7 2 4 4.0 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
44289035 100514 0 None - 0 Human 8.7 pKi = 8.7 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 524 7 1 4 4.4 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL291166 100514 0 None - 0 Human 8.7 pKi = 8.7 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 524 7 1 4 4.4 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
53327992 63405 0 None - 0 Human 8.0 pKi = 8 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation countingAntagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation counting
ChEMBL 461 7 0 5 3.6 COc1ccccc1N1CCN(CCCCN2C(=O)CC3(CCc4ccccc43)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796050 63405 0 None - 0 Human 8.0 pKi = 8 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation countingAntagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation counting
ChEMBL 461 7 0 5 3.6 COc1ccccc1N1CCN(CCCCN2C(=O)CC3(CCc4ccccc43)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
71451044 80474 0 None - 0 Human 7.0 pKi = 7 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 410 7 0 5 4.3 CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cccnc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146807 80474 0 None - 0 Human 7.0 pKi = 7 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 410 7 0 5 4.3 CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cccnc2c1=O 10.1016/j.bmc.2012.08.032
25071930 19080 0 None - 0 Human 7.0 pKi = 7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 366 2 1 4 3.7 O=C1OC2(CCN(c3nc4cc(F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
CHEMBL1289039 19080 0 None - 0 Human 7.0 pKi = 7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 366 2 1 4 3.7 O=C1OC2(CCN(c3nc4cc(F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
25072242 19338 0 None - 0 Human 7.0 pKi = 7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 416 2 1 4 4.6 O=C1OC2(CCN(c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
CHEMBL1290706 19338 0 None - 0 Human 7.0 pKi = 7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 416 2 1 4 4.6 O=C1OC2(CCN(c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
25022356 19339 0 None - 0 Human 7.0 pKi = 7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 348 2 1 4 3.6 O=C1OC2(CCN(c3nc4ccccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
CHEMBL1290707 19339 0 None - 0 Human 7.0 pKi = 7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 348 2 1 4 3.6 O=C1OC2(CCN(c3nc4ccccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
71452871 80468 0 None - 0 Human 7.9 pKi = 7.9 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 412 7 0 6 3.1 COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cnccc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146801 80468 0 None - 0 Human 7.9 pKi = 7.9 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 412 7 0 6 3.1 COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cnccc2c1=O 10.1016/j.bmc.2012.08.032
71458203 80472 0 None - 0 Human 7.9 pKi = 7.9 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 368 4 0 5 3.1 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cnccc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146805 80472 0 None - 0 Human 7.9 pKi = 7.9 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 368 4 0 5 3.1 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cnccc2c1=O 10.1016/j.bmc.2012.08.032
25071310 19114 0 None - 0 Human 5.9 pKi = 5.9 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 431 3 1 4 5.5 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
CHEMBL1289267 19114 0 None - 0 Human 5.9 pKi = 5.9 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 431 3 1 4 5.5 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
25072876 19212 0 None - 0 Human 5.9 pKi = 5.9 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 416 2 1 4 5.0 O=C1O[C@]2(CC[C@H](c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.09.064
CHEMBL1289936 19212 0 None - 0 Human 5.9 pKi = 5.9 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 416 2 1 4 5.0 O=C1O[C@]2(CC[C@H](c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.09.064
44288843 168678 0 None - 0 Human 7.9 pKi = 7.9 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 531 7 1 5 4.1 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL43651 168678 0 None - 0 Human 7.9 pKi = 7.9 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 531 7 1 5 4.1 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
71461781 80469 0 None - 0 Human 7.8 pKi = 7.8 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 409 7 0 4 4.9 CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146802 80469 0 None - 0 Human 7.8 pKi = 7.8 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 409 7 0 4 4.9 CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1016/j.bmc.2012.08.032
71458205 80478 0 None - 0 Human 6.8 pKi = 6.8 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 412 7 0 6 3.1 COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ncccc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146811 80478 0 None - 0 Human 6.8 pKi = 6.8 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 412 7 0 6 3.1 COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ncccc2c1=O 10.1016/j.bmc.2012.08.032
25072875 19167 0 None - 0 Human 5.8 pKi = 5.8 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 446 3 1 5 5.2 Cc1cccc(N2C[C@]3(CC[C@@H](c4nc5cc(OC(F)(F)F)ccc5[nH]4)CC3)OC2=O)n1 10.1016/j.bmcl.2010.09.064
CHEMBL1289609 19167 0 None - 0 Human 5.8 pKi = 5.8 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 446 3 1 5 5.2 Cc1cccc(N2C[C@]3(CC[C@@H](c4nc5cc(OC(F)(F)F)ccc5[nH]4)CC3)OC2=O)n1 10.1016/j.bmcl.2010.09.064
71456359 80470 0 None - 0 Human 7.7 pKi = 7.7 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 411 7 0 5 3.8 COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146803 80470 0 None - 0 Human 7.7 pKi = 7.7 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 411 7 0 5 3.8 COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1016/j.bmc.2012.08.032
71449250 80471 0 None - 0 Human 7.7 pKi = 7.7 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 368 4 0 5 3.1 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccncc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146804 80471 0 None - 0 Human 7.7 pKi = 7.7 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 368 4 0 5 3.1 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccncc2c1=O 10.1016/j.bmc.2012.08.032
71458204 80476 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 368 4 0 5 3.1 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ncccc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146809 80476 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 368 4 0 5 3.1 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ncccc2c1=O 10.1016/j.bmc.2012.08.032
25071621 19100 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 432 3 1 5 4.5 O=C1OC2(CCN(c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
CHEMBL1289154 19100 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 432 3 1 5 4.5 O=C1OC2(CCN(c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
25073191 19151 0 None - 0 Human 5.7 pKi = 5.7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 432 3 1 5 4.9 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.09.064
CHEMBL1289503 19151 0 None - 0 Human 5.7 pKi = 5.7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 432 3 1 5 4.9 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccn1 10.1016/j.bmcl.2010.09.064
25071931 19201 0 None - 0 Human 5.7 pKi = 5.7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 415 2 1 3 5.6 O=C1O[C@]2(CC[C@H](c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
CHEMBL1289820 19201 0 None - 0 Human 5.7 pKi = 5.7 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 415 2 1 3 5.6 O=C1O[C@]2(CC[C@H](c3nc4cc(C(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
53327748 63388 0 None - 0 Human 8.6 pKi = 8.6 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation countingAntagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation counting
ChEMBL 435 8 0 5 3.5 COc1ccccc1N1CCN(CCCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796033 63388 0 None - 0 Human 8.6 pKi = 8.6 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation countingAntagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation counting
ChEMBL 435 8 0 5 3.5 COc1ccccc1N1CCN(CCCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
44288864 163462 0 None - 0 Human 6.6 pKi = 6.6 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 507 7 1 5 3.6 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL41996 163462 0 None - 0 Human 6.6 pKi = 6.6 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 507 7 1 5 3.6 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
44289103 155624 0 None - 0 Human 8.5 pKi = 8.5 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 506 7 1 4 4.4 CC1=C(C(=O)NCCCN2CCC(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL40464 155624 0 None - 0 Human 8.5 pKi = 8.5 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 506 7 1 4 4.4 CC1=C(C(=O)NCCCN2CCC(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
44288858 169155 0 None - 0 Human 8.5 pKi = 8.5 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 517 7 2 5 3.8 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL44042 169155 0 None - 0 Human 8.5 pKi = 8.5 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 517 7 2 5 3.8 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
49864841 15731 0 None - 0 Human 8.4 pKi = 8.4 Functional
Antagonist activity at human adrenergic alpha1A receptor assessed as intracellular calcium luminescence by cell based aequorin assayAntagonist activity at human adrenergic alpha1A receptor assessed as intracellular calcium luminescence by cell based aequorin assay
ChEMBL 266 1 1 4 1.6 C1=C(N2CCNCC2)c2nccn2Cc2ccccc21 10.1016/j.bmcl.2010.07.029
CHEMBL1222552 15731 0 None - 0 Human 8.4 pKi = 8.4 Functional
Antagonist activity at human adrenergic alpha1A receptor assessed as intracellular calcium luminescence by cell based aequorin assayAntagonist activity at human adrenergic alpha1A receptor assessed as intracellular calcium luminescence by cell based aequorin assay
ChEMBL 266 1 1 4 1.6 C1=C(N2CCNCC2)c2nccn2Cc2ccccc21 10.1016/j.bmcl.2010.07.029
53327991 63401 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation countingAntagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation counting
ChEMBL 449 8 0 5 3.7 COc1ccccc1N1CCN(CCCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796046 63401 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation countingAntagonist activity at human adrenergic alpha1A receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation counting
ChEMBL 449 8 0 5 3.7 COc1ccccc1N1CCN(CCCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
15254720 61301 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 367 4 0 4 3.7 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL1767136 61301 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 367 4 0 4 3.7 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1016/j.bmc.2012.08.032
24804150 80480 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 641 14 0 7 7.2 O=c1c2ccncc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1016/j.bmc.2012.08.032
CHEMBL2146813 80480 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 641 14 0 7 7.2 O=c1c2ccncc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1016/j.bmc.2012.08.032
71456360 80475 0 None - 0 Human 6.5 pKi = 6.5 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 412 7 0 6 3.1 COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cccnc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146808 80475 0 None - 0 Human 6.5 pKi = 6.5 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 412 7 0 6 3.1 COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cccnc2c1=O 10.1016/j.bmc.2012.08.032
2419 695 28 None - 3 Human 6.4 pKi = 6.4 Functional
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm021078o
9 695 28 None - 3 Human 6.4 pKi = 6.4 Functional
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm021078o
CHEMBL13647 695 28 None - 3 Human 6.4 pKi = 6.4 Functional
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm021078o
17747460 61329 12 None - 2 Human 7.4 pKi = 7.4 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 640 14 0 6 7.8 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1016/j.bmc.2012.08.032
CHEMBL1767164 61329 12 None - 2 Human 7.4 pKi = 7.4 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 640 14 0 6 7.8 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1016/j.bmc.2012.08.032
25071929 19079 0 None - 0 Human 7.4 pKi = 7.4 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 426 2 1 4 4.3 O=C1OC2(CCN(c3nc4cc(Br)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
CHEMBL1289038 19079 0 None - 0 Human 7.4 pKi = 7.4 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 426 2 1 4 4.3 O=C1OC2(CCN(c3nc4cc(Br)ccc4[nH]3)CC2)CN1c1ccccc1 10.1016/j.bmcl.2010.09.064
71456361 80479 0 None - 0 Human 6.4 pKi = 6.4 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 369 4 0 6 2.5 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2nccnc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146812 80479 0 None - 0 Human 6.4 pKi = 6.4 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 369 4 0 6 2.5 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2nccnc2c1=O 10.1016/j.bmc.2012.08.032
44288729 163739 0 None - 0 Human 7.4 pKi = 7.4 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 507 7 2 5 3.5 CC1=C(C(=O)NCC(C)CN2CCC(C#N)(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
CHEMBL42053 163739 0 None - 0 Human 7.4 pKi = 7.4 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 507 7 2 5 3.5 CC1=C(C(=O)NCC(C)CN2CCC(C#N)(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1 10.1016/s0960-894x(99)00696-4
2267 559 71 None -45 14 Human 7.3 pKi = 7.3 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1016/j.bmc.2012.08.032
271 559 71 None -45 14 Human 7.3 pKi = 7.3 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1016/j.bmc.2012.08.032
7121 559 71 None -45 14 Human 7.3 pKi = 7.3 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1016/j.bmc.2012.08.032
CHEMBL639 559 71 None -45 14 Human 7.3 pKi = 7.3 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1016/j.bmc.2012.08.032
DB00972 559 71 None -45 14 Human 7.3 pKi = 7.3 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1016/j.bmc.2012.08.032
71454639 80477 0 None - 0 Human 7.3 pKi = 7.3 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 410 7 0 5 4.3 CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ncccc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146810 80477 0 None - 0 Human 7.3 pKi = 7.3 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 410 7 0 5 4.3 CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ncccc2c1=O 10.1016/j.bmc.2012.08.032
25073801 19184 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 450 3 1 5 5.0 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1cccc(F)n1 10.1016/j.bmcl.2010.09.064
CHEMBL1289714 19184 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 450 3 1 5 5.0 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1cccc(F)n1 10.1016/j.bmcl.2010.09.064
71461782 80473 0 None - 0 Human 8.2 pKi = 8.2 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 410 7 0 5 4.3 CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cnccc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146806 80473 0 None - 0 Human 8.2 pKi = 8.2 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 410 7 0 5 4.3 CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cnccc2c1=O 10.1016/j.bmc.2012.08.032
71452872 80434 0 None - 0 Human 6.2 pKi = 6.2 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 368 4 0 5 3.1 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cccnc2c1=O 10.1016/j.bmc.2012.08.032
CHEMBL2146484 80434 0 None - 0 Human 6.2 pKi = 6.2 Functional
Antagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imagingAntagonist activity at human adrenergic alpha1A receptor expressed in rat fibroblasts by by plate-based calcium imaging
ChEMBL 368 4 0 5 3.1 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cccnc2c1=O 10.1016/j.bmc.2012.08.032
44288877 168599 0 None - 0 Human 8.2 pKi = 8.2 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 549 7 1 5 4.3 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
CHEMBL43594 168599 0 None - 0 Human 8.2 pKi = 8.2 Functional
In vitro antagonism at Alpha-1A adrenergic receptorIn vitro antagonism at Alpha-1A adrenergic receptor
ChEMBL 549 7 1 5 4.3 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C 10.1016/s0960-894x(99)00696-4
25073189 19115 0 None - 0 Human 6.1 pKi = 6.1 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 449 3 1 4 5.7 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1F 10.1016/j.bmcl.2010.09.064
CHEMBL1289268 19115 0 None - 0 Human 6.1 pKi = 6.1 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 449 3 1 4 5.7 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccccc1F 10.1016/j.bmcl.2010.09.064
25072880 19134 0 None - 0 Human 6.1 pKi = 6.1 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 449 3 1 4 5.7 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccc(F)cc1 10.1016/j.bmcl.2010.09.064
CHEMBL1289386 19134 0 None - 0 Human 6.1 pKi = 6.1 Functional
Antagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assayAntagonistic activity at human alpha1A receptor expressed in rat 1 fibroblast cells assessed as inhibition of calcium level by FLIPR assay
ChEMBL 449 3 1 4 5.7 O=C1O[C@]2(CC[C@H](c3nc4cc(OC(F)(F)F)ccc4[nH]3)CC2)CN1c1ccc(F)cc1 10.1016/j.bmcl.2010.09.064
135398745 2914 112 None -2 33 Rat 7.4 pA2 = 7.4 Functional
Measured as antagonism of phenylephrine-induced contraction of endothelium-denuded rat small mesenteric artery.Measured as antagonism of phenylephrine-induced contraction of endothelium-denuded rat small mesenteric artery.
Guide to Pharmacology 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 18542932
47 2914 112 None -2 33 Rat 7.4 pA2 = 7.4 Functional
Measured as antagonism of phenylephrine-induced contraction of endothelium-denuded rat small mesenteric artery.Measured as antagonism of phenylephrine-induced contraction of endothelium-denuded rat small mesenteric artery.
Guide to Pharmacology 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 18542932
CHEMBL715 2914 112 None -2 33 Rat 7.4 pA2 = 7.4 Functional
Measured as antagonism of phenylephrine-induced contraction of endothelium-denuded rat small mesenteric artery.Measured as antagonism of phenylephrine-induced contraction of endothelium-denuded rat small mesenteric artery.
Guide to Pharmacology 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 18542932
DB00334 2914 112 None -2 33 Rat 7.4 pA2 = 7.4 Functional
Measured as antagonism of phenylephrine-induced contraction of endothelium-denuded rat small mesenteric artery.Measured as antagonism of phenylephrine-induced contraction of endothelium-denuded rat small mesenteric artery.
Guide to Pharmacology 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 18542932
41835 217715 0 None -54 2 Human 6.1 pA2 = 6.1 Functional
NoneNone
Drug Central 372 8 4 6 1.9 CC(CCC1=CC2=C(OCO2)C=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1 None
1753 2504 28 None 2 4 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC None
483 2504 28 None 2 4 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC None
6082 2504 28 None 2 4 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC None
CHEMBL524 2504 28 None 2 4 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC None
DB00723 2504 28 None 2 4 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC None
2435 722 100 None -25 10 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
395 722 100 None -25 10 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
520 722 100 None -25 10 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
5386 722 100 None -25 10 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
CHEMBL844 722 100 None -25 10 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
DB00484 722 100 None -25 10 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
521 1404 69 None -501 5 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
5311068 1404 69 None -501 5 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
835 1404 69 None -501 5 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
CHEMBL778 1404 69 None -501 5 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
DB00633 1404 69 None -501 5 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
2683 3834 60 None 1 6 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
5487 3834 60 None 1 6 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
7308 3834 60 None 1 6 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
CHEMBL1079 3834 60 None 1 6 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
DB00697 3834 60 None 1 6 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 None
2803 955 58 None -6 14 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 955 58 None -6 14 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 955 58 None -6 14 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 955 58 None -6 14 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 955 58 None -6 14 Bovine 8.2 pEC50 = 8.2 Functional
Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assayAgonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
1753 2504 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 20978120
1753 2504 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 28444738
1753 2504 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 34355529
483 2504 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 20978120
483 2504 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 28444738
483 2504 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 34355529
6082 2504 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 20978120
6082 2504 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 28444738
6082 2504 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 34355529
CHEMBL524 2504 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 20978120
CHEMBL524 2504 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 28444738
CHEMBL524 2504 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 34355529
DB00723 2504 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 20978120
DB00723 2504 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 28444738
DB00723 2504 28 None 2 4 Human 6.3 pEC50 = 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 34355529
2146 3100 67 None -20 14 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 20978120
2146 3100 67 None -20 14 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 28444738
2146 3100 67 None -20 14 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 34355529
485 3100 67 None -20 14 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 20978120
485 3100 67 None -20 14 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 28444738
485 3100 67 None -20 14 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 34355529
6041 3100 67 None -20 14 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 20978120
6041 3100 67 None -20 14 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 28444738
6041 3100 67 None -20 14 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 34355529
CHEMBL1215 3100 67 None -20 14 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 20978120
CHEMBL1215 3100 67 None -20 14 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 28444738
CHEMBL1215 3100 67 None -20 14 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 34355529
DB00388 3100 67 None -20 14 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 20978120
DB00388 3100 67 None -20 14 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 28444738
DB00388 3100 67 None -20 14 Human 6.6 pEC50 = 6.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 34355529
1960 2857 67 None -2 18 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20978120
1960 2857 67 None -2 18 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 28444738
1960 2857 67 None -2 18 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 34355529
439260 2857 67 None -2 18 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20978120
439260 2857 67 None -2 18 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 28444738
439260 2857 67 None -2 18 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 34355529
505 2857 67 None -2 18 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20978120
505 2857 67 None -2 18 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 28444738
505 2857 67 None -2 18 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 34355529
CHEMBL1437 2857 67 None -2 18 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20978120
CHEMBL1437 2857 67 None -2 18 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 28444738
CHEMBL1437 2857 67 None -2 18 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 34355529
DB00368 2857 67 None -2 18 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20978120
DB00368 2857 67 None -2 18 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 28444738
DB00368 2857 67 None -2 18 Human 7.1 pEC50 = 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 34355529
1028 291 71 None 1 19 Human 7.4 pEC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
139148732 291 71 None 1 19 Human 7.4 pEC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
479 291 71 None 1 19 Human 7.4 pEC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
5816 291 71 None 1 19 Human 7.4 pEC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
CHEMBL679 291 71 None 1 19 Human 7.4 pEC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
DB00668 291 71 None 1 19 Human 7.4 pEC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
11079 2733 63 None 5 7 Human 7.8 pEC50 = 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
3369 2733 63 None 5 7 Human 7.8 pEC50 = 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
4436 2733 63 None 5 7 Human 7.8 pEC50 = 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
5509 2733 63 None 5 7 Human 7.8 pEC50 = 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
CHEMBL761 2733 63 None 5 7 Human 7.8 pEC50 = 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
DB06711 2733 63 None 5 7 Human 7.8 pEC50 = 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
2765 943 19 None 4 7 Human 8.1 pEC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 20978120
2765 943 19 None 4 7 Human 8.1 pEC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 34355529
515 943 19 None 4 7 Human 8.1 pEC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 20978120
515 943 19 None 4 7 Human 8.1 pEC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 34355529
CHEMBL13852 943 19 None 4 7 Human 8.1 pEC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 20978120
CHEMBL13852 943 19 None 4 7 Human 8.1 pEC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 34355529
DB09202 943 19 None 4 7 Human 8.1 pEC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 20978120
DB09202 943 19 None 4 7 Human 8.1 pEC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 34355529
124 2981 47 None -8 24 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 20978120
124 2981 47 None -8 24 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 28444738
124 2981 47 None -8 24 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 34355529
2032 2981 47 None -8 24 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 20978120
2032 2981 47 None -8 24 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 28444738
2032 2981 47 None -8 24 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 34355529
4636 2981 47 None -8 24 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 20978120
4636 2981 47 None -8 24 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 28444738
4636 2981 47 None -8 24 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 34355529
CHEMBL762 2981 47 None -8 24 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 20978120
CHEMBL762 2981 47 None -8 24 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 28444738
CHEMBL762 2981 47 None -8 24 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 34355529
DB00935 2981 47 None -8 24 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 20978120
DB00935 2981 47 None -8 24 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 28444738
DB00935 2981 47 None -8 24 Human 8.3 pEC50 = 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 34355529
4038180 204 14 None -1 5 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 20978120
4038180 204 14 None -1 5 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 28444738
4038180 204 14 None -1 5 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 34355529
4038180 204 14 None -1 5 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 7616455
480 204 14 None -1 5 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 20978120
480 204 14 None -1 5 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 28444738
480 204 14 None -1 5 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 34355529
480 204 14 None -1 5 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 7616455
CHEMBL109783 204 14 None -1 5 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 20978120
CHEMBL109783 204 14 None -1 5 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 28444738
CHEMBL109783 204 14 None -1 5 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 34355529
CHEMBL109783 204 14 None -1 5 Human 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 7616455
13442 2684 0 None 1 4 Human 10.0 pIC50 < 10 Functional
UnclassifiedUnclassified
Guide to Pharmacology 392 6 0 7 3.6 C12=CC=CC=C1SN=C2N3CCN(CCCCN4N=NC5=C4C=CC=C5)CC3 38968440
76283388 2684 0 None 1 4 Human 10.0 pIC50 < 10 Functional
UnclassifiedUnclassified
Guide to Pharmacology 392 6 0 7 3.6 C12=CC=CC=C1SN=C2N3CCN(CCCCN4N=NC5=C4C=CC=C5)CC3 38968440
135 2532 43 None -2 33 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
1796 2532 43 None -2 33 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
4184 2532 43 None -2 33 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
CHEMBL6437 2532 43 None -2 33 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
DB06148 2532 43 None -2 33 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
2398 954 62 None -2 36 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
2801 954 62 None -2 36 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
701 954 62 None -2 36 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
CHEMBL415 954 62 None -2 36 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
DB01242 954 62 None -2 36 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
1971 2866 38 None -6 32 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
2404 2866 38 None -6 32 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
4543 2866 38 None -6 32 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
CHEMBL445 2866 38 None -6 32 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
DB00540 2866 38 None -6 32 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
180 401 56 None -3 38 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
200 401 56 None -3 38 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
2160 401 56 None -3 38 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
CHEMBL629 401 56 None -3 38 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
DB00321 401 56 None -3 38 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
1225 1471 26 None -5 11 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
3958 1471 26 None -5 11 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
667477 1471 26 None -5 11 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
CHEMBL860 1471 26 None -5 11 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
DB01142 1471 26 None -5 11 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
3823 50221 42 None 26 15 Rat 8.4 pIC50 = 8.4 Functional
NoneNone
Drug Central 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 None
76973198 50221 42 None 26 15 Rat 8.4 pIC50 = 8.4 Functional
NoneNone
Drug Central 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 None
CHEMBL157101 50221 42 None 26 15 Rat 8.4 pIC50 = 8.4 Functional
NoneNone
Drug Central 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 None
2812 4779 101 None -3 44 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 None
CHEMBL104 4779 101 None -3 44 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 None
1016 3747 78 None -41 40 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
2561 3747 78 None -41 40 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
2733526 3747 78 None -41 40 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
5384 3747 78 None -41 40 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
CHEMBL83 3747 78 None -41 40 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
DB00675 3747 78 None -41 40 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 None
3198 205513 76 None -1 37 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
CHEMBL1201049 205513 76 None -1 37 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
CHEMBL808 205513 76 None -1 37 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 None
448537 160250 89 None 8 31 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 None
CHEMBL411 160250 89 None 8 31 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 None
441383 20333 57 None -2 19 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 None
CHEMBL1306 20333 57 None -2 19 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 None
10219 188796 37 None -1 10 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 None
CHEMBL493439 188796 37 None -1 10 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 None
CHEMBL50588 188796 37 None -1 10 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 None
1599 2341 50 None -97 21 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 None
3955 2341 50 None -97 21 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 None
7215 2341 50 None -97 21 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 None
CHEMBL841 2341 50 None -97 21 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 None
DB00836 2341 50 None -97 21 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 None
2291 3184 58 None -3 13 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
2561 3184 58 None -3 13 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
4932 3184 58 None -3 13 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
CHEMBL631 3184 58 None -3 13 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
DB01182 3184 58 None -3 13 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O None
1935 3734 97 None -1 12 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 None
2551 3734 97 None -1 12 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 None
6687 3734 97 None -1 12 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 None
CHEMBL95 3734 97 None -1 12 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 None
DB00382 3734 97 None -1 12 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 None
3191 102858 97 None -6 33 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 None
CHEMBL305660 102858 97 None -6 33 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 None
2351 3286 64 None -16 27 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O None
2820 3286 64 None -16 27 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O None
5035 3286 64 None -16 27 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O None
CHEMBL81 3286 64 None -16 27 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O None
DB00481 3286 64 None -16 27 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O None
2520 204008 70 None 1 20 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC None
CHEMBL1280 204008 70 None 1 20 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC None
CHEMBL6966 204008 70 None 1 20 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC None
2105 3054 37 None -22 25 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
47811 3054 37 None -22 25 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
48 3054 37 None -22 25 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
CHEMBL531 3054 37 None -22 25 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
DB01186 3054 37 None -22 25 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
1547484 940 74 None -1 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
654 940 74 None -1 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
9072 940 74 None -1 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
CHEMBL43064 940 74 None -1 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
DB00568 940 74 None -1 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 None
2771 195017 74 None 3 16 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 None
CHEMBL1200781 195017 74 None 3 16 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 None
CHEMBL549 195017 74 None 3 16 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 None
1343 1889 62 None -7 12 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
3519 1889 62 None -7 12 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
522 1889 62 None -7 12 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
CHEMBL862 1889 62 None -7 12 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
DB01018 1889 62 None -7 12 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N None
102 4127 48 None -12 20 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4127 48 None -12 20 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4127 48 None -12 20 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4127 48 None -12 20 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4127 48 None -12 20 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
4735 195115 96 None 7 14 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 None
CHEMBL361506 195115 96 None 7 14 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 None
CHEMBL55 195115 96 None 7 14 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 None
12488 1657 56 None -2 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F None
941361 1657 56 None -2 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F None
CHEMBL30008 1657 56 None -2 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F None
DB04841 1657 56 None -2 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F None
1028 291 71 None -3 19 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
139148732 291 71 None -3 19 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
479 291 71 None -3 19 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
5816 291 71 None -3 19 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL679 291 71 None -3 19 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
DB00668 291 71 None -3 19 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
4011 82408 49 None -7 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 None
CHEMBL21731 82408 49 None -7 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 None
3952 1888 38 None -5 21 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5353646 1888 38 None -5 21 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5443 1888 38 None -5 21 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
5702063 1888 38 None -5 21 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
CHEMBL1331786 1888 38 None -5 21 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
CHEMBL420 1888 38 None -5 21 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N None
191 403 98 None -7 36 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 None
201 403 98 None -7 36 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 None
2170 403 98 None -7 36 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 None
CHEMBL1113 403 98 None -7 36 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 None
DB00543 403 98 None -7 36 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 None
3151 1462 97 None -16 24 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
945 1462 97 None -16 24 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
965 1462 97 None -16 24 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
CHEMBL219916 1462 97 None -16 24 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
DB01184 1462 97 None -16 24 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
277 1301 62 None -40 29 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
2913 1301 62 None -40 29 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
765 1301 62 None -40 29 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
CHEMBL516 1301 62 None -40 29 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
DB00434 1301 62 None -40 29 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
6075 150108 42 None -1 20 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 None
CHEMBL395110 150108 42 None -1 20 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 None
1201549 597 24 None -15 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
333 597 24 None -15 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
7601 597 24 None -15 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
CHEMBL1201203 597 24 None -15 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
CHEMBL438151 597 24 None -15 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
DB00245 597 24 None -15 26 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 None
213 3853 55 None -3 22 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
2717 3853 55 None -3 22 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
5533 3853 55 None -3 22 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
CHEMBL621 3853 55 None -3 22 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
DB00656 3853 55 None -3 22 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
36811 1454 37 None 1 17 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O None
535 1454 37 None 1 17 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O None
937 1454 37 None 1 17 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O None
CHEMBL926 1454 37 None 1 17 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O None
DB00841 1454 37 None 1 17 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O None
3033538 1319 39 None -3 13 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 None
7155 1319 39 None -3 13 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 None
781 1319 39 None -3 13 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 None
CHEMBL1201216 1319 39 None -3 13 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 None
DB00298 1319 39 None -3 13 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 None
133 2496 52 None -66 27 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C None
1723 2496 52 None -66 27 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C None
28693 2496 52 None -66 27 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C None
CHEMBL19215 2496 52 None -66 27 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C None
DB13520 2496 52 None -66 27 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C None
2337 3256 77 None -4 29 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
50 3256 77 None -4 29 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
5002 3256 77 None -4 29 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
CHEMBL716 3256 77 None -4 29 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
DB01224 3256 77 None -4 29 Human 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
2337 3256 77 None -1 29 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
50 3256 77 None -1 29 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
5002 3256 77 None -1 29 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
CHEMBL716 3256 77 None -1 29 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
DB01224 3256 77 None -1 29 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
2286 3183 51 None -5 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C None
4927 3183 51 None -5 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C None
7282 3183 51 None -5 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C None
CHEMBL643 3183 51 None -5 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C None
DB01069 3183 51 None -5 28 Rat 8.2 pIC50 = 8.2 Functional
NoneNone
Drug Central 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C None
135398745 2914 112 None -2 33 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
47 2914 112 None -2 33 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
CHEMBL715 2914 112 None -2 33 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
DB00334 2914 112 None -2 33 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
1531 2266 69 None -2 12 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O None
3869 2266 69 None -2 12 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O None
7207 2266 69 None -2 12 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O None
CHEMBL429 2266 69 None -2 12 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O None
DB00598 2266 69 None -2 12 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O None
2136 3095 30 None 1 21 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
4768 3095 30 None 1 21 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
7268 3095 30 None 1 21 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
CHEMBL753 3095 30 None 1 21 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
DB00925 3095 30 None 1 21 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 303 8 0 2 4.2 ClCCN(C(COc1ccccc1)C)Cc1ccccc1 None
26987 949 33 None -16 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C None
6063 949 33 None -16 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C None
671 949 33 None -16 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C None
CHEMBL1626 949 33 None -16 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C None
DB00283 949 33 None -16 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C None
2274 3173 58 None 1 36 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
4917 3173 58 None 1 36 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
7279 3173 58 None 1 36 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
CHEMBL728 3173 58 None 1 36 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
DB00433 3173 58 None 1 36 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
1427 2013 54 None -112 30 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
357 2013 54 None -112 30 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
3696 2013 54 None -112 30 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
CHEMBL11 2013 54 None -112 30 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
DB00458 2013 54 None -112 30 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
2247 505 81 None 4 42 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
249 505 81 None 4 42 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
2603 505 81 None 4 42 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
CHEMBL296419 505 81 None 4 42 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
DB00637 505 81 None 4 42 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 None
1212 1662 50 None -6 35 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
204 1662 50 None -6 35 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
3372 1662 50 None -6 35 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
CHEMBL726 1662 50 None -6 35 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
DB00623 1662 50 None -6 35 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
1588 2325 27 None -77 23 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
28864 2325 27 None -77 23 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
43 2325 27 None -77 23 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL157138 2325 27 None -77 23 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
DB00589 2325 27 None -77 23 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
180 401 56 None -63 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
200 401 56 None -63 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
2160 401 56 None -63 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
CHEMBL629 401 56 None -63 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
DB00321 401 56 None -63 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C None
100 3805 58 None -8 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
2637 3805 58 None -8 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
5452 3805 58 None -8 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
CHEMBL479 3805 58 None -8 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
DB00679 3805 58 None -8 38 Human 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
134551 358 27 None -15 17 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C None
271 358 27 None -15 17 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C None
885 358 27 None -15 17 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C None
CHEMBL1403281 358 27 None -15 17 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C None
2142 3096 58 None 1 18 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3096 58 None 1 18 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3096 58 None 1 18 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3096 58 None 1 18 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3096 58 None 1 18 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3096 58 None 1 18 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
2284 3182 33 None -1 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
4926 3182 33 None -1 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
7281 3182 33 None -1 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
CHEMBL564 3182 33 None -1 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
DB00420 3182 33 None -1 34 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
2726 919 68 None -3 42 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 919 68 None -3 42 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 919 68 None -3 42 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 919 68 None -3 42 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 919 68 None -3 42 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
11954224 215953 0 None -1 5 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 581 4 3 6 2.0 CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CN(C6CC7=CNC8=CC=CC(=C78)C6=C5)C None
2585 803 103 None -10 33 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
522 803 103 None -10 33 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
551 803 103 None -10 33 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
CHEMBL723 803 103 None -10 33 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
DB01136 803 103 None -10 33 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
31101 729 40 None -2 29 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
35 729 40 None -2 29 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
403 729 40 None -2 29 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
CHEMBL493 729 40 None -2 29 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
DB01200 729 40 None -2 29 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
100 3805 58 None -1 38 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
2637 3805 58 None -1 38 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
5452 3805 58 None -1 38 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
CHEMBL479 3805 58 None -1 38 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
DB00679 3805 58 None -1 38 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
6761 67799 19 None -3 17 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 None
CHEMBL1909072 67799 19 None -3 17 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 None
10531 1420 21 None -7 25 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
121 1420 21 None -7 25 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
888 1420 21 None -7 25 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
CHEMBL1732 1420 21 None -7 25 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
DB00320 1420 21 None -7 25 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O None
3168 9262 92 None -1 16 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 None
CHEMBL1108 9262 92 None -1 16 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 None
107715 200945 22 None -2 18 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O None
CHEMBL1255837 200945 22 None -2 18 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O None
CHEMBL601773 200945 22 None -2 18 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O None
3157 1470 71 None -2 21 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
7170 1470 71 None -2 21 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
954 1470 71 None -2 21 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
CHEMBL707 1470 71 None -2 21 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
DB00590 1470 71 None -2 21 Rat 8.1 pIC50 = 8.1 Functional
NoneNone
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
4151 3607 89 None -1 10 Rat 8.0 pIC50 = 8.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
Drug Central 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N None
493 3607 89 None -1 10 Rat 8.0 pIC50 = 8.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
Drug Central 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N None
5312125 3607 89 None -1 10 Rat 8.0 pIC50 = 8.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
Drug Central 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N None
CHEMBL24778 3607 89 None -1 10 Rat 8.0 pIC50 = 8.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
Drug Central 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N None
DB06207 3607 89 None -1 10 Rat 8.0 pIC50 = 8.0 Functional
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
Drug Central 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N None
213 3853 55 None -18 22 Human 8.0 pIC50 = 8.0 Functional
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
2717 3853 55 None -18 22 Human 8.0 pIC50 = 8.0 Functional
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
5533 3853 55 None -18 22 Human 8.0 pIC50 = 8.0 Functional
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
CHEMBL621 3853 55 None -18 22 Human 8.0 pIC50 = 8.0 Functional
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
DB00656 3853 55 None -18 22 Human 8.0 pIC50 = 8.0 Functional
NoneNone
Drug Central 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 None
2995 204405 53 None -2 18 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
CHEMBL1696 204405 53 None -2 18 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
CHEMBL72 204405 53 None -2 18 Rat 8.0 pIC50 = 8.0 Functional
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
Drug Central 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
4011 82408 49 None -8 26 Human 8.0 pIC50 = 8.0 Functional
NoneNone
Drug Central 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 None
CHEMBL21731 82408 49 None -8 26 Human 8.0 pIC50 = 8.0 Functional
NoneNone
Drug Central 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 None
1531 2266 69 None -1 12 Human 7.7 pIC50 = 7.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 34355529
3869 2266 69 None -1 12 Human 7.7 pIC50 = 7.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 34355529
7207 2266 69 None -1 12 Human 7.7 pIC50 = 7.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 34355529
CHEMBL429 2266 69 None -1 12 Human 7.7 pIC50 = 7.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 34355529
DB00598 2266 69 None -1 12 Human 7.7 pIC50 = 7.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 34355529




Ligands (move mouse cursor over ligand name to see structure) Receptor Assay information Chemical information
Sel. page Similar-
ity
Common
name
GPCRdb
ID
#Vendors

Reference
ligand
Fold
selectivity
# Tested
GPCRs
Species

p-value
(-log)
Activity
Type
Activity
Relation
Activity
Value
Assay
Type
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

3294 2006 111 None -10 45 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
71360 2006 111 None -10 45 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
87 2006 111 None -10 45 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
CHEMBL14376 2006 111 None -10 45 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
DB04946 2006 111 None -10 45 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C 10.1038/s41467-023-40064-9
3584 3777 64 None -2 13 Human 8.0 pAC50 = 8.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
5401 3777 64 None -2 13 Human 8.0 pAC50 = 8.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
7302 3777 64 None -2 13 Human 8.0 pAC50 = 8.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
CHEMBL611 3777 64 None -2 13 Human 8.0 pAC50 = 8.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
DB01162 3777 64 None -2 13 Human 8.0 pAC50 = 8.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
31729 205784 10 None - 0 Human 5.0 pAC50 = 5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 287 6 4 4 2.4 CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL83063 205784 10 None - 0 Human 5.0 pAC50 = 5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 287 6 4 4 2.4 CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
1193 1656 108 None - 0 Human 6.0 pAC50 = 6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 3 2 2 4.1 OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F 10.1038/s41467-023-40064-9
2447 1656 108 None - 0 Human 6.0 pAC50 = 6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 3 2 2 4.1 OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F 10.1038/s41467-023-40064-9
3371 1656 108 None - 0 Human 6.0 pAC50 = 6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 3 2 2 4.1 OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL23588 1656 108 None - 0 Human 6.0 pAC50 = 6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 3 2 2 4.1 OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F 10.1038/s41467-023-40064-9
DB02266 1656 108 None - 0 Human 6.0 pAC50 = 6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 3 2 2 4.1 OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F 10.1038/s41467-023-40064-9
5468 127228 85 None - 0 Human 5.0 pAC50 = 5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 260 4 1 3 3.2 CC(C(=O)O)c1ccc(C(=O)c2ccccc2)s1 10.1038/s41467-023-40064-9
CHEMBL365795 127228 85 None - 0 Human 5.0 pAC50 = 5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 260 4 1 3 3.2 CC(C(=O)O)c1ccc(C(=O)c2ccccc2)s1 10.1038/s41467-023-40064-9
5833 30484 74 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 416 1 0 5 4.9 CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@H]12 10.1038/s41467-023-40064-9
CHEMBL1393 30484 74 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 416 1 0 5 4.9 CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@H]12 10.1038/s41467-023-40064-9
1530 2182 50 None - 21 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
3827 2182 50 None - 21 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
7206 2182 50 None - 21 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
CHEMBL534 2182 50 None - 21 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
DB00920 2182 50 None - 21 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 0 0 3 4.0 CN1CCC(=C2c3ccccc3CC(=O)c3c2ccs3)CC1 10.1038/s41467-023-40064-9
202 1508 77 None - 30 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
60835 1508 77 None - 30 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
972 1508 77 None - 30 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL1175 1508 77 None - 30 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
DB00476 1508 77 None - 30 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 297 6 1 3 4.6 CNCC[C@@H](c1cccs1)Oc1cccc2c1cccc2 10.1038/s41467-023-40064-9
3339 203641 117 None - 5 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 360 6 0 4 4.7 CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL672 203641 117 None - 5 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 360 6 0 4 4.7 CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1 10.1038/s41467-023-40064-9
4679 42761 89 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 7 1 6 2.9 COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[nH]2)c1OC 10.1038/s41467-023-40064-9
CHEMBL1502 42761 89 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 7 1 6 2.9 COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[nH]2)c1OC 10.1038/s41467-023-40064-9
2762 3863 31 None - 2 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 3 2.7 CN(CCN(c1ccccn1)Cc1ccccc1)C 10.1038/s41467-023-40064-9
5587 3863 31 None - 2 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 3 2.7 CN(CCN(c1ccccn1)Cc1ccccc1)C 10.1038/s41467-023-40064-9
7318 3863 31 None - 2 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 3 2.7 CN(CCN(c1ccccn1)Cc1ccccc1)C 10.1038/s41467-023-40064-9
CHEMBL1241 3863 31 None - 2 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 3 2.7 CN(CCN(c1ccccn1)Cc1ccccc1)C 10.1038/s41467-023-40064-9
DB00792 3863 31 None - 2 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 3 2.7 CN(CCN(c1ccccn1)Cc1ccccc1)C 10.1038/s41467-023-40064-9
154257 178619 67 None - 0 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 470 7 2 5 6.3 Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12 10.1038/s41467-023-40064-9
CHEMBL46740 178619 67 None - 0 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 470 7 2 5 6.3 Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12 10.1038/s41467-023-40064-9
2303 3187 68 None - 26 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
4946 3187 68 None - 26 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
564 3187 68 None - 26 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
63 3187 68 None - 26 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
91536 3187 68 None - 26 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL27 3187 68 None - 26 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL452861 3187 68 None - 26 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
DB00571 3187 68 None - 26 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 259 6 2 3 2.6 O[C@H](COc1cccc2c1cccc2)CNC(C)C 10.1038/s41467-023-40064-9
3121 7885 104 None - 0 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 144 5 1 1 2.3 CCCC(CCC)C(=O)O 10.1038/s41467-023-40064-9
CHEMBL109 7885 104 None - 0 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 144 5 1 1 2.3 CCCC(CCC)C(=O)O 10.1038/s41467-023-40064-9
CHEMBL433 7885 104 None - 0 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 144 5 1 1 2.3 CCCC(CCC)C(=O)O 10.1038/s41467-023-40064-9
1212 1662 50 None -16 65 Human 8.0 pAC50 = 8.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
204 1662 50 None -16 65 Human 8.0 pAC50 = 8.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
3372 1662 50 None -16 65 Human 8.0 pAC50 = 8.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL726 1662 50 None -16 65 Human 8.0 pAC50 = 8.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
DB00623 1662 50 None -16 65 Human 8.0 pAC50 = 8.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
5311507 194815 41 None - 1 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 400 5 1 4 4.2 OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(Cl)cc32)CC1 10.1038/s41467-023-40064-9
CHEMBL53904 194815 41 None - 1 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 400 5 1 4 4.2 OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(Cl)cc32)CC1 10.1038/s41467-023-40064-9
68602 205126 80 None - 7 Human 7.0 pAC50 = 7.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C 10.1038/s41467-023-40064-9
CHEMBL77921 205126 80 None - 7 Human 7.0 pAC50 = 7.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 200 2 1 1 3.2 Cc1cccc(C(C)c2c[nH]cn2)c1C 10.1038/s41467-023-40064-9
2771 195017 74 None - 27 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
CHEMBL1200781 195017 74 None - 27 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
CHEMBL549 195017 74 None - 27 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
3878 204703 122 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 1 2 5 2.0 Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1 10.1038/s41467-023-40064-9
CHEMBL741 204703 122 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 1 2 5 2.0 Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1 10.1038/s41467-023-40064-9
5666 102992 35 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 237 5 1 4 1.5 CCOc1ccccc1OCC1CNCCO1 10.1038/s41467-023-40064-9
CHEMBL306700 102992 35 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 237 5 1 4 1.5 CCOc1ccccc1OCC1CNCCO1 10.1038/s41467-023-40064-9
54477 84653 36 None - 23 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 370 6 1 4 2.7 CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC 10.1038/s41467-023-40064-9
CHEMBL22242 84653 36 None - 23 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 370 6 1 4 2.7 CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC 10.1038/s41467-023-40064-9
1971 2866 38 None -1 30 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
2404 2866 38 None -1 30 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
4543 2866 38 None -1 30 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL445 2866 38 None -1 30 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
DB00540 2866 38 None -1 30 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1038/s41467-023-40064-9
1155 1629 53 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
3343 1629 53 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
557 1629 53 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL32800 1629 53 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
DB01288 1629 53 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
3324 206438 115 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 321 7 1 9 0.5 CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O 10.1038/s41467-023-40064-9
CHEMBL880 206438 115 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 321 7 1 9 0.5 CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O 10.1038/s41467-023-40064-9
2795 14494 37 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 289 5 1 2 3.5 CN(C)CCC(O)(c1ccccc1)c1ccccc1Cl 10.1038/s41467-023-40064-9
CHEMBL1201313 14494 37 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 289 5 1 2 3.5 CN(C)CCC(O)(c1ccccc1)c1ccccc1Cl 10.1038/s41467-023-40064-9
2802 173089 36 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 315 2 1 4 3.0 O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1 10.1038/s41467-023-40064-9
CHEMBL452 173089 36 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 315 2 1 4 3.0 O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1 10.1038/s41467-023-40064-9
2372 106468 40 None - 0 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 345 10 2 5 2.6 COc1ccc(CCNCC(O)COc2cccc(C)c2)cc1OC 10.1038/s41467-023-40064-9
CHEMBL314010 106468 40 None - 0 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 345 10 2 5 2.6 COc1ccc(CCNCC(O)COc2cccc(C)c2)cc1OC 10.1038/s41467-023-40064-9
150 2509 21 None - 16 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
1764 2509 21 None - 16 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
8226 2509 21 None - 16 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
CHEMBL1201356 2509 21 None - 16 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
DB00353 2509 21 None - 16 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 339 4 3 3 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO 10.1038/s41467-023-40064-9
5770 205058 82 None - 7 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 608 8 1 10 4.2 COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC 10.1038/s41467-023-40064-9
CHEMBL772 205058 82 None - 7 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 608 8 1 10 4.2 COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC 10.1038/s41467-023-40064-9
2200 20203 61 None - 2 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 265 5 1 3 2.7 c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL1256819 20203 61 None - 2 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 265 5 1 3 2.7 c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL1305 20203 61 None - 2 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 265 5 1 3 2.7 c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
102 4127 48 None -346 49 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
3659 4127 48 None -346 49 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
8969 4127 48 None -346 49 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
CHEMBL15245 4127 48 None -346 49 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
DB01392 4127 48 None -346 49 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
9931954 10934 76 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 323 3 3 2 3.0 CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1 10.1038/s41467-023-40064-9
CHEMBL1173055 10934 76 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 323 3 3 2 3.0 CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1 10.1038/s41467-023-40064-9
5591 157531 90 None - 2 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 441 5 2 6 4.4 Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2 10.1038/s41467-023-40064-9
CHEMBL408 157531 90 None - 2 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 441 5 2 6 4.4 Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2 10.1038/s41467-023-40064-9
2274 3173 58 None -3 31 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
4917 3173 58 None -3 31 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
7279 3173 58 None -3 31 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
CHEMBL728 3173 58 None -3 31 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
DB00433 3173 58 None -3 31 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
26757 207978 31 None - 2 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 187 4 0 1 2.2 C#CCN(C)[C@H](C)Cc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL972 207978 31 None - 2 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 187 4 0 1 2.2 C#CCN(C)[C@H](C)Cc1ccccc1 10.1038/s41467-023-40064-9
3658 4107 53 None -9 8 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
517 4107 53 None -9 8 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
5709 4107 53 None -9 8 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
CHEMBL312448 4107 53 None -9 8 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
DB06694 4107 53 None -9 8 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1038/s41467-023-40064-9
3151 1462 97 None -8 27 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
945 1462 97 None -8 27 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
965 1462 97 None -8 27 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL219916 1462 97 None -8 27 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
DB01184 1462 97 None -8 27 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
3333 40168 111 None - 1 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 5 4.0 CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl 10.1038/s41467-023-40064-9
CHEMBL1480 40168 111 None - 1 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 5 4.0 CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl 10.1038/s41467-023-40064-9
12582 950 45 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 10.1038/s41467-023-40064-9
2783 950 45 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 10.1038/s41467-023-40064-9
CHEMBL49080 950 45 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 10.1038/s41467-023-40064-9
DB01407 950 45 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 3 3 3 3.0 CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O 10.1038/s41467-023-40064-9
56959 31556 103 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 427 9 2 6 2.3 COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1 10.1038/s41467-023-40064-9
CHEMBL1404 31556 103 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 427 9 2 6 2.3 COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1 10.1038/s41467-023-40064-9
CHEMBL1526084 31556 103 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 427 9 2 6 2.3 COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1 10.1038/s41467-023-40064-9
135398737 958 93 None -5 89 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
38 958 93 None -5 89 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
722 958 93 None -5 89 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL42 958 93 None -5 89 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
DB00363 958 93 None -5 89 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
2284 3182 33 None -3 29 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
4926 3182 33 None -3 29 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
7281 3182 33 None -3 29 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL564 3182 33 None -3 29 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00420 3182 33 None -3 29 Human 7.9 pAC50 = 7.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
2337 3256 77 None -5 62 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
50 3256 77 None -5 62 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
5002 3256 77 None -5 62 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL716 3256 77 None -5 62 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
DB01224 3256 77 None -5 62 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
1890 2759 49 None -1 16 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
4449 2759 49 None -1 16 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
7247 2759 49 None -1 16 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
CHEMBL623 2759 49 None -1 16 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
DB01149 2759 49 None -1 16 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
2218 15283 23 None - 0 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 322 8 0 2 4.4 CCN(CC)CCCN(c1ccccc1)C1Cc2ccccc2C1 10.1038/s41467-023-40064-9
CHEMBL1213033 15283 23 None - 0 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 322 8 0 2 4.4 CCN(CC)CCCN(c1ccccc1)C1Cc2ccccc2C1 10.1038/s41467-023-40064-9
25151352 140606 67 None - 0 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 417 5 2 4 5.2 FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1 10.1038/s41467-023-40064-9
CHEMBL3813873 140606 67 None - 0 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 417 5 2 4 5.2 FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1 10.1038/s41467-023-40064-9
2576 16443 62 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 260 7 2 4 2.0 CCCC(C)(COC(N)=O)COC(=O)NC(C)C 10.1038/s41467-023-40064-9
CHEMBL1233 16443 62 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 260 7 2 4 2.0 CCCC(C)(COC(N)=O)COC(=O)NC(C)C 10.1038/s41467-023-40064-9
5280343 188275 124 None - 32 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1038/s41467-023-40064-9
CHEMBL1520590 188275 124 None - 32 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1038/s41467-023-40064-9
CHEMBL50 188275 124 None - 32 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1038/s41467-023-40064-9
2237 3162 79 None - 3 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 481 9 2 7 4.6 O=C(c1ccc(cc1)OCCCCc1ccccc1)Nc1cccc2c1oc(cc2=O)c1[nH]nnn1 10.1038/s41467-023-40064-9
3634 3162 79 None - 3 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 481 9 2 7 4.6 O=C(c1ccc(cc1)OCCCCc1ccccc1)Nc1cccc2c1oc(cc2=O)c1[nH]nnn1 10.1038/s41467-023-40064-9
4887 3162 79 None - 3 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 481 9 2 7 4.6 O=C(c1ccc(cc1)OCCCCc1ccccc1)Nc1cccc2c1oc(cc2=O)c1[nH]nnn1 10.1038/s41467-023-40064-9
CHEMBL21333 3162 79 None - 3 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 481 9 2 7 4.6 O=C(c1ccc(cc1)OCCCCc1ccccc1)Nc1cccc2c1oc(cc2=O)c1[nH]nnn1 10.1038/s41467-023-40064-9
DB01411 3162 79 None - 3 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 481 9 2 7 4.6 O=C(c1ccc(cc1)OCCCCc1ccccc1)Nc1cccc2c1oc(cc2=O)c1[nH]nnn1 10.1038/s41467-023-40064-9
2520 204008 70 None - 12 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
CHEMBL1280 204008 70 None - 12 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
CHEMBL6966 204008 70 None - 12 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
135 2532 43 None -40 58 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
1796 2532 43 None -40 58 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
4184 2532 43 None -40 58 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
CHEMBL6437 2532 43 None -40 58 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
DB06148 2532 43 None -40 58 Human 6.9 pAC50 = 6.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
5482 14420 80 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 386 6 0 4 5.9 Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1200438 14420 80 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 386 6 0 4 5.9 Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
1224 1432 83 None - 13 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
3100 1432 83 None - 13 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
8980 1432 83 None - 13 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
916 1432 83 None - 13 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
CHEMBL657 1432 83 None - 13 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
DB01075 1432 83 None - 13 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
5329 169476 119 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 3 2 5 1.4 Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1 10.1038/s41467-023-40064-9
CHEMBL443 169476 119 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 3 2 5 1.4 Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1 10.1038/s41467-023-40064-9
104850 3330 96 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
4150 3330 96 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
743 3330 96 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
CHEMBL111 3330 96 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
DB06155 3330 96 None - 5 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
3463 175146 107 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 250 6 1 2 3.6 Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 10.1038/s41467-023-40064-9
CHEMBL457 175146 107 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 250 6 1 2 3.6 Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 10.1038/s41467-023-40064-9
2351 3286 64 None - 21 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O 10.1038/s41467-023-40064-9
2820 3286 64 None - 21 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O 10.1038/s41467-023-40064-9
5035 3286 64 None - 21 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O 10.1038/s41467-023-40064-9
CHEMBL81 3286 64 None - 21 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O 10.1038/s41467-023-40064-9
DB00481 3286 64 None - 21 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O 10.1038/s41467-023-40064-9
4775 39096 132 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 164 4 1 1 2.1 O=C(O)CCCc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1469 39096 132 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 164 4 1 1 2.1 O=C(O)CCCc1ccccc1 10.1038/s41467-023-40064-9
9417 133512 54 None - 0 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 363 6 1 4 3.3 OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 10.1038/s41467-023-40064-9
CHEMBL1524185 133512 54 None - 0 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 363 6 1 4 3.3 OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 10.1038/s41467-023-40064-9
CHEMBL370753 133512 54 None - 0 Human 5.9 pAC50 = 5.9 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 363 6 1 4 3.3 OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 10.1038/s41467-023-40064-9
4659569 22331 101 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 10.1038/s41467-023-40064-9
CHEMBL1324 22331 101 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 10.1038/s41467-023-40064-9
1786 2520 85 None - 11 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
4171 2520 85 None - 11 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
553 2520 85 None - 11 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
CHEMBL13 2520 85 None - 11 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
DB00264 2520 85 None - 11 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 267 9 2 4 1.6 COCCc1ccc(cc1)OCC(CNC(C)C)O 10.1038/s41467-023-40064-9
1830 2590 44 None 1 28 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
207 2590 44 None 1 28 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
23897 2590 44 None 1 28 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
CHEMBL460 2590 44 None 1 28 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
DB01618 2590 44 None 1 28 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 10.1038/s41467-023-40064-9
8249 59405 65 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 205 3 5 2 0.2 N=C(N)NC(=N)NCCc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1528839 59405 65 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 205 3 5 2 0.2 N=C(N)NC(=N)NCCc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL170988 59405 65 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 205 3 5 2 0.2 N=C(N)NC(=N)NCCc1ccccc1 10.1038/s41467-023-40064-9
2200 20203 61 None - 2 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 265 5 1 3 2.7 c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL1256819 20203 61 None - 2 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 265 5 1 3 2.7 c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL1305 20203 61 None - 2 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 265 5 1 3 2.7 c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
31729 205784 10 None - 0 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 287 6 4 4 2.4 CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL83063 205784 10 None - 0 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 287 6 4 4 2.4 CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
5284616 161627 55 None - 0 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 914 6 3 13 6.2 CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C 10.1038/s41467-023-40064-9
CHEMBL413 161627 55 None - 0 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 914 6 3 13 6.2 CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C 10.1038/s41467-023-40064-9
191 403 98 None - 29 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
201 403 98 None - 29 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
2170 403 98 None - 29 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
CHEMBL1113 403 98 None - 29 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
DB00543 403 98 None - 29 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
100 3805 58 None - 55 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
2637 3805 58 None - 55 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
5452 3805 58 None - 55 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
CHEMBL479 3805 58 None - 55 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
DB00679 3805 58 None - 55 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 10.1038/s41467-023-40064-9
4499 59775 99 None - 2 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 388 6 1 7 3.2 COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-] 10.1038/s41467-023-40064-9
CHEMBL1726 59775 99 None - 2 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 388 6 1 7 3.2 COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-] 10.1038/s41467-023-40064-9
5280453 205971 74 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 416 6 3 3 5.7 C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O 10.1038/s41467-023-40064-9
CHEMBL846 205971 74 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 416 6 3 3 5.7 C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O 10.1038/s41467-023-40064-9
1577 3703 110 None - 21 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
2537 3703 110 None - 21 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
5355 3703 110 None - 21 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
5501 3703 110 None - 21 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
643497 3703 110 None - 21 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
688272 3703 110 None - 21 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
958 3703 110 None - 21 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
960 3703 110 None - 21 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
CHEMBL196677 3703 110 None - 21 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
CHEMBL26 3703 110 None - 21 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
CHEMBL267044 3703 110 None - 21 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
DB00391 3703 110 None - 21 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
DB16021 3703 110 None - 21 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 341 6 2 5 0.6 CCN1CCC[C@@H]1CNC(=O)c1cc(ccc1OC)S(=O)(=O)N 10.1038/s41467-023-40064-9
2286 3183 51 None - 30 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
4927 3183 51 None - 30 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
7282 3183 51 None - 30 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
CHEMBL643 3183 51 None - 30 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
DB01069 3183 51 None - 30 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
2220 3134 82 None - 14 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
27400 3134 82 None - 14 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
93 3134 82 None - 14 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
CHEMBL294951 3134 82 None - 14 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
DB06153 3134 82 None - 14 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 295 0 0 2 4.4 CN1CCC(=C2c3ccsc3CCc3c2cccc3)CC1 10.1038/s41467-023-40064-9
1400 1957 70 None - 3 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
3658 1957 70 None - 3 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
7199 1957 70 None - 3 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
91513 1957 70 None - 3 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL896 1957 70 None - 3 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
DB00557 1957 70 None - 3 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
1613 2348 53 None -2 44 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
205 2348 53 None -2 44 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
3964 2348 53 None -2 44 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
CHEMBL831 2348 53 None -2 44 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
DB00408 2348 53 None -2 44 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
176 398 66 None - 31 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 10.1038/s41467-023-40064-9
2157 398 66 None - 31 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 10.1038/s41467-023-40064-9
2566 398 66 None - 31 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 10.1038/s41467-023-40064-9
CHEMBL633 398 66 None - 31 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 10.1038/s41467-023-40064-9
DB01118 398 66 None - 31 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 645 11 0 4 6.9 CCCCc1oc2c(c1C(=O)c1cc(I)c(c(c1)I)OCCN(CC)CC)cccc2 10.1038/s41467-023-40064-9
1222 1664 49 None - 33 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
3396 1664 49 None - 33 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
85 1664 49 None - 33 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL46516 1664 49 None - 33 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
DB04842 1664 49 None - 33 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
2435 3590 83 None -16 48 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
60149 3590 83 None -16 48 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
98 3590 83 None -16 48 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
CHEMBL12713 3590 83 None -16 48 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
DB06144 3590 83 None -16 48 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1038/s41467-023-40064-9
2284 3182 33 None -3 29 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
4926 3182 33 None -3 29 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
7281 3182 33 None -3 29 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL564 3182 33 None -3 29 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00420 3182 33 None -3 29 Human 7.8 pAC50 = 7.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C 10.1038/s41467-023-40064-9
2105 3054 37 None -9 33 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
47811 3054 37 None -9 33 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
48 3054 37 None -9 33 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
CHEMBL531 3054 37 None -9 33 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
DB01186 3054 37 None -9 33 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 10.1038/s41467-023-40064-9
37264 189422 24 None - 0 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 435 6 2 10 1.3 COc1cc2c(N)nc(N3CCN(C(=O)OCC(C)(C)O)CC3)nc2c(OC)c1OC 10.1038/s41467-023-40064-9
CHEMBL513301 189422 24 None - 0 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 435 6 2 10 1.3 COc1cc2c(N)nc(N3CCN(C(=O)OCC(C)(C)O)CC3)nc2c(OC)c1OC 10.1038/s41467-023-40064-9
5282230 161921 87 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 6 2 4 3.1 COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC 10.1038/s41467-023-40064-9
CHEMBL415324 161921 87 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 6 2 4 3.1 COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC 10.1038/s41467-023-40064-9
3584 3777 64 None -2 13 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
5401 3777 64 None -2 13 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
7302 3777 64 None -2 13 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
CHEMBL611 3777 64 None -2 13 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
DB01162 3777 64 None -2 13 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1038/s41467-023-40064-9
2389 3331 118 None -11 67 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
5073 3331 118 None -11 67 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
96 3331 118 None -11 67 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
CHEMBL85 3331 118 None -11 67 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
DB00734 3331 118 None -11 67 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
19675 51670 43 None - 0 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 7 1 5 5.0 CC(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL1584 51670 43 None - 0 Human 6.8 pAC50 = 6.8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 7 1 5 5.0 CC(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
213 3853 55 None - 44 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
2717 3853 55 None - 44 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
5533 3853 55 None - 44 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
CHEMBL621 3853 55 None - 44 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
DB00656 3853 55 None - 44 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 10.1038/s41467-023-40064-9
5329102 194726 86 None - 0 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 398 7 3 3 3.3 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C 10.1038/s41467-023-40064-9
CHEMBL535 194726 86 None - 0 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 398 7 3 3 3.3 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C 10.1038/s41467-023-40064-9
43815 186920 64 None - 25 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 329 4 1 4 3.3 Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1 10.1038/s41467-023-40064-9
CHEMBL1708 186920 64 None - 25 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 329 4 1 4 3.3 Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1 10.1038/s41467-023-40064-9
CHEMBL490 186920 64 None - 25 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 329 4 1 4 3.3 Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1 10.1038/s41467-023-40064-9
5039 63183 17 None - 1 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 314 10 2 7 1.5 CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1 10.1038/s41467-023-40064-9
CHEMBL1790041 63183 17 None - 1 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 314 10 2 7 1.5 CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1 10.1038/s41467-023-40064-9
2585 803 103 None -9 21 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
522 803 103 None -9 21 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
551 803 103 None -9 21 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
CHEMBL723 803 103 None -9 21 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
DB01136 803 103 None -9 21 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
2726 919 68 None -5 72 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
621 919 68 None -5 72 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
83 919 68 None -5 72 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
CHEMBL71 919 68 None -5 72 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
DB00477 919 68 None -5 72 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
2683 3834 60 None - 4 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
5487 3834 60 None - 4 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
7308 3834 60 None - 4 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
CHEMBL1079 3834 60 None - 4 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
DB00697 3834 60 None - 4 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
1353 1911 93 None -6 83 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
3559 1911 93 None -6 83 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
86 1911 93 None -6 83 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
CHEMBL54 1911 93 None -6 83 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
DB00502 1911 93 None -6 83 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
31101 729 40 None -12 36 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
35 729 40 None -12 36 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
403 729 40 None -12 36 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
CHEMBL493 729 40 None -12 36 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
DB01200 729 40 None -12 36 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
9915743 63542 93 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 556 11 2 8 5.9 CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C 10.1038/s41467-023-40064-9
CHEMBL180022 63542 93 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 556 11 2 8 5.9 CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C 10.1038/s41467-023-40064-9
4209 3163 75 None -3 33 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
4893 3163 75 None -3 33 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
503 3163 75 None -3 33 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
5385 3163 75 None -3 33 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
CHEMBL2 3163 75 None -3 33 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
DB00457 3163 75 None -3 33 Human 8.7 pAC50 = 8.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
4418 34222 85 None -1 6 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1038/s41467-023-40064-9
CHEMBL142635 34222 85 None -1 6 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1038/s41467-023-40064-9
4046 2483 33 None - 2 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
4252 2483 33 None - 2 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
CHEMBL416956 2483 33 None - 2 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
DB00358 2483 33 None - 2 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
3052776 206556 90 None - 1 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 171 2 1 1 1.9 C#CCN[C@@H]1CCc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL887 206556 90 None - 1 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 171 2 1 1 1.9 C#CCN[C@@H]1CCc2ccccc21 10.1038/s41467-023-40064-9
135409453 3773 41 None - 2 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
226 3773 41 None - 2 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
CHEMBL76370 3773 41 None - 2 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
4034 55822 55 None - 1 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 390 5 0 2 5.6 Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1 10.1038/s41467-023-40064-9
CHEMBL1623 55822 55 None - 1 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 390 5 0 2 5.6 Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1 10.1038/s41467-023-40064-9
16362 3125 71 None -35 30 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
2172 3125 71 None -35 30 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
90 3125 71 None -35 30 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL1423 3125 71 None -35 30 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
DB01100 3125 71 None -35 30 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
2536 199365 40 None - 0 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 398 7 3 6 1.4 CN(C)C(=O)COC(=O)Cc1ccc(OC(=O)c2ccc(NC(=N)N)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL590799 199365 40 None - 0 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 398 7 3 6 1.4 CN(C)C(=O)COC(=O)Cc1ccc(OC(=O)c2ccc(NC(=N)N)cc2)cc1 10.1038/s41467-023-40064-9
3158 56267 27 None - 20 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1628227 56267 27 None - 20 Human 7.7 pAC50 = 7.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1038/s41467-023-40064-9
2803 955 58 None -8 19 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
516 955 58 None -8 19 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
704 955 58 None -8 19 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
CHEMBL134 955 58 None -8 19 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
DB00575 955 58 None -8 19 Human 6.7 pAC50 = 6.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1038/s41467-023-40064-9
47641 202871 32 None - 0 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 287 5 0 1 5.0 CN(C/C=C/c1ccccc1)Cc1cccc2ccccc12 10.1038/s41467-023-40064-9
CHEMBL626 202871 32 None - 0 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 287 5 0 1 5.0 CN(C/C=C/c1ccccc1)Cc1cccc2ccccc12 10.1038/s41467-023-40064-9
2419 3463 84 None - 6 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
5152 3463 84 None - 6 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
559 3463 84 None - 6 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
CHEMBL1263 3463 84 None - 6 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
DB00938 3463 84 None - 6 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.1038/s41467-023-40064-9
21722 17992 31 None - 6 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 2 4.3 CN(C)CCCn1c2c(c3ccccc31)CCCCCC2 10.1038/s41467-023-40064-9
CHEMBL126224 17992 31 None - 6 Human 5.7 pAC50 = 5.7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 2 4.3 CN(C)CCCn1c2c(c3ccccc31)CCCCCC2 10.1038/s41467-023-40064-9
4567 9948 34 None - 0 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 299 7 3 3 3.4 CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL114655 9948 34 None - 0 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 299 7 3 3 3.4 CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
4046 2483 33 None - 2 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
4252 2483 33 None - 2 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
CHEMBL416956 2483 33 None - 2 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
DB00358 2483 33 None - 2 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 378 2 2 3 4.4 OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1 10.1038/s41467-023-40064-9
2161 8733 121 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 298 2 2 5 2.7 CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1 10.1038/s41467-023-40064-9
CHEMBL1096 8733 121 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 298 2 2 5 2.7 CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1 10.1038/s41467-023-40064-9
135398735 136968 32 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
136262914 136968 32 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
CHEMBL374478 136968 32 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
4756 16649 50 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 213 2 2 5 2.7 Nc1ccc(/N=N/c2ccccc2)c(N)n1 10.1038/s41467-023-40064-9
CHEMBL1201022 16649 50 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 213 2 2 5 2.7 Nc1ccc(/N=N/c2ccccc2)c(N)n1 10.1038/s41467-023-40064-9
CHEMBL1242 16649 50 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 213 2 2 5 2.7 Nc1ccc(/N=N/c2ccccc2)c(N)n1 10.1038/s41467-023-40064-9
1427 2013 54 None - 27 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
357 2013 54 None - 27 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
3696 2013 54 None - 27 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL11 2013 54 None - 27 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00458 2013 54 None - 27 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
154417 23181 60 None - 5 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 289 4 1 4 1.9 CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)[C@H](CO)c1ccccc1)C2 10.1038/s41467-023-40064-9
CHEMBL1331216 23181 60 None - 5 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 289 4 1 4 1.9 CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)[C@H](CO)c1ccccc1)C2 10.1038/s41467-023-40064-9
212 3806 47 None -7 25 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
2639 3806 47 None -7 25 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
941651 3806 47 None -7 25 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
CHEMBL1201 3806 47 None -7 25 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
DB01623 3806 47 None -7 25 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
3083544 26809 51 None - 5 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
CHEMBL1200811 26809 51 None - 5 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
CHEMBL1363 26809 51 None - 5 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
CHEMBL1951071 26809 51 None - 5 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
CHEMBL605993 26809 51 None - 5 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 344 9 4 5 2.2 COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 10.1038/s41467-023-40064-9
5280793 46337 65 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 396 5 1 1 7.6 C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@@H]12 10.1038/s41467-023-40064-9
CHEMBL1536 46337 65 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 396 5 1 1 7.6 C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@@H]12 10.1038/s41467-023-40064-9
209 3057 97 None -11 23 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
2113 3057 97 None -11 23 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
4748 3057 97 None -11 23 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
CHEMBL567 3057 97 None -11 23 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
DB00850 3057 97 None -11 23 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
10219 188796 37 None - 5 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 10.1038/s41467-023-40064-9
CHEMBL493439 188796 37 None - 5 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 10.1038/s41467-023-40064-9
CHEMBL50588 188796 37 None - 5 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 10.1038/s41467-023-40064-9
1228 3866 34 None - 4 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 278 4 0 2 3.9 Cc1ccc(cc1)/C(=C\CN1CCCC1)/c1ccccn1 10.1038/s41467-023-40064-9
2763 3866 34 None - 4 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 278 4 0 2 3.9 Cc1ccc(cc1)/C(=C\CN1CCCC1)/c1ccccn1 10.1038/s41467-023-40064-9
5282443 3866 34 None - 4 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 278 4 0 2 3.9 Cc1ccc(cc1)/C(=C\CN1CCCC1)/c1ccccn1 10.1038/s41467-023-40064-9
CHEMBL855 3866 34 None - 4 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 278 4 0 2 3.9 Cc1ccc(cc1)/C(=C\CN1CCCC1)/c1ccccn1 10.1038/s41467-023-40064-9
DB00427 3866 34 None - 4 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 278 4 0 2 3.9 Cc1ccc(cc1)/C(=C\CN1CCCC1)/c1ccccn1 10.1038/s41467-023-40064-9
5324346 205582 59 None - 10 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 318 9 1 4 3.2 COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
CHEMBL1409 205582 59 None - 10 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 318 9 1 4 3.2 COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
CHEMBL814 205582 59 None - 10 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 318 9 1 4 3.2 COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
36811 1454 37 None - 7 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
535 1454 37 None - 7 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
937 1454 37 None - 7 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL926 1454 37 None - 7 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
DB00841 1454 37 None - 7 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
1690 3058 19 None - 3 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
4058 3058 19 None - 3 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
5750 3058 19 None - 3 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
7221 3058 19 None - 3 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL607 3058 19 None - 3 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
DB00454 3058 19 None - 3 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 247 3 0 3 2.2 CCOC(=O)C1(CCN(CC1)C)c1ccccc1 10.1038/s41467-023-40064-9
2895 203592 41 None - 8 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 275 3 0 1 4.6 CN(C)CCC=C1c2ccccc2C=Cc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL669 203592 41 None - 8 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 275 3 0 1 4.6 CN(C)CCC=C1c2ccccc2C=Cc2ccccc21 10.1038/s41467-023-40064-9
102 4127 48 None -346 49 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
3659 4127 48 None -346 49 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
8969 4127 48 None -346 49 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
CHEMBL15245 4127 48 None -346 49 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
DB01392 4127 48 None -346 49 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1038/s41467-023-40064-9
135409453 3773 41 None - 2 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
226 3773 41 None - 2 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
CHEMBL76370 3773 41 None - 2 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
16231 207509 57 None - 17 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 229 1 5 6 -1.1 N=C(N)NC(=O)c1nc(Cl)c(N)nc1N 10.1038/s41467-023-40064-9
CHEMBL945 207509 57 None - 17 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 229 1 5 6 -1.1 N=C(N)NC(=O)c1nc(Cl)c(N)nc1N 10.1038/s41467-023-40064-9
2600 3779 74 None - 13 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
2608 3779 74 None - 13 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
5405 3779 74 None - 13 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
CHEMBL17157 3779 74 None - 13 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
DB00342 3779 74 None - 13 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
2865 4143 73 None -14 53 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
59 4143 73 None -14 53 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
60854 4143 73 None -14 53 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL708 4143 73 None -14 53 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
DB00246 4143 73 None -14 53 Human 7.6 pAC50 = 7.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
22323 15299 32 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 287 2 5 2 2.9 CC(C)NC(=N)NC(=N)Nc1ccc(Cl)c(Cl)c1 10.1038/s41467-023-40064-9
9571037 15299 32 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 287 2 5 2 2.9 CC(C)NC(=N)NC(=N)Nc1ccc(Cl)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1213553 15299 32 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 287 2 5 2 2.9 CC(C)NC(=N)NC(=N)Nc1ccc(Cl)c(Cl)c1 10.1038/s41467-023-40064-9
2705 3842 64 None - 10 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.1038/s41467-023-40064-9
360 3842 64 None - 10 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.1038/s41467-023-40064-9
443879 3842 64 None - 10 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.1038/s41467-023-40064-9
CHEMBL1382 3842 64 None - 10 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.1038/s41467-023-40064-9
DB01036 3842 64 None - 10 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 325 7 1 2 5.3 Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O 10.1038/s41467-023-40064-9
2247 505 81 None - 42 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
249 505 81 None - 42 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
2603 505 81 None - 42 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
CHEMBL296419 505 81 None - 42 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
DB00637 505 81 None - 42 Human 6.6 pAC50 = 6.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
1024 1289 71 None - 1 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL None None None None 10.1038/s41467-023-40064-9
162639143 1289 71 None - 1 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL None None None None 10.1038/s41467-023-40064-9
5284373 1289 71 None - 1 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL None None None None 10.1038/s41467-023-40064-9
760 1289 71 None - 1 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL None None None None 10.1038/s41467-023-40064-9
CHEMBL160 1289 71 None - 1 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL None None None None 10.1038/s41467-023-40064-9
DB00091 1289 71 None - 1 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL None None None None 10.1038/s41467-023-40064-9
367 3824 12 None - 8 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 392 4 1 6 2.3 O=C(C(c1cccs1)(c1cccs1)O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3 10.1038/s41467-023-40064-9
5487427 3824 12 None - 8 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 392 4 1 6 2.3 O=C(C(c1cccs1)(c1cccs1)O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3 10.1038/s41467-023-40064-9
8592 3824 12 None - 8 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 392 4 1 6 2.3 O=C(C(c1cccs1)(c1cccs1)O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3 10.1038/s41467-023-40064-9
CHEMBL1900528 3824 12 None - 8 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 392 4 1 6 2.3 O=C(C(c1cccs1)(c1cccs1)O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3 10.1038/s41467-023-40064-9
CHEMBL3305968 3824 12 None - 8 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 392 4 1 6 2.3 O=C(C(c1cccs1)(c1cccs1)O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3 10.1038/s41467-023-40064-9
CHEMBL4650755 3824 12 None - 8 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 392 4 1 6 2.3 O=C(C(c1cccs1)(c1cccs1)O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3 10.1038/s41467-023-40064-9
DB01409 3824 12 None - 8 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 392 4 1 6 2.3 O=C(C(c1cccs1)(c1cccs1)O)OC1C[C@@H]2[C@@H]3[C@H]([C@H](C1)[N+]2(C)C)O3 10.1038/s41467-023-40064-9
135401907 38858 136 None - 1 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 136 0 2 3 -0.4 O=c1ncnc2[nH][nH]cc1-2 10.1038/s41467-023-40064-9
CHEMBL1467 38858 136 None - 1 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 136 0 2 3 -0.4 O=c1ncnc2[nH][nH]cc1-2 10.1038/s41467-023-40064-9
4940 14470 35 None - 0 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 340 5 0 4 4.8 CCC(=O)c1ccc2c(c1)N(CC(C)N(C)C)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL1201210 14470 35 None - 0 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 340 5 0 4 4.8 CCC(=O)c1ccc2c(c1)N(CC(C)N(C)C)c1ccccc1S2 10.1038/s41467-023-40064-9
180 401 56 None -12 40 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
200 401 56 None -12 40 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
2160 401 56 None -12 40 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL629 401 56 None -12 40 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00321 401 56 None -12 40 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
1547484 940 74 None - 20 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
654 940 74 None - 20 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
9072 940 74 None - 20 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL43064 940 74 None - 20 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
DB00568 940 74 None - 20 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
5288783 14433 50 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 5 3 3 5.1 C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)/C=C/[C@@H](O)C4CC4)CC[C@@H]23)C[C@@H](O)C[C@@H]1O 10.1038/s41467-023-40064-9
CHEMBL1200666 14433 50 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 5 3 3 5.1 C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)/C=C/[C@@H](O)C4CC4)CC[C@@H]23)C[C@@H](O)C[C@@H]1O 10.1038/s41467-023-40064-9
119182 60407 92 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 2 3 8 -0.3 Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F 10.1038/s41467-023-40064-9
CHEMBL1750 60407 92 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 2 3 8 -0.3 Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F 10.1038/s41467-023-40064-9
55645 84370 8 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 7 2 4 2.1 CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21 10.1038/s41467-023-40064-9
CHEMBL2218861 84370 8 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 7 2 4 2.1 CCCN1CC(NS(=O)(=O)N(CC)CC)CC2Cc3c(O)cccc3CC21 10.1038/s41467-023-40064-9
24958200 8574 76 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 320 3 2 4 2.6 NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12 10.1038/s41467-023-40064-9
CHEMBL1094636 8574 76 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 320 3 2 4 2.6 NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12 10.1038/s41467-023-40064-9
18283 208312 96 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 224 2 2 5 -0.7 Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O 10.1038/s41467-023-40064-9
CHEMBL991 208312 96 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 224 2 2 5 -0.7 Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O 10.1038/s41467-023-40064-9
4631 194972 29 None - 7 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 265 9 2 4 2.0 C=CCOc1ccccc1OCC(O)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL546 194972 29 None - 7 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 265 9 2 4 2.0 C=CCOc1ccccc1OCC(O)CNC(C)C 10.1038/s41467-023-40064-9
5906 14495 23 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 2 3 3 0.8 C[C@H](N)[C@H](O)c1cccc(O)c1 10.1038/s41467-023-40064-9
CHEMBL1201319 14495 23 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 2 3 3 0.8 C[C@H](N)[C@H](O)c1cccc(O)c1 10.1038/s41467-023-40064-9
103 4153 61 None -6 53 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
2875 4153 61 None -6 53 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
5736 4153 61 None -6 53 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
CHEMBL285802 4153 61 None -6 53 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
DB09225 4153 61 None -6 53 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
9429 202133 58 None - 5 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 446 6 0 6 3.2 CN1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1 10.1038/s41467-023-40064-9
CHEMBL609109 202133 58 None - 5 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 446 6 0 6 3.2 CN1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1 10.1038/s41467-023-40064-9
4209 3163 75 None -3 33 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
4893 3163 75 None -3 33 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
503 3163 75 None -3 33 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
5385 3163 75 None -3 33 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
CHEMBL2 3163 75 None -3 33 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
DB00457 3163 75 None -3 33 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1038/s41467-023-40064-9
2389 3331 118 None -11 67 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
5073 3331 118 None -11 67 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
96 3331 118 None -11 67 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
CHEMBL85 3331 118 None -11 67 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
DB00734 3331 118 None -11 67 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1038/s41467-023-40064-9
3157 1470 71 None -2 10 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
7170 1470 71 None -2 10 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
954 1470 71 None -2 10 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
CHEMBL707 1470 71 None -2 10 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
DB00590 1470 71 None -2 10 Human 8.5 pAC50 = 8.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
2286 3183 51 None - 30 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
4927 3183 51 None - 30 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
7282 3183 51 None - 30 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
CHEMBL643 3183 51 None - 30 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
DB01069 3183 51 None - 30 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
2169 44847 35 None - 0 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 380 9 3 6 1.4 COc1ccccc1OCCNCC(O)c1ccc(C)c(S(N)(=O)=O)c1 10.1038/s41467-023-40064-9
CHEMBL152231 44847 35 None - 0 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 380 9 3 6 1.4 COc1ccccc1OCCNCC(O)c1ccc(C)c(S(N)(=O)=O)c1 10.1038/s41467-023-40064-9
60065 84369 6 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 505 7 1 8 4.2 COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@@H]2CCCN(Cc3ccccc3)C2)C1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
CHEMBL2218858 84369 6 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 505 7 1 8 4.2 COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@@H]2CCCN(Cc3ccccc3)C2)C1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
5328940 100216 107 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 529 9 1 8 5.2 COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl 10.1038/s41467-023-40064-9
CHEMBL288441 100216 107 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 529 9 1 8 5.2 COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl 10.1038/s41467-023-40064-9
2865 4143 73 None -14 53 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
59 4143 73 None -14 53 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
60854 4143 73 None -14 53 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL708 4143 73 None -14 53 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
DB00246 4143 73 None -14 53 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1038/s41467-023-40064-9
2470 3653 50 None -208 59 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
3300 3653 50 None -208 59 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
5265 3653 50 None -208 59 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
99 3653 50 None -208 59 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL267930 3653 50 None -208 59 Human 6.5 pAC50 = 6.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1038/s41467-023-40064-9
5284550 41721 15 None 1 9 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 295 3 0 2 4.7 CN(C)CC/C=C1\c2ccccc2CSc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1492500 41721 15 None 1 9 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 295 3 0 2 4.7 CN(C)CC/C=C1\c2ccccc2CSc2ccccc21 10.1038/s41467-023-40064-9
3152 188411 103 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 379 6 0 4 4.4 COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2 10.1038/s41467-023-40064-9
CHEMBL502 188411 103 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 379 6 0 4 4.4 COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2 10.1038/s41467-023-40064-9
54671203 35010 53 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 444 2 6 9 -0.3 C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21 10.1038/s41467-023-40064-9
CHEMBL1433 35010 53 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 444 2 6 9 -0.3 C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21 10.1038/s41467-023-40064-9
1231 937 116 None - 7 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 252 5 3 4 0.6 N#CNC(=NC)NCCSCc1nc[nH]c1C 10.1038/s41467-023-40064-9
2756 937 116 None - 7 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 252 5 3 4 0.6 N#CNC(=NC)NCCSCc1nc[nH]c1C 10.1038/s41467-023-40064-9
645 937 116 None - 7 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 252 5 3 4 0.6 N#CNC(=NC)NCCSCc1nc[nH]c1C 10.1038/s41467-023-40064-9
CHEMBL30 937 116 None - 7 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 252 5 3 4 0.6 N#CNC(=NC)NCCSCc1nc[nH]c1C 10.1038/s41467-023-40064-9
DB00501 937 116 None - 7 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 252 5 3 4 0.6 N#CNC(=NC)NCCSCc1nc[nH]c1C 10.1038/s41467-023-40064-9
446598 60455 50 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 424 7 4 7 0.4 CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1 10.1038/s41467-023-40064-9
CHEMBL1753 60455 50 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 424 7 4 7 0.4 CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1 10.1038/s41467-023-40064-9
68617 205527 62 None 3 26 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1709 205527 62 None 3 26 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL809 205527 62 None 3 26 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL3039583 210949 0 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL None None None NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2C[C@H](OC(=O)NCCN)CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O 10.1038/s41467-023-40064-9
5280954 57599 32 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 634 9 1 10 4.6 COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)/C=C/c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC 10.1038/s41467-023-40064-9
CHEMBL1668 57599 32 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 634 9 1 10 4.6 COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)/C=C/c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC 10.1038/s41467-023-40064-9
1155 1629 53 None - 5 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
3343 1629 53 None - 5 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
557 1629 53 None - 5 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL32800 1629 53 None - 5 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
DB01288 1629 53 None - 5 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 303 6 5 5 2.1 CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O 10.1038/s41467-023-40064-9
5360696 1406 30 None - 3 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 271 1 0 2 3.4 COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C 10.1038/s41467-023-40064-9
6953 1406 30 None - 3 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 271 1 0 2 3.4 COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C 10.1038/s41467-023-40064-9
842 1406 30 None - 3 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 271 1 0 2 3.4 COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C 10.1038/s41467-023-40064-9
CHEMBL52440 1406 30 None - 3 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 271 1 0 2 3.4 COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C 10.1038/s41467-023-40064-9
DB00514 1406 30 None - 3 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 271 1 0 2 3.4 COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C 10.1038/s41467-023-40064-9
37 778 60 None -18 17 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
460 778 60 None -18 17 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
54746 778 60 None -18 17 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
CHEMBL1201087 778 60 None -18 17 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
DB00248 778 60 None -18 17 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 10.1038/s41467-023-40064-9
25271887 5160 84 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 159 5 2 2 1.1 CC(C)C[C@H](CN)CC(=O)O 10.1038/s41467-023-40064-9
5486971 5160 84 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 159 5 2 2 1.1 CC(C)C[C@H](CN)CC(=O)O 10.1038/s41467-023-40064-9
CHEMBL1059 5160 84 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 159 5 2 2 1.1 CC(C)C[C@H](CN)CC(=O)O 10.1038/s41467-023-40064-9
10531 1420 21 None - 23 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
121 1420 21 None - 23 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
888 1420 21 None - 23 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
CHEMBL1732 1420 21 None - 23 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
DB00320 1420 21 None - 23 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
3152 188411 103 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 379 6 0 4 4.4 COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2 10.1038/s41467-023-40064-9
CHEMBL502 188411 103 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 379 6 0 4 4.4 COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2 10.1038/s41467-023-40064-9
242 470 124 None -14 51 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
34 470 124 None -14 51 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
60795 470 124 None -14 51 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
CHEMBL1112 470 124 None -14 51 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
DB01238 470 124 None -14 51 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
71109 78206 10 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 272 4 1 4 2.9 OC(CN1CCCCC1)c1cc(-c2ccccc2)on1 10.1038/s41467-023-40064-9
CHEMBL2105453 78206 10 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 272 4 1 4 2.9 OC(CN1CCCCC1)c1cc(-c2ccccc2)on1 10.1038/s41467-023-40064-9
124087 1389 114 None - 15 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
7157 1389 114 None - 15 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
814 1389 114 None - 15 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
CHEMBL1172 1389 114 None - 15 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
DB00967 1389 114 None - 15 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
2683 3834 60 None - 4 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
5487 3834 60 None - 4 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
7308 3834 60 None - 4 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
CHEMBL1079 3834 60 None - 4 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
DB00697 3834 60 None - 4 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 253 1 2 6 1.7 Clc1ccc2c(c1NC1=NCCN1)nsn2 10.1038/s41467-023-40064-9
2176 3127 68 None - 27 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1038/s41467-023-40064-9
4828 3127 68 None - 27 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1038/s41467-023-40064-9
91 3127 68 None - 27 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1038/s41467-023-40064-9
CHEMBL500 3127 68 None - 27 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1038/s41467-023-40064-9
DB00960 3127 68 None - 27 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 248 6 3 3 1.9 OC(COc1cccc2c1cc[nH]2)CNC(C)C 10.1038/s41467-023-40064-9
5639 98895 75 None -1 5 Human 8.4 pAC50 = 8.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 7 1 8 0.7 COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1038/s41467-023-40064-9
CHEMBL279229 98895 75 None -1 5 Human 8.4 pAC50 = 8.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 387 7 1 8 0.7 COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1038/s41467-023-40064-9
4993 122357 110 None - 1 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 248 2 2 4 2.5 CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL36 122357 110 None - 1 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 248 2 2 4 2.5 CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1 10.1038/s41467-023-40064-9
2099 9307 55 None - 1 Human 4.4 pAC50 = 4.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 294 2 1 3 2.4 Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O 10.1038/s41467-023-40064-9
CHEMBL1110 9307 55 None - 1 Human 4.4 pAC50 = 4.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 294 2 1 3 2.4 Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O 10.1038/s41467-023-40064-9
2351 4300 49 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 366 10 0 3 4.8 CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1 10.1038/s41467-023-40064-9
CHEMBL1008 4300 49 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 366 10 0 3 4.8 CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1 10.1038/s41467-023-40064-9
CHEMBL1257078 4300 49 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 366 10 0 3 4.8 CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1 10.1038/s41467-023-40064-9
135398744 68662 86 None - 3 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 474 7 1 8 1.6 CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12 10.1038/s41467-023-40064-9
CHEMBL192 68662 86 None - 3 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 474 7 1 8 1.6 CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12 10.1038/s41467-023-40064-9
2142 3096 58 None -2 36 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
4920903 3096 58 None -2 36 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
502 3096 58 None -2 36 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
5775 3096 58 None -2 36 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
CHEMBL597 3096 58 None -2 36 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
DB00692 3096 58 None -2 36 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1038/s41467-023-40064-9
2378 98687 103 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 310 4 0 2 5.2 c1ccc(-c2ccc(C(c3ccccc3)n3ccnc3)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL277535 98687 103 None - 0 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 310 4 0 2 5.2 c1ccc(-c2ccc(C(c3ccccc3)n3ccnc3)cc2)cc1 10.1038/s41467-023-40064-9
1353 1911 93 None -6 83 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
3559 1911 93 None -6 83 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
86 1911 93 None -6 83 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
CHEMBL54 1911 93 None -6 83 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
DB00502 1911 93 None -6 83 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1038/s41467-023-40064-9
2520 204008 70 None - 12 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
CHEMBL1280 204008 70 None - 12 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
CHEMBL6966 204008 70 None - 12 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
68712 100338 60 None -8 5 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1038/s41467-023-40064-9
CHEMBL289480 100338 60 None -8 5 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1038/s41467-023-40064-9
2398 954 62 None 1 29 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
2801 954 62 None 1 29 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
701 954 62 None 1 29 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
CHEMBL415 954 62 None 1 29 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
DB01242 954 62 None 1 29 Human 7.4 pAC50 = 7.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
4034 55822 55 None - 1 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 390 5 0 2 5.6 Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1 10.1038/s41467-023-40064-9
CHEMBL1623 55822 55 None - 1 Human 5.4 pAC50 = 5.4 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 390 5 0 2 5.6 Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1 10.1038/s41467-023-40064-9
3157 1470 71 None -2 10 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
7170 1470 71 None -2 10 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
954 1470 71 None -2 10 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
CHEMBL707 1470 71 None -2 10 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
DB00590 1470 71 None -2 10 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
4976 203579 29 None - 12 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 263 4 1 1 4.3 CNCCCC1c2ccccc2C=Cc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL668 203579 29 None - 12 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 263 4 1 1 4.3 CNCCCC1c2ccccc2C=Cc2ccccc21 10.1038/s41467-023-40064-9
135 2532 43 None -40 58 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
1796 2532 43 None -40 58 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
4184 2532 43 None -40 58 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
CHEMBL6437 2532 43 None -40 58 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
DB06148 2532 43 None -40 58 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1038/s41467-023-40064-9
21722 17992 31 None - 6 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 2 4.3 CN(C)CCCn1c2c(c3ccccc31)CCCCCC2 10.1038/s41467-023-40064-9
CHEMBL126224 17992 31 None - 6 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 4 0 2 4.3 CN(C)CCCn1c2c(c3ccccc31)CCCCCC2 10.1038/s41467-023-40064-9
3365 5178 126 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 306 5 1 7 0.7 OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F 10.1038/s41467-023-40064-9
CHEMBL106 5178 126 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 306 5 1 7 0.7 OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F 10.1038/s41467-023-40064-9
135398737 958 93 None -5 89 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
38 958 93 None -5 89 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
722 958 93 None -5 89 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL42 958 93 None -5 89 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
DB00363 958 93 None -5 89 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
135398745 2914 112 None -39 65 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
47 2914 112 None -39 65 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
CHEMBL715 2914 112 None -39 65 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
DB00334 2914 112 None -39 65 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
5029 15545 92 None - 4 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 359 8 1 5 3.0 COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C 10.1038/s41467-023-40064-9
CHEMBL1219 15545 92 None - 4 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 359 8 1 5 3.0 COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C 10.1038/s41467-023-40064-9
3033 30152 102 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 295 4 2 2 4.4 O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
CHEMBL1034 30152 102 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 295 4 2 2 4.4 O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
CHEMBL139 30152 102 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 295 4 2 2 4.4 O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
11434515 261 6 None - 5 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 484 9 1 6 4.7 O=C(C(c1cccs1)(c1cccs1)O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2 10.1038/s41467-023-40064-9
11519741 261 6 None - 5 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 484 9 1 6 4.7 O=C(C(c1cccs1)(c1cccs1)O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2 10.1038/s41467-023-40064-9
4484 261 6 None - 5 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 484 9 1 6 4.7 O=C(C(c1cccs1)(c1cccs1)O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2 10.1038/s41467-023-40064-9
7449 261 6 None - 5 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 484 9 1 6 4.7 O=C(C(c1cccs1)(c1cccs1)O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2 10.1038/s41467-023-40064-9
CHEMBL1194325 261 6 None - 5 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 484 9 1 6 4.7 O=C(C(c1cccs1)(c1cccs1)O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2 10.1038/s41467-023-40064-9
DB08897 261 6 None - 5 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 484 9 1 6 4.7 O=C(C(c1cccs1)(c1cccs1)O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2 10.1038/s41467-023-40064-9
5340 168730 106 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 3 2 5 1.5 Nc1ccc(S(=O)(=O)Nc2nccs2)cc1 10.1038/s41467-023-40064-9
CHEMBL437 168730 106 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 3 2 5 1.5 Nc1ccc(S(=O)(=O)Nc2nccs2)cc1 10.1038/s41467-023-40064-9
1613 2348 53 None -2 44 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
205 2348 53 None -2 44 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
3964 2348 53 None -2 44 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
CHEMBL831 2348 53 None -2 44 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
DB00408 2348 53 None -2 44 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
1209 1658 75 None -1 32 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
203 1658 75 None -1 32 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
3386 1658 75 None -1 32 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL41 1658 75 None -1 32 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
DB00472 1658 75 None -1 32 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
5360696 1406 30 None - 3 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 271 1 0 2 3.4 COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C 10.1038/s41467-023-40064-9
6953 1406 30 None - 3 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 271 1 0 2 3.4 COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C 10.1038/s41467-023-40064-9
842 1406 30 None - 3 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 271 1 0 2 3.4 COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C 10.1038/s41467-023-40064-9
CHEMBL52440 1406 30 None - 3 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 271 1 0 2 3.4 COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C 10.1038/s41467-023-40064-9
DB00514 1406 30 None - 3 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 271 1 0 2 3.4 COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C 10.1038/s41467-023-40064-9
1209 1658 75 None -1 32 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
203 1658 75 None -1 32 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
3386 1658 75 None -1 32 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL41 1658 75 None -1 32 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
DB00472 1658 75 None -1 32 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F 10.1038/s41467-023-40064-9
3337 206367 27 None 13 40 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
65801 206367 27 None 13 40 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
66264 206367 27 None 13 40 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
91452 206367 27 None 13 40 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
CHEMBL87493 206367 27 None 13 40 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
214 3860 58 None -9 30 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
2740 3860 58 None -9 30 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
5566 3860 58 None -9 30 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
66064 3860 58 None -9 30 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
CHEMBL422 3860 58 None -9 30 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
DB00831 3860 58 None -9 30 Human 7.3 pAC50 = 7.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F 10.1038/s41467-023-40064-9
4418 34222 85 None -1 6 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1038/s41467-023-40064-9
CHEMBL142635 34222 85 None -1 6 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1038/s41467-023-40064-9
242 470 124 None -14 51 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
34 470 124 None -14 51 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
60795 470 124 None -14 51 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
CHEMBL1112 470 124 None -14 51 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
DB01238 470 124 None -14 51 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
1400 1957 70 None - 3 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
3658 1957 70 None - 3 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
7199 1957 70 None - 3 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
91513 1957 70 None - 3 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL896 1957 70 None - 3 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
DB00557 1957 70 None - 3 Human 6.3 pAC50 = 6.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 374 8 1 4 3.1 OCCOCCN1CCN(CC1)C(c1ccc(cc1)Cl)c1ccccc1 10.1038/s41467-023-40064-9
155906370 34790 70 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 129 0 4 2 -1.0 CN(C)C(=N)NC(=N)N 10.1038/s41467-023-40064-9
4091 34790 70 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 129 0 4 2 -1.0 CN(C)C(=N)NC(=N)N 10.1038/s41467-023-40064-9
CHEMBL1431 34790 70 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 129 0 4 2 -1.0 CN(C)C(=N)NC(=N)N 10.1038/s41467-023-40064-9
57469 18866 125 None - 3 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 240 2 1 4 2.8 CC(C)Cn1cnc2c(N)nc3ccccc3c21 10.1038/s41467-023-40064-9
CHEMBL1282 18866 125 None - 3 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 240 2 1 4 2.8 CC(C)Cn1cnc2c(N)nc3ccccc3c21 10.1038/s41467-023-40064-9
2727 188090 95 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 4 2 3 1.7 CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL498 188090 95 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 276 4 2 3 1.7 CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1 10.1038/s41467-023-40064-9
65866 94264 73 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 611 12 1 8 6.5 COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
CHEMBL250270 94264 73 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 611 12 1 8 6.5 COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
2162 41514 100 None -3 6 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1038/s41467-023-40064-9
CHEMBL1491 41514 100 None -3 6 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1038/s41467-023-40064-9
27447 59803 63 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 347 4 3 5 0.4 CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1 10.1038/s41467-023-40064-9
6560168 59803 63 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 347 4 3 5 0.4 CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1 10.1038/s41467-023-40064-9
CHEMBL1727 59803 63 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 347 4 3 5 0.4 CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1 10.1038/s41467-023-40064-9
92727 204552 77 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 628 15 4 5 4.3 Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O 10.1038/s41467-023-40064-9
CHEMBL729 204552 77 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 628 15 4 5 4.3 Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O 10.1038/s41467-023-40064-9
1524 2181 96 None -5 52 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
197 2181 96 None -5 52 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
3822 2181 96 None -5 52 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
88 2181 96 None -5 52 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
CHEMBL51 2181 96 None -5 52 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
DB12465 2181 96 None -5 52 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1038/s41467-023-40064-9
240 944 43 None - 24 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
2769 944 43 None - 24 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
44279790 944 43 None - 24 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
660 944 43 None - 24 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
CHEMBL1729 944 43 None - 24 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
CHEMBL560739 944 43 None - 24 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
DB00604 944 43 None - 24 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
2337 3256 77 None -5 62 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
50 3256 77 None -5 62 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
5002 3256 77 None -5 62 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL716 3256 77 None -5 62 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
DB01224 3256 77 None -5 62 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1038/s41467-023-40064-9
10219 188796 37 None - 5 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 10.1038/s41467-023-40064-9
CHEMBL493439 188796 37 None - 5 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 10.1038/s41467-023-40064-9
CHEMBL50588 188796 37 None - 5 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 10.1038/s41467-023-40064-9
2713 205271 82 None - 0 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
5353524 205271 82 None - 0 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
5360566 205271 82 None - 0 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
88536661 205271 82 None - 0 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
9552079 205271 82 None - 0 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL1330113 205271 82 None - 0 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL790 205271 82 None - 0 Human 6.2 pAC50 = 6.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 504 9 10 4 4.2 N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 10.1038/s41467-023-40064-9
2771 195017 74 None - 27 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
CHEMBL1200781 195017 74 None - 27 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
CHEMBL549 195017 74 None - 27 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 10.1038/s41467-023-40064-9
2146 3100 67 None -2 9 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
485 3100 67 None -2 9 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
6041 3100 67 None -2 9 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL1215 3100 67 None -2 9 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
DB00388 3100 67 None -2 9 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
212 3806 47 None -7 25 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
2639 3806 47 None -7 25 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
941651 3806 47 None -7 25 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
CHEMBL1201 3806 47 None -7 25 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
DB01623 3806 47 None -7 25 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
1224 1432 83 None - 13 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
3100 1432 83 None - 13 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
8980 1432 83 None - 13 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
916 1432 83 None - 13 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
CHEMBL657 1432 83 None - 13 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
DB01075 1432 83 None - 13 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 255 6 0 2 3.4 CN(CCOC(c1ccccc1)c1ccccc1)C 10.1038/s41467-023-40064-9
39186 85935 54 None - 2 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 414 6 0 6 3.4 COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1 10.1038/s41467-023-40064-9
CHEMBL23 85935 54 None - 2 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 414 6 0 6 3.4 COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1 10.1038/s41467-023-40064-9
2247 505 81 None - 42 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
249 505 81 None - 42 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
2603 505 81 None - 42 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
CHEMBL296419 505 81 None - 42 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
DB00637 505 81 None - 42 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
5732 206935 59 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 307 3 0 3 3.2 Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1 10.1038/s41467-023-40064-9
CHEMBL911 206935 59 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 307 3 0 3 3.2 Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1 10.1038/s41467-023-40064-9
3158 56267 27 None - 20 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1628227 56267 27 None - 20 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1038/s41467-023-40064-9
5311017 120604 11 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 239 5 0 1 3.8 C[C@@H](Cc1ccccc1)N(C)Cc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL3545985 120604 11 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 239 5 0 1 3.8 C[C@@H](Cc1ccccc1)N(C)Cc1ccccc1 10.1038/s41467-023-40064-9
2146 3100 67 None -2 9 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
485 3100 67 None -2 9 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
6041 3100 67 None -2 9 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL1215 3100 67 None -2 9 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
DB00388 3100 67 None -2 9 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1038/s41467-023-40064-9
26987 949 33 None - 21 Human 8.1 pAC50 = 8.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
6063 949 33 None - 21 Human 8.1 pAC50 = 8.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
671 949 33 None - 21 Human 8.1 pAC50 = 8.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
CHEMBL1626 949 33 None - 21 Human 8.1 pAC50 = 8.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
DB00283 949 33 None - 21 Human 8.1 pAC50 = 8.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation countingBinding affinity towards human ADRA1A in an in vitro assay (CRO assay) measured by scintillation counting
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
36811 1454 37 None - 7 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
535 1454 37 None - 7 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
937 1454 37 None - 7 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
CHEMBL926 1454 37 None - 7 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
DB00841 1454 37 None - 7 Human 7.2 pAC50 = 7.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O 10.1038/s41467-023-40064-9
1210 918 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
1213 918 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
2725 918 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
33036 918 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
4411 918 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
616 918 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
6976 918 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
716121 918 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
CHEMBL1201353 918 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
CHEMBL1554789 918 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
CHEMBL505 918 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
DB01114 918 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
DB13679 918 51 None - 21 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 274 5 0 2 3.8 CN(CC[C@H](c1ccccn1)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
5353627 84541 8 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 411 8 3 4 4.6 CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL2220442 84541 8 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 411 8 3 4 4.6 CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21 10.1038/s41467-023-40064-9
135398745 2914 112 None -39 65 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
47 2914 112 None -39 65 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
CHEMBL715 2914 112 None -39 65 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
DB00334 2914 112 None -39 65 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
38853 176022 79 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 211 3 4 4 0.4 C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O 10.1038/s41467-023-40064-9
6919173 176022 79 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 211 3 4 4 0.4 C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O 10.1038/s41467-023-40064-9
CHEMBL459 176022 79 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 211 3 4 4 0.4 C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O 10.1038/s41467-023-40064-9
4212 198679 82 None - 4 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 444 12 8 10 -0.1 O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21 10.1038/s41467-023-40064-9
CHEMBL1417019 198679 82 None - 4 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 444 12 8 10 -0.1 O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21 10.1038/s41467-023-40064-9
CHEMBL58 198679 82 None - 4 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 444 12 8 10 -0.1 O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21 10.1038/s41467-023-40064-9
11626560 200937 94 None - 0 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 449 5 2 6 5.0 C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl 10.1038/s41467-023-40064-9
CHEMBL601719 200937 94 None - 0 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 449 5 2 6 5.0 C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl 10.1038/s41467-023-40064-9
16129706 209031 40 None - 5 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL None None None C[C@H](N)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O 10.1038/s41467-023-40064-9
CHEMBL1823872 209031 40 None - 5 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL None None None C[C@H](N)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O 10.1038/s41467-023-40064-9
26987 949 33 None - 21 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
6063 949 33 None - 21 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
671 949 33 None - 21 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
CHEMBL1626 949 33 None - 21 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
DB00283 949 33 None - 21 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C 10.1038/s41467-023-40064-9
1343 1889 62 None - 9 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
3519 1889 62 None - 9 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
522 1889 62 None - 9 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
CHEMBL862 1889 62 None - 9 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
DB01018 1889 62 None - 9 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N 10.1038/s41467-023-40064-9
5472 205818 75 None - 3 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 10.1038/s41467-023-40064-9
CHEMBL1717 205818 75 None - 3 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 10.1038/s41467-023-40064-9
CHEMBL833 205818 75 None - 3 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 10.1038/s41467-023-40064-9
1201549 597 24 None - 20 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
333 597 24 None - 20 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
7601 597 24 None - 20 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1201203 597 24 None - 20 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL438151 597 24 None - 20 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
DB00245 597 24 None - 20 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
16362 3125 71 None -35 30 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
2172 3125 71 None -35 30 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
90 3125 71 None -35 30 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL1423 3125 71 None -35 30 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
DB01100 3125 71 None -35 30 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
115 343 71 None -3 6 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
2092 343 71 None -3 6 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
7109 343 71 None -3 6 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
CHEMBL709 343 71 None -3 6 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
DB00346 343 71 None -3 6 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1038/s41467-023-40064-9
1427 2013 54 None - 27 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
357 2013 54 None - 27 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
3696 2013 54 None - 27 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL11 2013 54 None - 27 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00458 2013 54 None - 27 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
1593 2340 66 None - 4 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
30668 2340 66 None - 4 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
9868 2340 66 None - 4 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
CHEMBL17860 2340 66 None - 4 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
DB04948 2340 66 None - 4 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 258 3 1 3 2.8 CC(C1=NCCN1)Oc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
10100 15294 12 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 339 8 0 3 4.3 CCC(=O)O[C@](Cc1ccccc1)(c1ccccc1)[C@H](C)CN(C)C 10.1038/s41467-023-40064-9
CHEMBL1213351 15294 12 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 339 8 0 3 4.3 CCC(=O)O[C@](Cc1ccccc1)(c1ccccc1)[C@H](C)CN(C)C 10.1038/s41467-023-40064-9
191 403 98 None - 29 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
201 403 98 None - 29 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
2170 403 98 None - 29 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
CHEMBL1113 403 98 None - 29 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
DB00543 403 98 None - 29 Human 7.1 pAC50 = 7.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 10.1038/s41467-023-40064-9
1890 2759 49 None -1 16 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
4449 2759 49 None -1 16 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
7247 2759 49 None -1 16 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
CHEMBL623 2759 49 None -1 16 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
DB01149 2759 49 None -1 16 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
71398 106439 44 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 302 5 4 4 3.6 C[C@@H](Cc1ccc(O)c(O)c1)[C@H](C)Cc1ccc(O)c(O)c1 10.1038/s41467-023-40064-9
CHEMBL313972 106439 44 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 302 5 4 4 3.6 C[C@@H](Cc1ccc(O)c(O)c1)[C@H](C)Cc1ccc(O)c(O)c1 10.1038/s41467-023-40064-9
19861 207523 50 None - 1 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 290 0 0 2 3.7 CN1CCC(=C2c3ccccc3CCc3cccnc32)CC1 10.1038/s41467-023-40064-9
CHEMBL946 207523 50 None - 1 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 290 0 0 2 3.7 CN1CCC(=C2c3ccccc3CCc3cccnc32)CC1 10.1038/s41467-023-40064-9
9801 91585 35 None - 0 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 329 8 1 1 5.4 CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL24072 91585 35 None - 0 Human 6.1 pAC50 = 6.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 329 8 1 1 5.4 CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
65709 59881 39 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 365 8 0 5 3.3 CCN(CC)CCn1c(=O)c(Cc2ccc(OC)cc2)nc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1729803 59881 39 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 365 8 0 5 3.3 CCN(CC)CCn1c(=O)c(Cc2ccc(OC)cc2)nc2ccccc21 10.1038/s41467-023-40064-9
2585 803 103 None -9 21 Human 8.0 pAC50 = 8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
522 803 103 None -9 21 Human 8.0 pAC50 = 8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
551 803 103 None -9 21 Human 8.0 pAC50 = 8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
CHEMBL723 803 103 None -9 21 Human 8.0 pAC50 = 8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
DB01136 803 103 None -9 21 Human 8.0 pAC50 = 8 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 10.1038/s41467-023-40064-9
319 1324 44 None - 9 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1038/s41467-023-40064-9
321 1324 44 None - 9 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1038/s41467-023-40064-9
444031 1324 44 None - 9 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1038/s41467-023-40064-9
784 1324 44 None - 9 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1038/s41467-023-40064-9
CHEMBL1346 1324 44 None - 9 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1038/s41467-023-40064-9
DB00496 1324 44 None - 9 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 426 7 1 3 4.0 NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(C1)CCc1ccc2c(c1)CCO2 10.1038/s41467-023-40064-9
3337 206367 27 None 13 40 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
65801 206367 27 None 13 40 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
66264 206367 27 None 13 40 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
91452 206367 27 None 13 40 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
CHEMBL87493 206367 27 None 13 40 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 10.1038/s41467-023-40064-9
4614 5391 103 None - 0 Human 7.0 pAC50 = 7.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 293 5 1 3 4.0 O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1 10.1038/s41467-023-40064-9
CHEMBL1071 5391 103 None - 0 Human 7.0 pAC50 = 7.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 293 5 1 3 4.0 O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1 10.1038/s41467-023-40064-9
5329102 194726 86 None - 0 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 398 7 3 3 3.3 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C 10.1038/s41467-023-40064-9
CHEMBL535 194726 86 None - 0 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 398 7 3 3 3.3 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C 10.1038/s41467-023-40064-9
441074 19414 82 None - 0 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 324 4 1 4 3.2 C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12 10.1038/s41467-023-40064-9
CHEMBL1294 19414 82 None - 0 Human 6.0 pAC50 = 6.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 324 4 1 4 3.2 C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12 10.1038/s41467-023-40064-9
2880 98008 49 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 310 5 0 3 4.6 C=C(c1ccccc1OCc1cccc(Cl)c1)n1ccnc1 10.1038/s41467-023-40064-9
CHEMBL27289 98008 49 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 310 5 0 3 4.6 C=C(c1ccccc1OCc1cccc(Cl)c1)n1ccnc1 10.1038/s41467-023-40064-9
1499 2091 47 None - 17 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
3779 2091 47 None - 17 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
536 2091 47 None - 17 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
CHEMBL434 2091 47 None - 17 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
DB01064 2091 47 None - 17 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 211 4 4 4 1.1 CC(NCC(c1ccc(c(c1)O)O)O)C 10.1038/s41467-023-40064-9
2540 4401 111 None - 4 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 610 10 1 11 6.3 CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1 10.1038/s41467-023-40064-9
CHEMBL1014 4401 111 None - 4 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 610 10 1 11 6.3 CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1 10.1038/s41467-023-40064-9
3180 14473 41 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 289 8 0 3 3.9 CCCCOc1ccc(C(=O)CCN2CCCCC2)cc1 10.1038/s41467-023-40064-9
CHEMBL1201217 14473 41 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 289 8 0 3 3.9 CCCCOc1ccc(C(=O)CCN2CCCCC2)cc1 10.1038/s41467-023-40064-9
4567 9948 34 None - 0 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 299 7 3 3 3.4 CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL114655 9948 34 None - 0 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 299 7 3 3 3.4 CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1 10.1038/s41467-023-40064-9
2286 3183 51 None - 30 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
4927 3183 51 None - 30 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
7282 3183 51 None - 30 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
CHEMBL643 3183 51 None - 30 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
DB01069 3183 51 None - 30 Human 7.0 pAC50 = 7 Binding
Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assayBinding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
129211 3749 78 None -1 15 Human 10.2 pEC50 = 10.2 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmc.2016.09.017
2562 3749 78 None -1 15 Human 10.2 pEC50 = 10.2 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmc.2016.09.017
488 3749 78 None -1 15 Human 10.2 pEC50 = 10.2 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmc.2016.09.017
CHEMBL836 3749 78 None -1 15 Human 10.2 pEC50 = 10.2 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmc.2016.09.017
DB00706 3749 78 None -1 15 Human 10.2 pEC50 = 10.2 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmc.2016.09.017
132578519 149709 0 None - 0 Human 8.0 pEC50 = 8.0 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 484 10 1 5 4.3 CC(C)Oc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cccc(Cl)c2F)CC1 10.1016/j.bmc.2016.09.017
CHEMBL3947830 149709 0 None - 0 Human 8.0 pEC50 = 8.0 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 484 10 1 5 4.3 CC(C)Oc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cccc(Cl)c2F)CC1 10.1016/j.bmc.2016.09.017
134154987 150832 0 None - 0 Human 6.9 pEC50 = 6.9 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 438 9 1 5 3.4 COc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cccc(Cl)c2)CC1 10.1016/j.bmc.2016.09.017
CHEMBL3956998 150832 0 None - 0 Human 6.9 pEC50 = 6.9 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 438 9 1 5 3.4 COc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cccc(Cl)c2)CC1 10.1016/j.bmc.2016.09.017
9813756 9016 0 None - 3 Rabbit 5.9 pEC50 = 5.9 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 255 2 2 2 2.8 CC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL109848 9016 0 None - 3 Rabbit 5.9 pEC50 = 5.9 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 255 2 2 2 2.8 CC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
118727916 120694 0 None - 0 Human 6.9 pEC50 = 6.9 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 335 6 0 3 2.9 O=C1CCCN1CCCCN1CCN(c2ccccc2Cl)CC1 10.1016/j.bmc.2015.03.009
CHEMBL3400597 120694 0 None - 0 Human 6.9 pEC50 = 6.9 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 335 6 0 3 2.9 O=C1CCCN1CCCCN1CCN(c2ccccc2Cl)CC1 10.1016/j.bmc.2015.03.009
CHEMBL3547118 120694 0 None - 0 Human 6.9 pEC50 = 6.9 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 335 6 0 3 2.9 O=C1CCCN1CCCCN1CCN(c2ccccc2Cl)CC1 10.1016/j.bmc.2015.03.009
134156323 154257 0 None - 0 Human 6.9 pEC50 = 6.9 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 455 9 1 6 3.3 COc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cncc3ccccc23)CC1 10.1016/j.bmc.2016.09.017
CHEMBL3986337 154257 0 None - 0 Human 6.9 pEC50 = 6.9 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 455 9 1 6 3.3 COc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cncc3ccccc23)CC1 10.1016/j.bmc.2016.09.017
134148920 148449 0 None - 0 Human 6.8 pEC50 = 6.8 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 456 9 1 5 3.6 COc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cc(Cl)ccc2F)CC1 10.1016/j.bmc.2016.09.017
CHEMBL3937911 148449 0 None - 0 Human 6.8 pEC50 = 6.8 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 456 9 1 5 3.6 COc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cc(Cl)ccc2F)CC1 10.1016/j.bmc.2016.09.017
9944409 7613 0 None - 4 Rabbit 7.8 pEC50 = 7.8 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 307 3 3 4 2.0 CS(=O)(=O)Nc1c(O)ccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL108804 7613 0 None - 4 Rabbit 7.8 pEC50 = 7.8 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 307 3 3 4 2.0 CS(=O)(=O)Nc1c(O)ccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
134151231 152211 0 None - 0 Human 6.8 pEC50 = 6.8 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 464 11 1 7 2.8 COc1ccc(S(=O)(=O)NCC2CCN(CCOc3ccccc3OC)CC2)cc1OC 10.1016/j.bmc.2016.09.017
CHEMBL3968662 152211 0 None - 0 Human 6.8 pEC50 = 6.8 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 464 11 1 7 2.8 COc1ccc(S(=O)(=O)NCC2CCN(CCOc3ccccc3OC)CC2)cc1OC 10.1016/j.bmc.2016.09.017
76326541 85341 0 None - 3 Rabbit 6.8 pEC50 = 6.8 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCC[C@H]2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL2261355 85341 0 None - 3 Rabbit 6.8 pEC50 = 6.8 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCC[C@H]2c1c[nH]cn1 10.1007/s00044-004-0020-z
168290235 192968 0 None -16 20 Human 5.7 pEC50 = 5.7 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
CHEMBL5201074 192968 0 None -16 20 Human 5.7 pEC50 = 5.7 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
CHEMBL5222491 192968 0 None -16 20 Human 5.7 pEC50 = 5.7 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
9815005 109661 0 None - 2 Rabbit 4.7 pEC50 = 4.7 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 305 3 2 3 2.6 CS(=O)(=O)Nc1cccc2c1CCCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL322492 109661 0 None - 2 Rabbit 4.7 pEC50 = 4.7 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 305 3 2 3 2.6 CS(=O)(=O)Nc1cccc2c1CCCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
134148037 149772 0 None - 0 Human 6.7 pEC50 = 6.7 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 450 10 1 7 2.5 COc1ccc(S(=O)(=O)NC2CCN(CCOc3ccccc3OC)CC2)cc1OC 10.1016/j.bmc.2016.09.017
CHEMBL3948333 149772 0 None - 0 Human 6.7 pEC50 = 6.7 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 450 10 1 7 2.5 COc1ccc(S(=O)(=O)NC2CCN(CCOc3ccccc3OC)CC2)cc1OC 10.1016/j.bmc.2016.09.017
164612037 185377 0 None -4 20 Human 5.7 pEC50 = 5.7 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 326 8 4 4 1.8 CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C 10.1021/acs.jmedchem.1c00692
CHEMBL4860528 185377 0 None -4 20 Human 5.7 pEC50 = 5.7 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 326 8 4 4 1.8 CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C 10.1021/acs.jmedchem.1c00692
146762 13310 6 None - 0 Human 7.6 pEC50 = 7.6 Binding
Effective concentration (EC50) against alpha-1-adrenoceptor in the isolated rabbit ear arteryEffective concentration (EC50) against alpha-1-adrenoceptor in the isolated rabbit ear artery
ChEMBL 244 5 3 4 0.5 CNCCc1ccc(O)c(NS(C)(=O)=O)c1 10.1021/jm00380a017
CHEMBL1191956 13310 6 None - 0 Human 7.6 pEC50 = 7.6 Binding
Effective concentration (EC50) against alpha-1-adrenoceptor in the isolated rabbit ear arteryEffective concentration (EC50) against alpha-1-adrenoceptor in the isolated rabbit ear artery
ChEMBL 244 5 3 4 0.5 CNCCc1ccc(O)c(NS(C)(=O)=O)c1 10.1021/jm00380a017
CHEMBL543126 13310 6 None - 0 Human 7.6 pEC50 = 7.6 Binding
Effective concentration (EC50) against alpha-1-adrenoceptor in the isolated rabbit ear arteryEffective concentration (EC50) against alpha-1-adrenoceptor in the isolated rabbit ear artery
ChEMBL 244 5 3 4 0.5 CNCCc1ccc(O)c(NS(C)(=O)=O)c1 10.1021/jm00380a017
9903797 9439 5 None - 3 Rabbit 5.6 pEC50 = 5.6 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 279 5 2 3 2.1 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1C 10.1007/s00044-004-0020-z
CHEMBL111734 9439 5 None - 3 Rabbit 5.6 pEC50 = 5.6 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 279 5 2 3 2.1 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1C 10.1007/s00044-004-0020-z
11183468 109872 2 None - 5 Rabbit 6.6 pEC50 = 6.6 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 213 1 2 2 2.5 Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL323402 109872 2 None - 5 Rabbit 6.6 pEC50 = 6.6 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 213 1 2 2 2.5 Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
9950711 109206 0 None - 3 Rabbit 5.6 pEC50 = 5.6 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 359 4 2 3 3.2 O=S(=O)(CC(F)(F)F)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL321644 109206 0 None - 3 Rabbit 5.6 pEC50 = 5.6 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 359 4 2 3 3.2 O=S(=O)(CC(F)(F)F)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
118727910 120682 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 427 8 0 3 4.1 O=C1CCCN1CCCCN1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1016/j.bmc.2015.03.009
CHEMBL3400594 120682 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 427 8 0 3 4.1 O=C1CCCN1CCCCN1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1016/j.bmc.2015.03.009
CHEMBL3547015 120682 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 427 8 0 3 4.1 O=C1CCCN1CCCCN1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1016/j.bmc.2015.03.009
134136412 142954 0 None - 0 Human 7.5 pEC50 = 7.5 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 483 10 1 6 4.1 CC(C)Oc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cccc3cccnc23)CC1 10.1016/j.bmc.2016.09.017
CHEMBL3894175 142954 0 None - 0 Human 7.5 pEC50 = 7.5 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 483 10 1 6 4.1 CC(C)Oc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cccc3cccnc23)CC1 10.1016/j.bmc.2016.09.017
168294767 193019 0 None -4 20 Human 5.5 pEC50 = 5.5 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5207281 193019 0 None -4 20 Human 5.5 pEC50 = 5.5 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5222802 193019 0 None -4 20 Human 5.5 pEC50 = 5.5 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
9904117 9402 3 None - 4 Rabbit 6.4 pEC50 = 6.4 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL111554 9402 3 None - 4 Rabbit 6.4 pEC50 = 6.4 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
3584 3777 64 None -2 13 Human 7.3 pEC50 = 7.3 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmc.2015.03.009
5401 3777 64 None -2 13 Human 7.3 pEC50 = 7.3 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmc.2015.03.009
7302 3777 64 None -2 13 Human 7.3 pEC50 = 7.3 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmc.2015.03.009
CHEMBL611 3777 64 None -2 13 Human 7.3 pEC50 = 7.3 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmc.2015.03.009
DB01162 3777 64 None -2 13 Human 7.3 pEC50 = 7.3 Binding
Antagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assayAntagonist activity at alpha-1A adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmc.2015.03.009
3584 3777 64 None -2 13 Human 7.3 pEC50 = 7.3 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmc.2016.09.017
5401 3777 64 None -2 13 Human 7.3 pEC50 = 7.3 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmc.2016.09.017
7302 3777 64 None -2 13 Human 7.3 pEC50 = 7.3 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmc.2016.09.017
CHEMBL611 3777 64 None -2 13 Human 7.3 pEC50 = 7.3 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmc.2016.09.017
DB01162 3777 64 None -2 13 Human 7.3 pEC50 = 7.3 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.bmc.2016.09.017
9796525 9407 0 None - 2 Rabbit 5.3 pEC50 = 5.3 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 305 3 1 4 2.3 Cn1cnc(C2CCCc3c(NS(C)(=O)=O)cccc32)c1 10.1007/s00044-004-0020-z
CHEMBL111584 9407 0 None - 2 Rabbit 5.3 pEC50 = 5.3 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 305 3 1 4 2.3 Cn1cnc(C2CCCc3c(NS(C)(=O)=O)cccc32)c1 10.1007/s00044-004-0020-z
2146 3100 67 None -2 9 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at alpha-1A adrenergic receptor (unknown origin) after 5 hrs by CCF4-AM staining-based cellular assayAgonist activity at alpha-1A adrenergic receptor (unknown origin) after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1016/j.bmc.2015.03.009
485 3100 67 None -2 9 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at alpha-1A adrenergic receptor (unknown origin) after 5 hrs by CCF4-AM staining-based cellular assayAgonist activity at alpha-1A adrenergic receptor (unknown origin) after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1016/j.bmc.2015.03.009
6041 3100 67 None -2 9 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at alpha-1A adrenergic receptor (unknown origin) after 5 hrs by CCF4-AM staining-based cellular assayAgonist activity at alpha-1A adrenergic receptor (unknown origin) after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1016/j.bmc.2015.03.009
CHEMBL1215 3100 67 None -2 9 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at alpha-1A adrenergic receptor (unknown origin) after 5 hrs by CCF4-AM staining-based cellular assayAgonist activity at alpha-1A adrenergic receptor (unknown origin) after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1016/j.bmc.2015.03.009
DB00388 3100 67 None -2 9 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at alpha-1A adrenergic receptor (unknown origin) after 5 hrs by CCF4-AM staining-based cellular assayAgonist activity at alpha-1A adrenergic receptor (unknown origin) after 5 hrs by CCF4-AM staining-based cellular assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1016/j.bmc.2015.03.009
2146 3100 67 None -2 9 Human 7.3 pEC50 = 7.3 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1016/j.bmc.2016.09.017
485 3100 67 None -2 9 Human 7.3 pEC50 = 7.3 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1016/j.bmc.2016.09.017
6041 3100 67 None -2 9 Human 7.3 pEC50 = 7.3 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1016/j.bmc.2016.09.017
CHEMBL1215 3100 67 None -2 9 Human 7.3 pEC50 = 7.3 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1016/j.bmc.2016.09.017
DB00388 3100 67 None -2 9 Human 7.3 pEC50 = 7.3 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1016/j.bmc.2016.09.017
10267873 110660 0 None - 1 Rabbit 5.3 pEC50 = 5.3 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 317 4 2 3 2.8 O=S(=O)(Nc1cccc2c1CCCC2c1c[nH]cn1)C1CC1 10.1007/s00044-004-0020-z
CHEMBL325897 110660 0 None - 1 Rabbit 5.3 pEC50 = 5.3 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 317 4 2 3 2.8 O=S(=O)(Nc1cccc2c1CCCC2c1c[nH]cn1)C1CC1 10.1007/s00044-004-0020-z
9838192 111312 18 None - 5 Human 6.2 pEC50 = 6.2 Binding
Effective concentration in vitro against rabbit urethra Alpha-1A adrenergic receptorEffective concentration in vitro against rabbit urethra Alpha-1A adrenergic receptor
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1021/jm025550h
CHEMBL326702 111312 18 None - 5 Human 6.2 pEC50 = 6.2 Binding
Effective concentration in vitro against rabbit urethra Alpha-1A adrenergic receptorEffective concentration in vitro against rabbit urethra Alpha-1A adrenergic receptor
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1021/jm025550h
9838192 111312 18 None - 5 Rabbit 6.2 pEC50 = 6.2 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1007/s00044-004-0020-z
CHEMBL326702 111312 18 None - 5 Rabbit 6.2 pEC50 = 6.2 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1007/s00044-004-0020-z
9926529 9389 2 None - 4 Rabbit 6.2 pEC50 = 6.2 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL111496 9389 2 None - 4 Rabbit 6.2 pEC50 = 6.2 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
9879119 9446 0 None - 4 Rabbit 7.2 pEC50 = 7.2 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 291 4 2 3 2.2 CCS(=O)(=O)Nc1cccc2c1CCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL111771 9446 0 None - 4 Rabbit 7.2 pEC50 = 7.2 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 291 4 2 3 2.2 CCS(=O)(=O)Nc1cccc2c1CCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
11301627 9398 0 None - 1 Rabbit 5.2 pEC50 = 5.2 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 319 4 2 3 3.0 CC(C)S(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL111537 9398 0 None - 1 Rabbit 5.2 pEC50 = 5.2 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 319 4 2 3 3.0 CC(C)S(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
43260 5482 65 None - 4 Rabbit 5.2 pEC50 = 5.2 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1007/s00044-004-0020-z
CHEMBL1076 5482 65 None - 4 Rabbit 5.2 pEC50 = 5.2 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1007/s00044-004-0020-z
43260 5482 65 None - 4 Human 5.2 pEC50 = 5.2 Binding
Effective concentration in vitro against rabbit urethra Alpha-1 adrenergic receptorEffective concentration in vitro against rabbit urethra Alpha-1 adrenergic receptor
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1021/jm025550h
CHEMBL1076 5482 65 None - 4 Human 5.2 pEC50 = 5.2 Binding
Effective concentration in vitro against rabbit urethra Alpha-1 adrenergic receptorEffective concentration in vitro against rabbit urethra Alpha-1 adrenergic receptor
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1021/jm025550h
134136428 143142 0 None - 0 Human 7.1 pEC50 = 7.1 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 456 9 1 5 3.6 COc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cccc(Cl)c2F)CC1 10.1016/j.bmc.2016.09.017
CHEMBL3895815 143142 0 None - 0 Human 7.1 pEC50 = 7.1 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 456 9 1 5 3.6 COc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cccc(Cl)c2F)CC1 10.1016/j.bmc.2016.09.017
168295528 193031 0 None -4 20 Human 6.1 pEC50 = 6.1 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5206565 193031 0 None -4 20 Human 6.1 pEC50 = 6.1 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5222872 193031 0 None -4 20 Human 6.1 pEC50 = 6.1 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
4038180 204 14 None -6 7 Human 8.0 pEC50 = 8.0 Binding
Effective concentration in vitro against rabbit urethra Alpha-1 adrenergic receptorEffective concentration in vitro against rabbit urethra Alpha-1 adrenergic receptor
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm025550h
480 204 14 None -6 7 Human 8.0 pEC50 = 8.0 Binding
Effective concentration in vitro against rabbit urethra Alpha-1 adrenergic receptorEffective concentration in vitro against rabbit urethra Alpha-1 adrenergic receptor
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm025550h
CHEMBL109783 204 14 None -6 7 Human 8.0 pEC50 = 8.0 Binding
Effective concentration in vitro against rabbit urethra Alpha-1 adrenergic receptorEffective concentration in vitro against rabbit urethra Alpha-1 adrenergic receptor
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm025550h
4038180 204 14 None - 7 Rabbit 8.0 pEC50 = 8.0 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
480 204 14 None - 7 Rabbit 8.0 pEC50 = 8.0 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
CHEMBL109783 204 14 None - 7 Rabbit 8.0 pEC50 = 8.0 Binding
Agonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethraAgonist activity at alpha1A adrenoreceptor in Oryctolagus cuniculus (rabbit) urethra
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
132578518 148652 0 None - 0 Human 7.0 pEC50 = 7 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 441 8 1 6 3.1 COc1ccccc1OCCN1CCC(NS(=O)(=O)c2cncc3ccccc23)CC1 10.1016/j.bmc.2016.09.017
CHEMBL3939560 148652 0 None - 0 Human 7.0 pEC50 = 7 Binding
Intrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assayIntrinsic activity at alpha1A adrenergic receptor (unknown origin) assessed as inhibition of agonist induced effect preincubated for 30 mins followed by agonist addition measured after 5 hrs in presence of CCF4-AM by cell based beta lactamase reporter gene assay
ChEMBL 441 8 1 6 3.1 COc1ccccc1OCCN1CCC(NS(=O)(=O)c2cncc3ccccc23)CC1 10.1016/j.bmc.2016.09.017
3158 56267 27 None -295 20 Rat 11.0 pIC50 = 11 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1021/jm9910369
CHEMBL1628227 56267 27 None -295 20 Rat 11.0 pIC50 = 11 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 10.1021/jm9910369
180 401 56 None -10 40 Rat 10.7 pIC50 = 10.7 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1021/jm9910369
200 401 56 None -10 40 Rat 10.7 pIC50 = 10.7 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1021/jm9910369
2160 401 56 None -10 40 Rat 10.7 pIC50 = 10.7 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1021/jm9910369
CHEMBL629 401 56 None -10 40 Rat 10.7 pIC50 = 10.7 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1021/jm9910369
DB00321 401 56 None -10 40 Rat 10.7 pIC50 = 10.7 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1021/jm9910369
2398 954 62 None -4 29 Rat 10.4 pIC50 = 10.4 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1021/jm9910369
2801 954 62 None -4 29 Rat 10.4 pIC50 = 10.4 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1021/jm9910369
701 954 62 None -4 29 Rat 10.4 pIC50 = 10.4 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1021/jm9910369
CHEMBL415 954 62 None -4 29 Rat 10.4 pIC50 = 10.4 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1021/jm9910369
DB01242 954 62 None -4 29 Rat 10.4 pIC50 = 10.4 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1021/jm9910369
1971 2866 38 None -24 30 Rat 10.4 pIC50 = 10.4 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1021/jm9910369
2404 2866 38 None -24 30 Rat 10.4 pIC50 = 10.4 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1021/jm9910369
4543 2866 38 None -24 30 Rat 10.4 pIC50 = 10.4 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1021/jm9910369
CHEMBL445 2866 38 None -24 30 Rat 10.4 pIC50 = 10.4 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1021/jm9910369
DB00540 2866 38 None -24 30 Rat 10.4 pIC50 = 10.4 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 10.1021/jm9910369
135 2532 43 None -46 58 Rat 10.2 pIC50 = 10.2 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm9910369
1796 2532 43 None -46 58 Rat 10.2 pIC50 = 10.2 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm9910369
4184 2532 43 None -46 58 Rat 10.2 pIC50 = 10.2 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm9910369
CHEMBL6437 2532 43 None -46 58 Rat 10.2 pIC50 = 10.2 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm9910369
DB06148 2532 43 None -46 58 Rat 10.2 pIC50 = 10.2 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm9910369
4209 3163 75 None -3 33 Rat 9.7 pIC50 = 9.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
4893 3163 75 None -3 33 Rat 9.7 pIC50 = 9.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
503 3163 75 None -3 33 Rat 9.7 pIC50 = 9.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
5385 3163 75 None -3 33 Rat 9.7 pIC50 = 9.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
CHEMBL2 3163 75 None -3 33 Rat 9.7 pIC50 = 9.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
DB00457 3163 75 None -3 33 Rat 9.7 pIC50 = 9.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
2995 204405 53 None - 23 Rat 9.6 pIC50 = 9.6 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1021/jm9910369
CHEMBL1696 204405 53 None - 23 Rat 9.6 pIC50 = 9.6 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1021/jm9910369
CHEMBL72 204405 53 None - 23 Rat 9.6 pIC50 = 9.6 Binding
Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptorCompound was tested for its inhibitory activity against Alpha-1 adrenergic receptor
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1021/jm9910369
4209 3163 75 None -3 33 Rat 9.6 pIC50 = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm900458r
4893 3163 75 None -3 33 Rat 9.6 pIC50 = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm900458r
503 3163 75 None -3 33 Rat 9.6 pIC50 = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm900458r
5385 3163 75 None -3 33 Rat 9.6 pIC50 = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm900458r
CHEMBL2 3163 75 None -3 33 Rat 9.6 pIC50 = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm900458r
DB00457 3163 75 None -3 33 Rat 9.6 pIC50 = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm900458r
11638677 84589 0 None 8 5 Rat 9.6 pIC50 = 9.6 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 340 5 0 5 2.8 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2011.04.032
CHEMBL2153423 84589 0 None 8 5 Rat 9.6 pIC50 = 9.6 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 340 5 0 5 2.8 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2011.04.032
CHEMBL2220978 84589 0 None 8 5 Rat 9.6 pIC50 = 9.6 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 340 5 0 5 2.8 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2011.04.032
10809876 102653 0 None - 0 Bovine 9.3 pIC50 = 9.3 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 381 5 0 5 2.4 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCC(=O)N3C)CC1 10.1021/jm970298c
CHEMBL304438 102653 0 None - 0 Bovine 9.3 pIC50 = 9.3 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 381 5 0 5 2.4 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCC(=O)N3C)CC1 10.1021/jm970298c
76071739 142797 0 None - 0 Rat 9.3 pIC50 = 9.3 Binding
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
ChEMBL 348 1 1 4 3.6 COc1ccc2[nH]c3c(c2c1)C[C@H]1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3892879 142797 0 None - 0 Rat 9.3 pIC50 = 9.3 Binding
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
ChEMBL 348 1 1 4 3.6 COc1ccc2[nH]c3c(c2c1)C[C@H]1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
10547091 202098 0 None - 0 Bovine 9.2 pIC50 = 9.2 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 369 5 1 6 3.4 COc1ccccc1N1CCN(CCc2ccc3nc(O)sc3c2)CC1 10.1021/jm970298c
CHEMBL60885 202098 0 None - 0 Bovine 9.2 pIC50 = 9.2 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 369 5 1 6 3.4 COc1ccccc1N1CCN(CCc2ccc3nc(O)sc3c2)CC1 10.1021/jm970298c
122179430 121441 0 None -3 3 Human 9.2 pIC50 = 9.2 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 599 8 1 13 2.7 CCN(CC)c1ccc2cc(-n3cc(C(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)nn3)c(=O)oc2c1 10.1021/ml5004298
CHEMBL3582270 121441 0 None -3 3 Human 9.2 pIC50 = 9.2 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 599 8 1 13 2.7 CCN(CC)c1ccc2cc(-n3cc(C(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)nn3)c(=O)oc2c1 10.1021/ml5004298
4209 3163 75 None -3 33 Rat 9.2 pIC50 = 9.2 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
4893 3163 75 None -3 33 Rat 9.2 pIC50 = 9.2 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
503 3163 75 None -3 33 Rat 9.2 pIC50 = 9.2 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
5385 3163 75 None -3 33 Rat 9.2 pIC50 = 9.2 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
CHEMBL2 3163 75 None -3 33 Rat 9.2 pIC50 = 9.2 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
DB00457 3163 75 None -3 33 Rat 9.2 pIC50 = 9.2 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
3157 1470 71 None -1 10 Rat 9.1 pIC50 = 9.1 Binding
Displacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysisDisplacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysis
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1016/j.ejmech.2017.10.026
7170 1470 71 None -1 10 Rat 9.1 pIC50 = 9.1 Binding
Displacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysisDisplacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysis
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1016/j.ejmech.2017.10.026
954 1470 71 None -1 10 Rat 9.1 pIC50 = 9.1 Binding
Displacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysisDisplacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysis
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1016/j.ejmech.2017.10.026
CHEMBL707 1470 71 None -1 10 Rat 9.1 pIC50 = 9.1 Binding
Displacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysisDisplacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysis
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1016/j.ejmech.2017.10.026
DB00590 1470 71 None -1 10 Rat 9.1 pIC50 = 9.1 Binding
Displacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysisDisplacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysis
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1016/j.ejmech.2017.10.026
4151 3607 89 None - 3 Rat 9.1 pIC50 = 9.1 Binding
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.6b01217
493 3607 89 None - 3 Rat 9.1 pIC50 = 9.1 Binding
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.6b01217
5312125 3607 89 None - 3 Rat 9.1 pIC50 = 9.1 Binding
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.6b01217
CHEMBL24778 3607 89 None - 3 Rat 9.1 pIC50 = 9.1 Binding
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.6b01217
DB06207 3607 89 None - 3 Rat 9.1 pIC50 = 9.1 Binding
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/acs.jmedchem.6b01217
10524876 203325 0 None - 0 Bovine 9.1 pIC50 = 9.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 397 7 1 6 4.2 COc1ccccc1N1CCN(CCCCc2ccc3nc(O)sc3c2)CC1 10.1021/jm970298c
CHEMBL64878 203325 0 None - 0 Bovine 9.1 pIC50 = 9.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 397 7 1 6 4.2 COc1ccccc1N1CCN(CCCCc2ccc3nc(O)sc3c2)CC1 10.1021/jm970298c
2389 3331 118 None -6 67 Rat 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
5073 3331 118 None -6 67 Rat 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
96 3331 118 None -6 67 Rat 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
CHEMBL85 3331 118 None -6 67 Rat 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
DB00734 3331 118 None -6 67 Rat 9.0 pIC50 = 9.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
10691383 100775 0 None - 0 Bovine 9.0 pIC50 = 9 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 383 6 1 6 3.8 COc1ccccc1N1CCN(CCCc2ccc3nc(O)sc3c2)CC1 10.1021/jm970298c
CHEMBL292935 100775 0 None - 0 Bovine 9.0 pIC50 = 9 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 383 6 1 6 3.8 COc1ccccc1N1CCN(CCCc2ccc3nc(O)sc3c2)CC1 10.1021/jm970298c
19972363 94406 0 None - 0 Rat 9.0 pIC50 = 9 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 539 9 1 6 5.5 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OC(C)C)CC3)cccc2c1=O 10.1021/jm960697s
CHEMBL25098 94406 0 None - 0 Rat 9.0 pIC50 = 9 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 539 9 1 6 5.5 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OC(C)C)CC3)cccc2c1=O 10.1021/jm960697s
44275384 98810 0 None - 0 Rat 9.0 pIC50 = 9 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 529 7 1 5 5.7 Cc1ccc(Cl)cc1N1CCN(CCCNC(=O)c2cccc3c(=O)c(C)c(-c4ccccc4)oc23)CC1 10.1021/jm960697s
CHEMBL278518 98810 0 None - 0 Rat 9.0 pIC50 = 9 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 529 7 1 5 5.7 Cc1ccc(Cl)cc1N1CCN(CCCNC(=O)c2cccc3c(=O)c(C)c(-c4ccccc4)oc23)CC1 10.1021/jm960697s
2142 3096 58 None -2 36 Human 9.0 pIC50 = 9.0 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
4920903 3096 58 None -2 36 Human 9.0 pIC50 = 9.0 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
502 3096 58 None -2 36 Human 9.0 pIC50 = 9.0 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
5775 3096 58 None -2 36 Human 9.0 pIC50 = 9.0 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
CHEMBL597 3096 58 None -2 36 Human 9.0 pIC50 = 9.0 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
DB00692 3096 58 None -2 36 Human 9.0 pIC50 = 9.0 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
19972428 98096 0 None - 0 Rat 8.8 pIC50 = 8.8 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 496 8 0 6 5.6 COc1ccccc1N1CCN(CCCC(=O)c2cccc3c(=O)c(C)c(-c4ccccc4)oc23)CC1 10.1021/jm960697s
CHEMBL27341 98096 0 None - 0 Rat 8.8 pIC50 = 8.8 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 496 8 0 6 5.6 COc1ccccc1N1CCN(CCCC(=O)c2cccc3c(=O)c(C)c(-c4ccccc4)oc23)CC1 10.1021/jm960697s
3157 1470 71 None -1 10 Rat 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 nan
7170 1470 71 None -1 10 Rat 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 nan
954 1470 71 None -1 10 Rat 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 nan
CHEMBL707 1470 71 None -1 10 Rat 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 nan
DB00590 1470 71 None -1 10 Rat 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 nan
107715 200945 22 None -1 19 Rat 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
CHEMBL1255837 200945 22 None -1 19 Rat 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
CHEMBL601773 200945 22 None -1 19 Rat 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
3168 9262 92 None 1 21 Rat 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 nan
CHEMBL1108 9262 92 None 1 21 Rat 8.8 pIC50 = 8.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 nan
1427 2013 54 None - 27 Rat 8.8 pIC50 = 8.8 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1021/jm00172a035
357 2013 54 None - 27 Rat 8.8 pIC50 = 8.8 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1021/jm00172a035
3696 2013 54 None - 27 Rat 8.8 pIC50 = 8.8 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1021/jm00172a035
CHEMBL11 2013 54 None - 27 Rat 8.8 pIC50 = 8.8 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1021/jm00172a035
DB00458 2013 54 None - 27 Rat 8.8 pIC50 = 8.8 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C 10.1021/jm00172a035
9821397 100921 21 None - 0 Bovine 8.0 pIC50 = 8 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 383 5 0 6 3.0 COc1ccccc1N1CCN(CCc2ccc3c(c2)sc(=O)n3C)CC1 10.1021/jm970298c
CHEMBL293923 100921 21 None - 0 Bovine 8.0 pIC50 = 8 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 383 5 0 6 3.0 COc1ccccc1N1CCN(CCc2ccc3c(c2)sc(=O)n3C)CC1 10.1021/jm970298c
2389 3331 118 None -11 67 Human 8.0 pIC50 = 8 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2016.04.087
5073 3331 118 None -11 67 Human 8.0 pIC50 = 8 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2016.04.087
96 3331 118 None -11 67 Human 8.0 pIC50 = 8 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2016.04.087
CHEMBL85 3331 118 None -11 67 Human 8.0 pIC50 = 8 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2016.04.087
DB00734 3331 118 None -11 67 Human 8.0 pIC50 = 8 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2016.04.087
19972481 93509 0 None - 0 Rat 8.0 pIC50 = 8 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 498 9 0 6 5.8 COc1ccccc1N1CCN(CCCCOc2cccc3c(=O)c(C)c(-c4ccccc4)oc23)CC1 10.1021/jm960697s
CHEMBL24629 93509 0 None - 0 Rat 8.0 pIC50 = 8 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 498 9 0 6 5.8 COc1ccccc1N1CCN(CCCCOc2cccc3c(=O)c(C)c(-c4ccccc4)oc23)CC1 10.1021/jm960697s
119146 97151 18 None - 4 Rat 8.0 pIC50 = 8 Binding
Displacement of [3H]prazosin from rat cerebral cortex alpha1 adrenergic receptorDisplacement of [3H]prazosin from rat cerebral cortex alpha1 adrenergic receptor
ChEMBL 409 6 0 4 3.6 CN1CN(c2ccccc2)C2(CCN(CCCC(=O)c3ccc(F)cc3)CC2)C1=O 10.1021/acs.jmedchem.2c00633
CHEMBL267932 97151 18 None - 4 Rat 8.0 pIC50 = 8 Binding
Displacement of [3H]prazosin from rat cerebral cortex alpha1 adrenergic receptorDisplacement of [3H]prazosin from rat cerebral cortex alpha1 adrenergic receptor
ChEMBL 409 6 0 4 3.6 CN1CN(c2ccccc2)C2(CCN(CCCC(=O)c3ccc(F)cc3)CC2)C1=O 10.1021/acs.jmedchem.2c00633
10409553 18908 0 None - 0 Bovine 7.0 pIC50 = 7 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 414 5 1 5 3.1 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccccc3)CC1)O2 10.1021/jm00099a028
CHEMBL1203299 18908 0 None - 0 Bovine 7.0 pIC50 = 7 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 414 5 1 5 3.1 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccccc3)CC1)O2 10.1021/jm00099a028
CHEMBL128451 18908 0 None - 0 Bovine 7.0 pIC50 = 7 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 414 5 1 5 3.1 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccccc3)CC1)O2 10.1021/jm00099a028
11198145 9815 2 None 1 5 Human 7.0 pIC50 = 7 Binding
Inhibition of Alpha-1 adrenergic receptorInhibition of Alpha-1 adrenergic receptor
ChEMBL 325 5 2 3 3.8 C[C@H]([C@@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/jm990199u
CHEMBL113830 9815 2 None 1 5 Human 7.0 pIC50 = 7 Binding
Inhibition of Alpha-1 adrenergic receptorInhibition of Alpha-1 adrenergic receptor
ChEMBL 325 5 2 3 3.8 C[C@H]([C@@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/jm990199u
13520310 163839 0 None - 0 Rat 7.0 pIC50 = 7 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 281 4 1 2 3.7 CN(C)CC(c1ccc(Cl)cc1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL420644 163839 0 None - 0 Rat 7.0 pIC50 = 7 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 281 4 1 2 3.7 CN(C)CC(c1ccc(Cl)cc1)C1(O)CCCCC1 10.1021/jm00172a035
10072866 197475 0 None - 0 Bovine 6.0 pIC50 = 6 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 458 9 0 6 3.3 CCCN(CCCCN1C(=O)c2ccccc2S1(=O)=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL51561 197475 0 None - 0 Bovine 6.0 pIC50 = 6 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 458 9 0 6 3.3 CCCN(CCCCN1C(=O)c2ccccc2S1(=O)=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL56990 197475 0 None - 0 Bovine 6.0 pIC50 = 6 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 458 9 0 6 3.3 CCCN(CCCCN1C(=O)c2ccccc2S1(=O)=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10478362 20100 0 None - 0 Bovine 6.0 pIC50 = 6 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 439 5 1 6 3.0 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccc(C#N)cc3)CC1)O2 10.1021/jm00099a028
CHEMBL1203297 20100 0 None - 0 Bovine 6.0 pIC50 = 6 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 439 5 1 6 3.0 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccc(C#N)cc3)CC1)O2 10.1021/jm00099a028
CHEMBL130410 20100 0 None - 0 Bovine 6.0 pIC50 = 6 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 439 5 1 6 3.0 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccc(C#N)cc3)CC1)O2 10.1021/jm00099a028
10048445 35277 4 None - 0 Rat 6.0 pIC50 = 6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 432 5 1 3 4.6 Cc1ccc2c(c1)c(-c1ccc(F)cc1)c(C)n2C1=CCN(CCN2CCNC2=O)CC1 10.1021/jm00104a007
CHEMBL143617 35277 4 None - 0 Rat 6.0 pIC50 = 6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 432 5 1 3 4.6 Cc1ccc2c(c1)c(-c1ccc(F)cc1)c(C)n2C1=CCN(CCN2CCNC2=O)CC1 10.1021/jm00104a007
10391177 189254 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 497 7 0 4 4.0 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)N1CCCC1=O 10.1016/j.bmcl.2009.04.016
CHEMBL511747 189254 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 497 7 0 4 4.0 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)N1CCCC1=O 10.1016/j.bmcl.2009.04.016
9978353 11253 0 None - 0 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 400 7 1 5 3.1 COc1cccc2c1CC(NCCCCN1C(=O)CC3(CCCC3)CC1=O)CO2 10.1021/jm00038a007
CHEMBL1178987 11253 0 None - 0 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 400 7 1 5 3.1 COc1cccc2c1CC(NCCCCN1C(=O)CC3(CCCC3)CC1=O)CO2 10.1021/jm00038a007
CHEMBL52785 11253 0 None - 0 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 400 7 1 5 3.1 COc1cccc2c1CC(NCCCCN1C(=O)CC3(CCCC3)CC1=O)CO2 10.1021/jm00038a007
11743327 98702 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 428 8 1 5 3.9 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(O)c2C1 10.1021/jm00038a007
CHEMBL27763 98702 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 428 8 1 5 3.9 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(O)c2C1 10.1021/jm00038a007
9975915 99736 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 362 9 0 5 2.8 CCCN(CCCCN1CCOCC1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL284912 99736 0 None - 1 Bovine 5.0 pIC50 = 5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 362 9 0 5 2.8 CCCN(CCCCN1CCOCC1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
11524225 188999 0 None - 1 Human 5.0 pIC50 = 5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 403 4 0 5 4.3 Cc1cccc2c(=O)n(C)c(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)nc12 10.1016/j.bmcl.2008.10.034
CHEMBL508712 188999 0 None - 1 Human 5.0 pIC50 = 5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 403 4 0 5 4.3 Cc1cccc2c(=O)n(C)c(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)nc12 10.1016/j.bmcl.2008.10.034
131001 98993 7 None - 1 Bovine 4.0 pIC50 = 4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 249 5 1 3 2.8 CCCN(CCC)C1COc2cccc(O)c2C1 10.1021/jm00038a007
CHEMBL27995 98993 7 None - 1 Bovine 4.0 pIC50 = 4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 249 5 1 3 2.8 CCCN(CCC)C1COc2cccc(O)c2C1 10.1021/jm00038a007
10364722 99085 0 None - 1 Bovine 4.0 pIC50 = 4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 418 9 1 5 3.0 CCCN(CCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL280608 99085 0 None - 1 Bovine 4.0 pIC50 = 4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 418 9 1 5 3.0 CCCN(CCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL51888 99085 0 None - 1 Bovine 4.0 pIC50 = 4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 418 9 1 5 3.0 CCCN(CCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10199052 207954 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 258 5 3 4 1.0 O=C(NC1CC1)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL97044 207954 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 258 5 3 4 1.0 O=C(NC1CC1)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
3158 56267 27 None -295 20 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 nan
CHEMBL1628227 56267 27 None -295 20 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 nan
11108001 10872 2 None -3 6 Human 7.0 pIC50 = 7.0 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
CHEMBL117248 10872 2 None -3 6 Human 7.0 pIC50 = 7.0 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
CHEMBL540542 10872 2 None -3 6 Human 7.0 pIC50 = 7.0 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
12488 1657 56 None -77 23 Rat 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
941361 1657 56 None -77 23 Rat 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
CHEMBL30008 1657 56 None -77 23 Rat 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
DB04841 1657 56 None -77 23 Rat 6.0 pIC50 = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
5656 203066 87 None - 40 Rat 7.0 pIC50 = 7.0 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 10.1021/jm00172a035
CHEMBL637 203066 87 None - 40 Rat 7.0 pIC50 = 7.0 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 10.1021/jm00172a035
134551 358 27 None -3 21 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
271 358 27 None -3 21 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
885 358 27 None -3 21 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
CHEMBL1403281 358 27 None -3 21 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
2142 3096 58 None -2 36 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
4920903 3096 58 None -2 36 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
502 3096 58 None -2 36 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
5775 3096 58 None -2 36 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
CHEMBL597 3096 58 None -2 36 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
DB00692 3096 58 None -2 36 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
73453 29616 24 None -6 17 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 561 4 3 6 2.0 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 nan
CHEMBL1385840 29616 24 None -6 17 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 561 4 3 6 2.0 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 nan
10094822 164888 4 None - 0 Rat 8.0 pIC50 = 8.0 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 440 5 1 3 4.8 O=C1NCCN1CCN1CCC(n2cc(-c3ccc(F)cc3)c3ccc(Cl)cc32)CC1 10.1021/jm00104a007
CHEMBL422130 164888 4 None - 0 Rat 8.0 pIC50 = 8.0 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 440 5 1 3 4.8 O=C1NCCN1CCN1CCC(n2cc(-c3ccc(F)cc3)c3ccc(Cl)cc32)CC1 10.1021/jm00104a007
10595604 114137 0 None - 0 Rat 7.0 pIC50 = 7.0 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 374 5 0 4 4.1 Fc1ccc(-n2cc(OCCN3CCOCC3)c3cc(Cl)ccc32)cc1 10.1021/jm960159f
CHEMBL332913 114137 0 None - 0 Rat 7.0 pIC50 = 7.0 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 374 5 0 4 4.1 Fc1ccc(-n2cc(OCCN3CCOCC3)c3cc(Cl)ccc32)cc1 10.1021/jm960159f
36811 1454 37 None -2 7 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
535 1454 37 None -2 7 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
937 1454 37 None -2 7 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
CHEMBL926 1454 37 None -2 7 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
DB00841 1454 37 None -2 7 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
11668594 186674 0 None - 1 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 405 7 0 5 4.9 CC(C)n1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
CHEMBL488251 186674 0 None - 1 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 405 7 0 5 4.9 CC(C)n1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
44376958 57479 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1ccn2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc2c1 10.1016/s0960-894x(99)00591-0
CHEMBL165796 57479 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1ccn2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc2c1 10.1016/s0960-894x(99)00591-0
22120332 56045 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 389 4 0 6 3.4 COc1cccn2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc12 10.1016/s0960-894x(99)00591-0
CHEMBL162490 56045 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 389 4 0 6 3.4 COc1cccn2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc12 10.1016/s0960-894x(99)00591-0
10015132 163869 1 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 253 4 1 4 2.1 c1ccc(-c2ccccc2OCC2=NCCN2)nc1 10.1016/s0960-894x(01)00764-8
CHEMBL420683 163869 1 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 253 4 1 4 2.1 c1ccc(-c2ccccc2OCC2=NCCN2)nc1 10.1016/s0960-894x(01)00764-8
44573964 178654 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 483 7 0 4 4.5 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)N1CCCC1 10.1016/j.bmcl.2009.04.016
CHEMBL467668 178654 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 483 7 0 4 4.5 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)N1CCCC1 10.1016/j.bmcl.2009.04.016
213 3853 55 None -4 44 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
2717 3853 55 None -4 44 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
5533 3853 55 None -4 44 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
CHEMBL621 3853 55 None -4 44 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
DB00656 3853 55 None -4 44 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
10503470 164323 0 None - 0 Rat 7.9 pIC50 = 7.9 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 444 9 1 4 4.1 CCN(CCOc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
CHEMBL421239 164323 0 None - 0 Rat 7.9 pIC50 = 7.9 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 444 9 1 4 4.1 CCN(CCOc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
127049863 140252 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 443 8 1 5 4.5 CNC(=O)c1cc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccc1F 10.1016/j.bmcl.2016.04.087
CHEMBL3805518 140252 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 443 8 1 5 4.5 CNC(=O)c1cc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccc1F 10.1016/j.bmcl.2016.04.087
240 944 43 None -4 24 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
2769 944 43 None -4 24 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
44279790 944 43 None -4 24 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
660 944 43 None -4 24 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
CHEMBL1729 944 43 None -4 24 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
CHEMBL560739 944 43 None -4 24 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
DB00604 944 43 None -4 24 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
85469808 136630 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 439 7 0 4 3.8 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(Cc3ccccc3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3739900 136630 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 439 7 0 4 3.8 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(Cc3ccccc3)CC2)cc1 10.1016/j.bmc.2015.11.020
42 2063 57 None - 18 Bovine 5.9 pIC50 = 5.9 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 401 6 0 7 1.2 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
56971 2063 57 None - 18 Bovine 5.9 pIC50 = 5.9 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 401 6 0 7 1.2 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
CHEMBL8412 2063 57 None - 18 Bovine 5.9 pIC50 = 5.9 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 401 6 0 7 1.2 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
4735 195115 96 None -77 10 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 nan
CHEMBL361506 195115 96 None -77 10 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 nan
CHEMBL55 195115 96 None -77 10 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 nan
102 4127 48 None -1258 49 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
3659 4127 48 None -1258 49 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
8969 4127 48 None -1258 49 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
CHEMBL15245 4127 48 None -1258 49 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
DB01392 4127 48 None -1258 49 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
13520332 4294 0 None - 0 Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 263 5 1 3 2.6 COc1ccc(C(CN(C)C)C2(O)CCCC2)cc1 10.1021/jm00172a035
CHEMBL100774 4294 0 None - 0 Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 263 5 1 3 2.6 COc1ccc(C(CN(C)C)C2(O)CCCC2)cc1 10.1021/jm00172a035
85469757 136739 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 468 6 0 5 3.9 N#Cc1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)c(F)c1 10.1016/j.bmc.2015.11.020
CHEMBL3740874 136739 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 468 6 0 5 3.9 N#Cc1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)c(F)c1 10.1016/j.bmc.2015.11.020
44362511 119348 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 267 4 1 4 2.4 Cc1ccnc(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL344294 119348 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 267 4 1 4 2.4 Cc1ccnc(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
10829244 16508 0 None - 0 Rat 6.9 pIC50 = 6.9 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 316 4 0 2 4.5 CN(C)CCc1cn(-c2ccc(F)cc2)c2cc(Cl)ccc12 10.1021/jm960159f
CHEMBL123640 16508 0 None - 0 Rat 6.9 pIC50 = 6.9 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 316 4 0 2 4.5 CN(C)CCc1cn(-c2ccc(F)cc2)c2cc(Cl)ccc12 10.1021/jm960159f
10265758 4478 4 None - 0 Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 281 4 1 2 3.7 CN(C)CC(c1cccc(Cl)c1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL101899 4478 4 None - 0 Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 281 4 1 2 3.7 CN(C)CC(c1cccc(Cl)c1)C1(O)CCCCC1 10.1021/jm00172a035
2995 204405 53 None - 23 Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1021/jm00172a035
CHEMBL1696 204405 53 None - 23 Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1021/jm00172a035
CHEMBL72 204405 53 None - 23 Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 10.1021/jm00172a035
11689687 191279 0 None - 1 Human 5.9 pIC50 = 5.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 391 7 0 5 4.3 CCn1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
CHEMBL519067 191279 0 None - 1 Human 5.9 pIC50 = 5.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 391 7 0 5 4.3 CCn1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
45485061 198754 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 489 5 2 5 5.0 Cc1cc(N(C)C)nc(N[C@H]2CC[C@@H](NC(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)CC2)n1 10.1016/j.bmcl.2009.09.003
CHEMBL583014 198754 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 489 5 2 5 5.0 Cc1cc(N(C)C)nc(N[C@H]2CC[C@@H](NC(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)CC2)n1 10.1016/j.bmcl.2009.09.003
441383 20333 57 None -257 16 Rat 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
CHEMBL1306 20333 57 None -257 16 Rat 4.9 pIC50 = 4.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
1343 1889 62 None -87 9 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
3519 1889 62 None -87 9 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
522 1889 62 None -87 9 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
CHEMBL862 1889 62 None -87 9 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
DB01018 1889 62 None -87 9 Rat 5.9 pIC50 = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
72197484 102494 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 330 4 2 4 3.5 c1ccc(Cc2nc3c(c(Nc4ccccc4)n2)CCNCC3)cc1 10.1016/j.ejmech.2013.02.020
CHEMBL2393243 102494 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 330 4 2 4 3.5 c1ccc(Cc2nc3c(c(Nc4ccccc4)n2)CCNCC3)cc1 10.1016/j.ejmech.2013.02.020
CHEMBL3040324 102494 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 330 4 2 4 3.5 c1ccc(Cc2nc3c(c(Nc4ccccc4)n2)CCNCC3)cc1 10.1016/j.ejmech.2013.02.020
10645487 15757 0 None - 0 Rat 7.9 pIC50 = 7.9 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 414 7 1 3 3.9 CN(CCc1cn(-c2ccc(F)cc2)c2cc(Cl)ccc12)CCN1CCNC1=O 10.1021/jm960159f
CHEMBL122269 15757 0 None - 0 Rat 7.9 pIC50 = 7.9 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 414 7 1 3 3.9 CN(CCc1cn(-c2ccc(F)cc2)c2cc(Cl)ccc12)CCN1CCNC1=O 10.1021/jm960159f
10788685 118460 0 None - 0 Rat 7.9 pIC50 = 7.9 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 428 8 1 3 4.3 CN(CCCN1CCNC1=O)CCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
CHEMBL341229 118460 0 None - 0 Rat 7.9 pIC50 = 7.9 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 428 8 1 3 4.3 CN(CCCN1CCNC1=O)CCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
19972519 94248 0 None - 0 Rat 7.9 pIC50 = 7.9 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 497 7 1 6 4.3 COc1ccccc1N1CCN(CCNC(=O)c2cccc3c(=O)c(C)c(-c4ccccc4)oc23)CC1 10.1021/jm960697s
CHEMBL25012 94248 0 None - 0 Rat 7.9 pIC50 = 7.9 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 497 7 1 6 4.3 COc1ccccc1N1CCN(CCNC(=O)c2cccc3c(=O)c(C)c(-c4ccccc4)oc23)CC1 10.1021/jm960697s
180 401 56 None -10 40 Rat 7.9 pIC50 = 7.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
200 401 56 None -10 40 Rat 7.9 pIC50 = 7.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
2160 401 56 None -10 40 Rat 7.9 pIC50 = 7.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
CHEMBL629 401 56 None -10 40 Rat 7.9 pIC50 = 7.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
DB00321 401 56 None -10 40 Rat 7.9 pIC50 = 7.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
85469809 136701 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 467 7 0 5 4.1 CC(=O)c1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3740558 136701 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 467 7 0 5 4.1 CC(=O)c1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
10381889 107069 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity against Alpha-1A adrenergic receptorBinding affinity against Alpha-1A adrenergic receptor
ChEMBL 328 2 0 3 4.1 CN(C)CC1CC2c3ccccc3Cc3ccc(Cl)cc3N2O1 10.1016/s0960-894x(02)00796-5
CHEMBL315772 107069 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity against Alpha-1A adrenergic receptorBinding affinity against Alpha-1A adrenergic receptor
ChEMBL 328 2 0 3 4.1 CN(C)CC1CC2c3ccccc3Cc3ccc(Cl)cc3N2O1 10.1016/s0960-894x(02)00796-5
10381889 107069 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 328 2 0 3 4.1 CN(C)CC1CC2c3ccccc3Cc3ccc(Cl)cc3N2O1 10.1016/s0960-894x(01)00721-1
CHEMBL315772 107069 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 328 2 0 3 4.1 CN(C)CC1CC2c3ccccc3Cc3ccc(Cl)cc3N2O1 10.1016/s0960-894x(01)00721-1
5656 203066 87 None - 40 Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 10.1021/jm00172a035
CHEMBL637 203066 87 None - 40 Rat 6.9 pIC50 = 6.9 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 10.1021/jm00172a035
1201549 597 24 None -51 20 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
333 597 24 None -51 20 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
7601 597 24 None -51 20 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
CHEMBL1201203 597 24 None -51 20 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
CHEMBL438151 597 24 None -51 20 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
DB00245 597 24 None -51 20 Rat 6.9 pIC50 = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
6075 150108 42 None -11 16 Rat 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 nan
CHEMBL395110 150108 42 None -11 16 Rat 6.8 pIC50 = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 nan
11796106 15580 0 None - 0 Rat 7.8 pIC50 = 7.8 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 414 7 1 3 3.9 CN(CCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
CHEMBL122113 15580 0 None - 0 Rat 7.8 pIC50 = 7.8 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 414 7 1 3 3.9 CN(CCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
85469811 136884 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 459 6 0 4 4.5 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccc3Cl)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3742198 136884 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 459 6 0 4 4.5 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccc3Cl)CC2)cc1 10.1016/j.bmc.2015.11.020
9886555 16495 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 387 5 0 4 4.0 CN1CCN(CCOc2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1 10.1021/jm960159f
CHEMBL123584 16495 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 387 5 0 4 4.0 CN1CCN(CCOc2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1 10.1021/jm960159f
13520317 4350 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 277 5 1 3 3.0 COc1cccc(C(CN(C)C)C2(O)CCCCC2)c1 10.1021/jm00172a035
CHEMBL101055 4350 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 277 5 1 3 3.0 COc1cccc(C(CN(C)C)C2(O)CCCCC2)c1 10.1021/jm00172a035
160023 19448 7 None - 0 Bovine 5.8 pIC50 = 5.8 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 456 5 1 8 2.6 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccc4nonc4c3)CC1)O2 10.1021/jm00099a028
CHEMBL1204345 19448 7 None - 0 Bovine 5.8 pIC50 = 5.8 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 456 5 1 8 2.6 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccc4nonc4c3)CC1)O2 10.1021/jm00099a028
CHEMBL129583 19448 7 None - 0 Bovine 5.8 pIC50 = 5.8 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 456 5 1 8 2.6 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccc4nonc4c3)CC1)O2 10.1021/jm00099a028
10255678 117371 0 None - 0 Bovine 4.8 pIC50 = 4.8 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 507 7 2 7 2.5 CS(=O)(=O)Nc1ccc(CCN2CCC3(CC2)CC(=O)c2cc(NS(C)(=O)=O)ccc2O3)cc1 10.1021/jm00099a028
CHEMBL1203296 117371 0 None - 0 Bovine 4.8 pIC50 = 4.8 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 507 7 2 7 2.5 CS(=O)(=O)Nc1ccc(CCN2CCC3(CC2)CC(=O)c2cc(NS(C)(=O)=O)ccc2O3)cc1 10.1021/jm00099a028
CHEMBL339769 117371 0 None - 0 Bovine 4.8 pIC50 = 4.8 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 507 7 2 7 2.5 CS(=O)(=O)Nc1ccc(CCN2CCC3(CC2)CC(=O)c2cc(NS(C)(=O)=O)ccc2O3)cc1 10.1021/jm00099a028
85469698 136826 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 425 6 0 4 3.8 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccc3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3741658 136826 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 425 6 0 4 3.8 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccc3)CC2)cc1 10.1016/j.bmc.2015.11.020
5282322 78244 21 None - 1 Rat 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 785 11 4 15 2.4 CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O nan
CHEMBL2106399 78244 21 None - 1 Rat 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 785 11 4 15 2.4 CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O nan
135398737 958 93 None - 89 Bovine 6.8 pIC50 = 6.8 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm970298c
38 958 93 None - 89 Bovine 6.8 pIC50 = 6.8 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm970298c
722 958 93 None - 89 Bovine 6.8 pIC50 = 6.8 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm970298c
CHEMBL42 958 93 None - 89 Bovine 6.8 pIC50 = 6.8 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm970298c
DB00363 958 93 None - 89 Bovine 6.8 pIC50 = 6.8 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm970298c
2477 745 59 None - 29 Bovine 4.8 pIC50 = 4.8 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
36 745 59 None - 29 Bovine 4.8 pIC50 = 4.8 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
437 745 59 None - 29 Bovine 4.8 pIC50 = 4.8 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
CHEMBL49 745 59 None - 29 Bovine 4.8 pIC50 = 4.8 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
DB00490 745 59 None - 29 Bovine 4.8 pIC50 = 4.8 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1021/jm00038a007
10246054 106544 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 330 2 0 3 3.7 CN(C)CC1CC2c3cc(F)ccc3Cc3ccc(F)cc3N2O1 10.1016/s0960-894x(01)00721-1
CHEMBL314107 106544 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 330 2 0 3 3.7 CN(C)CC1CC2c3cc(F)ccc3Cc3ccc(F)cc3N2O1 10.1016/s0960-894x(01)00721-1
44343410 11555 2 None - 0 Human 6.8 pIC50 = 6.8 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 219 4 2 3 2.7 CSc1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
CHEMBL118055 11555 2 None - 0 Human 6.8 pIC50 = 6.8 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 219 4 2 3 2.7 CSc1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
10592734 17081 0 None - 0 Rat 7.8 pIC50 = 7.8 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 332 5 0 3 4.4 CN(C)CCOc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
CHEMBL125483 17081 0 None - 0 Rat 7.8 pIC50 = 7.8 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 332 5 0 3 4.4 CN(C)CCOc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
8459 3298 4 None - 3 Bovine 7.8 pIC50 = 7.8 Binding
Binding affinity was tested on cloned bovine Alpha-1A adrenergic receptorBinding affinity was tested on cloned bovine Alpha-1A adrenergic receptor
ChEMBL 495 8 1 9 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)COc1c(OC)cccc1C(C)C 10.1021/jm960697s
9891980 3298 4 None - 3 Bovine 7.8 pIC50 = 7.8 Binding
Binding affinity was tested on cloned bovine Alpha-1A adrenergic receptorBinding affinity was tested on cloned bovine Alpha-1A adrenergic receptor
ChEMBL 495 8 1 9 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)COc1c(OC)cccc1C(C)C 10.1021/jm960697s
CHEMBL430717 3298 4 None - 3 Bovine 7.8 pIC50 = 7.8 Binding
Binding affinity was tested on cloned bovine Alpha-1A adrenergic receptorBinding affinity was tested on cloned bovine Alpha-1A adrenergic receptor
ChEMBL 495 8 1 9 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)COc1c(OC)cccc1C(C)C 10.1021/jm960697s
242 470 124 None -14 51 Human 6.8 pIC50 = 6.8 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.bmcl.2016.04.087
34 470 124 None -14 51 Human 6.8 pIC50 = 6.8 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.bmcl.2016.04.087
60795 470 124 None -14 51 Human 6.8 pIC50 = 6.8 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.bmcl.2016.04.087
CHEMBL1112 470 124 None -14 51 Human 6.8 pIC50 = 6.8 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.bmcl.2016.04.087
DB01238 470 124 None -14 51 Human 6.8 pIC50 = 6.8 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1016/j.bmcl.2016.04.087
10544602 117469 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 332 5 0 3 4.4 CN(C)CCOc1cn(-c2ccc(F)cc2)c2cc(Cl)ccc12 10.1021/jm960159f
CHEMBL339919 117469 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 332 5 0 3 4.4 CN(C)CCOc1cn(-c2ccc(F)cc2)c2cc(Cl)ccc12 10.1021/jm960159f
10739024 69833 0 None -33 5 Human 5.8 pIC50 = 5.8 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtype.Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtype.
ChEMBL 388 4 3 8 0.9 COc1cc2nc(N3CCN[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
CHEMBL19376 69833 0 None -33 5 Human 5.8 pIC50 = 5.8 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtype.Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtype.
ChEMBL 388 4 3 8 0.9 COc1cc2nc(N3CCN[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
2771 195017 74 None -8 27 Rat 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 nan
CHEMBL1200781 195017 74 None -8 27 Rat 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 nan
CHEMBL549 195017 74 None -8 27 Rat 5.8 pIC50 = 5.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 nan
10518508 102052 1 None - 0 Rat 7.8 pIC50 = 7.8 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 302 3 0 2 4.5 CN(C)Cc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
CHEMBL301956 102052 1 None - 0 Rat 7.8 pIC50 = 7.8 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 302 3 0 2 4.5 CN(C)Cc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
11502343 186150 0 None - 1 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 405 8 0 5 4.7 CCCn1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
CHEMBL487230 186150 0 None - 1 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 405 8 0 5 4.7 CCCn1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
10477439 36006 4 None - 0 Rat 7.7 pIC50 = 7.7 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 424 5 1 3 4.2 O=C1NCCN1CCN1CCC(n2cc(-c3ccc(F)cc3)c3cc(F)ccc32)CC1 10.1021/jm00104a007
CHEMBL144318 36006 4 None - 0 Rat 7.7 pIC50 = 7.7 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 424 5 1 3 4.2 O=C1NCCN1CCN1CCC(n2cc(-c3ccc(F)cc3)c3cc(F)ccc32)CC1 10.1021/jm00104a007
10426286 119353 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 322 2 0 2 5.0 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2C1CCN(C)CC1 10.1021/jm00104a007
CHEMBL344335 119353 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 322 2 0 2 5.0 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2C1CCN(C)CC1 10.1021/jm00104a007
10254306 120875 4 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 474 5 1 3 5.1 O=C1NCCN1CCN1CCC(n2cc(-c3ccc(F)cc3)c3cc(C(F)(F)F)ccc32)CC1 10.1021/jm00104a007
CHEMBL355917 120875 4 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 474 5 1 3 5.1 O=C1NCCN1CCN1CCC(n2cc(-c3ccc(F)cc3)c3cc(C(F)(F)F)ccc32)CC1 10.1021/jm00104a007
13520327 208365 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 355 5 1 3 3.8 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1Br 10.1021/jm00172a035
CHEMBL99503 208365 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 355 5 1 3 3.8 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1Br 10.1021/jm00172a035
19426635 205593 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 280 2 1 3 3.1 CNCC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(01)00721-1
CHEMBL81485 205593 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 280 2 1 3 3.1 CNCC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(01)00721-1
22493269 46826 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 256 4 2 5 2.1 Cc1ncoc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL154023 46826 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 256 4 2 5 2.1 Cc1ncoc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
22493289 49688 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 253 4 2 5 1.6 c1cnc(-c2ccccc2NCC2=NCCN2)nc1 10.1016/s0960-894x(01)00822-8
CHEMBL156661 49688 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 253 4 2 5 1.6 c1cnc(-c2ccccc2NCC2=NCCN2)nc1 10.1016/s0960-894x(01)00822-8
9934955 72276 0 None -489 5 Human 5.7 pIC50 = 5.7 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtypeCompound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtype
ChEMBL 482 5 2 9 2.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
CHEMBL19826 72276 0 None -489 5 Human 5.7 pIC50 = 5.7 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtypeCompound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtype
ChEMBL 482 5 2 9 2.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
25014630 83539 1 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition of alpha1A adrenergic receptorInhibition of alpha1A adrenergic receptor
ChEMBL 326 3 3 4 3.3 N=C(Nc1ccc2c(c1)CCN2C1CCNCC1)c1cccs1 10.1016/j.ejmech.2012.07.006
CHEMBL2203713 83539 1 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition of alpha1A adrenergic receptorInhibition of alpha1A adrenergic receptor
ChEMBL 326 3 3 4 3.3 N=C(Nc1ccc2c(c1)CCN2C1CCNCC1)c1cccs1 10.1016/j.ejmech.2012.07.006
44461606 105995 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 308 3 0 3 3.8 CN(C)CCC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(01)00721-1
CHEMBL313189 105995 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 308 3 0 3 3.8 CN(C)CCC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(01)00721-1
10073934 187490 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 481 7 0 6 3.5 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)n1cncn1 10.1016/j.bmcl.2009.04.016
CHEMBL494155 187490 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 481 7 0 6 3.5 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)n1cncn1 10.1016/j.bmcl.2009.04.016
44573932 187491 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 482 7 0 7 2.9 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)n1cnnn1 10.1016/j.bmcl.2009.04.016
CHEMBL494156 187491 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 482 7 0 7 2.9 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)n1cnnn1 10.1016/j.bmcl.2009.04.016
1547484 940 74 None -125 20 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
654 940 74 None -125 20 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
9072 940 74 None -125 20 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
CHEMBL43064 940 74 None -125 20 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
DB00568 940 74 None -125 20 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
10345121 187453 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 481 7 0 6 3.5 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)n1ccnn1 10.1016/j.bmcl.2009.04.016
CHEMBL493967 187453 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 481 7 0 6 3.5 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)n1ccnn1 10.1016/j.bmcl.2009.04.016
2105 3054 37 None -1258 33 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
47811 3054 37 None -1258 33 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
48 3054 37 None -1258 33 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
CHEMBL531 3054 37 None -1258 33 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
DB01186 3054 37 None -1258 33 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
448537 160250 89 None -1584 25 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
CHEMBL411 160250 89 None -1584 25 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
9837963 62971 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibitory concentration against radioligand binding to human Alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cellsInhibitory concentration against radioligand binding to human Alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cells
ChEMBL 255 4 2 5 1.5 Cn1nccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
CHEMBL17851 62971 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibitory concentration against radioligand binding to human Alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cellsInhibitory concentration against radioligand binding to human Alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cells
ChEMBL 255 4 2 5 1.5 Cn1nccc1-c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(03)00050-7
148842 3946 27 None -8 5 Rat 8.7 pIC50 = 8.7 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm960697s
496 3946 27 None -8 5 Rat 8.7 pIC50 = 8.7 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm960697s
CHEMBL278865 3946 27 None -8 5 Rat 8.7 pIC50 = 8.7 Binding
Binding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptorBinding affinity was tested on CEC-pretreated rat hippocampus Alpha-1A adrenergic receptor
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm960697s
85469933 136648 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 439 6 0 4 4.2 Cc1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3740019 136648 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 439 6 0 4 4.2 Cc1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
56961506 121439 0 None - 1 Human 8.6 pIC50 = 8.6 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 544 5 2 13 1.6 COc1cc2nc(N3CCN(C(=O)c4cn(-c5cc6ccc(O)cc6oc5=O)nn4)CC3)nc(N)c2cc1OC 10.1021/ml5004298
CHEMBL3582269 121439 0 None - 1 Human 8.6 pIC50 = 8.6 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 544 5 2 13 1.6 COc1cc2nc(N3CCN(C(=O)c4cn(-c5cc6ccc(O)cc6oc5=O)nn4)CC3)nc(N)c2cc1OC 10.1021/ml5004298
137380627 162666 3 None - 0 Rat 8.6 pIC50 = 8.6 Binding
Displacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysisDisplacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysis
ChEMBL 772 17 2 14 4.7 COc1cc2nc(N3CCN(C(=O)CCCCCCCCCCC(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)CC3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.10.026
CHEMBL4170029 162666 3 None - 0 Rat 8.6 pIC50 = 8.6 Binding
Displacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysisDisplacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysis
ChEMBL 772 17 2 14 4.7 COc1cc2nc(N3CCN(C(=O)CCCCCCCCCCC(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)CC3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.10.026
1353 1911 93 None - 83 Bovine 7.7 pIC50 = 7.7 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1021/jm970298c
3559 1911 93 None - 83 Bovine 7.7 pIC50 = 7.7 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1021/jm970298c
86 1911 93 None - 83 Bovine 7.7 pIC50 = 7.7 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1021/jm970298c
CHEMBL54 1911 93 None - 83 Bovine 7.7 pIC50 = 7.7 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1021/jm970298c
DB00502 1911 93 None - 83 Bovine 7.7 pIC50 = 7.7 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1021/jm970298c
10573576 200432 0 None - 0 Bovine 7.7 pIC50 = 7.7 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 409 7 0 5 3.2 COc1ccccc1N1CCN(CCCCc2ccc3c(c2)OCC(=O)N3C)CC1 10.1021/jm970298c
CHEMBL59823 200432 0 None - 0 Bovine 7.7 pIC50 = 7.7 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 409 7 0 5 3.2 COc1ccccc1N1CCN(CCCCc2ccc3c(c2)OCC(=O)N3C)CC1 10.1021/jm970298c
10671211 202727 0 None - 0 Bovine 6.7 pIC50 = 6.7 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 449 6 0 5 4.8 Cn1c(=O)sc2cc(CCCCN3CCN(c4cccc(C(F)(F)F)c4)CC3)ccc21 10.1021/jm970298c
CHEMBL61818 202727 0 None - 0 Bovine 6.7 pIC50 = 6.7 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 449 6 0 5 4.8 Cn1c(=O)sc2cc(CCCCN3CCN(c4cccc(C(F)(F)F)c4)CC3)ccc21 10.1021/jm970298c
10319624 98987 0 None - 1 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 10 1 4 4.1 CCCN(CCCCNC(=O)c1ccc(F)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL27991 98987 0 None - 1 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 10 1 4 4.1 CCCN(CCCCNC(=O)c1ccc(F)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL298534 98987 0 None - 1 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 10 1 4 4.1 CCCN(CCCCNC(=O)c1ccc(F)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10265863 193324 0 None - 0 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 283 5 0 2 4.3 CCCN(CCC)C1COc2ccc3ccccc3c2C1 10.1021/jm00038a007
CHEMBL52438 193324 0 None - 0 Bovine 5.7 pIC50 = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 283 5 0 2 4.3 CCCN(CCC)C1COc2ccc3ccccc3c2C1 10.1021/jm00038a007
9934955 72276 0 None -165 5 Rat 5.7 pIC50 = 5.7 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the rat prostate Alpha-1A adrenergic receptor subtypeCompound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the rat prostate Alpha-1A adrenergic receptor subtype
ChEMBL 482 5 2 9 2.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
CHEMBL19826 72276 0 None -165 5 Rat 5.7 pIC50 = 5.7 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the rat prostate Alpha-1A adrenergic receptor subtypeCompound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the rat prostate Alpha-1A adrenergic receptor subtype
ChEMBL 482 5 2 9 2.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
121852 10166 7 None - 1 Bovine 4.7 pIC50 = 4.7 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL11592 10166 7 None - 1 Bovine 4.7 pIC50 = 4.7 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL301060 10166 7 None - 1 Bovine 4.7 pIC50 = 4.7 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
44376975 55986 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 435 5 0 5 4.6 O=c1c(CCN2CCc3oc4ccccc4c3C2)c(Cc2ccccc2)nc2ccccn12 10.1016/s0960-894x(99)00591-0
CHEMBL162436 55986 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 435 5 0 5 4.6 O=c1c(CCN2CCc3oc4ccccc4c3C2)c(Cc2ccccc2)nc2ccccn12 10.1016/s0960-894x(99)00591-0
9903313 172678 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 260 5 2 4 1.2 CCN(C)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL450018 172678 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 260 5 2 4 1.2 CCN(C)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
14739944 208400 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 261 4 1 2 3.3 Cc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 10.1021/jm00172a035
CHEMBL99670 208400 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 261 4 1 2 3.3 Cc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 10.1021/jm00172a035
2520 204008 70 None -147 12 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC nan
CHEMBL1280 204008 70 None -147 12 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC nan
CHEMBL6966 204008 70 None -147 12 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC nan
3198 205513 76 None -1698 34 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL1201049 205513 76 None -1698 34 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL808 205513 76 None -1698 34 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
9951544 57376 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 375 3 0 5 3.8 Cc1nc2ccccn2c(=O)c1CCN1CCc2sc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL165181 57376 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 375 3 0 5 3.8 Cc1nc2ccccn2c(=O)c1CCN1CCc2sc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
10198532 207696 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 232 4 3 4 0.5 CNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL95523 207696 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 232 4 3 4 0.5 CNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
11581337 186672 0 None - 3 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 363 6 0 5 3.5 Cn1c(-c2ccc(OCCCN3CCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
CHEMBL488248 186672 0 None - 3 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 363 6 0 5 3.5 Cn1c(-c2ccc(OCCCN3CCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
CHEMBL557214 186672 0 None - 3 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 363 6 0 5 3.5 Cn1c(-c2ccc(OCCCN3CCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
2351 3286 64 None -138 21 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
2820 3286 64 None -138 21 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
5035 3286 64 None -138 21 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
CHEMBL81 3286 64 None -138 21 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
DB00481 3286 64 None -138 21 Rat 5.7 pIC50 = 5.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
1016 3747 78 None -1737 35 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2561 3747 78 None -1737 35 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2733526 3747 78 None -1737 35 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
5384 3747 78 None -1737 35 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
CHEMBL83 3747 78 None -1737 35 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
DB00675 3747 78 None -1737 35 Rat 4.7 pIC50 = 4.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
44329797 108106 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 261 5 2 5 1.7 CC(C)OC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL319553 108106 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 261 5 2 5 1.7 CC(C)OC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
135 2532 43 None -46 58 Rat 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
1796 2532 43 None -46 58 Rat 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
4184 2532 43 None -46 58 Rat 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
CHEMBL6437 2532 43 None -46 58 Rat 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
DB06148 2532 43 None -46 58 Rat 6.7 pIC50 = 6.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
85469870 136650 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 439 6 0 4 4.2 Cc1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
CHEMBL3740042 136650 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 439 6 0 4 4.2 Cc1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
85469934 136735 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 443 6 0 4 4.0 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(F)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3740847 136735 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 443 6 0 4 4.0 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(F)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
10834872 15565 0 None - 0 Rat 7.6 pIC50 = 7.6 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 400 6 1 3 3.9 CN(CCN1CCNC1=O)Cc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
CHEMBL122018 15565 0 None - 0 Rat 7.6 pIC50 = 7.6 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 400 6 1 3 3.9 CN(CCN1CCNC1=O)Cc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
1588 2325 27 None -26 44 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
28864 2325 27 None -26 44 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
43 2325 27 None -26 44 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
CHEMBL157138 2325 27 None -26 44 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
DB00589 2325 27 None -26 44 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
10047772 36671 0 None - 0 Rat 7.6 pIC50 = 7.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 420 5 1 3 4.4 Cc1cccc2c(-c3ccc(F)cc3)cn(C3CCN(CCN4CCNC4=O)CC3)c12 10.1021/jm00104a007
CHEMBL144901 36671 0 None - 0 Rat 7.6 pIC50 = 7.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 420 5 1 3 4.4 Cc1cccc2c(-c3ccc(F)cc3)cn(C3CCN(CCN4CCNC4=O)CC3)c12 10.1021/jm00104a007
44573821 192733 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 503 6 0 2 6.8 Cc1ccc(N(C(=O)N(C)CCCN2CCC3(CCc4ccccc43)CC2)c2ccc(F)c(F)c2)cc1 10.1016/j.bmcl.2009.04.016
CHEMBL522037 192733 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 503 6 0 2 6.8 Cc1ccc(N(C(=O)N(C)CCCN2CCC3(CCc4ccccc43)CC2)c2ccc(F)c(F)c2)cc1 10.1016/j.bmcl.2009.04.016
3082597 99559 8 None - 1 Bovine 5.6 pIC50 = 5.6 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 263 6 0 3 3.1 CCCN(CCC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL283606 99559 8 None - 1 Bovine 5.6 pIC50 = 5.6 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 263 6 0 3 3.1 CCCN(CCC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
11753909 18968 0 None - 0 Bovine 5.6 pIC50 = 5.6 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 458 5 2 8 2.5 CS(=O)(=O)Nc1ccc2c(c1)C(O)CC1(CCN(CCc3ccc4nonc4c3)CC1)O2 10.1021/jm00099a028
CHEMBL1203301 18968 0 None - 0 Bovine 5.6 pIC50 = 5.6 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 458 5 2 8 2.5 CS(=O)(=O)Nc1ccc2c(c1)C(O)CC1(CCN(CCc3ccc4nonc4c3)CC1)O2 10.1021/jm00099a028
CHEMBL128745 18968 0 None - 0 Bovine 5.6 pIC50 = 5.6 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 458 5 2 8 2.5 CS(=O)(=O)Nc1ccc2c(c1)C(O)CC1(CCN(CCc3ccc4nonc4c3)CC1)O2 10.1021/jm00099a028
9845791 119231 4 None - 0 Rat 5.6 pIC50 = 5.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 434 5 1 3 4.7 Cc1ccc2c(c1)c(-c1ccc(F)cc1)c(C)n2C1CCN(CCN2CCNC2=O)CC1 10.1021/jm00104a007
CHEMBL343444 119231 4 None - 0 Rat 5.6 pIC50 = 5.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 434 5 1 3 4.7 Cc1ccc2c(c1)c(-c1ccc(F)cc1)c(C)n2C1CCN(CCN2CCNC2=O)CC1 10.1021/jm00104a007
44376954 55740 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 387 3 0 5 4.0 Cc1cc(C)n2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc2c1 10.1016/s0960-894x(99)00591-0
CHEMBL162232 55740 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 387 3 0 5 4.0 Cc1cc(C)n2c(=O)c(CCN3CCc4oc5ccccc5c4C3)c(C)nc2c1 10.1016/s0960-894x(99)00591-0
2247 505 81 None -5 42 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
249 505 81 None -5 42 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
2603 505 81 None -5 42 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
CHEMBL296419 505 81 None -5 42 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
DB00637 505 81 None -5 42 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
1212 1662 50 None -19 65 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
204 1662 50 None -19 65 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
3372 1662 50 None -19 65 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
CHEMBL726 1662 50 None -19 65 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
DB00623 1662 50 None -19 65 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
3584 3777 64 None -2 13 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
5401 3777 64 None -2 13 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
7302 3777 64 None -2 13 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
CHEMBL611 3777 64 None -2 13 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
DB01162 3777 64 None -2 13 Rat 7.6 pIC50 = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
9931837 119173 4 None - 0 Rat 7.6 pIC50 = 7.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 418 5 1 3 4.3 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2C1=CCN(CCN2CCNC2=O)CC1 10.1021/jm00104a007
CHEMBL343034 119173 4 None - 0 Rat 7.6 pIC50 = 7.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 418 5 1 3 4.3 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2C1=CCN(CCN2CCNC2=O)CC1 10.1021/jm00104a007
44563063 186025 0 None - 1 Human 5.6 pIC50 = 5.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 439 7 0 5 5.3 O=c1c2ccccc2nc(-c2ccc(OCCCN3CCCCC3)cc2)n1-c1ccccc1 10.1016/j.bmcl.2008.10.034
CHEMBL487060 186025 0 None - 1 Human 5.6 pIC50 = 5.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 439 7 0 5 5.3 O=c1c2ccccc2nc(-c2ccc(OCCCN3CCCCC3)cc2)n1-c1ccccc1 10.1016/j.bmcl.2008.10.034
277 1301 62 None -117 50 Rat 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
2913 1301 62 None -117 50 Rat 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
765 1301 62 None -117 50 Rat 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
CHEMBL516 1301 62 None -117 50 Rat 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
DB00434 1301 62 None -117 50 Rat 6.6 pIC50 = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
44376900 56268 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 375 3 1 6 3.1 Cc1nc2c(O)cccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL162826 56268 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 375 3 1 6 3.1 Cc1nc2c(O)cccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
11292933 56394 45 None - 9 Rat 7.6 pIC50 = 7.6 Binding
Inhibition of rat adrenergic alpha1A receptorInhibition of rat adrenergic alpha1A receptor
ChEMBL 415 5 1 4 3.4 Cc1ccc2c(N3CCN(CCc4cccc(N5CCNC5=O)c4)CC3)cccc2n1 10.1021/jm100714c
CHEMBL1631540 56394 45 None - 9 Rat 7.6 pIC50 = 7.6 Binding
Inhibition of rat adrenergic alpha1A receptorInhibition of rat adrenergic alpha1A receptor
ChEMBL 415 5 1 4 3.4 Cc1ccc2c(N3CCN(CCc4cccc(N5CCNC5=O)c4)CC3)cccc2n1 10.1021/jm100714c
22493258 98664 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibitory concentration against radioligand binding to human Alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cellsInhibitory concentration against radioligand binding to human Alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cells
ChEMBL 241 4 3 4 1.5 c1ccc(-c2cc[nH]n2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(03)00050-7
CHEMBL277375 98664 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibitory concentration against radioligand binding to human Alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cellsInhibitory concentration against radioligand binding to human Alpha-1A adrenergic receptor, expressed in rat 1 fibroblast cells
ChEMBL 241 4 3 4 1.5 c1ccc(-c2cc[nH]n2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(03)00050-7
73603034 125952 29 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at alpha 1a adrenergic receptor (unknown origin)Antagonist activity at alpha 1a adrenergic receptor (unknown origin)
ChEMBL 465 4 3 8 2.9 Cn1ncc(NC(=O)c2nc(-c3c(F)cccc3F)sc2N)c1N1CC[C@@H](N)[C@H](F)CC1 10.1021/acs.jmedchem.8b01857
CHEMBL3648680 125952 29 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at alpha 1a adrenergic receptor (unknown origin)Antagonist activity at alpha 1a adrenergic receptor (unknown origin)
ChEMBL 465 4 3 8 2.9 Cn1ncc(NC(=O)c2nc(-c3c(F)cccc3F)sc2N)c1N1CC[C@@H](N)[C@H](F)CC1 10.1021/acs.jmedchem.8b01857
44376993 56484 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 427 3 0 5 4.7 Cc1nc2c(Cl)cc(Cl)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL163247 56484 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 427 3 0 5 4.7 Cc1nc2c(Cl)cc(Cl)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
14739954 109110 0 None - 0 Rat 6.6 pIC50 = 6.6 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 325 4 1 2 3.8 CN(C)CC(c1ccccc1Br)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL321364 109110 0 None - 0 Rat 6.6 pIC50 = 6.6 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 325 4 1 2 3.8 CN(C)CC(c1ccccc1Br)C1(O)CCCCC1 10.1021/jm00172a035
3191 102858 97 None -204 25 Rat 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 nan
CHEMBL305660 102858 97 None -204 25 Rat 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 nan
2812 4779 101 None -2238 34 Rat 4.6 pIC50 = 4.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
CHEMBL104 4779 101 None -2238 34 Rat 4.6 pIC50 = 4.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
10341964 33070 0 None - 0 Rat 7.6 pIC50 = 7.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 418 5 1 3 4.3 Cc1cccc2c(-c3ccc(F)cc3)cn(C3=CCN(CCN4CCNC4=O)CC3)c12 10.1021/jm00104a007
CHEMBL141667 33070 0 None - 0 Rat 7.6 pIC50 = 7.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 418 5 1 3 4.3 Cc1cccc2c(-c3ccc(F)cc3)cn(C3=CCN(CCN4CCNC4=O)CC3)c12 10.1021/jm00104a007
44269124 28818 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 252 4 1 3 2.7 c1ccc(-c2ccccc2OCC2=NCCN2)cc1 10.1016/s0960-894x(01)00764-8
CHEMBL13789 28818 1 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 252 4 1 3 2.7 c1ccc(-c2ccccc2OCC2=NCCN2)cc1 10.1016/s0960-894x(01)00764-8
10427137 36050 4 None -1 2 Rat 5.6 pIC50 = 5.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 336 2 0 2 5.3 Cc1ccc2c(c1)c(-c1ccc(F)cc1)c(C)n2C1CCN(C)CC1 10.1021/jm00104a007
CHEMBL144362 36050 4 None -1 2 Rat 5.6 pIC50 = 5.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 336 2 0 2 5.3 Cc1ccc2c(c1)c(-c1ccc(F)cc1)c(C)n2C1CCN(C)CC1 10.1021/jm00104a007
127046693 139667 0 None -2 2 Human 5.6 pIC50 = 5.6 Binding
Selectivity interaction (Binding assay) EUB0000341aCl ADRA1ASelectivity interaction (Binding assay) EUB0000341aCl ADRA1A
ChEMBL 300 3 2 4 2.2 C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N 10.6019/CHEMBL5212743
CHEMBL3797887 139667 0 None -2 2 Human 5.6 pIC50 = 5.6 Binding
Selectivity interaction (Binding assay) EUB0000341aCl ADRA1ASelectivity interaction (Binding assay) EUB0000341aCl ADRA1A
ChEMBL 300 3 2 4 2.2 C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N 10.6019/CHEMBL5212743
CHEMBL4762646 139667 0 None -2 2 Human 5.6 pIC50 = 5.6 Binding
Selectivity interaction (Binding assay) EUB0000341aCl ADRA1ASelectivity interaction (Binding assay) EUB0000341aCl ADRA1A
ChEMBL 300 3 2 4 2.2 C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N 10.6019/CHEMBL5212743
1935 3734 97 None -190 6 Rat 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 nan
2551 3734 97 None -190 6 Rat 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 nan
6687 3734 97 None -190 6 Rat 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 nan
CHEMBL95 3734 97 None -190 6 Rat 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 nan
DB00382 3734 97 None -190 6 Rat 5.6 pIC50 = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 nan
45485062 197168 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 367 5 2 5 3.3 Cc1cccc(C(=O)N[C@H]2CC[C@@H](Nc3ncc(C)c(N(C)C)n3)CC2)c1 10.1016/j.bmcl.2009.09.003
CHEMBL567993 197168 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 367 5 2 5 3.3 Cc1cccc(C(=O)N[C@H]2CC[C@@H](Nc3ncc(C)c(N(C)C)n3)CC2)c1 10.1016/j.bmcl.2009.09.003
9956013 37637 4 None - 0 Rat 6.6 pIC50 = 6.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 462 6 0 3 5.5 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2C1CCN(CCN2CCN(C(C)C)C2=O)CC1 10.1021/jm00104a007
CHEMBL145712 37637 4 None - 0 Rat 6.6 pIC50 = 6.6 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 462 6 0 3 5.5 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2C1CCN(CCN2CCN(C(C)C)C2=O)CC1 10.1021/jm00104a007
44377007 57148 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 393 3 0 5 4.0 Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3c(Cl)cccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL164612 57148 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 393 3 0 5 4.0 Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3c(Cl)cccc3c2C1 10.1016/s0960-894x(99)00591-0
9795167 107494 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 260 6 3 4 1.2 CCCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
CHEMBL318544 107494 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 260 6 3 4 1.2 CCCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(02)00753-9
10399043 120162 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 232 5 2 5 1.1 CO/N=C/c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
CHEMBL351542 120162 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 232 5 2 5 1.1 CO/N=C/c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00822-8
3151 1462 97 None -147 27 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
945 1462 97 None -147 27 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
965 1462 97 None -147 27 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
CHEMBL219916 1462 97 None -147 27 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
DB01184 1462 97 None -147 27 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
22120322 55921 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1ccc2nc(C)c(CCN3CCc4oc5ccccc5c4C3)c(=O)n2c1 10.1016/s0960-894x(99)00591-0
CHEMBL162370 55921 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1ccc2nc(C)c(CCN3CCc4oc5ccccc5c4C3)c(=O)n2c1 10.1016/s0960-894x(99)00591-0
12575 1988 30 None - 17 Human 5.5 pIC50 = 5.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/s0960-894x(99)00591-0
54459 1988 30 None - 17 Human 5.5 pIC50 = 5.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/s0960-894x(99)00591-0
CHEMBL10316 1988 30 None - 17 Human 5.5 pIC50 = 5.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1016/s0960-894x(99)00591-0
11516386 186031 0 None - 1 Human 5.5 pIC50 = 5.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 377 6 0 5 3.9 Cn1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
CHEMBL487064 186031 0 None - 1 Human 5.5 pIC50 = 5.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 377 6 0 5 3.9 Cn1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
2435 3590 83 None - 48 Rat 8.5 pIC50 = 8.5 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm960159f
60149 3590 83 None - 48 Rat 8.5 pIC50 = 8.5 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm960159f
98 3590 83 None - 48 Rat 8.5 pIC50 = 8.5 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm960159f
CHEMBL12713 3590 83 None - 48 Rat 8.5 pIC50 = 8.5 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm960159f
DB06144 3590 83 None - 48 Rat 8.5 pIC50 = 8.5 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm960159f
2435 3590 83 None - 48 Rat 8.5 pIC50 = 8.5 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm00104a007
60149 3590 83 None - 48 Rat 8.5 pIC50 = 8.5 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm00104a007
98 3590 83 None - 48 Rat 8.5 pIC50 = 8.5 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm00104a007
CHEMBL12713 3590 83 None - 48 Rat 8.5 pIC50 = 8.5 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm00104a007
DB06144 3590 83 None - 48 Rat 8.5 pIC50 = 8.5 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm00104a007
56961460 121438 0 None - 1 Human 8.4 pIC50 = 8.4 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 477 4 2 10 2.0 COc1cc2nc(N3CCN(C(=O)c4cc5ccc(O)cc5oc4=O)CC3)nc(N)c2cc1OC 10.1021/ml5004298
CHEMBL3582268 121438 0 None - 1 Human 8.4 pIC50 = 8.4 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 477 4 2 10 2.0 COc1cc2nc(N3CCN(C(=O)c4cc5ccc(O)cc5oc4=O)CC3)nc(N)c2cc1OC 10.1021/ml5004298
10809238 201141 0 None - 0 Bovine 7.5 pIC50 = 7.5 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 371 4 0 5 3.1 Cn1c(=O)sc2cc(CCN3CCN(c4ccc(F)cc4)CC3)ccc21 10.1021/jm970298c
CHEMBL60318 201141 0 None - 0 Bovine 7.5 pIC50 = 7.5 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 371 4 0 5 3.1 Cn1c(=O)sc2cc(CCN3CCN(c4ccc(F)cc4)CC3)ccc21 10.1021/jm970298c
10501785 202728 0 None - 0 Bovine 7.5 pIC50 = 7.5 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 411 7 0 6 3.8 COc1ccccc1N1CCN(CCCCc2ccc3c(c2)sc(=O)n3C)CC1 10.1021/jm970298c
CHEMBL61819 202728 0 None - 0 Bovine 7.5 pIC50 = 7.5 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 411 7 0 6 3.8 COc1ccccc1N1CCN(CCCCc2ccc3c(c2)sc(=O)n3C)CC1 10.1021/jm970298c
10718277 203262 0 None - 0 Bovine 7.5 pIC50 = 7.5 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 447 6 0 4 4.2 CN1C(=O)COc2cc(CCCCN3CCN(c4cccc(C(F)(F)F)c4)CC3)ccc21 10.1021/jm970298c
CHEMBL64610 203262 0 None - 0 Bovine 7.5 pIC50 = 7.5 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 447 6 0 4 4.2 CN1C(=O)COc2cc(CCCCN3CCN(c4cccc(C(F)(F)F)c4)CC3)ccc21 10.1021/jm970298c
85469932 136786 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 455 7 0 5 3.9 COc1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
CHEMBL3741318 136786 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 455 7 0 5 3.9 COc1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
1305 511 14 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 425 5 2 5 4.1 O=C(c1ccc(c(c1)F)F)N[C@@H]1CC[C@@H](CC1)Nc1nc2ccccc2c(n1)N(C)C 10.1016/j.bmcl.2009.09.003
9934033 511 14 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 425 5 2 5 4.1 O=C(c1ccc(c(c1)F)F)N[C@@H]1CC[C@@H](CC1)Nc1nc2ccccc2c(n1)N(C)C 10.1016/j.bmcl.2009.09.003
CHEMBL182150 511 14 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 425 5 2 5 4.1 O=C(c1ccc(c(c1)F)F)N[C@@H]1CC[C@@H](CC1)Nc1nc2ccccc2c(n1)N(C)C 10.1016/j.bmcl.2009.09.003
138753277 177295 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition of adrenergic receptor alpha1a (unknown origin)Inhibition of adrenergic receptor alpha1a (unknown origin)
ChEMBL 303 1 2 3 3.3 Cc1cc(Br)c(NC2=NCCN2)c2ccccc12 10.1021/acs.jmedchem.9b01870
CHEMBL4636550 177295 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibition of adrenergic receptor alpha1a (unknown origin)Inhibition of adrenergic receptor alpha1a (unknown origin)
ChEMBL 303 1 2 3 3.3 Cc1cc(Br)c(NC2=NCCN2)c2ccccc12 10.1021/acs.jmedchem.9b01870
13520336 4351 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 291 5 1 3 3.4 COc1ccc(C(CN(C)C)C2(O)CCCCCC2)cc1 10.1021/jm00172a035
CHEMBL101056 4351 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 291 5 1 3 3.4 COc1ccc(C(CN(C)C)C2(O)CCCCCC2)cc1 10.1021/jm00172a035
3501942 9465 55 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 263 5 2 3 2.7 CNCC(c1ccc(OC)cc1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL1119 9465 55 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 263 5 2 3 2.7 CNCC(c1ccc(OC)cc1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL1628258 9465 55 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 263 5 2 3 2.7 CNCC(c1ccc(OC)cc1)C1(O)CCCCC1 10.1021/jm00172a035
13520306 208235 12 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 247 4 1 2 3.0 CN(C)CC(c1ccccc1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL98660 208235 12 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 247 4 1 2 3.0 CN(C)CC(c1ccccc1)C1(O)CCCCC1 10.1021/jm00172a035
10251234 11245 0 None - 0 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL1178932 11245 0 None - 0 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL50530 11245 0 None - 0 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10476735 13731 0 None - 0 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 411 9 0 7 3.5 CCCN(CCCCn1c(=O)oc2cccnc21)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL1195096 13731 0 None - 0 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 411 9 0 7 3.5 CCCN(CCCCn1c(=O)oc2cccnc21)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL553833 13731 0 None - 0 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 411 9 0 7 3.5 CCCN(CCCCn1c(=O)oc2cccnc21)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
9981024 96097 0 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 446 11 1 5 3.8 CCCN(CCCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL26018 96097 0 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 446 11 1 5 3.8 CCCN(CCCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL300735 96097 0 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 446 11 1 5 3.8 CCCN(CCCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
9980269 99083 0 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 432 10 1 5 3.4 CCCN(CCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL280586 99083 0 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 432 10 1 5 3.4 CCCN(CCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL54266 99083 0 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 432 10 1 5 3.4 CCCN(CCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10342423 99469 0 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 426 11 1 5 3.9 CCCN(CCCCNC(=O)c1ccccc1OC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL28312 99469 0 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 426 11 1 5 3.9 CCCN(CCCCNC(=O)c1ccccc1OC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL48925 99469 0 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 426 11 1 5 3.9 CCCN(CCCCNC(=O)c1ccccc1OC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10366072 116897 0 None - 0 Bovine 5.5 pIC50 = 5.5 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 442 5 1 7 3.0 CS(=O)(=O)Nc1ccc2c(c1)CCC1(CCN(CCc3ccc4nonc4c3)CC1)O2 10.1021/jm00099a028
CHEMBL1203300 116897 0 None - 0 Bovine 5.5 pIC50 = 5.5 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 442 5 1 7 3.0 CS(=O)(=O)Nc1ccc2c(c1)CCC1(CCN(CCc3ccc4nonc4c3)CC1)O2 10.1021/jm00099a028
CHEMBL338361 116897 0 None - 0 Bovine 5.5 pIC50 = 5.5 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 442 5 1 7 3.0 CS(=O)(=O)Nc1ccc2c(c1)CCC1(CCN(CCc3ccc4nonc4c3)CC1)O2 10.1021/jm00099a028
23027245 197128 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 387 5 2 5 3.7 Cc1cc(N(C)C)nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(Cl)cc3)CC2)n1 10.1016/j.bmcl.2009.09.003
CHEMBL567791 197128 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 387 5 2 5 3.7 Cc1cc(N(C)C)nc(N[C@H]2CC[C@@H](NC(=O)c3ccc(Cl)cc3)CC2)n1 10.1016/j.bmcl.2009.09.003
1220 187 55 None - 44 Bovine 4.5 pIC50 = 4.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm00038a007
31 187 55 None - 44 Bovine 4.5 pIC50 = 4.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm00038a007
7 187 55 None - 44 Bovine 4.5 pIC50 = 4.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm00038a007
CHEMBL56 187 55 None - 44 Bovine 4.5 pIC50 = 4.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm00038a007
44343257 10500 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 250 4 1 2 3.7 c1ccc(-c2ccccc2OCc2c[nH]cn2)cc1 10.1016/s0960-894x(02)00753-9
CHEMBL116700 10500 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 250 4 1 2 3.7 c1ccc(-c2ccccc2OCc2c[nH]cn2)cc1 10.1016/s0960-894x(02)00753-9
1971 2866 38 None -24 30 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
2404 2866 38 None -24 30 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
4543 2866 38 None -24 30 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
CHEMBL445 2866 38 None -24 30 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
DB00540 2866 38 None -24 30 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
10497675 16097 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 344 6 0 2 5.3 CN(C)CCCCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
CHEMBL122384 16097 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 344 6 0 2 5.3 CN(C)CCCCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
1816 2540 102 None - 18 Human 5.5 pIC50 = 5.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1016/s0960-894x(99)00591-0
4205 2540 102 None - 18 Human 5.5 pIC50 = 5.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1016/s0960-894x(99)00591-0
7241 2540 102 None - 18 Human 5.5 pIC50 = 5.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1016/s0960-894x(99)00591-0
CHEMBL654 2540 102 None - 18 Human 5.5 pIC50 = 5.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1016/s0960-894x(99)00591-0
DB00370 2540 102 None - 18 Human 5.5 pIC50 = 5.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 10.1016/s0960-894x(99)00591-0
10499570 16932 0 None - 0 Rat 7.5 pIC50 = 7.5 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 372 5 0 3 5.3 Fc1ccc(-n2cc(OCCN3CCCCC3)c3cc(Cl)ccc32)cc1 10.1021/jm960159f
CHEMBL125291 16932 0 None - 0 Rat 7.5 pIC50 = 7.5 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 372 5 0 3 5.3 Fc1ccc(-n2cc(OCCN3CCCCC3)c3cc(Cl)ccc32)cc1 10.1021/jm960159f
2274 3173 58 None -6 31 Rat 7.5 pIC50 = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
4917 3173 58 None -6 31 Rat 7.5 pIC50 = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
7279 3173 58 None -6 31 Rat 7.5 pIC50 = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
CHEMBL728 3173 58 None -6 31 Rat 7.5 pIC50 = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
DB00433 3173 58 None -6 31 Rat 7.5 pIC50 = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
44362195 121089 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 241 4 2 3 2.1 c1c[nH]c(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL357129 121089 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 241 4 2 3 2.1 c1c[nH]c(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
85469812 136686 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 469 8 0 5 4.2 CCOc1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
CHEMBL3740351 136686 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 469 8 0 5 4.2 CCOc1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
15987265 196887 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 503 6 2 5 5.3 Cc1cnc(N[C@H]2CC[C@@H](CNC(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
CHEMBL566075 196887 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 503 6 2 5 5.3 Cc1cnc(N[C@H]2CC[C@@H](CNC(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
196129 67798 17 None -1698 15 Rat 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 917 13 4 16 4.3 CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC nan
CHEMBL1909065 67798 17 None -1698 15 Rat 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 917 13 4 16 4.3 CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC nan
10409893 119116 0 None - 0 Rat 7.5 pIC50 = 7.5 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 420 5 1 3 4.4 Cc1cccc2c1c(-c1ccc(F)cc1)cn2C1CCN(CCN2CCNC2=O)CC1 10.1021/jm00104a007
CHEMBL342730 119116 0 None - 0 Rat 7.5 pIC50 = 7.5 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 420 5 1 3 4.4 Cc1cccc2c1c(-c1ccc(F)cc1)cn2C1CCN(CCN2CCNC2=O)CC1 10.1021/jm00104a007
85469930 136874 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 473 6 0 4 4.8 Cc1ccc(Cl)cc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
CHEMBL3742103 136874 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 473 6 0 4 4.8 Cc1ccc(Cl)cc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
10060965 35234 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 256 4 1 4 2.6 Cc1ccoc1-c1ccccc1OCC1=NCCN1 10.1016/s0960-894x(01)00764-8
CHEMBL143562 35234 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 256 4 1 4 2.6 Cc1ccoc1-c1ccccc1OCC1=NCCN1 10.1016/s0960-894x(01)00764-8
506 2252 39 None -97 5 Rat 6.5 pIC50 = 6.5 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the rat prostate Alpha-1A adrenergic receptor subtype.Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the rat prostate Alpha-1A adrenergic receptor subtype.
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
6603904 2252 39 None -97 5 Rat 6.5 pIC50 = 6.5 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the rat prostate Alpha-1A adrenergic receptor subtype.Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the rat prostate Alpha-1A adrenergic receptor subtype.
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
CHEMBL19476 2252 39 None -97 5 Rat 6.5 pIC50 = 6.5 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the rat prostate Alpha-1A adrenergic receptor subtype.Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the rat prostate Alpha-1A adrenergic receptor subtype.
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
44574357 178707 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 471 6 1 2 6.4 Cc1ccc(N(C(=O)NCCCN2CCC3(CCc4ccccc43)CC2)c2ccc(F)cc2)cc1 10.1016/j.bmcl.2009.04.016
CHEMBL468298 178707 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 471 6 1 2 6.4 Cc1ccc(N(C(=O)NCCCN2CCC3(CCc4ccccc43)CC2)c2ccc(F)cc2)cc1 10.1016/j.bmcl.2009.04.016
85469753 136761 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 503 6 0 4 4.6 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(Br)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3741079 136761 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 503 6 0 4 4.6 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(Br)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
3045401 56059 32 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 359 3 0 5 3.4 Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL162501 56059 32 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 359 3 0 5 3.4 Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
2477 745 59 None -218 29 Rat 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 nan
36 745 59 None -218 29 Rat 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 nan
437 745 59 None -218 29 Rat 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 nan
CHEMBL49 745 59 None -218 29 Rat 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 nan
DB00490 745 59 None -218 29 Rat 5.5 pIC50 = 5.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 nan
127049862 140257 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 425 8 1 5 4.4 CNC(=O)c1cccc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1 10.1016/j.bmcl.2016.04.087
CHEMBL3805559 140257 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assayAntagonistic activity at alpha-1A adrenergic receptor (unknown origin) after 10 mins by FLIPR assay
ChEMBL 425 8 1 5 4.4 CNC(=O)c1cccc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1 10.1016/j.bmcl.2016.04.087
22493280 48275 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 242 4 2 5 1.8 c1ccc(-c2ccno2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
CHEMBL155327 48275 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 242 4 2 5 1.8 c1ccc(-c2ccno2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
44573820 193268 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 489 6 1 2 6.5 Cc1ccc(N(C(=O)NCCCN2CCC3(CCc4ccccc43)CC2)c2ccc(F)c(F)c2)cc1 10.1016/j.bmcl.2009.04.016
CHEMBL523882 193268 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 489 6 1 2 6.5 Cc1ccc(N(C(=O)NCCCN2CCC3(CCc4ccccc43)CC2)c2ccc(F)c(F)c2)cc1 10.1016/j.bmcl.2009.04.016
3082597 99559 8 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 263 6 0 3 3.1 CCCN(CCC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL283606 99559 8 None - 1 Bovine 5.5 pIC50 = 5.5 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 263 6 0 3 3.1 CCCN(CCC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
191 403 98 None -107 29 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
201 403 98 None -107 29 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
2170 403 98 None -107 29 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
CHEMBL1113 403 98 None -107 29 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
DB00543 403 98 None -107 29 Rat 6.5 pIC50 = 6.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
3823 50221 42 None -3019 10 Rat 4.5 pIC50 = 4.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
76973198 50221 42 None -3019 10 Rat 4.5 pIC50 = 4.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
CHEMBL157101 50221 42 None -3019 10 Rat 4.5 pIC50 = 4.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
127041710 136616 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 450 6 0 4 4.4 [C-]#[N+]c1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
CHEMBL3739762 136616 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 450 6 0 4 4.4 [C-]#[N+]c1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
10403428 208397 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 315 4 1 2 4.0 CN(C)CC(c1cccc(C(F)(F)F)c1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL99653 208397 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 315 4 1 2 4.0 CN(C)CC(c1cccc(C(F)(F)F)c1)C1(O)CCCCC1 10.1021/jm00172a035
45484995 198519 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 403 6 2 5 3.5 Cc1cnc(N[C@H]2CC[C@@H](CNC(=O)c3ccc(F)c(F)c3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
CHEMBL577904 198519 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 403 6 2 5 3.5 Cc1cnc(N[C@H]2CC[C@@H](CNC(=O)c3ccc(F)c(F)c3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
44573931 187452 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 479 7 0 4 5.6 CN(CCCC1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)n1cccn1 10.1016/j.bmcl.2009.04.016
CHEMBL493962 187452 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 479 7 0 4 5.6 CN(CCCC1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccc(F)c(F)c1)n1cccn1 10.1016/j.bmcl.2009.04.016
146431 208276 1 None - 0 Rat 7.4 pIC50 = 7.4 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 315 4 1 2 4.3 CN(C)CC(c1ccc(Cl)c(Cl)c1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL98894 208276 1 None - 0 Rat 7.4 pIC50 = 7.4 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 315 4 1 2 4.3 CN(C)CC(c1ccc(Cl)c(Cl)c1)C1(O)CCCCC1 10.1021/jm00172a035
2803 955 58 None -3 19 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
516 955 58 None -3 19 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
704 955 58 None -3 19 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
CHEMBL134 955 58 None -3 19 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
DB00575 955 58 None -3 19 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
135398737 958 93 None -5 89 Rat 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
38 958 93 None -5 89 Rat 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
722 958 93 None -5 89 Rat 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
CHEMBL42 958 93 None -5 89 Rat 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
DB00363 958 93 None -5 89 Rat 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
124 2981 47 None -13 33 Rat 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
2032 2981 47 None -13 33 Rat 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
4636 2981 47 None -13 33 Rat 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
CHEMBL762 2981 47 None -13 33 Rat 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
DB00935 2981 47 None -13 33 Rat 7.4 pIC50 = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
85469873 136592 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 493 6 0 4 4.9 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccc3C(F)(F)F)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3739542 136592 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 493 6 0 4 4.9 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccc3C(F)(F)F)CC2)cc1 10.1016/j.bmc.2015.11.020
3952 1888 38 None -26 12 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5353646 1888 38 None -26 12 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5443 1888 38 None -26 12 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5702063 1888 38 None -26 12 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
CHEMBL1331786 1888 38 None -26 12 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
CHEMBL420 1888 38 None -26 12 Rat 6.4 pIC50 = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
10108561 112944 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity against Alpha-1A adrenergic receptorBinding affinity against Alpha-1A adrenergic receptor
ChEMBL 295 2 0 4 2.8 CN(C)CC1CC2c3ccccc3Cc3ccncc3N2O1 10.1016/s0960-894x(02)00796-5
CHEMBL331077 112944 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity against Alpha-1A adrenergic receptorBinding affinity against Alpha-1A adrenergic receptor
ChEMBL 295 2 0 4 2.8 CN(C)CC1CC2c3ccccc3Cc3ccncc3N2O1 10.1016/s0960-894x(02)00796-5
44376923 56427 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1nc2cccc(C)n2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL163190 56427 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1nc2cccc(C)n2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
137399257 162450 0 None - 0 Rat 8.4 pIC50 = 8.4 Binding
Displacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysisDisplacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysis
ChEMBL 513 8 1 8 3.7 COc1cc2nc(N3CCN(C(=O)Cc4ccc(OCc5ccccc5)cc4)CC3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.10.026
CHEMBL4166644 162450 0 None - 0 Rat 8.4 pIC50 = 8.4 Binding
Displacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysisDisplacement of [3H]-prazosin from rat alpha1A adrenergic receptor after 60 mins by scintillation counting analysis
ChEMBL 513 8 1 8 3.7 COc1cc2nc(N3CCN(C(=O)Cc4ccc(OCc5ccccc5)cc4)CC3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.10.026
10734233 113744 0 None - 0 Rat 7.4 pIC50 = 7.4 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 316 4 0 2 4.5 CN(C)CCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
CHEMBL332365 113744 0 None - 0 Rat 7.4 pIC50 = 7.4 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 316 4 0 2 4.5 CN(C)CCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
10717072 163243 0 None - 0 Bovine 6.4 pIC50 = 6.4 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 421 4 0 5 4.0 Cn1c(=O)sc2cc(CCN3CCN(c4cccc(C(F)(F)F)c4)CC3)ccc21 10.1021/jm970298c
CHEMBL418499 163243 0 None - 0 Bovine 6.4 pIC50 = 6.4 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 421 4 0 5 4.0 Cn1c(=O)sc2cc(CCN3CCN(c4cccc(C(F)(F)F)c4)CC3)ccc21 10.1021/jm970298c
10527817 113068 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 456 8 0 3 5.0 CC(C)N1CCN(CCN(C)CCc2cn(-c3ccc(F)cc3)c3cc(Cl)ccc23)C1=O 10.1021/jm960159f
CHEMBL331193 113068 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 456 8 0 3 5.0 CC(C)N1CCN(CCN(C)CCc2cn(-c3ccc(F)cc3)c3cc(Cl)ccc23)C1=O 10.1021/jm960159f
10070029 165417 0 None - 1 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 408 8 0 5 3.4 CCCN(CCCN1C(=O)c2ccccc2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL423841 165417 0 None - 1 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 408 8 0 5 3.4 CCCN(CCCN1C(=O)c2ccccc2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL54089 165417 0 None - 1 Bovine 5.4 pIC50 = 5.4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 408 8 0 5 3.4 CCCN(CCCN1C(=O)c2ccccc2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
121852 10166 7 None - 1 Bovine 4.4 pIC50 = 4.4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL11592 10166 7 None - 1 Bovine 4.4 pIC50 = 4.4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL301060 10166 7 None - 1 Bovine 4.4 pIC50 = 4.4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10014217 99748 0 None - 1 Bovine 4.4 pIC50 = 4.4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 233 2 0 3 2.1 COc1cccc2c1CC(N1CCCC1)CO2 10.1021/jm00038a007
CHEMBL285010 99748 0 None - 1 Bovine 4.4 pIC50 = 4.4 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 233 2 0 3 2.1 COc1cccc2c1CC(N1CCCC1)CO2 10.1021/jm00038a007
135 2532 43 None -40 58 Human 6.4 pIC50 = 6.4 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1016/s0960-894x(01)00721-1
1796 2532 43 None -40 58 Human 6.4 pIC50 = 6.4 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1016/s0960-894x(01)00721-1
4184 2532 43 None -40 58 Human 6.4 pIC50 = 6.4 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1016/s0960-894x(01)00721-1
CHEMBL6437 2532 43 None -40 58 Human 6.4 pIC50 = 6.4 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1016/s0960-894x(01)00721-1
DB06148 2532 43 None -40 58 Human 6.4 pIC50 = 6.4 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1016/s0960-894x(01)00721-1
10550615 114586 0 None - 0 Rat 7.4 pIC50 = 7.4 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 430 8 1 4 3.8 CN(CCOc1cn(-c2ccc(F)cc2)c2cc(Cl)ccc12)CCN1CCNC1=O 10.1021/jm960159f
CHEMBL333774 114586 0 None - 0 Rat 7.4 pIC50 = 7.4 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 430 8 1 4 3.8 CN(CCOc1cn(-c2ccc(F)cc2)c2cc(Cl)ccc12)CCN1CCNC1=O 10.1021/jm960159f
44318842 206108 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 308 2 0 3 3.7 Cc1ccc2c(c1)N1OC(CN(C)C)CC1c1ccccc1C2 10.1016/s0960-894x(01)00721-1
CHEMBL85735 206108 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 308 2 0 3 3.7 Cc1ccc2c(c1)N1OC(CN(C)C)CC1c1ccccc1C2 10.1016/s0960-894x(01)00721-1
11517341 173739 0 None - 1 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 419 5 0 6 4.0 COc1cccc2nc(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)n(C)c(=O)c12 10.1016/j.bmcl.2008.10.034
CHEMBL453653 173739 0 None - 1 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 419 5 0 6 4.0 COc1cccc2nc(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)n(C)c(=O)c12 10.1016/j.bmcl.2008.10.034
10812487 15571 0 None - 0 Rat 7.4 pIC50 = 7.4 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 428 8 1 3 4.3 CN(CCCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
CHEMBL122042 15571 0 None - 0 Rat 7.4 pIC50 = 7.4 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 428 8 1 3 4.3 CN(CCCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
10361439 109633 0 None - 1 Human 7.4 pIC50 = 7.4 Binding
Inhibition of alpha 1A adrenergic receptor (unknown origin)Inhibition of alpha 1A adrenergic receptor (unknown origin)
ChEMBL 364 6 0 3 4.7 COc1cccc2c1CCCC2CCCN1CCN(c2ccccc2)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL322275 109633 0 None - 1 Human 7.4 pIC50 = 7.4 Binding
Inhibition of alpha 1A adrenergic receptor (unknown origin)Inhibition of alpha 1A adrenergic receptor (unknown origin)
ChEMBL 364 6 0 3 4.7 COc1cccc2c1CCCC2CCCN1CCN(c2ccccc2)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL5206987 109633 0 None - 1 Human 7.4 pIC50 = 7.4 Binding
Inhibition of alpha 1A adrenergic receptor (unknown origin)Inhibition of alpha 1A adrenergic receptor (unknown origin)
ChEMBL 364 6 0 3 4.7 COc1cccc2c1CCCC2CCCN1CCN(c2ccccc2)CC1 10.1021/acs.jmedchem.2c00633
13520334 112545 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 297 4 1 2 3.0 CN(C)CC(c1ccc(Br)cc1)C1(O)CCC1 10.1021/jm00172a035
CHEMBL329923 112545 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 297 4 1 2 3.0 CN(C)CC(c1ccc(Br)cc1)C1(O)CCC1 10.1021/jm00172a035
44318454 206009 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 312 2 0 3 3.5 CN(C)CC1CC2c3ccccc3Cc3ccc(F)cc3N2O1 10.1016/s0960-894x(01)00721-1
CHEMBL84931 206009 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 312 2 0 3 3.5 CN(C)CC1CC2c3ccccc3Cc3ccc(F)cc3N2O1 10.1016/s0960-894x(01)00721-1
78243717 137350 53 None - 0 Human 6.4 pIC50 = 6.4 Binding
Selectivity interaction (CEREP panel (cellular receptors and 30 other enzymes)) EUB0000199c ADRA1ASelectivity interaction (CEREP panel (cellular receptors and 30 other enzymes)) EUB0000199c ADRA1A
ChEMBL 321 4 1 5 2.4 O=C(/C=C/N1C[C@H]2C[C@@H]1CN2c1ccccn1)c1ccccc1O 10.6019/CHEMBL5212743
CHEMBL3752911 137350 53 None - 0 Human 6.4 pIC50 = 6.4 Binding
Selectivity interaction (CEREP panel (cellular receptors and 30 other enzymes)) EUB0000199c ADRA1ASelectivity interaction (CEREP panel (cellular receptors and 30 other enzymes)) EUB0000199c ADRA1A
ChEMBL 321 4 1 5 2.4 O=C(/C=C/N1C[C@H]2C[C@@H]1CN2c1ccccn1)c1ccccc1O 10.6019/CHEMBL5212743
10789000 203318 0 None - 0 Bovine 7.4 pIC50 = 7.4 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 435 6 1 5 5.2 Oc1nc2ccc(CCCCN3CCN(c4cccc(C(F)(F)F)c4)CC3)cc2s1 10.1021/jm970298c
CHEMBL64845 203318 0 None - 0 Bovine 7.4 pIC50 = 7.4 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 435 6 1 5 5.2 Oc1nc2ccc(CCCCN3CCN(c4cccc(C(F)(F)F)c4)CC3)cc2s1 10.1021/jm970298c
134142282 145690 0 None - 0 Rat 7.3 pIC50 = 7.3 Binding
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
ChEMBL 348 1 1 4 3.6 COc1ccc2[nH]c3c(c2c1)CC1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL3916182 145690 0 None - 0 Rat 7.3 pIC50 = 7.3 Binding
Antagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 minsAntagonist activity at alpha1A adrenoceptor in Sprague-Dawley rat urethra assessed as inhibition of norepinephrine-induced smooth muscle contraction after 20 mins
ChEMBL 348 1 1 4 3.6 COc1ccc2[nH]c3c(c2c1)CC1c2cc4c(cc2CCN1C3)OCO4 10.1021/acs.jmedchem.6b01217
22493352 48274 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 242 4 2 5 1.8 c1ccc(-c2ncco2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
CHEMBL155326 48274 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 242 4 2 5 1.8 c1ccc(-c2ncco2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
11502381 174144 0 None - 1 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 407 4 0 5 4.1 Cn1c(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)nc2c(F)cccc2c1=O 10.1016/j.bmcl.2008.10.034
CHEMBL454642 174144 0 None - 1 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 407 4 0 5 4.1 Cn1c(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)nc2c(F)cccc2c1=O 10.1016/j.bmcl.2008.10.034
9794803 11006 2 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 242 4 2 5 1.8 c1ccc(-c2cnco2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
CHEMBL117381 11006 2 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 242 4 2 5 1.8 c1ccc(-c2cnco2)c(NCC2=NCCN2)c1 10.1016/s0960-894x(01)00822-8
85469754 136895 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 503 7 0 6 3.3 CS(=O)(=O)c1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
CHEMBL3742276 136895 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 503 7 0 6 3.3 CS(=O)(=O)c1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1 10.1016/j.bmc.2015.11.020
10378649 108593 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 274 7 3 4 1.6 CCCCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL320419 108593 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 274 7 3 4 1.6 CCCCNC(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
5074 3332 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm960159f
97 3332 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm960159f
CHEMBL267777 3332 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm960159f
DB12693 3332 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm960159f
5074 3332 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Compound was tested for i the displacement of [3H]prazosin from alpha-1 adrenergic receptorCompound was tested for i the displacement of [3H]prazosin from alpha-1 adrenergic receptor
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm00104a007
97 3332 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Compound was tested for i the displacement of [3H]prazosin from alpha-1 adrenergic receptorCompound was tested for i the displacement of [3H]prazosin from alpha-1 adrenergic receptor
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm00104a007
CHEMBL267777 3332 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Compound was tested for i the displacement of [3H]prazosin from alpha-1 adrenergic receptorCompound was tested for i the displacement of [3H]prazosin from alpha-1 adrenergic receptor
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm00104a007
DB12693 3332 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Compound was tested for i the displacement of [3H]prazosin from alpha-1 adrenergic receptorCompound was tested for i the displacement of [3H]prazosin from alpha-1 adrenergic receptor
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm00104a007
5074 3332 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Compound was tested for the displacement of [3H]prazosin from alpha-1 adrenergic receptor of rat striatal membranesCompound was tested for the displacement of [3H]prazosin from alpha-1 adrenergic receptor of rat striatal membranes
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm00104a006
97 3332 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Compound was tested for the displacement of [3H]prazosin from alpha-1 adrenergic receptor of rat striatal membranesCompound was tested for the displacement of [3H]prazosin from alpha-1 adrenergic receptor of rat striatal membranes
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm00104a006
CHEMBL267777 3332 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Compound was tested for the displacement of [3H]prazosin from alpha-1 adrenergic receptor of rat striatal membranesCompound was tested for the displacement of [3H]prazosin from alpha-1 adrenergic receptor of rat striatal membranes
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm00104a006
DB12693 3332 80 None - 30 Rat 7.3 pIC50 = 7.3 Binding
Compound was tested for the displacement of [3H]prazosin from alpha-1 adrenergic receptor of rat striatal membranesCompound was tested for the displacement of [3H]prazosin from alpha-1 adrenergic receptor of rat striatal membranes
ChEMBL 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 10.1021/jm00104a006
44573822 187465 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 505 6 0 3 6.4 Cc1ccc(N(C(=O)N(C)CCCN2CCC3(CC2)OCc2ccccc23)c2ccc(F)c(F)c2)cc1 10.1016/j.bmcl.2009.04.016
CHEMBL494009 187465 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 505 6 0 3 6.4 Cc1ccc(N(C(=O)N(C)CCCN2CCC3(CC2)OCc2ccccc23)c2ccc(F)c(F)c2)cc1 10.1016/j.bmcl.2009.04.016
44376984 56223 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 485 3 0 5 4.0 Cc1nc2ccc(I)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL162682 56223 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 485 3 0 5 4.0 Cc1nc2ccc(I)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
85469869 136591 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 426 6 0 5 3.2 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccn3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3739533 136591 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 426 6 0 5 3.2 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccn3)CC2)cc1 10.1016/j.bmc.2015.11.020
44574359 178735 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 471 6 1 2 6.4 Cc1ccc(N(C(=O)NCCCN2CCC3(CCc4ccccc43)CC2)c2cccc(F)c2)cc1 10.1016/j.bmcl.2009.04.016
CHEMBL468509 178735 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 471 6 1 2 6.4 Cc1ccc(N(C(=O)NCCCN2CCC3(CCc4ccccc43)CC2)c2cccc(F)c2)cc1 10.1016/j.bmcl.2009.04.016
10531 1420 21 None -5 23 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
121 1420 21 None -5 23 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
888 1420 21 None -5 23 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
CHEMBL1732 1420 21 None -5 23 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
DB00320 1420 21 None -5 23 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
100 3805 58 None 1 55 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
2637 3805 58 None 1 55 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
5452 3805 58 None 1 55 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
CHEMBL479 3805 58 None 1 55 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
DB00679 3805 58 None 1 55 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
6761 67799 19 None 1 18 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 nan
CHEMBL1909072 67799 19 None 1 18 Rat 8.3 pIC50 = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 nan
9802796 164330 0 None - 0 Rat 8.2 pIC50 = 8.2 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 430 8 1 4 3.8 CN(CCOc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
CHEMBL421244 164330 0 None - 0 Rat 8.2 pIC50 = 8.2 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 430 8 1 4 3.8 CN(CCOc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
44362185 121029 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 253 4 1 4 2.1 c1cncc(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
CHEMBL356605 121029 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Binding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptorBinding affinity of compound towards Alpha-1A adrenergic receptor using membranes prepared from Rat-1 fibroblasts expressing human Alpha-1A adrenergic receptor
ChEMBL 253 4 1 4 2.1 c1cncc(-c2ccccc2OCC2=NCCN2)c1 10.1016/s0960-894x(01)00764-8
10364538 4386 0 None - 1 Bovine 6.3 pIC50 = 6.3 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 415 5 1 6 2.5 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccccn3)CC1)O2 10.1021/jm00099a028
CHEMBL101322 4386 0 None - 1 Bovine 6.3 pIC50 = 6.3 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 415 5 1 6 2.5 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccccn3)CC1)O2 10.1021/jm00099a028
CHEMBL1204312 4386 0 None - 1 Bovine 6.3 pIC50 = 6.3 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligandCompound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor in a filtration-based assay using [3H]prazosin as the radioligand
ChEMBL 415 5 1 6 2.5 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccccn3)CC1)O2 10.1021/jm00099a028
10245637 33134 2 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 323 2 0 3 3.6 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2N1CCN(C)CC1 10.1021/jm00104a007
CHEMBL141721 33134 2 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 323 2 0 3 3.6 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2N1CCN(C)CC1 10.1021/jm00104a007
9885114 119604 5 None -47 12 Rat 6.3 pIC50 = 6.3 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 357 3 1 4 3.0 O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1 10.1021/jm990277d
CHEMBL346389 119604 5 None -47 12 Rat 6.3 pIC50 = 6.3 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 357 3 1 4 3.0 O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1 10.1021/jm990277d
59271992 118048 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition of alpha-adrenoceptor 1A (unknown origin)Inhibition of alpha-adrenoceptor 1A (unknown origin)
ChEMBL 513 13 2 7 3.5 COCCCOc1cc(C(=O)N(C[C@@H]2CNC[C@H]2OC(=O)NCc2ccccc2)C(C)C)ccc1OC 10.1016/j.bmcl.2015.02.040
CHEMBL3403995 118048 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition of alpha-adrenoceptor 1A (unknown origin)Inhibition of alpha-adrenoceptor 1A (unknown origin)
ChEMBL 513 13 2 7 3.5 COCCCOc1cc(C(=O)N(C[C@@H]2CNC[C@H]2OC(=O)NCc2ccccc2)C(C)C)ccc1OC 10.1016/j.bmcl.2015.02.040
10092409 12046 0 None - 0 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 400 9 0 4 3.7 CCCN(CCCCN1CC2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL1183479 12046 0 None - 0 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 400 9 0 4 3.7 CCCN(CCCCN1CC2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL299561 12046 0 None - 0 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 400 9 0 4 3.7 CCCN(CCCCN1CC2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10095594 12368 0 None - 0 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 456 10 0 5 4.6 CCCN(CCCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL1185501 12368 0 None - 0 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 456 10 0 5 4.6 CCCN(CCCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL417550 12368 0 None - 0 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 456 10 0 5 4.6 CCCN(CCCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10251673 99490 0 None - 1 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 422 9 0 5 3.8 CCCN(CCCCN1C(=O)c2ccccc2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL283207 99490 0 None - 1 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 422 9 0 5 3.8 CCCN(CCCCN1C(=O)c2ccccc2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL52396 99490 0 None - 1 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 422 9 0 5 3.8 CCCN(CCCCN1C(=O)c2ccccc2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10338595 162499 0 None - 1 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 360 9 0 4 4.0 CCCN(CCCCN1CCCCC1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL416747 162499 0 None - 1 Bovine 5.3 pIC50 = 5.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 360 9 0 4 4.0 CCCN(CCCCN1CCCCC1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
13520313 107751 0 None - 0 Rat 7.3 pIC50 = 7.3 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 325 4 1 2 3.8 CN(C)CC(c1cccc(Br)c1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL319142 107751 0 None - 0 Rat 7.3 pIC50 = 7.3 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 325 4 1 2 3.8 CN(C)CC(c1cccc(Br)c1)C1(O)CCCCC1 10.1021/jm00172a035
122179431 121443 0 None -1 3 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 585 9 1 13 3.1 CCN(CC)c1ccc2cc(-n3cc(CN4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)nn3)c(=O)oc2c1 10.1021/ml5004298
CHEMBL3582272 121443 0 None -1 3 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 585 9 1 13 3.1 CCN(CC)c1ccc2cc(-n3cc(CN4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)nn3)c(=O)oc2c1 10.1021/ml5004298
132499 107244 8 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 281 4 1 2 3.7 CN(C)CC(c1ccccc1Cl)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL316862 107244 8 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 281 4 1 2 3.7 CN(C)CC(c1ccccc1Cl)C1(O)CCCCC1 10.1021/jm00172a035
44376845 55545 1 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 419 5 0 7 3.4 COc1cc2nc(C)c(CCN3CCc4oc5ccccc5c4C3)c(=O)n2cc1OC 10.1016/s0960-894x(99)00591-0
CHEMBL162058 55545 1 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 419 5 0 7 3.4 COc1cc2nc(C)c(CCN3CCc4oc5ccccc5c4C3)c(=O)n2cc1OC 10.1016/s0960-894x(99)00591-0
26987 949 33 None -75 21 Rat 7.3 pIC50 = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
6063 949 33 None -75 21 Rat 7.3 pIC50 = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
671 949 33 None -75 21 Rat 7.3 pIC50 = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
CHEMBL1626 949 33 None -75 21 Rat 7.3 pIC50 = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
DB00283 949 33 None -75 21 Rat 7.3 pIC50 = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
9904205 205850 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity against Alpha-1A adrenergic receptorBinding affinity against Alpha-1A adrenergic receptor
ChEMBL 294 2 0 3 3.4 CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(02)00796-5
CHEMBL83658 205850 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity against Alpha-1A adrenergic receptorBinding affinity against Alpha-1A adrenergic receptor
ChEMBL 294 2 0 3 3.4 CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(02)00796-5
9904205 205850 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 294 2 0 3 3.4 CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(01)00721-1
CHEMBL83658 205850 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
ChEMBL 294 2 0 3 3.4 CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1 10.1016/s0960-894x(01)00721-1
10432755 113796 0 None - 0 Rat 7.3 pIC50 = 7.3 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 428 8 1 3 4.3 CN(CCCN1CCNC1=O)CCc1cn(-c2ccc(F)cc2)c2cc(Cl)ccc12 10.1021/jm960159f
CHEMBL332425 113796 0 None - 0 Rat 7.3 pIC50 = 7.3 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 428 8 1 3 4.3 CN(CCCN1CCNC1=O)CCc1cn(-c2ccc(F)cc2)c2cc(Cl)ccc12 10.1021/jm960159f
10047887 121049 0 None - 0 Rat 7.3 pIC50 = 7.3 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 422 5 1 3 4.7 CNC(=O)N(C)CCN1CCC(n2cc(-c3ccc(F)cc3)c3cc(C)ccc32)CC1 10.1021/jm00104a007
CHEMBL356799 121049 0 None - 0 Rat 7.3 pIC50 = 7.3 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 422 5 1 3 4.7 CNC(=O)N(C)CCN1CCC(n2cc(-c3ccc(F)cc3)c3cc(C)ccc32)CC1 10.1021/jm00104a007
4452 2762 19 None - 19 Rat 6.3 pIC50 = 6.3 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 387 6 2 4 3.8 COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl 10.1021/jm960159f
983 2762 19 None - 19 Rat 6.3 pIC50 = 6.3 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 387 6 2 4 3.8 COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl 10.1021/jm960159f
CHEMBL20734 2762 19 None - 19 Rat 6.3 pIC50 = 6.3 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 387 6 2 4 3.8 COc1cc(NC)c(cc1C(=O)NC1CCN(C1C)Cc1ccccc1)Cl 10.1021/jm960159f
44574358 178708 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 467 6 1 2 6.5 Cc1ccc(N(C(=O)NCCCN2CCC3(CCc4ccccc43)CC2)c2ccc(C)cc2)cc1 10.1016/j.bmcl.2009.04.016
CHEMBL468299 178708 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 467 6 1 2 6.5 Cc1ccc(N(C(=O)NCCCN2CCC3(CCc4ccccc43)CC2)c2ccc(C)cc2)cc1 10.1016/j.bmcl.2009.04.016
85469872 136805 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 459 6 0 4 4.5 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(Cl)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3741483 136805 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 459 6 0 4 4.5 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(Cl)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
4418 34222 85 None -1 6 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmc.2015.11.020
CHEMBL142635 34222 85 None -1 6 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmc.2015.11.020
44596863 198927 0 None - 0 Rat 7.3 pIC50 = 7.3 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 367 6 1 6 2.3 C=Cc1c(C)nn(CCCN2CCN(c3ccc(C)cc3)CC2)c(=O)c1N 10.1021/jm900458r
CHEMBL584606 198927 0 None - 0 Rat 7.3 pIC50 = 7.3 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]prazosin from adrenergic alpha1A receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 367 6 1 6 2.3 C=Cc1c(C)nn(CCCN2CCN(c3ccc(C)cc3)CC2)c(=O)c1N 10.1021/jm900458r
4011 82408 49 None -125 24 Rat 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 nan
CHEMBL21731 82408 49 None -125 24 Rat 6.3 pIC50 = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 nan
1531 2266 69 None -3 16 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
3869 2266 69 None -3 16 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
7207 2266 69 None -3 16 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
CHEMBL429 2266 69 None -3 16 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
DB00598 2266 69 None -3 16 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
44376927 55637 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 461 3 0 5 5.0 Cc1nc2c(Cl)cc(C(F)(F)F)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL162147 55637 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 461 3 0 5 5.0 Cc1nc2c(Cl)cc(C(F)(F)F)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
506 2252 39 None -81 5 Human 6.2 pIC50 = 6.2 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtypeCompound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtype
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
6603904 2252 39 None -81 5 Human 6.2 pIC50 = 6.2 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtypeCompound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtype
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
CHEMBL19476 2252 39 None -81 5 Human 6.2 pIC50 = 6.2 Binding
Compound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtypeCompound was tested for the tissue binding affinity using [3H]- Prazosin as radioligand to the human prostate Alpha-1A adrenergic receptor subtype
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
11502638 173743 0 None - 1 Human 5.2 pIC50 = 5.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 419 5 0 6 4.0 COc1ccc2nc(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)n(C)c(=O)c2c1 10.1016/j.bmcl.2008.10.034
CHEMBL453654 173743 0 None - 1 Human 5.2 pIC50 = 5.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 419 5 0 6 4.0 COc1ccc2nc(-c3ccc(OC4CCN(C5CCC5)CC4)cc3)n(C)c(=O)c2c1 10.1016/j.bmcl.2008.10.034
10644514 101057 0 None - 0 Bovine 8.2 pIC50 = 8.2 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 397 6 0 6 3.4 COc1ccccc1N1CCN(CCCc2ccc3c(c2)sc(=O)n3C)CC1 10.1021/jm970298c
CHEMBL294730 101057 0 None - 0 Bovine 8.2 pIC50 = 8.2 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 397 6 0 6 3.4 COc1ccccc1N1CCN(CCCc2ccc3c(c2)sc(=O)n3C)CC1 10.1021/jm970298c
10409070 121924 4 None - 0 Rat 8.2 pIC50 = 8.2 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 406 5 1 3 4.1 O=C1NCCN1CCN1CCC(n2cc(-c3ccc(F)cc3)c3ccccc32)CC1 10.1021/jm00104a007
CHEMBL359031 121924 4 None - 0 Rat 8.2 pIC50 = 8.2 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 406 5 1 3 4.1 O=C1NCCN1CCN1CCC(n2cc(-c3ccc(F)cc3)c3ccccc32)CC1 10.1021/jm00104a007
31101 729 40 None -4 36 Rat 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
35 729 40 None -4 36 Rat 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
403 729 40 None -4 36 Rat 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
CHEMBL493 729 40 None -4 36 Rat 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
DB01200 729 40 None -4 36 Rat 8.2 pIC50 = 8.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
125017 9451 99 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 263 4 2 3 2.7 CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL1118 9451 99 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 263 4 2 3 2.7 CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1 10.1021/jm00172a035
10528455 15572 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 472 9 0 4 4.9 CC(C)N1CCN(CCN(C)CCOc2cn(-c3ccc(F)cc3)c3cc(Cl)ccc23)C1=O 10.1021/jm960159f
CHEMBL122047 15572 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 472 9 0 4 4.9 CC(C)N1CCN(CCN(C)CCOc2cn(-c3ccc(F)cc3)c3cc(Cl)ccc23)C1=O 10.1021/jm960159f
10413283 187468 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 490 7 0 3 5.5 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccccc1)c1ccc(F)c(F)c1 10.1016/j.bmcl.2009.04.016
CHEMBL494016 187468 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 490 7 0 3 5.5 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)C(c1ccccc1)c1ccc(F)c(F)c1 10.1016/j.bmcl.2009.04.016
121852 10166 7 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL11592 10166 7 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL301060 10166 7 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 442 9 0 5 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10024943 97390 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 416 9 0 5 3.7 CCCN(CCCCN1C(=O)CC(C)(C)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL26975 97390 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 416 9 0 5 3.7 CCCN(CCCCN1C(=O)CC(C)(C)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL52485 97390 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 416 9 0 5 3.7 CCCN(CCCCN1C(=O)CC(C)(C)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
2291 3184 58 None -446 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
2561 3184 58 None -446 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
4932 3184 58 None -446 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
CHEMBL631 3184 58 None -446 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
DB01182 3184 58 None -446 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
14183742 208322 0 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 325 4 1 2 3.8 CN(C)CC(c1ccc(Br)cc1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL99175 208322 0 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 325 4 1 2 3.8 CN(C)CC(c1ccc(Br)cc1)C1(O)CCCCC1 10.1021/jm00172a035
119081417 151659 38 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [3H]prazosin from recombinant human adrenergic A1a receptor after 60 mins by scintillation counting methodDisplacement of [3H]prazosin from recombinant human adrenergic A1a receptor after 60 mins by scintillation counting method
ChEMBL 488 10 0 7 5.2 CCCOc1ccc(CCc2nc3cc(-c4c(C)noc4C)ccc3n2CCN2CCOCC2)cc1 10.1021/acs.jmedchem.6b01839
CHEMBL3963965 151659 38 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [3H]prazosin from recombinant human adrenergic A1a receptor after 60 mins by scintillation counting methodDisplacement of [3H]prazosin from recombinant human adrenergic A1a receptor after 60 mins by scintillation counting method
ChEMBL 488 10 0 7 5.2 CCCOc1ccc(CCc2nc3cc(-c4c(C)noc4C)ccc3n2CCN2CCOCC2)cc1 10.1021/acs.jmedchem.6b01839
11567596 174582 0 None - 1 Human 5.2 pIC50 = 5.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 403 4 0 5 4.4 Cn1c(-c2ccc(OC3CCN(C4CCCC4)CC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
CHEMBL455681 174582 0 None - 1 Human 5.2 pIC50 = 5.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 403 4 0 5 4.4 Cn1c(-c2ccc(OC3CCN(C4CCCC4)CC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
1599 2341 50 None -3019 16 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 nan
3955 2341 50 None -3019 16 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 nan
7215 2341 50 None -3019 16 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 nan
CHEMBL841 2341 50 None -3019 16 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 nan
DB00836 2341 50 None -3019 16 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 nan
1028 291 71 None -47 30 Rat 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
139148732 291 71 None -47 30 Rat 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
479 291 71 None -47 30 Rat 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
5816 291 71 None -47 30 Rat 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
CHEMBL679 291 71 None -47 30 Rat 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
DB00668 291 71 None -47 30 Rat 6.2 pIC50 = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
11618024 186673 0 None - 1 Human 5.2 pIC50 = 5.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 389 4 0 5 4.0 Cn1c(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
CHEMBL488249 186673 0 None - 1 Human 5.2 pIC50 = 5.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 389 4 0 5 4.0 Cn1c(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)nc2ccccc2c1=O 10.1016/j.bmcl.2008.10.034
2435 722 100 None -436 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
395 722 100 None -436 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
520 722 100 None -436 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
5386 722 100 None -436 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
CHEMBL844 722 100 None -436 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
DB00484 722 100 None -436 12 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
135398745 2914 112 None -13 65 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
47 2914 112 None -13 65 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
CHEMBL715 2914 112 None -13 65 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
DB00334 2914 112 None -13 65 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
10647075 16895 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 446 8 1 4 4.5 CN(CCSc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
CHEMBL125072 16895 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 446 8 1 4 4.5 CN(CCSc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
11618702 173844 0 None - 1 Human 5.2 pIC50 = 5.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 423 4 0 5 4.7 Cn1c(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)nc2c(Cl)cccc2c1=O 10.1016/j.bmcl.2008.10.034
CHEMBL453893 173844 0 None - 1 Human 5.2 pIC50 = 5.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 423 4 0 5 4.7 Cn1c(-c2ccc(OC3CCN(C4CCC4)CC3)cc2)nc2c(Cl)cccc2c1=O 10.1016/j.bmcl.2008.10.034
23151199 186028 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 377 6 0 5 3.9 Cc1nc2ccccc2c(=O)n1-c1ccc(OCCCN2CCCCC2)cc1 10.1016/j.bmcl.2008.10.034
CHEMBL487063 186028 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 377 6 0 5 3.9 Cc1nc2ccccc2c(=O)n1-c1ccc(OCCCN2CCCCC2)cc1 10.1016/j.bmcl.2008.10.034
10219 188796 37 None -467 5 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 nan
CHEMBL493439 188796 37 None -467 5 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 nan
CHEMBL50588 188796 37 None -467 5 Rat 5.2 pIC50 = 5.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 nan
44269124 28818 1 None - 0 Human 7.2 pIC50 = 7.2 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 252 4 1 3 2.7 c1ccc(-c2ccccc2OCC2=NCCN2)cc1 10.1016/s0960-894x(02)00753-9
CHEMBL13789 28818 1 None - 0 Human 7.2 pIC50 = 7.2 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 252 4 1 3 2.7 c1ccc(-c2ccccc2OCC2=NCCN2)cc1 10.1016/s0960-894x(02)00753-9
85469931 136892 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 493 6 0 4 4.9 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3742253 136892 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 493 6 0 4 4.9 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
10003405 121075 4 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 440 5 1 3 4.8 O=C1NCCN1CCN1CCC(n2cc(-c3ccc(F)cc3)c3cc(Cl)ccc32)CC1 10.1021/jm00104a007
CHEMBL357019 121075 4 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 440 5 1 3 4.8 O=C1NCCN1CCN1CCC(n2cc(-c3ccc(F)cc3)c3cc(Cl)ccc32)CC1 10.1021/jm00104a007
1353 1911 93 None -10 83 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
3559 1911 93 None -10 83 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
86 1911 93 None -10 83 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
CHEMBL54 1911 93 None -10 83 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
DB00502 1911 93 None -10 83 Rat 7.2 pIC50 = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
44377035 120130 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1nc2c(C)cccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL351200 120130 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 373 3 0 5 3.7 Cc1nc2c(C)cccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
2585 803 103 None -5 21 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
522 803 103 None -5 21 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
551 803 103 None -5 21 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
CHEMBL723 803 103 None -5 21 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
DB01136 803 103 None -5 21 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
9826570 113312 0 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 482 6 0 3 5.7 CC(C)N1CCN(CCN2CCC(c3cn(-c4ccc(F)cc4)c4cc(Cl)ccc34)CC2)C1=O 10.1021/jm960159f
CHEMBL331545 113312 0 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 482 6 0 3 5.7 CC(C)N1CCN(CCN2CCC(c3cn(-c4ccc(F)cc4)c4cc(Cl)ccc34)CC2)C1=O 10.1021/jm960159f
9826570 113312 0 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 482 6 0 3 5.7 CC(C)N1CCN(CCN2CCC(c3cn(-c4ccc(F)cc4)c4cc(Cl)ccc34)CC2)C1=O 10.1021/jm00104a007
CHEMBL331545 113312 0 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 482 6 0 3 5.7 CC(C)N1CCN(CCN2CCC(c3cn(-c4ccc(F)cc4)c4cc(Cl)ccc34)CC2)C1=O 10.1021/jm00104a007
14739952 4474 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 307 6 1 4 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1OC 10.1021/jm00172a035
CHEMBL101819 4474 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 307 6 1 4 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1OC 10.1021/jm00172a035
10251234 11245 0 None - 0 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL1178932 11245 0 None - 0 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL50530 11245 0 None - 0 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
9981024 96097 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 446 11 1 5 3.8 CCCN(CCCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL26018 96097 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 446 11 1 5 3.8 CCCN(CCCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL300735 96097 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 446 11 1 5 3.8 CCCN(CCCCNS(=O)(=O)c1ccc(C)cc1)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10047322 97140 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 412 8 0 4 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2ccccc2C1 10.1021/jm00038a007
CHEMBL26783 97140 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 412 8 0 4 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2ccccc2C1 10.1021/jm00038a007
CHEMBL50993 97140 0 None - 1 Bovine 5.2 pIC50 = 5.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 412 8 0 4 4.2 CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2ccccc2C1 10.1021/jm00038a007
10008463 11249 0 None - 0 Bovine 4.2 pIC50 = 4.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 457 9 0 4 4.3 CCC[N+](C)(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL1178971 11249 0 None - 0 Bovine 4.2 pIC50 = 4.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 457 9 0 4 4.3 CCC[N+](C)(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL51985 11249 0 None - 0 Bovine 4.2 pIC50 = 4.2 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 457 9 0 4 4.3 CCC[N+](C)(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10364835 36497 4 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 420 5 1 3 4.4 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2C1CCN(CCN2CCNC2=O)CC1 10.1021/jm00104a007
CHEMBL144767 36497 4 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 420 5 1 3 4.4 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2C1CCN(CCN2CCNC2=O)CC1 10.1021/jm00104a007
11641036 186023 0 None - 1 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 453 8 0 5 5.4 O=c1c2ccccc2nc(-c2ccc(OCCCN3CCCCC3)cc2)n1Cc1ccccc1 10.1016/j.bmcl.2008.10.034
CHEMBL487059 186023 0 None - 1 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in LMtk- cells
ChEMBL 453 8 0 5 5.4 O=c1c2ccccc2nc(-c2ccc(OCCCN3CCCCC3)cc2)n1Cc1ccccc1 10.1016/j.bmcl.2008.10.034
44377036 120156 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 393 3 0 5 4.0 Cc1nc2ccc(Cl)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL351483 120156 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 393 3 0 5 4.0 Cc1nc2ccc(Cl)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
10544460 16410 0 None - 0 Rat 7.1 pIC50 = 7.1 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 330 5 0 2 4.9 CN(C)CCCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
CHEMBL123094 16410 0 None - 0 Rat 7.1 pIC50 = 7.1 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 330 5 0 2 4.9 CN(C)CCCc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
42636941 178949 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]prazosin form human recombinant alpha1A adrenergic receptorDisplacement of [3H]prazosin form human recombinant alpha1A adrenergic receptor
ChEMBL 343 5 0 5 4.4 CCCN1CCC(COc2nc3scc(C)c3n3cccc23)CC1 10.1016/j.bmc.2008.11.045
CHEMBL470432 178949 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]prazosin form human recombinant alpha1A adrenergic receptorDisplacement of [3H]prazosin form human recombinant alpha1A adrenergic receptor
ChEMBL 343 5 0 5 4.4 CCCN1CCC(COc2nc3scc(C)c3n3cccc23)CC1 10.1016/j.bmc.2008.11.045
23027527 196792 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 371 5 2 5 3.1 Cc1cnc(N[C@H]2CC[C@@H](NC(=O)c3ccc(F)cc3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
CHEMBL565551 196792 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 371 5 2 5 3.1 Cc1cnc(N[C@H]2CC[C@@H](NC(=O)c3ccc(F)cc3)CC2)nc1N(C)C 10.1016/j.bmcl.2009.09.003
44343247 110635 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 258 6 3 3 2.2 CCCNC(=O)c1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
CHEMBL325745 110635 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
In vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblastsIn vitro binding affinity against cloned human alpha-1A-adrenoceptor receptors expressed in rat-1 fibroblasts
ChEMBL 258 6 3 3 2.2 CCCNC(=O)c1ccccc1NCc1c[nH]cn1 10.1016/s0960-894x(02)00753-9
2286 3183 51 None -10 30 Rat 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
4927 3183 51 None -10 30 Rat 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
7282 3183 51 None -10 30 Rat 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
CHEMBL643 3183 51 None -10 30 Rat 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
DB01069 3183 51 None -10 30 Rat 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
1043 1582 14 None -35 28 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
149 1582 14 None -35 28 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
8223 1582 14 None -35 28 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
CHEMBL442 1582 14 None -35 28 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
DB00696 1582 14 None -35 28 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
2726 919 68 None -2 72 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
621 919 68 None -2 72 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
83 919 68 None -2 72 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
CHEMBL71 919 68 None -2 72 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
DB00477 919 68 None -2 72 Rat 8.1 pIC50 = 8.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
56961507 121442 0 None 1 3 Human 8.1 pIC50 = 8.1 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 678 6 4 11 5.0 COc1cc2nc(N3CCN(C(=S)Nc4ccc(-c5c6ccc(=O)cc-6oc6cc(O)ccc56)c(C(=O)O)c4)CC3)nc(N)c2cc1OC 10.1021/ml5004298
CHEMBL3582271 121442 0 None 1 3 Human 8.1 pIC50 = 8.1 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 678 6 4 11 5.0 COc1cc2nc(N3CCN(C(=S)Nc4ccc(-c5c6ccc(=O)cc-6oc6cc(O)ccc56)c(C(=O)O)c4)CC3)nc(N)c2cc1OC 10.1021/ml5004298
10251234 11245 0 None - 0 Bovine 5.1 pIC50 = 5.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL1178932 11245 0 None - 0 Bovine 5.1 pIC50 = 5.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL50530 11245 0 None - 0 Bovine 5.1 pIC50 = 5.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 414 9 0 5 3.3 CCCN(CCCCN1C(=O)C2CCCC2C1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
10252000 98547 0 None - 1 Bovine 5.1 pIC50 = 5.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 428 8 0 5 3.8 CCCN(CCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL27650 98547 0 None - 1 Bovine 5.1 pIC50 = 5.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 428 8 0 5 3.8 CCCN(CCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL50188 98547 0 None - 1 Bovine 5.1 pIC50 = 5.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 428 8 0 5 3.8 CCCN(CCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
3082597 99559 8 None - 1 Bovine 4.1 pIC50 = 4.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 263 6 0 3 3.1 CCCN(CCC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL283606 99559 8 None - 1 Bovine 4.1 pIC50 = 4.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 263 6 0 3 3.1 CCCN(CCC)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
22493392 47155 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 252 4 2 4 2.2 c1ccc(-c2ccccc2NCC2=NCCN2)nc1 10.1016/s0960-894x(01)00822-8
CHEMBL154298 47155 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
In vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cellsIn vitro binding affinity against human Alpha-1A adrenergic receptor expressed in rat-1 fibroblasts cells
ChEMBL 252 4 2 4 2.2 c1ccc(-c2ccccc2NCC2=NCCN2)nc1 10.1016/s0960-894x(01)00822-8
44376936 57474 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 373 4 0 5 3.7 Cc1nc2ccccn2c(=O)c1CCCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL165776 57474 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 373 4 0 5 3.7 Cc1nc2ccccn2c(=O)c1CCCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
46182745 57327 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibition of radioligand binding to human adrenergic alpha1a receptorInhibition of radioligand binding to human adrenergic alpha1a receptor
ChEMBL 461 6 1 3 6.2 O=C(O)c1cc(-c2cccc(COc3ccc4c(c3)CN(C3CCCC3)C4=O)c2)ccc1Cl 10.1021/jm3005306
CHEMBL1651208 57327 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibition of radioligand binding to human adrenergic alpha1a receptorInhibition of radioligand binding to human adrenergic alpha1a receptor
ChEMBL 461 6 1 3 6.2 O=C(O)c1cc(-c2cccc(COc3ccc4c(c3)CN(C3CCCC3)C4=O)c2)ccc1Cl 10.1021/jm3005306
10736518 16393 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 348 5 0 3 5.1 CN(C)CCSc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
CHEMBL123027 16393 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 348 5 0 3 5.1 CN(C)CCSc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12 10.1021/jm960159f
10788207 200767 0 None - 0 Bovine 7.1 pIC50 = 7.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 419 4 0 4 3.4 CN1C(=O)COc2cc(CCN3CCN(c4cccc(C(F)(F)F)c4)CC3)ccc21 10.1021/jm970298c
CHEMBL60047 200767 0 None - 0 Bovine 7.1 pIC50 = 7.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 419 4 0 4 3.4 CN1C(=O)COc2cc(CCN3CCN(c4cccc(C(F)(F)F)c4)CC3)ccc21 10.1021/jm970298c
9816986 164139 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 274 6 2 4 1.6 CCN(CC)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
CHEMBL421011 164139 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Concentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in humanConcentration required for 50% inhibition of binding against Alpha-1A adrenergic receptor in human
ChEMBL 274 6 2 4 1.6 CCN(CC)C(=O)c1ccccc1NCC1=NCCN1 10.1016/s0960-894x(01)00569-8
2337 3256 77 None -3 62 Rat 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
50 3256 77 None -3 62 Rat 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
5002 3256 77 None -3 62 Rat 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
CHEMBL716 3256 77 None -3 62 Rat 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
DB01224 3256 77 None -3 62 Rat 7.1 pIC50 = 7.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
10551704 116838 0 None - 0 Rat 7.1 pIC50 = 7.1 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 454 9 1 4 3.8 C#CCN(CCOc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
CHEMBL338022 116838 0 None - 0 Rat 7.1 pIC50 = 7.1 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
ChEMBL 454 9 1 4 3.8 C#CCN(CCOc1cn(-c2ccc(F)cc2)c2ccc(Cl)cc12)CCN1CCNC1=O 10.1021/jm960159f
13520319 163405 0 None - 0 Rat 7.1 pIC50 = 7.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 315 4 1 2 4.0 CN(C)CC(c1ccc(C(F)(F)F)cc1)C1(O)CCCCC1 10.1021/jm00172a035
CHEMBL419533 163405 0 None - 0 Rat 7.1 pIC50 = 7.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 315 4 1 2 4.0 CN(C)CC(c1ccc(C(F)(F)F)cc1)C1(O)CCCCC1 10.1021/jm00172a035
85469756 136587 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 455 7 0 5 3.9 COc1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3739513 136587 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 455 7 0 5 3.9 COc1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
10093723 36436 0 None - 0 Rat 7.1 pIC50 = 7.1 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 422 5 1 3 4.7 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2C1CCN(CCNC(=O)N(C)C)CC1 10.1021/jm00104a007
CHEMBL144710 36436 0 None - 0 Rat 7.1 pIC50 = 7.1 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
ChEMBL 422 5 1 3 4.7 Cc1ccc2c(c1)c(-c1ccc(F)cc1)cn2C1CCN(CCNC(=O)N(C)C)CC1 10.1021/jm00104a007
85469868 136780 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 450 6 0 5 3.7 N#Cc1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3741260 136780 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 450 6 0 5 3.7 N#Cc1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)cc1 10.1016/j.bmc.2015.11.020
85469755 136769 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 461 6 0 4 4.1 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(F)cc3F)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3741161 136769 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 461 6 0 4 4.1 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(F)cc3F)CC2)cc1 10.1016/j.bmc.2015.11.020
44377200 57420 1 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 437 3 0 5 4.1 Cc1nc2ccc(Br)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
CHEMBL165350 57420 1 None - 0 Human 6.1 pIC50 = 6.1 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
ChEMBL 437 3 0 5 4.1 Cc1nc2ccc(Br)cn2c(=O)c1CCN1CCc2oc3ccccc3c2C1 10.1016/s0960-894x(99)00591-0
2284 3182 33 None -1 29 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
4926 3182 33 None -1 29 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
7281 3182 33 None -1 29 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
CHEMBL564 3182 33 None -1 29 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
DB00420 3182 33 None -1 29 Rat 8.0 pIC50 = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
10645076 200310 0 None - 0 Bovine 7.1 pIC50 = 7.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 407 4 1 5 4.4 Oc1nc2ccc(CCN3CCN(c4cccc(C(F)(F)F)c4)CC3)cc2s1 10.1021/jm970298c
CHEMBL59741 200310 0 None - 0 Bovine 7.1 pIC50 = 7.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
ChEMBL 407 4 1 5 4.4 Oc1nc2ccc(CCN3CCN(c4cccc(C(F)(F)F)c4)CC3)cc2s1 10.1021/jm970298c
5656 203066 87 None - 40 Rat 7.1 pIC50 = 7.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 10.1021/jm00172a035
CHEMBL637 203066 87 None - 40 Rat 7.1 pIC50 = 7.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 10.1021/jm00172a035
10321964 18851 0 None - 0 Bovine 6.1 pIC50 = 6.1 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor determined in a filtration-based assay using [3H]prazosin as the radioligand.Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor determined in a filtration-based assay using [3H]prazosin as the radioligand.
ChEMBL 459 6 1 7 3.0 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccc([N+](=O)[O-])cc3)CC1)O2 10.1021/jm00099a028
CHEMBL1203302 18851 0 None - 0 Bovine 6.1 pIC50 = 6.1 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor determined in a filtration-based assay using [3H]prazosin as the radioligand.Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor determined in a filtration-based assay using [3H]prazosin as the radioligand.
ChEMBL 459 6 1 7 3.0 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccc([N+](=O)[O-])cc3)CC1)O2 10.1021/jm00099a028
CHEMBL128132 18851 0 None - 0 Bovine 6.1 pIC50 = 6.1 Binding
Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor determined in a filtration-based assay using [3H]prazosin as the radioligand.Compound was evaluated for binding affinity at bovine brain Alpha-1 adrenergic receptor determined in a filtration-based assay using [3H]prazosin as the radioligand.
ChEMBL 459 6 1 7 3.0 CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccc([N+](=O)[O-])cc3)CC1)O2 10.1021/jm00099a028
9795857 208148 59 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 249 4 2 3 2.4 COc1ccc(C(CN)C2(O)CCCCC2)cc1 10.1021/jm00172a035
CHEMBL98158 208148 59 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 249 4 2 3 2.4 COc1ccc(C(CN)C2(O)CCCCC2)cc1 10.1021/jm00172a035
10321248 99426 0 None - 1 Bovine 5.1 pIC50 = 5.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 444 9 0 6 3.7 CCCN(CCCON1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL28287 99426 0 None - 1 Bovine 5.1 pIC50 = 5.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 444 9 0 6 3.7 CCCN(CCCON1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
CHEMBL50722 99426 0 None - 1 Bovine 5.1 pIC50 = 5.1 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
ChEMBL 444 9 0 6 3.7 CCCN(CCCON1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1 10.1021/jm00038a007
53246941 69422 42 None - 0 Human 6.0 pIC50 = 6.0 Binding
Selectivity interaction (Enzyme panel (receptors, ion channels, other enzymes)) EUB0000679a ADRA1ASelectivity interaction (Enzyme panel (receptors, ion channels, other enzymes)) EUB0000679a ADRA1A
ChEMBL 458 6 2 6 3.9 C[C@@H]1CCNC(=O)c2cc3ccc(C(=O)Nc4nc5ccccc5n4CCCN(C)C)cc3n21 10.6019/CHEMBL5212743
CHEMBL1933288 69422 42 None - 0 Human 6.0 pIC50 = 6.0 Binding
Selectivity interaction (Enzyme panel (receptors, ion channels, other enzymes)) EUB0000679a ADRA1ASelectivity interaction (Enzyme panel (receptors, ion channels, other enzymes)) EUB0000679a ADRA1A
ChEMBL 458 6 2 6 3.9 C[C@@H]1CCNC(=O)c2cc3ccc(C(=O)Nc4nc5ccccc5n4CCCN(C)C)cc3n21 10.6019/CHEMBL5212743
44573823 193234 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 491 6 0 3 6.1 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)N(c1ccccc1)c1ccc(F)c(F)c1 10.1016/j.bmcl.2009.04.016
CHEMBL523697 193234 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in thymidine kinase-deficient mouse LM cells
ChEMBL 491 6 0 3 6.1 CN(CCCN1CCC2(CC1)OCc1ccccc12)C(=O)N(c1ccccc1)c1ccc(F)c(F)c1 10.1016/j.bmcl.2009.04.016
3033538 1319 39 None -7 9 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
7155 1319 39 None -7 9 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
781 1319 39 None -7 9 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
CHEMBL1201216 1319 39 None -7 9 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
DB00298 1319 39 None -7 9 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
133 2496 52 None -70 42 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
1723 2496 52 None -70 42 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
28693 2496 52 None -70 42 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
CHEMBL19215 2496 52 None -70 42 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
DB13520 2496 52 None -70 42 Rat 7.0 pIC50 = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
14739950 208266 0 None - 0 Rat 7.0 pIC50 = 7.0 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 263 5 1 3 2.6 COc1cccc(C(CN(C)C)C2(O)CCCC2)c1 10.1021/jm00172a035
CHEMBL98842 208266 0 None - 0 Rat 7.0 pIC50 = 7.0 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
ChEMBL 263 5 1 3 2.6 COc1cccc(C(CN(C)C)C2(O)CCCC2)c1 10.1021/jm00172a035
19063108 93484 0 None - 0 Bovine 6.0 pIC50 = 6.0 Binding
Binding affinity was tested on cloned bovine Alpha-1A adrenergic receptorBinding affinity was tested on cloned bovine Alpha-1A adrenergic receptor
ChEMBL 546 9 1 10 4.6 COc1ccc(CC2c3cc(OC)c(OC)cc3CCN2c2nc(N)c3cc(OC)c(OC)cc3n2)cc1OC 10.1021/jm960697s
CHEMBL24619 93484 0 None - 0 Bovine 6.0 pIC50 = 6.0 Binding
Binding affinity was tested on cloned bovine Alpha-1A adrenergic receptorBinding affinity was tested on cloned bovine Alpha-1A adrenergic receptor
ChEMBL 546 9 1 10 4.6 COc1ccc(CC2c3cc(OC)c(OC)cc3CCN2c2nc(N)c3cc(OC)c(OC)cc3n2)cc1OC 10.1021/jm960697s
85469871 136584 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 443 6 0 4 4.0 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccc3F)CC2)cc1 10.1016/j.bmc.2015.11.020
CHEMBL3739505 136584 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by firefly and renilla dual glo luciferase assay
ChEMBL 443 6 0 4 4.0 O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccc3F)CC2)cc1 10.1016/j.bmc.2015.11.020
2398 954 62 None -4 29 Rat 7.0 pIC50 = 7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
2801 954 62 None -4 29 Rat 7.0 pIC50 = 7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
701 954 62 None -4 29 Rat 7.0 pIC50 = 7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
CHEMBL415 954 62 None -4 29 Rat 7.0 pIC50 = 7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
DB01242 954 62 None -4 29 Rat 7.0 pIC50 = 7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
4209 3163 75 None -3 33 Rat 9.8 pKd = 9.8 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00025a012
4893 3163 75 None -3 33 Rat 9.8 pKd = 9.8 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00025a012
503 3163 75 None -3 33 Rat 9.8 pKd = 9.8 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00025a012
5385 3163 75 None -3 33 Rat 9.8 pKd = 9.8 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00025a012
CHEMBL2 3163 75 None -3 33 Rat 9.8 pKd = 9.8 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00025a012
DB00457 3163 75 None -3 33 Rat 9.8 pKd = 9.8 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00025a012
164612037 185377 0 None -4 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 326 8 4 4 1.8 CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C 10.1021/acs.jmedchem.1c00692
CHEMBL4860528 185377 0 None -4 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 326 8 4 4 1.8 CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C 10.1021/acs.jmedchem.1c00692
168290235 192968 0 None -16 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
CHEMBL5201074 192968 0 None -16 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
CHEMBL5222491 192968 0 None -16 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 315 6 4 3 1.1 C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1 10.1021/acs.jmedchem.1c00692
168294767 193019 0 None -4 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5207281 193019 0 None -4 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5222802 193019 0 None -4 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 313 8 4 5 0.9 CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
168295528 193031 0 None -4 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5206565 193031 0 None -4 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
CHEMBL5222872 193031 0 None -4 20 Human 9.6 pKd = 9.6 Binding
Displacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysisDisplacement of [3H]prazosin from human alpha-1A adrenergic receptor stably expressed in HEK293T cell membrane incubated for 2 hrs by scintillation counting analysis
ChEMBL 333 6 4 5 0.9 N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1 10.1021/acs.jmedchem.1c00692
44363762 40150 0 None - 1 Rat 9.2 pKd = 9.2 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 497 6 1 11 1.8 COc1cc2nc(N3CCN(S(=O)(=O)c4nonc4-c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm00025a012
CHEMBL147984 40150 0 None - 1 Rat 9.2 pKd = 9.2 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 497 6 1 11 1.8 COc1cc2nc(N3CCN(S(=O)(=O)c4nonc4-c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm00025a012
10250895 190342 0 None 1 5 Human 9.1 pKd = 9.1 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin)Binding affinity to alpha-1A adrenergic receptor (unknown origin)
ChEMBL 408 7 0 6 3.7 COc1ccccc1N1CCN(CCCOc2ccc3c(C)cc(=O)oc3c2)CC1 10.1021/jm400408r
CHEMBL51767 190342 0 None 1 5 Human 9.1 pKd = 9.1 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin)Binding affinity to alpha-1A adrenergic receptor (unknown origin)
ChEMBL 408 7 0 6 3.7 COc1ccccc1N1CCN(CCCOc2ccc3c(C)cc(=O)oc3c2)CC1 10.1021/jm400408r
10250895 190342 0 None -1 5 Rat 9.1 pKd = 9.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 408 7 0 6 3.7 COc1ccccc1N1CCN(CCCOc2ccc3c(C)cc(=O)oc3c2)CC1 10.1016/s0960-894x(02)00933-2
CHEMBL51767 190342 0 None -1 5 Rat 9.1 pKd = 9.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 408 7 0 6 3.7 COc1ccccc1N1CCN(CCCOc2ccc3c(C)cc(=O)oc3c2)CC1 10.1016/s0960-894x(02)00933-2
44364207 37797 0 None - 1 Rat 9.0 pKd = 9.0 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 513 6 1 11 1.0 COc1cc2nc(N3CCN(S(=O)(=O)c4no[n+]([O-])c4-c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm00025a012
CHEMBL145838 37797 0 None - 1 Rat 9.0 pKd = 9.0 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 513 6 1 11 1.0 COc1cc2nc(N3CCN(S(=O)(=O)c4no[n+]([O-])c4-c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm00025a012
71817386 102586 0 None -6 6 Rat 8.7 pKd = 8.7 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL2419769 102586 0 None -6 6 Rat 8.7 pKd = 8.7 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL3040851 102586 0 None -6 6 Rat 8.7 pKd = 8.7 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
2419 695 28 None -288 12 Rat 6.0 pKd = 6.0 Binding
In vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferensIn vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
9 695 28 None -288 12 Rat 6.0 pKd = 6.0 Binding
In vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferensIn vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
CHEMBL13647 695 28 None -288 12 Rat 6.0 pKd = 6.0 Binding
In vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferensIn vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
10317514 192529 0 None -14 6 Rat 7.9 pKd = 7.9 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 378 6 0 5 3.7 Cc1cc(=O)oc2cc(OCCCN3CCN(c4ccccc4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
CHEMBL52096 192529 0 None -14 6 Rat 7.9 pKd = 7.9 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 378 6 0 5 3.7 Cc1cc(=O)oc2cc(OCCCN3CCN(c4ccccc4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
2419 695 28 None -288 12 Rat 6.9 pKd = 6.9 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm400867d
9 695 28 None -288 12 Rat 6.9 pKd = 6.9 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm400867d
CHEMBL13647 695 28 None -288 12 Rat 6.9 pKd = 6.9 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm400867d
3584 3777 64 None -2 13 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.ejmech.2015.04.005
5401 3777 64 None -2 13 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.ejmech.2015.04.005
7302 3777 64 None -2 13 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.ejmech.2015.04.005
CHEMBL611 3777 64 None -2 13 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.ejmech.2015.04.005
DB01162 3777 64 None -2 13 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/j.ejmech.2015.04.005
73437674 118531 0 None 7 2 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 434 10 2 4 3.8 COc1ccccc1N1CCN(CCCNC(=O)CCCc2c[nH]c3ccccc23)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL3415014 118531 0 None 7 2 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 434 10 2 4 3.8 COc1ccccc1N1CCN(CCCNC(=O)CCCc2c[nH]c3ccccc23)CC1 10.1016/j.ejmech.2015.04.005
14348818 109774 0 None 5 3 Rat 4.9 pKd = 4.9 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
CHEMBL323176 109774 0 None 5 3 Rat 4.9 pKd = 4.9 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
71817545 92124 0 None 2 6 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 354 7 2 5 3.0 COc1ccc2cc[nH]c2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL2419765 92124 0 None 2 6 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 354 7 2 5 3.0 COc1ccc2cc[nH]c2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
71817547 102578 0 None -10 6 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
CHEMBL2419771 102578 0 None -10 6 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
CHEMBL3040800 102578 0 None -10 6 Rat 7.9 pKd = 7.9 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
76308474 106234 0 None -162 4 Rat 6.9 pKd = 6.9 Binding
Competitive antagonist activity at alpha1A adrenergic receptor in Rattus norvegicus (rat) vas deferens assessed as inhibition of (-)-noradrenaline-induced contractionCompetitive antagonist activity at alpha1A adrenergic receptor in Rattus norvegicus (rat) vas deferens assessed as inhibition of (-)-noradrenaline-induced contraction
ChEMBL 467 5 1 9 3.1 COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@H]3CCCC[C@@H]32)o1 10.1007/s00044-004-0024-8
CHEMBL2261607 106234 0 None -162 4 Rat 6.9 pKd = 6.9 Binding
Competitive antagonist activity at alpha1A adrenergic receptor in Rattus norvegicus (rat) vas deferens assessed as inhibition of (-)-noradrenaline-induced contractionCompetitive antagonist activity at alpha1A adrenergic receptor in Rattus norvegicus (rat) vas deferens assessed as inhibition of (-)-noradrenaline-induced contraction
ChEMBL 467 5 1 9 3.1 COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@H]3CCCC[C@@H]32)o1 10.1007/s00044-004-0024-8
CHEMBL3138856 106234 0 None -162 4 Rat 6.9 pKd = 6.9 Binding
Competitive antagonist activity at alpha1A adrenergic receptor in Rattus norvegicus (rat) vas deferens assessed as inhibition of (-)-noradrenaline-induced contractionCompetitive antagonist activity at alpha1A adrenergic receptor in Rattus norvegicus (rat) vas deferens assessed as inhibition of (-)-noradrenaline-induced contraction
ChEMBL 467 5 1 9 3.1 COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@H]3CCCC[C@@H]32)o1 10.1007/s00044-004-0024-8
10252540 85357 1 None -83 5 Rat 7.8 pKd = 7.8 Binding
Antagonist activity at alpha1A adrenoreceptor in Rattus norvegicus (rat) small mesenteric arteryAntagonist activity at alpha1A adrenoreceptor in Rattus norvegicus (rat) small mesenteric artery
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
CHEMBL2261604 85357 1 None -83 5 Rat 7.8 pKd = 7.8 Binding
Antagonist activity at alpha1A adrenoreceptor in Rattus norvegicus (rat) small mesenteric arteryAntagonist activity at alpha1A adrenoreceptor in Rattus norvegicus (rat) small mesenteric artery
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
10252540 85357 1 None -83 5 Rat 7.8 pKd = 7.8 Binding
Competitive antagonist activity at alpha1A adrenergic receptor in Rattus norvegicus (rat) vas deferens assessed as inhibition of (-)-noradrenaline-induced contractionCompetitive antagonist activity at alpha1A adrenergic receptor in Rattus norvegicus (rat) vas deferens assessed as inhibition of (-)-noradrenaline-induced contraction
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
CHEMBL2261604 85357 1 None -83 5 Rat 7.8 pKd = 7.8 Binding
Competitive antagonist activity at alpha1A adrenergic receptor in Rattus norvegicus (rat) vas deferens assessed as inhibition of (-)-noradrenaline-induced contractionCompetitive antagonist activity at alpha1A adrenergic receptor in Rattus norvegicus (rat) vas deferens assessed as inhibition of (-)-noradrenaline-induced contraction
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
1353 1911 93 None -10 83 Rat 7.8 pKd = 7.8 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1016/s0960-894x(02)00933-2
3559 1911 93 None -10 83 Rat 7.8 pKd = 7.8 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1016/s0960-894x(02)00933-2
86 1911 93 None -10 83 Rat 7.8 pKd = 7.8 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1016/s0960-894x(02)00933-2
CHEMBL54 1911 93 None -10 83 Rat 7.8 pKd = 7.8 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1016/s0960-894x(02)00933-2
DB00502 1911 93 None -10 83 Rat 7.8 pKd = 7.8 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl 10.1016/s0960-894x(02)00933-2
155559152 174780 0 None 3 2 Rat 5.7 pKd = 5.7 Binding
Antagonistic activity at alpha1A adrenoceptor in Sprague-Dawley rat vas deferens assessed as inhibition of noradrenaline-induced contractions after 0.5 hrs in presence of alpha2/beta adrenoceptor blocker yohimbine, propranolol by Schild plot analysisAntagonistic activity at alpha1A adrenoceptor in Sprague-Dawley rat vas deferens assessed as inhibition of noradrenaline-induced contractions after 0.5 hrs in presence of alpha2/beta adrenoceptor blocker yohimbine, propranolol by Schild plot analysis
ChEMBL 431 7 2 5 3.9 COc1ccc(N2CCN(CC(O)COc3cccc4[nH]c5ccccc5c34)CC2)cc1 10.1016/j.bmc.2016.09.010
CHEMBL4561614 174780 0 None 3 2 Rat 5.7 pKd = 5.7 Binding
Antagonistic activity at alpha1A adrenoceptor in Sprague-Dawley rat vas deferens assessed as inhibition of noradrenaline-induced contractions after 0.5 hrs in presence of alpha2/beta adrenoceptor blocker yohimbine, propranolol by Schild plot analysisAntagonistic activity at alpha1A adrenoceptor in Sprague-Dawley rat vas deferens assessed as inhibition of noradrenaline-induced contractions after 0.5 hrs in presence of alpha2/beta adrenoceptor blocker yohimbine, propranolol by Schild plot analysis
ChEMBL 431 7 2 5 3.9 COc1ccc(N2CCN(CC(O)COc3cccc4[nH]c5ccccc5c34)CC2)cc1 10.1016/j.bmc.2016.09.010
44294972 184018 0 None -1 2 Rat 6.7 pKd = 6.7 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 395 7 0 7 2.8 COc1cc(=O)oc2cc(OCCCN3CCN(c4ccccn4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
CHEMBL48205 184018 0 None -1 2 Rat 6.7 pKd = 6.7 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 395 7 0 7 2.8 COc1cc(=O)oc2cc(OCCCN3CCN(c4ccccn4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
73437673 118530 0 None 1 2 Rat 6.7 pKd = 6.7 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 420 9 2 4 3.4 COc1ccccc1N1CCN(CCCNC(=O)CCc2c[nH]c3ccccc23)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL3415013 118530 0 None 1 2 Rat 6.7 pKd = 6.7 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 420 9 2 4 3.4 COc1ccccc1N1CCN(CCCNC(=O)CCc2c[nH]c3ccccc23)CC1 10.1016/j.ejmech.2015.04.005
10527913 121524 0 None - 1 Rat 8.6 pKd = 8.6 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 459 5 1 12 -0.4 COC(=O)c1c(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)CC2)no[n+]1[O-] 10.1021/jm00025a012
CHEMBL358498 121524 0 None - 1 Rat 8.6 pKd = 8.6 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 459 5 1 12 -0.4 COC(=O)c1c(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)CC2)no[n+]1[O-] 10.1021/jm00025a012
155567902 175994 0 None -6 2 Rat 6.7 pKd = 6.7 Binding
Antagonist activity at alpha-1a adrenergic receptor in SPF rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionsAntagonist activity at alpha-1a adrenergic receptor in SPF rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions
ChEMBL 448 7 1 8 0.9 COc1cc2c(cc1OCC(O)CN1CCN(C(=O)C3CCCO3)CC1)C(=O)C(C)OC2 10.1016/j.bmc.2019.05.004
CHEMBL4589115 175994 0 None -6 2 Rat 6.7 pKd = 6.7 Binding
Antagonist activity at alpha-1a adrenergic receptor in SPF rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractionsAntagonist activity at alpha-1a adrenergic receptor in SPF rat prostatic vas deferens assessed as inhibition of noradrenaline-induced contractions
ChEMBL 448 7 1 8 0.9 COc1cc2c(cc1OCC(O)CN1CCN(C(=O)C3CCCO3)CC1)C(=O)C(C)OC2 10.1016/j.bmc.2019.05.004
92766 106542 35 None 1 6 Human 6.6 pKd = 6.6 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 10.1021/jm00370a011
CHEMBL31410 106542 35 None 1 6 Human 6.6 pKd = 6.6 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 10.1021/jm00370a011
2803 955 58 None -3 19 Rat 6.6 pKd = 6.6 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00115a008
516 955 58 None -3 19 Rat 6.6 pKd = 6.6 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00115a008
704 955 58 None -3 19 Rat 6.6 pKd = 6.6 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00115a008
CHEMBL134 955 58 None -3 19 Rat 6.6 pKd = 6.6 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00115a008
DB00575 955 58 None -3 19 Rat 6.6 pKd = 6.6 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1021/jm00115a008
73438500 118528 0 None 4 2 Rat 7.6 pKd = 7.6 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 392 7 2 4 3.1 COc1ccccc1N1CCN(CCCNC(=O)c2ccc3[nH]ccc3c2)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL3415011 118528 0 None 4 2 Rat 7.6 pKd = 7.6 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 392 7 2 4 3.1 COc1ccccc1N1CCN(CCCNC(=O)c2ccc3[nH]ccc3c2)CC1 10.1016/j.ejmech.2015.04.005
44294683 189867 0 None -3 2 Rat 6.6 pKd = 6.6 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 379 6 0 6 3.1 Cc1cc(=O)oc2cc(OCCCN3CCN(c4ccccn4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
CHEMBL51681 189867 0 None -3 2 Rat 6.6 pKd = 6.6 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 379 6 0 6 3.1 Cc1cc(=O)oc2cc(OCCCN3CCN(c4ccccn4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
44364190 39765 0 None - 1 Rat 8.5 pKd = 8.5 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 539 6 1 11 1.4 COc1cc2nc(N3CCN(S(=O)(=O)c4no[n+]([O-])c4C4=C/C=C\C=C/C=C\4)CC3)nc(N)c2cc1OC 10.1021/jm00025a012
CHEMBL147624 39765 0 None - 1 Rat 8.5 pKd = 8.5 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 539 6 1 11 1.4 COc1cc2nc(N3CCN(S(=O)(=O)c4no[n+]([O-])c4C4=C/C=C\C=C/C=C\4)CC3)nc(N)c2cc1OC 10.1021/jm00025a012
71817549 102580 0 None -7 6 Rat 8.4 pKd = 8.4 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
CHEMBL3040803 102580 0 None -7 6 Rat 8.4 pKd = 8.4 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
CHEMBL3216590 102580 0 None -7 6 Rat 8.4 pKd = 8.4 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostate assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
2142 3096 58 None -2 36 Human 7.5 pKd = 7.5 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00370a011
4920903 3096 58 None -2 36 Human 7.5 pKd = 7.5 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00370a011
502 3096 58 None -2 36 Human 7.5 pKd = 7.5 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00370a011
5775 3096 58 None -2 36 Human 7.5 pKd = 7.5 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00370a011
CHEMBL597 3096 58 None -2 36 Human 7.5 pKd = 7.5 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00370a011
DB00692 3096 58 None -2 36 Human 7.5 pKd = 7.5 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm00370a011
4418 34222 85 None -10 6 Rat 7.5 pKd = 7.5 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL142635 34222 85 None -10 6 Rat 7.5 pKd = 7.5 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.ejmech.2015.04.005
71817547 102578 0 None -10 6 Rat 7.5 pKd = 7.5 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
CHEMBL2419771 102578 0 None -10 6 Rat 7.5 pKd = 7.5 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
CHEMBL3040800 102578 0 None -10 6 Rat 7.5 pKd = 7.5 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
44294973 184001 0 None 1 2 Rat 6.5 pKd = 6.5 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 394 7 0 6 3.4 COc1cc(=O)oc2cc(OCCCN3CCN(c4ccccc4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
CHEMBL48194 184001 0 None 1 2 Rat 6.5 pKd = 6.5 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 394 7 0 6 3.4 COc1cc(=O)oc2cc(OCCCN3CCN(c4ccccc4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
135398737 958 93 None -5 89 Human 7.4 pKd = 7.4 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm00370a011
38 958 93 None -5 89 Human 7.4 pKd = 7.4 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm00370a011
722 958 93 None -5 89 Human 7.4 pKd = 7.4 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm00370a011
CHEMBL42 958 93 None -5 89 Human 7.4 pKd = 7.4 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm00370a011
DB00363 958 93 None -5 89 Human 7.4 pKd = 7.4 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm00370a011
86288949 112625 0 None 3 3 Rat 7.4 pKd = 7.4 Binding
Antagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 mins
ChEMBL 434 8 0 4 3.8 CN1C(=O)N(CCCCCN2CCN(c3ccccc3)CC2)C(C)(c2ccccc2)C1=O 10.1016/j.ejmech.2014.01.065
CHEMBL3233665 112625 0 None 3 3 Rat 7.4 pKd = 7.4 Binding
Antagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 mins
ChEMBL 434 8 0 4 3.8 CN1C(=O)N(CCCCCN2CCN(c3ccccc3)CC2)C(C)(c2ccccc2)C1=O 10.1016/j.ejmech.2014.01.065
CHEMBL3302599 112625 0 None 3 3 Rat 7.4 pKd = 7.4 Binding
Antagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 mins
ChEMBL 434 8 0 4 3.8 CN1C(=O)N(CCCCCN2CCN(c3ccccc3)CC2)C(C)(c2ccccc2)C1=O 10.1016/j.ejmech.2014.01.065
2419 695 28 None -288 12 Human 6.4 pKd = 6.4 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm011066n
9 695 28 None -288 12 Human 6.4 pKd = 6.4 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm011066n
CHEMBL13647 695 28 None -288 12 Human 6.4 pKd = 6.4 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm011066n
102 4127 48 None -346 49 Human 6.4 pKd = 6.4 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00370a011
3659 4127 48 None -346 49 Human 6.4 pKd = 6.4 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00370a011
8969 4127 48 None -346 49 Human 6.4 pKd = 6.4 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00370a011
CHEMBL15245 4127 48 None -346 49 Human 6.4 pKd = 6.4 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00370a011
DB01392 4127 48 None -346 49 Human 6.4 pKd = 6.4 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00370a011
15112598 9321 0 None -2 3 Rat 5.4 pKd = 5.4 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 444 9 3 7 3.3 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(OC(C)C2=NCCN2)c(Cl)c1 10.1021/jm00115a008
CHEMBL111090 9321 0 None -2 3 Rat 5.4 pKd = 5.4 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 444 9 3 7 3.3 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(OC(C)C2=NCCN2)c(Cl)c1 10.1021/jm00115a008
134149596 148465 0 None -10 4 Rat 8.4 pKd = 8.4 Binding
Competitive antagonist activity at alpha1A-adrenoceptor in Wistar rat prostatic vas deference assessed as inhibition of (-)-NE-induced contractions preincubated for 60 mins before (-)-NE challenge measured after 45 mins by Schild plot analysisCompetitive antagonist activity at alpha1A-adrenoceptor in Wistar rat prostatic vas deference assessed as inhibition of (-)-NE-induced contractions preincubated for 60 mins before (-)-NE challenge measured after 45 mins by Schild plot analysis
ChEMBL 368 6 0 5 3.6 CC(C)Oc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2016.06.052
CHEMBL3938038 148465 0 None -10 4 Rat 8.4 pKd = 8.4 Binding
Competitive antagonist activity at alpha1A-adrenoceptor in Wistar rat prostatic vas deference assessed as inhibition of (-)-NE-induced contractions preincubated for 60 mins before (-)-NE challenge measured after 45 mins by Schild plot analysisCompetitive antagonist activity at alpha1A-adrenoceptor in Wistar rat prostatic vas deference assessed as inhibition of (-)-NE-induced contractions preincubated for 60 mins before (-)-NE challenge measured after 45 mins by Schild plot analysis
ChEMBL 368 6 0 5 3.6 CC(C)Oc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2016.06.052
491 192 9 None -22 12 Rat 8.4 pKd = 8.4 Binding
In vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferensIn vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
9891167 192 9 None -22 12 Rat 8.4 pKd = 8.4 Binding
In vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferensIn vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
CHEMBL13856 192 9 None -22 12 Rat 8.4 pKd = 8.4 Binding
In vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferensIn vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
71817545 92124 0 None 2 6 Rat 8.3 pKd = 8.3 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 354 7 2 5 3.0 COc1ccc2cc[nH]c2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL2419765 92124 0 None 2 6 Rat 8.3 pKd = 8.3 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 354 7 2 5 3.0 COc1ccc2cc[nH]c2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
14348818 109774 0 None 5 3 Rat 5.4 pKd = 5.4 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
CHEMBL323176 109774 0 None 5 3 Rat 5.4 pKd = 5.4 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
44294687 96907 0 None 7 2 Rat 7.4 pKd = 7.4 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 380 6 0 7 2.5 Cc1cc(=O)oc2cc(OCCCN3CCN(c4ncccn4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
CHEMBL265805 96907 0 None 7 2 Rat 7.4 pKd = 7.4 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 380 6 0 7 2.5 Cc1cc(=O)oc2cc(OCCCN3CCN(c4ncccn4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
155534921 171987 0 None -5 2 Rat 6.4 pKd = 6.4 Binding
Antagonistic activity at alpha1A adrenoceptor in Sprague-Dawley rat vas deferens assessed as inhibition of noradrenaline-induced contractions after 0.5 hrs in presence of alpha2/beta adrenoceptor blocker yohimbine, propranolol by Schild plot analysisAntagonistic activity at alpha1A adrenoceptor in Sprague-Dawley rat vas deferens assessed as inhibition of noradrenaline-induced contractions after 0.5 hrs in presence of alpha2/beta adrenoceptor blocker yohimbine, propranolol by Schild plot analysis
ChEMBL 461 8 2 6 3.9 COc1ccc(OC)c(N2CCN(CC(O)COc3cccc4[nH]c5ccccc5c34)CC2)c1 10.1016/j.bmc.2016.09.010
CHEMBL4471070 171987 0 None -5 2 Rat 6.4 pKd = 6.4 Binding
Antagonistic activity at alpha1A adrenoceptor in Sprague-Dawley rat vas deferens assessed as inhibition of noradrenaline-induced contractions after 0.5 hrs in presence of alpha2/beta adrenoceptor blocker yohimbine, propranolol by Schild plot analysisAntagonistic activity at alpha1A adrenoceptor in Sprague-Dawley rat vas deferens assessed as inhibition of noradrenaline-induced contractions after 0.5 hrs in presence of alpha2/beta adrenoceptor blocker yohimbine, propranolol by Schild plot analysis
ChEMBL 461 8 2 6 3.9 COc1ccc(OC)c(N2CCN(CC(O)COc3cccc4[nH]c5ccccc5c34)CC2)c1 10.1016/j.bmc.2016.09.010
44294988 193260 0 None 1 2 Rat 7.4 pKd = 7.4 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 396 7 0 8 2.2 COc1cc(=O)oc2cc(OCCCN3CCN(c4ncccn4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
CHEMBL52384 193260 0 None 1 2 Rat 7.4 pKd = 7.4 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 396 7 0 8 2.2 COc1cc(=O)oc2cc(OCCCN3CCN(c4ncccn4)CC3)ccc12 10.1016/s0960-894x(02)00933-2
73437729 118535 0 None 5 2 Rat 7.3 pKd = 7.3 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 426 7 2 4 3.8 COc1ccccc1N1CCN(CCCNC(=O)c2cc3cc(Cl)ccc3[nH]2)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL3415018 118535 0 None 5 2 Rat 7.3 pKd = 7.3 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 426 7 2 4 3.8 COc1ccccc1N1CCN(CCCNC(=O)c2cc3cc(Cl)ccc3[nH]2)CC1 10.1016/j.ejmech.2015.04.005
86288950 112643 0 None 2 4 Rat 7.3 pKd = 7.3 Binding
Antagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 mins
ChEMBL 452 8 0 4 3.9 CN1C(=O)N(CCCCCN2CCN(c3ccccc3F)CC2)C(C)(c2ccccc2)C1=O 10.1016/j.ejmech.2014.01.065
CHEMBL3233666 112643 0 None 2 4 Rat 7.3 pKd = 7.3 Binding
Antagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 mins
ChEMBL 452 8 0 4 3.9 CN1C(=O)N(CCCCCN2CCN(c3ccccc3F)CC2)C(C)(c2ccccc2)C1=O 10.1016/j.ejmech.2014.01.065
CHEMBL3302931 112643 0 None 2 4 Rat 7.3 pKd = 7.3 Binding
Antagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 minsAntagonist activity at alpha1A adrenoceptor in Wistar (Krf:(WI) WU) rat endothelium-denuded tail artery assessed as inhibition of noradrenaline-induced contraction after 30 mins
ChEMBL 452 8 0 4 3.9 CN1C(=O)N(CCCCCN2CCN(c3ccccc3F)CC2)C(C)(c2ccccc2)C1=O 10.1016/j.ejmech.2014.01.065
71817386 102586 0 None -6 6 Rat 8.3 pKd = 8.3 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL2419769 102586 0 None -6 6 Rat 8.3 pKd = 8.3 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL3040851 102586 0 None -6 6 Rat 8.3 pKd = 8.3 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
10694582 38567 0 None - 1 Rat 8.3 pKd = 8.3 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 444 5 2 11 -1.1 COc1cc2nc(N3CCN(C(=O)c4no[n+]([O-])c4C(N)=O)CC3)nc(N)c2cc1OC 10.1021/jm00025a012
CHEMBL146481 38567 0 None - 1 Rat 8.3 pKd = 8.3 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 444 5 2 11 -1.1 COc1cc2nc(N3CCN(C(=O)c4no[n+]([O-])c4C(N)=O)CC3)nc(N)c2cc1OC 10.1021/jm00025a012
73437677 118536 0 None 3 2 Rat 7.3 pKd = 7.3 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 406 7 1 5 3.1 COc1ccccc1N1CCN(CCCNC(=O)c2cn(C)c3ccccc23)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL3415019 118536 0 None 3 2 Rat 7.3 pKd = 7.3 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 406 7 1 5 3.1 COc1ccccc1N1CCN(CCCNC(=O)c2cn(C)c3ccccc23)CC1 10.1016/j.ejmech.2015.04.005
73437675 118532 0 None 2 2 Rat 7.3 pKd = 7.3 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 408 7 3 5 2.8 COc1ccccc1N1CCN(CCCNC(=O)c2cc3cc(O)ccc3[nH]2)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL3415015 118532 0 None 2 2 Rat 7.3 pKd = 7.3 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 408 7 3 5 2.8 COc1ccccc1N1CCN(CCCNC(=O)c2cc3cc(O)ccc3[nH]2)CC1 10.1016/j.ejmech.2015.04.005
73437730 118533 0 None 10 2 Rat 7.2 pKd = 7.2 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 437 8 2 6 3.0 COc1ccccc1N1CCN(CCCNC(=O)c2cc3cccc([N+](=O)[O-])c3[nH]2)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL3415016 118533 0 None 10 2 Rat 7.2 pKd = 7.2 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 437 8 2 6 3.0 COc1ccccc1N1CCN(CCCNC(=O)c2cc3cccc([N+](=O)[O-])c3[nH]2)CC1 10.1016/j.ejmech.2015.04.005
73437678 118534 0 None 3 2 Rat 7.2 pKd = 7.2 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 470 7 2 4 3.9 COc1ccccc1N1CCN(CCCNC(=O)c2cc3ccc(Br)cc3[nH]2)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL3415017 118534 0 None 3 2 Rat 7.2 pKd = 7.2 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 470 7 2 4 3.9 COc1ccccc1N1CCN(CCCNC(=O)c2cc3ccc(Br)cc3[nH]2)CC1 10.1016/j.ejmech.2015.04.005
9871544 14216 3 None -141 11 Human 6.2 pKd = 6.2 Binding
Binding affinity to Alpha-1A adrenergic receptorBinding affinity to Alpha-1A adrenergic receptor
ChEMBL 526 7 0 5 4.6 COc1ccc(C[C@H](C)CN2C[C@@H](C(=O)N3CCN(c4ccc(F)c(F)c4)CC3)[C@H]3CCCC[C@H]3C2)cn1 10.1016/j.bmcl.2010.01.063
CHEMBL1076624 14216 3 None -141 11 Human 6.2 pKd = 6.2 Binding
Binding affinity to Alpha-1A adrenergic receptorBinding affinity to Alpha-1A adrenergic receptor
ChEMBL 526 7 0 5 4.6 COc1ccc(C[C@H](C)CN2C[C@@H](C(=O)N3CCN(c4ccc(F)c(F)c4)CC3)[C@H]3CCCC[C@H]3C2)cn1 10.1016/j.bmcl.2010.01.063
CHEMBL1198948 14216 3 None -141 11 Human 6.2 pKd = 6.2 Binding
Binding affinity to Alpha-1A adrenergic receptorBinding affinity to Alpha-1A adrenergic receptor
ChEMBL 526 7 0 5 4.6 COc1ccc(C[C@H](C)CN2C[C@@H](C(=O)N3CCN(c4ccc(F)c(F)c4)CC3)[C@H]3CCCC[C@H]3C2)cn1 10.1016/j.bmcl.2010.01.063
118733023 118537 0 None 19 2 Rat 8.1 pKd = 8.1 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 482 9 1 5 4.6 COc1ccccc1N1CCN(CCCNC(=O)c2cc3ccccc3n2Cc2ccccc2)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL3415020 118537 0 None 19 2 Rat 8.1 pKd = 8.1 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 482 9 1 5 4.6 COc1ccccc1N1CCN(CCCNC(=O)c2cc3ccccc3n2Cc2ccccc2)CC1 10.1016/j.ejmech.2015.04.005
73438501 118529 0 None 64 2 Rat 8.1 pKd = 8.1 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 406 8 2 4 3.0 COc1ccccc1N1CCN(CCCNC(=O)Cc2c[nH]c3ccccc23)CC1 10.1016/j.ejmech.2015.04.005
CHEMBL3415012 118529 0 None 64 2 Rat 8.1 pKd = 8.1 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 406 8 2 4 3.0 COc1ccccc1N1CCN(CCCNC(=O)Cc2c[nH]c3ccccc23)CC1 10.1016/j.ejmech.2015.04.005
44294991 101523 0 None 2 2 Rat 8.1 pKd = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 424 8 0 7 3.4 COc1ccccc1N1CCN(CCCOc2ccc3c(OC)cc(=O)oc3c2)CC1 10.1016/s0960-894x(02)00933-2
CHEMBL298108 101523 0 None 2 2 Rat 8.1 pKd = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
ChEMBL 424 8 0 7 3.4 COc1ccccc1N1CCN(CCCOc2ccc3c(OC)cc(=O)oc3c2)CC1 10.1016/s0960-894x(02)00933-2
73437676 118496 0 None 18 2 Rat 7.1 pKd = 7.1 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 422 8 2 5 3.1 COc1ccc2[nH]c(C(=O)NCCCN3CCN(c4ccccc4OC)CC3)cc2c1 10.1016/j.ejmech.2015.04.005
CHEMBL3414578 118496 0 None 18 2 Rat 7.1 pKd = 7.1 Binding
Antagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 minsAntagonist activity at Sprague-Dawley rat prostatic vas deferens adrenergic alpha-1A receptor after 20 mins
ChEMBL 422 8 2 5 3.1 COc1ccc2[nH]c(C(=O)NCCCN3CCN(c4ccccc4OC)CC3)cc2c1 10.1016/j.ejmech.2015.04.005
14348818 109774 0 None 5 3 Rat 5.1 pKd = 5.1 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
CHEMBL323176 109774 0 None 5 3 Rat 5.1 pKd = 5.1 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
ChEMBL 415 7 4 7 2.9 C/C(=N\OCC(O)CNC(C)(C)C)c1cc(Cl)c(NC2=NCCN2)c(Cl)c1 10.1021/jm00115a008
490 191 8 None -18 12 Rat 8.1 pKd = 8.1 Binding
In vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferensIn vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
9890547 191 8 None -18 12 Rat 8.1 pKd = 8.1 Binding
In vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferensIn vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
CHEMBL268758 191 8 None -18 12 Rat 8.1 pKd = 8.1 Binding
In vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferensIn vitro functional activity at Alpha-1A adrenergic receptor in rat vas deferens
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
10550345 119194 0 None - 1 Rat 8.0 pKd = 8.0 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 426 4 1 11 -0.3 COc1cc2nc(N3CCN(C(=O)c4no[n+]([O-])c4C#N)CC3)nc(N)c2cc1OC 10.1021/jm00025a012
CHEMBL343188 119194 0 None - 1 Rat 8.0 pKd = 8.0 Binding
Partial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic stripsPartial affinity towards Alpha-1 adrenergic receptor was assessed on rat aortic strips
ChEMBL 426 4 1 11 -0.3 COc1cc2nc(N3CCN(C(=O)c4no[n+]([O-])c4C#N)CC3)nc(N)c2cc1OC 10.1021/jm00025a012
71817549 102580 0 None -7 6 Rat 8.0 pKd = 8.0 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
CHEMBL3040803 102580 0 None -7 6 Rat 8.0 pKd = 8.0 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
CHEMBL3216590 102580 0 None -7 6 Rat 8.0 pKd = 8.0 Binding
Antagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysisAntagonist activity at alpha-1A adrenoreceptor in Sprague-Dawley rat prostatic vas deferens assessed as inhibition of noradrenaline-induced tissue contraction after 30 mins by Schild plot analysis
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
10531157 37802 0 None 2290 3 Human 11.0 pKi = 11 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 572 8 2 8 3.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3[N+](=O)[O-])CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145843 37802 0 None 2290 3 Human 11.0 pKi = 11 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 572 8 2 8 3.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3[N+](=O)[O-])CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
60820 4308 14 None 1 13 Human 10.7 pKi = 10.7 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 421 6 0 4 4.4 CC(C)Oc1ccccc1N1CCN(Cc2cccc(C(=O)N3CCCCC3)c2)CC1 10.1016/j.bmc.2008.02.091
CHEMBL10085 4308 14 None 1 13 Human 10.7 pKi = 10.7 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 421 6 0 4 4.4 CC(C)Oc1ccccc1N1CCN(Cc2cccc(C(=O)N3CCCCC3)c2)CC1 10.1016/j.bmc.2008.02.091
10745901 37464 0 None 1698 3 Human 10.7 pKi = 10.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 586 8 2 8 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3[N+](=O)[O-])C[C@@H]2C)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145547 37464 0 None 1698 3 Human 10.7 pKi = 10.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 586 8 2 8 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3[N+](=O)[O-])C[C@@H]2C)C1c1ccc(F)c(F)c1 10.1021/jm990202+
129211 3749 78 None -1 15 Human 10.5 pKi = 10.5 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
2562 3749 78 None -1 15 Human 10.5 pKi = 10.5 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
488 3749 78 None -1 15 Human 10.5 pKi = 10.5 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
CHEMBL836 3749 78 None -1 15 Human 10.5 pKi = 10.5 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
DB00706 3749 78 None -1 15 Human 10.5 pKi = 10.5 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970364a
164089 110353 24 None 1 4 Bovine 10.5 pKi = 10.5 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 395 5 1 7 3.4 COc1cc2c(cc1OC)CN(c1cc(N)c3cc(OC)c(OC)cc3n1)CC2 10.1021/jm00018a001
CHEMBL324090 110353 24 None 1 4 Bovine 10.5 pKi = 10.5 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 395 5 1 7 3.4 COc1cc2c(cc1OC)CN(c1cc(N)c3cc(OC)c(OC)cc3n1)CC2 10.1021/jm00018a001
129211 3749 78 None -2 15 Rat 10.5 pKi = 10.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm990567u
2562 3749 78 None -2 15 Rat 10.5 pKi = 10.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm990567u
488 3749 78 None -2 15 Rat 10.5 pKi = 10.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm990567u
CHEMBL836 3749 78 None -2 15 Rat 10.5 pKi = 10.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm990567u
DB00706 3749 78 None -2 15 Rat 10.5 pKi = 10.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm990567u
4151 3607 89 None 33 3 Human 10.4 pKi = 10.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1016/j.bmcl.2004.11.032
493 3607 89 None 33 3 Human 10.4 pKi = 10.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1016/j.bmcl.2004.11.032
5312125 3607 89 None 33 3 Human 10.4 pKi = 10.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1016/j.bmcl.2004.11.032
CHEMBL24778 3607 89 None 33 3 Human 10.4 pKi = 10.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1016/j.bmcl.2004.11.032
DB06207 3607 89 None 33 3 Human 10.4 pKi = 10.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1016/j.bmcl.2004.11.032
4151 3607 89 None 33 3 Human 10.4 pKi = 10.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/jm960697s
493 3607 89 None 33 3 Human 10.4 pKi = 10.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/jm960697s
5312125 3607 89 None 33 3 Human 10.4 pKi = 10.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/jm960697s
CHEMBL24778 3607 89 None 33 3 Human 10.4 pKi = 10.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/jm960697s
DB06207 3607 89 None 33 3 Human 10.4 pKi = 10.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 10.1021/jm960697s
44298611 100653 0 None 125 3 Human 10.4 pKi = 10.4 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 440 7 1 6 2.3 Cc1[nH]c(=O)n(CCCN2CCN(c3ccccc3OCC(F)(F)F)CC2)c(=O)c1C 10.1016/s0960-894x(03)00305-6
CHEMBL292189 100653 0 None 125 3 Human 10.4 pKi = 10.4 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 440 7 1 6 2.3 Cc1[nH]c(=O)n(CCCN2CCN(c3ccccc3OCC(F)(F)F)CC2)c(=O)c1C 10.1016/s0960-894x(03)00305-6
164089 110353 24 None -1 4 Human 10.4 pKi = 10.4 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 395 5 1 7 3.4 COc1cc2c(cc1OC)CN(c1cc(N)c3cc(OC)c(OC)cc3n1)CC2 10.1021/jm00018a001
CHEMBL324090 110353 24 None -1 4 Human 10.4 pKi = 10.4 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 395 5 1 7 3.4 COc1cc2c(cc1OC)CN(c1cc(N)c3cc(OC)c(OC)cc3n1)CC2 10.1021/jm00018a001
10789770 100885 0 None 1 4 Rat 10.4 pKi = 10.4 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 451 6 1 7 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(OC)c(OC)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL293695 100885 0 None 1 4 Rat 10.4 pKi = 10.4 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 451 6 1 7 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(OC)c(OC)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
10622402 202760 0 None 18 2 Rat 10.4 pKi = 10.4 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 427 5 1 7 2.4 COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2s1 10.1021/jm000541z
CHEMBL62028 202760 0 None 18 2 Rat 10.4 pKi = 10.4 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 427 5 1 7 2.4 COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2s1 10.1021/jm000541z
4209 3163 75 None -3 33 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2014.12.045
4893 3163 75 None -3 33 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2014.12.045
503 3163 75 None -3 33 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2014.12.045
5385 3163 75 None -3 33 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2014.12.045
CHEMBL2 3163 75 None -3 33 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2014.12.045
DB00457 3163 75 None -3 33 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2014.12.045
4209 3163 75 None -3 33 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm401895u
4893 3163 75 None -3 33 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm401895u
503 3163 75 None -3 33 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm401895u
5385 3163 75 None -3 33 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm401895u
CHEMBL2 3163 75 None -3 33 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm401895u
DB00457 3163 75 None -3 33 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm401895u
76333279 84816 0 None - 1 Human 10.3 pKi = 10.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 405 8 1 5 4.6 COc1cccc(OC)c1OCCN[C@H]1C[C@@H](c2ccccc2)c2ccccc2O1 10.1007/s00044-010-9379-1
CHEMBL2234441 84816 0 None - 1 Human 10.3 pKi = 10.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 405 8 1 5 4.6 COc1cccc(OC)c1OCCN[C@H]1C[C@@H](c2ccccc2)c2ccccc2O1 10.1007/s00044-010-9379-1
10698570 118758 0 None 257 3 Human 10.3 pKi = 10.3 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 586 8 2 8 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3[N+](=O)[O-])C[C@H]2C)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL341849 118758 0 None 257 3 Human 10.3 pKi = 10.3 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 586 8 2 8 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3[N+](=O)[O-])C[C@H]2C)C1c1ccc(F)c(F)c1 10.1021/jm990202+
11742834 165770 0 None -1 6 Human 10.3 pKi = 10.3 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 419 9 1 5 4.7 COc1cccc(OC)c1OCCNC[C@@H]1C[C@H](c2ccccc2)c2ccccc2O1 10.1021/jm011066n
CHEMBL42472 165770 0 None -1 6 Human 10.3 pKi = 10.3 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 419 9 1 5 4.7 COc1cccc(OC)c1OCCNC[C@@H]1C[C@H](c2ccccc2)c2ccccc2O1 10.1021/jm011066n
76333279 84816 0 None - 1 Human 10.3 pKi = 10.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 405 8 1 5 4.6 COc1cccc(OC)c1OCCN[C@H]1C[C@@H](c2ccccc2)c2ccccc2O1 10.1007/s00044-010-9379-1
CHEMBL2234441 84816 0 None - 1 Human 10.3 pKi = 10.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 405 8 1 5 4.6 COc1cccc(OC)c1OCCN[C@H]1C[C@@H](c2ccccc2)c2ccccc2O1 10.1007/s00044-010-9379-1
129211 3749 78 None -1 15 Human 10.3 pKi = 10.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2010.09.042
2562 3749 78 None -1 15 Human 10.3 pKi = 10.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2010.09.042
488 3749 78 None -1 15 Human 10.3 pKi = 10.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2010.09.042
CHEMBL836 3749 78 None -1 15 Human 10.3 pKi = 10.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2010.09.042
DB00706 3749 78 None -1 15 Human 10.3 pKi = 10.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2010.09.042
19085858 104152 0 None 173 3 Human 10.2 pKi = 10.2 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in CHO cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in CHO cells
ChEMBL 501 7 0 8 3.6 CSc1ccc2c(c1)C(=O)N(CCCCN1CCC(n3c(=O)oc4ccccc43)CC1)S2(=O)=O 10.1016/s0960-894x(98)00446-6
CHEMBL309518 104152 0 None 173 3 Human 10.2 pKi = 10.2 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in CHO cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in CHO cells
ChEMBL 501 7 0 8 3.6 CSc1ccc2c(c1)C(=O)N(CCCCN1CCC(n3c(=O)oc4ccccc43)CC1)S2(=O)=O 10.1016/s0960-894x(98)00446-6
10817365 36713 0 None 501 3 Human 10.2 pKi = 10.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 599 9 2 7 3.9 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL144933 36713 0 None 501 3 Human 10.2 pKi = 10.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 599 9 2 7 3.9 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)C(=O)N1 10.1021/jm990201h
10651636 37861 0 None 1318 3 Human 10.2 pKi = 10.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 630 8 2 5 6.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccc(C)cc3)(c3ccccc3C)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL145894 37861 0 None 1318 3 Human 10.2 pKi = 10.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 630 8 2 5 6.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccc(C)cc3)(c3ccccc3C)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
44298664 197286 0 None 31 3 Human 10.2 pKi = 10.2 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 462 7 1 6 2.8 O=c1[nH]c2ccccc2c(=O)n1CCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
CHEMBL56863 197286 0 None 31 3 Human 10.2 pKi = 10.2 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 462 7 1 6 2.8 O=c1[nH]c2ccccc2c(=O)n1CCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
19085914 205825 0 None 234 3 Human 10.2 pKi = 10.2 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 485 7 0 8 2.9 COc1ccc2c(c1)C(=O)N(CCCCN1CCC(n3c(=O)oc4ccccc43)CC1)S2(=O)=O 10.1016/s0960-894x(98)00446-6
CHEMBL83340 205825 0 None 234 3 Human 10.2 pKi = 10.2 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 485 7 0 8 2.9 COc1ccc2c(c1)C(=O)N(CCCCN1CCC(n3c(=O)oc4ccccc43)CC1)S2(=O)=O 10.1016/s0960-894x(98)00446-6
49781233 17925 0 None 5 2 Bovine 10.2 pKi = 10.2 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 392 2 0 7 2.9 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4nnnn4C)cc32)CC1 10.1021/jm100652h
CHEMBL1259217 17925 0 None 5 2 Bovine 10.2 pKi = 10.2 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 392 2 0 7 2.9 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4nnnn4C)cc32)CC1 10.1021/jm100652h
44324405 206761 0 None 117 3 Human 10.2 pKi = 10.2 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 511 7 2 4 3.9 CN1C=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC1=O 10.1021/jm990612y
CHEMBL90086 206761 0 None 117 3 Human 10.2 pKi = 10.2 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 511 7 2 4 3.9 CN1C=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC1=O 10.1021/jm990612y
10767606 207451 0 None 371 3 Human 10.2 pKi = 10.2 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 497 7 3 4 3.6 N#Cc1cc(F)ccc1C1CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1016/j.ejmech.2017.03.025
CHEMBL94188 207451 0 None 371 3 Human 10.2 pKi = 10.2 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 497 7 3 4 3.6 N#Cc1cc(F)ccc1C1CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1016/j.ejmech.2017.03.025
10767606 207451 0 None 371 3 Human 10.2 pKi = 10.2 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 497 7 3 4 3.6 N#Cc1cc(F)ccc1C1CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
CHEMBL94188 207451 0 None 371 3 Human 10.2 pKi = 10.2 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 497 7 3 4 3.6 N#Cc1cc(F)ccc1C1CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
4209 3163 75 None -3 33 Rat 10.2 pKi = 10.2 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990277d
4893 3163 75 None -3 33 Rat 10.2 pKi = 10.2 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990277d
503 3163 75 None -3 33 Rat 10.2 pKi = 10.2 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990277d
5385 3163 75 None -3 33 Rat 10.2 pKi = 10.2 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990277d
CHEMBL2 3163 75 None -3 33 Rat 10.2 pKi = 10.2 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990277d
DB00457 3163 75 None -3 33 Rat 10.2 pKi = 10.2 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990277d
9913449 106452 1 None 13 3 Human 10.1 pKi = 10.1 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 489 6 0 7 3.5 O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL313990 106452 1 None 13 3 Human 10.1 pKi = 10.1 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 489 6 0 7 3.5 O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
10526964 206965 0 None 1 2 Bovine 10.1 pKi = 10.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 437 10 1 6 3.2 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2OCC2CC2)CC1 10.1021/jm970166j
CHEMBL91278 206965 0 None 1 2 Bovine 10.1 pKi = 10.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 437 10 1 6 3.2 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2OCC2CC2)CC1 10.1021/jm970166j
76315111 84818 0 None - 1 Human 10.1 pKi = 10.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 421 8 1 5 5.3 COc1cccc(OC)c1OCCN[C@H]1C[C@@H](c2ccccc2)c2ccccc2S1 10.1007/s00044-010-9379-1
CHEMBL2234443 84818 0 None - 1 Human 10.1 pKi = 10.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 421 8 1 5 5.3 COc1cccc(OC)c1OCCN[C@H]1C[C@@H](c2ccccc2)c2ccccc2S1 10.1007/s00044-010-9379-1
10699164 37028 0 None 151 3 Human 10.1 pKi = 10.1 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 552 7 2 7 3.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C#N)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145190 37028 0 None 151 3 Human 10.1 pKi = 10.1 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 552 7 2 7 3.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C#N)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
499 4077 18 None -1 14 Rat 10.1 pKi = 10.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
5685 4077 18 None -1 14 Rat 10.1 pKi = 10.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
CHEMBL25554 4077 18 None -1 14 Rat 10.1 pKi = 10.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
52942381 17892 0 None -2 3 Bovine 10.1 pKi = 10.1 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 339 2 1 4 3.1 CN1CCN(C2Cc3ccccc3Sc3ccc(CN)cc32)CC1 10.1021/jm100652h
CHEMBL1259113 17892 0 None -2 3 Bovine 10.1 pKi = 10.1 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 339 2 1 4 3.1 CN1CCN(C2Cc3ccccc3Sc3ccc(CN)cc32)CC1 10.1021/jm100652h
19085876 205814 0 None 87 3 Human 10.1 pKi = 10.1 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 473 6 0 7 3.0 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3cc(F)ccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL83272 205814 0 None 87 3 Human 10.1 pKi = 10.1 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 473 6 0 7 3.0 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3cc(F)ccc32)CC1 10.1016/s0960-894x(98)00446-6
49781447 17844 0 None 14 3 Bovine 10.1 pKi = 10.1 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 391 2 0 6 3.5 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ncn(C)n4)cc32)CC1 10.1021/jm100652h
CHEMBL1258988 17844 0 None 14 3 Bovine 10.1 pKi = 10.1 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 391 2 0 6 3.5 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ncn(C)n4)cc32)CC1 10.1021/jm100652h
4209 3163 75 None -3 33 Rat 10.1 pKi = 10.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
4893 3163 75 None -3 33 Rat 10.1 pKi = 10.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
503 3163 75 None -3 33 Rat 10.1 pKi = 10.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
5385 3163 75 None -3 33 Rat 10.1 pKi = 10.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
CHEMBL2 3163 75 None -3 33 Rat 10.1 pKi = 10.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
DB00457 3163 75 None -3 33 Rat 10.1 pKi = 10.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 nan
49781892 17901 0 None -1 3 Bovine 10.1 pKi = 10.1 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 381 3 1 4 3.3 CC(=O)NCc1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
CHEMBL1259144 17901 0 None -1 3 Bovine 10.1 pKi = 10.1 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 381 3 1 4 3.3 CC(=O)NCc1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
44289248 168976 0 None 4 6 Human 10.1 pKi = 10.1 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2S1 10.1021/jm011066n
CHEMBL43905 168976 0 None 4 6 Human 10.1 pKi = 10.1 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2S1 10.1021/jm011066n
76315111 84818 0 None - 1 Human 10.1 pKi = 10.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 421 8 1 5 5.3 COc1cccc(OC)c1OCCN[C@H]1C[C@@H](c2ccccc2)c2ccccc2S1 10.1007/s00044-010-9379-1
CHEMBL2234443 84818 0 None - 1 Human 10.1 pKi = 10.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 421 8 1 5 5.3 COc1cccc(OC)c1OCCN[C@H]1C[C@@H](c2ccccc2)c2ccccc2S1 10.1007/s00044-010-9379-1
10716965 167960 0 None 14 2 Rat 10.1 pKi = 10.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 419 4 1 5 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C)c(C)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL431720 167960 0 None 14 2 Rat 10.1 pKi = 10.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 419 4 1 5 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C)c(C)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
10812130 199181 0 None 7 2 Rat 10.1 pKi = 10.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 421 5 1 6 2.4 COc1ccc2c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)[nH]c2c1 10.1021/jm000541z
CHEMBL58956 199181 0 None 7 2 Rat 10.1 pKi = 10.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 421 5 1 6 2.4 COc1ccc2c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)[nH]c2c1 10.1021/jm000541z
10693231 202762 0 None -2 4 Rat 10.1 pKi = 10.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 416 4 1 6 2.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(C#N)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL62033 202762 0 None -2 4 Rat 10.1 pKi = 10.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 416 4 1 6 2.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(C#N)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
11039289 116840 0 None 12 5 Human 10.0 pKi = 10.0 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 600 13 1 9 4.7 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCCCO[N+](=O)[O-])CC3)cccc2c1=O 10.1021/jm030825u
CHEMBL338029 116840 0 None 12 5 Human 10.0 pKi = 10.0 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 600 13 1 9 4.7 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCCCO[N+](=O)[O-])CC3)cccc2c1=O 10.1021/jm030825u
34580 17891 2 None -1 3 Bovine 10.0 pKi = 10.0 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 335 1 0 4 3.6 CN1CCN(C2Cc3ccccc3Sc3ccc(C#N)cc32)CC1 10.1021/jm100652h
CHEMBL1259112 17891 2 None -1 3 Bovine 10.0 pKi = 10.0 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 335 1 0 4 3.6 CN1CCN(C2Cc3ccccc3Sc3ccc(C#N)cc32)CC1 10.1021/jm100652h
19085926 205543 0 None 199 3 Human 10.0 pKi = 10 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 469 6 0 7 3.2 Cc1ccc2c(c1)C(=O)N(CCCCN1CCC(n3c(=O)oc4ccccc43)CC1)S2(=O)=O 10.1016/s0960-894x(98)00446-6
CHEMBL81006 205543 0 None 199 3 Human 10.0 pKi = 10 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 469 6 0 7 3.2 Cc1ccc2c(c1)C(=O)N(CCCCN1CCC(n3c(=O)oc4ccccc43)CC1)S2(=O)=O 10.1016/s0960-894x(98)00446-6
9959671 32671 0 None 363 3 Human 10.0 pKi = 10 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 0 7 5.6 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL141322 32671 0 None 363 3 Human 10.0 pKi = 10 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 0 7 5.6 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10721751 34630 0 None 1412 3 Human 10.0 pKi = 10 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 569 10 1 6 4.9 COC(=O)C1=C(C)NC(=O)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL142981 34630 0 None 1412 3 Human 10.0 pKi = 10 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 569 10 1 6 4.9 COC(=O)C1=C(C)NC(=O)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10031709 37311 0 None 2511 3 Human 10.0 pKi = 10 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 613 10 0 5 8.1 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccc(C)cc3)(c3ccccc3C)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL145411 37311 0 None 2511 3 Human 10.0 pKi = 10 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 613 10 0 5 8.1 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccc(C)cc3)(c3ccccc3C)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10651219 33738 0 None 1000 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 600 10 3 8 2.1 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C(=O)N1 10.1021/jm990202+
CHEMBL142236 33738 0 None 1000 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 600 10 3 8 2.1 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C(=O)N1 10.1021/jm990202+
10650726 33758 0 None 87 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 571 9 2 7 3.8 CCOc1ccccc1N1CCN(CCCNC(=O)N2C(=O)NC(C)=C(C(=O)OC)C2c2ccc(F)c(F)c2)CC1 10.1021/jm990202+
CHEMBL142251 33758 0 None 87 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 571 9 2 7 3.8 CCOc1ccccc1N1CCN(CCCNC(=O)N2C(=O)NC(C)=C(C(=O)OC)C2c2ccc(F)c(F)c2)CC1 10.1021/jm990202+
10531476 34345 0 None 269 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 590 8 2 10 3.0 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc2nonc2c1 10.1021/jm990200p
CHEMBL142743 34345 0 None 269 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 590 8 2 10 3.0 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc2nonc2c1 10.1021/jm990200p
10747201 36882 0 None 1288 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 618 10 3 8 2.3 COCC1=C(C(=O)OC)C(c2cc(F)c(F)cc2F)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C(=O)N1 10.1021/jm990202+
CHEMBL145072 36882 0 None 1288 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 618 10 3 8 2.3 COCC1=C(C(=O)OC)C(c2cc(F)c(F)cc2F)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C(=O)N1 10.1021/jm990202+
10699164 37028 0 None 151 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 552 7 2 7 3.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C#N)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145190 37028 0 None 151 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 552 7 2 7 3.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C#N)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
10745380 38791 0 None 177 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 557 8 2 7 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3OC)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL146654 38791 0 None 177 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 557 8 2 7 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3OC)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
10438280 101598 0 None 446 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 584 8 2 7 3.8 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990200p
CHEMBL298713 101598 0 None 446 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 584 8 2 7 3.8 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990200p
11802456 170960 0 None 316 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 584 9 3 7 2.9 CCC1=C(C(=O)OC)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C(=O)N1 10.1021/jm990202+
CHEMBL445577 170960 0 None 316 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 584 9 3 7 2.9 CCC1=C(C(=O)OC)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C(=O)N1 10.1021/jm990202+
10627090 34561 0 None 1288 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 581 9 2 7 3.8 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL142929 34561 0 None 1288 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 581 9 2 7 3.8 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
10721751 34630 0 None 1412 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 569 10 1 6 4.9 COC(=O)C1=C(C)NC(=O)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL142981 34630 0 None 1412 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 569 10 1 6 4.9 COC(=O)C1=C(C)NC(=O)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
10438280 101598 0 None 446 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 584 8 2 7 3.8 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL298713 101598 0 None 446 3 Human 10.0 pKi = 10 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 584 8 2 7 3.8 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
10578715 102675 0 None 144 3 Human 10.0 pKi = 10.0 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 556 10 1 7 4.2 COc1ccc(N2C(=O)c3ccc(C(=O)NCCCN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
CHEMBL304591 102675 0 None 144 3 Human 10.0 pKi = 10.0 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 556 10 1 7 4.2 COc1ccc(N2C(=O)c3ccc(C(=O)NCCCN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
10815593 207039 0 None 436 3 Human 9.9 pKi = 9.9 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 511 7 2 4 3.7 CN1C=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC1=O 10.1021/jm990612y
CHEMBL91616 207039 0 None 436 3 Human 9.9 pKi = 9.9 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 511 7 2 4 3.7 CN1C=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC1=O 10.1021/jm990612y
19085866 105417 0 None 117 3 Human 9.9 pKi = 9.9 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 455 6 0 7 2.9 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL311890 105417 0 None 117 3 Human 9.9 pKi = 9.9 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 455 6 0 7 2.9 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
49781893 17902 0 None 2 3 Bovine 9.9 pKi = 9.9 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 409 4 1 4 4.0 CC(C)C(=O)NCc1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
CHEMBL1259145 17902 0 None 2 3 Bovine 9.9 pKi = 9.9 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 409 4 1 4 4.0 CC(C)C(=O)NCc1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
10673657 206733 0 None 1071 3 Human 9.9 pKi = 9.9 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 525 7 2 4 4.3 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1021/jm990612y
CHEMBL89927 206733 0 None 1071 3 Human 9.9 pKi = 9.9 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 525 7 2 4 4.3 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1021/jm990612y
9985476 37284 0 None 912 3 Human 9.9 pKi = 9.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 570 8 3 7 2.5 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145394 37284 0 None 912 3 Human 9.9 pKi = 9.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 570 8 3 7 2.5 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
4209 3163 75 None -4 33 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
4893 3163 75 None -4 33 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
503 3163 75 None -4 33 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
5385 3163 75 None -4 33 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
CHEMBL2 3163 75 None -4 33 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
DB00457 3163 75 None -4 33 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970166j
129211 3749 78 None -7 15 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970166j
2562 3749 78 None -7 15 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970166j
488 3749 78 None -7 15 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970166j
CHEMBL836 3749 78 None -7 15 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970166j
DB00706 3749 78 None -7 15 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm970166j
10499343 206525 0 None - 1 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 369 8 2 6 1.8 COc1ccccc1N1CCN(CCCNc2ncccc2C(N)=O)CC1 10.1021/jm970166j
CHEMBL88512 206525 0 None - 1 Bovine 9.9 pKi = 9.9 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 369 8 2 6 1.8 COc1ccccc1N1CCN(CCCNc2ncccc2C(N)=O)CC1 10.1021/jm970166j
19085820 205804 0 None 1023 3 Human 9.9 pKi = 9.9 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 500 7 0 9 2.8 O=C1c2cc([N+](=O)[O-])ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL83226 205804 0 None 1023 3 Human 9.9 pKi = 9.9 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 500 7 0 9 2.8 O=C1c2cc([N+](=O)[O-])ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
129211 3749 78 None -1 15 Human 9.9 pKi = 9.9 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm9905918
2562 3749 78 None -1 15 Human 9.9 pKi = 9.9 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm9905918
488 3749 78 None -1 15 Human 9.9 pKi = 9.9 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm9905918
CHEMBL836 3749 78 None -1 15 Human 9.9 pKi = 9.9 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm9905918
DB00706 3749 78 None -1 15 Human 9.9 pKi = 9.9 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm9905918
10576661 206858 0 None 1230 3 Human 9.9 pKi = 9.9 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 479 7 3 4 3.5 N#Cc1ccccc1C1CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1016/j.ejmech.2017.03.025
CHEMBL90652 206858 0 None 1230 3 Human 9.9 pKi = 9.9 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 479 7 3 4 3.5 N#Cc1ccccc1C1CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1016/j.ejmech.2017.03.025
129211 3749 78 None -2 15 Rat 9.9 pKi = 9.9 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2011.04.032
2562 3749 78 None -2 15 Rat 9.9 pKi = 9.9 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2011.04.032
488 3749 78 None -2 15 Rat 9.9 pKi = 9.9 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2011.04.032
CHEMBL836 3749 78 None -2 15 Rat 9.9 pKi = 9.9 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2011.04.032
DB00706 3749 78 None -2 15 Rat 9.9 pKi = 9.9 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.ejmech.2011.04.032
10576661 206858 0 None 1230 3 Human 9.9 pKi = 9.9 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 479 7 3 4 3.5 N#Cc1ccccc1C1CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
CHEMBL90652 206858 0 None 1230 3 Human 9.9 pKi = 9.9 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 479 7 3 4 3.5 N#Cc1ccccc1C1CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
10649481 206818 0 None 123 3 Human 9.9 pKi = 9.9 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 514 7 1 3 4.8 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N(C)C(=O)N1C 10.1016/j.ejmech.2017.03.025
CHEMBL90420 206818 0 None 123 3 Human 9.9 pKi = 9.9 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 514 7 1 3 4.8 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N(C)C(=O)N1C 10.1016/j.ejmech.2017.03.025
11638677 84589 0 None 8 5 Rat 9.9 pKi = 9.9 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 340 5 0 5 2.8 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2011.04.032
CHEMBL2153423 84589 0 None 8 5 Rat 9.9 pKi = 9.9 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 340 5 0 5 2.8 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2011.04.032
CHEMBL2220978 84589 0 None 8 5 Rat 9.9 pKi = 9.9 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counterDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha 1A receptor after 45 mins by liquid scintillation counter
ChEMBL 340 5 0 5 2.8 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2011.04.032
10840194 111828 0 None 245 3 Human 9.9 pKi = 9.9 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 541 9 3 5 3.6 COCC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
CHEMBL328763 111828 0 None 245 3 Human 9.9 pKi = 9.9 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 541 9 3 5 3.6 COCC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
10815240 206852 0 None 33 3 Human 9.9 pKi = 9.9 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 500 7 2 3 4.5 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N(C)C(=O)N1 10.1021/jm990612y
CHEMBL90606 206852 0 None 33 3 Human 9.9 pKi = 9.9 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 500 7 2 3 4.5 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N(C)C(=O)N1 10.1021/jm990612y
4209 3163 75 None -3 33 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting methodDisplacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting method
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.12.063
4893 3163 75 None -3 33 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting methodDisplacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting method
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.12.063
503 3163 75 None -3 33 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting methodDisplacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting method
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.12.063
5385 3163 75 None -3 33 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting methodDisplacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting method
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.12.063
CHEMBL2 3163 75 None -3 33 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting methodDisplacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting method
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.12.063
DB00457 3163 75 None -3 33 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting methodDisplacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting method
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.12.063
463 1405 22 None 5 12 Human 9.8 pKi = 9.8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960697s
6918097 1405 22 None 5 12 Human 9.8 pKi = 9.8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960697s
837 1405 22 None 5 12 Human 9.8 pKi = 9.8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960697s
CHEMBL2051956 1405 22 None 5 12 Human 9.8 pKi = 9.8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960697s
DB14068 1405 22 None 5 12 Human 9.8 pKi = 9.8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960697s
499 4077 18 None 1 14 Human 9.8 pKi = 9.8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm960697s
5685 4077 18 None 1 14 Human 9.8 pKi = 9.8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm960697s
CHEMBL25554 4077 18 None 1 14 Human 9.8 pKi = 9.8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm960697s
44298624 195707 0 None 63 2 Human 9.8 pKi = 9.8 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 458 8 1 6 2.5 Cc1c[nH]c(=O)n(CCCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL55695 195707 0 None 63 2 Human 9.8 pKi = 9.8 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 458 8 1 6 2.5 Cc1c[nH]c(=O)n(CCCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
487 3634 21 None -1 11 Human 9.8 pKi = 9.8 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
60602 3634 21 None -1 11 Human 9.8 pKi = 9.8 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
CHEMBL405355 3634 21 None -1 11 Human 9.8 pKi = 9.8 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
DB09239 3634 21 None -1 11 Human 9.8 pKi = 9.8 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
19085881 205768 0 None 478 3 Human 9.8 pKi = 9.8 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in CHO cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in CHO cells
ChEMBL 500 7 0 9 2.8 O=C1c2ccc([N+](=O)[O-])cc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL82877 205768 0 None 478 3 Human 9.8 pKi = 9.8 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in CHO cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in CHO cells
ChEMBL 500 7 0 9 2.8 O=C1c2ccc([N+](=O)[O-])cc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
10530491 102605 0 None 234 2 Human 9.8 pKi = 9.8 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 540 9 1 6 4.5 Cc1ccc(N2C(=O)c3ccc(C(=O)NCCCN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
CHEMBL304132 102605 0 None 234 2 Human 9.8 pKi = 9.8 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 540 9 1 6 4.5 Cc1ccc(N2C(=O)c3ccc(C(=O)NCCCN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
487 3634 21 None -1 11 Human 9.8 pKi = 9.8 Binding
Binding affinity towards recombinant human alpha-1A adrenergic receptorBinding affinity towards recombinant human alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm030480f
60602 3634 21 None -1 11 Human 9.8 pKi = 9.8 Binding
Binding affinity towards recombinant human alpha-1A adrenergic receptorBinding affinity towards recombinant human alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm030480f
CHEMBL405355 3634 21 None -1 11 Human 9.8 pKi = 9.8 Binding
Binding affinity towards recombinant human alpha-1A adrenergic receptorBinding affinity towards recombinant human alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm030480f
DB09239 3634 21 None -1 11 Human 9.8 pKi = 9.8 Binding
Binding affinity towards recombinant human alpha-1A adrenergic receptorBinding affinity towards recombinant human alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm030480f
487 3634 21 None -1 11 Human 9.8 pKi = 9.8 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1016/j.bmcl.2004.11.032
60602 3634 21 None -1 11 Human 9.8 pKi = 9.8 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1016/j.bmcl.2004.11.032
CHEMBL405355 3634 21 None -1 11 Human 9.8 pKi = 9.8 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1016/j.bmcl.2004.11.032
DB09239 3634 21 None -1 11 Human 9.8 pKi = 9.8 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1016/j.bmcl.2004.11.032
137659584 159382 0 None - 1 Human 9.8 pKi = 9.8 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 548 9 3 6 3.2 COCC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(C#N)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1016/j.ejmech.2017.03.025
CHEMBL4100620 159382 0 None - 1 Human 9.8 pKi = 9.8 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 548 9 3 6 3.2 COCC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(C#N)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1016/j.ejmech.2017.03.025
499 4077 18 None 1 14 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/acs.jmedchem.9b01465
5685 4077 18 None 1 14 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/acs.jmedchem.9b01465
CHEMBL25554 4077 18 None 1 14 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/acs.jmedchem.9b01465
71508712 87068 0 None 40 4 Bovine 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 389 3 0 5 4.4 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ncn(C)n4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2326175 87068 0 None 40 4 Bovine 9.8 pKi = 9.8 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 389 3 0 5 4.4 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ncn(C)n4)cc23)CC1 10.1016/j.bmc.2012.10.049
49782998 17917 0 None 1 5 Bovine 9.8 pKi = 9.8 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 409 4 1 4 4.0 CC(C)C(=O)NCc1ccc2c(c1)[C@@H](N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
CHEMBL1259190 17917 0 None 1 5 Bovine 9.8 pKi = 9.8 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 409 4 1 4 4.0 CC(C)C(=O)NCc1ccc2c(c1)[C@@H](N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
10696866 206933 0 None 6165 3 Human 9.8 pKi = 9.8 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 504 7 3 5 3.1 N#Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
CHEMBL91091 206933 0 None 6165 3 Human 9.8 pKi = 9.8 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 504 7 3 5 3.1 N#Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
10974101 116953 0 None 10 5 Human 9.8 pKi = 9.8 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 609 10 1 9 4.2 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C)CC3)cccc2c1=O 10.1021/jm030825u
CHEMBL338608 116953 0 None 10 5 Human 9.8 pKi = 9.8 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 609 10 1 9 4.2 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C)CC3)cccc2c1=O 10.1021/jm030825u
14423371 97454 1 None -1 6 Human 9.8 pKi = 9.8 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 441 11 1 8 3.6 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL27013 97454 1 None -1 6 Human 9.8 pKi = 9.8 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 441 11 1 8 3.6 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1021/jm9810654
4209 3163 75 None -4 33 Bovine 9.8 pKi = 9.8 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
4893 3163 75 None -4 33 Bovine 9.8 pKi = 9.8 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
503 3163 75 None -4 33 Bovine 9.8 pKi = 9.8 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
5385 3163 75 None -4 33 Bovine 9.8 pKi = 9.8 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
CHEMBL2 3163 75 None -4 33 Bovine 9.8 pKi = 9.8 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
DB00457 3163 75 None -4 33 Bovine 9.8 pKi = 9.8 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
9830741 207856 1 None 1 6 Human 9.8 pKi = 9.8 Binding
Binding affinity towards Alpha1A human adrenergic receptors, using [125I]-HEAT as radioligand.Binding affinity towards Alpha1A human adrenergic receptors, using [125I]-HEAT as radioligand.
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1021/jm000085e
CHEMBL96467 207856 1 None 1 6 Human 9.8 pKi = 9.8 Binding
Binding affinity towards Alpha1A human adrenergic receptors, using [125I]-HEAT as radioligand.Binding affinity towards Alpha1A human adrenergic receptors, using [125I]-HEAT as radioligand.
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1021/jm000085e
9830741 207856 1 None 1 6 Human 9.8 pKi = 9.8 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1016/j.bmcl.2004.11.032
CHEMBL96467 207856 1 None 1 6 Human 9.8 pKi = 9.8 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1016/j.bmcl.2004.11.032
9913449 106452 1 None 13 3 Human 9.8 pKi = 9.8 Binding
Compound was evaluated for its affinity for alpha 1a receptor in human prostate tissue preparationsCompound was evaluated for its affinity for alpha 1a receptor in human prostate tissue preparations
ChEMBL 489 6 0 7 3.5 O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL313990 106452 1 None 13 3 Human 9.8 pKi = 9.8 Binding
Compound was evaluated for its affinity for alpha 1a receptor in human prostate tissue preparationsCompound was evaluated for its affinity for alpha 1a receptor in human prostate tissue preparations
ChEMBL 489 6 0 7 3.5 O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
137637836 156081 0 None - 1 Human 9.8 pKi = 9.8 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 509 9 3 6 3.1 COCC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)cc2)NCN1 10.1016/j.ejmech.2017.03.025
CHEMBL4062896 156081 0 None - 1 Human 9.8 pKi = 9.8 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 509 9 3 6 3.1 COCC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)cc2)NCN1 10.1016/j.ejmech.2017.03.025
10719222 207447 0 None 141 3 Human 9.8 pKi = 9.8 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 472 7 3 3 3.7 O=C1NC=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1016/j.ejmech.2017.03.025
CHEMBL94167 207447 0 None 141 3 Human 9.8 pKi = 9.8 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 472 7 3 3 3.7 O=C1NC=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1016/j.ejmech.2017.03.025
49781232 17924 0 None -1 4 Bovine 9.8 pKi = 9.8 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 392 2 0 7 2.9 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4nnn(C)n4)cc32)CC1 10.1021/jm100652h
CHEMBL1259216 17924 0 None -1 4 Bovine 9.8 pKi = 9.8 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 392 2 0 7 2.9 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4nnn(C)n4)cc32)CC1 10.1021/jm100652h
10767607 107129 0 None 831 3 Human 9.8 pKi = 9.8 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 497 7 3 4 3.4 N#CC1(c2ccc(F)cc2)CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
CHEMBL316100 107129 0 None 831 3 Human 9.8 pKi = 9.8 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 497 7 3 4 3.4 N#CC1(c2ccc(F)cc2)CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
10791844 207157 0 None 512 3 Human 9.8 pKi = 9.8 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 511 7 3 4 4.0 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
CHEMBL92328 207157 0 None 512 3 Human 9.8 pKi = 9.8 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 511 7 3 4 4.0 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
10719222 207447 0 None 141 3 Human 9.8 pKi = 9.8 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 472 7 3 3 3.7 O=C1NC=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1021/jm990612y
CHEMBL94167 207447 0 None 141 3 Human 9.8 pKi = 9.8 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 472 7 3 3 3.7 O=C1NC=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1021/jm990612y
9830741 207856 1 None 1 6 Human 9.8 pKi = 9.8 Binding
Tested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assayTested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assay
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1016/s0960-894x(00)00524-2
CHEMBL96467 207856 1 None 1 6 Human 9.8 pKi = 9.8 Binding
Tested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assayTested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assay
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1016/s0960-894x(00)00524-2
10649481 206818 0 None 123 3 Human 9.7 pKi = 9.7 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 514 7 1 3 4.8 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N(C)C(=O)N1C 10.1021/jm990612y
CHEMBL90420 206818 0 None 123 3 Human 9.7 pKi = 9.7 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 514 7 1 3 4.8 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N(C)C(=O)N1C 10.1021/jm990612y
10839105 206819 0 None 660 3 Human 9.7 pKi = 9.7 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 500 7 2 3 4.5 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1021/jm990612y
CHEMBL90421 206819 0 None 660 3 Human 9.7 pKi = 9.7 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 500 7 2 3 4.5 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1021/jm990612y
CHEMBL179334 63303 0 None 977 6 Human 9.7 pKi = 9.7 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@H]1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
10674564 203937 0 None 83 3 Human 9.7 pKi = 9.7 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 569 10 1 7 4.3 CC(C)Oc1ccccc1N1CCN(CCCNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(N(C)C)cc2)C3=O)CC1 10.1021/jm9905918
CHEMBL69264 203937 0 None 83 3 Human 9.7 pKi = 9.7 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 569 10 1 7 4.3 CC(C)Oc1ccccc1N1CCN(CCCNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(N(C)C)cc2)C3=O)CC1 10.1021/jm9905918
10074286 205504 0 None 2 4 Human 9.7 pKi = 9.7 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 489 9 1 8 3.5 COc1ccccc1N1CCN(CCNc2c(C(=O)C(C)C)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL80730 205504 0 None 2 4 Human 9.7 pKi = 9.7 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 489 9 1 8 3.5 COc1ccccc1N1CCN(CCNc2c(C(=O)C(C)C)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL179334 63303 0 None 977 6 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 608 10 2 7 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@H]1c1ccc([N+](=O)[O-])cc1 10.1016/j.bmcl.2004.11.032
137646446 157672 0 None - 1 Human 9.7 pKi = 9.7 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 518 7 2 3 4.6 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)c(F)c3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1016/j.ejmech.2017.03.025
CHEMBL4081581 157672 0 None - 1 Human 9.7 pKi = 9.7 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 518 7 2 3 4.6 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)c(F)c3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1016/j.ejmech.2017.03.025
9932698 17909 0 None 6 5 Bovine 9.7 pKi = 9.7 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 435 6 2 4 3.4 NCc1ccc2c(c1)c(C1CCN(CCN3CCNC3=O)CC1)cn2-c1ccc(F)cc1 10.1021/jm100652h
CHEMBL1259172 17909 0 None 6 5 Bovine 9.7 pKi = 9.7 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 435 6 2 4 3.4 NCc1ccc2c(c1)c(C1CCN(CCN3CCNC3=O)CC1)cn2-c1ccc(F)cc1 10.1021/jm100652h
10697623 107167 0 None 2398 3 Human 9.7 pKi = 9.7 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 536 7 2 5 3.6 CN1C=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC1=O 10.1021/jm990612y
CHEMBL316358 107167 0 None 2398 3 Human 9.7 pKi = 9.7 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 536 7 2 5 3.6 CN1C=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC1=O 10.1021/jm990612y
13911290 28171 0 None 1 5 Bovine 9.7 pKi = 9.7 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 386 5 1 7 1.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sccc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL13735 28171 0 None 1 5 Bovine 9.7 pKi = 9.7 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 386 5 1 7 1.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sccc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
129211 3749 78 None -1 15 Human 9.7 pKi = 9.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.04.008
2562 3749 78 None -1 15 Human 9.7 pKi = 9.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.04.008
488 3749 78 None -1 15 Human 9.7 pKi = 9.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.04.008
CHEMBL836 3749 78 None -1 15 Human 9.7 pKi = 9.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.04.008
DB00706 3749 78 None -1 15 Human 9.7 pKi = 9.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.04.008
129211 3749 78 None -1 15 Human 9.7 pKi = 9.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.04.098
2562 3749 78 None -1 15 Human 9.7 pKi = 9.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.04.098
488 3749 78 None -1 15 Human 9.7 pKi = 9.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.04.098
CHEMBL836 3749 78 None -1 15 Human 9.7 pKi = 9.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.04.098
DB00706 3749 78 None -1 15 Human 9.7 pKi = 9.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.04.098
10005161 205249 0 None 1 4 Human 9.7 pKi = 9.7 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 475 9 1 8 3.3 CCC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1NCCN1CCN(c2ccccc2OC)CC1 10.1021/jm0009336
CHEMBL78874 205249 0 None 1 4 Human 9.7 pKi = 9.7 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 475 9 1 8 3.3 CCC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1NCCN1CCN(c2ccccc2OC)CC1 10.1021/jm0009336
129211 3749 78 None -1 15 Human 9.7 pKi = 9.7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.11.068
2562 3749 78 None -1 15 Human 9.7 pKi = 9.7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.11.068
488 3749 78 None -1 15 Human 9.7 pKi = 9.7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.11.068
CHEMBL836 3749 78 None -1 15 Human 9.7 pKi = 9.7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.11.068
DB00706 3749 78 None -1 15 Human 9.7 pKi = 9.7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2007.11.068
49781450 17857 0 None 1 3 Bovine 9.7 pKi = 9.7 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 387 2 0 4 4.7 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4cccnc4)cc32)CC1 10.1021/jm100652h
CHEMBL1259023 17857 0 None 1 3 Bovine 9.7 pKi = 9.7 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 387 2 0 4 4.7 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4cccnc4)cc32)CC1 10.1021/jm100652h
9916549 121564 0 None 1 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of humanIn vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of human
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL358595 121564 0 None 1 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of humanIn vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of human
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
463 1405 22 None 5 12 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960697s
6918097 1405 22 None 5 12 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960697s
837 1405 22 None 5 12 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960697s
CHEMBL2051956 1405 22 None 5 12 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960697s
DB14068 1405 22 None 5 12 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960697s
4209 3163 75 None -3 33 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960697s
4893 3163 75 None -3 33 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960697s
503 3163 75 None -3 33 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960697s
5385 3163 75 None -3 33 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960697s
CHEMBL2 3163 75 None -3 33 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960697s
DB00457 3163 75 None -3 33 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960697s
129211 3749 78 None -1 15 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm960697s
2562 3749 78 None -1 15 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm960697s
488 3749 78 None -1 15 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm960697s
CHEMBL836 3749 78 None -1 15 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm960697s
DB00706 3749 78 None -1 15 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm960697s
9872851 97085 3 None 79 3 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 571 10 1 7 4.6 COc1ccc(CCN2CCC(c3nc(COCC(F)(F)F)c(-c4ccc(F)cc4)o3)CC2)cc1S(N)(=O)=O 10.1021/jm960697s
CHEMBL267336 97085 3 None 79 3 Human 9.7 pKi = 9.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 571 10 1 7 4.6 COc1ccc(CCN2CCC(c3nc(COCC(F)(F)F)c(-c4ccc(F)cc4)o3)CC2)cc1S(N)(=O)=O 10.1021/jm960697s
9809007 172564 8 None 134 6 Human 9.7 pKi = 9.7 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm9902032
CHEMBL448620 172564 8 None 134 6 Human 9.7 pKi = 9.7 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm9902032
60820 4308 14 None -10 13 Rat 9.7 pKi = 9.7 Binding
Binding affinity towards alpha-1A adrenergic receptors using alpha-1A ligand WB-4101Binding affinity towards alpha-1A adrenergic receptors using alpha-1A ligand WB-4101
ChEMBL 421 6 0 4 4.4 CC(C)Oc1ccccc1N1CCN(Cc2cccc(C(=O)N3CCCCC3)c2)CC1 10.1021/jm00034a003
CHEMBL10085 4308 14 None -10 13 Rat 9.7 pKi = 9.7 Binding
Binding affinity towards alpha-1A adrenergic receptors using alpha-1A ligand WB-4101Binding affinity towards alpha-1A adrenergic receptors using alpha-1A ligand WB-4101
ChEMBL 421 6 0 4 4.4 CC(C)Oc1ccccc1N1CCN(Cc2cccc(C(=O)N3CCCCC3)c2)CC1 10.1021/jm00034a003
10674055 204216 0 None 50 3 Human 9.7 pKi = 9.7 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 542 9 2 7 3.9 CC(C)Oc1ccccc1N1CCN(CCCNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(O)cc2)C3=O)CC1 10.1021/jm9905918
CHEMBL70892 204216 0 None 50 3 Human 9.7 pKi = 9.7 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 542 9 2 7 3.9 CC(C)Oc1ccccc1N1CCN(CCCNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(O)cc2)C3=O)CC1 10.1021/jm9905918
129211 3749 78 None -1 15 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2004.11.032
2562 3749 78 None -1 15 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2004.11.032
488 3749 78 None -1 15 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2004.11.032
CHEMBL836 3749 78 None -1 15 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2004.11.032
DB00706 3749 78 None -1 15 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1016/j.bmcl.2004.11.032
44390739 64342 1 None - 1 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 361 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1CSc2ccccc2O1 10.1016/j.bmcl.2004.11.032
CHEMBL181215 64342 1 None - 1 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 361 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1CSc2ccccc2O1 10.1016/j.bmcl.2004.11.032
10099811 121023 4 None 676 4 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1016/j.bmcl.2004.11.032
CHEMBL356584 121023 4 None 676 4 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1016/j.bmcl.2004.11.032
18738386 204038 0 None 125 3 Human 9.7 pKi = 9.7 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 413 7 0 5 4.0 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCC3=O)cs2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL69848 204038 0 None 125 3 Human 9.7 pKi = 9.7 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 413 7 0 5 4.0 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCC3=O)cs2)CC1 10.1016/s0960-894x(02)00347-5
11984570 92804 0 None 2 3 Human 9.7 pKi = 9.7 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 465 5 0 5 4.3 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4cccc(F)c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
CHEMBL243694 92804 0 None 2 3 Human 9.7 pKi = 9.7 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 465 5 0 5 4.3 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4cccc(F)c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
49781452 17866 0 None -1 3 Bovine 9.7 pKi = 9.7 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 388 2 0 5 4.1 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4cncnc4)cc32)CC1 10.1021/jm100652h
CHEMBL1259042 17866 0 None -1 3 Bovine 9.7 pKi = 9.7 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 388 2 0 5 4.1 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4cncnc4)cc32)CC1 10.1021/jm100652h
10722045 32815 0 None 436 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 584 8 2 7 3.8 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)cc1F 10.1021/jm990200p
CHEMBL141444 32815 0 None 436 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 584 8 2 7 3.8 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)cc1F 10.1021/jm990200p
10626726 33944 0 None 70 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 561 7 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3Cl)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL142398 33944 0 None 70 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 561 7 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3Cl)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
10371061 36701 0 None 1380 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL144925 36701 0 None 1380 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
10627155 37219 0 None 125 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 585 8 2 8 3.2 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(=O)OC)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145338 37219 0 None 125 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 585 8 2 8 3.2 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(=O)OC)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
10554140 119117 0 None 38 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 527 7 2 6 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL342731 119117 0 None 38 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 527 7 2 6 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
10099811 121023 4 None 676 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
10099811 121023 4 None 676 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990202+
CHEMBL356584 121023 4 None 676 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL356584 121023 4 None 676 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990202+
9916549 121564 0 None 1 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL358595 121564 0 None 1 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
10371061 36701 0 None 1380 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL144925 36701 0 None 1380 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
10745870 36718 0 None 3090 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 584 9 2 7 2.8 COC(=O)C1=C(C)NC(=O)N(CC(=O)NCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL144938 36718 0 None 3090 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 584 9 2 7 2.8 COC(=O)C1=C(C)NC(=O)N(CC(=O)NCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
10720893 37368 0 None 181 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 526 7 2 5 4.5 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL145459 37368 0 None 181 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 526 7 2 5 4.5 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
10675068 96450 0 None 758 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 599 9 2 7 3.9 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C#N)(c3cccc(F)c3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL262217 96450 0 None 758 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 599 9 2 7 3.9 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C#N)(c3cccc(F)c3)CC2)C(=O)N1 10.1021/jm990201h
10508330 118794 0 None 99 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 638 8 2 5 5.9 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)(c3ccc(F)cc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL342126 118794 0 None 99 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 638 8 2 5 5.9 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)(c3ccc(F)cc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
10099811 121023 4 None 676 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL356584 121023 4 None 676 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
10507500 121694 0 None 1258 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 582 6 2 7 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)OC(=O)Cc2ccccc23)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL358785 121694 0 None 1258 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 582 6 2 7 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)OC(=O)Cc2ccccc23)C1c1ccc(F)c(F)c1 10.1021/jm990201h
10555024 121889 0 None 2454 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 568 6 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)OCCc2ccccc23)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL359012 121889 0 None 2454 3 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 568 6 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)OCCc2ccccc23)C1c1ccc(F)c(F)c1 10.1021/jm990201h
10099811 121023 4 None 676 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity radioligandIn vitro binding affinity radioligand
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL356584 121023 4 None 676 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity radioligandIn vitro binding affinity radioligand
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
4013695 102015 20 None 1 5 Rat 9.7 pKi = 9.7 Binding
Binding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranesBinding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranes
ChEMBL 419 5 2 6 2.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1021/jm00110a014
CHEMBL301707 102015 20 None 1 5 Rat 9.7 pKi = 9.7 Binding
Binding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranesBinding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranes
ChEMBL 419 5 2 6 2.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1021/jm00110a014
10099811 121023 4 None 676 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of humanIn vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of human
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL356584 121023 4 None 676 4 Human 9.7 pKi = 9.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of humanIn vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of human
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
10527469 156265 3 None 1 15 Human 9.7 pKi = 9.7 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm970364a
CHEMBL40650 156265 3 None 1 15 Human 9.7 pKi = 9.7 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm970364a
10916771 105214 0 None 9 4 Human 9.7 pKi = 9.7 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 419 7 1 7 2.7 COc1ccccc1N1CCN(CCNc2cc(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL311479 105214 0 None 9 4 Human 9.7 pKi = 9.7 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 419 7 1 7 2.7 COc1ccccc1N1CCN(CCNc2cc(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
10527469 156265 3 None 1 15 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1016/j.bmcl.2004.11.032
CHEMBL40650 156265 3 None 1 15 Human 9.7 pKi = 9.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1016/j.bmcl.2004.11.032
9828476 206924 0 None 58 6 Human 9.6 pKi = 9.6 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 532 9 2 7 5.2 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL91022 206924 0 None 58 6 Human 9.6 pKi = 9.6 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 532 9 2 7 5.2 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
9828476 85282 0 None - 1 Human 9.6 pKi = 9.6 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 532 9 2 7 4.4 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL2260360 85282 0 None - 1 Human 9.6 pKi = 9.6 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 532 9 2 7 4.4 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
9830741 207856 1 None 1 6 Human 9.6 pKi = 9.6 Binding
Binding affinity towards Alpha1A dog adrenergic receptors, using [125I]HEAT as radioligand.Binding affinity towards Alpha1A dog adrenergic receptors, using [125I]HEAT as radioligand.
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1021/jm000085e
CHEMBL96467 207856 1 None 1 6 Human 9.6 pKi = 9.6 Binding
Binding affinity towards Alpha1A dog adrenergic receptors, using [125I]HEAT as radioligand.Binding affinity towards Alpha1A dog adrenergic receptors, using [125I]HEAT as radioligand.
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1021/jm000085e
10626910 203784 0 None 537 2 Human 9.6 pKi = 9.6 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 572 10 2 8 3.2 COc1ccc(N2C(=O)c3ccc(C(=O)NC[C@H](O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
CHEMBL68203 203784 0 None 537 2 Human 9.6 pKi = 9.6 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 572 10 2 8 3.2 COc1ccc(N2C(=O)c3ccc(C(=O)NC[C@H](O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
9826801 107937 0 None 4 11 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 488 6 1 7 3.2 Cn1nnc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
CHEMBL319352 107937 0 None 4 11 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 488 6 1 7 3.2 Cn1nnc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
135418497 63039 0 None 1 4 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(C[C@H]2CN=C3c4ccccc4NC(=O)N32)CC1 10.1021/jm970159v
CHEMBL1788222 63039 0 None 1 4 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(C[C@H]2CN=C3c4ccccc4NC(=O)N32)CC1 10.1021/jm970159v
4209 3163 75 None -3 33 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2006.05.002
4893 3163 75 None -3 33 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2006.05.002
503 3163 75 None -3 33 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2006.05.002
5385 3163 75 None -3 33 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2006.05.002
CHEMBL2 3163 75 None -3 33 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2006.05.002
DB00457 3163 75 None -3 33 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2006.05.002
9826801 107937 0 None 4 11 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 488 6 1 7 3.2 Cn1nnc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1016/j.bmc.2012.10.049
CHEMBL319352 107937 0 None 4 11 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 488 6 1 7 3.2 Cn1nnc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1016/j.bmc.2012.10.049
9826801 107937 0 None 4 11 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 488 6 1 7 3.2 Cn1nnc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm100652h
CHEMBL319352 107937 0 None 4 11 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 488 6 1 7 3.2 Cn1nnc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm100652h
9809007 172564 8 None 134 6 Human 9.6 pKi = 9.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm960697s
CHEMBL448620 172564 8 None 134 6 Human 9.6 pKi = 9.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm960697s
10369288 207258 0 None 169 3 Human 9.6 pKi = 9.6 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 516 9 3 4 3.7 COCC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
CHEMBL92951 207258 0 None 169 3 Human 9.6 pKi = 9.6 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 516 9 3 4 3.7 COCC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
10456471 100533 0 None 1 4 Rat 9.6 pKi = 9.6 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 451 6 1 7 2.4 COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
CHEMBL291303 100533 0 None 1 4 Rat 9.6 pKi = 9.6 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 451 6 1 7 2.4 COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
9913449 106452 1 None 13 3 Human 9.6 pKi = 9.6 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparations
ChEMBL 489 6 0 7 3.5 O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL313990 106452 1 None 13 3 Human 9.6 pKi = 9.6 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparations
ChEMBL 489 6 0 7 3.5 O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
44300165 101851 0 None 66 3 Human 9.6 pKi = 9.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.5 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@H](N3CCC(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL300540 101851 0 None 66 3 Human 9.6 pKi = 9.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.5 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@H](N3CCC(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
10369288 207258 0 None 169 3 Human 9.6 pKi = 9.6 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 516 9 3 4 3.7 COCC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1016/j.ejmech.2017.03.025
CHEMBL92951 207258 0 None 169 3 Human 9.6 pKi = 9.6 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 516 9 3 4 3.7 COCC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1016/j.ejmech.2017.03.025
49781236 17843 0 None -1 3 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 390 2 0 5 4.1 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4cnn(C)c4)cc32)CC1 10.1021/jm100652h
CHEMBL1258987 17843 0 None -1 3 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 390 2 0 5 4.1 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4cnn(C)c4)cc32)CC1 10.1021/jm100652h
49781449 17851 0 None 6 3 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 387 2 0 4 4.7 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccccn4)cc32)CC1 10.1021/jm100652h
CHEMBL1259006 17851 0 None 6 3 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 387 2 0 4 4.7 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccccn4)cc32)CC1 10.1021/jm100652h
9847196 30181 0 None 2 4 Bovine 9.6 pKi = 9.6 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(-c4ccccc4)cc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL13903 30181 0 None 2 4 Bovine 9.6 pKi = 9.6 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(-c4ccccc4)cc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
10606670 199092 0 None 13 2 Rat 9.6 pKi = 9.6 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 465 6 0 8 2.4 COc1cc2c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)n(C)c2cc1OC 10.1021/jm000541z
CHEMBL58862 199092 0 None 13 2 Rat 9.6 pKi = 9.6 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 465 6 0 8 2.4 COc1cc2c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)n(C)c2cc1OC 10.1021/jm000541z
3567002 3387 9 None 58 3 Human 9.6 pKi = 9.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 10.1016/j.bmcl.2004.11.032
7381 3387 9 None 58 3 Human 9.6 pKi = 9.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 10.1016/j.bmcl.2004.11.032
CHEMBL56331 3387 9 None 58 3 Human 9.6 pKi = 9.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 10.1016/j.bmcl.2004.11.032
10624993 111687 0 None 630 3 Human 9.6 pKi = 9.6 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 493 7 3 4 3.9 CC1=C(C(=O)NCCCN2CCC(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
CHEMBL328658 111687 0 None 630 3 Human 9.6 pKi = 9.6 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 493 7 3 4 3.9 CC1=C(C(=O)NCCCN2CCC(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
11626704 72454 0 None -5 4 Human 9.6 pKi = 9.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 457 13 1 6 5.0 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc(Cl)c1 10.1007/s00044-010-9379-1
CHEMBL198860 72454 0 None -5 4 Human 9.6 pKi = 9.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 457 13 1 6 5.0 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc(Cl)c1 10.1007/s00044-010-9379-1
44289437 169863 0 None -1 6 Human 9.6 pKi = 9.6 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 431 9 1 5 4.7 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2C1=O 10.1021/jm011066n
CHEMBL44403 169863 0 None -1 6 Human 9.6 pKi = 9.6 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 431 9 1 5 4.7 COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2C1=O 10.1021/jm011066n
11626704 72454 0 None -5 4 Human 9.6 pKi = 9.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 457 13 1 6 5.0 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc(Cl)c1 10.1007/s00044-010-9379-1
CHEMBL198860 72454 0 None -5 4 Human 9.6 pKi = 9.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 457 13 1 6 5.0 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc(Cl)c1 10.1007/s00044-010-9379-1
11626704 72454 0 None -5 4 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 457 13 1 6 5.0 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc(Cl)c1 10.1021/jm0580398
CHEMBL198860 72454 0 None -5 4 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 457 13 1 6 5.0 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc(Cl)c1 10.1021/jm0580398
11583392 72914 1 None -7 4 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 457 13 1 6 5.0 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc(Cl)cc1 10.1021/jm0580398
CHEMBL200446 72914 1 None -7 4 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 457 13 1 6 5.0 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc(Cl)cc1 10.1021/jm0580398
3567002 3387 9 None 58 3 Human 9.6 pKi = 9.6 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 10.1016/s0960-894x(03)00305-6
7381 3387 9 None 58 3 Human 9.6 pKi = 9.6 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 10.1016/s0960-894x(03)00305-6
CHEMBL56331 3387 9 None 58 3 Human 9.6 pKi = 9.6 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 10.1016/s0960-894x(03)00305-6
44298650 163155 0 None 100 3 Human 9.6 pKi = 9.6 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 448 7 1 6 2.0 O=c1[nH]cc(F)c(=O)n1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
CHEMBL417954 163155 0 None 100 3 Human 9.6 pKi = 9.6 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 448 7 1 6 2.0 O=c1[nH]cc(F)c(=O)n1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
4431 2729 25 None 1 12 Human 9.6 pKi = 9.6 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 393 7 0 5 2.9 COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2 10.1016/j.bmcl.2006.12.111
73 2729 25 None 1 12 Human 9.6 pKi = 9.6 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 393 7 0 5 2.9 COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2 10.1016/j.bmcl.2006.12.111
CHEMBL8618 2729 25 None 1 12 Human 9.6 pKi = 9.6 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 393 7 0 5 2.9 COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2 10.1016/j.bmcl.2006.12.111
132891 5312 14 None 2 5 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(CC2CN=C3c4ccccc4NC(=O)N32)CC1 10.1021/jm970159v
CHEMBL106737 5312 14 None 2 5 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(CC2CN=C3c4ccccc4NC(=O)N32)CC1 10.1021/jm970159v
49781235 17930 0 None -1 3 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 390 2 0 5 4.1 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccn(C)n4)cc32)CC1 10.1021/jm100652h
CHEMBL1259232 17930 0 None -1 3 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 390 2 0 5 4.1 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccn(C)n4)cc32)CC1 10.1021/jm100652h
9985476 37284 0 None 912 3 Human 9.6 pKi = 9.6 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 570 8 3 7 2.5 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145394 37284 0 None 912 3 Human 9.6 pKi = 9.6 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 570 8 3 7 2.5 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
52949448 16661 0 None 3 4 Human 9.6 pKi = 9.6 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 430 6 0 5 4.1 COc1ccccc1N1CCN(CC2OCC(c3ccccc3)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242352 16661 0 None 3 4 Human 9.6 pKi = 9.6 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 430 6 0 5 4.1 COc1ccccc1N1CCN(CC2OCC(c3ccccc3)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
57393527 71558 0 None 3 4 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 430 6 0 5 4.1 COc1ccccc1N1CCN(CC2COC(c3ccccc3)(c3ccccc3)O2)CC1 10.1021/jm200421e
CHEMBL1946777 71558 0 None 3 4 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 430 6 0 5 4.1 COc1ccccc1N1CCN(CC2COC(c3ccccc3)(c3ccccc3)O2)CC1 10.1021/jm200421e
CHEMBL1963046 71558 0 None 3 4 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 430 6 0 5 4.1 COc1ccccc1N1CCN(CC2COC(c3ccccc3)(c3ccccc3)O2)CC1 10.1021/jm200421e
4013695 102015 20 None -1 5 Human 9.6 pKi = 9.6 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 419 5 2 6 2.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL301707 102015 20 None -1 5 Human 9.6 pKi = 9.6 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 419 5 2 6 2.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1016/j.ejmech.2011.03.054
4013695 102015 20 None -1 5 Human 9.6 pKi = 9.6 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 419 5 2 6 2.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL301707 102015 20 None -1 5 Human 9.6 pKi = 9.6 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 419 5 2 6 2.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1016/j.ejmech.2011.03.054
4209 3163 75 None -3 33 Human 9.6 pKi = 9.6 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
4893 3163 75 None -3 33 Human 9.6 pKi = 9.6 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
503 3163 75 None -3 33 Human 9.6 pKi = 9.6 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
5385 3163 75 None -3 33 Human 9.6 pKi = 9.6 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
CHEMBL2 3163 75 None -3 33 Human 9.6 pKi = 9.6 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
DB00457 3163 75 None -3 33 Human 9.6 pKi = 9.6 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00010a001
19085829 205846 0 None 186 3 Human 9.6 pKi = 9.6 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in HEK cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in HEK cells
ChEMBL 473 6 0 7 3.0 O=C1c2cc(F)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL83592 205846 0 None 186 3 Human 9.6 pKi = 9.6 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in HEK cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in HEK cells
ChEMBL 473 6 0 7 3.0 O=C1c2cc(F)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
10647175 131455 0 None 6 2 Rat 9.6 pKi = 9.6 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 449 5 1 7 2.1 COC(=O)c1ccc2c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)[nH]c2c1 10.1021/jm000541z
CHEMBL369154 131455 0 None 6 2 Rat 9.6 pKi = 9.6 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 449 5 1 7 2.1 COC(=O)c1ccc2c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)[nH]c2c1 10.1021/jm000541z
10478121 170802 0 None 1 4 Rat 9.6 pKi = 9.6 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 435 6 0 7 3.1 COc1cc2ncn(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
CHEMBL445325 170802 0 None 1 4 Rat 9.6 pKi = 9.6 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 435 6 0 7 3.1 COc1cc2ncn(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC 10.1021/jm000541z
10527469 156265 3 None -1 15 Rat 9.6 pKi = 9.6 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL40650 156265 3 None -1 15 Rat 9.6 pKi = 9.6 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21 10.1021/jm990567u
490 191 8 None -1 12 Bovine 9.6 pKi = 9.6 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
9890547 191 8 None -1 12 Bovine 9.6 pKi = 9.6 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
CHEMBL268758 191 8 None -1 12 Bovine 9.6 pKi = 9.6 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
18187410 104898 0 None 10 3 Human 9.6 pKi = 9.6 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 418 6 1 6 3.5 O=C1c2ccccc2C(=O)N1CCCCN1CCC(n2c(O)nc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL311247 104898 0 None 10 3 Human 9.6 pKi = 9.6 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 418 6 1 6 3.5 O=C1c2ccccc2C(=O)N1CCCCN1CCC(n2c(O)nc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
11092254 205466 0 None 1 4 Human 9.6 pKi = 9.6 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 495 8 1 8 3.5 COc1ccc(Cl)cc1N1CCN(CCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL80458 205466 0 None 1 4 Human 9.6 pKi = 9.6 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 495 8 1 8 3.5 COc1ccc(Cl)cc1N1CCN(CCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
4209 3163 75 None -3 33 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
4893 3163 75 None -3 33 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
503 3163 75 None -3 33 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
5385 3163 75 None -3 33 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
CHEMBL2 3163 75 None -3 33 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
DB00457 3163 75 None -3 33 Rat 9.6 pKi = 9.6 Binding
Displacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 minsDisplacement of [3H]Prazosin from alpha1A adrenergic receptor in Wistar rat submaxillary gland after 60 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.01.025
9843389 87057 0 None 245 2 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 390 3 0 6 3.8 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4nnn(C)n4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2325935 87057 0 None 245 2 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 390 3 0 6 3.8 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4nnn(C)n4)cc23)CC1 10.1016/j.bmc.2012.10.049
12765746 102280 4 None -1 9 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 344 1 0 3 4.3 CN1CCN([C@H]2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1021/jm100652h
CHEMBL303313 102280 4 None -1 9 Bovine 9.6 pKi = 9.6 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 344 1 0 3 4.3 CN1CCN([C@H]2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1021/jm100652h
10698013 100440 0 None 6 2 Rat 9.6 pKi = 9.6 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 518 5 1 7 3.3 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(C(=O)N(C)C)cc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL290519 100440 0 None 6 2 Rat 9.6 pKi = 9.6 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 518 5 1 7 3.3 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(C(=O)N(C)C)cc54)c3=O)C[C@@H]21 10.1021/jm990567u
4013695 102015 20 None -1 5 Human 9.5 pKi = 9.5 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 419 5 2 6 2.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
CHEMBL301707 102015 20 None -1 5 Human 9.5 pKi = 9.5 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 419 5 2 6 2.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
11430491 63001 0 None 1 5 Human 9.5 pKi = 9.5 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 435 5 1 9 2.4 COc1cc2nc(N3CCN(C(=O)CC4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
CHEMBL178673 63001 0 None 1 5 Human 9.5 pKi = 9.5 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 435 5 1 9 2.4 COc1cc2nc(N3CCN(C(=O)CC4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
10792897 167914 0 None 186 2 Human 9.5 pKi = 9.5 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 556 9 2 7 3.5 Cc1ccc(N2C(=O)c3ccc(C(=O)NC[C@H](O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
CHEMBL431362 167914 0 None 186 2 Human 9.5 pKi = 9.5 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 556 9 2 7 3.5 Cc1ccc(N2C(=O)c3ccc(C(=O)NC[C@H](O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
10673690 100502 0 None 2 2 Rat 9.5 pKi = 9.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 490 5 2 7 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cc(C(N)=O)ccc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL291073 100502 0 None 2 2 Rat 9.5 pKi = 9.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 490 5 2 7 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cc(C(N)=O)ccc54)c3=O)C[C@@H]21 10.1021/jm990567u
10721171 37710 0 None 398 3 Human 9.5 pKi = 9.5 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 539 10 0 6 6.2 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3OC)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL145770 37710 0 None 398 3 Human 9.5 pKi = 9.5 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 539 10 0 6 6.2 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3OC)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
11134424 104731 0 None -1 4 Human 9.5 pKi = 9.5 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 465 7 1 7 3.5 CC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1NCCN1CCN(c2ccccc2Cl)CC1 10.1021/jm0009336
CHEMBL310599 104731 0 None -1 4 Human 9.5 pKi = 9.5 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 465 7 1 7 3.5 CC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1NCCN1CCN(c2ccccc2Cl)CC1 10.1021/jm0009336
4209 3163 75 None -3 33 Rat 9.5 pKi = 9.5 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
4893 3163 75 None -3 33 Rat 9.5 pKi = 9.5 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
503 3163 75 None -3 33 Rat 9.5 pKi = 9.5 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
5385 3163 75 None -3 33 Rat 9.5 pKi = 9.5 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
CHEMBL2 3163 75 None -3 33 Rat 9.5 pKi = 9.5 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
DB00457 3163 75 None -3 33 Rat 9.5 pKi = 9.5 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
10836245 102747 0 None 10 5 Human 9.5 pKi = 9.5 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 427 7 0 5 4.4 CC(C)Oc1ccccc1N1CCN(Cc2ccc(CN3CCCCC3=O)s2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL305029 102747 0 None 10 5 Human 9.5 pKi = 9.5 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 427 7 0 5 4.4 CC(C)Oc1ccccc1N1CCN(Cc2ccc(CN3CCCCC3=O)s2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL552830 102747 0 None 10 5 Human 9.5 pKi = 9.5 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 427 7 0 5 4.4 CC(C)Oc1ccccc1N1CCN(Cc2ccc(CN3CCCCC3=O)s2)CC1 10.1016/s0960-894x(02)00347-5
122179430 121441 0 None -3 3 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 599 8 1 13 2.7 CCN(CC)c1ccc2cc(-n3cc(C(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)nn3)c(=O)oc2c1 10.1021/ml5004298
CHEMBL3582270 121441 0 None -3 3 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 599 8 1 13 2.7 CCN(CC)c1ccc2cc(-n3cc(C(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)nn3)c(=O)oc2c1 10.1021/ml5004298
44447061 154368 0 None -1 4 Rat 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 474 5 1 5 4.3 O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)C(F)(F)F 10.1016/j.bmcl.2007.11.106
CHEMBL398711 154368 0 None -1 4 Rat 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 474 5 1 5 4.3 O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)C(F)(F)F 10.1016/j.bmcl.2007.11.106
10626493 207387 0 None 239 3 Human 9.5 pKi = 9.5 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 550 7 1 5 4.0 CN1C=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)N(C)C1=O 10.1021/jm990612y
CHEMBL93843 207387 0 None 239 3 Human 9.5 pKi = 9.5 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 550 7 1 5 4.0 CN1C=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)N(C)C1=O 10.1021/jm990612y
10770007 34594 0 None 50 3 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 607 10 2 9 3.8 CCOC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
CHEMBL142957 34594 0 None 50 3 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 607 10 2 9 3.8 CCOC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
10768829 119384 0 None 32 3 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 541 7 2 6 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL344525 119384 0 None 32 3 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 541 7 2 6 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
10722099 121094 0 None 190 3 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 588 8 3 7 2.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1cc(F)c(F)c(F)c1 10.1021/jm990202+
CHEMBL357172 121094 0 None 190 3 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 588 8 3 7 2.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1cc(F)c(F)c(F)c1 10.1021/jm990202+
10721476 36999 0 None 691 3 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 554 6 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)OCc2ccccc23)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL145170 36999 0 None 691 3 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 554 6 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)OCc2ccccc23)C1c1ccc(F)c(F)c1 10.1021/jm990201h
10769621 118993 0 None 2290 3 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 584 8 2 7 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(OC(C)=O)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL342543 118993 0 None 2290 3 Human 9.5 pKi = 9.5 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 584 8 2 7 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(OC(C)=O)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
11712470 72005 0 None -5 4 Human 9.5 pKi = 9.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 468 14 1 8 4.2 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc([N+](=O)[O-])c1 10.1007/s00044-010-9379-1
CHEMBL197442 72005 0 None -5 4 Human 9.5 pKi = 9.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 468 14 1 8 4.2 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc([N+](=O)[O-])c1 10.1007/s00044-010-9379-1
11712470 72005 0 None -5 4 Human 9.5 pKi = 9.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 468 14 1 8 4.2 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc([N+](=O)[O-])c1 10.1007/s00044-010-9379-1
CHEMBL197442 72005 0 None -5 4 Human 9.5 pKi = 9.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 468 14 1 8 4.2 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc([N+](=O)[O-])c1 10.1007/s00044-010-9379-1
11712470 72005 0 None -5 4 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 468 14 1 8 4.2 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc([N+](=O)[O-])c1 10.1021/jm0580398
CHEMBL197442 72005 0 None -5 4 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 468 14 1 8 4.2 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc([N+](=O)[O-])c1 10.1021/jm0580398
44298626 195477 0 None 25 3 Human 9.5 pKi = 9.5 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 427 7 1 7 1.4 Cc1n[nH]c(=O)n(CCCN2CCN(c3ccccc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL55290 195477 0 None 25 3 Human 9.5 pKi = 9.5 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 427 7 1 7 1.4 Cc1n[nH]c(=O)n(CCCN2CCN(c3ccccc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
9960497 100476 0 None 154 6 Human 9.5 pKi = 9.5 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.9 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
CHEMBL290860 100476 0 None 154 6 Human 9.5 pKi = 9.5 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.9 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
3416533 194989 6 None 4 2 Rat 9.5 pKi = 9.5 Binding
Binding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranesBinding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranes
ChEMBL 447 5 0 8 2.0 COc1ccccc1N1CCN(CCn2c(=O)c3c(c4ccccc4n3C)n(C)c2=O)CC1 10.1021/jm00110a014
CHEMBL54716 194989 6 None 4 2 Rat 9.5 pKi = 9.5 Binding
Binding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranesBinding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranes
ChEMBL 447 5 0 8 2.0 COc1ccccc1N1CCN(CCn2c(=O)c3c(c4ccccc4n3C)n(C)c2=O)CC1 10.1021/jm00110a014
10961351 163501 0 None 1 4 Human 9.5 pKi = 9.5 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 449 7 1 7 3.0 CC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1NCCN1CCN(c2ccccc2F)CC1 10.1021/jm0009336
CHEMBL420205 163501 0 None 1 4 Human 9.5 pKi = 9.5 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 449 7 1 7 3.0 CC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1NCCN1CCN(c2ccccc2F)CC1 10.1021/jm0009336
71508640 87047 0 None 46 2 Bovine 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 388 3 0 4 5.0 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ccnn4C)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2325926 87047 0 None 46 2 Bovine 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 388 3 0 4 5.0 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ccnn4C)cc23)CC1 10.1016/j.bmc.2012.10.049
10097792 118589 0 None -1 7 Human 9.5 pKi = 9.5 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 508 13 1 8 4.1 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CN(C)C)c3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL341665 118589 0 None -1 7 Human 9.5 pKi = 9.5 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 508 13 1 8 4.1 COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CN(C)C)c3)nc(N)c2cc1OC 10.1021/jm9810654
90645597 112489 0 None -2 3 Human 9.5 pKi = 9.5 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 654 12 3 9 4.2 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCC(=O)NCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298750 112489 0 None -2 3 Human 9.5 pKi = 9.5 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 654 12 3 9 4.2 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCC(=O)NCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
10841070 37679 0 None 2 4 Human 9.5 pKi = 9.5 Binding
Binding affinity against isolated human prostate using [3H]- prazosin.Binding affinity against isolated human prostate using [3H]- prazosin.
ChEMBL 585 10 0 5 7.4 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL145746 37679 0 None 2 4 Human 9.5 pKi = 9.5 Binding
Binding affinity against isolated human prostate using [3H]- prazosin.Binding affinity against isolated human prostate using [3H]- prazosin.
ChEMBL 585 10 0 5 7.4 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10504673 202673 0 None -1 2 Rat 9.5 pKi = 9.5 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 473 5 1 6 4.1 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(-c5ccccc5)csc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL61483 202673 0 None -1 2 Rat 9.5 pKi = 9.5 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 473 5 1 6 4.1 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(-c5ccccc5)csc4c3=O)C[C@@H]21 10.1021/jm000541z
9894665 103813 1 None 30 8 Human 9.5 pKi = 9.5 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 585 10 2 8 3.3 CC(C)Oc1ccccc1N1CCN(C[C@@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(N(C)C)cc2)C3=O)CC1 10.1021/jm9905918
CHEMBL309106 103813 1 None 30 8 Human 9.5 pKi = 9.5 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 585 10 2 8 3.3 CC(C)Oc1ccccc1N1CCN(C[C@@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(N(C)C)cc2)C3=O)CC1 10.1021/jm9905918
10474042 170253 0 None -1 6 Human 9.5 pKi = 9.5 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 365 6 0 4 4.1 COc1cccc2c1CCCC2CCCN1CCN(c2ccccn2)CC1 10.1021/jm010866v
CHEMBL444590 170253 0 None -1 6 Human 9.5 pKi = 9.5 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 365 6 0 4 4.1 COc1cccc2c1CCCC2CCCN1CCN(c2ccccn2)CC1 10.1021/jm010866v
9955302 100167 0 None 14 2 Rat 9.5 pKi = 9.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccncc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL287965 100167 0 None 14 2 Rat 9.5 pKi = 9.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccncc54)c3=O)C[C@@H]21 10.1021/jm990567u
50905381 56350 0 None -1 3 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 422 11 2 6 2.7 COc1ccc(C[C@@H](C)NCCOc2ccccc2OC(C)C)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
CHEMBL1630938 56350 0 None -1 3 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 422 11 2 6 2.7 COc1ccc(C[C@@H](C)NCCOc2ccccc2OC(C)C)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
49782792 17911 0 None 1 5 Bovine 9.5 pKi = 9.5 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 381 3 1 4 3.3 CC(=O)NCc1ccc2c(c1)[C@@H](N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
CHEMBL1259174 17911 0 None 1 5 Bovine 9.5 pKi = 9.5 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 381 3 1 4 3.3 CC(=O)NCc1ccc2c(c1)[C@@H](N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
148842 3946 27 None 8 5 Human 9.5 pKi = 9.5 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm030825u
496 3946 27 None 8 5 Human 9.5 pKi = 9.5 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm030825u
CHEMBL278865 3946 27 None 8 5 Human 9.5 pKi = 9.5 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm030825u
13911290 28171 0 None -1 5 Human 9.5 pKi = 9.5 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 386 5 1 7 1.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sccc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL13735 28171 0 None -1 5 Human 9.5 pKi = 9.5 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 386 5 1 7 1.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sccc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
9809007 172564 8 None 134 6 Human 9.5 pKi = 9.5 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL448620 172564 8 None 134 6 Human 9.5 pKi = 9.5 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
9809007 172564 8 None 134 6 Human 9.5 pKi = 9.5 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL448620 172564 8 None 134 6 Human 9.5 pKi = 9.5 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
50905585 56351 0 None -1 3 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 470 12 2 6 3.5 COc1ccc(C[C@@H](C)NCCOc2ccccc2OCc2ccccc2)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
CHEMBL1630939 56351 0 None -1 3 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 470 12 2 6 3.5 COc1ccc(C[C@@H](C)NCCOc2ccccc2OCc2ccccc2)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
491 192 9 None -2 12 Bovine 9.5 pKi = 9.5 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
9891167 192 9 None -2 12 Bovine 9.5 pKi = 9.5 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
CHEMBL13856 192 9 None -2 12 Bovine 9.5 pKi = 9.5 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
9809007 172564 8 None 134 6 Human 9.5 pKi = 9.5 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
CHEMBL448620 172564 8 None 134 6 Human 9.5 pKi = 9.5 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
499 4077 18 None -1 14 Bovine 9.5 pKi = 9.5 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
5685 4077 18 None -1 14 Bovine 9.5 pKi = 9.5 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
CHEMBL25554 4077 18 None -1 14 Bovine 9.5 pKi = 9.5 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
9809007 172564 8 None 134 6 Human 9.5 pKi = 9.5 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
CHEMBL448620 172564 8 None 134 6 Human 9.5 pKi = 9.5 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
10599007 204515 0 None -1 7 Bovine 9.5 pKi = 9.5 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccc(C)cc1 10.1021/jm960069a
CHEMBL72657 204515 0 None -1 7 Bovine 9.5 pKi = 9.5 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccc(C)cc1 10.1021/jm960069a
10599007 204515 0 None 1 7 Human 9.5 pKi = 9.5 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccc(C)cc1 10.1016/j.bmcl.2004.11.032
CHEMBL72657 204515 0 None 1 7 Human 9.5 pKi = 9.5 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccc(C)cc1 10.1016/j.bmcl.2004.11.032
10917953 207988 0 None 1 9 Bovine 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 489 6 0 8 3.6 Cn1nnc(-c2ccc3c(c2)c(C2CCN(CCN4CCOC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
CHEMBL97242 207988 0 None 1 9 Bovine 9.5 pKi = 9.5 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 489 6 0 8 3.6 Cn1nnc(-c2ccc3c(c2)c(C2CCN(CCN4CCOC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
10743310 169232 0 None 10 2 Rat 9.5 pKi = 9.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 479 5 1 9 2.4 COc1cnc2sc3c(=O)n(CCN4C[C@@H]5CCc6c(OC)cccc6[C@@H]5C4)c(=O)[nH]c3c2n1 10.1021/jm990567u
CHEMBL441032 169232 0 None 10 2 Rat 9.5 pKi = 9.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 479 5 1 9 2.4 COc1cnc2sc3c(=O)n(CCN4C[C@@H]5CCc6c(OC)cccc6[C@@H]5C4)c(=O)[nH]c3c2n1 10.1021/jm990567u
9830741 207856 1 None -1 6 Rat 9.4 pKi = 9.4 Binding
Binding affinity towards Alpha1A rat adrenergic receptors, using [125I]HEAT as radioligand.Binding affinity towards Alpha1A rat adrenergic receptors, using [125I]HEAT as radioligand.
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1021/jm000085e
CHEMBL96467 207856 1 None -1 6 Rat 9.4 pKi = 9.4 Binding
Binding affinity towards Alpha1A rat adrenergic receptors, using [125I]HEAT as radioligand.Binding affinity towards Alpha1A rat adrenergic receptors, using [125I]HEAT as radioligand.
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1021/jm000085e
44275505 96801 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity towards recombinant human alpha-1A adrenergic receptorBinding affinity towards recombinant human alpha-1A adrenergic receptor
ChEMBL 556 10 2 7 2.6 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)C(C(=O)NCCCN2CCC(c3ccccn3)CC2)C(=O)N1 10.1021/jm030480f
CHEMBL265001 96801 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity towards recombinant human alpha-1A adrenergic receptorBinding affinity towards recombinant human alpha-1A adrenergic receptor
ChEMBL 556 10 2 7 2.6 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)C(C(=O)NCCCN2CCC(c3ccccn3)CC2)C(=O)N1 10.1021/jm030480f
9874983 65467 18 None - 1 Human 9.4 pKi = 9.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 557 9 2 7 3.5 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(c3ccccn3)CC2)C(=O)N1 10.1016/j.bmcl.2004.11.032
CHEMBL182998 65467 18 None - 1 Human 9.4 pKi = 9.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 557 9 2 7 3.5 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(c3ccccn3)CC2)C(=O)N1 10.1016/j.bmcl.2004.11.032
499 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
5685 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
CHEMBL25554 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm00018a001
9830292 168189 0 None 562 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.3 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@@H](N3CCC(C#N)(c4ccccc4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL433284 168189 0 None 562 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.3 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@@H](N3CCC(C#N)(c4ccccc4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
2435 3590 83 None -3 48 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm020938y
60149 3590 83 None -3 48 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm020938y
98 3590 83 None -3 48 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm020938y
CHEMBL12713 3590 83 None -3 48 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm020938y
DB06144 3590 83 None -3 48 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm020938y
2435 3590 83 None -3 48 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1016/j.bmc.2012.10.049
60149 3590 83 None -3 48 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1016/j.bmc.2012.10.049
98 3590 83 None -3 48 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1016/j.bmc.2012.10.049
CHEMBL12713 3590 83 None -3 48 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1016/j.bmc.2012.10.049
DB06144 3590 83 None -3 48 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1016/j.bmc.2012.10.049
2435 3590 83 None -3 48 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm100652h
60149 3590 83 None -3 48 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm100652h
98 3590 83 None -3 48 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm100652h
CHEMBL12713 3590 83 None -3 48 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm100652h
DB06144 3590 83 None -3 48 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O 10.1021/jm100652h
9847845 28453 0 None 1 5 Bovine 9.4 pKi = 9.4 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(C)c(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL13754 28453 0 None 1 5 Bovine 9.4 pKi = 9.4 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(C)c(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
487 3634 21 None 1 11 Bovine 9.4 pKi = 9.4 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960069a
60602 3634 21 None 1 11 Bovine 9.4 pKi = 9.4 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960069a
CHEMBL405355 3634 21 None 1 11 Bovine 9.4 pKi = 9.4 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960069a
DB09239 3634 21 None 1 11 Bovine 9.4 pKi = 9.4 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960069a
44300129 167428 0 None 912 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 583 7 2 7 4.0 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@@H](N3CCC(c4ccccn4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL429697 167428 0 None 912 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 583 7 2 7 4.0 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@@H](N3CCC(c4ccccn4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
10838523 101200 0 None 10 2 Rat 9.4 pKi = 9.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 482 4 1 7 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(Cl)nc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL295741 101200 0 None 10 2 Rat 9.4 pKi = 9.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 482 4 1 7 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(Cl)nc54)c3=O)C[C@@H]21 10.1021/jm990567u
134149596 148465 0 None 4 4 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 368 6 0 5 3.6 CC(C)Oc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2016.06.052
CHEMBL3938038 148465 0 None 4 4 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 368 6 0 5 3.6 CC(C)Oc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2016.06.052
10767264 206994 0 None 102 3 Human 9.4 pKi = 9.4 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 486 7 3 3 4.1 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
CHEMBL91405 206994 0 None 102 3 Human 9.4 pKi = 9.4 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 486 7 3 3 4.1 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
4209 3163 75 None -3 33 Human 9.4 pKi = 9.4 Binding
Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
4893 3163 75 None -3 33 Human 9.4 pKi = 9.4 Binding
Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
503 3163 75 None -3 33 Human 9.4 pKi = 9.4 Binding
Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
5385 3163 75 None -3 33 Human 9.4 pKi = 9.4 Binding
Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
CHEMBL2 3163 75 None -3 33 Human 9.4 pKi = 9.4 Binding
Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
DB00457 3163 75 None -3 33 Human 9.4 pKi = 9.4 Binding
Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980053f
10839825 206741 0 None 2818 3 Human 9.4 pKi = 9.4 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 525 7 2 4 4.1 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1021/jm990612y
CHEMBL89965 206741 0 None 2818 3 Human 9.4 pKi = 9.4 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 525 7 2 4 4.1 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1021/jm990612y
10552608 100418 0 None 35 2 Rat 9.4 pKi = 9.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 477 4 1 8 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5nc(C)c(C)nc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL290243 100418 0 None 35 2 Rat 9.4 pKi = 9.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 477 4 1 8 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5nc(C)c(C)nc54)c3=O)C[C@@H]21 10.1021/jm990567u
11133288 166033 0 None 7 6 Human 9.4 pKi = 9.4 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 407 12 1 5 4.3 COc1cccc(OC)c1OCCNCCOc1ccccc1Cc1ccccc1 10.1021/jm011066n
CHEMBL42558 166033 0 None 7 6 Human 9.4 pKi = 9.4 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 407 12 1 5 4.3 COc1cccc(OC)c1OCCNCCOc1ccccc1Cc1ccccc1 10.1021/jm011066n
9865801 94724 10 None 3 3 Human 9.4 pKi = 9.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 401 8 2 5 5.0 COc1c(C)c(C)c(O)c(C)c1CN(C)CCOc1cc(C)c(O)cc1C(C)C 10.1021/jm960697s
CHEMBL25300 94724 10 None 3 3 Human 9.4 pKi = 9.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 401 8 2 5 5.0 COc1c(C)c(C)c(O)c(C)c1CN(C)CCOc1cc(C)c(O)cc1C(C)C 10.1021/jm960697s
11633517 72525 0 None -1 4 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 437 13 1 6 4.6 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc(C)c1 10.1021/jm0580398
CHEMBL199080 72525 0 None -1 4 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 437 13 1 6 4.6 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc(C)c1 10.1021/jm0580398
10572854 112566 0 None 2 2 Bovine 9.4 pKi = 9.4 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 396 8 1 5 3.0 COc1ccccc1N1CCN(CCCNc2ccccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL330060 112566 0 None 2 2 Bovine 9.4 pKi = 9.4 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 396 8 1 5 3.0 COc1ccccc1N1CCN(CCCNc2ccccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10525639 207145 0 None - 1 Bovine 9.4 pKi = 9.4 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 410 8 1 6 3.9 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)C(C)(C)C)CC1 10.1021/jm970166j
CHEMBL92261 207145 0 None - 1 Bovine 9.4 pKi = 9.4 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 410 8 1 6 3.9 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)C(C)(C)C)CC1 10.1021/jm970166j
10554957 32993 0 None 1000 3 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 564 11 0 7 5.5 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(CCCCCN2CCC(C#N)(c3ccccc3)CC2)C(C)=N1 10.1021/jm9902032
CHEMBL141604 32993 0 None 1000 3 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 564 11 0 7 5.5 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(CCCCCN2CCC(C#N)(c3ccccc3)CC2)C(C)=N1 10.1021/jm9902032
10626772 36236 0 None 776 3 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 564 11 0 7 5.5 COCC1=NC(C)=C(C(=O)OC)C(c2ccc(F)c(F)c2)N1CCCCCN1CCC(C#N)(c2ccccc2)CC1 10.1021/jm9902032
CHEMBL144534 36236 0 None 776 3 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 564 11 0 7 5.5 COCC1=NC(C)=C(C(=O)OC)C(c2ccc(F)c(F)c2)N1CCCCCN1CCC(C#N)(c2ccccc2)CC1 10.1021/jm9902032
10650129 37508 0 None 162 3 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 540 10 0 7 5.2 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCN(c3ccccc3OC)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL145587 37508 0 None 162 3 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 540 10 0 7 5.2 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCN(c3ccccc3OC)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10841070 37679 0 None 2 4 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 585 10 0 5 7.4 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL145746 37679 0 None 2 4 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 585 10 0 5 7.4 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10815549 122014 0 None 234 3 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 509 9 0 5 6.2 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL359421 122014 0 None 234 3 Human 9.4 pKi = 9.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 509 9 0 5 6.2 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10032383 110110 0 None 194 6 Human 9.4 pKi = 9.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
136680387 110110 0 None 194 6 Human 9.4 pKi = 9.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL323579 110110 0 None 194 6 Human 9.4 pKi = 9.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
44390708 64271 0 None 630 3 Human 9.4 pKi = 9.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)[C@H](c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/j.bmcl.2004.11.032
CHEMBL180932 64271 0 None 630 3 Human 9.4 pKi = 9.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)[C@H](c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/j.bmcl.2004.11.032
9865801 94724 10 None 3 3 Human 9.4 pKi = 9.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 401 8 2 5 5.0 COc1c(C)c(C)c(O)c(C)c1CN(C)CCOc1cc(C)c(O)cc1C(C)C 10.1016/j.bmcl.2004.11.032
CHEMBL25300 94724 10 None 3 3 Human 9.4 pKi = 9.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 401 8 2 5 5.0 COc1c(C)c(C)c(O)c(C)c1CN(C)CCOc1cc(C)c(O)cc1C(C)C 10.1016/j.bmcl.2004.11.032
2389 3331 118 None -6 67 Rat 9.4 pKi = 9.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
5073 3331 118 None -6 67 Rat 9.4 pKi = 9.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
96 3331 118 None -6 67 Rat 9.4 pKi = 9.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
CHEMBL85 3331 118 None -6 67 Rat 9.4 pKi = 9.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
DB00734 3331 118 None -6 67 Rat 9.4 pKi = 9.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
44300111 100860 0 None 794 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 583 7 2 7 4.0 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@H](N3CCC(c4ccccn4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL293515 100860 0 None 794 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 583 7 2 7 4.0 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@H](N3CCC(c4ccccn4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
44431194 92560 0 None 1 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 448 5 0 6 3.6 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4ccncc4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
CHEMBL243229 92560 0 None 1 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 448 5 0 6 3.6 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4ccncc4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
9959689 101813 0 None 281 3 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 568 7 2 7 3.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
CHEMBL300222 101813 0 None 281 3 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 568 7 2 7 3.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
10393665 33922 0 None 47 3 Human 9.4 pKi = 9.4 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 593 9 2 9 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
CHEMBL142383 33922 0 None 47 3 Human 9.4 pKi = 9.4 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 593 9 2 9 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
10556164 121696 0 None 549 3 Human 9.4 pKi = 9.4 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 572 8 3 6 3.1 CC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1cc(F)c(F)c(F)c1 10.1021/jm990202+
CHEMBL358795 121696 0 None 549 3 Human 9.4 pKi = 9.4 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 572 8 3 6 3.1 CC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1cc(F)c(F)c(F)c1 10.1021/jm990202+
9809007 172564 8 None 134 6 Human 9.4 pKi = 9.4 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
CHEMBL448620 172564 8 None 134 6 Human 9.4 pKi = 9.4 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
10816815 119355 0 None 776 3 Human 9.4 pKi = 9.4 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 566 6 2 5 4.9 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CCCc4ccccc43)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL344339 119355 0 None 776 3 Human 9.4 pKi = 9.4 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 566 6 2 5 4.9 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CCCc4ccccc43)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
10839391 157370 0 None 15 2 Rat 9.4 pKi = 9.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 472 4 1 7 3.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cc(C#N)ccc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL40780 157370 0 None 15 2 Rat 9.4 pKi = 9.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 472 4 1 7 3.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cc(C#N)ccc54)c3=O)C[C@@H]21 10.1021/jm990567u
101333429 117076 0 None 588 6 Human 9.4 pKi = 9.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1 10.1021/jm00019a001
CHEMBL3392247 117076 0 None 588 6 Human 9.4 pKi = 9.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1 10.1021/jm00019a001
13305910 11836 1 None -2 8 Human 9.4 pKi = 9.4 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2020.112419
CHEMBL1182155 11836 1 None -2 8 Human 9.4 pKi = 9.4 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2020.112419
CHEMBL215421 11836 1 None -2 8 Human 9.4 pKi = 9.4 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2020.112419
CHEMBL3741808 11836 1 None -2 8 Human 9.4 pKi = 9.4 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2020.112419
13305910 11836 1 None -2 8 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182155 11836 1 None -2 8 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL215421 11836 1 None -2 8 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL3741808 11836 1 None -2 8 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
13305910 11836 1 None -2 8 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL1182155 11836 1 None -2 8 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL215421 11836 1 None -2 8 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL3741808 11836 1 None -2 8 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
13305910 11836 1 None -2 8 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL1182155 11836 1 None -2 8 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL215421 11836 1 None -2 8 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL3741808 11836 1 None -2 8 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
13305910 11836 1 None -2 8 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm301525w
CHEMBL1182155 11836 1 None -2 8 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm301525w
CHEMBL215421 11836 1 None -2 8 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm301525w
CHEMBL3741808 11836 1 None -2 8 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm301525w
13305910 11836 1 None -2 8 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1039/C4MD00484A
CHEMBL1182155 11836 1 None -2 8 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1039/C4MD00484A
CHEMBL215421 11836 1 None -2 8 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1039/C4MD00484A
CHEMBL3741808 11836 1 None -2 8 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1 10.1039/C4MD00484A
10624165 100562 0 None 5 2 Rat 9.4 pKi = 9.4 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 469 6 1 7 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C(C)C)c(OC)sc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL291528 100562 0 None 5 2 Rat 9.4 pKi = 9.4 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 469 6 1 7 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C(C)C)c(OC)sc4c3=O)C[C@@H]21 10.1021/jm000541z
10506729 203699 0 None 53 3 Human 9.4 pKi = 9.4 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 544 9 1 6 4.4 CC(C)Oc1ccccc1N1CCN(CCCNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
CHEMBL67552 203699 0 None 53 3 Human 9.4 pKi = 9.4 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 544 9 1 6 4.4 CC(C)Oc1ccccc1N1CCN(CCCNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
49781234 17929 0 None -1 3 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 390 2 0 5 4.1 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccnn4C)cc32)CC1 10.1021/jm100652h
CHEMBL1259231 17929 0 None -1 3 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 390 2 0 5 4.1 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccnn4C)cc32)CC1 10.1021/jm100652h
10344976 101215 2 None 1 5 Human 9.4 pKi = 9.4 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 477 11 1 10 3.4 COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1021/jm9810654
CHEMBL29591 101215 2 None 1 5 Human 9.4 pKi = 9.4 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 477 11 1 10 3.4 COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC 10.1021/jm9810654
49782791 17910 0 None 2 5 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 381 3 1 4 3.3 CC(=O)NCc1ccc2c(c1)[C@H](N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
CHEMBL1259173 17910 0 None 2 5 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 381 3 1 4 3.3 CC(=O)NCc1ccc2c(c1)[C@H](N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
10506222 111486 0 None 691 3 Human 9.4 pKi = 9.4 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 523 9 3 5 3.5 COCC1=C(C(=O)NCCCN2CCC(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
CHEMBL327716 111486 0 None 691 3 Human 9.4 pKi = 9.4 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 523 9 3 5 3.5 COCC1=C(C(=O)NCCCN2CCC(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
499 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1007/s00044-010-9379-1
5685 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1007/s00044-010-9379-1
CHEMBL25554 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1007/s00044-010-9379-1
499 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm021078o
5685 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm021078o
CHEMBL25554 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm021078o
499 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm030952q
5685 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm030952q
CHEMBL25554 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm030952q
499 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1007/s00044-010-9379-1
5685 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1007/s00044-010-9379-1
CHEMBL25554 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1007/s00044-010-9379-1
499 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1016/j.bmc.2010.08.002
5685 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1016/j.bmc.2010.08.002
CHEMBL25554 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1016/j.bmc.2010.08.002
499 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm991065j
5685 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm991065j
CHEMBL25554 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm991065j
499 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm800461k
5685 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm800461k
CHEMBL25554 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm800461k
499 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm301525w
5685 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm301525w
CHEMBL25554 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm301525w
10527466 202687 0 None 1 2 Rat 9.4 pKi = 9.4 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 448 5 2 6 2.3 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(NC(C)=O)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL61598 202687 0 None 1 2 Rat 9.4 pKi = 9.4 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 448 5 2 6 2.3 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(NC(C)=O)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
49782794 17916 0 None -1 5 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 409 4 1 4 4.0 CC(C)C(=O)NCc1ccc2c(c1)[C@H](N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
CHEMBL1259189 17916 0 None -1 5 Bovine 9.4 pKi = 9.4 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 409 4 1 4 4.0 CC(C)C(=O)NCc1ccc2c(c1)[C@H](N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
9891166 33612 0 None 6 4 Bovine 9.4 pKi = 9.4 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 476 6 0 8 3.3 COc1ccccc1N1CCN(CCn2c(=O)c3c(-c4ccccc4)csc3n(C)c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL14213 33612 0 None 6 4 Bovine 9.4 pKi = 9.4 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 476 6 0 8 3.3 COc1ccccc1N1CCN(CCn2c(=O)c3c(-c4ccccc4)csc3n(C)c2=O)CC1 10.1016/s0960-894x(01)00159-7
10994812 205096 0 None 3 4 Human 9.4 pKi = 9.4 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 509 9 1 8 3.9 COc1ccc(Cl)cc1N1CCN(CCCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL77618 205096 0 None 3 4 Human 9.4 pKi = 9.4 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 509 9 1 8 3.9 COc1ccc(Cl)cc1N1CCN(CCCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
44299974 101894 0 None 89 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 608 7 2 8 3.4 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL300821 101894 0 None 89 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 608 7 2 8 3.4 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
10553935 161820 0 None 4 2 Rat 9.4 pKi = 9.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 481 4 1 6 4.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(Cl)cc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL41444 161820 0 None 4 2 Rat 9.4 pKi = 9.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 481 4 1 6 4.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(Cl)cc54)c3=O)C[C@@H]21 10.1021/jm990567u
10529370 206939 0 None 524 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 499 9 3 5 3.0 COCC1=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1016/j.ejmech.2017.03.025
CHEMBL91125 206939 0 None 524 3 Human 9.4 pKi = 9.4 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 499 9 3 5 3.0 COCC1=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1016/j.ejmech.2017.03.025
44447063 94584 0 None -1 3 Rat 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 434 6 1 5 4.2 CCC(=O)NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21 10.1016/j.bmcl.2007.11.106
CHEMBL252031 94584 0 None -1 3 Rat 9.4 pKi = 9.4 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 434 6 1 5 4.2 CCC(=O)NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21 10.1016/j.bmcl.2007.11.106
10529370 206939 0 None 524 3 Human 9.4 pKi = 9.4 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 499 9 3 5 3.0 COCC1=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
CHEMBL91125 206939 0 None 524 3 Human 9.4 pKi = 9.4 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 499 9 3 5 3.0 COCC1=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
10602912 102738 0 None 301 2 Human 9.3 pKi = 9.3 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 558 9 3 8 2.9 CC(C)Oc1ccccc1N1CCN(C[C@@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(O)cc2)C3=O)CC1 10.1021/jm9905918
CHEMBL304977 102738 0 None 301 2 Human 9.3 pKi = 9.3 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 558 9 3 8 2.9 CC(C)Oc1ccccc1N1CCN(C[C@@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(O)cc2)C3=O)CC1 10.1021/jm9905918
44300087 96421 0 None 67 3 Human 9.3 pKi = 9.3 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.5 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@@H](N3CCC(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL262002 96421 0 None 67 3 Human 9.3 pKi = 9.3 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.5 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@@H](N3CCC(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
10364994 167885 0 None -6 4 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 423 13 1 6 4.3 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1021/jm0580398
CHEMBL43116 167885 0 None -6 4 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 423 13 1 6 4.3 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1021/jm0580398
10364994 167885 0 None -6 4 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 423 13 1 6 4.3 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL43116 167885 0 None -6 4 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 423 13 1 6 4.3 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
10095156 78543 0 None 2 2 Rat 9.3 pKi = 9.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL2112073 78543 0 None 2 2 Rat 9.3 pKi = 9.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)C[C@@H]21 10.1021/jm990567u
10678154 170601 0 None 2 2 Rat 9.3 pKi = 9.3 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 397 4 1 6 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cscc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL445071 170601 0 None 2 2 Rat 9.3 pKi = 9.3 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 397 4 1 6 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cscc4c3=O)C[C@@H]21 10.1021/jm000541z
10414908 202764 0 None 204 3 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 539 7 0 4 5.9 Cc1ccc(C2(c3ccc(C)cc3)CC(=O)N(CCCN3CCC(C#N)(c4ccccc4Cl)CC3)C2=O)cc1 10.1016/s0960-894x(01)00320-1
CHEMBL62045 202764 0 None 204 3 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 539 7 0 4 5.9 Cc1ccc(C2(c3ccc(C)cc3)CC(=O)N(CCCN3CCC(C#N)(c4ccccc4Cl)CC3)C2=O)cc1 10.1016/s0960-894x(01)00320-1
71817386 102586 0 None 3 6 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL2419769 102586 0 None 3 6 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL3040851 102586 0 None 3 6 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
11049209 207405 0 None 8 8 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 486 6 1 5 4.4 Cn1ccc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
CHEMBL93923 207405 0 None 8 8 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 486 6 1 5 4.4 Cn1ccc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
44447068 154123 0 None 1 3 Rat 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 448 6 1 5 4.4 CC(C)C(=O)NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21 10.1016/j.bmcl.2007.11.106
CHEMBL398525 154123 0 None 1 3 Rat 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 448 6 1 5 4.4 CC(C)C(=O)NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21 10.1016/j.bmcl.2007.11.106
10647790 101391 0 None 27 2 Rat 9.3 pKi = 9.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 463 4 1 8 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5nc(C)cnc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL297218 101391 0 None 27 2 Rat 9.3 pKi = 9.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 463 4 1 8 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5nc(C)cnc54)c3=O)C[C@@H]21 10.1021/jm990567u
10507220 121276 0 None 316 3 Human 9.3 pKi = 9.3 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 0 7 5.6 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)cc1F 10.1021/jm9902032
CHEMBL357842 121276 0 None 316 3 Human 9.3 pKi = 9.3 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 0 7 5.6 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)cc1F 10.1021/jm9902032
10626843 168665 0 None 67 3 Human 9.3 pKi = 9.3 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 568 10 0 8 5.0 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCN(c3ccccc3C(=O)OC)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL436407 168665 0 None 67 3 Human 9.3 pKi = 9.3 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 568 10 0 8 5.0 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCN(c3ccccc3C(=O)OC)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10032383 110110 0 None 194 6 Human 9.3 pKi = 9.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
136680387 110110 0 None 194 6 Human 9.3 pKi = 9.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL323579 110110 0 None 194 6 Human 9.3 pKi = 9.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
18738385 203724 0 None 181 3 Human 9.3 pKi = 9.3 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 427 7 0 5 4.4 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)cs2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL67713 203724 0 None 181 3 Human 9.3 pKi = 9.3 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 427 7 0 5 4.4 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)cs2)CC1 10.1016/s0960-894x(02)00347-5
122065 189549 3 None 2 8 Rat 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 380 5 1 6 1.5 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1 10.1021/jm970159v
CHEMBL51433 189549 3 None 2 8 Rat 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 380 5 1 6 1.5 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1 10.1021/jm970159v
2865 4143 73 None -4 53 Rat 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1016/j.bmcl.2007.11.106
59 4143 73 None -4 53 Rat 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1016/j.bmcl.2007.11.106
60854 4143 73 None -4 53 Rat 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1016/j.bmcl.2007.11.106
CHEMBL708 4143 73 None -4 53 Rat 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1016/j.bmcl.2007.11.106
DB00246 4143 73 None -4 53 Rat 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 10.1016/j.bmcl.2007.11.106
49781453 17867 0 None -1 3 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 386 2 0 3 5.3 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccccc4)cc32)CC1 10.1021/jm100652h
CHEMBL1259043 17867 0 None -1 3 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 386 2 0 3 5.3 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccccc4)cc32)CC1 10.1021/jm100652h
10393665 33922 0 None 47 3 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 593 9 2 9 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
CHEMBL142383 33922 0 None 47 3 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 593 9 2 9 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
9916549 121564 0 None 1 4 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL358595 121564 0 None 1 4 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
11757736 33747 0 None 870 4 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 570 9 2 6 4.3 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL142243 33747 0 None 870 4 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 570 9 2 6 4.3 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
10840177 38116 0 None 537 3 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 540 7 2 5 4.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL146109 38116 0 None 537 3 Human 9.3 pKi = 9.3 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 540 7 2 5 4.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
9891213 161502 0 None -12 5 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 477 5 1 8 4.0 COc1cc2nc(N3CCN(C(=O)OCc4ccccc4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4128084 161502 0 None -12 5 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 477 5 1 8 4.0 COc1cc2nc(N3CCN(C(=O)OCc4ccccc4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
489 145 28 None -4 12 Bovine 9.3 pKi = 9.3 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm970166j
5640 145 28 None -4 12 Bovine 9.3 pKi = 9.3 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm970166j
CHEMBL420060 145 28 None -4 12 Bovine 9.3 pKi = 9.3 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm970166j
44298447 100799 0 None 5 3 Human 9.3 pKi = 9.3 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 430 6 1 6 1.7 Cc1c[nH]c(=O)n(CCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL293149 100799 0 None 5 3 Human 9.3 pKi = 9.3 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 430 6 1 6 1.7 Cc1c[nH]c(=O)n(CCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
4209 3163 75 None -3 33 Human 9.3 pKi = 9.3 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
4893 3163 75 None -3 33 Human 9.3 pKi = 9.3 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
503 3163 75 None -3 33 Human 9.3 pKi = 9.3 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
5385 3163 75 None -3 33 Human 9.3 pKi = 9.3 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
CHEMBL2 3163 75 None -3 33 Human 9.3 pKi = 9.3 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
DB00457 3163 75 None -3 33 Human 9.3 pKi = 9.3 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm00018a001
10029146 205691 0 None 331 3 Human 9.3 pKi = 9.3 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 504 8 0 6 3.9 CCOC(=O)[C@@H]1CN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CC[C@@H]1c1ccccc1 10.1016/s0960-894x(98)00451-x
CHEMBL82267 205691 0 None 331 3 Human 9.3 pKi = 9.3 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 504 8 0 6 3.9 CCOC(=O)[C@@H]1CN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CC[C@@H]1c1ccccc1 10.1016/s0960-894x(98)00451-x
11800077 100512 0 None 6 2 Rat 9.3 pKi = 9.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 481 4 1 6 4.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccc(Cl)c54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL291154 100512 0 None 6 2 Rat 9.3 pKi = 9.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 481 4 1 6 4.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccc(Cl)c54)c3=O)C[C@@H]21 10.1021/jm990567u
44289261 164912 0 None 12 6 Human 9.3 pKi = 9.3 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 417 9 1 4 5.1 COc1cccc(OC)c1OCCNCC1Cc2ccccc2C(c2ccccc2)C1 10.1021/jm011066n
CHEMBL42231 164912 0 None 12 6 Human 9.3 pKi = 9.3 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 417 9 1 4 5.1 COc1cccc(OC)c1OCCNCC1Cc2ccccc2C(c2ccccc2)C1 10.1021/jm011066n
52942395 17921 0 None 3 5 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 386 3 0 4 5.0 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cncnc4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL1259203 17921 0 None 3 5 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 386 3 0 4 5.0 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cncnc4)cc23)CC1 10.1016/j.bmc.2012.10.049
49781448 17850 0 None 1 3 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 406 2 0 4 5.7 Cc1ccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)s1 10.1021/jm100652h
CHEMBL1259005 17850 0 None 1 3 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 406 2 0 4 5.7 Cc1ccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)s1 10.1021/jm100652h
52942395 17921 0 None 3 5 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 386 3 0 4 5.0 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cncnc4)cc23)CC1 10.1021/jm100652h
CHEMBL1259203 17921 0 None 3 5 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 386 3 0 4 5.0 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cncnc4)cc23)CC1 10.1021/jm100652h
10744687 100426 0 None 12 2 Rat 9.3 pKi = 9.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 490 5 2 7 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(C(N)=O)cc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL290388 100426 0 None 12 2 Rat 9.3 pKi = 9.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 490 5 2 7 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(C(N)=O)cc54)c3=O)C[C@@H]21 10.1021/jm990567u
13911290 28171 0 None -2 5 Rat 9.3 pKi = 9.3 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 386 5 1 7 1.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sccc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL13735 28171 0 None -2 5 Rat 9.3 pKi = 9.3 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 386 5 1 7 1.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sccc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
10769331 111533 0 None 79 6 Human 9.3 pKi = 9.3 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 566 9 2 7 5.9 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc(Cl)c([N+](=O)[O-])c1 10.1021/jm980077m
CHEMBL327931 111533 0 None 79 6 Human 9.3 pKi = 9.3 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 566 9 2 7 5.9 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc(Cl)c([N+](=O)[O-])c1 10.1021/jm980077m
10769331 85292 0 None - 1 Human 9.3 pKi = 9.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 566 9 2 7 5.0 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc(Cl)c([N+](=O)[O-])c1 10.1007/s00044-004-0120-9
CHEMBL2260370 85292 0 None - 1 Human 9.3 pKi = 9.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 566 9 2 7 5.0 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc(Cl)c([N+](=O)[O-])c1 10.1007/s00044-004-0120-9
15054191 197751 0 None 4 2 Rat 9.3 pKi = 9.3 Binding
Binding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranesBinding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranes
ChEMBL 423 4 2 5 2.6 O=c1[nH]c2c([nH]c3ccccc32)c(=O)n1CCN1CCN(c2ccccc2Cl)CC1 10.1021/jm00110a014
CHEMBL57163 197751 0 None 4 2 Rat 9.3 pKi = 9.3 Binding
Binding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranesBinding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranes
ChEMBL 423 4 2 5 2.6 O=c1[nH]c2c([nH]c3ccccc32)c(=O)n1CCN1CCN(c2ccccc2Cl)CC1 10.1021/jm00110a014
10917316 205487 0 None 10 4 Human 9.3 pKi = 9.3 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 447 8 1 8 2.6 COc1ccc(Cl)cc1N1CCN(CCCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL80599 205487 0 None 10 4 Human 9.3 pKi = 9.3 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 447 8 1 8 2.6 COc1ccc(Cl)cc1N1CCN(CCCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1 10.1021/jm0009336
10411384 157164 0 None 6 2 Rat 9.3 pKi = 9.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cnccc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL40754 157164 0 None 6 2 Rat 9.3 pKi = 9.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cnccc54)c3=O)C[C@@H]21 10.1021/jm990567u
3157 1470 71 None -2 10 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm0580398
7170 1470 71 None -2 10 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm0580398
954 1470 71 None -2 10 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm0580398
CHEMBL707 1470 71 None -2 10 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm0580398
DB00590 1470 71 None -2 10 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm0580398
3157 1470 71 None -2 10 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm8016046
7170 1470 71 None -2 10 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm8016046
954 1470 71 None -2 10 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm8016046
CHEMBL707 1470 71 None -2 10 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm8016046
DB00590 1470 71 None -2 10 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm8016046
71508713 87069 0 None 295 2 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 388 3 0 4 5.0 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ccn(C)n4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2326176 87069 0 None 295 2 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 388 3 0 4 5.0 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ccn(C)n4)cc23)CC1 10.1016/j.bmc.2012.10.049
44358574 119369 0 None -2 5 Human 9.3 pKi = 9.3 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 340 9 1 4 4.0 COc1cccc2c1CCCC2CCCNCCOc1ccccn1 10.1021/jm010866v
CHEMBL344432 119369 0 None -2 5 Human 9.3 pKi = 9.3 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 340 9 1 4 4.0 COc1cccc2c1CCCC2CCCNCCOc1ccccn1 10.1021/jm010866v
44431607 147595 0 None 42 4 Human 9.3 pKi = 9.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 509 7 1 5 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccc(Cl)c3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL393105 147595 0 None 42 4 Human 9.3 pKi = 9.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 509 7 1 5 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccc(Cl)c3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
12765746 102280 4 None -1 9 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 344 1 0 3 4.3 CN1CCN([C@H]2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1021/jm020938y
CHEMBL303313 102280 4 None -1 9 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 344 1 0 3 4.3 CN1CCN([C@H]2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1021/jm020938y
11092112 207628 0 None 3 8 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 485 6 0 6 4.9 O=C1OCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ncccn4)cc23)CC1 10.1021/jm020938y
CHEMBL95175 207628 0 None 3 8 Bovine 9.3 pKi = 9.3 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 485 6 0 6 4.9 O=C1OCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ncccn4)cc23)CC1 10.1021/jm020938y
10844296 201415 0 None 4 2 Rat 9.2 pKi = 9.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 425 4 1 5 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(Cl)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL60471 201415 0 None 4 2 Rat 9.2 pKi = 9.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 425 4 1 5 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(Cl)ccc4c3=O)C[C@@H]21 10.1021/jm000541z
9847196 30181 0 None -2 4 Rat 9.2 pKi = 9.2 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(-c4ccccc4)cc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL13903 30181 0 None -2 4 Rat 9.2 pKi = 9.2 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(-c4ccccc4)cc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
4209 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity against human Alpha-1A adrenergic receptorBinding affinity against human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(99)00484-9
4893 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity against human Alpha-1A adrenergic receptorBinding affinity against human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(99)00484-9
503 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity against human Alpha-1A adrenergic receptorBinding affinity against human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(99)00484-9
5385 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity against human Alpha-1A adrenergic receptorBinding affinity against human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(99)00484-9
CHEMBL2 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity against human Alpha-1A adrenergic receptorBinding affinity against human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(99)00484-9
DB00457 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity against human Alpha-1A adrenergic receptorBinding affinity against human Alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/s0960-894x(99)00484-9
4209 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980506g
4893 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980506g
503 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980506g
5385 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980506g
CHEMBL2 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980506g
DB00457 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm980506g
9916549 121564 0 None -1 4 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of ratIn vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of rat
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL358595 121564 0 None -1 4 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of ratIn vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of rat
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
4209 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm981006q
4893 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm981006q
503 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm981006q
5385 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm981006q
CHEMBL2 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm981006q
DB00457 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm981006q
4209 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
4893 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
503 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
5385 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
CHEMBL2 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
DB00457 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
4209 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
4893 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
503 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
5385 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
CHEMBL2 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
DB00457 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm9810654
4209 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm030952q
4893 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm030952q
503 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm030952q
5385 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm030952q
CHEMBL2 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm030952q
DB00457 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm030952q
4209 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
4893 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
503 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
5385 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
CHEMBL2 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
DB00457 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1007/s00044-010-9379-1
9824384 118787 1 None -14 7 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL342062 118787 1 None -14 7 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
4209 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.05.003
4893 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.05.003
503 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.05.003
5385 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.05.003
CHEMBL2 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.05.003
DB00457 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.ejmech.2017.05.003
4209 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
4893 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
503 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
5385 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
CHEMBL2 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
DB00457 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm049153d
4209 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
4893 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
503 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
5385 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
CHEMBL2 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
DB00457 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
10718317 100526 0 None 10 2 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ncccc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL291262 100526 0 None 10 2 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 448 4 1 7 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ncccc54)c3=O)C[C@@H]21 10.1021/jm990567u
10437624 121271 0 None 398 3 Human 9.2 pKi = 9.2 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 553 10 1 7 4.3 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL357828 121271 0 None 398 3 Human 9.2 pKi = 9.2 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 553 10 1 7 4.3 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
499 4077 18 None -1 14 Bovine 9.2 pKi = 9.2 Binding
Binding affinity of compound towards Alpha-1 adrenergic receptor using [3H]prazosin 0.5 nM ligand in frontal cortex calf was determinedBinding affinity of compound towards Alpha-1 adrenergic receptor using [3H]prazosin 0.5 nM ligand in frontal cortex calf was determined
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm950759z
5685 4077 18 None -1 14 Bovine 9.2 pKi = 9.2 Binding
Binding affinity of compound towards Alpha-1 adrenergic receptor using [3H]prazosin 0.5 nM ligand in frontal cortex calf was determinedBinding affinity of compound towards Alpha-1 adrenergic receptor using [3H]prazosin 0.5 nM ligand in frontal cortex calf was determined
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm950759z
CHEMBL25554 4077 18 None -1 14 Bovine 9.2 pKi = 9.2 Binding
Binding affinity of compound towards Alpha-1 adrenergic receptor using [3H]prazosin 0.5 nM ligand in frontal cortex calf was determinedBinding affinity of compound towards Alpha-1 adrenergic receptor using [3H]prazosin 0.5 nM ligand in frontal cortex calf was determined
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm950759z
3894573 3393 6 None -1 5 Human 9.2 pKi = 9.2 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1016/j.bmcl.2004.11.032
495 3393 6 None -1 5 Human 9.2 pKi = 9.2 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1016/j.bmcl.2004.11.032
CHEMBL88272 3393 6 None -1 5 Human 9.2 pKi = 9.2 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1016/j.bmcl.2004.11.032
44300107 100687 0 None 114 3 Human 9.2 pKi = 9.2 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.5 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL292365 100687 0 None 114 3 Human 9.2 pKi = 9.2 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.5 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
44294957 191044 0 None 295 3 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 556 7 2 8 2.7 O=C1OCC2=C1C(c1ccc(F)c(F)c1)N(C(=O)NCCCN1CCN(c3ccccc3[N+](=O)[O-])CC1)C(=O)N2 10.1016/s0960-894x(99)00653-8
CHEMBL51871 191044 0 None 295 3 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 556 7 2 8 2.7 O=C1OCC2=C1C(c1ccc(F)c(F)c1)N(C(=O)NCCCN1CCN(c3ccccc3[N+](=O)[O-])CC1)C(=O)N2 10.1016/s0960-894x(99)00653-8
2142 3096 58 None -2 36 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
4920903 3096 58 None -2 36 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
502 3096 58 None -2 36 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
5775 3096 58 None -2 36 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
CHEMBL597 3096 58 None -2 36 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
DB00692 3096 58 None -2 36 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/ml5004298
10697912 206992 0 None - 1 Human 9.2 pKi = 9.2 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 550 7 2 5 4.0 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1021/jm990612y
CHEMBL91403 206992 0 None - 1 Human 9.2 pKi = 9.2 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 550 7 2 5 4.0 CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1021/jm990612y
10530552 33245 0 None 26 3 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 543 7 3 7 3.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL141821 33245 0 None 26 3 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 543 7 3 7 3.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
4209 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990201h
4893 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990201h
503 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990201h
5385 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990201h
CHEMBL2 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990201h
DB00457 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm990201h
24897950 56352 0 None -2 5 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 462 11 2 6 2.9 COc1ccc(C[C@@H](C)NCCOc2ccccc2OCC(F)(F)F)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
CHEMBL1630940 56352 0 None -2 5 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 462 11 2 6 2.9 COc1ccc(C[C@@H](C)NCCOc2ccccc2OCC(F)(F)F)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
4209 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm0009336
4893 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm0009336
503 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm0009336
5385 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm0009336
CHEMBL2 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm0009336
DB00457 3163 75 None -3 33 Human 9.2 pKi = 9.2 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm0009336
499 4077 18 None -1 14 Bovine 9.2 pKi = 9.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm960069a
5685 4077 18 None -1 14 Bovine 9.2 pKi = 9.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm960069a
CHEMBL25554 4077 18 None -1 14 Bovine 9.2 pKi = 9.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm960069a
11016418 106122 0 None 5 8 Bovine 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 488 6 0 7 4.2 Cn1cnc(-c2ccc3c(c2)c(C2CCN(CCN4CCOC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
CHEMBL313424 106122 0 None 5 8 Bovine 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 488 6 0 7 4.2 Cn1cnc(-c2ccc3c(c2)c(C2CCN(CCN4CCOC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
3157 1470 71 None -1 10 Rat 9.2 pKi = 9.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 nan
7170 1470 71 None -1 10 Rat 9.2 pKi = 9.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 nan
954 1470 71 None -1 10 Rat 9.2 pKi = 9.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 nan
CHEMBL707 1470 71 None -1 10 Rat 9.2 pKi = 9.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 nan
DB00590 1470 71 None -1 10 Rat 9.2 pKi = 9.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 nan
10434440 205494 0 None -4 4 Human 9.2 pKi = 9.2 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 461 8 1 8 2.9 COc1ccccc1N1CCN(CCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL80641 205494 0 None -4 4 Human 9.2 pKi = 9.2 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 461 8 1 8 2.9 COc1ccccc1N1CCN(CCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
489 145 28 None -3 12 Human 9.2 pKi = 9.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm960697s
5640 145 28 None -3 12 Human 9.2 pKi = 9.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm960697s
CHEMBL420060 145 28 None -3 12 Human 9.2 pKi = 9.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm960697s
3894573 3393 6 None -1 5 Human 9.2 pKi = 9.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1021/jm960697s
495 3393 6 None -1 5 Human 9.2 pKi = 9.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1021/jm960697s
CHEMBL88272 3393 6 None -1 5 Human 9.2 pKi = 9.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1021/jm960697s
46934643 16677 0 None 6 4 Human 9.2 pKi = 9.2 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 479 7 0 6 3.5 COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3CCCCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242632 16677 0 None 6 4 Human 9.2 pKi = 9.2 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 479 7 0 6 3.5 COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3CCCCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
145956955 162101 0 None -2 3 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 397 5 2 8 2.2 COc1cc2nc(N3CCC[C@H](NC(=O)c4ccco4)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
CHEMBL4161165 162101 0 None -2 3 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 397 5 2 8 2.2 COc1cc2nc(N3CCC[C@H](NC(=O)c4ccco4)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
10742076 100318 0 None 3 2 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1cccc2c1CCC1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC21 10.1021/jm990567u
CHEMBL289361 100318 0 None 3 2 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1cccc2c1CCC1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC21 10.1021/jm990567u
44390708 64271 0 None 630 3 Human 9.2 pKi = 9.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)[C@H](c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1021/jm960697s
CHEMBL180932 64271 0 None 630 3 Human 9.2 pKi = 9.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)[C@H](c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1021/jm960697s
10834793 84579 0 None -1 6 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153557 84579 0 None -1 6 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220925 84579 0 None -1 6 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
56946573 71526 0 None 6 4 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 428 6 0 4 4.9 COc1ccccc1N1CCN(CC2CCC(c3ccccc3)(c3ccccc3)O2)CC1 10.1021/jm200421e
CHEMBL1946780 71526 0 None 6 4 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 428 6 0 4 4.9 COc1ccccc1N1CCN(CC2CCC(c3ccccc3)(c3ccccc3)O2)CC1 10.1021/jm200421e
CHEMBL1962870 71526 0 None 6 4 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 428 6 0 4 4.9 COc1ccccc1N1CCN(CC2CCC(c3ccccc3)(c3ccccc3)O2)CC1 10.1021/jm200421e
9866614 14715 1 None 120 3 Human 9.2 pKi = 9.2 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 416 9 1 5 2.1 CC(C)Oc1ccccc1N1CCN(CCCNC(=O)CN2CCCCC2=O)CC1 10.1016/j.bmcl.2004.11.032
CHEMBL12062 14715 1 None 120 3 Human 9.2 pKi = 9.2 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
ChEMBL 416 9 1 5 2.1 CC(C)Oc1ccccc1N1CCN(CCCNC(=O)CN2CCCCC2=O)CC1 10.1016/j.bmcl.2004.11.032
135559170 102060 0 None 8 7 Rat 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(CC2CN3C(=O)Nc4ccccc4C3=N2)CC1 10.1021/jm970159v
CHEMBL302021 102060 0 None 8 7 Rat 9.2 pKi = 9.2 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(CC2CN3C(=O)Nc4ccccc4C3=N2)CC1 10.1021/jm970159v
107715 200945 22 None -1 19 Rat 9.2 pKi = 9.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
CHEMBL1255837 200945 22 None -1 19 Rat 9.2 pKi = 9.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
CHEMBL601773 200945 22 None -1 19 Rat 9.2 pKi = 9.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 611 5 3 6 2.7 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O nan
9866614 14715 1 None 120 3 Human 9.2 pKi = 9.2 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 416 9 1 5 2.1 CC(C)Oc1ccccc1N1CCN(CCCNC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL12062 14715 1 None 120 3 Human 9.2 pKi = 9.2 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 416 9 1 5 2.1 CC(C)Oc1ccccc1N1CCN(CCCNC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
10792898 203945 0 None 93 2 Human 9.2 pKi = 9.2 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 556 9 2 7 3.5 Cc1ccc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
CHEMBL69295 203945 0 None 93 2 Human 9.2 pKi = 9.2 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 556 9 2 7 3.5 Cc1ccc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
9913988 17915 0 None -1 3 Bovine 9.2 pKi = 9.2 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 502 7 1 7 3.1 Cn1nnc(Cc2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm100652h
CHEMBL1259188 17915 0 None -1 3 Bovine 9.2 pKi = 9.2 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 502 7 1 7 3.1 Cn1nnc(Cc2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm100652h
1238 203174 24 None -3 16 Bovine 9.2 pKi = 9.2 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 344 1 0 3 4.3 CN1CCN(C2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1021/jm100652h
CHEMBL64249 203174 24 None -3 16 Bovine 9.2 pKi = 9.2 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 344 1 0 3 4.3 CN1CCN(C2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1021/jm100652h
10552656 161312 0 None 4 2 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 478 5 1 8 3.0 COc1ccc2sc3c(=O)n(CCN4C[C@@H]5CCc6c(OC)cccc6[C@@H]5C4)c(=O)[nH]c3c2n1 10.1021/jm990567u
CHEMBL41234 161312 0 None 4 2 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 478 5 1 8 3.0 COc1ccc2sc3c(=O)n(CCN4C[C@@H]5CCc6c(OC)cccc6[C@@H]5C4)c(=O)[nH]c3c2n1 10.1021/jm990567u
9895338 94445 0 None 223 3 Human 9.2 pKi = 9.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 622 11 2 7 6.8 CCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)/C(=C(\O)OC)C(C)=N1 10.1021/jm960697s
CHEMBL25121 94445 0 None 223 3 Human 9.2 pKi = 9.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 622 11 2 7 6.8 CCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)/C(=C(\O)OC)C(C)=N1 10.1021/jm960697s
3168 9262 92 None 1 21 Rat 9.2 pKi = 9.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 nan
CHEMBL1108 9262 92 None 1 21 Rat 9.2 pKi = 9.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 379 6 1 4 3.7 O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1 nan
10763038 202675 0 None 1 2 Rat 9.2 pKi = 9.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 391 4 1 5 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4ccccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL61491 202675 0 None 1 2 Rat 9.2 pKi = 9.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 391 4 1 5 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4ccccc4c3=O)C[C@@H]21 10.1021/jm000541z
52946023 17914 0 None 2 5 Bovine 9.2 pKi = 9.2 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 477 7 2 4 3.6 CC(=O)NCc1ccc2c(c1)c(C1CCN(CCN3CCNC3=O)CC1)cn2-c1ccc(F)cc1 10.1021/jm100652h
CHEMBL1259187 17914 0 None 2 5 Bovine 9.2 pKi = 9.2 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 477 7 2 4 3.6 CC(=O)NCc1ccc2c(c1)c(C1CCN(CCN3CCNC3=O)CC1)cn2-c1ccc(F)cc1 10.1021/jm100652h
10718348 100245 0 None 22 2 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 449 4 1 8 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ncncc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL288678 100245 0 None 22 2 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 449 4 1 8 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ncncc54)c3=O)C[C@@H]21 10.1021/jm990567u
10415038 4439 0 None 3 4 Human 9.2 pKi = 9.2 Binding
Ability to displace [125I]HEAT from cloned human Alpha-1A adrenergic receptor stably expressed in CHO cellsAbility to displace [125I]HEAT from cloned human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 545 6 1 7 5.3 Cc1noc(C)c1S(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3cccc4ccccc34)CC1)O2 10.1016/s0960-894x(98)00732-x
CHEMBL101610 4439 0 None 3 4 Human 9.2 pKi = 9.2 Binding
Ability to displace [125I]HEAT from cloned human Alpha-1A adrenergic receptor stably expressed in CHO cellsAbility to displace [125I]HEAT from cloned human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 545 6 1 7 5.3 Cc1noc(C)c1S(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3cccc4ccccc34)CC1)O2 10.1016/s0960-894x(98)00732-x
10368033 100425 0 None 50 3 Rat 9.2 pKi = 9.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 483 4 1 8 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ncc(Cl)nc54)c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL290387 100425 0 None 50 3 Rat 9.2 pKi = 9.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 483 4 1 8 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ncc(Cl)nc54)c3=O)C[C@@H]21 10.1021/jm000541z
10368033 100425 0 None 50 3 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 483 4 1 8 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ncc(Cl)nc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL290387 100425 0 None 50 3 Rat 9.2 pKi = 9.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 483 4 1 8 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ncc(Cl)nc54)c3=O)C[C@@H]21 10.1021/jm990567u
6603950 203324 9 None -1 8 Bovine 9.2 pKi = 9.2 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 344 1 0 3 4.3 CN1CCN([C@@H]2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1021/jm100652h
CHEMBL64875 203324 9 None -1 8 Bovine 9.2 pKi = 9.2 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 344 1 0 3 4.3 CN1CCN([C@@H]2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1021/jm100652h
10554913 37346 0 None 11 3 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 561 7 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3cccc(Cl)c3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145443 37346 0 None 11 3 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 561 7 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3cccc(Cl)c3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
10745766 37484 0 None 141 3 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 578 9 3 8 2.7 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm990200p
CHEMBL145562 37484 0 None 141 3 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 578 9 3 8 2.7 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm990200p
10674333 37494 0 None 239 3 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 554 8 3 6 2.9 CC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145574 37494 0 None 239 3 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 554 8 3 6 2.9 CC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
10415156 121138 0 None 870 4 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 550 8 3 5 3.8 CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL357628 121138 0 None 870 4 Human 9.2 pKi = 9.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 550 8 3 5 3.8 CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
489 145 28 None -2 12 Rat 9.2 pKi = 9.2 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
5640 145 28 None -2 12 Rat 9.2 pKi = 9.2 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
CHEMBL420060 145 28 None -2 12 Rat 9.2 pKi = 9.2 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
10741071 169217 0 None 1 2 Rat 9.2 pKi = 9.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 425 4 1 5 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cccc(Cl)c4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL440865 169217 0 None 1 2 Rat 9.2 pKi = 9.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 425 4 1 5 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cccc(Cl)c4c3=O)C[C@@H]21 10.1021/jm000541z
10478895 100227 0 None 17 2 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 449 4 1 8 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5nccnc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL288530 100227 0 None 17 2 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 449 4 1 8 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5nccnc54)c3=O)C[C@@H]21 10.1021/jm990567u
20215436 28515 3 None -1 3 Rat 9.1 pKi = 9.1 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 355 4 1 8 2.1 COc1cc2nc(N3CCN(c4ccco4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL137598 28515 3 None -1 3 Rat 9.1 pKi = 9.1 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 355 4 1 8 2.1 COc1cc2nc(N3CCN(c4ccco4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
4209 3163 75 None -4 33 Bovine 9.1 pKi = 9.1 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
4893 3163 75 None -4 33 Bovine 9.1 pKi = 9.1 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
503 3163 75 None -4 33 Bovine 9.1 pKi = 9.1 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
5385 3163 75 None -4 33 Bovine 9.1 pKi = 9.1 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
CHEMBL2 3163 75 None -4 33 Bovine 9.1 pKi = 9.1 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
DB00457 3163 75 None -4 33 Bovine 9.1 pKi = 9.1 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
44431551 87211 0 None 33 4 Human 9.1 pKi = 9.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL232780 87211 0 None 33 4 Human 9.1 pKi = 9.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
44447067 94615 0 None -1 3 Rat 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 446 6 1 5 4.2 O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)C1CC1 10.1016/j.bmcl.2007.11.106
CHEMBL252230 94615 0 None -1 3 Rat 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 446 6 1 5 4.2 O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)C1CC1 10.1016/j.bmcl.2007.11.106
10348924 17945 0 None 3 5 Human 9.1 pKi = 9.1 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 620 10 1 10 3.8 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C#N)CC3)cccc2c1=O 10.1021/jm030825u
CHEMBL125989 17945 0 None 3 5 Human 9.1 pKi = 9.1 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 620 10 1 10 3.8 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C#N)CC3)cccc2c1=O 10.1021/jm030825u
10721564 207350 0 None 33 3 Human 9.1 pKi = 9.1 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 558 7 1 5 4.9 COC(=O)N1C(=O)N(C)C(C)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1016/j.ejmech.2017.03.025
CHEMBL93623 207350 0 None 33 3 Human 9.1 pKi = 9.1 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 558 7 1 5 4.9 COC(=O)N1C(=O)N(C)C(C)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1016/j.ejmech.2017.03.025
10721564 207350 0 None 33 3 Human 9.1 pKi = 9.1 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 558 7 1 5 4.9 COC(=O)N1C(=O)N(C)C(C)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1021/jm990612y
CHEMBL93623 207350 0 None 33 3 Human 9.1 pKi = 9.1 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 558 7 1 5 4.9 COC(=O)N1C(=O)N(C)C(C)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1021/jm990612y
10627003 204340 0 None 53 3 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 576 9 2 7 3.8 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(Cl)c2)C3=O)CC1 10.1021/jm9905918
CHEMBL71580 204340 0 None 53 3 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 576 9 2 7 3.8 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(Cl)c2)C3=O)CC1 10.1021/jm9905918
44431546 88142 0 None 3 4 Human 9.1 pKi = 9.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 482 7 1 6 3.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3C#N)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234680 88142 0 None 3 4 Human 9.1 pKi = 9.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 482 7 1 6 3.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3C#N)CC2)CC1 10.1016/j.bmcl.2007.04.008
10626911 102220 0 None 66 2 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 572 10 2 8 3.2 COc1ccc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
CHEMBL302940 102220 0 None 66 2 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 572 10 2 8 3.2 COc1ccc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
10625617 161696 0 None 3 2 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 477 5 1 7 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccc(OC)c54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL41344 161696 0 None 3 2 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 477 5 1 7 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccc(OC)c54)c3=O)C[C@@H]21 10.1021/jm990567u
3157 1470 71 None -2 10 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1016/j.ejmech.2017.05.003
7170 1470 71 None -2 10 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1016/j.ejmech.2017.05.003
954 1470 71 None -2 10 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1016/j.ejmech.2017.05.003
CHEMBL707 1470 71 None -2 10 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1016/j.ejmech.2017.05.003
DB00590 1470 71 None -2 10 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1016/j.ejmech.2017.05.003
10648335 100162 0 None 8 2 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 478 5 1 8 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5c(OC)ccnc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL287928 100162 0 None 8 2 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 478 5 1 8 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5c(OC)ccnc54)c3=O)C[C@@H]21 10.1021/jm990567u
10765077 100262 0 None 2 2 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 430 4 2 5 2.8 COc1cccc2c1CCC1CN(CCn3c(=O)[nH]c4c([nH]c5ccccc54)c3=O)CC21 10.1021/jm990567u
CHEMBL288809 100262 0 None 2 2 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 430 4 2 5 2.8 COc1cccc2c1CCC1CN(CCn3c(=O)[nH]c4c([nH]c5ccccc54)c3=O)CC21 10.1021/jm990567u
2142 3096 58 None -1 36 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
4920903 3096 58 None -1 36 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
502 3096 58 None -1 36 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
5775 3096 58 None -1 36 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
CHEMBL597 3096 58 None -1 36 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
DB00692 3096 58 None -1 36 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm970166j
3894573 3393 6 None 1 5 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1021/jm970166j
495 3393 6 None 1 5 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1021/jm970166j
CHEMBL88272 3393 6 None 1 5 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10.1021/jm970166j
10833725 206511 0 None 2 2 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 381 7 1 5 2.7 Cc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL88435 206511 0 None 2 2 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 381 7 1 5 2.7 Cc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10647341 206934 0 None - 1 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 453 9 1 6 3.8 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2OCC(C)(C)C)CC1 10.1021/jm970166j
CHEMBL91093 206934 0 None - 1 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 453 9 1 6 3.8 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2OCC(C)(C)C)CC1 10.1021/jm970166j
10550225 207082 0 None - 1 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 423 8 1 6 3.0 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N2CCCC2)CC1 10.1021/jm970166j
CHEMBL91876 207082 0 None - 1 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 423 8 1 6 3.0 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N2CCCC2)CC1 10.1021/jm970166j
10524875 207372 0 None 15 2 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 397 8 1 6 2.4 COc1ccccc1N1CCN(CCCNc2ccncc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL93736 207372 0 None 15 2 Bovine 9.1 pKi = 9.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 397 8 1 6 2.4 COc1ccccc1N1CCN(CCCNc2ccncc2C(=O)N(C)C)CC1 10.1021/jm970166j
9891937 194748 0 None 31 3 Human 9.1 pKi = 9.1 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 458 8 1 6 2.4 CCc1c[nH]c(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL53675 194748 0 None 31 3 Human 9.1 pKi = 9.1 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 458 8 1 6 2.4 CCc1c[nH]c(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
44298746 195632 0 None 19 3 Human 9.1 pKi = 9.1 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 452 7 1 6 2.4 Cc1c[nH]c(=O)n(CC2(CN3CCN(c4ccccc4OCC(F)(F)F)CC3)CC2)c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL55629 195632 0 None 19 3 Human 9.1 pKi = 9.1 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 452 7 1 6 2.4 Cc1c[nH]c(=O)n(CC2(CN3CCN(c4ccccc4OCC(F)(F)F)CC3)CC2)c1=O 10.1016/s0960-894x(03)00305-6
9865577 112309 2 None 1 2 Bovine 9.1 pKi = 9.1 Binding
The compound was screened in vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorThe compound was screened in vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 397 8 1 6 2.4 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL329160 112309 2 None 1 2 Bovine 9.1 pKi = 9.1 Binding
The compound was screened in vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorThe compound was screened in vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 397 8 1 6 2.4 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10674840 203716 0 None 50 2 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 585 10 2 8 3.3 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(N(C)C)cc2)C3=O)CC1 10.1021/jm9905918
CHEMBL67648 203716 0 None 50 2 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 585 10 2 8 3.3 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(N(C)C)cc2)C3=O)CC1 10.1021/jm9905918
44431192 92559 0 None 1 3 Human 9.1 pKi = 9.1 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 448 5 0 6 3.6 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4cccnc4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
CHEMBL243228 92559 0 None 1 3 Human 9.1 pKi = 9.1 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 448 5 0 6 3.6 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4cccnc4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
10917920 111446 0 None 8 9 Bovine 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 487 6 1 6 3.8 Cn1cnc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
CHEMBL327527 111446 0 None 8 9 Bovine 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 487 6 1 6 3.8 Cn1cnc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
56944383 112119 0 None -1 12 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
ChEMBL 487 8 1 6 5.1 O=S(=O)(NCCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cc2ccccc2s1 10.1021/jm401895u
CHEMBL3290012 112119 0 None -1 12 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
ChEMBL 487 8 1 6 5.1 O=S(=O)(NCCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cc2ccccc2s1 10.1021/jm401895u
10603739 16389 0 None 46 3 Human 9.1 pKi = 9.1 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 607 10 2 9 3.8 CCC1=C(C(=O)OC)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL123012 16389 0 None 46 3 Human 9.1 pKi = 9.1 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 607 10 2 9 3.8 CCC1=C(C(=O)OC)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
10698141 33825 0 None 21 3 Human 9.1 pKi = 9.1 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 561 7 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccc(Cl)cc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL142307 33825 0 None 21 3 Human 9.1 pKi = 9.1 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 561 7 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccc(Cl)cc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
11430126 60563 0 None -1 5 Human 9.1 pKi = 9.1 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 421 4 1 9 2.0 COc1cc2nc(N3CCN(C(=O)C4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
CHEMBL175934 60563 0 None -1 5 Human 9.1 pKi = 9.1 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 421 4 1 9 2.0 COc1cc2nc(N3CCN(C(=O)C4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
3584 3777 64 None -2 13 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990567u
5401 3777 64 None -2 13 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990567u
7302 3777 64 None -2 13 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990567u
CHEMBL611 3777 64 None -2 13 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990567u
DB01162 3777 64 None -2 13 Rat 9.1 pKi = 9.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990567u
10793261 121053 0 None 2290 4 Human 9.1 pKi = 9.1 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 575 10 3 8 3.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
CHEMBL356829 121053 0 None 2290 4 Human 9.1 pKi = 9.1 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 575 10 3 8 3.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
57402366 69315 0 None -1 5 Pig 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1033 32 2 17 5.4 COc1ccccc1N1CCN(CCCCNC(=O)c2cnn3ccc(COCCOCCOCCOCCOCc4ccn5ncc(C(=O)NCCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928139 69315 0 None -1 5 Pig 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1033 32 2 17 5.4 COc1ccccc1N1CCN(CCCCNC(=O)c2cnn3ccc(COCCOCCOCCOCCOCc4ccn5ncc(C(=O)NCCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1 10.1016/j.bmc.2011.10.063
10740866 102095 0 None 2 2 Rat 9.1 pKi = 9.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 421 5 1 6 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(OC)cccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL302203 102095 0 None 2 2 Rat 9.1 pKi = 9.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 421 5 1 6 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(OC)cccc4c3=O)C[C@@H]21 10.1021/jm000541z
10740369 201863 0 None 1 2 Rat 9.1 pKi = 9.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 411 4 1 6 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C)csc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL60721 201863 0 None 1 2 Rat 9.1 pKi = 9.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 411 4 1 6 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C)csc4c3=O)C[C@@H]21 10.1021/jm000541z
9847196 30181 0 None -3 4 Human 9.1 pKi = 9.1 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(-c4ccccc4)cc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL13903 30181 0 None -3 4 Human 9.1 pKi = 9.1 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(-c4ccccc4)cc3c2=O)CC1 10.1016/s0960-894x(01)00159-7
49781676 17872 0 None 1 3 Bovine 9.1 pKi = 9.1 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 400 2 0 3 5.7 Cc1ccccc1-c1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
CHEMBL1259062 17872 0 None 1 3 Bovine 9.1 pKi = 9.1 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 400 2 0 3 5.7 Cc1ccccc1-c1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
46934639 16670 0 None 6 4 Human 9.1 pKi = 9.1 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 465 7 0 6 3.1 COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3CCCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242541 16670 0 None 6 4 Human 9.1 pKi = 9.1 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 465 7 0 6 3.1 COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3CCCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
69782867 161583 0 None -5 5 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 549 8 1 9 4.4 COc1cc2nc(N3CCN(C(=O)COc4c(OC)cccc4C(C)C)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4129291 161583 0 None -5 5 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 549 8 1 9 4.4 COc1cc2nc(N3CCN(C(=O)COc4c(OC)cccc4C(C)C)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
44431547 88143 0 None 34 4 Human 9.1 pKi = 9.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234681 88143 0 None 34 4 Human 9.1 pKi = 9.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
10721568 203850 0 None 32 2 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 558 9 3 8 2.9 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(O)cc2)C3=O)CC1 10.1021/jm9905918
CHEMBL68604 203850 0 None 32 2 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 558 9 3 8 2.9 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(O)cc2)C3=O)CC1 10.1021/jm9905918
2389 3331 118 None -6 67 Rat 9.1 pKi = 9.1 Binding
Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
5073 3331 118 None -6 67 Rat 9.1 pKi = 9.1 Binding
Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
96 3331 118 None -6 67 Rat 9.1 pKi = 9.1 Binding
Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
CHEMBL85 3331 118 None -6 67 Rat 9.1 pKi = 9.1 Binding
Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
DB00734 3331 118 None -6 67 Rat 9.1 pKi = 9.1 Binding
Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
10949698 205287 0 None 1 4 Human 9.1 pKi = 9.1 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 413 8 1 8 1.9 COc1ccccc1N1CCN(CCCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL79161 205287 0 None 1 4 Human 9.1 pKi = 9.1 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 413 8 1 8 1.9 COc1ccccc1N1CCN(CCCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1 10.1021/jm0009336
71462043 84568 0 None -1 6 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153555 84568 0 None -1 6 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220895 84568 0 None -1 6 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
44431564 87642 0 None 34 4 Human 9.1 pKi = 9.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 501 8 1 6 4.2 COc1ccc(C)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233623 87642 0 None 34 4 Human 9.1 pKi = 9.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 501 8 1 6 4.2 COc1ccc(C)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
9872440 102266 0 None 81 2 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 556 9 2 7 3.5 Cc1cccc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)c1 10.1021/jm9905918
CHEMBL303248 102266 0 None 81 2 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 556 9 2 7 3.5 Cc1cccc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)c1 10.1021/jm9905918
10506673 203925 0 None 72 2 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 542 9 2 7 3.2 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccccc2)C3=O)CC1 10.1021/jm9905918
CHEMBL69143 203925 0 None 72 2 Human 9.1 pKi = 9.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 542 9 2 7 3.2 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccccc2)C3=O)CC1 10.1021/jm9905918
10047430 104761 0 None 117 3 Human 9.1 pKi = 9.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 414 7 0 6 3.4 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCC3=O)cs2)CC1 10.1016/s0960-894x(02)00436-5
CHEMBL310768 104761 0 None 117 3 Human 9.1 pKi = 9.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 414 7 0 6 3.4 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCC3=O)cs2)CC1 10.1016/s0960-894x(02)00436-5
44299973 197452 0 None 6 3 Human 9.1 pKi = 9.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 608 7 2 8 3.4 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@@H](N3CCN(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL56974 197452 0 None 6 3 Human 9.1 pKi = 9.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 608 7 2 8 3.4 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@@H](N3CCN(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
44295192 101722 0 None 338 3 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 574 7 2 10 2.4 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc3nonc3c2)CC1 10.1016/s0960-894x(99)00653-8
CHEMBL299539 101722 0 None 338 3 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 574 7 2 10 2.4 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc3nonc3c2)CC1 10.1016/s0960-894x(99)00653-8
9959689 101813 0 None 281 3 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 568 7 2 7 3.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
CHEMBL300222 101813 0 None 281 3 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 568 7 2 7 3.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
44447065 94612 0 None -1 3 Rat 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 448 7 1 5 4.6 CCCC(=O)NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21 10.1016/j.bmcl.2007.11.106
CHEMBL252228 94612 0 None -1 3 Rat 9.1 pKi = 9.1 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 448 7 1 5 4.6 CCCC(=O)NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21 10.1016/j.bmcl.2007.11.106
71452768 79571 0 None 53 3 Human 9.1 pKi = 9.1 Binding
Tested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assayTested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assay
ChEMBL 475 6 1 4 5.0 C[C@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1016/s0960-894x(00)00524-2
CHEMBL2114249 79571 0 None 53 3 Human 9.1 pKi = 9.1 Binding
Tested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assayTested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assay
ChEMBL 475 6 1 4 5.0 C[C@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1016/s0960-894x(00)00524-2
10503057 102621 0 None 3 2 Rat 9.0 pKi = 9.0 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 436 5 1 7 2.3 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc([N+](=O)[O-])ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL304215 102621 0 None 3 2 Rat 9.0 pKi = 9.0 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 436 5 1 7 2.3 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc([N+](=O)[O-])ccc4c3=O)C[C@@H]21 10.1021/jm000541z
11519153 85749 0 None 2 4 Human 9.0 pKi = 9.0 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 514 9 1 6 4.7 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL229085 85749 0 None 2 4 Human 9.0 pKi = 9.0 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 514 9 1 6 4.7 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
11519153 85749 0 None 2 4 Human 9.0 pKi = 9.0 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 514 9 1 6 4.7 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL229085 85749 0 None 2 4 Human 9.0 pKi = 9.0 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 514 9 1 6 4.7 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
44289525 165995 0 None 4 8 Bovine 9.0 pKi = 9.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]-prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]-prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNCC1Oc2ccccc2OC1c1ccc(C)cc1 10.1021/jm960069a
CHEMBL42539 165995 0 None 4 8 Bovine 9.0 pKi = 9.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]-prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]-prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNCC1Oc2ccccc2OC1c1ccc(C)cc1 10.1021/jm960069a
10601065 112308 0 None 173 3 Human 9.0 pKi = 9.0 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 488 7 4 4 2.8 O=C1NC=C(C(=O)NCCCN2CCC(O)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1021/jm990612y
CHEMBL329143 112308 0 None 173 3 Human 9.0 pKi = 9.0 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 488 7 4 4 2.8 O=C1NC=C(C(=O)NCCCN2CCC(O)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1021/jm990612y
90645605 112438 0 None -1 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 666 13 2 9 5.2 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)CCCC(=O)NCCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298023 112438 0 None -1 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 666 13 2 9 5.2 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)CCCC(=O)NCCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
10549596 84605 1 None -3 6 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153553 84605 1 None -3 6 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2221147 84605 1 None -3 6 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
4209 3163 75 None -4 33 Bovine 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm020938y
4893 3163 75 None -4 33 Bovine 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm020938y
503 3163 75 None -4 33 Bovine 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm020938y
5385 3163 75 None -4 33 Bovine 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm020938y
CHEMBL2 3163 75 None -4 33 Bovine 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm020938y
DB00457 3163 75 None -4 33 Bovine 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm020938y
9931976 60318 1 None 4 4 Rat 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 421 4 0 7 3.3 COc1ccccc1N1CCN(CC2CN=C3c4ccccc4N=C(SC)N32)CC1 10.1021/jm970159v
CHEMBL1744044 60318 1 None 4 4 Rat 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 421 4 0 7 3.3 COc1ccccc1N1CCN(CC2CN=C3c4ccccc4N=C(SC)N32)CC1 10.1021/jm970159v
4209 3163 75 None -3 33 Rat 9.0 pKi = 9.0 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
4893 3163 75 None -3 33 Rat 9.0 pKi = 9.0 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
503 3163 75 None -3 33 Rat 9.0 pKi = 9.0 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
5385 3163 75 None -3 33 Rat 9.0 pKi = 9.0 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
CHEMBL2 3163 75 None -3 33 Rat 9.0 pKi = 9.0 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
DB00457 3163 75 None -3 33 Rat 9.0 pKi = 9.0 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm960510x
13155 3422 0 None -16 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 668 12 2 9 4.5 CN(C(CCCC(=O)NC=1C=CC2=C(C1)C=3NC(N(C(C3S2)=O)CCN4CCN(CC4)C5=C(C=CC=C5)OC)=O)=O)CC6=CC=CC=C6 10.1016/j.ejmech.2014.06.057
90645598 3422 0 None -16 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 668 12 2 9 4.5 CN(C(CCCC(=O)NC=1C=CC2=C(C1)C=3NC(N(C(C3S2)=O)CCN4CCN(CC4)C5=C(C=CC=C5)OC)=O)=O)CC6=CC=CC=C6 10.1016/j.ejmech.2014.06.057
CHEMBL3297829 3422 0 None -16 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 668 12 2 9 4.5 CN(C(CCCC(=O)NC=1C=CC2=C(C1)C=3NC(N(C(C3S2)=O)CCN4CCN(CC4)C5=C(C=CC=C5)OC)=O)=O)CC6=CC=CC=C6 10.1016/j.ejmech.2014.06.057
10650843 203849 0 None 57 3 Human 9.0 pKi = 9.0 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 576 9 2 7 3.8 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(Cl)cc2)C3=O)CC1 10.1021/jm9905918
CHEMBL68601 203849 0 None 57 3 Human 9.0 pKi = 9.0 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 576 9 2 7 3.8 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(Cl)cc2)C3=O)CC1 10.1021/jm9905918
49781677 17873 0 None -1 3 Bovine 9.0 pKi = 9.0 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 400 2 0 3 5.7 Cc1cccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)c1 10.1021/jm100652h
CHEMBL1259063 17873 0 None -1 3 Bovine 9.0 pKi = 9.0 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 400 2 0 3 5.7 Cc1cccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)c1 10.1021/jm100652h
10841070 37679 0 None -2 4 Rat 9.0 pKi = 9.0 Binding
Binding affinity against isolated rat prostate using [3H]- prazosin.Binding affinity against isolated rat prostate using [3H]- prazosin.
ChEMBL 585 10 0 5 7.4 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL145746 37679 0 None -2 4 Rat 9.0 pKi = 9.0 Binding
Binding affinity against isolated rat prostate using [3H]- prazosin.Binding affinity against isolated rat prostate using [3H]- prazosin.
ChEMBL 585 10 0 5 7.4 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
57390116 69298 0 None -1 5 Pig 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 925 30 2 13 5.9 COc1ccccc1N1CCN(CCCCNC(=O)c2cccc(OCCOCCOCCOCCOc3cccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)c3)c2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928122 69298 0 None -1 5 Pig 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 925 30 2 13 5.9 COc1ccccc1N1CCN(CCCCNC(=O)c2cccc(OCCOCCOCCOCCOc3cccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)c3)c2)CC1 10.1016/j.bmc.2011.10.063
10793720 204071 0 None 57 2 Human 9.0 pKi = 9.0 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 602 11 2 9 3.2 COc1ccc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1OC 10.1021/jm9905918
CHEMBL70095 204071 0 None 57 2 Human 9.0 pKi = 9.0 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 602 11 2 9 3.2 COc1ccc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1OC 10.1021/jm9905918
9910451 164130 0 None 3 6 Bovine 9.0 pKi = 9 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 428 5 0 6 4.7 Cn1cnc(-c2ccc3c(c2)c(C2CCN(CCC#N)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
CHEMBL420997 164130 0 None 3 6 Bovine 9.0 pKi = 9 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 428 5 0 6 4.7 Cn1cnc(-c2ccc3c(c2)c(C2CCN(CCC#N)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
10481087 169466 0 None 281 3 Human 9.0 pKi = 9 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 499 8 1 3 6.2 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3Cl)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL44294 169466 0 None 281 3 Human 9.0 pKi = 9 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 499 8 1 3 6.2 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3Cl)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
9959671 32671 0 None 363 3 Human 9.0 pKi = 9 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 0 7 5.6 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL141322 32671 0 None 363 3 Human 9.0 pKi = 9 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 0 7 5.6 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10506484 36798 0 None 489 3 Human 9.0 pKi = 9 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 534 9 0 6 5.9 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C#N)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL145001 36798 0 None 489 3 Human 9.0 pKi = 9 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 534 9 0 6 5.9 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C#N)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
9894818 98925 0 None 83 7 Human 9.0 pKi = 9 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL279436 98925 0 None 83 7 Human 9.0 pKi = 9 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
9894818 98925 0 None 83 7 Human 9.0 pKi = 9 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
CHEMBL279436 98925 0 None 83 7 Human 9.0 pKi = 9 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
44431548 87051 0 None 26 4 Human 9.0 pKi = 9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 502 8 1 7 3.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3[N+](=O)[O-])CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL232593 87051 0 None 26 4 Human 9.0 pKi = 9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 502 8 1 7 3.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3[N+](=O)[O-])CC2)CC1 10.1016/j.bmcl.2007.04.008
17753379 87803 0 None -1 4 Human 9.0 pKi = 9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 521 8 1 6 4.5 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233816 87803 0 None -1 4 Human 9.0 pKi = 9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 521 8 1 6 4.5 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
44431594 88019 0 None 17 4 Human 9.0 pKi = 9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 532 9 1 8 3.8 COc1ccc([N+](=O)[O-])cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234422 88019 0 None 17 4 Human 9.0 pKi = 9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 532 9 1 8 3.8 COc1ccc([N+](=O)[O-])cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
10928520 205594 0 None 1 4 Human 9.0 pKi = 9 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 453 7 1 7 3.3 COc1ccc(Cl)cc1N1CCN(CCNc2cc(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL81486 205594 0 None 1 4 Human 9.0 pKi = 9 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 453 7 1 7 3.3 COc1ccc(Cl)cc1N1CCN(CCNc2cc(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
497 3365 8 None 61 3 Human 9.0 pKi = 9 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10.1021/jm960697s
9872515 3365 8 None 61 3 Human 9.0 pKi = 9 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10.1021/jm960697s
CHEMBL24777 3365 8 None 61 3 Human 9.0 pKi = 9 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10.1021/jm960697s
148842 3946 27 None 8 5 Human 9.0 pKi = 9 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm960697s
496 3946 27 None 8 5 Human 9.0 pKi = 9 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm960697s
CHEMBL278865 3946 27 None 8 5 Human 9.0 pKi = 9 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1021/jm960697s
148842 3946 27 None 8 5 Human 9.0 pKi = 9 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1016/j.bmcl.2004.11.032
496 3946 27 None 8 5 Human 9.0 pKi = 9 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1016/j.bmcl.2004.11.032
CHEMBL278865 3946 27 None 8 5 Human 9.0 pKi = 9 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 10.1016/j.bmcl.2004.11.032
609483 123662 15 None - 1 Human 9.0 pKi = 9 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 407 5 0 5 2.8 COc1ccccc1N1CCN(CCN2C(=O)c3ccccc3C(C)(C)C2=O)CC1 10.1016/j.bmcl.2004.11.032
CHEMBL362051 123662 15 None - 1 Human 9.0 pKi = 9 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 407 5 0 5 2.8 COc1ccccc1N1CCN(CCN2C(=O)c3ccccc3C(C)(C)C2=O)CC1 10.1016/j.bmcl.2004.11.032
90645606 112439 0 None 2 3 Human 9.0 pKi = 9 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 652 12 2 9 4.8 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)CCCNC(=O)Cc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298024 112439 0 None 2 3 Human 9.0 pKi = 9 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 652 12 2 9 4.8 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)CCCNC(=O)Cc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
56668277 63180 0 None 616 3 Human 9.0 pKi = 9 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.3 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@H](N3CCC(C#N)(c4ccccc4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL1789975 63180 0 None 616 3 Human 9.0 pKi = 9 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.3 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@H](N3CCC(C#N)(c4ccccc4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
11984570 92804 0 None 2 3 Human 9.0 pKi = 9 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 465 5 0 5 4.3 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4cccc(F)c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
CHEMBL243694 92804 0 None 2 3 Human 9.0 pKi = 9 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 465 5 0 5 4.3 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4cccc(F)c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
49781680 17885 0 None 4 3 Bovine 9.0 pKi = 9 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 414 2 0 3 6.0 Cc1cccc(C)c1-c1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
CHEMBL1259097 17885 0 None 4 3 Bovine 9.0 pKi = 9 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 414 2 0 3 6.0 Cc1cccc(C)c1-c1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2 10.1021/jm100652h
10626610 36752 0 None 251 3 Human 9.0 pKi = 9 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 556 8 2 6 4.2 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL144965 36752 0 None 251 3 Human 9.0 pKi = 9 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 556 8 2 6 4.2 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
44298770 101611 0 None 10 3 Human 9.0 pKi = 9 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 464 7 1 6 2.5 O=c1[nH]cc(Cl)c(=O)n1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
CHEMBL298838 101611 0 None 10 3 Human 9.0 pKi = 9 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 464 7 1 6 2.5 O=c1[nH]cc(Cl)c(=O)n1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
15840661 199462 0 None 31 3 Human 9.0 pKi = 9 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 432 7 1 5 2.2 O=C1CCNC(=O)N1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
CHEMBL59153 199462 0 None 31 3 Human 9.0 pKi = 9 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 432 7 1 5 2.2 O=C1CCNC(=O)N1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
10717073 202625 0 None 3 2 Rat 9.0 pKi = 9.0 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 421 5 1 6 2.4 COc1ccc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2c1 10.1021/jm000541z
CHEMBL61225 202625 0 None 3 2 Rat 9.0 pKi = 9.0 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 421 5 1 6 2.4 COc1ccc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2c1 10.1021/jm000541z
10507089 102328 0 None 186 2 Human 9.0 pKi = 9.0 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 560 9 2 7 3.3 CC(C)Oc1ccccc1N1CCN(C[C@@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
CHEMBL303627 102328 0 None 186 2 Human 9.0 pKi = 9.0 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 560 9 2 7 3.3 CC(C)Oc1ccccc1N1CCN(C[C@@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
10644505 100764 0 None 2 2 Rat 9.0 pKi = 9.0 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 397 4 1 6 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4sccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL292881 100764 0 None 2 2 Rat 9.0 pKi = 9.0 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 397 4 1 6 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4sccc4c3=O)C[C@@H]21 10.1021/jm000541z
4209 3163 75 None -3 33 Rat 9.0 pKi = 9.0 Binding
Compound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary glandCompound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970740r
4893 3163 75 None -3 33 Rat 9.0 pKi = 9.0 Binding
Compound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary glandCompound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970740r
503 3163 75 None -3 33 Rat 9.0 pKi = 9.0 Binding
Compound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary glandCompound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970740r
5385 3163 75 None -3 33 Rat 9.0 pKi = 9.0 Binding
Compound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary glandCompound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970740r
CHEMBL2 3163 75 None -3 33 Rat 9.0 pKi = 9.0 Binding
Compound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary glandCompound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970740r
DB00457 3163 75 None -3 33 Rat 9.0 pKi = 9.0 Binding
Compound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary glandCompound was tested for its binding affinity towards Alpha-1A adrenergic receptor using [3H]prazosin from rat submaxillary gland
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1021/jm970740r
9895326 207027 0 None 177 6 Human 9.0 pKi = 9.0 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 621 12 3 6 5.7 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CC)N1 10.1021/jm980077m
CHEMBL91550 207027 0 None 177 6 Human 9.0 pKi = 9.0 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 621 12 3 6 5.7 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CC)N1 10.1021/jm980077m
9895326 207027 0 None 177 6 Human 9.0 pKi = 9.0 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 621 12 3 6 5.7 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CC)N1 10.1007/s00044-004-0120-9
CHEMBL91550 207027 0 None 177 6 Human 9.0 pKi = 9.0 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 621 12 3 6 5.7 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CC)N1 10.1007/s00044-004-0120-9
10742076 100318 0 None 3 2 Rat 9.0 pKi = 9.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1cccc2c1CCC1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC21 10.1021/jm990567u
CHEMBL289361 100318 0 None 3 2 Rat 9.0 pKi = 9.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1cccc2c1CCC1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC21 10.1021/jm990567u
10606661 100939 0 None 6 2 Rat 9.0 pKi = 9.0 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 441 5 1 7 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C)c(OC)sc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL294027 100939 0 None 6 2 Rat 9.0 pKi = 9.0 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 441 5 1 7 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C)c(OC)sc4c3=O)C[C@@H]21 10.1021/jm000541z
90645592 112484 0 None -1 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 555 7 2 8 4.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)c5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298745 112484 0 None -1 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 555 7 2 8 4.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)c5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
90645596 112488 0 None -2 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 640 11 3 9 3.8 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCC(=O)NCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298749 112488 0 None -2 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 640 11 3 9 3.8 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCC(=O)NCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
10507411 34182 0 None 457 3 Human 9.0 pKi = 9.0 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 577 9 0 5 7.3 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3C(F)(F)F)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL142606 34182 0 None 457 3 Human 9.0 pKi = 9.0 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 577 9 0 5 7.3 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3C(F)(F)F)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10318686 104283 0 None 60 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 398 7 0 6 2.9 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCC3=O)no2)CC1 10.1016/s0960-894x(02)00436-5
CHEMBL309969 104283 0 None 60 3 Human 9.0 pKi = 9.0 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 398 7 0 6 2.9 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCC3=O)no2)CC1 10.1016/s0960-894x(02)00436-5
44295046 101933 0 None 117 3 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 577 8 2 9 2.8 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(99)00653-8
CHEMBL301077 101933 0 None 117 3 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 577 8 2 9 2.8 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(99)00653-8
57390118 69302 0 None -1 5 Pig 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 953 32 2 13 6.2 COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928126 69302 0 None -1 5 Pig 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 953 32 2 13 6.2 COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
57393628 69313 0 None -3 5 Pig 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1005 30 2 17 5.2 COc1ccccc1N1CCN(CCCCNC(=O)c2cnn3ccc(OCCOCCOCCOCCOc4ccn5ncc(C(=O)NCCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928137 69313 0 None -3 5 Pig 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1005 30 2 17 5.2 COc1ccccc1N1CCN(CCCCNC(=O)c2cnn3ccc(OCCOCCOCCOCCOc4ccn5ncc(C(=O)NCCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1 10.1016/j.bmc.2011.10.063
49781678 17878 0 None -1 3 Bovine 9.0 pKi = 9.0 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 400 2 0 3 5.7 Cc1ccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)cc1 10.1021/jm100652h
CHEMBL1259079 17878 0 None -1 3 Bovine 9.0 pKi = 9.0 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 400 2 0 3 5.7 Cc1ccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)cc1 10.1021/jm100652h
10555288 34740 0 None 45 3 Human 9.0 pKi = 9.0 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 582 8 2 7 4.2 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1cccc(Cl)c1 10.1021/jm990200p
CHEMBL143066 34740 0 None 45 3 Human 9.0 pKi = 9.0 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 582 8 2 7 4.2 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1cccc(Cl)c1 10.1021/jm990200p
10769058 165678 0 None 208 3 Human 9.0 pKi = 9.0 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 552 6 2 5 4.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CCc4ccccc43)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL424494 165678 0 None 208 3 Human 9.0 pKi = 9.0 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 552 6 2 5 4.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CCc4ccccc43)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
44289321 161968 0 None 6 3 Human 9.0 pKi = 9.0 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 455 8 1 3 5.1 Cc1ccc(C(C(=O)NCCCN2CCN(c3ccccc3C)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL415887 161968 0 None 6 3 Human 9.0 pKi = 9.0 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 455 8 1 3 5.1 Cc1ccc(C(C(=O)NCCCN2CCN(c3ccccc3C)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
9982050 101934 0 None 2 4 Human 9.0 pKi = 9.0 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 467 6 1 9 2.5 COc1ccccc1N1CCN(CCNc2ccc3c4c(=O)n(C)nc(Cl)c4cn3n2)CC1 10.1021/jm981006q
CHEMBL301078 101934 0 None 2 4 Human 9.0 pKi = 9.0 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 467 6 1 9 2.5 COc1ccccc1N1CCN(CCNc2ccc3c4c(=O)n(C)nc(Cl)c4cn3n2)CC1 10.1021/jm981006q
10531766 206997 0 None 199 6 Human 9.0 pKi = 9.0 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 607 9 2 7 6.3 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
CHEMBL91415 206997 0 None 199 6 Human 9.0 pKi = 9.0 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 607 9 2 7 6.3 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
10531766 85288 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 607 9 2 7 5.4 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1007/s00044-004-0120-9
CHEMBL2260366 85288 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 607 9 2 7 5.4 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1007/s00044-004-0120-9
52942152 17067 0 None -2 4 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 438 13 1 7 4.2 COc1cccc([N+](=O)[O-])c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1254743 17067 0 None -2 4 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 438 13 1 7 4.2 COc1cccc([N+](=O)[O-])c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
71659980 145893 0 None 1 3 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 354 6 0 5 3.2 CCOc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2016.06.052
CHEMBL3917716 145893 0 None 1 3 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 354 6 0 5 3.2 CCOc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2016.06.052
78815633 147516 2 None 1 3 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 340 7 0 4 3.5 CCOc1ccccc1N1CCN(CCc2ccc(OC)cc2)CC1 10.1016/j.ejmech.2016.06.052
CHEMBL3930616 147516 2 None 1 3 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 340 7 0 4 3.5 CCOc1ccccc1N1CCN(CCc2ccc(OC)cc2)CC1 10.1016/j.ejmech.2016.06.052
10621309 202775 0 None -1 2 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 405 4 1 5 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cccc(C)c4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL62110 202775 0 None -1 2 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 405 4 1 5 2.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cccc(C)c4c3=O)C[C@@H]21 10.1021/jm000541z
9851486 206699 0 None 223 6 Human 8.9 pKi = 8.9 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 592 10 2 6 6.0 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL89685 206699 0 None 223 6 Human 8.9 pKi = 8.9 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 592 10 2 6 6.0 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
9851486 206699 0 None 223 6 Human 8.9 pKi = 8.9 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 592 10 2 6 6.0 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL89685 206699 0 None 223 6 Human 8.9 pKi = 8.9 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 592 10 2 6 6.0 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
10409038 85242 0 None 41 4 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membraneDisplacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membrane
ChEMBL 405 2 2 5 3.6 COc1cc2c(cc1O)C[C@H]1c3c(c(Br)c(O)c(OC)c3-2)CCN1C 10.1021/np990433j
CHEMBL225853 85242 0 None 41 4 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membraneDisplacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membrane
ChEMBL 405 2 2 5 3.6 COc1cc2c(cc1O)C[C@H]1c3c(c(Br)c(O)c(OC)c3-2)CCN1C 10.1021/np990433j
10620533 201864 0 None 2 2 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 392 4 1 6 1.8 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4ncccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL60722 201864 0 None 2 2 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 392 4 1 6 1.8 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4ncccc4c3=O)C[C@@H]21 10.1021/jm000541z
10770057 102072 0 None 42 3 Human 8.9 pKi = 8.9 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 610 9 2 7 4.5 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(Cl)c(Cl)c2)C3=O)CC1 10.1021/jm9905918
CHEMBL302092 102072 0 None 42 3 Human 8.9 pKi = 8.9 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 610 9 2 7 4.5 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(Cl)c(Cl)c2)C3=O)CC1 10.1021/jm9905918
19085869 168125 0 None 30 3 Human 8.9 pKi = 8.9 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 469 6 0 7 3.2 Cc1ccc2oc(=O)n(C3CCN(CCCCN4C(=O)c5ccccc5S4(=O)=O)CC3)c2c1 10.1016/s0960-894x(98)00446-6
CHEMBL432947 168125 0 None 30 3 Human 8.9 pKi = 8.9 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 469 6 0 7 3.2 Cc1ccc2oc(=O)n(C3CCN(CCCCN4C(=O)c5ccccc5S4(=O)=O)CC3)c2c1 10.1016/s0960-894x(98)00446-6
10578548 37012 0 None 398 3 Human 8.9 pKi = 8.9 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 548 9 0 6 6.2 COC(=O)C1=C(C)N=C(C)N(CCC[C@H](C)CN2CCC(C#N)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL145178 37012 0 None 398 3 Human 8.9 pKi = 8.9 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 548 9 0 6 6.2 COC(=O)C1=C(C)N=C(C)N(CCC[C@H](C)CN2CCC(C#N)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10643502 100949 0 None 2 2 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 380 4 2 5 1.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4[nH]ccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL294098 100949 0 None 2 2 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 380 4 2 5 1.7 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4[nH]ccc4c3=O)C[C@@H]21 10.1021/jm000541z
11505007 168923 0 None -3 4 Human 8.9 pKi = 8.9 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 557 9 1 7 4.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL438673 168923 0 None -3 4 Human 8.9 pKi = 8.9 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 557 9 1 7 4.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
44431616 88076 0 None 3 4 Human 8.9 pKi = 8.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 471 8 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234649 88076 0 None 3 4 Human 8.9 pKi = 8.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 471 8 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
10342554 104782 0 None 33 3 Human 8.9 pKi = 8.9 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 428 7 0 6 3.8 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCCC3=O)cs2)CC1 10.1016/s0960-894x(02)00436-5
CHEMBL310890 104782 0 None 33 3 Human 8.9 pKi = 8.9 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 428 7 0 6 3.8 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCCC3=O)cs2)CC1 10.1016/s0960-894x(02)00436-5
57400556 69310 0 None -1 5 Pig 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 495 13 1 8 3.1 CCOCCOc1ccn2ncc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)c2c1 10.1016/j.bmc.2011.10.063
CHEMBL1928134 69310 0 None -1 5 Pig 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 495 13 1 8 3.1 CCOCCOc1ccn2ncc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)c2c1 10.1016/j.bmc.2011.10.063
57400557 69312 0 None -1 5 Pig 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 509 14 1 8 3.2 CCOCCOCc1ccn2ncc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)c2c1 10.1016/j.bmc.2011.10.063
CHEMBL1928136 69312 0 None -1 5 Pig 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 509 14 1 8 3.2 CCOCCOCc1ccn2ncc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)c2c1 10.1016/j.bmc.2011.10.063
10650633 37537 0 None 64 3 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 566 8 2 7 3.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)cc1 10.1021/jm990200p
CHEMBL145610 37537 0 None 64 3 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 566 8 2 7 3.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)cc1 10.1021/jm990200p
10603727 37690 0 None 114 3 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 606 10 3 8 3.4 CCC1=C(C(=O)NC)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL145752 37690 0 None 114 3 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 606 10 3 8 3.4 CCC1=C(C(=O)NC)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
11994665 11834 0 None 2 6 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cccc(-c2ccccc2)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182151 11834 0 None 2 6 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cccc(-c2ccccc2)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL215151 11834 0 None 2 6 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cccc(-c2ccccc2)c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
10770317 203891 0 None 123 2 Human 8.9 pKi = 8.9 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 632 12 2 10 3.2 COc1cc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc(OC)c1OC 10.1021/jm9905918
CHEMBL68913 203891 0 None 123 2 Human 8.9 pKi = 8.9 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 632 12 2 10 3.2 COc1cc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc(OC)c1OC 10.1021/jm9905918
44268966 33437 0 None 5 5 Bovine 8.9 pKi = 8.9 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 476 7 1 7 3.6 COc1ccccc1N1CCN(CCCn2c(=O)[nH]c3scc(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL14199 33437 0 None 5 5 Bovine 8.9 pKi = 8.9 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 476 7 1 7 3.6 COc1ccccc1N1CCN(CCCn2c(=O)[nH]c3scc(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
44275255 98604 0 None 223 3 Human 8.9 pKi = 8.9 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 636 12 2 7 7.2 CCC1=NC(CC)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)/C1=C(\O)OC 10.1021/jm960697s
CHEMBL276932 98604 0 None 223 3 Human 8.9 pKi = 8.9 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 636 12 2 7 7.2 CCC1=NC(CC)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)/C1=C(\O)OC 10.1021/jm960697s
11554541 71808 0 None -25 4 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 468 14 1 8 4.2 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc([N+](=O)[O-])cc1 10.1021/jm0580398
CHEMBL196817 71808 0 None -25 4 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 468 14 1 8 4.2 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc([N+](=O)[O-])cc1 10.1021/jm0580398
11751173 63426 0 None -1 5 Human 8.9 pKi = 8.9 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 445 4 1 9 2.3 COc1cc2nc(N3CCN(C4=CC(=O)c5ccccc5C4=O)CC3)nc(N)c2cc1OC 10.1021/jm049153d
CHEMBL179743 63426 0 None -1 5 Human 8.9 pKi = 8.9 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 445 4 1 9 2.3 COc1cc2nc(N3CCN(C4=CC(=O)c5ccccc5C4=O)CC3)nc(N)c2cc1OC 10.1021/jm049153d
497 3365 8 None 61 3 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10.1016/s0960-894x(03)00305-6
9872515 3365 8 None 61 3 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10.1016/s0960-894x(03)00305-6
CHEMBL24777 3365 8 None 61 3 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10.1016/s0960-894x(03)00305-6
9804599 101700 0 None 25 3 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 430 7 1 6 1.8 O=c1cc[nH]c(=O)n1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
CHEMBL299452 101700 0 None 25 3 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 430 7 1 6 1.8 O=c1cc[nH]c(=O)n1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
10506361 157705 0 None 6 2 Rat 8.9 pKi = 8.9 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 492 5 1 8 3.5 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc([N+](=O)[O-])cc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL40819 157705 0 None 6 2 Rat 8.9 pKi = 8.9 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 492 5 1 8 3.5 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc([N+](=O)[O-])cc54)c3=O)C[C@@H]21 10.1021/jm990567u
499 4077 18 None -1 14 Rat 8.9 pKi = 8.9 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm960069a
5685 4077 18 None -1 14 Rat 8.9 pKi = 8.9 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm960069a
CHEMBL25554 4077 18 None -1 14 Rat 8.9 pKi = 8.9 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10.1021/jm960069a
10696645 144122 0 None 5 2 Rat 8.9 pKi = 8.9 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 461 4 1 6 3.9 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccc(C)c54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL39037 144122 0 None 5 2 Rat 8.9 pKi = 8.9 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 461 4 1 6 3.9 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccc(C)c54)c3=O)C[C@@H]21 10.1021/jm990567u
44431554 166678 0 None 20 4 Human 8.9 pKi = 8.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(F)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL428197 166678 0 None 20 4 Human 8.9 pKi = 8.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(F)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
11857710 142363 0 None 1 4 Human 8.9 pKi = 8.9 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 518 8 1 5 5.4 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1 10.1016/j.bmcl.2007.04.098
CHEMBL388897 142363 0 None 1 4 Human 8.9 pKi = 8.9 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 518 8 1 5 5.4 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1 10.1016/j.bmcl.2007.04.098
497 3365 8 None 61 3 Human 8.9 pKi = 8.9 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10.1016/j.bmcl.2004.11.032
9872515 3365 8 None 61 3 Human 8.9 pKi = 8.9 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10.1016/j.bmcl.2004.11.032
CHEMBL24777 3365 8 None 61 3 Human 8.9 pKi = 8.9 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10.1016/j.bmcl.2004.11.032
56961506 121439 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 544 5 2 13 1.6 COc1cc2nc(N3CCN(C(=O)c4cn(-c5cc6ccc(O)cc6oc5=O)nn4)CC3)nc(N)c2cc1OC 10.1021/ml5004298
CHEMBL3582269 121439 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 544 5 2 13 1.6 COc1cc2nc(N3CCN(C(=O)c4cn(-c5cc6ccc(O)cc6oc5=O)nn4)CC3)nc(N)c2cc1OC 10.1021/ml5004298
10973768 107560 0 None -3 9 Bovine 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 563 6 1 8 4.4 Cn1cnc(-c2ccc3c(c2)c(C2CCN(CCn4c(=O)[nH]c5ccccc5c4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
CHEMBL318901 107560 0 None -3 9 Bovine 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 563 6 1 8 4.4 Cn1cnc(-c2ccc3c(c2)c(C2CCN(CCn4c(=O)[nH]c5ccccc5c4=O)CC2)cn3-c2ccc(F)cc2)n1 10.1021/jm020938y
49781894 17906 0 None -2 3 Bovine 8.9 pKi = 8.9 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 423 3 1 4 4.3 CN1CCN(C2Cc3ccccc3Sc3ccc(CNC(=O)C(C)(C)C)cc32)CC1 10.1021/jm100652h
CHEMBL1259158 17906 0 None -2 3 Bovine 8.9 pKi = 8.9 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 423 3 1 4 4.3 CN1CCN(C2Cc3ccccc3Sc3ccc(CNC(=O)C(C)(C)C)cc32)CC1 10.1021/jm100652h
10099811 121023 4 None 676 4 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of dogIn vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of dog
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL356584 121023 4 None 676 4 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of dogIn vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of dog
ChEMBL 583 9 3 6 3.5 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
10841851 34315 0 None 562 3 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 569 9 4 6 2.2 CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C(=O)N1 10.1021/jm990202+
CHEMBL142718 34315 0 None 562 3 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 569 9 4 6 2.2 CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C(=O)N1 10.1021/jm990202+
9894818 98925 0 None 83 7 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm00019a001
CHEMBL279436 98925 0 None 83 7 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm00019a001
9809007 172564 8 None 134 6 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
CHEMBL448620 172564 8 None 134 6 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
9982585 101516 0 None 281 3 Human 8.9 pKi = 8.9 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 479 8 1 3 5.8 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL298058 101516 0 None 281 3 Human 8.9 pKi = 8.9 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 479 8 1 3 5.8 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
16721110 83689 0 None -7 3 Human 8.9 pKi = 8.9 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 451 5 1 6 3.7 COc1ccc(Cl)cc1N1CCN(CCn2c(C)nc3c([nH]c4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
CHEMBL220515 83689 0 None -7 3 Human 8.9 pKi = 8.9 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 451 5 1 6 3.7 COc1ccc(Cl)cc1N1CCN(CCn2c(C)nc3c([nH]c4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
11384634 94698 0 None -134 4 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 420 5 1 5 3.8 CC(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
CHEMBL252818 94698 0 None -134 4 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 420 5 1 5 3.8 CC(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
10480509 142331 0 None 89 2 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membraneDisplacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membrane
ChEMBL 483 2 2 5 4.4 COc1cc2c(c(Br)c1O)C[C@H]1c3c(c(Br)c(O)c(OC)c3-2)CCN1C 10.1021/np990433j
CHEMBL388564 142331 0 None 89 2 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membraneDisplacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membrane
ChEMBL 483 2 2 5 4.4 COc1cc2c(c(Br)c1O)C[C@H]1c3c(c(Br)c(O)c(OC)c3-2)CCN1C 10.1021/np990433j
136806217 207699 0 None 12 3 Human 8.9 pKi = 8.9 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 576 13 4 8 2.7 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
44328806 207699 0 None 12 3 Human 8.9 pKi = 8.9 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 576 13 4 8 2.7 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL95548 207699 0 None 12 3 Human 8.9 pKi = 8.9 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 576 13 4 8 2.7 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
10627021 107095 0 None 194 6 Human 8.9 pKi = 8.9 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 577 9 2 5 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C)cc1 10.1021/jm980077m
CHEMBL315914 107095 0 None 194 6 Human 8.9 pKi = 8.9 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 577 9 2 5 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C)cc1 10.1021/jm980077m
10627021 85287 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 577 9 2 5 6.0 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C)cc1 10.1007/s00044-004-0120-9
CHEMBL2260365 85287 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 577 9 2 5 6.0 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C)cc1 10.1007/s00044-004-0120-9
10606657 201488 0 None 2 2 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 419 4 1 5 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(C)c(C)cc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL60510 201488 0 None 2 2 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 419 4 1 5 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(C)c(C)cc4c3=O)C[C@@H]21 10.1021/jm000541z
52942047 16665 0 None 5 4 Human 8.9 pKi = 8.9 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 451 7 0 6 2.7 COc1ccccc1N1CCN(C[C@H]2CO[C@](CN3CCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242444 16665 0 None 5 4 Human 8.9 pKi = 8.9 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 451 7 0 6 2.7 COc1ccccc1N1CCN(C[C@H]2CO[C@](CN3CCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
44447039 154386 0 None -2 4 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 472 6 1 6 4.7 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccco1 10.1016/j.bmcl.2007.11.106
CHEMBL398744 154386 0 None -2 4 Rat 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 472 6 1 6 4.7 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccco1 10.1016/j.bmcl.2007.11.106
71454559 79644 0 None 1 2 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 397 4 1 6 2.4 COc1cccc2c1CCC1CN(CCn3c(=O)[nH]c4ccsc4c3=O)CC21 10.1021/jm000541z
CHEMBL2115086 79644 0 None 1 2 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 397 4 1 6 2.4 COc1cccc2c1CCC1CN(CCn3c(=O)[nH]c4ccsc4c3=O)CC21 10.1021/jm000541z
10692195 100606 0 None 1 2 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 397 4 1 6 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4ccsc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL291839 100606 0 None 1 2 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 397 4 1 6 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4ccsc4c3=O)C[C@@H]21 10.1021/jm000541z
20215436 28515 3 None -3 3 Human 8.9 pKi = 8.9 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 355 4 1 8 2.1 COc1cc2nc(N3CCN(c4ccco4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL137598 28515 3 None -3 3 Human 8.9 pKi = 8.9 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 355 4 1 8 2.1 COc1cc2nc(N3CCN(c4ccco4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
11857639 85748 1 None 56 4 Human 8.9 pKi = 8.9 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 492 7 1 4 5.2 CC(C)Oc1ccccc1C1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(F)c(F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.098
CHEMBL229084 85748 1 None 56 4 Human 8.9 pKi = 8.9 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 492 7 1 4 5.2 CC(C)Oc1ccccc1C1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(F)c(F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.098
6603950 203324 9 None -1 8 Bovine 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 344 1 0 3 4.3 CN1CCN([C@@H]2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1021/jm020938y
CHEMBL64875 203324 9 None -1 8 Bovine 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 344 1 0 3 4.3 CN1CCN([C@@H]2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 10.1021/jm020938y
56837636 69297 0 None 7 5 Pig 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 897 28 2 13 5.1 COc1ccccc1N1CCN(CCCNC(=O)c2cccc(OCCOCCOCCOCCOc3cccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)c3)c2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928121 69297 0 None 7 5 Pig 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 897 28 2 13 5.1 COc1ccccc1N1CCN(CCCNC(=O)c2cccc(OCCOCCOCCOCCOc3cccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)c3)c2)CC1 10.1016/j.bmc.2011.10.063
10095044 102304 0 None 1 3 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 445 6 0 8 3.2 COc1ccccc1N1CCN(CCn2nc(-c3ccccc3)c3c(C)onc3c2=O)CC1 10.1021/jm0307741
CHEMBL303464 102304 0 None 1 3 Human 8.9 pKi = 8.9 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 445 6 0 8 3.2 COc1ccccc1N1CCN(CCn2nc(-c3ccccc3)c3c(C)onc3c2=O)CC1 10.1021/jm0307741
11189150 131933 0 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranesInhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranes
ChEMBL 413 7 1 6 3.2 O=C(NCCCCN1CCN(c2csc3cc(F)ccc23)CC1)c1cnccn1 10.1021/jm0491804
CHEMBL369520 131933 0 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranesInhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranes
ChEMBL 413 7 1 6 3.2 O=C(NCCCCN1CCN(c2csc3cc(F)ccc23)CC1)c1cnccn1 10.1021/jm0491804
10691912 168020 0 None 2 2 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 392 4 1 6 1.8 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cnccc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL432147 168020 0 None 2 2 Rat 8.9 pKi = 8.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 392 4 1 6 1.8 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cnccc4c3=O)C[C@@H]21 10.1021/jm000541z
46224879 201547 3 None -6 7 Human 8.9 pKi = 8.9 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 302 2 0 2 4.6 Cc1ccc2c(c1)c1c(n2/C=C\c2ccccc2)CCN(C)C1 10.1016/j.bmcl.2009.11.037
CHEMBL605405 201547 3 None -6 7 Human 8.9 pKi = 8.9 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 302 2 0 2 4.6 Cc1ccc2c(c1)c1c(n2/C=C\c2ccccc2)CCN(C)C1 10.1016/j.bmcl.2009.11.037
11712250 73000 0 None -5 4 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 457 13 1 6 5.0 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1Cl 10.1021/jm0580398
CHEMBL200839 73000 0 None -5 4 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 457 13 1 6 5.0 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1Cl 10.1021/jm0580398
11454386 63107 0 None -1 5 Human 8.9 pKi = 8.9 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 477 8 1 9 3.6 COc1cc2nc(N3CCN(C(=O)CCCCC4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
CHEMBL178923 63107 0 None -1 5 Human 8.9 pKi = 8.9 Binding
Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cellsEquilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells
ChEMBL 477 8 1 9 3.6 COc1cc2nc(N3CCN(C(=O)CCCCC4CCSS4)CC3)nc(N)c2cc1OC 10.1021/jm049153d
11270912 199592 0 None 1 4 Human 8.8 pKi = 8.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 451 6 0 4 4.6 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL59262 199592 0 None 1 4 Human 8.8 pKi = 8.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 451 6 0 4 4.6 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
11270912 199592 0 None 1 4 Human 8.8 pKi = 8.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 451 6 0 4 4.6 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL59262 199592 0 None 1 4 Human 8.8 pKi = 8.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 451 6 0 4 4.6 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
10578990 203841 0 None 48 3 Human 8.8 pKi = 8.8 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 572 10 2 8 3.2 COc1ccccc1N1C(=O)c2ccc(C(=O)NCC(O)CN3CCN(c4ccccc4OC(C)C)CC3)cc2C1=O 10.1021/jm9905918
CHEMBL68565 203841 0 None 48 3 Human 8.8 pKi = 8.8 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 572 10 2 8 3.2 COc1ccccc1N1C(=O)c2ccc(C(=O)NCC(O)CN3CCN(c4ccccc4OC(C)C)CC3)cc2C1=O 10.1021/jm9905918
10508332 105991 0 None 109 6 Human 8.8 pKi = 8.8 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 638 11 2 8 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])c(OC)c1 10.1021/jm980077m
CHEMBL313160 105991 0 None 109 6 Human 8.8 pKi = 8.8 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 638 11 2 8 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])c(OC)c1 10.1021/jm980077m
10508332 85290 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 638 11 2 8 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])c(OC)c1 10.1007/s00044-004-0120-9
CHEMBL2260368 85290 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 638 11 2 8 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])c(OC)c1 10.1007/s00044-004-0120-9
44420428 83494 0 None -3 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 434 5 0 7 3.8 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccccc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL220221 83494 0 None -3 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 434 5 0 7 3.8 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccccc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
90645593 112485 0 None -1 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 569 8 2 8 3.9 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)Cc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298746 112485 0 None -1 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 569 8 2 8 3.9 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)Cc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
44420428 83494 0 None -3 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 434 5 0 7 3.8 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
CHEMBL220221 83494 0 None -3 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 434 5 0 7 3.8 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
10678161 100815 0 None 2 2 Rat 8.8 pKi = 8.8 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 455 5 1 8 2.2 COC(=O)c1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2s1 10.1021/jm000541z
CHEMBL293236 100815 0 None 2 2 Rat 8.8 pKi = 8.8 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 455 5 1 8 2.2 COC(=O)c1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2s1 10.1021/jm000541z
10256583 28832 0 None 1 3 Rat 8.8 pKi = 8.8 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 497 7 1 7 4.1 COc1cc2nc(N3CCN(C(=O)CC(c4ccccc4)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL137903 28832 0 None 1 3 Rat 8.8 pKi = 8.8 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 497 7 1 7 4.1 COc1cc2nc(N3CCN(C(=O)CC(c4ccccc4)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
44431599 88064 0 None 10 4 Human 8.8 pKi = 8.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 505 7 1 5 4.8 Cc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1Cl 10.1016/j.bmcl.2007.04.008
CHEMBL234609 88064 0 None 10 4 Human 8.8 pKi = 8.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 505 7 1 5 4.8 Cc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1Cl 10.1016/j.bmcl.2007.04.008
9915831 102104 0 None 50 2 Human 8.8 pKi = 8.8 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 560 9 2 7 3.3 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
CHEMBL302246 102104 0 None 50 2 Human 8.8 pKi = 8.8 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 560 9 2 7 3.3 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
9850782 103599 0 None 72 2 Human 8.8 pKi = 8.8 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 560 9 2 7 3.3 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(F)cc2)C3=O)CC1 10.1021/jm9905918
CHEMBL308671 103599 0 None 72 2 Human 8.8 pKi = 8.8 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 560 9 2 7 3.3 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(F)cc2)C3=O)CC1 10.1021/jm9905918
9931977 63040 0 None -1 4 Rat 8.8 pKi = 8.8 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 421 4 0 7 3.3 COc1ccccc1N1CCN(C[C@H]2CN=C3c4ccccc4N=C(SC)N32)CC1 10.1021/jm970159v
CHEMBL1788223 63040 0 None -1 4 Rat 8.8 pKi = 8.8 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 421 4 0 7 3.3 COc1ccccc1N1CCN(C[C@H]2CN=C3c4ccccc4N=C(SC)N32)CC1 10.1021/jm970159v
49781451 17858 0 None -1 3 Bovine 8.8 pKi = 8.8 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 387 2 0 4 4.7 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccncc4)cc32)CC1 10.1021/jm100652h
CHEMBL1259024 17858 0 None -1 3 Bovine 8.8 pKi = 8.8 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 387 2 0 4 4.7 CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccncc4)cc32)CC1 10.1021/jm100652h
49781679 17879 0 None -1 3 Bovine 8.8 pKi = 8.8 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 414 2 0 3 6.0 Cc1cccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)c1C 10.1021/jm100652h
CHEMBL1259080 17879 0 None -1 3 Bovine 8.8 pKi = 8.8 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 414 2 0 3 6.0 Cc1cccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)c1C 10.1021/jm100652h
10531022 121069 0 None 44 3 Human 8.8 pKi = 8.8 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 566 8 2 7 3.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1cccc(F)c1 10.1021/jm990200p
CHEMBL356978 121069 0 None 44 3 Human 8.8 pKi = 8.8 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 566 8 2 7 3.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1cccc(F)c1 10.1021/jm990200p
11123606 205435 0 None 2 4 Human 8.8 pKi = 8.8 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 475 9 1 8 3.3 COc1ccccc1N1CCN(CCCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL80260 205435 0 None 2 4 Human 8.8 pKi = 8.8 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 475 9 1 8 3.3 COc1ccccc1N1CCN(CCCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
16121006 11841 0 None -7 7 Human 8.8 pKi = 8.8 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2020.112419
CHEMBL1182182 11841 0 None -7 7 Human 8.8 pKi = 8.8 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2020.112419
CHEMBL217469 11841 0 None -7 7 Human 8.8 pKi = 8.8 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1016/j.ejmech.2020.112419
11539392 141242 0 None -12 4 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 437 13 1 6 4.6 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1C 10.1021/jm0580398
CHEMBL382972 141242 0 None -12 4 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 437 13 1 6 4.6 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1C 10.1021/jm0580398
16121006 11841 0 None -7 7 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182182 11841 0 None -7 7 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL217469 11841 0 None -7 7 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
16121006 11841 0 None -7 7 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL1182182 11841 0 None -7 7 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL217469 11841 0 None -7 7 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
10716502 206575 0 None - 1 Bovine 8.8 pKi = 8.8 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 410 7 1 5 2.5 COc1ccccc1N1CCN(CCC(=O)Nc2ccccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL88820 206575 0 None - 1 Bovine 8.8 pKi = 8.8 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 410 7 1 5 2.5 COc1ccccc1N1CCN(CCC(=O)Nc2ccccc2C(=O)N(C)C)CC1 10.1021/jm970166j
10789868 206730 0 None - 1 Bovine 8.8 pKi = 8.8 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 453 10 1 6 4.0 COc1ccccc1N1CCN(CCCNc2ccncc2C(=O)N(C(C)C)C(C)C)CC1 10.1021/jm970166j
CHEMBL89916 206730 0 None - 1 Bovine 8.8 pKi = 8.8 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 453 10 1 6 4.0 COc1ccccc1N1CCN(CCCNc2ccncc2C(=O)N(C(C)C)C(C)C)CC1 10.1021/jm970166j
10552164 206900 0 None -1 2 Bovine 8.8 pKi = 8.8 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 466 9 1 6 3.4 CN(C)C(=O)c1cccnc1N1CCC(NCCOc2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
CHEMBL90869 206900 0 None -1 2 Bovine 8.8 pKi = 8.8 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 466 9 1 6 3.4 CN(C)C(=O)c1cccnc1N1CCC(NCCOc2ccccc2OCC(F)(F)F)CC1 10.1021/jm970166j
10646065 206902 0 None -1 2 Bovine 8.8 pKi = 8.8 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 425 8 2 6 3.2 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)NC(C)(C)C)CC1 10.1021/jm970166j
CHEMBL90874 206902 0 None -1 2 Bovine 8.8 pKi = 8.8 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 425 8 2 6 3.2 COc1ccccc1N1CCN(CCCNc2ncccc2C(=O)NC(C)(C)C)CC1 10.1021/jm970166j
44324012 207249 0 None 6 2 Bovine 8.8 pKi = 8.8 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 397 8 2 6 2.4 COc1ccccc1N1CCN(CCCNc2nc(C)cc(C)c2C(N)=O)CC1 10.1021/jm970166j
CHEMBL92901 207249 0 None 6 2 Bovine 8.8 pKi = 8.8 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 397 8 2 6 2.4 COc1ccccc1N1CCN(CCCNc2nc(C)cc(C)c2C(N)=O)CC1 10.1021/jm970166j
44298671 163176 0 None 19 3 Human 8.8 pKi = 8.8 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 460 8 1 7 1.8 COc1c[nH]c(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL418112 163176 0 None 19 3 Human 8.8 pKi = 8.8 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 460 8 1 7 1.8 COc1c[nH]c(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
44298734 196708 0 None 31 3 Human 8.8 pKi = 8.8 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 444 7 1 6 2.1 Cc1cc(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c(=O)[nH]1 10.1016/s0960-894x(03)00305-6
CHEMBL56489 196708 0 None 31 3 Human 8.8 pKi = 8.8 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 444 7 1 6 2.1 Cc1cc(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c(=O)[nH]1 10.1016/s0960-894x(03)00305-6
10256583 28832 0 None -1 3 Human 8.8 pKi = 8.8 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 497 7 1 7 4.1 COc1cc2nc(N3CCN(C(=O)CC(c4ccccc4)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL137903 28832 0 None -1 3 Human 8.8 pKi = 8.8 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 497 7 1 7 4.1 COc1cc2nc(N3CCN(C(=O)CC(c4ccccc4)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
10627094 121091 0 None 269 3 Human 8.8 pKi = 8.8 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 581 10 0 7 5.8 COC(=O)C1=C(C)N=C(C)N(CCC[C@H](C)CN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL357131 121091 0 None 269 3 Human 8.8 pKi = 8.8 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 581 10 0 7 5.8 COC(=O)C1=C(C)N=C(C)N(CCC[C@H](C)CN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
44431587 87834 0 None -1 4 Human 8.8 pKi = 8.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 565 8 1 6 4.7 COc1ccc(Br)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233849 87834 0 None -1 4 Human 8.8 pKi = 8.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 565 8 1 6 4.7 COc1ccc(Br)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
44431560 145578 0 None -2 4 Human 8.8 pKi = 8.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.008
CHEMBL391530 145578 0 None -2 4 Human 8.8 pKi = 8.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.008
44431602 147594 0 None 5 4 Human 8.8 pKi = 8.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 525 7 1 5 5.2 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL393104 147594 0 None 5 4 Human 8.8 pKi = 8.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 525 7 1 5 5.2 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2007.04.008
44299975 101888 0 None 4 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 608 7 2 8 3.4 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@H](N3CCN(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL300766 101888 0 None 4 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 608 7 2 8 3.4 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@H](N3CCN(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
155552185 174061 0 None -2 16 Human 8.8 pKi = 8.8 Binding
Displacement of [3H] prazosin from alpha1A adrenergic receptor (unknown origin)Displacement of [3H] prazosin from alpha1A adrenergic receptor (unknown origin)
ChEMBL 491 10 2 5 4.3 COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(F)cc2)c2ccccc2)CC1 10.1021/acs.jmedchem.9b01085
CHEMBL4544086 174061 0 None -2 16 Human 8.8 pKi = 8.8 Binding
Displacement of [3H] prazosin from alpha1A adrenergic receptor (unknown origin)Displacement of [3H] prazosin from alpha1A adrenergic receptor (unknown origin)
ChEMBL 491 10 2 5 4.3 COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(F)cc2)c2ccccc2)CC1 10.1021/acs.jmedchem.9b01085
9959689 101813 0 None 281 3 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 568 7 2 7 3.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
CHEMBL300222 101813 0 None 281 3 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 568 7 2 7 3.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
11046644 30704 0 None -4 6 Human 8.8 pKi = 8.8 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 361 6 0 4 4.0 COc1cccc2c(CCCN3CCN(c4ccccn4)CC3)cccc12 10.1021/jm010866v
CHEMBL139505 30704 0 None -4 6 Human 8.8 pKi = 8.8 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 361 6 0 4 4.0 COc1cccc2c(CCCN3CCN(c4ccccn4)CC3)cccc12 10.1021/jm010866v
10813408 158353 0 None 9 2 Rat 8.8 pKi = 8.8 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 449 4 1 8 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cncnc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL40896 158353 0 None 9 2 Rat 8.8 pKi = 8.8 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 449 4 1 8 2.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cncnc54)c3=O)C[C@@H]21 10.1021/jm990567u
90645599 112432 0 None -1 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 668 13 3 9 4.2 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCC(=O)NCCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298017 112432 0 None -1 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 668 13 3 9 4.2 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCC(=O)NCCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
10767959 160946 0 None 8 2 Rat 8.8 pKi = 8.8 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 472 4 1 7 3.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(C#N)cc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL41155 160946 0 None 8 2 Rat 8.8 pKi = 8.8 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 472 4 1 7 3.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(C#N)cc54)c3=O)C[C@@H]21 10.1021/jm990567u
132266 1278 12 None -18 9 Rat 8.8 pKi = 8.8 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm960510x
486 1278 12 None -18 9 Rat 8.8 pKi = 8.8 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm960510x
CHEMBL423294 1278 12 None -18 9 Rat 8.8 pKi = 8.8 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm960510x
90645601 112434 0 None -1 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 564 10 2 9 3.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCN(C)C)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298019 112434 0 None -1 3 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 564 10 2 9 3.0 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCN(C)C)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
136680383 168002 0 None 21 3 Human 8.8 pKi = 8.8 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(N)=O)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
44328800 168002 0 None 21 3 Human 8.8 pKi = 8.8 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(N)=O)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL432026 168002 0 None 21 3 Human 8.8 pKi = 8.8 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(N)=O)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
16041629 95446 0 None 1 4 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cc(F)ccc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL257097 95446 0 None 1 4 Human 8.8 pKi = 8.8 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cc(F)ccc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
155515982 170010 0 None -6 17 Human 8.8 pKi = 8.8 Binding
Displacement of [3H] prazosin from alpha1A adrenergic receptor (unknown origin)Displacement of [3H] prazosin from alpha1A adrenergic receptor (unknown origin)
ChEMBL 473 10 2 5 4.1 COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccccc2)CC1 10.1021/acs.jmedchem.9b01085
CHEMBL4442460 170010 0 None -6 17 Human 8.8 pKi = 8.8 Binding
Displacement of [3H] prazosin from alpha1A adrenergic receptor (unknown origin)Displacement of [3H] prazosin from alpha1A adrenergic receptor (unknown origin)
ChEMBL 473 10 2 5 4.1 COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccccc2)CC1 10.1021/acs.jmedchem.9b01085
10580182 37473 0 None 1862 3 Human 8.8 pKi = 8.8 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 658 7 1 8 4.0 COCC1=C(C(=O)OC)C(c2cc(F)c(F)c(F)c2)N(C(=O)N2CCC(N3CCC(C(=O)OC)(c4ccccc4)CC3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL145553 37473 0 None 1862 3 Human 8.8 pKi = 8.8 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 658 7 1 8 4.0 COCC1=C(C(=O)OC)C(c2cc(F)c(F)c(F)c2)N(C(=O)N2CCC(N3CCC(C(=O)OC)(c4ccccc4)CC3)CC2)C(=O)N1 10.1021/jm990201h
9984150 101769 0 None 891 3 Human 8.8 pKi = 8.8 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 519 7 0 4 5.6 Cc1ccc(C2(c3ccc(C)cc3)CC(=O)N(CCCN3CCC(C#N)(c4ccccc4C)CC3)C2=O)cc1 10.1016/s0960-894x(01)00320-1
CHEMBL299914 101769 0 None 891 3 Human 8.8 pKi = 8.8 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 519 7 0 4 5.6 Cc1ccc(C2(c3ccc(C)cc3)CC(=O)N(CCCN3CCC(C#N)(c4ccccc4C)CC3)C2=O)cc1 10.1016/s0960-894x(01)00320-1
10599007 204515 0 None -5 7 Rat 8.8 pKi = 8.8 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccc(C)cc1 10.1021/jm960069a
CHEMBL72657 204515 0 None -5 7 Rat 8.8 pKi = 8.8 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccc(C)cc1 10.1021/jm960069a
10793665 106952 0 None 69 6 Human 8.8 pKi = 8.8 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 597 9 2 5 7.2 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)cc1 10.1021/jm980077m
CHEMBL314960 106952 0 None 69 6 Human 8.8 pKi = 8.8 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 597 9 2 5 7.2 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)cc1 10.1021/jm980077m
10793665 85281 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 597 9 2 5 6.3 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)cc1 10.1007/s00044-004-0120-9
CHEMBL2260359 85281 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 597 9 2 5 6.3 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)cc1 10.1007/s00044-004-0120-9
15054187 191666 0 None - 1 Rat 8.7 pKi = 8.7 Binding
Binding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranesBinding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranes
ChEMBL 389 4 2 5 2.0 O=c1[nH]c2c([nH]c3ccccc32)c(=O)n1CCN1CCN(c2ccccc2)CC1 10.1021/jm00110a014
CHEMBL51963 191666 0 None - 1 Rat 8.7 pKi = 8.7 Binding
Binding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranesBinding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranes
ChEMBL 389 4 2 5 2.0 O=c1[nH]c2c([nH]c3ccccc32)c(=O)n1CCN1CCN(c2ccccc2)CC1 10.1021/jm00110a014
11857709 85628 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 556 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL228334 85628 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 556 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
11857638 143810 0 None -1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 516 9 1 6 5.0 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL390129 143810 0 None -1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 516 9 1 6 5.0 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
11857711 85621 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 506 7 1 4 5.5 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1cc(Cl)ccc1F 10.1016/j.bmcl.2007.04.098
CHEMBL228280 85621 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 506 7 1 4 5.5 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1cc(Cl)ccc1F 10.1016/j.bmcl.2007.04.098
11857709 85628 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 556 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL228334 85628 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 556 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
9808529 203872 0 None 20 2 Human 8.7 pKi = 8.7 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 587 10 2 9 3.1 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc([N+](=O)[O-])cc2)C3=O)CC1 10.1021/jm9905918
CHEMBL68746 203872 0 None 20 2 Human 8.7 pKi = 8.7 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 587 10 2 9 3.1 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc([N+](=O)[O-])cc2)C3=O)CC1 10.1021/jm9905918
18738384 164377 0 None 25 3 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 441 7 0 5 4.8 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCCC3=O)cs2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL421297 164377 0 None 25 3 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 441 7 0 5 4.8 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCCC3=O)cs2)CC1 10.1016/s0960-894x(02)00347-5
44431180 92849 0 None -9 3 Human 8.7 pKi = 8.7 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 497 5 0 5 5.4 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4ccc5ccccc5c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
CHEMBL243864 92849 0 None -9 3 Human 8.7 pKi = 8.7 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 497 5 0 5 5.4 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4ccc5ccccc5c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
10793023 121522 0 None 60 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 562 8 2 7 3.8 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1cccc(C)c1 10.1021/jm990200p
CHEMBL358489 121522 0 None 60 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 562 8 2 7 3.8 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1cccc(C)c1 10.1021/jm990200p
10394346 16963 0 None -1 5 Human 8.7 pKi = 8.7 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 638 11 2 10 3.0 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C(N)=O)CC3)cccc2c1=O 10.1021/jm030825u
CHEMBL125365 16963 0 None -1 5 Human 8.7 pKi = 8.7 Binding
Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)Inhibition of [3H]prazosin binding to cloned human Alpha-1A adrenergic receptor in CHO cells (chinese hamster ovary cells)
ChEMBL 638 11 2 10 3.0 Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C(N)=O)CC3)cccc2c1=O 10.1021/jm030825u
487 3634 21 None -1 11 Human 8.7 pKi = 8.7 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00019a001
60602 3634 21 None -1 11 Human 8.7 pKi = 8.7 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00019a001
CHEMBL405355 3634 21 None -1 11 Human 8.7 pKi = 8.7 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00019a001
DB09239 3634 21 None -1 11 Human 8.7 pKi = 8.7 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00019a001
11270912 199592 0 None -1 4 Rat 8.7 pKi = 8.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 451 6 0 4 4.6 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL59262 199592 0 None -1 4 Rat 8.7 pKi = 8.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 451 6 0 4 4.6 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
10674896 206644 0 None 83 6 Human 8.7 pKi = 8.7 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 588 9 2 6 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C#N)cc1 10.1021/jm980077m
CHEMBL89243 206644 0 None 83 6 Human 8.7 pKi = 8.7 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 588 9 2 6 6.4 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C#N)cc1 10.1021/jm980077m
10674896 85272 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 588 9 2 6 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C#N)cc1 10.1007/s00044-004-0120-9
CHEMBL2260149 85272 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 588 9 2 6 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C#N)cc1 10.1007/s00044-004-0120-9
53327748 63388 0 None 2 3 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 435 8 0 5 3.5 COc1ccccc1N1CCN(CCCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796033 63388 0 None 2 3 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 435 8 0 5 3.5 COc1ccccc1N1CCN(CCCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
9894818 98925 0 None 83 7 Human 8.7 pKi = 8.7 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL279436 98925 0 None 83 7 Human 8.7 pKi = 8.7 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
10651654 111483 0 None 61 6 Human 8.7 pKi = 8.7 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 631 9 2 5 7.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)c(Cl)c1 10.1021/jm980077m
CHEMBL327712 111483 0 None 61 6 Human 8.7 pKi = 8.7 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 631 9 2 5 7.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)c(Cl)c1 10.1021/jm980077m
10651654 85289 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 631 9 2 5 7.0 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)c(Cl)c1 10.1007/s00044-004-0120-9
CHEMBL2260367 85289 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 631 9 2 5 7.0 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)c(Cl)c1 10.1007/s00044-004-0120-9
9894818 98925 0 None 83 7 Human 8.7 pKi = 8.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
CHEMBL279436 98925 0 None 83 7 Human 8.7 pKi = 8.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
44390749 63910 0 None 173 6 Human 8.7 pKi = 8.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 607 11 3 6 5.3 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm960697s
CHEMBL180561 63910 0 None 173 6 Human 8.7 pKi = 8.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 607 11 3 6 5.3 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm960697s
4209 3163 75 None -3 33 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
4893 3163 75 None -3 33 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
503 3163 75 None -3 33 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
5385 3163 75 None -3 33 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
CHEMBL2 3163 75 None -3 33 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
DB00457 3163 75 None -3 33 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10.1016/j.bmcl.2013.12.024
145962342 161423 0 None -29 3 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 521 9 0 8 5.1 CCCN(CCC)c1nc(N2CCN(C(=O)c3ccco3)[C@@H]3CCCC[C@@H]32)nc2cc(OC)c(OC)cc12 10.1016/j.bmc.2018.05.023
CHEMBL4126860 161423 0 None -29 3 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 521 9 0 8 5.1 CCCN(CCC)c1nc(N2CCN(C(=O)c3ccco3)[C@@H]3CCCC[C@@H]32)nc2cc(OC)c(OC)cc12 10.1016/j.bmc.2018.05.023
10767981 196262 0 None -1 3 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 509 11 1 9 3.5 COc1cc2nc(N(C)CCCCCCN(C)C(=O)C3COc4ccccc4O3)nc(N)c2cc1OC 10.1021/jm8016046
CHEMBL561851 196262 0 None -1 3 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 509 11 1 9 3.5 COc1cc2nc(N(C)CCCCCCN(C)C(=O)C3COc4ccccc4O3)nc(N)c2cc1OC 10.1021/jm8016046
44390749 63910 0 None 173 6 Human 8.7 pKi = 8.7 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 607 11 3 6 5.3 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1016/s0960-894x(99)00484-9
CHEMBL180561 63910 0 None 173 6 Human 8.7 pKi = 8.7 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 607 11 3 6 5.3 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1016/s0960-894x(99)00484-9
9894818 98925 0 None 83 7 Human 8.7 pKi = 8.7 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
CHEMBL279436 98925 0 None 83 7 Human 8.7 pKi = 8.7 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
44447059 94549 0 None -23 4 Rat 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 473 6 1 7 4.1 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccno1 10.1016/j.bmcl.2007.11.106
CHEMBL251834 94549 0 None -23 4 Rat 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 473 6 1 7 4.1 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccno1 10.1016/j.bmcl.2007.11.106
10742417 202773 0 None 4 2 Rat 8.7 pKi = 8.7 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 455 5 1 6 3.0 COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1Cl 10.1021/jm000541z
CHEMBL62109 202773 0 None 4 2 Rat 8.7 pKi = 8.7 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 455 5 1 6 3.0 COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1Cl 10.1021/jm000541z
10793503 119715 0 None 616 3 Human 8.7 pKi = 8.7 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 588 11 2 8 4.5 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
CHEMBL347499 119715 0 None 616 3 Human 8.7 pKi = 8.7 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 588 11 2 8 4.5 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
44390749 63910 0 None 173 6 Human 8.7 pKi = 8.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 607 11 3 6 5.3 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1016/j.bmcl.2004.11.032
CHEMBL180561 63910 0 None 173 6 Human 8.7 pKi = 8.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 607 11 3 6 5.3 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1016/j.bmcl.2004.11.032
57391895 69301 0 None 14 5 Pig 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 925 30 2 13 5.4 COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928125 69301 0 None 14 5 Pig 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 925 30 2 13 5.4 COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
9916549 121564 0 None 1 4 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of dogIn vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of dog
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL358595 121564 0 None 1 4 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of dogIn vitro binding affinity against Alpha-1A adrenergic receptor in isolated prostate tissue of dog
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
9916549 121564 0 None 1 4 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
CHEMBL358595 121564 0 None 1 4 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 592 10 3 8 3.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990200p
10531675 36781 0 None 19 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 602 8 2 5 5.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL144989 36781 0 None 19 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 602 8 2 5 5.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
10793503 119715 0 None 616 3 Human 8.7 pKi = 8.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 588 11 2 8 4.5 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
CHEMBL347499 119715 0 None 616 3 Human 8.7 pKi = 8.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 588 11 2 8 4.5 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
44446999 94697 0 None 2 3 Rat 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 474 5 1 5 4.3 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)C(F)(F)F 10.1016/j.bmcl.2007.11.106
CHEMBL252816 94697 0 None 2 3 Rat 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 474 5 1 5 4.3 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)C(F)(F)F 10.1016/j.bmcl.2007.11.106
10048729 189143 0 None 3 4 Human 8.7 pKi = 8.7 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 437 5 1 8 2.5 Cn1nc(Cl)c2cn3nc(NCCN4CCN(c5ccccc5)CC4)ccc3c2c1=O 10.1021/jm981006q
CHEMBL51074 189143 0 None 3 4 Human 8.7 pKi = 8.7 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 437 5 1 8 2.5 Cn1nc(Cl)c2cn3nc(NCCN4CCN(c5ccccc5)CC4)ccc3c2c1=O 10.1021/jm981006q
9847845 28453 0 None -5 5 Rat 8.7 pKi = 8.7 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(C)c(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL13754 28453 0 None -5 5 Rat 8.7 pKi = 8.7 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(C)c(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
11604548 72888 0 None -31 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 437 13 1 6 4.6 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc(C)cc1 10.1007/s00044-010-9379-1
CHEMBL200366 72888 0 None -31 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 437 13 1 6 4.6 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc(C)cc1 10.1007/s00044-010-9379-1
11532563 166379 0 None -6 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 453 14 1 7 4.3 COc1cccc(COc2ccccc2OCCNCCOc2c(OC)cccc2OC)c1 10.1007/s00044-010-9379-1
CHEMBL427552 166379 0 None -6 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 453 14 1 7 4.3 COc1cccc(COc2ccccc2OCCNCCOc2c(OC)cccc2OC)c1 10.1007/s00044-010-9379-1
11604548 72888 0 None -31 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 437 13 1 6 4.6 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc(C)cc1 10.1007/s00044-010-9379-1
CHEMBL200366 72888 0 None -31 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 437 13 1 6 4.6 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc(C)cc1 10.1007/s00044-010-9379-1
11532563 166379 0 None -6 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 453 14 1 7 4.3 COc1cccc(COc2ccccc2OCCNCCOc2c(OC)cccc2OC)c1 10.1007/s00044-010-9379-1
CHEMBL427552 166379 0 None -6 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 453 14 1 7 4.3 COc1cccc(COc2ccccc2OCCNCCOc2c(OC)cccc2OC)c1 10.1007/s00044-010-9379-1
9809007 172564 8 None 134 6 Human 8.7 pKi = 8.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm960697s
CHEMBL448620 172564 8 None 134 6 Human 8.7 pKi = 8.7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm960697s
11705133 72330 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 453 14 1 7 4.3 COc1ccccc1COc1ccccc1OCCNCCOc1c(OC)cccc1OC 10.1021/jm0580398
CHEMBL198431 72330 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 453 14 1 7 4.3 COc1ccccc1COc1ccccc1OCCNCCOc1c(OC)cccc1OC 10.1021/jm0580398
11604548 72888 0 None -31 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 437 13 1 6 4.6 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc(C)cc1 10.1021/jm0580398
CHEMBL200366 72888 0 None -31 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 437 13 1 6 4.6 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc(C)cc1 10.1021/jm0580398
11669646 72948 0 None -19 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 453 14 1 7 4.3 COc1ccc(COc2ccccc2OCCNCCOc2c(OC)cccc2OC)cc1 10.1021/jm0580398
CHEMBL200580 72948 0 None -19 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 453 14 1 7 4.3 COc1ccc(COc2ccccc2OCCNCCOc2c(OC)cccc2OC)cc1 10.1021/jm0580398
11532563 166379 0 None -6 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 453 14 1 7 4.3 COc1cccc(COc2ccccc2OCCNCCOc2c(OC)cccc2OC)c1 10.1021/jm0580398
CHEMBL427552 166379 0 None -6 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 453 14 1 7 4.3 COc1cccc(COc2ccccc2OCCNCCOc2c(OC)cccc2OC)c1 10.1021/jm0580398
52941004 17091 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 407 13 1 5 4.7 CCOc1ccccc1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1254914 17091 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 407 13 1 5 4.7 CCOc1ccccc1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
71817547 102578 0 None 1 6 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
CHEMBL2419771 102578 0 None 1 6 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
CHEMBL3040800 102578 0 None 1 6 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
134139869 146200 0 None -1 3 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 384 8 0 5 3.9 COc1ccc(CCN2CCN(c3ccccc3OC(C)C)CC2)cc1OC 10.1016/j.ejmech.2016.06.052
CHEMBL3920110 146200 0 None -1 3 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 384 8 0 5 3.9 COc1ccc(CCN2CCN(c3ccccc3OC(C)C)CC2)cc1OC 10.1016/j.ejmech.2016.06.052
10642742 206795 0 None 3 2 Bovine 8.7 pKi = 8.7 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 367 7 1 5 2.4 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2)CC1 10.1021/jm970166j
CHEMBL90287 206795 0 None 3 2 Bovine 8.7 pKi = 8.7 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 367 7 1 5 2.4 CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2)CC1 10.1021/jm970166j
44298694 100692 0 None 9 3 Human 8.7 pKi = 8.7 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 426 7 1 6 2.0 Cc1cn(CCCN2CCN(c3ccccc3OCC(F)(F)F)CC2)c(=O)[nH]c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL292403 100692 0 None 9 3 Human 8.7 pKi = 8.7 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 426 7 1 6 2.0 Cc1cn(CCCN2CCN(c3ccccc3OCC(F)(F)F)CC2)c(=O)[nH]c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL5272464 194625 0 None -11 3 Human 8.0 pKi = 8 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 480 10 1 5 4.4 CCCNC(=O)CCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5315453 194625 0 None -11 3 Human 8.0 pKi = 8 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 480 10 1 5 4.4 CCCNC(=O)CCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
10415038 4439 0 None 3 4 Human 8.0 pKi = 8 Binding
Binding affinity against Alpha-1A adrenergic receptor in human prostatic tissueBinding affinity against Alpha-1A adrenergic receptor in human prostatic tissue
ChEMBL 545 6 1 7 5.3 Cc1noc(C)c1S(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3cccc4ccccc34)CC1)O2 10.1016/s0960-894x(98)00732-x
CHEMBL101610 4439 0 None 3 4 Human 8.0 pKi = 8 Binding
Binding affinity against Alpha-1A adrenergic receptor in human prostatic tissueBinding affinity against Alpha-1A adrenergic receptor in human prostatic tissue
ChEMBL 545 6 1 7 5.3 Cc1noc(C)c1S(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3cccc4ccccc34)CC1)O2 10.1016/s0960-894x(98)00732-x
10415038 4439 0 None -3 4 Rat 8.0 pKi = 8 Binding
Binding affinity against Alpha-1A adrenergic receptor in rat prostatic tissueBinding affinity against Alpha-1A adrenergic receptor in rat prostatic tissue
ChEMBL 545 6 1 7 5.3 Cc1noc(C)c1S(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3cccc4ccccc34)CC1)O2 10.1016/s0960-894x(98)00732-x
CHEMBL101610 4439 0 None -3 4 Rat 8.0 pKi = 8 Binding
Binding affinity against Alpha-1A adrenergic receptor in rat prostatic tissueBinding affinity against Alpha-1A adrenergic receptor in rat prostatic tissue
ChEMBL 545 6 1 7 5.3 Cc1noc(C)c1S(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3cccc4ccccc34)CC1)O2 10.1016/s0960-894x(98)00732-x
135398737 958 93 None -5 89 Human 8.0 pKi = 8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1039/C2MD00311B
38 958 93 None -5 89 Human 8.0 pKi = 8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1039/C2MD00311B
722 958 93 None -5 89 Human 8.0 pKi = 8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1039/C2MD00311B
CHEMBL42 958 93 None -5 89 Human 8.0 pKi = 8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1039/C2MD00311B
DB00363 958 93 None -5 89 Human 8.0 pKi = 8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1039/C2MD00311B
2389 3331 118 None -11 67 Human 8.0 pKi = 8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1039/C2MD00311B
5073 3331 118 None -11 67 Human 8.0 pKi = 8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1039/C2MD00311B
96 3331 118 None -11 67 Human 8.0 pKi = 8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1039/C2MD00311B
CHEMBL85 3331 118 None -11 67 Human 8.0 pKi = 8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1039/C2MD00311B
DB00734 3331 118 None -11 67 Human 8.0 pKi = 8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1039/C2MD00311B
52937631 61307 0 None -50 3 Human 8.0 pKi = 8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 347 4 0 4 3.4 Cc1ccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)cc1 10.1021/jm1013874
CHEMBL1767141 61307 0 None -50 3 Human 8.0 pKi = 8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 347 4 0 4 3.4 Cc1ccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)cc1 10.1021/jm1013874
44431587 167152 0 None 3 4 Human 8.0 pKi = 8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 565 8 1 6 4.7 COc1ccc(Br)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL429076 167152 0 None 3 4 Human 8.0 pKi = 8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 565 8 1 6 4.7 COc1ccc(Br)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
11857792 143903 0 None 3 4 Human 8.0 pKi = 8 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 560 8 1 5 5.8 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1 10.1016/j.bmcl.2007.04.098
CHEMBL390192 143903 0 None 3 4 Human 8.0 pKi = 8 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 560 8 1 5 5.8 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1 10.1016/j.bmcl.2007.04.098
1524 2181 96 None -7 52 Rat 8.0 pKi = 8 Binding
Binding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 minsBinding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 mins
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1021/acs.jmedchem.2c00633
197 2181 96 None -7 52 Rat 8.0 pKi = 8 Binding
Binding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 minsBinding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 mins
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1021/acs.jmedchem.2c00633
3822 2181 96 None -7 52 Rat 8.0 pKi = 8 Binding
Binding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 minsBinding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 mins
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1021/acs.jmedchem.2c00633
88 2181 96 None -7 52 Rat 8.0 pKi = 8 Binding
Binding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 minsBinding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 mins
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1021/acs.jmedchem.2c00633
CHEMBL51 2181 96 None -7 52 Rat 8.0 pKi = 8 Binding
Binding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 minsBinding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 mins
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1021/acs.jmedchem.2c00633
DB12465 2181 96 None -7 52 Rat 8.0 pKi = 8 Binding
Binding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 minsBinding affinity to rat forebrain homogenate membrane alpha 1 adrenergic receptor incubated for 10 mins
ChEMBL 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 10.1021/acs.jmedchem.2c00633
115 343 71 None -3 6 Human 8.0 pKi = 8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm960697s
2092 343 71 None -3 6 Human 8.0 pKi = 8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm960697s
7109 343 71 None -3 6 Human 8.0 pKi = 8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm960697s
CHEMBL709 343 71 None -3 6 Human 8.0 pKi = 8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm960697s
DB00346 343 71 None -3 6 Human 8.0 pKi = 8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm960697s
46934793 16629 0 None -7 4 Human 8.0 pKi = 8 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 533 7 0 7 3.8 COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3C(=O)CC4(CCCC4)CC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1241557 16629 0 None -7 4 Human 8.0 pKi = 8 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 533 7 0 7 3.8 COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3C(=O)CC4(CCCC4)CC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
52941056 17123 0 None -1 4 Human 8.0 pKi = 8 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 363 11 1 4 4.3 c1ccc(COc2ccccc2OCCNCCOc2ccccc2)cc1 10.1016/j.bmc.2010.08.002
CHEMBL1255086 17123 0 None -1 4 Human 8.0 pKi = 8 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 363 11 1 4 4.3 c1ccc(COc2ccccc2OCCNCCOc2ccccc2)cc1 10.1016/j.bmc.2010.08.002
11668565 16072 0 None -3 3 Human 8.0 pKi = 8 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 404 8 1 4 4.9 Fc1ccccc1N1CCN(CCCCNc2ccc(-c3ccccc3)cn2)CC1 10.1016/j.bmcl.2010.07.096
CHEMBL1223799 16072 0 None -3 3 Human 8.0 pKi = 8 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 404 8 1 4 4.9 Fc1ccccc1N1CCN(CCCCNc2ccc(-c3ccccc3)cn2)CC1 10.1016/j.bmcl.2010.07.096
71508685 87052 0 None 2 2 Bovine 8.0 pKi = 8 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 385 3 0 3 5.6 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ccncc4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2325930 87052 0 None 2 2 Bovine 8.0 pKi = 8 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 385 3 0 3 5.6 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ccncc4)cc23)CC1 10.1016/j.bmc.2012.10.049
10555223 37125 0 None 158 3 Human 8.0 pKi = 8 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 579 9 3 8 3.3 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC(C)=C(C(=O)O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm990200p
CHEMBL145267 37125 0 None 158 3 Human 8.0 pKi = 8 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 579 9 3 8 3.3 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC(C)=C(C(=O)O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm990200p
53328685 63399 0 None 5 3 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 435 7 0 5 3.3 COc1ccccc1N1CCN(CCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796044 63399 0 None 5 3 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 435 7 0 5 3.3 COc1ccccc1N1CCN(CCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
118716707 115001 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 519 5 0 6 3.9 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)c4ccc(C(F)(F)F)cc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342860 115001 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 519 5 0 6 3.9 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)c4ccc(C(F)(F)F)cc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
44447013 169403 0 None -4 4 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 500 6 1 5 5.2 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccc(F)cc1 10.1016/j.bmcl.2007.11.106
CHEMBL442290 169403 0 None -4 4 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 500 6 1 5 5.2 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccc(F)cc1 10.1016/j.bmcl.2007.11.106
127028034 137650 0 None 3 3 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 404 9 0 4 5.2 COc1ccccc1N1CCN(CCCCCOc2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2015.12.068
CHEMBL3758368 137650 0 None 3 3 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 404 9 0 4 5.2 COc1ccccc1N1CCN(CCCCCOc2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2015.12.068
44447028 94607 0 None -10 4 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 510 8 1 5 5.4 O=C(CCc1ccccc1)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
CHEMBL252201 94607 0 None -10 4 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 510 8 1 5 5.4 O=C(CCc1ccccc1)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
8459 3298 4 None -10 3 Human 8.0 pKi = 8.0 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 495 8 1 9 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)COc1c(OC)cccc1C(C)C 10.1021/jm9805337
9891980 3298 4 None -10 3 Human 8.0 pKi = 8.0 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 495 8 1 9 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)COc1c(OC)cccc1C(C)C 10.1021/jm9805337
CHEMBL430717 3298 4 None -10 3 Human 8.0 pKi = 8.0 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 495 8 1 9 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)COc1c(OC)cccc1C(C)C 10.1021/jm9805337
44428849 143629 0 None -6 3 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 436 4 2 7 2.8 COc1cc2nc(N3CCN(C(=O)c4ccc[nH]4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
CHEMBL389978 143629 0 None -6 3 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 436 4 2 7 2.8 COc1cc2nc(N3CCN(C(=O)c4ccc[nH]4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
118716706 114999 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 451 5 0 6 2.9 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)c4ccccc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342859 114999 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 451 5 0 6 2.9 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)c4ccccc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
11474937 197174 0 None -9 3 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 395 5 0 4 3.4 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2C2CC2)CC1 10.1021/jm030944+
CHEMBL56804 197174 0 None -9 3 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 395 5 0 4 3.4 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2C2CC2)CC1 10.1021/jm030944+
44447008 94767 0 None -2 4 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 482 6 1 5 5.1 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccccc1 10.1016/j.bmcl.2007.11.106
CHEMBL253233 94767 0 None -2 4 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 482 6 1 5 5.1 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccccc1 10.1016/j.bmcl.2007.11.106
9867616 168326 0 None -2 3 Rat 8.0 pKi = 8.0 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 435 6 1 8 2.2 COc1cc2nc(N3CCN(C(=O)CC(=O)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL434228 168326 0 None -2 3 Rat 8.0 pKi = 8.0 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 435 6 1 8 2.2 COc1cc2nc(N3CCN(C(=O)CC(=O)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
44318081 163313 0 None 3 3 Human 7.0 pKi = 7 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 504 8 0 6 3.9 CCOC(=O)[C@H]1CN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CC[C@@H]1c1ccccc1 10.1016/s0960-894x(98)00451-x
CHEMBL418926 163313 0 None 3 3 Human 7.0 pKi = 7 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 504 8 0 6 3.9 CCOC(=O)[C@H]1CN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CC[C@@H]1c1ccccc1 10.1016/s0960-894x(98)00451-x
9822477 199452 0 None -1 4 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 403 4 0 4 3.5 Cc1ccc(Cl)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1007/s00044-010-9379-1
CHEMBL59149 199452 0 None -1 4 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 403 4 0 4 3.5 Cc1ccc(Cl)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1007/s00044-010-9379-1
242 470 124 None -14 51 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1039/C2MD00311B
34 470 124 None -14 51 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1039/C2MD00311B
60795 470 124 None -14 51 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1039/C2MD00311B
CHEMBL1112 470 124 None -14 51 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1039/C2MD00311B
DB01238 470 124 None -14 51 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1039/C2MD00311B
2337 3256 77 None -5 62 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1039/C2MD00311B
50 3256 77 None -5 62 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1039/C2MD00311B
5002 3256 77 None -5 62 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1039/C2MD00311B
CHEMBL716 3256 77 None -5 62 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1039/C2MD00311B
DB01224 3256 77 None -5 62 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 10.1039/C2MD00311B
52937119 61320 0 None -15 3 Human 7.0 pKi = 7 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 367 4 0 4 3.6 CN1CCC(Cn2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)C1 10.1021/jm1013874
CHEMBL1767155 61320 0 None -15 3 Human 7.0 pKi = 7 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 367 4 0 4 3.6 CN1CCC(Cn2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)C1 10.1021/jm1013874
24803641 61324 0 None -199 4 Human 7.0 pKi = 7 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 612 10 0 6 7.5 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C1CCCN(Cc2ccc(OCCCN3CCCCCC3)cc2)CC1 10.1021/jm1013874
CHEMBL1767159 61324 0 None -199 4 Human 7.0 pKi = 7 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 612 10 0 6 7.5 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C1CCCN(Cc2ccc(OCCCN3CCCCCC3)cc2)CC1 10.1021/jm1013874
24803639 61331 0 None -251 4 Human 7.0 pKi = 7 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 622 14 1 7 6.8 O=c1c2ccccc2c(Cc2ccc(O)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1021/jm1013874
CHEMBL1767166 61331 0 None -251 4 Human 7.0 pKi = 7 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 622 14 1 7 6.8 O=c1c2ccccc2c(Cc2ccc(O)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1021/jm1013874
44431557 146672 0 None -1 4 Human 7.0 pKi = 7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 541 8 1 6 4.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(OC(F)(F)F)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL392377 146672 0 None -1 4 Human 7.0 pKi = 7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 541 8 1 6 4.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(OC(F)(F)F)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
10362296 95088 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 378 8 1 3 3.6 CC(=O)CC(=O)NCCCN1CCC(c2ccccc2)(c2ccccc2)CC1 10.1021/jm960697s
CHEMBL25537 95088 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 378 8 1 3 3.6 CC(=O)CC(=O)NCCCN1CCC(c2ccccc2)(c2ccccc2)CC1 10.1021/jm960697s
44417715 11838 0 None 2 4 Human 7.0 pKi = 7 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 399 8 1 6 3.4 COc1cccc(OC)c1OCCNC[C@@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL1182160 11838 0 None 2 4 Human 7.0 pKi = 7 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 399 8 1 6 3.4 COc1cccc(OC)c1OCCNC[C@@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL215857 11838 0 None 2 4 Human 7.0 pKi = 7 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 399 8 1 6 3.4 COc1cccc(OC)c1OCCNC[C@@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
11135150 7603 0 None -1 4 Human 7.0 pKi = 7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 435 10 1 6 4.0 COc1cccc(OC)c1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
CHEMBL1087942 7603 0 None -1 4 Human 7.0 pKi = 7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 435 10 1 6 4.0 COc1cccc(OC)c1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
CHEMBL287686 7603 0 None -1 4 Human 7.0 pKi = 7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 435 10 1 6 4.0 COc1cccc(OC)c1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
9822477 199452 0 None -1 4 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 403 4 0 4 3.5 Cc1ccc(Cl)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1007/s00044-010-9379-1
CHEMBL59149 199452 0 None -1 4 Human 7.0 pKi = 7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 403 4 0 4 3.5 Cc1ccc(Cl)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1007/s00044-010-9379-1
9908478 195636 1 None -1047 7 Human 6.0 pKi = 6 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 391 4 0 4 2.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2F)CC1 10.1021/jm0491391
CHEMBL556313 195636 1 None -1047 7 Human 6.0 pKi = 6 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 391 4 0 4 2.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2F)CC1 10.1021/jm0491391
135398745 2914 112 None -39 65 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1039/C2MD00311B
47 2914 112 None -39 65 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1039/C2MD00311B
CHEMBL715 2914 112 None -39 65 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1039/C2MD00311B
DB00334 2914 112 None -39 65 Human 6.0 pKi = 6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1039/C2MD00311B
9923249 5597 0 None - 1 Rat 6.0 pKi = 6 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 323 4 2 4 2.8 CCS(=O)(=O)Nc1cccc2c1SCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL107726 5597 0 None - 1 Rat 6.0 pKi = 6 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 323 4 2 4 2.8 CCS(=O)(=O)Nc1cccc2c1SCCC2c1c[nH]cn1 10.1021/jm030551a
16041451 97808 0 None -5 4 Human 7.0 pKi = 7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 500 7 2 5 5.4 COc1ccc(Cl)cc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL271913 97808 0 None -5 4 Human 7.0 pKi = 7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 500 7 2 5 5.4 COc1ccc(Cl)cc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.11.068
16756753 92128 1 None -37 3 Human 6.0 pKi = 6 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 478 7 1 3 7.0 Cc1ccc(C2CCN(Cc3ccc(Oc4ccc(F)c(F)c4)cc3)CC2)cc1NC(=O)C(C)C 10.1021/jm060383x
CHEMBL242003 92128 1 None -37 3 Human 6.0 pKi = 6 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 478 7 1 3 7.0 Cc1ccc(C2CCN(Cc3ccc(Oc4ccc(F)c(F)c4)cc3)CC2)cc1NC(=O)C(C)C 10.1021/jm060383x
44417709 12420 0 None 2 4 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@@H]1COc2cc3ccccc3cc2O1 10.1021/jm060358r
CHEMBL1185857 12420 0 None 2 4 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@@H]1COc2cc3ccccc3cc2O1 10.1021/jm060358r
CHEMBL436955 12420 0 None 2 4 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@@H]1COc2cc3ccccc3cc2O1 10.1021/jm060358r
127025275 137682 0 None -263 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 474 9 2 5 4.7 CCOC(=O)Nc1cccc(N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)c1 10.1016/j.bmcl.2015.12.068
CHEMBL3758665 137682 0 None -263 3 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 474 9 2 5 4.7 CCOC(=O)Nc1cccc(N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)c1 10.1016/j.bmcl.2015.12.068
19085921 104909 0 None 1 3 Human 6.0 pKi = 6.0 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 513 7 0 9 2.6 COC(=O)c1ccc2c(c1)oc(=O)n2C1CCN(CCCCN2C(=O)c3ccccc3S2(=O)=O)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL311290 104909 0 None 1 3 Human 6.0 pKi = 6.0 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 513 7 0 9 2.6 COC(=O)c1ccc2c(c1)oc(=O)n2C1CCN(CCCCN2C(=O)c3ccccc3S2(=O)=O)CC1 10.1016/s0960-894x(98)00446-6
10939408 47423 0 None -181 6 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 455 7 1 3 5.5 O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
CHEMBL154508 47423 0 None -181 6 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 455 7 1 3 5.5 O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
25022505 188291 0 None 6 2 Rat 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 586 10 1 8 2.9 COC(=O)C(C)N1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL500266 188291 0 None 6 2 Rat 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 586 10 1 8 2.9 COC(=O)C(C)N1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
3191 102858 97 None -204 25 Rat 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 nan
CHEMBL305660 102858 97 None -204 25 Rat 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 469 9 0 3 7.2 CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 nan
102 4127 48 None -346 49 Human 6.0 pKi = 6.0 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
3659 4127 48 None -346 49 Human 6.0 pKi = 6.0 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
8969 4127 48 None -346 49 Human 6.0 pKi = 6.0 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
CHEMBL15245 4127 48 None -346 49 Human 6.0 pKi = 6.0 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
DB01392 4127 48 None -346 49 Human 6.0 pKi = 6.0 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
127046693 139667 0 None -2 2 Human 6.0 pKi = 6.0 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000341aCl ADRA1ASelectivity interaction (GPCR panel (PDSP screen)) EUB0000341aCl ADRA1A
ChEMBL 300 3 2 4 2.2 C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N 10.6019/CHEMBL5212743
CHEMBL3797887 139667 0 None -2 2 Human 6.0 pKi = 6.0 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000341aCl ADRA1ASelectivity interaction (GPCR panel (PDSP screen)) EUB0000341aCl ADRA1A
ChEMBL 300 3 2 4 2.2 C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N 10.6019/CHEMBL5212743
CHEMBL4762646 139667 0 None -2 2 Human 6.0 pKi = 6.0 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000341aCl ADRA1ASelectivity interaction (GPCR panel (PDSP screen)) EUB0000341aCl ADRA1A
ChEMBL 300 3 2 4 2.2 C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N 10.6019/CHEMBL5212743
2812 4779 101 None -2238 34 Rat 5.0 pKi = 5.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
CHEMBL104 4779 101 None -2238 34 Rat 5.0 pKi = 5.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 nan
9844321 100861 0 None -10 4 Rat 7.0 pKi = 7.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 407 4 0 4 3.3 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL293539 100861 0 None -10 4 Rat 7.0 pKi = 7.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 407 4 0 4 3.3 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2Cl)CC1 10.1021/jm030944+
10669270 166289 0 None -28 2 Rat 7.0 pKi = 7.0 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 410 5 0 4 2.6 O=C1C2CCCN2C(=O)N1CCCN1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1021/jm970216k
CHEMBL42706 166289 0 None -28 2 Rat 7.0 pKi = 7.0 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 410 5 0 4 2.6 O=C1C2CCCN2C(=O)N1CCCN1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1021/jm970216k
14004040 51635 0 None -6 2 Bovine 7.0 pKi = 7.0 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 227 0 0 2 3.5 c1ccc2c3c(oc2c1)C1CCCCN1CC3 10.1021/jm00398a025
CHEMBL158371 51635 0 None -6 2 Bovine 7.0 pKi = 7.0 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 227 0 0 2 3.5 c1ccc2c3c(oc2c1)C1CCCCN1CC3 10.1021/jm00398a025
145951352 162760 0 None -2 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 397 5 2 8 2.2 COc1cc2nc(N3CCC[C@@H](NC(=O)c4ccco4)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
CHEMBL4171710 162760 0 None -2 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 397 5 2 8 2.2 COc1cc2nc(N3CCC[C@@H](NC(=O)c4ccco4)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
56945164 71514 0 None -338 4 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 417 9 2 4 4.4 COc1ccccc1OCCNC[C@H]1CCC(c2ccccc2)(c2ccccc2)[C@@H]1O 10.1021/jm200421e
CHEMBL1946786 71514 0 None -338 4 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 417 9 2 4 4.4 COc1ccccc1OCCNC[C@H]1CCC(c2ccccc2)(c2ccccc2)[C@@H]1O 10.1021/jm200421e
CHEMBL1962756 71514 0 None -338 4 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 417 9 2 4 4.4 COc1ccccc1OCCNC[C@H]1CCC(c2ccccc2)(c2ccccc2)[C@@H]1O 10.1021/jm200421e
14004039 119561 3 None -5 2 Bovine 6.0 pKi = 6.0 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 193 0 0 2 2.8 c1cc2c(s1)C1CCCCN1CC2 10.1021/jm00398a025
CHEMBL346016 119561 3 None -5 2 Bovine 6.0 pKi = 6.0 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 193 0 0 2 2.8 c1cc2c(s1)C1CCCCN1CC2 10.1021/jm00398a025
10744391 207363 0 None 7 3 Human 8.0 pKi = 8.0 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 514 7 1 3 4.8 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H](c2ccc(F)c(F)c2)N(C)C(=O)N1C 10.1021/jm990612y
CHEMBL93693 207363 0 None 7 3 Human 8.0 pKi = 8.0 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 514 7 1 3 4.8 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H](c2ccc(F)c(F)c2)N(C)C(=O)N1C 10.1021/jm990612y
1353 1911 93 None -6 83 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
3559 1911 93 None -6 83 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
86 1911 93 None -6 83 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
CHEMBL54 1911 93 None -6 83 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
DB00502 1911 93 None -6 83 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
10092649 193073 56 None 1 9 Human 8.0 pKi = 8.0 Binding
Binding affinity to human adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to human adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 404 4 1 4 3.9 Cc1ccccc1CN1CCC(N2CCC(n3c(=O)[nH]c4ccccc43)CC2)CC1 10.1021/jm100697g
CHEMBL522460 193073 56 None 1 9 Human 8.0 pKi = 8.0 Binding
Binding affinity to human adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to human adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 404 4 1 4 3.9 Cc1ccccc1CN1CCC(N2CCC(n3c(=O)[nH]c4ccccc43)CC2)CC1 10.1021/jm100697g
11519153 85619 0 None 3 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 514 9 1 6 4.7 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL228278 85619 0 None 3 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 514 9 1 6 4.7 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
11857861 194780 0 None -1 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 520 10 1 6 4.5 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL538397 194780 0 None -1 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 520 10 1 6 4.5 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
44431611 87485 0 None -7 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 509 7 1 5 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(Cl)cc3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233410 87485 0 None -7 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 509 7 1 5 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(Cl)cc3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
17753379 87803 0 None -1 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 521 8 1 6 4.5 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233816 87803 0 None -1 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 521 8 1 6 4.5 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
44431599 88020 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 505 7 1 5 4.8 Cc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1Cl 10.1016/j.bmcl.2007.04.008
CHEMBL234423 88020 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 505 7 1 5 4.8 Cc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1Cl 10.1016/j.bmcl.2007.04.008
44431574 146270 0 None 6 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 505 8 1 6 4.0 COc1ccc(F)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL392066 146270 0 None 6 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 505 8 1 6 4.0 COc1ccc(F)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
11519153 85619 0 None 3 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 514 9 1 6 4.7 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL228278 85619 0 None 3 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 514 9 1 6 4.7 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
16041091 95221 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 468 7 2 4 4.5 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)NCc3cccc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL256041 95221 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 468 7 2 4 4.5 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)NCc3cccc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
16041263 95447 0 None -1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 470 6 2 4 5.4 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccccc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL257098 95447 0 None -1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 470 6 2 4 5.4 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccccc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
145946966 167597 0 None -5 5 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 354 7 0 4 3.9 COc1ccccc1N1CCN(CCCOc2ccc(C)cc2C)CC1 10.1016/j.bmcl.2018.04.059
CHEMBL4209888 167597 0 None -5 5 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 354 7 0 4 3.9 COc1ccccc1N1CCN(CCCOc2ccc(C)cc2C)CC1 10.1016/j.bmcl.2018.04.059
CHEMBL4300899 167597 0 None -5 5 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 354 7 0 4 3.9 COc1ccccc1N1CCN(CCCOc2ccc(C)cc2C)CC1 10.1016/j.bmcl.2018.04.059
6603808 127522 3 None -1 8 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL214986 127522 3 None -1 8 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL36622 127522 3 None -1 8 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL3740374 127522 3 None -1 8 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
6603808 127522 3 None -1 8 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL214986 127522 3 None -1 8 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL36622 127522 3 None -1 8 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL3740374 127522 3 None -1 8 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1016/j.ejmech.2012.09.049
6603808 127522 3 None -1 8 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm301525w
CHEMBL214986 127522 3 None -1 8 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm301525w
CHEMBL36622 127522 3 None -1 8 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm301525w
CHEMBL3740374 127522 3 None -1 8 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm301525w
6603808 127522 3 None -1 8 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1039/C4MD00484A
CHEMBL214986 127522 3 None -1 8 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1039/C4MD00484A
CHEMBL36622 127522 3 None -1 8 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1039/C4MD00484A
CHEMBL3740374 127522 3 None -1 8 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 345 8 1 6 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1 10.1039/C4MD00484A
46934637 16671 0 None -7 4 Human 7.9 pKi = 7.9 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 465 7 0 6 3.1 COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3CCCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242542 16671 0 None -7 4 Human 7.9 pKi = 7.9 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 465 7 0 6 3.1 COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3CCCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
11994551 11840 0 None 1 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 369 7 1 5 3.4 COc1ccc2c(c1OCCNC[C@@H]1COc3ccccc3O1)CCCC2 10.1021/jm060358r
CHEMBL1182179 11840 0 None 1 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 369 7 1 5 3.4 COc1ccc2c(c1OCCNC[C@@H]1COc3ccccc3O1)CCCC2 10.1021/jm060358r
CHEMBL217143 11840 0 None 1 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 369 7 1 5 3.4 COc1ccc2c(c1OCCNC[C@@H]1COc3ccccc3O1)CCCC2 10.1021/jm060358r
50905589 56354 0 None 1 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 406 7 2 6 2.1 COc1ccc(C[C@@H](C)NC[C@@H]2Oc3ccccc3O[C@@H]2C)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
CHEMBL1630942 56354 0 None 1 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 406 7 2 6 2.1 COc1ccc(C[C@@H](C)NC[C@@H]2Oc3ccccc3O[C@@H]2C)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
44328920 108641 0 None 15 6 Human 7.9 pKi = 7.9 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 705 14 3 7 5.9 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCC(F)(F)F)N1 10.1016/s0960-894x(99)00484-9
CHEMBL320736 108641 0 None 15 6 Human 7.9 pKi = 7.9 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 705 14 3 7 5.9 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCC(F)(F)F)N1 10.1016/s0960-894x(99)00484-9
118716710 115004 0 None 2 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 444 5 1 7 1.3 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)C4CCCN4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342863 115004 0 None 2 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 444 5 1 7 1.3 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)C4CCCN4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
14004040 51635 0 None -6 2 Bovine 7.0 pKi = 7.0 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 227 0 0 2 3.5 c1ccc2c3c(oc2c1)C1CCCCN1CC3 10.1021/jm00398a025
CHEMBL158371 51635 0 None -6 2 Bovine 7.0 pKi = 7.0 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 227 0 0 2 3.5 c1ccc2c3c(oc2c1)C1CCCCN1CC3 10.1021/jm00398a025
10254390 71688 0 None -851 8 Rat 7.0 pKi = 7.0 Binding
Binding affinity for rat Alpha-1A adrenergic receptor using [11C] radiotracerBinding affinity for rat Alpha-1A adrenergic receptor using [11C] radiotracer
ChEMBL 475 8 1 5 5.1 COc1cccc2cc(C(=O)NCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)oc12 10.1021/jm050171k
CHEMBL196476 71688 0 None -851 8 Rat 7.0 pKi = 7.0 Binding
Binding affinity for rat Alpha-1A adrenergic receptor using [11C] radiotracerBinding affinity for rat Alpha-1A adrenergic receptor using [11C] radiotracer
ChEMBL 475 8 1 5 5.1 COc1cccc2cc(C(=O)NCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)oc12 10.1021/jm050171k
16041090 95393 0 None -1 4 Human 7.0 pKi = 7.0 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 496 8 2 6 4.7 COc1ccc(NC(=O)NC2CCC(N3CCN(c4ccccc4OC(C)C)CC3)CC2)c(OC)c1 10.1016/j.bmcl.2007.11.068
CHEMBL256853 95393 0 None -1 4 Human 7.0 pKi = 7.0 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 496 8 2 6 4.7 COc1ccc(NC(=O)NC2CCC(N3CCN(c4ccccc4OC(C)C)CC3)CC2)c(OC)c1 10.1016/j.bmcl.2007.11.068
13938361 185363 0 None -141 2 Bovine 7.0 pKi = 7.0 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 364 4 1 5 1.7 CN([C@@H]1CCN2CCc3c(oc4ccccc34)[C@@H]2C1)S(=O)(=O)CCO 10.1021/jm00150a002
CHEMBL48603 185363 0 None -141 2 Bovine 7.0 pKi = 7.0 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 364 4 1 5 1.7 CN([C@@H]1CCN2CCc3c(oc4ccccc34)[C@@H]2C1)S(=O)(=O)CCO 10.1021/jm00150a002
14004039 119561 3 None -5 2 Bovine 6.0 pKi = 6.0 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 193 0 0 2 2.8 c1cc2c(s1)C1CCCCN1CC2 10.1021/jm00398a025
CHEMBL346016 119561 3 None -5 2 Bovine 6.0 pKi = 6.0 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 193 0 0 2 2.8 c1cc2c(s1)C1CCCCN1CC2 10.1021/jm00398a025
10242469 31441 0 None - 1 Bovine 6.0 pKi = 6.0 Binding
In Vitro Alpha-1 adrenergic receptor binding affinity on calf frontal cortex membrane preparationIn Vitro Alpha-1 adrenergic receptor binding affinity on calf frontal cortex membrane preparation
ChEMBL 217 1 1 4 0.9 CN1CC(C2=NCCN2)Oc2ccccc21 10.1021/jm021050c
CHEMBL14028 31441 0 None - 1 Bovine 6.0 pKi = 6.0 Binding
In Vitro Alpha-1 adrenergic receptor binding affinity on calf frontal cortex membrane preparationIn Vitro Alpha-1 adrenergic receptor binding affinity on calf frontal cortex membrane preparation
ChEMBL 217 1 1 4 0.9 CN1CC(C2=NCCN2)Oc2ccccc21 10.1021/jm021050c
9887884 119285 51 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of alpha1A adrenergic receptor (unknown origin)Inhibition of alpha1A adrenergic receptor (unknown origin)
ChEMBL 412 4 0 3 5.1 O=C1c2ccccc2C(Cc2ccnc(F)c2)(Cc2ccnc(F)c2)c2ccccc21 10.1016/j.bmcl.2019.126681
CHEMBL343822 119285 51 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of alpha1A adrenergic receptor (unknown origin)Inhibition of alpha1A adrenergic receptor (unknown origin)
ChEMBL 412 4 0 3 5.1 O=C1c2ccccc2C(Cc2ccnc(F)c2)(Cc2ccnc(F)c2)c2ccccc21 10.1016/j.bmcl.2019.126681
10577609 26986 0 None -75 3 Human 6.0 pKi = 6.0 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 509 8 1 9 3.5 COc1cc2nc(N3CCN(C(=O)C(C)Oc4c(OC)cccc4C(C)C)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL136458 26986 0 None -75 3 Human 6.0 pKi = 6.0 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 509 8 1 9 3.5 COc1cc2nc(N3CCN(C(=O)C(C)Oc4c(OC)cccc4C(C)C)CC3)nc(N)c2cc1OC 10.1021/jm9805337
1935 3734 97 None -190 6 Rat 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 nan
2551 3734 97 None -190 6 Rat 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 nan
6687 3734 97 None -190 6 Rat 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 nan
CHEMBL95 3734 97 None -190 6 Rat 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 nan
DB00382 3734 97 None -190 6 Rat 6.0 pKi = 6.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 198 0 1 2 2.7 Nc1c2CCCCc2nc2c1cccc2 nan
118717460 115142 0 None -2 4 Human 7.0 pKi = 7.0 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 412 10 2 4 6.9 Cc1ccc2c(NCCCCCCCNc3ccnc4cc(C)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343982 115142 0 None -2 4 Human 7.0 pKi = 7.0 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 412 10 2 4 6.9 Cc1ccc2c(NCCCCCCCNc3ccnc4cc(C)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
2419 695 28 None -288 12 Rat 7.0 pKi = 7.0 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
9 695 28 None -288 12 Rat 7.0 pKi = 7.0 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
CHEMBL13647 695 28 None -288 12 Rat 7.0 pKi = 7.0 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
118717460 115142 0 None -2 4 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 412 10 2 4 6.9 Cc1ccc2c(NCCCCCCCNc3ccnc4cc(C)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343982 115142 0 None -2 4 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 412 10 2 4 6.9 Cc1ccc2c(NCCCCCCCNc3ccnc4cc(C)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
481 2892 7 None 4 3 Human 6.0 pKi = 6.0 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 10.1021/jm000542r
9838763 2892 7 None 4 3 Human 6.0 pKi = 6.0 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 10.1021/jm000542r
CHEMBL72958 2892 7 None 4 3 Human 6.0 pKi = 6.0 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 10.1021/jm000542r
131829 204727 15 None -173 6 Human 6.0 pKi = 6.0 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 295 1 4 5 1.7 Brc1c(NC2=NCCN2)ccc2c1NCCN2 10.1016/0960-894X(95)00391-6
CHEMBL74283 204727 15 None -173 6 Human 6.0 pKi = 6.0 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 295 1 4 5 1.7 Brc1c(NC2=NCCN2)ccc2c1NCCN2 10.1016/0960-894X(95)00391-6
34458 98343 68 None - 1 Rat 6.0 pKi = 6.0 Binding
Displacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 minsDisplacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 mins
ChEMBL 339 2 0 5 3.1 COc1ccc2c(c1OC)CN1CCc3cc4c(cc3C1C2)OCO4 10.1021/acs.jmedchem.6b01217
CHEMBL275097 98343 68 None - 1 Rat 6.0 pKi = 6.0 Binding
Displacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 minsDisplacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 mins
ChEMBL 339 2 0 5 3.1 COc1ccc2c(c1OC)CN1CCc3cc4c(cc3C1C2)OCO4 10.1021/acs.jmedchem.6b01217
9892644 197346 0 None -2 3 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 511 4 0 4 4.0 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(Br)ccc2Br)CC1 10.1021/jm030944+
CHEMBL56899 197346 0 None -2 3 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 511 4 0 4 4.0 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(Br)ccc2Br)CC1 10.1021/jm030944+
9906978 42711 2 None -2 12 Human 6.9 pKi = 6.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assay
ChEMBL 361 6 1 3 4.0 O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
CHEMBL150161 42711 2 None -2 12 Human 6.9 pKi = 6.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assay
ChEMBL 361 6 1 3 4.0 O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
10775000 107394 2 None -30 4 Bovine 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 214 1 2 2 2.6 Oc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL317912 107394 2 None -30 4 Bovine 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 214 1 2 2 2.6 Oc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
11301627 9398 0 None - 1 Rat 5.9 pKi = 5.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 319 4 2 3 3.0 CC(C)S(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL111537 9398 0 None - 1 Rat 5.9 pKi = 5.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 319 4 2 3 3.0 CC(C)S(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
11301627 9398 0 None - 1 Rat 5.9 pKi = 5.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 319 4 2 3 3.0 CC(C)S(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111537 9398 0 None - 1 Rat 5.9 pKi = 5.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 319 4 2 3 3.0 CC(C)S(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
9922027 115410 0 None 10 2 Rat 5.9 pKi = 5.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 289 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCC=C2c1c[nH]cn1 10.1021/jm030551a
CHEMBL3350265 115410 0 None 10 2 Rat 5.9 pKi = 5.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 289 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCC=C2c1c[nH]cn1 10.1021/jm030551a
10835395 206809 0 None -7 2 Rat 6.9 pKi = 6.9 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 410 6 0 4 3.7 FC(F)(F)c1cccc(N2CCN(CCCCN3CC4CCCCN4C3)CC2)c1 10.1021/jm970216k
CHEMBL90384 206809 0 None -7 2 Rat 6.9 pKi = 6.9 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 410 6 0 4 3.7 FC(F)(F)c1cccc(N2CCN(CCCCN3CC4CCCCN4C3)CC2)c1 10.1021/jm970216k
3151 1462 97 None -147 27 Rat 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
945 1462 97 None -147 27 Rat 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
965 1462 97 None -147 27 Rat 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
CHEMBL219916 1462 97 None -147 27 Rat 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
DB01184 1462 97 None -147 27 Rat 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 nan
127027974 137761 0 None -9 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 396 8 1 4 3.4 COc1ccccc1N1CCN(CCCCNC(=O)N(C)c2ccccc2)CC1 10.1016/j.bmcl.2015.12.068
CHEMBL3759312 137761 0 None -9 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 396 8 1 4 3.4 COc1ccccc1N1CCN(CCCCNC(=O)N(C)c2ccccc2)CC1 10.1016/j.bmcl.2015.12.068
46881493 6988 0 None -14 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 389 8 1 4 4.3 Cc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
CHEMBL1084658 6988 0 None -14 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 389 8 1 4 4.3 Cc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
9845172 169109 0 None -3 3 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 422 4 0 3 4.9 O=C1CC2(CCCC2)CC(=O)N1CCN1CCC(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL440118 169109 0 None -3 3 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 422 4 0 3 4.9 O=C1CC2(CCCC2)CC(=O)N1CCN1CCC(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
11584530 16099 0 None -158 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 454 8 1 4 5.8 FC(F)(F)c1cccc(N2CCN(CCCCNc3cc(-c4ccccc4)ccn3)CC2)c1 10.1016/j.bmcl.2010.07.096
CHEMBL1223857 16099 0 None -158 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 454 8 1 4 5.8 FC(F)(F)c1cccc(N2CCN(CCCCNc3cc(-c4ccccc4)ccn3)CC2)c1 10.1016/j.bmcl.2010.07.096
9929936 167912 0 None -1 4 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 383 4 0 4 3.1 Cc1ccc(C)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1021/jm030944+
CHEMBL431354 167912 0 None -1 4 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 383 4 0 4 3.1 Cc1ccc(C)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1021/jm030944+
9822812 195872 0 None -1 2 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 409 4 0 4 3.4 O=C1CC2(CCC2)CC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL55882 195872 0 None -1 2 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 409 4 0 4 3.4 O=C1CC2(CCC2)CC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
11857862 142054 0 None -2 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 538 10 1 6 4.8 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL387833 142054 0 None -2 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 538 10 1 6 4.8 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
44431607 87484 0 None -1 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 509 7 1 5 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccc(Cl)c3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233407 87484 0 None -1 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 509 7 1 5 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccc(Cl)c3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
11857794 85668 0 None 5 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 562 9 1 5 5.7 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cccc(OC(F)F)c1 10.1016/j.bmcl.2007.04.098
CHEMBL228553 85668 0 None 5 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 562 9 1 5 5.7 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cccc(OC(F)F)c1 10.1016/j.bmcl.2007.04.098
11857862 142054 0 None -2 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 538 10 1 6 4.8 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL387833 142054 0 None -2 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 538 10 1 6 4.8 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
4038180 204 14 None 2 7 Rat 7.9 pKi = 7.9 Binding
Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (0.009 - 0.015)Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (0.009 - 0.015)
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm025550h
480 204 14 None 2 7 Rat 7.9 pKi = 7.9 Binding
Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (0.009 - 0.015)Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (0.009 - 0.015)
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm025550h
CHEMBL109783 204 14 None 2 7 Rat 7.9 pKi = 7.9 Binding
Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (0.009 - 0.015)Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (0.009 - 0.015)
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm025550h
44308466 203789 0 None 1 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 429 7 0 7 3.2 COC(=O)[C@@H]1CCCN1Cc1ccc(CN2CCN(c3ccccc3OC)CC2)s1 10.1016/s0960-894x(02)00347-5
CHEMBL68241 203789 0 None 1 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 429 7 0 7 3.2 COC(=O)[C@@H]1CCCN1Cc1ccc(CN2CCN(c3ccccc3OC)CC2)s1 10.1016/s0960-894x(02)00347-5
68604 78205 29 None -28 6 Rat 7.9 pKi = 7.9 Binding
Displacement of [3H]-WB4101 from rat forebrain homogenate alpha 1 adrenergic receptorDisplacement of [3H]-WB4101 from rat forebrain homogenate alpha 1 adrenergic receptor
ChEMBL 401 5 0 6 2.9 Cc1nc2n(c(=O)c1CCN1CCC(C(=O)c3ccc(F)cc3)CC1)CCS2 10.1021/acs.jmedchem.2c00633
CHEMBL2105437 78205 29 None -28 6 Rat 7.9 pKi = 7.9 Binding
Displacement of [3H]-WB4101 from rat forebrain homogenate alpha 1 adrenergic receptorDisplacement of [3H]-WB4101 from rat forebrain homogenate alpha 1 adrenergic receptor
ChEMBL 401 5 0 6 2.9 Cc1nc2n(c(=O)c1CCN1CCC(C(=O)c3ccc(F)cc3)CC1)CCS2 10.1021/acs.jmedchem.2c00633
11590801 16050 0 None -7 3 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 428 7 1 4 5.3 FC(F)(F)c1cccc(N2CCN(CCCCNc3ccc4ccccc4n3)CC2)c1 10.1016/j.bmcl.2010.07.096
CHEMBL1223747 16050 0 None -7 3 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 428 7 1 4 5.3 FC(F)(F)c1cccc(N2CCN(CCCCNc3ccc4ccccc4n3)CC2)c1 10.1016/j.bmcl.2010.07.096
2142 3096 58 None -2 36 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2018.04.059
4920903 3096 58 None -2 36 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2018.04.059
502 3096 58 None -2 36 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2018.04.059
5775 3096 58 None -2 36 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2018.04.059
CHEMBL597 3096 58 None -2 36 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2018.04.059
DB00692 3096 58 None -2 36 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2018.04.059
10745664 122016 0 None 12 3 Human 7.9 pKi = 7.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 572 8 2 8 3.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3cccc([N+](=O)[O-])c3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL359433 122016 0 None 12 3 Human 7.9 pKi = 7.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 572 8 2 8 3.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3cccc([N+](=O)[O-])c3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
44289344 168546 0 None 1 3 Human 7.9 pKi = 7.9 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 441 8 1 3 4.8 Cc1ccc(C(C(=O)NCCCN2CCN(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL435576 168546 0 None 1 3 Human 7.9 pKi = 7.9 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 441 8 1 3 4.8 Cc1ccc(C(C(=O)NCCCN2CCN(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
3039881 174257 10 None -19 3 Human 7.9 pKi = 7.9 Binding
The compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligandThe compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligand
ChEMBL 337 1 0 1 5.0 CN(C)C1C=CC2(CC1)c1ccccc1CCc1ccc(Cl)cc12 10.1021/jm00109a026
CHEMBL45491 174257 10 None -19 3 Human 7.9 pKi = 7.9 Binding
The compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligandThe compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligand
ChEMBL 337 1 0 1 5.0 CN(C)C1C=CC2(CC1)c1ccccc1CCc1ccc(Cl)cc12 10.1021/jm00109a026
1443 2028 34 None -2 10 Bovine 7.9 pKi = 7.9 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
33625 2028 34 None -2 10 Bovine 7.9 pKi = 7.9 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
501 2028 34 None -2 10 Bovine 7.9 pKi = 7.9 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
CHEMBL279516 2028 34 None -2 10 Bovine 7.9 pKi = 7.9 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
DB08950 2028 34 None -2 10 Bovine 7.9 pKi = 7.9 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
4038180 204 14 None 2 7 Rat 7.9 pKi = 7.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
480 204 14 None 2 7 Rat 7.9 pKi = 7.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
CHEMBL109783 204 14 None 2 7 Rat 7.9 pKi = 7.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
118716721 115015 0 None 1 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 466 5 1 6 3.3 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)Nc4ccccc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342874 115015 0 None 1 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 466 5 1 6 3.3 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)Nc4ccccc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
4038180 204 14 None 2 7 Rat 7.9 pKi = 7.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm030551a
480 204 14 None 2 7 Rat 7.9 pKi = 7.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm030551a
CHEMBL109783 204 14 None 2 7 Rat 7.9 pKi = 7.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm030551a
10644955 166187 7 None -1 3 Rat 7.9 pKi = 7.9 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 404 6 0 4 3.1 O=C1C2CCCCN2C(=O)N1CCCCN1CCN(c2cccc(Cl)c2)CC1 10.1021/jm970216k
CHEMBL42644 166187 7 None -1 3 Rat 7.9 pKi = 7.9 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 404 6 0 4 3.1 O=C1C2CCCCN2C(=O)N1CCCCN1CCN(c2cccc(Cl)c2)CC1 10.1021/jm970216k
9824384 118787 1 None -14 7 Human 7.9 pKi = 7.9 Binding
Compound was tested for binding affinity against human hippocampus Alpha-1A adrenergic receptor using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against human hippocampus Alpha-1A adrenergic receptor using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1021/jm960510x
CHEMBL342062 118787 1 None -14 7 Human 7.9 pKi = 7.9 Binding
Compound was tested for binding affinity against human hippocampus Alpha-1A adrenergic receptor using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against human hippocampus Alpha-1A adrenergic receptor using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1021/jm960510x
10252540 85357 1 None -58 5 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
CHEMBL2261604 85357 1 None -58 5 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
132266 1278 12 None -28 9 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2007.01.028
486 1278 12 None -28 9 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2007.01.028
CHEMBL423294 1278 12 None -28 9 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2007.01.028
132266 1278 12 None -28 9 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2018.05.023
486 1278 12 None -28 9 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2018.05.023
CHEMBL423294 1278 12 None -28 9 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1016/j.bmc.2018.05.023
52948119 16666 0 None -2 4 Human 7.9 pKi = 7.9 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 451 7 0 6 2.7 COc1ccccc1N1CCN(C[C@@H]2CO[C@](CN3CCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242445 16666 0 None -2 4 Human 7.9 pKi = 7.9 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 451 7 0 6 2.7 COc1ccccc1N1CCN(C[C@@H]2CO[C@](CN3CCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
118716723 115017 0 None 2 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 446 4 1 6 2.5 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)NC(C)(C)C)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342876 115017 0 None 2 4 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 446 4 1 6 2.5 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)NC(C)(C)C)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
44288162 168999 0 None 2 2 Rat 7.9 pKi = 7.9 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1ccc2c(c1)C1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC1CC2 10.1021/jm990567u
CHEMBL43921 168999 0 None 2 2 Rat 7.9 pKi = 7.9 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1ccc2c(c1)C1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC1CC2 10.1021/jm990567u
10622830 102426 0 None 7 2 Rat 7.9 pKi = 7.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 437 6 1 6 3.2 COc1cc2c(cc1OC)C(=O)N(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)CN2 10.1021/jm000541z
CHEMBL303988 102426 0 None 7 2 Rat 7.9 pKi = 7.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 437 6 1 6 3.2 COc1cc2c(cc1OC)C(=O)N(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)CN2 10.1021/jm000541z
118717456 115136 0 None -2 4 Human 6.9 pKi = 6.9 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 342 5 2 4 4.9 Cc1ccc2c(NCCNc3ccnc4cc(C)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343977 115136 0 None -2 4 Human 6.9 pKi = 6.9 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 342 5 2 4 4.9 Cc1ccc2c(NCCNc3ccnc4cc(C)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
9797396 12881 0 None -39 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 325 5 1 2 4.2 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
CHEMBL1188811 12881 0 None -39 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 325 5 1 2 4.2 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
CHEMBL537428 12881 0 None -39 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 325 5 1 2 4.2 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
9797396 12881 0 None -39 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 325 5 1 2 4.2 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2015.07.046
CHEMBL1188811 12881 0 None -39 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 325 5 1 2 4.2 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2015.07.046
CHEMBL537428 12881 0 None -39 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 325 5 1 2 4.2 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2015.07.046
44586430 187030 0 None 15 2 Rat 6.9 pKi = 6.9 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 528 9 1 6 3.4 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)N(C)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL490865 187030 0 None 15 2 Rat 6.9 pKi = 6.9 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 528 9 1 6 3.4 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)N(C)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
155525650 176638 0 None -22 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 9 1 4 4.2 c1ccc(OCCNC[C@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4457585 176638 0 None -22 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 9 1 4 4.2 c1ccc(OCCNC[C@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4597956 176638 0 None -22 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 9 1 4 4.2 c1ccc(OCCNC[C@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
118717456 115136 0 None -2 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 342 5 2 4 4.9 Cc1ccc2c(NCCNc3ccnc4cc(C)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343977 115136 0 None -2 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 342 5 2 4 4.9 Cc1ccc2c(NCCNc3ccnc4cc(C)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
145949210 162749 0 None -4 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 459 5 2 9 2.8 COc1cc2nc(N3CCC[C@@H](NC4=CC(=O)c5ccccc5C4=O)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
CHEMBL4171491 162749 0 None -4 3 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 459 5 2 9 2.8 COc1cc2nc(N3CCC[C@@H](NC4=CC(=O)c5ccccc5C4=O)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
145946292 167504 0 None -19 2 Human 5.9 pKi = 5.9 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 382 6 2 5 2.9 CNc1ccc2c(c1)[C@H](NCCOc1cc(F)ccc1F)CCS2(=O)=O 10.1016/j.ejmech.2017.07.071
CHEMBL4210954 167504 0 None -19 2 Human 5.9 pKi = 5.9 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 382 6 2 5 2.9 CNc1ccc2c(c1)[C@H](NCCOc1cc(F)ccc1F)CCS2(=O)=O 10.1016/j.ejmech.2017.07.071
CHEMBL4299802 167504 0 None -19 2 Human 5.9 pKi = 5.9 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 382 6 2 5 2.9 CNc1ccc2c(c1)[C@H](NCCOc1cc(F)ccc1F)CCS2(=O)=O 10.1016/j.ejmech.2017.07.071
12909389 60369 0 None 64 2 Bovine 5.9 pKi = 5.9 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 320 1 1 3 3.7 CN1CCC(=C2c3cc(C(=O)O)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
CHEMBL174649 60369 0 None 64 2 Bovine 5.9 pKi = 5.9 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 320 1 1 3 3.7 CN1CCC(=C2c3cc(C(=O)O)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
10221004 204231 0 None -1 5 Human 5.9 pKi = 5.9 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 267 5 2 5 0.9 CCS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70973 204231 0 None -1 5 Human 5.9 pKi = 5.9 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 267 5 2 5 0.9 CCS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
9953974 77833 0 None 5 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 421 4 0 7 3.3 COc1ccccc1N1CCN(C[C@@H]2CN=C3c4ccccc4N=C(SC)N32)CC1 10.1021/jm970159v
CHEMBL2092927 77833 0 None 5 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 421 4 0 7 3.3 COc1ccccc1N1CCN(C[C@@H]2CN=C3c4ccccc4N=C(SC)N32)CC1 10.1021/jm970159v
10694274 199022 0 None 1 2 Rat 6.9 pKi = 6.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 437 6 1 5 3.7 COc1cc2c(cc1OC)NC(=O)N(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)C2 10.1021/jm000541z
CHEMBL58585 199022 0 None 1 2 Rat 6.9 pKi = 6.9 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 437 6 1 5 3.7 COc1cc2c(cc1OC)NC(=O)N(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)C2 10.1021/jm000541z
1971 2866 38 None -24 30 Rat 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
2404 2866 38 None -24 30 Rat 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
4543 2866 38 None -24 30 Rat 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
CHEMBL445 2866 38 None -24 30 Rat 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
DB00540 2866 38 None -24 30 Rat 6.9 pKi = 6.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 nan
9950711 109206 0 None 5 3 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 359 4 2 3 3.2 O=S(=O)(CC(F)(F)F)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL321644 109206 0 None 5 3 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 359 4 2 3 3.2 O=S(=O)(CC(F)(F)F)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
16655023 107441 2 None -102 7 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human cloned alpha-1A receptorDisplacement of [3H]prazosin from human cloned alpha-1A receptor
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmc.2007.03.053
CHEMBL318235 107441 2 None -102 7 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human cloned alpha-1A receptorDisplacement of [3H]prazosin from human cloned alpha-1A receptor
ChEMBL 481 7 0 7 3.7 COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccc(F)cc4)CC3)[C@@H]1CO2 10.1016/j.bmc.2007.03.053
9822477 199452 0 None -1 4 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 403 4 0 4 3.5 Cc1ccc(Cl)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1021/jm030944+
CHEMBL59149 199452 0 None -1 4 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 403 4 0 4 3.5 Cc1ccc(Cl)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1021/jm030944+
11183468 109872 2 None -2 5 Rat 6.9 pKi = 6.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 213 1 2 2 2.5 Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL323402 109872 2 None -2 5 Rat 6.9 pKi = 6.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 213 1 2 2 2.5 Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
52937526 61302 0 None -1258 4 Human 6.9 pKi = 6.9 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 363 5 0 5 3.1 COc1ccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)cc1 10.1021/jm1013874
CHEMBL1767137 61302 0 None -1258 4 Human 6.9 pKi = 6.9 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 363 5 0 5 3.1 COc1ccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)cc1 10.1021/jm1013874
24803798 61325 0 None -501 4 Human 6.9 pKi = 6.9 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 640 12 0 6 7.9 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C1CCCN(CCCc2ccc(OCCCN3CCCCCC3)cc2)CC1 10.1021/jm1013874
CHEMBL1767160 61325 0 None -501 4 Human 6.9 pKi = 6.9 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 640 12 0 6 7.9 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C1CCCN(CCCc2ccc(OCCCN3CCCCCC3)cc2)CC1 10.1021/jm1013874
218362 204800 5 None -75 4 Human 6.9 pKi = 6.9 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 216 1 1 3 2.0 c1ccc2c(c1)CCCC2NC1=NCCO1 10.1016/0960-894X(94)85032-1
CHEMBL75030 204800 5 None -75 4 Human 6.9 pKi = 6.9 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 216 1 1 3 2.0 c1ccc2c(c1)CCCC2NC1=NCCO1 10.1016/0960-894X(94)85032-1
151779 194704 2 None 1 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 384 10 2 4 6.3 c1ccc2c(NCCCCCCCNc3ccnc4ccccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL533979 194704 2 None 1 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 384 10 2 4 6.3 c1ccc2c(NCCCCCCCNc3ccnc4ccccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
127040061 136926 0 None -33 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNC[C@H]2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1039/C4MD00484A
CHEMBL3739932 136926 0 None -33 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNC[C@H]2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1039/C4MD00484A
CHEMBL3742489 136926 0 None -33 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNC[C@H]2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1039/C4MD00484A
127036186 137414 0 None -39 19 Human 5.9 pKi = 5.9 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 254 7 1 1 3.7 C=CCN(CC=C)CCc1c[nH]c2ccc(C)cc12 10.1016/j.bmcl.2015.12.053
CHEMBL3753318 137414 0 None -39 19 Human 5.9 pKi = 5.9 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 254 7 1 1 3.7 C=CCN(CC=C)CCc1c[nH]c2ccc(C)cc12 10.1016/j.bmcl.2015.12.053
127026052 137553 0 None -75 19 Human 5.9 pKi = 5.9 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 258 7 1 1 3.5 C=CCN(CC=C)CCc1c[nH]c2ccc(F)cc12 10.1016/j.bmcl.2015.12.053
CHEMBL3754496 137553 0 None -75 19 Human 5.9 pKi = 5.9 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 258 7 1 1 3.5 C=CCN(CC=C)CCc1c[nH]c2ccc(F)cc12 10.1016/j.bmcl.2015.12.053
183528 168701 6 None -16 2 Human 4.9 pKi = 4.9 Binding
Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 420 3 4 3 4.7 O=C(c1nc(-c2c[nH]c3cc(Br)ccc23)c[nH]1)c1c[nH]c2cc(O)ccc12 10.1016/0960-894X(96)00376-9
CHEMBL436760 168701 6 None -16 2 Human 4.9 pKi = 4.9 Binding
Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 420 3 4 3 4.7 O=C(c1nc(-c2c[nH]c3cc(Br)ccc23)c[nH]1)c1c[nH]c2cc(O)ccc12 10.1016/0960-894X(96)00376-9
151779 194704 2 None 1 4 Human 6.9 pKi = 6.9 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 384 10 2 4 6.3 c1ccc2c(NCCCCCCCNc3ccnc4ccccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL533979 194704 2 None 1 4 Human 6.9 pKi = 6.9 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 384 10 2 4 6.3 c1ccc2c(NCCCCCCCNc3ccnc4ccccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
44328739 207651 0 None 1 3 Human 6.9 pKi = 6.9 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 691 16 3 6 7.5 CCCCCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCC)=C(CC)N1 10.1016/s0960-894x(99)00484-9
CHEMBL95263 207651 0 None 1 3 Human 6.9 pKi = 6.9 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 691 16 3 6 7.5 CCCCCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCC)=C(CC)N1 10.1016/s0960-894x(99)00484-9
1376848 203756 8 None -1 3 Human 6.9 pKi = 6.9 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 366 4 0 4 3.8 COc1ccccc1N1CCN(Cc2ccc(Br)s2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL67932 203756 8 None -1 3 Human 6.9 pKi = 6.9 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 366 4 0 4 3.8 COc1ccccc1N1CCN(Cc2ccc(Br)s2)CC1 10.1016/s0960-894x(02)00347-5
9954092 196646 0 None -1000 5 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 423 4 0 4 3.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL56438 196646 0 None -1000 5 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 423 4 0 4 3.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
9903797 9439 5 None 63 3 Rat 6.9 pKi = 6.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 279 5 2 3 2.1 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1C 10.1007/s00044-004-0020-z
CHEMBL111734 9439 5 None 63 3 Rat 6.9 pKi = 6.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 279 5 2 3 2.1 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1C 10.1007/s00044-004-0020-z
25181489 187357 0 None -158 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNC[C@@H]2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm301525w
CHEMBL493285 187357 0 None -158 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNC[C@@H]2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm301525w
9903797 9439 5 None 63 3 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 279 5 2 3 2.1 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1C 10.1021/jm030551a
CHEMBL111734 9439 5 None 63 3 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 279 5 2 3 2.1 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1C 10.1021/jm030551a
11747739 13235 0 None -1 4 Human 5.9 pKi = 5.9 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 237 4 2 4 0.8 C[S+]([O-])c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1191324 13235 0 None -1 4 Human 5.9 pKi = 5.9 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 237 4 2 4 0.8 C[S+]([O-])c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL542402 13235 0 None -1 4 Human 5.9 pKi = 5.9 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 237 4 2 4 0.8 C[S+]([O-])c1ccccc1NCC1=NCCN1 10.1021/jm000542r
44267890 16507 0 None 41 3 Human 6.9 pKi = 6.9 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 460 8 1 5 2.0 O=C(CN1CCCCC1=O)NCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL12364 16507 0 None 41 3 Human 6.9 pKi = 6.9 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 460 8 1 5 2.0 O=C(CN1CCCCC1=O)NCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(00)00169-4
44460394 205378 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 398 7 0 6 2.9 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCC3=O)co2)CC1 10.1016/s0960-894x(02)00436-5
CHEMBL79940 205378 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 398 7 0 6 2.9 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCC3=O)co2)CC1 10.1016/s0960-894x(02)00436-5
9959671 32671 0 None 363 3 Human 7.9 pKi = 7.9 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 0 7 5.6 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL141322 32671 0 None 363 3 Human 7.9 pKi = 7.9 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 0 7 5.6 COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
15054189 195584 0 None 23 3 Rat 7.9 pKi = 7.9 Binding
Binding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranesBinding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranes
ChEMBL 433 6 2 6 2.4 COc1ccccc1N1CCN(CCCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1021/jm00110a014
CHEMBL55528 195584 0 None 23 3 Rat 7.9 pKi = 7.9 Binding
Binding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranesBinding affinity for Alpha-1 adrenergic receptor measured by displacing [3H]prazosin from rat cortical membranes
ChEMBL 433 6 2 6 2.4 COc1ccccc1N1CCN(CCCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1021/jm00110a014
2389 3331 118 None -6 67 Rat 7.9 pKi = 7.9 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
5073 3331 118 None -6 67 Rat 7.9 pKi = 7.9 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
96 3331 118 None -6 67 Rat 7.9 pKi = 7.9 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
CHEMBL85 3331 118 None -6 67 Rat 7.9 pKi = 7.9 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
DB00734 3331 118 None -6 67 Rat 7.9 pKi = 7.9 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1021/jm9810396
10623356 168129 0 None -8 3 Human 7.9 pKi = 7.9 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 448 7 0 5 4.0 COc1ccccc1N1CCN(CCN(C(=O)c2ccc(F)c(C)c2)c2ccccn2)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL1910243 168129 0 None -8 3 Human 7.9 pKi = 7.9 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 448 7 0 5 4.0 COc1ccccc1N1CCN(CCN(C(=O)c2ccc(F)c(C)c2)c2ccccn2)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL43297 168129 0 None -8 3 Human 7.9 pKi = 7.9 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 448 7 0 5 4.0 COc1ccccc1N1CCN(CCN(C(=O)c2ccc(F)c(C)c2)c2ccccn2)CC1 10.1021/acs.jmedchem.2c00633
2274 3173 58 None -6 31 Rat 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
4917 3173 58 None -6 31 Rat 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
7279 3173 58 None -6 31 Rat 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
CHEMBL728 3173 58 None -6 31 Rat 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
DB00433 3173 58 None -6 31 Rat 7.9 pKi = 7.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 nan
44331136 109681 0 None 1 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 540 7 1 5 5.8 O=C1CC2(CCN(CCc3cccc4ccccc34)CC2)Oc2ccc(NS(=O)(=O)Cc3ccccc3)cc21 10.1016/s0960-894x(98)00732-x
CHEMBL322688 109681 0 None 1 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 540 7 1 5 5.8 O=C1CC2(CCN(CCc3cccc4ccccc34)CC2)Oc2ccc(NS(=O)(=O)Cc3ccccc3)cc21 10.1016/s0960-894x(98)00732-x
13141184 165890 0 None 17 2 Bovine 7.9 pKi = 7.9 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 376 1 0 3 5.6 CN1CCC(=C2c3cc(SC(F)(F)F)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
CHEMBL424967 165890 0 None 17 2 Bovine 7.9 pKi = 7.9 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 376 1 0 3 5.6 CN1CCC(=C2c3cc(SC(F)(F)F)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
57402365 69295 0 None 10 5 Pig 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 441 12 1 6 3.1 CCOCCOc1cccc(C(=O)NCCCN2CCN(c3ccccc3OC)CC2)c1 10.1016/j.bmc.2011.10.063
CHEMBL1928119 69295 0 None 10 5 Pig 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 441 12 1 6 3.1 CCOCCOc1cccc(C(=O)NCCCN2CCN(c3ccccc3OC)CC2)c1 10.1016/j.bmc.2011.10.063
11393666 192986 0 None -33 19 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysis
ChEMBL 340 2 1 2 4.6 CC1(C)CN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CCN1 10.1016/j.bmcl.2022.128879
CHEMBL5201983 192986 0 None -33 19 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysis
ChEMBL 340 2 1 2 4.6 CC1(C)CN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CCN1 10.1016/j.bmcl.2022.128879
CHEMBL5222597 192986 0 None -33 19 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysis
ChEMBL 340 2 1 2 4.6 CC1(C)CN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CCN1 10.1016/j.bmcl.2022.128879
53779053 78437 0 None 5 3 Human 7.9 pKi = 7.9 Binding
Tested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assayTested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assay
ChEMBL 475 6 1 4 5.0 C[C@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H]1c1ccc(F)c(F)c1 10.1016/s0960-894x(00)00524-2
CHEMBL2111563 78437 0 None 5 3 Human 7.9 pKi = 7.9 Binding
Tested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assayTested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assay
ChEMBL 475 6 1 4 5.0 C[C@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H]1c1ccc(F)c(F)c1 10.1016/s0960-894x(00)00524-2
124 2981 47 None -14 33 Bovine 7.9 pKi = 7.9 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
2032 2981 47 None -14 33 Bovine 7.9 pKi = 7.9 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
4636 2981 47 None -14 33 Bovine 7.9 pKi = 7.9 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
CHEMBL762 2981 47 None -14 33 Bovine 7.9 pKi = 7.9 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
DB00935 2981 47 None -14 33 Bovine 7.9 pKi = 7.9 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
10623356 168129 0 None -8 3 Human 7.9 pKi = 7.9 Binding
Binding affinity to alpha1A receptorBinding affinity to alpha1A receptor
ChEMBL 448 7 0 5 4.0 COc1ccccc1N1CCN(CCN(C(=O)c2ccc(F)c(C)c2)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
CHEMBL1910243 168129 0 None -8 3 Human 7.9 pKi = 7.9 Binding
Binding affinity to alpha1A receptorBinding affinity to alpha1A receptor
ChEMBL 448 7 0 5 4.0 COc1ccccc1N1CCN(CCN(C(=O)c2ccc(F)c(C)c2)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
CHEMBL43297 168129 0 None -8 3 Human 7.9 pKi = 7.9 Binding
Binding affinity to alpha1A receptorBinding affinity to alpha1A receptor
ChEMBL 448 7 0 5 4.0 COc1ccccc1N1CCN(CCN(C(=O)c2ccc(F)c(C)c2)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
44431618 144904 0 None 3 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 488 8 1 7 3.3 COc1ccncc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL391017 144904 0 None 3 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 488 8 1 7 3.3 COc1ccncc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
2470 3653 50 None -316 59 Bovine 7.9 pKi = 7.9 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm960510x
3300 3653 50 None -316 59 Bovine 7.9 pKi = 7.9 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm960510x
5265 3653 50 None -316 59 Bovine 7.9 pKi = 7.9 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm960510x
99 3653 50 None -316 59 Bovine 7.9 pKi = 7.9 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm960510x
CHEMBL267930 3653 50 None -316 59 Bovine 7.9 pKi = 7.9 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm960510x
44447010 154240 0 None -4 4 Rat 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 496 6 1 5 5.4 Cc1ccc(C(=O)NC2CCc3ccc(CCN4CCN(c5nsc6ccccc56)CC4)cc32)cc1 10.1016/j.bmcl.2007.11.106
CHEMBL398618 154240 0 None -4 4 Rat 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 496 6 1 5 5.4 Cc1ccc(C(=O)NC2CCc3ccc(CCN4CCN(c5nsc6ccccc56)CC4)cc32)cc1 10.1016/j.bmcl.2007.11.106
44431545 145020 0 None -2 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 457 7 1 5 3.9 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL391107 145020 0 None -2 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 457 7 1 5 3.9 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
2419 695 28 None -288 12 Human 6.9 pKi = 6.9 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
9 695 28 None -288 12 Human 6.9 pKi = 6.9 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
CHEMBL13647 695 28 None -288 12 Human 6.9 pKi = 6.9 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
9954092 196646 0 None -1000 5 Human 6.9 pKi = 6.9 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 423 4 0 4 3.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1016/j.bmcl.2004.11.032
CHEMBL56438 196646 0 None -1000 5 Human 6.9 pKi = 6.9 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 423 4 0 4 3.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1016/j.bmcl.2004.11.032
13156 3447 0 None -416 3 Human 6.9 pKi = 6.9 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 382 6 2 5 2.9 FC1=C(OCCN[C@H]2CCS(C3=CC=C(C=C23)NC)(=O)=O)C=C(C=C1)F 10.1016/j.ejmech.2017.07.071
145946376 3447 0 None -416 3 Human 6.9 pKi = 6.9 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 382 6 2 5 2.9 FC1=C(OCCN[C@H]2CCS(C3=CC=C(C=C23)NC)(=O)=O)C=C(C=C1)F 10.1016/j.ejmech.2017.07.071
CHEMBL4299993 3447 0 None -416 3 Human 6.9 pKi = 6.9 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 382 6 2 5 2.9 FC1=C(OCCN[C@H]2CCS(C3=CC=C(C=C23)NC)(=O)=O)C=C(C=C1)F 10.1016/j.ejmech.2017.07.071
12909383 130703 1 None 5 2 Bovine 6.9 pKi = 6.9 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 278 0 0 2 3.6 CN1CCC(=C2c3ccccc3CCn3cccc32)CC1 10.1021/jm00361a008
CHEMBL368413 130703 1 None 5 2 Bovine 6.9 pKi = 6.9 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 278 0 0 2 3.6 CN1CCC(=C2c3ccccc3CCn3cccc32)CC1 10.1021/jm00361a008
9929458 123062 0 None -61 2 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 373 5 1 2 4.8 c1ccc2c(c1)CCN(CCCN1CCC(c3c[nH]c4ccccc34)CC1)C2 10.1016/j.bmcl.2015.07.046
CHEMBL3609359 123062 0 None -61 2 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 373 5 1 2 4.8 c1ccc2c(c1)CCN(CCCN1CCC(c3c[nH]c4ccccc34)CC1)C2 10.1016/j.bmcl.2015.07.046
11169638 17194 0 None 11 2 Rat 6.9 pKi = 6.9 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 600 11 1 8 3.3 CCOC(=O)C(C)N1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL1256344 17194 0 None 11 2 Rat 6.9 pKi = 6.9 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 600 11 1 8 3.3 CCOC(=O)C(C)N1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
9838192 111312 18 None -2 5 Rat 6.9 pKi = 6.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1007/s00044-004-0020-z
CHEMBL326702 111312 18 None -2 5 Rat 6.9 pKi = 6.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1007/s00044-004-0020-z
118717455 115135 0 None -7 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 342 5 2 4 4.9 Cc1ccc2nccc(NCCNc3ccnc4ccc(C)cc34)c2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343976 115135 0 None -7 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 342 5 2 4 4.9 Cc1ccc2nccc(NCCNc3ccnc4ccc(C)cc34)c2c1 10.1016/j.bmc.2014.09.017
9838192 111312 18 None -2 5 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1021/jm030551a
CHEMBL326702 111312 18 None -2 5 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1021/jm030551a
13149 2545 36 None -22 17 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 398 5 1 5 3.8 CC[C@@H]1CN2CCC3=C([C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)NC4=C3C(=CC=C4)OC 10.1021/acs.jmedchem.9b01465
3034396 2545 36 None -22 17 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 398 5 1 5 3.8 CC[C@@H]1CN2CCC3=C([C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)NC4=C3C(=CC=C4)OC 10.1021/acs.jmedchem.9b01465
CHEMBL299031 2545 36 None -22 17 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 minsDisplacement of [3H]prazosin from human recombinant adrenergic alpha-1A receptor expressed in CHO cell membranes incubated for 60 mins
ChEMBL 398 5 1 5 3.8 CC[C@@H]1CN2CCC3=C([C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)NC4=C3C(=CC=C4)OC 10.1021/acs.jmedchem.9b01465
9815005 109661 0 None 7 2 Rat 5.9 pKi = 5.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 305 3 2 3 2.6 CS(=O)(=O)Nc1cccc2c1CCCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL322492 109661 0 None 7 2 Rat 5.9 pKi = 5.9 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 305 3 2 3 2.6 CS(=O)(=O)Nc1cccc2c1CCCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL4576555 214017 5 None -1 19 Human 5.9 pKi = 5.9 Binding
GPCRScan assay: inhibition of Alpha1AGPCRScan assay: inhibition of Alpha1A
ChEMBL None None None CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5cc(C(C)(C)C)cc(C(C)(C)C)c5)ccc4n3)cc2)CC1 10.6019/CHEMBL4507307
9815005 109661 0 None 7 2 Rat 5.9 pKi = 5.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 305 3 2 3 2.6 CS(=O)(=O)Nc1cccc2c1CCCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL322492 109661 0 None 7 2 Rat 5.9 pKi = 5.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 305 3 2 3 2.6 CS(=O)(=O)Nc1cccc2c1CCCCC2c1c[nH]cn1 10.1021/jm030551a
118717455 115135 0 None -7 4 Human 6.9 pKi = 6.9 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 342 5 2 4 4.9 Cc1ccc2nccc(NCCNc3ccnc4ccc(C)cc34)c2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343976 115135 0 None -7 4 Human 6.9 pKi = 6.9 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 342 5 2 4 4.9 Cc1ccc2nccc(NCCNc3ccnc4ccc(C)cc34)c2c1 10.1016/j.bmc.2014.09.017
9908478 195636 1 None -141 7 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 391 4 0 4 2.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2F)CC1 10.1021/jm030944+
CHEMBL556313 195636 1 None -141 7 Rat 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 391 4 0 4 2.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2F)CC1 10.1021/jm030944+
196129 67798 17 None -1698 15 Rat 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 917 13 4 16 4.3 CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC nan
CHEMBL1909065 67798 17 None -1698 15 Rat 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 917 13 4 16 4.3 CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC nan
9938248 102206 0 None -1 3 Rat 6.9 pKi = 6.9 Binding
Binding affinity was determined against Alpha-1a adrenergic receptorBinding affinity was determined against Alpha-1a adrenergic receptor
ChEMBL 580 2 4 3 6.0 CN1C[C@H](c2c[nH]c3c(Br)c(Br)cc(O)c23)NC[C@H]1c1c[nH]c2cc(Br)ccc12 10.1016/0960-894X(96)00376-9
CHEMBL302882 102206 0 None -1 3 Rat 6.9 pKi = 6.9 Binding
Binding affinity was determined against Alpha-1a adrenergic receptorBinding affinity was determined against Alpha-1a adrenergic receptor
ChEMBL 580 2 4 3 6.0 CN1C[C@H](c2c[nH]c3c(Br)c(Br)cc(O)c23)NC[C@H]1c1c[nH]c2cc(Br)ccc12 10.1016/0960-894X(96)00376-9
11183468 109872 2 None -2 5 Bovine 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 213 1 2 2 2.5 Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL323402 109872 2 None -2 5 Bovine 6.9 pKi = 6.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 213 1 2 2 2.5 Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
6918539 144219 2 None - 1 Rat 5.9 pKi = 5.9 Binding
Displacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 minsDisplacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 mins
ChEMBL 361 2 2 5 3.4 COc1cc2c(cc1O)[C@@H]1Cc3c(Cl)cc(OC)c(O)c3CN1CC2 10.1021/acs.jmedchem.6b01217
CHEMBL3904484 144219 2 None - 1 Rat 5.9 pKi = 5.9 Binding
Displacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 minsDisplacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 mins
ChEMBL 361 2 2 5 3.4 COc1cc2c(cc1O)[C@@H]1Cc3c(Cl)cc(OC)c(O)c3CN1CC2 10.1021/acs.jmedchem.6b01217
11173600 163380 0 None - 1 Rat 5.9 pKi = 5.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 282 5 2 3 2.1 CCS(=O)(=O)Nc1cccc2c1CCCC2CNC 10.1021/jm030551a
CHEMBL419369 163380 0 None - 1 Rat 5.9 pKi = 5.9 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 282 5 2 3 2.1 CCS(=O)(=O)Nc1cccc2c1CCCC2CNC 10.1021/jm030551a
CHEMBL4752561 214038 0 None 3 2 Human 5.9 pKi = 5.9 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000739a ADRA1ASelectivity interaction (GPCR panel (PDSP screen)) EUB0000739a ADRA1A
ChEMBL None None None COc1cc(-c2cn([C@H]3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1 10.6019/CHEMBL5212743
CHEMBL4576555 214017 5 None -1 19 Human 5.9 pKi = 5.9 Binding
GPCRScan assay: inhibition of Alpha1AGPCRScan assay: inhibition of Alpha1A
ChEMBL None None None CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5cc(C(C)(C)C)cc(C(C)(C)C)c5)ccc4n3)cc2)CC1 10.6019/CHEMBL4507307
10745566 34318 0 None 61 3 Human 7.9 pKi = 7.9 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 566 10 1 6 5.1 CNC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)cc1F 10.1021/jm9902032
CHEMBL142719 34318 0 None 61 3 Human 7.9 pKi = 7.9 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 566 10 1 6 5.1 CNC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)cc1F 10.1021/jm9902032
44431553 87584 0 None -10 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 525 7 1 5 4.9 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccc(C(F)(F)F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233592 87584 0 None -10 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 525 7 1 5 4.9 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccc(C(F)(F)F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
44426404 85627 0 None 4 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 498 7 1 6 4.4 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1ccc2c(c1)OCO2 10.1016/j.bmcl.2007.04.098
CHEMBL228333 85627 0 None 4 4 Human 7.9 pKi = 7.9 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 498 7 1 6 4.4 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1ccc2c(c1)OCO2 10.1016/j.bmcl.2007.04.098
18738387 163498 0 None -1 2 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 399 6 0 5 3.6 COc1ccccc1N1CCN(Cc2ccc(CN3CCCCC3=O)s2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL420184 163498 0 None -1 2 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 399 6 0 5 3.6 COc1ccccc1N1CCN(Cc2ccc(CN3CCCCC3=O)s2)CC1 10.1016/s0960-894x(02)00347-5
16041628 155350 0 None -1 4 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)cc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL403280 155350 0 None -1 4 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)cc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
49865640 16034 0 None 2 3 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 324 7 1 4 3.4 Cc1ccccc1N1CCN(CCCCNc2ccccn2)CC1 10.1016/j.bmcl.2010.07.096
CHEMBL1223681 16034 0 None 2 3 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 324 7 1 4 3.4 Cc1ccccc1N1CCN(CCCCNc2ccccn2)CC1 10.1016/j.bmcl.2010.07.096
57390117 69299 0 None 16 5 Pig 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 455 13 1 6 3.2 CCOCCOCc1ccc(C(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1 10.1016/j.bmc.2011.10.063
CHEMBL1928123 69299 0 None 16 5 Pig 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 455 13 1 6 3.2 CCOCCOCc1ccc(C(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1 10.1016/j.bmc.2011.10.063
145946714 167558 0 None 2 6 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 398 9 0 5 3.8 COc1ccccc1N1CCN(CCOCCOc2cc(C)cc(C)c2C)CC1 10.1016/j.bmcl.2018.04.059
CHEMBL4213352 167558 0 None 2 6 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 398 9 0 5 3.8 COc1ccccc1N1CCN(CCOCCOc2cc(C)cc(C)c2C)CC1 10.1016/j.bmcl.2018.04.059
CHEMBL4300399 167558 0 None 2 6 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 398 9 0 5 3.8 COc1ccccc1N1CCN(CCOCCOc2cc(C)cc(C)c2C)CC1 10.1016/j.bmcl.2018.04.059
10578735 121120 0 None 28 3 Human 7.9 pKi = 7.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 557 8 2 7 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccc(OC)cc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL357439 121120 0 None 28 3 Human 7.9 pKi = 7.9 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 557 8 2 7 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccc(OC)cc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
53328508 63397 0 None 4 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 466 8 0 7 3.0 COc1ccccc1N1CCN(CCCN2C(=O)CC(c3ccc([N+](=O)[O-])cc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796042 63397 0 None 4 3 Human 7.9 pKi = 7.9 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 466 8 0 7 3.0 COc1ccccc1N1CCN(CCCN2C(=O)CC(c3ccc([N+](=O)[O-])cc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
44431620 87067 0 None -102 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 570 7 1 6 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cnc(Cl)c(Br)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL232609 87067 0 None -102 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 570 7 1 6 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cnc(Cl)c(Br)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
11782656 29083 0 None -75 6 Human 7.8 pKi = 7.8 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 336 9 1 4 3.8 COc1cccc2c(CCCNCCOc3ccccn3)cccc12 10.1021/jm010866v
CHEMBL138109 29083 0 None -75 6 Human 7.8 pKi = 7.8 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 336 9 1 4 3.8 COc1cccc2c(CCCNCCOc3ccccn3)cccc12 10.1021/jm010866v
10793963 99672 0 None 9 6 Human 7.8 pKi = 7.8 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 622 11 2 7 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL284470 99672 0 None 9 6 Human 7.8 pKi = 7.8 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 622 11 2 7 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
10793963 85270 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 622 11 2 7 6.0 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL2260147 85270 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 622 11 2 7 6.0 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
9838192 111312 18 None -2 5 Rat 6.9 pKi = 6.9 Binding
Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (0.12 - 0.15)Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (0.12 - 0.15)
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1021/jm025550h
CHEMBL326702 111312 18 None -2 5 Rat 6.9 pKi = 6.9 Binding
Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (0.12 - 0.15)Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (0.12 - 0.15)
ChEMBL 265 5 2 3 1.8 CCS(=O)(=O)Nc1cccc(Cc2c[nH]cn2)c1 10.1021/jm025550h
9938248 102206 0 None -1 3 Human 6.9 pKi = 6.9 Binding
Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 580 2 4 3 6.0 CN1C[C@H](c2c[nH]c3c(Br)c(Br)cc(O)c23)NC[C@H]1c1c[nH]c2cc(Br)ccc12 10.1016/0960-894X(96)00376-9
CHEMBL302882 102206 0 None -1 3 Human 6.9 pKi = 6.9 Binding
Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 580 2 4 3 6.0 CN1C[C@H](c2c[nH]c3c(Br)c(Br)cc(O)c23)NC[C@H]1c1c[nH]c2cc(Br)ccc12 10.1016/0960-894X(96)00376-9
12909388 61056 0 None 14 2 Bovine 6.9 pKi = 6.9 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 303 0 0 3 3.4 CN1CCC(=C2c3cc(C#N)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
CHEMBL176365 61056 0 None 14 2 Bovine 6.9 pKi = 6.9 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 303 0 0 3 3.4 CN1CCC(=C2c3cc(C#N)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
6604117 187847 6 None -1 6 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@@H]([C@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
CHEMBL2062340 187847 6 None -1 6 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@@H]([C@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
CHEMBL49623 187847 6 None -1 6 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@@H]([C@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
122187555 123055 0 None -3 2 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 324 5 1 1 5.7 c1ccc2c(C3CCN(CCCC4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2015.07.046
CHEMBL3609352 123055 0 None -3 2 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 324 5 1 1 5.7 c1ccc2c(C3CCN(CCCC4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2015.07.046
9845181 208161 3 None -1445 13 Human 4.9 pKi = 4.9 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 423 4 0 4 3.3 C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1021/jm0491391
CHEMBL98241 208161 3 None -1445 13 Human 4.9 pKi = 4.9 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 423 4 0 4 3.3 C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1021/jm0491391
44314198 104412 0 None -95 4 Human 6.9 pKi = 6.9 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCCC1NC1=NCCO1 10.1016/0960-894X(94)85032-1
CHEMBL310335 104412 0 None -95 4 Human 6.9 pKi = 6.9 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCCC1NC1=NCCO1 10.1016/0960-894X(94)85032-1
155557696 176439 0 None -30 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 377 11 2 4 3.8 OCC(CNCCOc1ccccc1)OC(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2019.05.024
CHEMBL4558985 176439 0 None -30 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 377 11 2 4 3.8 OCC(CNCCOc1ccccc1)OC(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2019.05.024
CHEMBL4596295 176439 0 None -30 4 Human 6.9 pKi = 6.9 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 377 11 2 4 3.8 OCC(CNCCOc1ccccc1)OC(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2019.05.024
2477 745 59 None -218 29 Rat 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 nan
36 745 59 None -218 29 Rat 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 nan
437 745 59 None -218 29 Rat 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 nan
CHEMBL49 745 59 None -218 29 Rat 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 nan
DB00490 745 59 None -218 29 Rat 5.9 pKi = 5.9 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 nan
44311789 204735 0 None -1 5 Human 4.9 pKi = 4.9 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 345 1 2 5 3.1 Brc1c(NC2=N[C@@H]3CCCC[C@@H]3N2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL74342 204735 0 None -1 5 Human 4.9 pKi = 4.9 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 345 1 2 5 3.1 Brc1c(NC2=N[C@@H]3CCCC[C@@H]3N2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
92766 106542 35 None 1 6 Human 6.9 pKi = 6.9 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 10.1021/jm00019a001
CHEMBL31410 106542 35 None 1 6 Human 6.9 pKi = 6.9 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 10.1021/jm00019a001
191 403 98 None -107 29 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
201 403 98 None -107 29 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
2170 403 98 None -107 29 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
CHEMBL1113 403 98 None -107 29 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
DB00543 403 98 None -107 29 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 313 0 1 4 3.4 Clc1ccc2c(c1)C(=Nc1c(O2)cccc1)N1CCNCC1 nan
10804826 23615 2 None -1 3 Bovine 5.8 pKi = 5.8 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@@H]2C1=NCCN1 10.1021/jm960354u
CHEMBL133451 23615 2 None -1 3 Bovine 5.8 pKi = 5.8 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@@H]2C1=NCCN1 10.1021/jm960354u
3823 50221 42 None -3019 10 Rat 4.8 pKi = 4.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
76973198 50221 42 None -3019 10 Rat 4.8 pKi = 4.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
CHEMBL157101 50221 42 None -3019 10 Rat 4.8 pKi = 4.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 530 7 0 7 4.2 CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
44582676 189779 0 None -1 17 Human 6.8 pKi = 6.8 Binding
Inhibition of human cloned alpha1A adrenergic receptor by competitive binding experimentInhibition of human cloned alpha1A adrenergic receptor by competitive binding experiment
ChEMBL 403 9 0 4 4.3 COc1c(OCCF)cccc1C(=O)C1CCN(CCc2ccc(F)cc2)CC1 10.1016/j.bmc.2009.03.021
CHEMBL516088 189779 0 None -1 17 Human 6.8 pKi = 6.8 Binding
Inhibition of human cloned alpha1A adrenergic receptor by competitive binding experimentInhibition of human cloned alpha1A adrenergic receptor by competitive binding experiment
ChEMBL 403 9 0 4 4.3 COc1c(OCCF)cccc1C(=O)C1CCN(CCc2ccc(F)cc2)CC1 10.1016/j.bmc.2009.03.021
19085836 205665 0 None 6 3 Human 6.8 pKi = 6.8 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 469 6 0 7 3.2 Cc1cccc2oc(=O)n(C3CCN(CCCCN4C(=O)c5ccccc5S4(=O)=O)CC3)c12 10.1016/s0960-894x(98)00446-6
CHEMBL82056 205665 0 None 6 3 Human 6.8 pKi = 6.8 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 469 6 0 7 3.2 Cc1cccc2oc(=O)n(C3CCN(CCCCN4C(=O)c5ccccc5S4(=O)=O)CC3)c12 10.1016/s0960-894x(98)00446-6
11140345 204171 0 None 1 6 Human 6.8 pKi = 6.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 239 4 2 4 2.0 CSc1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70692 204171 0 None 1 6 Human 6.8 pKi = 6.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 239 4 2 4 2.0 CSc1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
9900133 8985 0 None -1 3 Bovine 6.8 pKi = 6.8 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 271 2 2 3 3.1 COC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL109827 8985 0 None -1 3 Bovine 6.8 pKi = 6.8 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 271 2 2 3 3.1 COC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
185076 187090 5 None -389 7 Human 5.8 pKi = 5.8 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 227 1 2 5 1.3 Cc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL49137 187090 5 None -389 7 Human 5.8 pKi = 5.8 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 227 1 2 5 1.3 Cc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
13298529 101219 57 None -134 2 Bovine 5.8 pKi = 5.8 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 241 1 1 3 1.3 Brc1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL295921 101219 57 None -134 2 Bovine 5.8 pKi = 5.8 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 241 1 1 3 1.3 Brc1cccnc1N1CCNCC1 10.1021/jm00366a007
11464777 101805 0 None -11 4 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 437 4 0 4 4.2 CC(CN1CCN(c2cc(Cl)ccc2Cl)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1007/s00044-010-9379-1
CHEMBL300152 101805 0 None -11 4 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 437 4 0 4 4.2 CC(CN1CCN(c2cc(Cl)ccc2Cl)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1007/s00044-010-9379-1
9845181 208161 3 None -1445 13 Human 4.8 pKi = 4.8 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 423 4 0 4 3.3 C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1016/s0960-894x(01)00159-7
CHEMBL98241 208161 3 None -1445 13 Human 4.8 pKi = 4.8 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 423 4 0 4 3.3 C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1016/s0960-894x(01)00159-7
44433348 167349 0 None 1 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 545 10 0 7 4.6 CCN([C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1)S(=O)(=O)c1ccc(OC)c(OC)c1 10.1016/j.bmcl.2007.09.051
CHEMBL429453 167349 0 None 1 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 545 10 0 7 4.6 CCN([C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1)S(=O)(=O)c1ccc(OC)c(OC)c1 10.1016/j.bmcl.2007.09.051
135398737 958 93 None -5 89 Rat 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
38 958 93 None -5 89 Rat 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
722 958 93 None -5 89 Rat 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
CHEMBL42 958 93 None -5 89 Rat 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
DB00363 958 93 None -5 89 Rat 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
44460423 205616 0 None 11 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 446 7 0 6 4.3 O=C1CCCCN1Cc1cc(CN2CCN(c3ccccc3Oc3ccccc3)CC2)on1 10.1016/s0960-894x(02)00436-5
CHEMBL81661 205616 0 None 11 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 446 7 0 6 4.3 O=C1CCCCN1Cc1cc(CN2CCN(c3ccccc3Oc3ccccc3)CC2)on1 10.1016/s0960-894x(02)00436-5
44431184 92850 0 None -2 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 515 5 0 5 5.5 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4ccc5ccc(F)cc5c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
CHEMBL243866 92850 0 None -2 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 515 5 0 5 5.5 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4ccc5ccc(F)cc5c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
44295218 189102 0 None 22 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 582 8 2 7 3.5 COC(=O)C1(c2ccccc2)CCN(CCCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
CHEMBL51019 189102 0 None 22 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 582 8 2 7 3.5 COC(=O)C1(c2ccccc2)CCN(CCCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
145947937 167723 0 None -3 6 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 398 9 0 5 3.8 COc1ccccc1N1CCN(CCOCCOc2c(C)cc(C)cc2C)CC1 10.1016/j.bmcl.2018.04.059
CHEMBL4207653 167723 0 None -3 6 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 398 9 0 5 3.8 COc1ccccc1N1CCN(CCOCCOc2c(C)cc(C)cc2C)CC1 10.1016/j.bmcl.2018.04.059
CHEMBL4302655 167723 0 None -3 6 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 398 9 0 5 3.8 COc1ccccc1N1CCN(CCOCCOc2c(C)cc(C)cc2C)CC1 10.1016/j.bmcl.2018.04.059
44447070 94645 0 None -9 4 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 500 6 1 5 5.2 O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)c1ccc(F)cc1 10.1016/j.bmcl.2007.11.106
CHEMBL252429 94645 0 None -9 4 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 500 6 1 5 5.2 O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)c1ccc(F)cc1 10.1016/j.bmcl.2007.11.106
124 2981 47 None -19 33 Human 7.8 pKi = 7.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
2032 2981 47 None -19 33 Human 7.8 pKi = 7.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
4636 2981 47 None -19 33 Human 7.8 pKi = 7.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
CHEMBL762 2981 47 None -19 33 Human 7.8 pKi = 7.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
DB00935 2981 47 None -19 33 Human 7.8 pKi = 7.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm000542r
CHEMBL5270515 194609 0 None -39 3 Human 7.8 pKi = 7.8 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 452 8 1 5 3.6 CCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5315265 194609 0 None -39 3 Human 7.8 pKi = 7.8 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 452 8 1 5 3.6 CCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
52937222 61321 0 None -15 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 367 3 0 4 3.9 CN1CCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1 10.1021/jm1013874
CHEMBL1767156 61321 0 None -15 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 367 3 0 4 3.9 CN1CCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1 10.1021/jm1013874
10089254 99981 0 None 12 3 Human 7.8 pKi = 7.8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 350 7 1 3 3.5 O=C(CCCN1CCC(NC(=O)c2ccccc2)CC1)c1ccccc1 10.1021/jm960697s
CHEMBL286591 99981 0 None 12 3 Human 7.8 pKi = 7.8 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 350 7 1 3 3.5 O=C(CCCN1CCC(NC(=O)c2ccccc2)CC1)c1ccccc1 10.1021/jm960697s
53328314 63389 0 None 1 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 439 7 0 4 4.2 O=C1CC(c2ccccc2)CC(=O)N1CCCCN1CCN(c2ccccc2Cl)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796034 63389 0 None 1 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 439 7 0 4 4.2 O=C1CC(c2ccccc2)CC(=O)N1CCCCN1CCN(c2ccccc2Cl)CC1 10.1016/j.ejmech.2011.03.054
144096995 164496 0 None -17 3 Human 6.8 pKi = 6.8 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 371 8 1 4 3.1 CS(=O)(=O)c1ccccc1CCNCCOc1cc(F)ccc1Cl 10.1016/j.ejmech.2017.07.071
CHEMBL4214499 164496 0 None -17 3 Human 6.8 pKi = 6.8 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 371 8 1 4 3.1 CS(=O)(=O)c1ccccc1CCNCCOc1cc(F)ccc1Cl 10.1016/j.ejmech.2017.07.071
173712 124321 20 None -8 3 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 391 6 1 3 4.9 O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(Cl)cc1 10.1021/jm060383x
CHEMBL363548 124321 20 None -8 3 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 391 6 1 3 4.9 O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(Cl)cc1 10.1021/jm060383x
1862 161 18 None -1 7 Human 5.8 pKi = 5.8 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 187 2 4 4 0.2 NCC(c1cc(O)c(cc1F)O)O 10.1021/jm00118a019
510 161 18 None -1 7 Human 5.8 pKi = 5.8 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 187 2 4 4 0.2 NCC(c1cc(O)c(cc1F)O)O 10.1021/jm00118a019
CHEMBL281232 161 18 None -1 7 Human 5.8 pKi = 5.8 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 187 2 4 4 0.2 NCC(c1cc(O)c(cc1F)O)O 10.1021/jm00118a019
1960 2857 67 None -57 26 Human 5.8 pKi = 5.8 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
439260 2857 67 None -57 26 Human 5.8 pKi = 5.8 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
505 2857 67 None -57 26 Human 5.8 pKi = 5.8 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
CHEMBL1437 2857 67 None -57 26 Human 5.8 pKi = 5.8 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
DB00368 2857 67 None -57 26 Human 5.8 pKi = 5.8 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
18738412 205409 0 None 2 3 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 365 6 1 6 3.3 OCc1cc(CN2CCN(c3ccccc3Oc3ccccc3)CC2)on1 10.1016/s0960-894x(02)00436-5
CHEMBL80125 205409 0 None 2 3 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 365 6 1 6 3.3 OCc1cc(CN2CCN(c3ccccc3Oc3ccccc3)CC2)on1 10.1016/s0960-894x(02)00436-5
6603915 99982 30 None -446 3 Human 6.8 pKi = 6.8 Binding
Binding affinity to alpha1A receptorBinding affinity to alpha1A receptor
ChEMBL 434 7 0 5 3.7 COc1ccccc1N1CCN(CCN(C(=O)c2ccc(F)cc2)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
CHEMBL1775000 99982 30 None -446 3 Human 6.8 pKi = 6.8 Binding
Binding affinity to alpha1A receptorBinding affinity to alpha1A receptor
ChEMBL 434 7 0 5 3.7 COc1ccccc1N1CCN(CCN(C(=O)c2ccc(F)cc2)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
CHEMBL286607 99982 30 None -446 3 Human 6.8 pKi = 6.8 Binding
Binding affinity to alpha1A receptorBinding affinity to alpha1A receptor
ChEMBL 434 7 0 5 3.7 COc1ccccc1N1CCN(CCN(C(=O)c2ccc(F)cc2)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
2803 955 58 None -3 19 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
516 955 58 None -3 19 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
704 955 58 None -3 19 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
CHEMBL134 955 58 None -3 19 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
DB00575 955 58 None -3 19 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl nan
11464777 101805 0 None -11 4 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 437 4 0 4 4.2 CC(CN1CCN(c2cc(Cl)ccc2Cl)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1007/s00044-010-9379-1
CHEMBL300152 101805 0 None -11 4 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 437 4 0 4 4.2 CC(CN1CCN(c2cc(Cl)ccc2Cl)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1007/s00044-010-9379-1
1220 187 55 None -407 44 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1016/j.bmcl.2010.01.030
31 187 55 None -407 44 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1016/j.bmcl.2010.01.030
7 187 55 None -407 44 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1016/j.bmcl.2010.01.030
CHEMBL56 187 55 None -407 44 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1016/j.bmcl.2010.01.030
1220 187 55 None -407 44 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm200421e
31 187 55 None -407 44 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm200421e
7 187 55 None -407 44 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm200421e
CHEMBL56 187 55 None -407 44 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm200421e
11201573 197657 0 None - 1 Rat 5.8 pKi = 5.8 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 442 5 0 6 1.6 COc1ccccc1N1CCN(CCN2C(=O)CC3(CCN(C(C)=O)CC3)CC2=O)CC1 10.1021/jm030944+
CHEMBL57097 197657 0 None - 1 Rat 5.8 pKi = 5.8 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 442 5 0 6 1.6 COc1ccccc1N1CCN(CCN2C(=O)CC3(CCN(C(C)=O)CC3)CC2=O)CC1 10.1021/jm030944+
127027077 137780 0 None -7585 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 403 7 2 4 3.9 O=C(NCCCCN1CCN(c2cccc(O)c2)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
CHEMBL3759491 137780 0 None -7585 3 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 403 7 2 4 3.9 O=C(NCCCCN1CCN(c2cccc(O)c2)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
10768423 101327 0 None 12 2 Rat 6.8 pKi = 6.8 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 525 5 1 8 4.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5nc(-c6ccccc6)cnc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL296711 101327 0 None 12 2 Rat 6.8 pKi = 6.8 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 525 5 1 8 4.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5nc(-c6ccccc6)cnc54)c3=O)C[C@@H]21 10.1021/jm990567u
16040907 97883 0 None -2 4 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 466 7 2 5 4.7 COc1ccccc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL272340 97883 0 None -2 4 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 466 7 2 5 4.7 COc1ccccc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.11.068
10577609 26986 0 None -10 3 Rat 6.8 pKi = 6.8 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 509 8 1 9 3.5 COc1cc2nc(N3CCN(C(=O)C(C)Oc4c(OC)cccc4C(C)C)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL136458 26986 0 None -10 3 Rat 6.8 pKi = 6.8 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 509 8 1 9 3.5 COc1cc2nc(N3CCN(C(=O)C(C)Oc4c(OC)cccc4C(C)C)CC3)nc(N)c2cc1OC 10.1021/jm9805337
3952 1888 38 None -26 12 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5353646 1888 38 None -26 12 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5443 1888 38 None -26 12 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
5702063 1888 38 None -26 12 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
CHEMBL1331786 1888 38 None -26 12 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
CHEMBL420 1888 38 None -26 12 Rat 6.8 pKi = 6.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N nan
127027080 137853 0 None -45 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 443 7 3 4 3.3 O=C(NCCCCN1CCN(c2cccc3[nH]c(=O)[nH]c23)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
CHEMBL3760110 137853 0 None -45 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 443 7 3 4 3.3 O=C(NCCCCN1CCN(c2cccc3[nH]c(=O)[nH]c23)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
11152823 165259 0 None -1 3 Human 6.8 pKi = 6.8 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 367 5 2 6 2.6 COc1cc2nc3c(c(N)c2cc1OC)CC(CNC(=O)c1ccco1)C3 10.1021/jm030952q
CHEMBL423018 165259 0 None -1 3 Human 6.8 pKi = 6.8 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 367 5 2 6 2.6 COc1cc2nc3c(c(N)c2cc1OC)CC(CNC(=O)c1ccco1)C3 10.1021/jm030952q
76333281 84825 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 367 5 2 6 2.6 COc1cc2nc3c(c(N)c2cc1OC)CC(CNC(=O)c1ccoc1)C3 10.1007/s00044-010-9379-1
CHEMBL2234450 84825 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 367 5 2 6 2.6 COc1cc2nc3c(c(N)c2cc1OC)CC(CNC(=O)c1ccoc1)C3 10.1007/s00044-010-9379-1
11273296 170296 0 None 9 2 Rat 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 586 11 1 8 2.9 CCOC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL444648 170296 0 None 9 2 Rat 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 586 11 1 8 2.9 CCOC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
203096 61299 3 None -630 3 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 341 5 0 4 3.2 CN(C)CCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767134 61299 3 None -630 3 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 341 5 0 4 3.2 CN(C)CCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
45358442 61323 0 None -63 3 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 381 3 0 4 4.3 CN1CCCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)C1 10.1021/jm1013874
CHEMBL1767158 61323 0 None -63 3 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 381 3 0 4 4.3 CN1CCCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)C1 10.1021/jm1013874
24803799 61326 0 None -79 4 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 654 13 0 6 8.3 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C1CCCN(CCCCc2ccc(OCCCN3CCCCCC3)cc2)CC1 10.1021/jm1013874
CHEMBL1767161 61326 0 None -79 4 Human 6.8 pKi = 6.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 654 13 0 6 8.3 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C1CCCN(CCCCc2ccc(OCCCN3CCCCCC3)cc2)CC1 10.1021/jm1013874
25130875 187627 0 None -4 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 343 8 1 5 2.8 COc1ccccc1OCCNC[C@@H]1CO[C@@H](c2ccccc2)CO1 10.1021/jm800461k
CHEMBL494908 187627 0 None -4 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 343 8 1 5 2.8 COc1ccccc1OCCNC[C@@H]1CO[C@@H](c2ccccc2)CO1 10.1021/jm800461k
52937730 61312 0 None -794 3 Human 5.8 pKi = 5.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 363 5 0 5 3.1 COc1cccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)c1 10.1021/jm1013874
CHEMBL1767147 61312 0 None -794 3 Human 5.8 pKi = 5.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 363 5 0 5 3.1 COc1cccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)c1 10.1021/jm1013874
24803480 61328 0 None -199 3 Human 5.8 pKi = 5.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 614 15 0 6 7.2 CN(CCCCc1ccc(OCCCN2CCCCCC2)cc1)CCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767163 61328 0 None -199 3 Human 5.8 pKi = 5.8 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 614 15 0 6 7.2 CN(CCCCc1ccc(OCCCN2CCCCCC2)cc1)CCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
153287574 175247 0 None -21 10 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-Prazosin from human recombinant adrenergic alpha1A receptor expressed in cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Prazosin from human recombinant adrenergic alpha1A receptor expressed in cells after 90 mins by microbeta scintillation counting method
ChEMBL 266 2 1 2 4.0 CC[C@H]1c2ccccc2N(c2ccccc2)C[C@@]1(C)N 10.1021/acsmedchemlett.9b00225
CHEMBL4572167 175247 0 None -21 10 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-Prazosin from human recombinant adrenergic alpha1A receptor expressed in cells after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Prazosin from human recombinant adrenergic alpha1A receptor expressed in cells after 90 mins by microbeta scintillation counting method
ChEMBL 266 2 1 2 4.0 CC[C@H]1c2ccccc2N(c2ccccc2)C[C@@]1(C)N 10.1021/acsmedchemlett.9b00225
11857863 85678 0 None -1 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 534 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccc(F)cc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL228608 85678 0 None -1 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 534 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccc(F)cc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
44426404 142566 0 None -1 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 498 7 1 6 4.4 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1ccc2c(c1)OCO2 10.1016/j.bmcl.2007.04.098
CHEMBL389104 142566 0 None -1 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 498 7 1 6 4.4 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1ccc2c(c1)OCO2 10.1016/j.bmcl.2007.04.098
124 2981 47 None -13 33 Rat 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
2032 2981 47 None -13 33 Rat 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
4636 2981 47 None -13 33 Rat 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
CHEMBL762 2981 47 None -13 33 Rat 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
DB00935 2981 47 None -13 33 Rat 7.8 pKi = 7.8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C nan
67753767 123054 1 None -1 2 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 318 5 1 1 5.0 c1ccc(CCCN2CCC(c3c[nH]c4ccccc34)CC2)cc1 10.1016/j.bmcl.2015.07.046
CHEMBL3609351 123054 1 None -1 2 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 318 5 1 1 5.0 c1ccc(CCCN2CCC(c3c[nH]c4ccccc34)CC2)cc1 10.1016/j.bmcl.2015.07.046
56649648 67855 0 None -47 8 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assayDisplacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assay
ChEMBL 474 8 0 5 3.0 COc1ccccc1N1CCN(CCN(C(=O)C23C4C5C2C2C3C4C52CF)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
CHEMBL1910139 67855 0 None -47 8 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assayDisplacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assay
ChEMBL 474 8 0 5 3.0 COc1ccccc1N1CCN(CCN(C(=O)C23C4C5C2C2C3C4C52CF)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
10816903 37693 0 None 32 3 Human 7.8 pKi = 7.8 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 571 8 2 7 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccc(OC)cc3C)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145756 37693 0 None 32 3 Human 7.8 pKi = 7.8 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 571 8 2 7 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccc(OC)cc3C)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
13507646 119614 0 None -3 2 Bovine 7.8 pKi = 7.8 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 243 0 0 2 4.0 c1ccc2c3c(sc2c1)C1CCCCN1CC3 10.1021/jm00398a025
CHEMBL346492 119614 0 None -3 2 Bovine 7.8 pKi = 7.8 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 243 0 0 2 4.0 c1ccc2c3c(sc2c1)C1CCCCN1CC3 10.1021/jm00398a025
11801828 206544 0 None 35 6 Human 7.8 pKi = 7.8 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 606 9 3 6 5.0 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
CHEMBL88628 206544 0 None 35 6 Human 7.8 pKi = 7.8 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 606 9 3 6 5.0 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
11801828 206544 0 None 35 6 Human 7.8 pKi = 7.8 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 606 9 3 6 5.0 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1007/s00044-004-0120-9
CHEMBL88628 206544 0 None 35 6 Human 7.8 pKi = 7.8 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 606 9 3 6 5.0 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1007/s00044-004-0120-9
13507646 119614 0 None -3 2 Bovine 7.8 pKi = 7.8 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 243 0 0 2 4.0 c1ccc2c3c(sc2c1)C1CCCCN1CC3 10.1021/jm00398a025
CHEMBL346492 119614 0 None -3 2 Bovine 7.8 pKi = 7.8 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 243 0 0 2 4.0 c1ccc2c3c(sc2c1)C1CCCCN1CC3 10.1021/jm00398a025
11994669 11830 0 None 3 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1ccc(-c2ccccc2)cc1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182141 11830 0 None 3 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1ccc(-c2ccccc2)cc1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL214552 11830 0 None 3 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1ccc(-c2ccccc2)cc1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
52942664 17644 0 None 1 2 Rat 7.8 pKi = 7.8 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 500 8 2 6 2.7 COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL1258345 17644 0 None 1 2 Rat 7.8 pKi = 7.8 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 500 8 2 6 2.7 COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
10621590 84606 0 None -1 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153554 84606 0 None -1 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2221148 84606 0 None -1 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(OC)c2O1 10.1016/j.ejmech.2012.09.049
25181488 187382 0 None -33 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNC[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm301525w
CHEMBL493486 187382 0 None -33 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNC[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm301525w
71151588 118258 0 None -169 10 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cells
ChEMBL 518 9 1 7 3.6 NC(=O)c1ccccc1OCCCN1CCN(c2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1 10.1016/j.ejmech.2014.12.045
CHEMBL3409256 118258 0 None -169 10 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A receptor expressed in CHO cells
ChEMBL 518 9 1 7 3.6 NC(=O)c1ccccc1OCCCN1CCN(c2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1 10.1016/j.ejmech.2014.12.045
14468881 176283 0 None -14 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 347 10 1 3 4.5 c1ccc(OCCNCCOC(c2ccccc2)c2ccccc2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4462600 176283 0 None -14 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 347 10 1 3 4.5 c1ccc(OCCNCCOC(c2ccccc2)c2ccccc2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4595111 176283 0 None -14 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 347 10 1 3 4.5 c1ccc(OCCNCCOC(c2ccccc2)c2ccccc2)cc1 10.1016/j.ejmech.2019.05.024
71817859 102579 0 None 1 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
CHEMBL2419772 102579 0 None 1 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
CHEMBL3040801 102579 0 None 1 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 357 7 1 6 2.4 COc1ccc2c(c1OCCNC[C@@H]1COc3ccccc3O1)OCC2 10.1021/jm400867d
145962945 161343 0 None -14 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 511 5 1 7 4.6 COc1cc2nc(N3CCN(C(=O)Cc4ccc5ccccc5c4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4125846 161343 0 None -14 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 511 5 1 7 4.6 COc1cc2nc(N3CCN(C(=O)Cc4ccc5ccccc5c4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
118716699 114831 0 None 1 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 348 4 0 6 1.7 COc1ccccc1N1CCN(CC2COC3(CCOCC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3341769 114831 0 None 1 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 348 4 0 6 1.7 COc1ccccc1N1CCN(CC2COC3(CCOCC3)O2)CC1 10.1016/j.ejmech.2014.09.070
12203911 188283 22 None -54 2 Bovine 6.8 pKi = 6.8 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 255 1 0 3 1.6 CN1CCN(c2ncccc2Br)CC1 10.1021/jm00366a007
CHEMBL50017 188283 22 None -54 2 Bovine 6.8 pKi = 6.8 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 255 1 0 3 1.6 CN1CCN(c2ncccc2Br)CC1 10.1021/jm00366a007
415628 208192 95 None -13 5 Bovine 6.8 pKi = 6.8 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 196 1 1 2 1.8 Clc1ccccc1N1CCNCC1 10.1021/jm00366a007
CHEMBL9841 208192 95 None -13 5 Bovine 6.8 pKi = 6.8 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 196 1 1 2 1.8 Clc1ccccc1N1CCNCC1 10.1021/jm00366a007
127027384 137678 0 None -100 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 480 9 2 5 3.5 CS(=O)(=O)Nc1cccc(N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)c1 10.1016/j.bmcl.2015.12.068
CHEMBL3758610 137678 0 None -100 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 480 9 2 5 3.5 CS(=O)(=O)Nc1cccc(N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)c1 10.1016/j.bmcl.2015.12.068
11500225 101201 61 None -38 2 Bovine 5.8 pKi = 5.8 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 289 1 1 3 1.1 Ic1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL295764 101201 61 None -38 2 Bovine 5.8 pKi = 5.8 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 289 1 1 3 1.1 Ic1cccnc1N1CCNCC1 10.1021/jm00366a007
44586429 184297 0 None 5 2 Rat 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 514 8 1 6 3.0 COc1ccccc1N1CCN(CC(O)CN2C(=O)N(C)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL484102 184297 0 None 5 2 Rat 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 514 8 1 6 3.0 COc1ccccc1N1CCN(CC(O)CN2C(=O)N(C)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
44361064 31615 0 None -6 5 Bovine 6.8 pKi = 6.8 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 338 7 2 4 4.5 N=CCC(O)CC1CCN(c2ccccc2Oc2ccccc2)CC1 10.1021/jm960510x
CHEMBL140450 31615 0 None -6 5 Bovine 6.8 pKi = 6.8 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 338 7 2 4 4.5 N=CCC(O)CC1CCN(c2ccccc2Oc2ccccc2)CC1 10.1021/jm960510x
11732516 205210 0 None 1 2 Human 6.8 pKi = 6.8 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 418 5 0 7 3.0 COc1ccccc1N1CCN(c2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL78584 205210 0 None 1 2 Human 6.8 pKi = 6.8 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 418 5 0 7 3.0 COc1ccccc1N1CCN(c2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
9817256 204238 0 None 2 4 Human 5.8 pKi = 5.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 283 5 2 6 0.5 COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
CHEMBL71001 204238 0 None 2 4 Human 5.8 pKi = 5.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 283 5 2 6 0.5 COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
44586483 172467 0 None 5 2 Rat 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 600 11 1 8 3.3 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)N(C(C)C(=O)OC)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL448198 172467 0 None 5 2 Rat 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 600 11 1 8 3.3 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)N(C(C)C(=O)OC)C(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
24894141 187409 0 None -30 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 449 10 1 6 4.0 COc1cccc(OC)c1OCCNC[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm301525w
CHEMBL493697 187409 0 None -30 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 449 10 1 6 4.0 COc1cccc(OC)c1OCCNC[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm301525w
9944467 9251 0 None 1 3 Rat 6.8 pKi = 6.8 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 309 2 2 2 3.4 O=C(Nc1cccc2c1CCCC2c1c[nH]cn1)C(F)(F)F 10.1021/jm030551a
CHEMBL110751 9251 0 None 1 3 Rat 6.8 pKi = 6.8 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 309 2 2 2 3.4 O=C(Nc1cccc2c1CCCC2c1c[nH]cn1)C(F)(F)F 10.1021/jm030551a
10420352 168740 10 None -63 4 Human 4.8 pKi = 4.8 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 201 3 4 4 0.5 CNCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
CHEMBL43711 168740 10 None -63 4 Human 4.8 pKi = 4.8 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 201 3 4 4 0.5 CNCC(O)c1ccc(O)c(O)c1F 10.1021/jm00118a019
24839550 137315 14 None -26 15 Human 5.8 pKi = 5.8 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 240 7 1 1 3.4 C=CCN(CC=C)CCc1c[nH]c2ccccc12 10.1016/j.bmcl.2015.12.053
CHEMBL3752576 137315 14 None -26 15 Human 5.8 pKi = 5.8 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 240 7 1 1 3.4 C=CCN(CC=C)CCc1c[nH]c2ccccc12 10.1016/j.bmcl.2015.12.053
127024960 137716 0 None -15 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 421 7 1 3 4.8 O=C(NCCCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
CHEMBL3758920 137716 0 None -15 3 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 421 7 1 3 4.8 O=C(NCCCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
11742585 163348 0 None 1 2 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 415 5 1 6 2.5 CS(=O)(=O)Nc1ccc2c(c1)OC1(CCN(CCc3ccccn3)CC1)CC2=O 10.1016/s0960-894x(98)00732-x
CHEMBL419164 163348 0 None 1 2 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 415 5 1 6 2.5 CS(=O)(=O)Nc1ccc2c(c1)OC1(CCN(CCc3ccccn3)CC1)CC2=O 10.1016/s0960-894x(98)00732-x
CHEMBL4576555 214017 5 None -1 19 Human 5.8 pKi = 5.8 Binding
Selectivity interaction (GPCR panel (PDSP screen)) EUB0000705a ADRA1ASelectivity interaction (GPCR panel (PDSP screen)) EUB0000705a ADRA1A
ChEMBL None None None CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5cc(C(C)(C)C)cc(C(C)(C)C)c5)ccc4n3)cc2)CC1 10.6019/CHEMBL5212743
76322411 84814 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 375 7 1 4 4.0 c1ccc(OCCNC2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1007/s00044-010-9379-1
CHEMBL2234439 84814 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 375 7 1 4 4.0 c1ccc(OCCNC2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1007/s00044-010-9379-1
11176459 101637 0 None -31 4 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 380 4 0 5 2.4 N#Cc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
CHEMBL299022 101637 0 None -31 4 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 380 4 0 5 2.4 N#Cc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
155536203 176407 0 None -2 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 403 10 1 4 4.6 c1ccc(OCCNCC[C@@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4473623 176407 0 None -2 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 403 10 1 4 4.6 c1ccc(OCCNCC[C@@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4596045 176407 0 None -2 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 403 10 1 4 4.6 c1ccc(OCCNCC[C@@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
25131198 86260 0 None -288 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNCC2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.02.056
CHEMBL2312537 86260 0 None -288 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNCC2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.02.056
25181489 187357 0 None -158 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNC[C@@H]2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm800461k
CHEMBL493285 187357 0 None -158 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNC[C@@H]2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm800461k
25131198 86260 0 None -288 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNCC2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm301525w
CHEMBL2312537 86260 0 None -288 4 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNCC2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm301525w
76307951 84826 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 453 9 2 8 3.6 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNCOc1c(OC)cccc1OC)C3 10.1007/s00044-010-9379-1
CHEMBL2234451 84826 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 453 9 2 8 3.6 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNCOc1c(OC)cccc1OC)C3 10.1007/s00044-010-9379-1
11784634 36514 0 None -7 3 Human 5.8 pKi = 5.8 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 468 10 2 8 3.7 COc1cc2nc3c(c(O)c2cc1OC)CCC(CNCCOc1c(OC)cccc1OC)C3 10.1021/jm030952q
CHEMBL144779 36514 0 None -7 3 Human 5.8 pKi = 5.8 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 468 10 2 8 3.7 COc1cc2nc3c(c(O)c2cc1OC)CCC(CNCCOc1c(OC)cccc1OC)C3 10.1021/jm030952q
76307951 84826 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 453 9 2 8 3.6 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNCOc1c(OC)cccc1OC)C3 10.1007/s00044-010-9379-1
CHEMBL2234451 84826 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 453 9 2 8 3.6 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNCOc1c(OC)cccc1OC)C3 10.1007/s00044-010-9379-1
9818490 9377 0 None - 1 Rat 5.8 pKi = 5.8 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 319 5 2 3 3.0 CCCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL111391 9377 0 None - 1 Rat 5.8 pKi = 5.8 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 319 5 2 3 3.0 CCCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
53328503 63392 0 None -15 3 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 441 6 0 5 3.4 COc1ccccc1N1CCN(CCN2C(=O)CC(c3ccc(Cl)cc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796037 63392 0 None -15 3 Human 5.8 pKi = 5.8 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 441 6 0 5 3.4 COc1ccccc1N1CCN(CCN2C(=O)CC(c3ccc(Cl)cc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
9818490 9377 0 None - 1 Rat 5.8 pKi = 5.8 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 319 5 2 3 3.0 CCCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111391 9377 0 None - 1 Rat 5.8 pKi = 5.8 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 319 5 2 3 3.0 CCCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
9966903 169413 0 None - 1 Rat 5.8 pKi = 5.8 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 321 4 2 4 2.3 COc1ccc(NS(C)(=O)=O)c2c1C(c1c[nH]cn1)CCC2 10.1021/jm030551a
CHEMBL442394 169413 0 None - 1 Rat 5.8 pKi = 5.8 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 321 4 2 4 2.3 COc1ccc(NS(C)(=O)=O)c2c1C(c1c[nH]cn1)CCC2 10.1021/jm030551a
44431562 87974 0 None 3 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(OC)c(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)c1 10.1016/j.bmcl.2007.04.008
CHEMBL234194 87974 0 None 3 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(OC)c(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)c1 10.1016/j.bmcl.2007.04.008
44431557 89278 0 None -8 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 541 8 1 6 4.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(OC(F)(F)F)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL236830 89278 0 None -8 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 541 8 1 6 4.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(OC(F)(F)F)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
49865639 16033 0 None -1 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 328 7 1 4 3.2 Fc1ccccc1N1CCN(CCCCNc2ccccn2)CC1 10.1016/j.bmcl.2010.07.096
CHEMBL1223680 16033 0 None -1 3 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 328 7 1 4 3.2 Fc1ccccc1N1CCN(CCCCNc2ccccn2)CC1 10.1016/j.bmcl.2010.07.096
44288485 162520 0 None 29 3 Human 7.8 pKi = 7.8 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 498 9 1 4 5.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C(c2ccc(C)cc2)c2ccc(C)cc2)CC1 10.1016/s0960-894x(01)00320-1
CHEMBL41677 162520 0 None 29 3 Human 7.8 pKi = 7.8 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 498 9 1 4 5.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C(c2ccc(C)cc2)c2ccc(C)cc2)CC1 10.1016/s0960-894x(01)00320-1
44288359 155746 0 None -1 2 Rat 7.8 pKi = 7.8 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 461 5 1 6 4.0 COc1cccc2c1CCC1CN(CCCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC21 10.1021/jm990567u
CHEMBL40564 155746 0 None -1 2 Rat 7.8 pKi = 7.8 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 461 5 1 6 4.0 COc1cccc2c1CCC1CN(CCCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC21 10.1021/jm990567u
44447072 94646 0 None -25 4 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 483 6 1 6 4.5 O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)c1cccnc1 10.1016/j.bmcl.2007.11.106
CHEMBL252430 94646 0 None -25 4 Rat 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 483 6 1 6 4.5 O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)c1cccnc1 10.1016/j.bmcl.2007.11.106
6604803 116518 2 None -7 3 Bovine 7.8 pKi = 7.8 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@H]2C1=NCCN1 10.1021/jm960354u
CHEMBL336161 116518 2 None -7 3 Bovine 7.8 pKi = 7.8 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@H]2C1=NCCN1 10.1021/jm960354u
118716705 114998 0 None -1 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 424 5 0 7 2.6 COc1ccccc1N1CCN(CC2COC3(CCN(c4ccccn4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342858 114998 0 None -1 4 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 424 5 0 7 2.6 COc1ccccc1N1CCN(CC2COC3(CCN(c4ccccn4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
11176459 101637 0 None -31 4 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 380 4 0 5 2.4 N#Cc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
CHEMBL299022 101637 0 None -31 4 Human 6.8 pKi = 6.8 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 380 4 0 5 2.4 N#Cc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
9934955 72276 0 None -489 5 Human 5.8 pKi = 5.8 Binding
Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 482 5 2 9 2.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
CHEMBL19826 72276 0 None -489 5 Human 5.8 pKi = 5.8 Binding
Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 482 5 2 9 2.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
11098175 204170 0 None -1 5 Human 6.8 pKi = 6.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 251 5 2 5 1.8 COc1ccc(SC)c(NCC2=NCCN2)c1 10.1021/jm000542r
CHEMBL70691 204170 0 None -1 5 Human 6.8 pKi = 6.8 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 251 5 2 5 1.8 COc1ccc(SC)c(NCC2=NCCN2)c1 10.1021/jm000542r
1220 187 55 None -407 44 Human 5.8 pKi = 5.8 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm010866v
31 187 55 None -407 44 Human 5.8 pKi = 5.8 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm010866v
7 187 55 None -407 44 Human 5.8 pKi = 5.8 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm010866v
CHEMBL56 187 55 None -407 44 Human 5.8 pKi = 5.8 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm010866v
1220 187 55 None -407 44 Human 5.8 pKi = 5.8 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm0009336
31 187 55 None -407 44 Human 5.8 pKi = 5.8 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm0009336
7 187 55 None -407 44 Human 5.8 pKi = 5.8 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm0009336
CHEMBL56 187 55 None -407 44 Human 5.8 pKi = 5.8 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm0009336
53248365 62086 0 None -186 7 Human 6.8 pKi = 6.8 Binding
Inhibition of adrenergic alpha1A receptorInhibition of adrenergic alpha1A receptor
ChEMBL 554 6 1 5 2.9 O=C(N(CCN1CCN(c2ccccc2O)CC1)c1ccccn1)C12C3C4C1C1C2C3C41I 10.1021/jm1009956
CHEMBL1774995 62086 0 None -186 7 Human 6.8 pKi = 6.8 Binding
Inhibition of adrenergic alpha1A receptorInhibition of adrenergic alpha1A receptor
ChEMBL 554 6 1 5 2.9 O=C(N(CCN1CCN(c2ccccc2O)CC1)c1ccccn1)C12C3C4C1C1C2C3C41I 10.1021/jm1009956
71817545 92124 0 None -22 6 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 354 7 2 5 3.0 COc1ccc2cc[nH]c2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL2419765 92124 0 None -22 6 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 354 7 2 5 3.0 COc1ccc2cc[nH]c2c1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm400867d
126720252 164675 0 None -63 12 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by scintillation counting methodDisplacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by scintillation counting method
ChEMBL 697 15 2 6 9.2 NCCCCCCn1cc(CCCCN2CCC(c3ccc(-c4cc(C(=O)O)cc5cc(-c6ccc(C(F)(F)F)cc6)ccc45)cc3)CC2)nn1 10.1021/acs.jmedchem.8b00168
CHEMBL4216870 164675 0 None -63 12 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by scintillation counting methodDisplacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by scintillation counting method
ChEMBL 697 15 2 6 9.2 NCCCCCCn1cc(CCCCN2CCC(c3ccc(-c4cc(C(=O)O)cc5cc(-c6ccc(C(F)(F)F)cc6)ccc45)cc3)CC2)nn1 10.1021/acs.jmedchem.8b00168
18738382 15267 0 None 33 3 Human 7.8 pKi = 7.8 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 399 8 0 5 2.7 CC(C)Oc1ccccc1N1CCN(C/C=C/C(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL12127 15267 0 None 33 3 Human 7.8 pKi = 7.8 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 399 8 0 5 2.7 CC(C)Oc1ccccc1N1CCN(C/C=C/C(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
9888164 17951 1 None 25 3 Human 7.8 pKi = 7.8 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 416 8 1 5 2.1 CC(C)Oc1ccccc1N1CCN(CCNC(=O)CN2CCCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL12603 17951 1 None 25 3 Human 7.8 pKi = 7.8 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 416 8 1 5 2.1 CC(C)Oc1ccccc1N1CCN(CCNC(=O)CN2CCCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
289 242 12 None -1 14 Human 7.8 pKi = 7.8 Binding
Binding affinity to human adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to human adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 301 8 0 2 4.9 CCCCC1CCN(CC1)CCCC(=O)c1ccccc1C 10.1021/jm100697g
9948320 242 12 None -1 14 Human 7.8 pKi = 7.8 Binding
Binding affinity to human adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to human adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 301 8 0 2 4.9 CCCCC1CCN(CC1)CCCC(=O)c1ccccc1C 10.1021/jm100697g
CHEMBL1242950 242 12 None -1 14 Human 7.8 pKi = 7.8 Binding
Binding affinity to human adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to human adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 301 8 0 2 4.9 CCCCC1CCN(CC1)CCCC(=O)c1ccccc1C 10.1021/jm100697g
44431564 148359 0 None -2 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 501 8 1 6 4.2 COc1ccc(C)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL393725 148359 0 None -2 4 Human 7.8 pKi = 7.8 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 501 8 1 6 4.2 COc1ccc(C)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
44308443 203953 0 None -1 2 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 413 6 0 5 4.0 COc1ccccc1N1CCN(Cc2ccc(CN3CCCCCC3=O)s2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL69339 203953 0 None -1 2 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 413 6 0 5 4.0 COc1ccccc1N1CCN(Cc2ccc(CN3CCCCCC3=O)s2)CC1 10.1016/s0960-894x(02)00347-5
9864676 127808 0 None -1 5 Bovine 7.8 pKi = 7.8 Binding
Inhibition of [3H]prazosin binding to Alpha-1 adrenergic receptor in bovine frontal cortexInhibition of [3H]prazosin binding to Alpha-1 adrenergic receptor in bovine frontal cortex
ChEMBL 380 6 0 3 4.5 O=C(CCCN1CCN(C2CCCc3ccccc32)CC1)c1ccc(F)cc1 10.1021/jm950759z
CHEMBL366388 127808 0 None -1 5 Bovine 7.8 pKi = 7.8 Binding
Inhibition of [3H]prazosin binding to Alpha-1 adrenergic receptor in bovine frontal cortexInhibition of [3H]prazosin binding to Alpha-1 adrenergic receptor in bovine frontal cortex
ChEMBL 380 6 0 3 4.5 O=C(CCCN1CCN(C2CCCc3ccccc32)CC1)c1ccc(F)cc1 10.1021/jm950759z
145950240 162701 0 None 2 3 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 465 5 2 9 2.2 COc1cc2nc(N3CCC[C@H](NC(=O)[C@H]4COc5ccccc5O4)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
CHEMBL4170675 162701 0 None 2 3 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 465 5 2 9 2.2 COc1cc2nc(N3CCC[C@H](NC(=O)[C@H]4COc5ccccc5O4)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
10787126 84570 0 None -2 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153558 84570 0 None -2 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220897 84570 0 None -2 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 363 8 1 6 2.7 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(F)c2O1 10.1016/j.ejmech.2012.09.049
10893672 205412 0 None -1 4 Human 7.7 pKi = 7.7 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 357 6 1 7 1.3 COc1ccccc1N1CCN(CCNc2cc(C)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL80132 205412 0 None -1 4 Human 7.7 pKi = 7.7 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 357 6 1 7 1.3 COc1ccccc1N1CCN(CCNc2cc(C)nn(C)c2=O)CC1 10.1021/jm0009336
11109088 204180 0 None -3 6 Human 7.7 pKi = 7.7 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 255 4 2 4 2.5 CSc1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70751 204180 0 None -3 6 Human 7.7 pKi = 7.7 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 255 4 2 4 2.5 CSc1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
9824384 118787 1 None -17 7 Rat 7.7 pKi = 7.7 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1021/jm960510x
CHEMBL342062 118787 1 None -17 7 Rat 7.7 pKi = 7.7 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1021/jm960510x
10252540 85357 1 None -83 5 Rat 7.7 pKi = 7.7 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) CEC-treated hippocampusBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) CEC-treated hippocampus
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
CHEMBL2261604 85357 1 None -83 5 Rat 7.7 pKi = 7.7 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) CEC-treated hippocampusBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) CEC-treated hippocampus
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
3251 4072 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2010.05.023
5684 4072 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2010.05.023
80 4072 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2010.05.023
CHEMBL31354 4072 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2010.05.023
3251 4072 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2019.05.024
5684 4072 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2019.05.024
80 4072 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2019.05.024
CHEMBL31354 4072 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2019.05.024
3251 4072 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2019.02.056
5684 4072 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2019.02.056
80 4072 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2019.02.056
CHEMBL31354 4072 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2019.02.056
3251 4072 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1021/jm200421e
5684 4072 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1021/jm200421e
80 4072 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1021/jm200421e
CHEMBL31354 4072 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1021/jm200421e
118716720 115014 0 None 1 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 425 5 0 7 1.0 COc1ccccc1N1CCN(CC2COC3(CCN(S(C)(=O)=O)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342873 115014 0 None 1 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 425 5 0 7 1.0 COc1ccccc1N1CCN(CC2COC3(CCN(S(C)(=O)=O)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
10575664 119208 0 None -2 3 Rat 7.7 pKi = 7.7 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 453 7 1 9 2.0 COc1cc2nc(N3CCN(C(=O)COc4ccccc4OC)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL343283 119208 0 None -2 3 Rat 7.7 pKi = 7.7 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 453 7 1 9 2.0 COc1cc2nc(N3CCN(C(=O)COc4ccccc4OC)CC3)nc(N)c2cc1OC 10.1021/jm9805337
10575664 119208 0 None -2 3 Human 7.7 pKi = 7.7 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 453 7 1 9 2.0 COc1cc2nc(N3CCN(C(=O)COc4ccccc4OC)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL343283 119208 0 None -2 3 Human 7.7 pKi = 7.7 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 453 7 1 9 2.0 COc1cc2nc(N3CCN(C(=O)COc4ccccc4OC)CC3)nc(N)c2cc1OC 10.1021/jm9805337
16756754 92129 27 None -81 3 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 478 7 1 3 7.0 Cc1ccc(NC(=O)C(C)C)cc1C1CCN(Cc2ccc(Oc3ccc(F)c(F)c3)cc2)CC1 10.1021/jm060383x
CHEMBL242004 92129 27 None -81 3 Human 6.8 pKi = 6.8 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 478 7 1 3 7.0 Cc1ccc(NC(=O)C(C)C)cc1C1CCN(Cc2ccc(Oc3ccc(F)c(F)c3)cc2)CC1 10.1021/jm060383x
11412944 101509 69 None -223 2 Bovine 5.8 pKi = 5.8 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL298004 101509 69 None -223 2 Bovine 5.8 pKi = 5.8 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1cccnc1N1CCNCC1 10.1021/jm00366a007
70820518 167527 0 None -104 3 Human 5.8 pKi = 5.8 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 391 7 1 4 3.7 CS(=O)(=O)c1ccc(Cl)cc1CNCCOc1cc(F)ccc1Cl 10.1016/j.ejmech.2017.07.071
CHEMBL4213747 167527 0 None -104 3 Human 5.8 pKi = 5.8 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 391 7 1 4 3.7 CS(=O)(=O)c1ccc(Cl)cc1CNCCOc1cc(F)ccc1Cl 10.1016/j.ejmech.2017.07.071
CHEMBL4300105 167527 0 None -104 3 Human 5.8 pKi = 5.8 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 391 7 1 4 3.7 CS(=O)(=O)c1ccc(Cl)cc1CNCCOc1cc(F)ccc1Cl 10.1016/j.ejmech.2017.07.071
57400562 69318 0 None -1 5 Pig 5.8 pKi = 5.8 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 469 14 1 6 3.6 CCOCCOCc1ccc(N2CCN(CCCCNC(=O)c3ccccc3)CC2)c(OC)c1 10.1016/j.bmc.2011.10.063
CHEMBL1928247 69318 0 None -1 5 Pig 5.8 pKi = 5.8 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 469 14 1 6 3.6 CCOCCOCc1ccc(N2CCN(CCCCNC(=O)c3ccccc3)CC2)c(OC)c1 10.1016/j.bmc.2011.10.063
44420419 83431 0 None 2 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 485 4 0 7 3.3 Cn1c(=O)n(CCN2CCN(c3ccc(Cl)c(Cl)c3)CC2)c(=O)c2c1c1ccccc1n2C 10.1016/j.bmcl.2006.09.034
CHEMBL219719 83431 0 None 2 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 485 4 0 7 3.3 Cn1c(=O)n(CCN2CCN(c3ccc(Cl)c(Cl)c3)CC2)c(=O)c2c1c1ccccc1n2C 10.1016/j.bmcl.2006.09.034
10198248 187449 40 None -83 6 Human 4.7 pKi = 4.7 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 213 1 2 5 1.0 c1cnc2cc(NC3=NCCN3)ccc2n1 10.1016/0960-894X(95)00391-6
CHEMBL49395 187449 40 None -83 6 Human 4.7 pKi = 4.7 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 213 1 2 5 1.0 c1cnc2cc(NC3=NCCN3)ccc2n1 10.1016/0960-894X(95)00391-6
134149777 148511 0 None -199 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 353 7 1 5 4.2 COc1ccccc1OCCNCC1CSC2(CCCCC2)S1 10.1016/j.ejmech.2016.09.050
CHEMBL3938383 148511 0 None -199 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 353 7 1 5 4.2 COc1ccccc1OCCNCC1CSC2(CCCCC2)S1 10.1016/j.ejmech.2016.09.050
11464777 101805 0 None -14 4 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 437 4 0 4 4.2 CC(CN1CCN(c2cc(Cl)ccc2Cl)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1021/jm030944+
CHEMBL300152 101805 0 None -14 4 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 437 4 0 4 4.2 CC(CN1CCN(c2cc(Cl)ccc2Cl)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1021/jm030944+
44431613 87582 0 None -2 4 Human 6.7 pKi = 6.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 529 10 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OCC4CC4)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.008
CHEMBL233584 87582 0 None -2 4 Human 6.7 pKi = 6.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 529 10 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OCC4CC4)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.008
10792536 206776 0 None 14 3 Human 7.7 pKi = 7.7 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 540 7 3 3 4.7 O=C1NC(C(F)(F)F)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1021/jm990612y
CHEMBL90184 206776 0 None 14 3 Human 7.7 pKi = 7.7 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 540 7 3 3 4.7 O=C1NC(C(F)(F)F)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1021/jm990612y
135398737 958 93 None -5 89 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
38 958 93 None -5 89 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
722 958 93 None -5 89 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
CHEMBL42 958 93 None -5 89 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
DB00363 958 93 None -5 89 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 nan
44431614 88037 0 None 2 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 533 9 1 6 4.5 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OCC3CC3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234474 88037 0 None 2 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 533 9 1 6 4.5 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OCC3CC3)CC2)CC1 10.1016/j.bmcl.2007.04.008
13141182 130893 1 None 10 2 Bovine 7.7 pKi = 7.7 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 354 0 0 2 4.7 CN1CCC(=C2c3cc(Br)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
CHEMBL368578 130893 1 None 10 2 Bovine 7.7 pKi = 7.7 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 354 0 0 2 4.7 CN1CCC(=C2c3cc(Br)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
127027078 137827 0 None -14 3 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 426 7 2 3 4.7 O=C(NCCCCN1CCN(c2cccc3[nH]ccc23)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
CHEMBL3759865 137827 0 None -14 3 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 426 7 2 3 4.7 O=C(NCCCCN1CCN(c2cccc3[nH]ccc23)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
57395341 69311 0 None 2 5 Pig 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 495 13 1 8 2.8 CCOCCOCc1ccn2ncc(C(=O)NCCCN3CCN(c4ccccc4OC)CC3)c2c1 10.1016/j.bmc.2011.10.063
CHEMBL1928135 69311 0 None 2 5 Pig 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 495 13 1 8 2.8 CCOCCOCc1ccn2ncc(C(=O)NCCCN3CCN(c4ccccc4OC)CC3)c2c1 10.1016/j.bmc.2011.10.063
71508682 87048 0 None 45 2 Bovine 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 371 3 0 5 4.2 CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4ccnn4C)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2325927 87048 0 None 45 2 Bovine 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 371 3 0 5 4.2 CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4ccnn4C)cc23)CC1 10.1016/j.bmc.2012.10.049
71508711 87056 0 None 43 2 Bovine 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 369 3 0 5 4.3 CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4cncnc4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2325934 87056 0 None 43 2 Bovine 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 369 3 0 5 4.3 CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4cncnc4)cc23)CC1 10.1016/j.bmc.2012.10.049
10698974 91122 0 None 102 3 Human 7.7 pKi = 7.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 610 5 1 7 4.3 COC(=O)C1=C(C)NC(=O)N(C(=O)N2CCC(N3CCC(C(=O)OC)(c4ccccc4)CC3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL239806 91122 0 None 102 3 Human 7.7 pKi = 7.7 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 610 5 1 7 4.3 COC(=O)C1=C(C)NC(=O)N(C(=O)N2CCC(N3CCC(C(=O)OC)(c4ccccc4)CC3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
135398737 958 93 None -5 89 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm401958n
38 958 93 None -5 89 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm401958n
722 958 93 None -5 89 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm401958n
CHEMBL42 958 93 None -5 89 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm401958n
DB00363 958 93 None -5 89 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm401958n
42631003 199618 13 None -97 8 Human 7.7 pKi = 7.7 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 304 3 0 2 4.2 Cc1ccc2c(c1)c1c(n2CCc2ccccc2)CCN(C)C1 10.1016/j.bmcl.2009.11.037
CHEMBL592752 199618 13 None -97 8 Human 7.7 pKi = 7.7 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 304 3 0 2 4.2 Cc1ccc2c(c1)c1c(n2CCc2ccccc2)CCN(C)C1 10.1016/j.bmcl.2009.11.037
50905588 56353 0 None -1 5 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 406 7 2 6 2.1 COc1ccc(C[C@@H](C)NC[C@H]2Oc3ccccc3O[C@H]2C)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
CHEMBL1630941 56353 0 None -1 5 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 406 7 2 6 2.1 COc1ccc(C[C@@H](C)NC[C@H]2Oc3ccccc3O[C@H]2C)cc1S(N)(=O)=O 10.1016/j.ejmech.2010.09.042
10575494 165747 0 None -4 3 Human 7.7 pKi = 7.7 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 449 7 1 8 2.5 COc1cc2nc(N3CCN(C(=O)CCC(=O)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL424658 165747 0 None -4 3 Human 7.7 pKi = 7.7 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 449 7 1 8 2.5 COc1cc2nc(N3CCN(C(=O)CCC(=O)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
44329027 4168 0 None 9 6 Human 7.7 pKi = 7.7 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 637 13 3 7 4.9 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COC)N1 10.1016/s0960-894x(99)00484-9
CHEMBL100045 4168 0 None 9 6 Human 7.7 pKi = 7.7 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 637 13 3 7 4.9 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COC)N1 10.1016/s0960-894x(99)00484-9
10363912 6538 0 None -36 6 Human 7.7 pKi = 7.7 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL1082862 6538 0 None -36 6 Human 7.7 pKi = 7.7 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL286003 6538 0 None -36 6 Human 7.7 pKi = 7.7 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
10363912 6538 0 None -36 6 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
CHEMBL1082862 6538 0 None -36 6 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
CHEMBL286003 6538 0 None -36 6 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
10363912 6538 0 None -36 6 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm200421e
CHEMBL1082862 6538 0 None -36 6 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm200421e
CHEMBL286003 6538 0 None -36 6 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm200421e
11653915 124012 0 None -5 6 Human 7.7 pKi = 7.7 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 296 4 2 5 2.6 COc1cccc(N(NC2=NCCN2)c2ccc(C)cc2)c1 10.1016/j.bmcl.2005.07.083
CHEMBL362954 124012 0 None -5 6 Human 7.7 pKi = 7.7 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 296 4 2 5 2.6 COc1cccc(N(NC2=NCCN2)c2ccc(C)cc2)c1 10.1016/j.bmcl.2005.07.083
52945156 17058 0 None -7 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 455 13 1 6 4.1 COc1cccc(OC)c1[S+]([O-])CCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1254660 17058 0 None -7 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 455 13 1 6 4.1 COc1cccc(OC)c1[S+]([O-])CCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
118716722 115016 0 None -1 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 446 7 1 6 2.5 CCCCNC(=O)N1CCC2(CC1)OCC(CN1CCN(c3ccccc3OC)CC1)O2 10.1016/j.ejmech.2014.09.070
CHEMBL3342875 115016 0 None -1 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 446 7 1 6 2.5 CCCCNC(=O)N1CCC2(CC1)OCC(CN1CCN(c3ccccc3OC)CC1)O2 10.1016/j.ejmech.2014.09.070
44298747 102008 0 None -3 2 Human 7.7 pKi = 7.7 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 480 7 1 6 2.7 O=c1[nH]cc(C(F)(F)F)c(=O)n1CCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
CHEMBL301650 102008 0 None -3 2 Human 7.7 pKi = 7.7 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 480 7 1 6 2.7 O=c1[nH]cc(C(F)(F)F)c(=O)n1CCCN1CCN(c2ccccc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
9887458 195673 0 None -7 3 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 403 4 0 4 3.5 Cc1ccc(Cl)cc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
CHEMBL55654 195673 0 None -7 3 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 403 4 0 4 3.5 Cc1ccc(Cl)cc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
53328313 63387 0 None 1 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 455 7 0 5 3.8 COc1ccc(Cl)cc1N1CCN(CCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796032 63387 0 None 1 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 455 7 0 5 3.8 COc1ccc(Cl)cc1N1CCN(CCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
145958538 162265 0 None -6 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 303 3 2 7 1.2 COc1cc2nc(N3CCC[C@H](N)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
CHEMBL4163810 162265 0 None -6 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 303 3 2 7 1.2 COc1cc2nc(N3CCC[C@H](N)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
9905929 12813 0 None -26 2 Rat 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 339 5 1 2 4.5 Cc1[nH]c2ccccc2c1C1CCN(CCCN2CCCCC2)CC1 10.1016/j.bmcl.2006.05.002
CHEMBL1188265 12813 0 None -26 2 Rat 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 339 5 1 2 4.5 Cc1[nH]c2ccccc2c1C1CCN(CCCN2CCCCC2)CC1 10.1016/j.bmcl.2006.05.002
CHEMBL535837 12813 0 None -26 2 Rat 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 339 5 1 2 4.5 Cc1[nH]c2ccccc2c1C1CCN(CCCN2CCCCC2)CC1 10.1016/j.bmcl.2006.05.002
9904117 9402 3 None -1 4 Rat 6.7 pKi = 6.7 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL111554 9402 3 None -1 4 Rat 6.7 pKi = 6.7 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
44531812 194682 0 None 1 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 374 7 2 6 4.3 COc1cccc2c(NCCNc3ccnc4c(OC)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
CHEMBL532818 194682 0 None 1 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 374 7 2 6 4.3 COc1cccc2c(NCCNc3ccnc4c(OC)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
9904117 9402 3 None -1 4 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111554 9402 3 None -1 4 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
44314200 102952 0 None -81 4 Human 5.7 pKi = 5.7 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 230 1 1 3 2.4 c1ccc2c(c1)CCCC2NC1=NCCCO1 10.1016/0960-894X(94)85032-1
CHEMBL306377 102952 0 None -81 4 Human 5.7 pKi = 5.7 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 230 1 1 3 2.4 c1ccc2c(c1)CCCC2NC1=NCCCO1 10.1016/0960-894X(94)85032-1
44531812 194682 0 None 1 4 Human 6.7 pKi = 6.7 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 374 7 2 6 4.3 COc1cccc2c(NCCNc3ccnc4c(OC)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
CHEMBL532818 194682 0 None 1 4 Human 6.7 pKi = 6.7 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 374 7 2 6 4.3 COc1cccc2c(NCCNc3ccnc4c(OC)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
CHEMBL5291469 194640 0 None -70 2 Human 6.7 pKi = 6.7 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 508 8 1 6 3.6 O=C(NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O)C1CCOCC1 10.1021/acsmedchemlett.7b00112
CHEMBL5315702 194640 0 None -70 2 Human 6.7 pKi = 6.7 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 508 8 1 6 3.6 O=C(NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O)C1CCOCC1 10.1021/acsmedchemlett.7b00112
44586479 188627 0 None 6 2 Rat 6.7 pKi = 6.7 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 572 10 1 8 2.6 COC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL503007 188627 0 None 6 2 Rat 6.7 pKi = 6.7 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 572 10 1 8 2.6 COC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
52937732 61314 0 None -794 3 Human 6.7 pKi = 6.7 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 369 4 0 4 3.4 CN1CCC[C@@H]1Cn1nc(Cc2ccc(F)c(F)c2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767149 61314 0 None -794 3 Human 6.7 pKi = 6.7 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 369 4 0 4 3.4 CN1CCC[C@@H]1Cn1nc(Cc2ccc(F)c(F)c2)c2ccccc2c1=O 10.1021/jm1013874
52937828 61317 0 None -6 3 Human 6.7 pKi = 6.7 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 347 5 0 4 3.3 CN1CCC[C@@H]1Cn1nc(CCc2ccccc2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767152 61317 0 None -6 3 Human 6.7 pKi = 6.7 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 347 5 0 4 3.3 CN1CCC[C@@H]1Cn1nc(CCc2ccccc2)c2ccccc2c1=O 10.1021/jm1013874
25130879 173237 0 None -47 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 343 8 1 5 2.8 COc1ccccc1OCCNC[C@@H]1COC[C@H](c2ccccc2)O1 10.1021/jm800461k
CHEMBL452437 173237 0 None -47 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 343 8 1 5 2.8 COc1ccccc1OCCNC[C@@H]1COC[C@H](c2ccccc2)O1 10.1021/jm800461k
134138438 147343 0 None -66 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 378 4 0 5 4.3 COc1ccccc1N1CCN(CC2CSC3(CCCCC3)S2)CC1 10.1016/j.ejmech.2016.09.050
CHEMBL3929328 147343 0 None -66 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 378 4 0 5 4.3 COc1ccccc1N1CCN(CC2CSC3(CCCCC3)S2)CC1 10.1016/j.ejmech.2016.09.050
25025581 201996 0 None -3 8 Human 6.7 pKi = 6.7 Binding
Inhibition of adrenergic alpha1A receptorInhibition of adrenergic alpha1A receptor
ChEMBL 285 4 1 2 3.1 CCOC[C@H]1[C@@H]2CNC[C@@]21c1ccc(Cl)c(Cl)c1 10.1021/jm901818u
CHEMBL608151 201996 0 None -3 8 Human 6.7 pKi = 6.7 Binding
Inhibition of adrenergic alpha1A receptorInhibition of adrenergic alpha1A receptor
ChEMBL 285 4 1 2 3.1 CCOC[C@H]1[C@@H]2CNC[C@@]21c1ccc(Cl)c(Cl)c1 10.1021/jm901818u
43260 5482 65 None -1 4 Rat 5.7 pKi = 5.7 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1007/s00044-004-0020-z
CHEMBL1076 5482 65 None -1 4 Rat 5.7 pKi = 5.7 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1007/s00044-004-0020-z
294234 102893 3 None -512 4 Human 5.7 pKi = 5.7 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 182 1 1 3 1.7 C1CCCC(NC2=NCCO2)CC1 10.1016/0960-894X(94)85032-1
CHEMBL305928 102893 3 None -512 4 Human 5.7 pKi = 5.7 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 182 1 1 3 1.7 C1CCCC(NC2=NCCO2)CC1 10.1016/0960-894X(94)85032-1
25164129 161160 0 None -3715 4 Rat 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
ChEMBL 447 12 1 5 4.1 CCCCc1cc(OC2CCN(CCCCNS(=O)(=O)CC)CC2)c2ncccc2c1 10.1016/j.bmcl.2017.09.020
CHEMBL4088036 161160 0 None -3715 4 Rat 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
ChEMBL 447 12 1 5 4.1 CCCCc1cc(OC2CCN(CCCCNS(=O)(=O)CC)CC2)c2ncccc2c1 10.1016/j.bmcl.2017.09.020
CHEMBL4117406 161160 0 None -3715 4 Rat 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
ChEMBL 447 12 1 5 4.1 CCCCc1cc(OC2CCN(CCCCNS(=O)(=O)CC)CC2)c2ncccc2c1 10.1016/j.bmcl.2017.09.020
43260 5482 65 None -1 4 Rat 5.7 pKi = 5.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1021/jm030551a
CHEMBL1076 5482 65 None -1 4 Rat 5.7 pKi = 5.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1021/jm030551a
3584 3777 64 None -2 13 Human 8.7 pKi = 8.7 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
5401 3777 64 None -2 13 Human 8.7 pKi = 8.7 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
7302 3777 64 None -2 13 Human 8.7 pKi = 8.7 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
CHEMBL611 3777 64 None -2 13 Human 8.7 pKi = 8.7 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
DB01162 3777 64 None -2 13 Human 8.7 pKi = 8.7 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970364a
44431560 145578 0 None -2 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL391530 145578 0 None -2 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
11081136 205226 0 None 1 3 Human 8.7 pKi = 8.7 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 467 8 1 7 3.7 COc1ccc(Cl)cc1N1CCN(CCCNc2cc(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL78676 205226 0 None 1 3 Human 8.7 pKi = 8.7 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 467 8 1 7 3.7 COc1ccc(Cl)cc1N1CCN(CCCNc2cc(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
4431 2729 25 None 1 12 Human 8.7 pKi = 8.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 393 7 0 5 2.9 COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2 10.1016/j.bmcl.2004.11.032
73 2729 25 None 1 12 Human 8.7 pKi = 8.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 393 7 0 5 2.9 COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2 10.1016/j.bmcl.2004.11.032
CHEMBL8618 2729 25 None 1 12 Human 8.7 pKi = 8.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 393 7 0 5 2.9 COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2 10.1016/j.bmcl.2004.11.032
9909211 94208 1 None 1 3 Human 8.7 pKi = 8.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 404 8 2 7 1.9 COc1ccc(Cl)cc1N1CCN(CCCNc2nccc(C(N)=O)n2)CC1 10.1016/j.bmcl.2004.11.032
CHEMBL24981 94208 1 None 1 3 Human 8.7 pKi = 8.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 404 8 2 7 1.9 COc1ccc(Cl)cc1N1CCN(CCCNc2nccc(C(N)=O)n2)CC1 10.1016/j.bmcl.2004.11.032
3584 3777 64 None -2 13 Human 8.7 pKi = 8.7 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
5401 3777 64 None -2 13 Human 8.7 pKi = 8.7 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
7302 3777 64 None -2 13 Human 8.7 pKi = 8.7 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
CHEMBL611 3777 64 None -2 13 Human 8.7 pKi = 8.7 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
DB01162 3777 64 None -2 13 Human 8.7 pKi = 8.7 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
181743 178572 5 None 24 22 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]Prazosin from human adrenergic alpha1A receptorDisplacement of [3H]Prazosin from human adrenergic alpha1A receptor
ChEMBL 339 2 0 5 3.2 COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2)OCO4 10.1016/j.bmcl.2009.11.053
CHEMBL467094 178572 5 None 24 22 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]Prazosin from human adrenergic alpha1A receptorDisplacement of [3H]Prazosin from human adrenergic alpha1A receptor
ChEMBL 339 2 0 5 3.2 COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2)OCO4 10.1016/j.bmcl.2009.11.053
49781681 17886 0 None -1 3 Bovine 8.7 pKi = 8.7 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 428 2 0 3 6.3 Cc1cc(C)c(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)c(C)c1 10.1021/jm100652h
CHEMBL1259098 17886 0 None -1 3 Bovine 8.7 pKi = 8.7 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 428 2 0 3 6.3 Cc1cc(C)c(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)c(C)c1 10.1021/jm100652h
10097317 200084 0 None 288 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 495 8 2 4 4.9 Cc1ccc(C(O)(C(=O)NCCCN2CCC(C#N)(c3ccccc3C)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(01)00320-1
CHEMBL59590 200084 0 None 288 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 495 8 2 4 4.9 Cc1ccc(C(O)(C(=O)NCCCN2CCC(C#N)(c3ccccc3C)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(01)00320-1
10026936 163458 0 None 114 3 Human 8.7 pKi = 8.7 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 453 8 1 3 5.1 Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(F)c(F)c2)C(C)C)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL41994 163458 0 None 114 3 Human 8.7 pKi = 8.7 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 453 8 1 3 5.1 Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(F)c(F)c2)C(C)C)CC1 10.1016/s0960-894x(00)00307-3
11200086 196424 0 None 2 3 Rat 8.7 pKi = 8.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 388 4 0 3 4.2 O=C1CC2(CCCC2)CC(=O)N1CCN1CCC(c2ccccc2Cl)CC1 10.1021/jm030944+
CHEMBL56292 196424 0 None 2 3 Rat 8.7 pKi = 8.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 388 4 0 3 4.2 O=C1CC2(CCCC2)CC(=O)N1CCN1CCC(c2ccccc2Cl)CC1 10.1021/jm030944+
44312563 204920 2 None -1 6 Bovine 8.7 pKi = 8.7 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]-prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]-prazosin as radioligand
ChEMBL 401 7 1 8 1.0 COc1ccc(C)cc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1021/jm960069a
CHEMBL76168 204920 2 None -1 6 Bovine 8.7 pKi = 8.7 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]-prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]-prazosin as radioligand
ChEMBL 401 7 1 8 1.0 COc1ccc(C)cc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1021/jm960069a
10531 1420 21 None -5 23 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
121 1420 21 None -5 23 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
888 1420 21 None -5 23 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
CHEMBL1732 1420 21 None -5 23 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
DB00320 1420 21 None -5 23 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
46934945 16698 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 533 7 0 7 3.8 COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3C(=O)CC4(CCCC4)CC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242912 16698 0 None 1 4 Human 8.7 pKi = 8.7 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 533 7 0 7 3.8 COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3C(=O)CC4(CCCC4)CC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
100 3805 58 None 1 55 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
2637 3805 58 None 1 55 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
5452 3805 58 None 1 55 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
CHEMBL479 3805 58 None 1 55 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
DB00679 3805 58 None 1 55 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 nan
6761 67799 19 None 1 18 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 nan
CHEMBL1909072 67799 19 None 1 18 Rat 8.7 pKi = 8.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 401 5 1 4 4.5 NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 nan
46882034 5801 0 None -1 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 433 10 1 5 4.8 CC(C)Oc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
CHEMBL1078773 5801 0 None -1 4 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 433 10 1 5 4.8 CC(C)Oc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
121102 143966 2 None -3 3 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 370 8 0 5 3.5 CCOc1ccccc1N1CCN(CCc2ccc(OC)c(OC)c2)CC1 10.1016/j.ejmech.2016.06.052
CHEMBL3902626 143966 2 None -3 3 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 370 8 0 5 3.5 CCOc1ccccc1N1CCN(CCc2ccc(OC)c(OC)c2)CC1 10.1016/j.ejmech.2016.06.052
11801214 102221 0 None 25 2 Human 8.7 pKi = 8.7 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 572 10 2 8 3.2 COc1ccc(N2C(=O)c3ccc(C(=O)NC[C@@H](O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
CHEMBL302942 102221 0 None 25 2 Human 8.7 pKi = 8.7 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 572 10 2 8 3.2 COc1ccc(N2C(=O)c3ccc(C(=O)NC[C@@H](O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1 10.1021/jm9905918
9844511 104596 0 None 85 3 Human 8.7 pKi = 8.7 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 411 7 1 5 3.0 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)n[nH]2)CC1 10.1016/s0960-894x(00)00472-8
CHEMBL310471 104596 0 None 85 3 Human 8.7 pKi = 8.7 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 411 7 1 5 3.0 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)n[nH]2)CC1 10.1016/s0960-894x(00)00472-8
56961460 121438 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 477 4 2 10 2.0 COc1cc2nc(N3CCN(C(=O)c4cc5ccc(O)cc5oc4=O)CC3)nc(N)c2cc1OC 10.1021/ml5004298
CHEMBL3582268 121438 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 477 4 2 10 2.0 COc1cc2nc(N3CCN(C(=O)c4cc5ccc(O)cc5oc4=O)CC3)nc(N)c2cc1OC 10.1021/ml5004298
10393665 33922 0 None 47 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 593 9 2 9 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
CHEMBL142383 33922 0 None 47 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 593 9 2 9 3.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
10627279 37213 0 None 47 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 592 9 3 8 3.0 CNC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
CHEMBL145334 37213 0 None 47 3 Human 8.7 pKi = 8.7 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 592 9 3 8 3.0 CNC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
10767626 155323 0 None 1 2 Rat 8.7 pKi = 8.7 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 461 4 1 6 3.9 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(C)cc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL40310 155323 0 None 1 2 Rat 8.7 pKi = 8.7 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 461 4 1 6 3.9 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccc(C)cc54)c3=O)C[C@@H]21 10.1021/jm990567u
10502807 163145 0 None 2 2 Rat 8.7 pKi = 8.7 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 431 4 1 6 3.1 COc1cccc2c1CCC1CN(CCn3c(=O)[nH]c4c(oc5ccccc54)c3=O)CC21 10.1021/jm990567u
CHEMBL417890 163145 0 None 2 2 Rat 8.7 pKi = 8.7 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 431 4 1 6 3.1 COc1cccc2c1CCC1CN(CCn3c(=O)[nH]c4c(oc5ccccc54)c3=O)CC21 10.1021/jm990567u
71454865 84603 0 None -2 6 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153551 84603 0 None -2 6 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2221145 84603 0 None -2 6 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
10698630 44433 0 None 1230 3 Human 8.7 pKi = 8.7 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 589 11 3 8 3.4 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
CHEMBL151878 44433 0 None 1230 3 Human 8.7 pKi = 8.7 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 589 11 3 8 3.4 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
11857791 85640 0 None 10 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 554 7 1 6 4.9 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc2c(c1)OCCO2 10.1016/j.bmcl.2007.04.098
CHEMBL228390 85640 0 None 10 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 554 7 1 6 4.9 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc2c(c1)OCCO2 10.1016/j.bmcl.2007.04.098
11857638 143810 0 None -1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 516 9 1 6 5.0 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL390129 143810 0 None -1 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 516 9 1 6 5.0 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
10792591 206823 0 None 15 3 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 542 7 1 4 4.7 CC(=O)N1C(=O)N(C)C(C)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1016/j.ejmech.2017.03.025
CHEMBL90453 206823 0 None 15 3 Human 8.7 pKi = 8.7 Binding
Displacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hrDisplacement of [125I]L-762,459 from recombinant human alpha1a adrenergic receptor expressed in mammalian cells measured after 1 hr
ChEMBL 542 7 1 4 4.7 CC(=O)N1C(=O)N(C)C(C)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1016/j.ejmech.2017.03.025
11071135 208008 0 None 3 7 Bovine 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 500 6 0 6 4.6 CN1CCC(CCN2CCC(c3cn(-c4ccc(F)cc4)c4ccc(-c5ncn(C)n5)cc34)CC2)C1=O 10.1021/jm020938y
CHEMBL97333 208008 0 None 3 7 Bovine 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 500 6 0 6 4.6 CN1CCC(CCN2CCC(c3cn(-c4ccc(F)cc4)c4ccc(-c5ncn(C)n5)cc34)CC2)C1=O 10.1021/jm020938y
56837419 69304 0 None -9 5 Pig 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 997 35 2 14 6.2 COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928128 69304 0 None -9 5 Pig 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 997 35 2 14 6.2 COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
10792591 206823 0 None 15 3 Human 8.7 pKi = 8.7 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 542 7 1 4 4.7 CC(=O)N1C(=O)N(C)C(C)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1021/jm990612y
CHEMBL90453 206823 0 None 15 3 Human 8.7 pKi = 8.7 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 542 7 1 4 4.7 CC(=O)N1C(=O)N(C)C(C)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1 10.1021/jm990612y
44447005 94726 0 None -7 4 Rat 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 446 6 1 5 4.2 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)C1CC1 10.1016/j.bmcl.2007.11.106
CHEMBL253024 94726 0 None -7 4 Rat 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 446 6 1 5 4.2 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)C1CC1 10.1016/j.bmcl.2007.11.106
6604803 116518 2 None 7 3 Rat 8.7 pKi = 8.7 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@H]2C1=NCCN1 10.1021/jm960354u
CHEMBL336161 116518 2 None 7 3 Rat 8.7 pKi = 8.7 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@H]2C1=NCCN1 10.1021/jm960354u
10406315 193325 0 None 120 2 Rat 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membraneDisplacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membrane
ChEMBL 361 2 2 5 3.5 COc1cc2c(cc1O)C[C@H]1c3c(c(Cl)c(O)c(OC)c3-2)CCN1C 10.1021/np990433j
CHEMBL524439 193325 0 None 120 2 Rat 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membraneDisplacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membrane
ChEMBL 361 2 2 5 3.5 COc1cc2c(cc1O)C[C@H]1c3c(c(Cl)c(O)c(OC)c3-2)CCN1C 10.1021/np990433j
134152568 153087 0 None 1 3 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 354 7 0 4 3.8 COc1ccc(CCN2CCN(c3ccccc3OC(C)C)CC2)cc1 10.1016/j.ejmech.2016.06.052
CHEMBL3976144 153087 0 None 1 3 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 354 7 0 4 3.8 COc1ccc(CCN2CCN(c3ccccc3OC(C)C)CC2)cc1 10.1016/j.ejmech.2016.06.052
11014848 205124 0 None 1 4 Human 8.6 pKi = 8.6 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 399 7 1 8 1.5 COc1ccccc1N1CCN(CCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL77901 205124 0 None 1 4 Human 8.6 pKi = 8.6 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 399 7 1 8 1.5 COc1ccccc1N1CCN(CCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1 10.1021/jm0009336
10791843 163400 0 None 138 3 Human 8.6 pKi = 8.6 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 511 7 2 4 3.7 CN1C=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@H](c2ccc(F)c(F)c2)NC1=O 10.1021/jm990612y
CHEMBL419497 163400 0 None 138 3 Human 8.6 pKi = 8.6 Binding
Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 511 7 2 4 3.7 CN1C=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@H](c2ccc(F)c(F)c2)NC1=O 10.1021/jm990612y
2389 3331 118 None -11 67 Human 8.6 pKi = 8.6 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
5073 3331 118 None -11 67 Human 8.6 pKi = 8.6 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
96 3331 118 None -11 67 Human 8.6 pKi = 8.6 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
CHEMBL85 3331 118 None -11 67 Human 8.6 pKi = 8.6 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
DB00734 3331 118 None -11 67 Human 8.6 pKi = 8.6 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 nan
44299945 101926 0 None 41 3 Human 8.6 pKi = 8.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.3 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@H](N3CCC(C#N)(c4ccccc4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL301024 101926 0 None 41 3 Human 8.6 pKi = 8.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.3 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@H](N3CCC(C#N)(c4ccccc4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
44294958 188331 0 None 151 3 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 554 7 3 7 1.9 NC(=O)c1ccccc1N1CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
CHEMBL50081 188331 0 None 151 3 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 554 7 3 7 1.9 NC(=O)c1ccccc1N1CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
71508687 87054 0 None 33 2 Bovine 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 385 3 0 3 5.6 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cccnc4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2325932 87054 0 None 33 2 Bovine 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 385 3 0 3 5.6 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cccnc4)cc23)CC1 10.1016/j.bmc.2012.10.049
489 145 28 None -3 12 Human 8.6 pKi = 8.6 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
5640 145 28 None -3 12 Human 8.6 pKi = 8.6 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
CHEMBL420060 145 28 None -3 12 Human 8.6 pKi = 8.6 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
76333280 84817 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 421 8 1 5 5.3 COc1cccc(OC)c1OCCN[C@H]1C[C@H](c2ccccc2)c2ccccc2S1 10.1007/s00044-010-9379-1
CHEMBL2234442 84817 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 421 8 1 5 5.3 COc1cccc(OC)c1OCCN[C@H]1C[C@H](c2ccccc2)c2ccccc2S1 10.1007/s00044-010-9379-1
11133868 155342 0 None 4 6 Human 8.6 pKi = 8.6 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNC[C@H]1C[C@H](c2ccccc2)c2ccccc2S1 10.1021/jm011066n
CHEMBL40325 155342 0 None 4 6 Human 8.6 pKi = 8.6 Binding
Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptorAffinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor
ChEMBL 435 9 1 5 5.4 COc1cccc(OC)c1OCCNC[C@H]1C[C@H](c2ccccc2)c2ccccc2S1 10.1021/jm011066n
76333280 84817 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 421 8 1 5 5.3 COc1cccc(OC)c1OCCN[C@H]1C[C@H](c2ccccc2)c2ccccc2S1 10.1007/s00044-010-9379-1
CHEMBL2234442 84817 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 421 8 1 5 5.3 COc1cccc(OC)c1OCCN[C@H]1C[C@H](c2ccccc2)c2ccccc2S1 10.1007/s00044-010-9379-1
132266 1278 12 None -7 9 Bovine 8.6 pKi = 8.6 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm960510x
486 1278 12 None -7 9 Bovine 8.6 pKi = 8.6 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm960510x
CHEMBL423294 1278 12 None -7 9 Bovine 8.6 pKi = 8.6 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm960510x
19085894 205559 0 None 2 3 Human 8.6 pKi = 8.6 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in COS-7 cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in COS-7 cells
ChEMBL 533 7 0 9 2.3 CS(=O)(=O)c1ccc2c(c1)S(=O)(=O)N(CCCCN1CCC(n3c(=O)oc4ccccc43)CC1)C2=O 10.1016/s0960-894x(98)00446-6
CHEMBL81173 205559 0 None 2 3 Human 8.6 pKi = 8.6 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in COS-7 cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in COS-7 cells
ChEMBL 533 7 0 9 2.3 CS(=O)(=O)c1ccc2c(c1)S(=O)(=O)N(CCCCN1CCC(n3c(=O)oc4ccccc43)CC1)C2=O 10.1016/s0960-894x(98)00446-6
3037308 44079 27 None 2 6 Rat 8.6 pKi = 8.6 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 452 7 1 7 4.2 O=c1c(CO)coc2cc(OCCCN3CCC(c4noc5cc(F)ccc45)CC3)ccc12 10.1021/jm9810396
CHEMBL151475 44079 27 None 2 6 Rat 8.6 pKi = 8.6 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 452 7 1 7 4.2 O=c1c(CO)coc2cc(OCCCN3CCC(c4noc5cc(F)ccc45)CC3)ccc12 10.1021/jm9810396
3584 3777 64 None -2 13 Human 8.6 pKi = 8.6 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
5401 3777 64 None -2 13 Human 8.6 pKi = 8.6 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
7302 3777 64 None -2 13 Human 8.6 pKi = 8.6 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
CHEMBL611 3777 64 None -2 13 Human 8.6 pKi = 8.6 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
DB01162 3777 64 None -2 13 Human 8.6 pKi = 8.6 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
44300159 101835 0 None 275 3 Human 8.6 pKi = 8.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.3 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@@H](N3CCC(C#N)(c4ccccc4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL300355 101835 0 None 275 3 Human 8.6 pKi = 8.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.3 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@@H](N3CCC(C#N)(c4ccccc4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
44300170 168260 0 None 4 3 Human 8.6 pKi = 8.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.5 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL433832 168260 0 None 4 3 Human 8.6 pKi = 8.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 607 7 2 7 4.5 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
10793261 121053 0 None 2290 4 Human 8.6 pKi = 8.6 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 575 10 3 8 3.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm990200p
CHEMBL356829 121053 0 None 2290 4 Human 8.6 pKi = 8.6 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 575 10 3 8 3.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm990200p
10326069 39296 1 None 23 9 Human 8.6 pKi = 8.6 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 589 10 3 8 3.3 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
CHEMBL147077 39296 1 None 23 9 Human 8.6 pKi = 8.6 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 589 10 3 8 3.3 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
490 191 8 None -18 12 Rat 8.6 pKi = 8.6 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
9890547 191 8 None -18 12 Rat 8.6 pKi = 8.6 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
CHEMBL268758 191 8 None -18 12 Rat 8.6 pKi = 8.6 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
10647424 206781 0 None 741 2 Human 8.6 pKi = 8.6 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 455 7 3 4 3.0 O=C1NC=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1021/jm990612y
CHEMBL90210 206781 0 None 741 2 Human 8.6 pKi = 8.6 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 455 7 3 4 3.0 O=C1NC=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1021/jm990612y
9909211 94208 1 None 1 3 Human 8.6 pKi = 8.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 404 8 2 7 1.9 COc1ccc(Cl)cc1N1CCN(CCCNc2nccc(C(N)=O)n2)CC1 10.1021/jm960697s
CHEMBL24981 94208 1 None 1 3 Human 8.6 pKi = 8.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 404 8 2 7 1.9 COc1ccc(Cl)cc1N1CCN(CCCNc2nccc(C(N)=O)n2)CC1 10.1021/jm960697s
52940951 17079 0 None -3 4 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 427 12 1 5 5.0 COc1cccc(Cl)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1254828 17079 0 None -3 4 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 427 12 1 5 5.0 COc1cccc(Cl)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
52943356 17080 0 None -2 4 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 407 12 1 5 4.6 COc1cccc(C)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1254829 17080 0 None -2 4 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 407 12 1 5 4.6 COc1cccc(C)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
3584 3777 64 None -3 13 Bovine 8.6 pKi = 8.6 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970166j
5401 3777 64 None -3 13 Bovine 8.6 pKi = 8.6 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970166j
7302 3777 64 None -3 13 Bovine 8.6 pKi = 8.6 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970166j
CHEMBL611 3777 64 None -3 13 Bovine 8.6 pKi = 8.6 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970166j
DB01162 3777 64 None -3 13 Bovine 8.6 pKi = 8.6 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm970166j
44298735 198460 0 None 39 2 Human 8.6 pKi = 8.6 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 472 8 1 6 3.0 CC(C)c1c[nH]c(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL57740 198460 0 None 39 2 Human 8.6 pKi = 8.6 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 472 8 1 6 3.0 CC(C)c1c[nH]c(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
10674647 38976 0 None 457 3 Human 8.6 pKi = 8.6 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 574 10 2 8 4.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
CHEMBL146815 38976 0 None 457 3 Human 8.6 pKi = 8.6 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 574 10 2 8 4.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
10674647 38976 0 None 457 3 Human 8.6 pKi = 8.6 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 574 10 2 8 4.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
CHEMBL146815 38976 0 None 457 3 Human 8.6 pKi = 8.6 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 574 10 2 8 4.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
11144555 205238 0 None 2 4 Human 8.6 pKi = 8.6 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 433 8 1 7 3.1 COc1ccccc1N1CCN(CCCNc2cc(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL78785 205238 0 None 2 4 Human 8.6 pKi = 8.6 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 433 8 1 7 3.1 COc1ccccc1N1CCN(CCCNc2cc(-c3ccccc3)nn(C)c2=O)CC1 10.1021/jm0009336
3157 1470 71 None -2 10 Human 8.6 pKi = 8.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm00018a001
7170 1470 71 None -2 10 Human 8.6 pKi = 8.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm00018a001
954 1470 71 None -2 10 Human 8.6 pKi = 8.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm00018a001
CHEMBL707 1470 71 None -2 10 Human 8.6 pKi = 8.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm00018a001
DB00590 1470 71 None -2 10 Human 8.6 pKi = 8.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm00018a001
490 191 8 None -12 12 Human 8.6 pKi = 8.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/j.bmcl.2004.11.032
9890547 191 8 None -12 12 Human 8.6 pKi = 8.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/j.bmcl.2004.11.032
CHEMBL268758 191 8 None -12 12 Human 8.6 pKi = 8.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/j.bmcl.2004.11.032
10576280 111417 0 None - 1 Human 8.6 pKi = 8.6 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 469 7 3 4 3.4 CC1=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
CHEMBL327327 111417 0 None - 1 Human 8.6 pKi = 8.6 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 469 7 3 4 3.4 CC1=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1 10.1021/jm990612y
9891166 33612 0 None -6 4 Rat 8.6 pKi = 8.6 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 476 6 0 8 3.3 COc1ccccc1N1CCN(CCn2c(=O)c3c(-c4ccccc4)csc3n(C)c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL14213 33612 0 None -6 4 Rat 8.6 pKi = 8.6 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 476 6 0 8 3.3 COc1ccccc1N1CCN(CCn2c(=O)c3c(-c4ccccc4)csc3n(C)c2=O)CC1 10.1016/s0960-894x(01)00159-7
490 191 8 None -12 12 Human 8.6 pKi = 8.6 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
9890547 191 8 None -12 12 Human 8.6 pKi = 8.6 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
CHEMBL268758 191 8 None -12 12 Human 8.6 pKi = 8.6 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 10.1016/s0960-894x(01)00159-7
9847845 28453 0 None -6 5 Human 8.6 pKi = 8.6 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(C)c(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL13754 28453 0 None -6 5 Human 8.6 pKi = 8.6 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(C)c(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
155532148 171701 0 None -1 7 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 444 6 0 5 4.2 COc1ccccc1N1CCN(CC2COCC(c3ccccc3)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2019.02.056
CHEMBL4466677 171701 0 None -1 7 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 444 6 0 5 4.2 COc1ccccc1N1CCN(CC2COCC(c3ccccc3)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2019.02.056
44431545 88081 0 None 12 4 Human 8.6 pKi = 8.6 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 457 7 1 5 3.9 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234669 88081 0 None 12 4 Human 8.6 pKi = 8.6 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 457 7 1 5 3.9 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
44431174 92803 0 None -8 3 Human 8.6 pKi = 8.6 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 515 5 0 5 5.5 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4cc(Cl)c(Cl)cc4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
CHEMBL243692 92803 0 None -8 3 Human 8.6 pKi = 8.6 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 515 5 0 5 5.5 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4cc(Cl)c(Cl)cc4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
71508683 87049 0 None 56 2 Bovine 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 388 3 0 4 5.0 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cnn(C)c4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2325928 87049 0 None 56 2 Bovine 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 388 3 0 4 5.0 CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cnn(C)c4)cc23)CC1 10.1016/j.bmc.2012.10.049
44447001 155473 0 None -30 4 Rat 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 378 4 1 5 3.6 NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
CHEMBL404000 155473 0 None -30 4 Rat 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 378 4 1 5 3.6 NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
10716964 100592 0 None 5 2 Rat 8.6 pKi = 8.6 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 419 4 1 5 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C)cc(C)cc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL291769 100592 0 None 5 2 Rat 8.6 pKi = 8.6 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 419 4 1 5 3.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C)cc(C)cc4c3=O)C[C@@H]21 10.1021/jm000541z
11655728 16644 8 None -39 6 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor by filtration binding assayDisplacement of [3H]prazosin from human adrenergic alpha1A receptor by filtration binding assay
ChEMBL 468 5 1 7 3.1 Cc1ccc2c(N3CCN(CCc4cccc5c4OCc4c(C(N)=O)ncn4-5)CC3)cccc2n1 10.1021/jm100482n
CHEMBL1241913 16644 8 None -39 6 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptor by filtration binding assayDisplacement of [3H]prazosin from human adrenergic alpha1A receptor by filtration binding assay
ChEMBL 468 5 1 7 3.1 Cc1ccc2c(N3CCN(CCc4cccc5c4OCc4c(C(N)=O)ncn4-5)CC3)cccc2n1 10.1021/jm100482n
134147055 149574 0 None -2 3 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 354 7 0 4 3.8 COc1cccc(CCN2CCN(c3ccccc3OC(C)C)CC2)c1 10.1016/j.ejmech.2016.06.052
CHEMBL3946843 149574 0 None -2 3 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 354 7 0 4 3.8 COc1cccc(CCN2CCN(c3ccccc3OC(C)C)CC2)c1 10.1016/j.ejmech.2016.06.052
2389 3331 118 None -11 67 Human 8.6 pKi = 8.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2004.11.032
5073 3331 118 None -11 67 Human 8.6 pKi = 8.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2004.11.032
96 3331 118 None -11 67 Human 8.6 pKi = 8.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2004.11.032
CHEMBL85 3331 118 None -11 67 Human 8.6 pKi = 8.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2004.11.032
DB00734 3331 118 None -11 67 Human 8.6 pKi = 8.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 10.1016/j.bmcl.2004.11.032
31101 729 40 None -4 36 Rat 8.6 pKi = 8.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
35 729 40 None -4 36 Rat 8.6 pKi = 8.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
403 729 40 None -4 36 Rat 8.6 pKi = 8.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
CHEMBL493 729 40 None -4 36 Rat 8.6 pKi = 8.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
DB01200 729 40 None -4 36 Rat 8.6 pKi = 8.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C nan
11154198 201614 0 None -5 4 Human 8.6 pKi = 8.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 413 6 0 5 3.3 CC(C)Oc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
CHEMBL60583 201614 0 None -5 4 Human 8.6 pKi = 8.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 413 6 0 5 3.3 CC(C)Oc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
11994797 12314 0 None 1 6 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 369 7 1 5 3.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)CCCC2 10.1021/jm060358r
CHEMBL1185017 12314 0 None 1 6 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 369 7 1 5 3.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)CCCC2 10.1021/jm060358r
CHEMBL383938 12314 0 None 1 6 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 369 7 1 5 3.4 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)CCCC2 10.1021/jm060358r
45268939 196660 0 None -4 4 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 505 4 1 9 3.0 COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1021/jm8016046
CHEMBL564481 196660 0 None -4 4 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 505 4 1 9 3.0 COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1021/jm8016046
11154198 201614 0 None -5 4 Human 8.6 pKi = 8.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 413 6 0 5 3.3 CC(C)Oc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
CHEMBL60583 201614 0 None -5 4 Human 8.6 pKi = 8.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 413 6 0 5 3.3 CC(C)Oc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
11487449 195489 0 None 4 3 Rat 8.5 pKi = 8.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 437 5 0 4 4.2 O=C1CC2(CCCC2)CC(=O)N1CCCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL55319 195489 0 None 4 3 Rat 8.5 pKi = 8.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 437 5 0 4 4.2 O=C1CC2(CCCC2)CC(=O)N1CCCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
10506674 119724 0 None 354 3 Human 8.5 pKi = 8.5 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 542 9 3 7 3.4 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
CHEMBL347559 119724 0 None 354 3 Human 8.5 pKi = 8.5 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 542 9 3 7 3.4 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
46934787 16686 0 None 1 4 Human 8.5 pKi = 8.5 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 465 7 0 7 2.2 COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3C(=O)CCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242724 16686 0 None 1 4 Human 8.5 pKi = 8.5 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 465 7 0 7 2.2 COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3C(=O)CCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
3584 3777 64 None -2 13 Human 8.5 pKi = 8.5 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human prostate tissue preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
5401 3777 64 None -2 13 Human 8.5 pKi = 8.5 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human prostate tissue preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
7302 3777 64 None -2 13 Human 8.5 pKi = 8.5 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human prostate tissue preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
CHEMBL611 3777 64 None -2 13 Human 8.5 pKi = 8.5 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human prostate tissue preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
DB01162 3777 64 None -2 13 Human 8.5 pKi = 8.5 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human prostate tissue preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
134147929 149641 0 None -1 3 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 340 7 0 4 3.5 CCOc1ccccc1N1CCN(CCc2cccc(OC)c2)CC1 10.1016/j.ejmech.2016.06.052
CHEMBL3947302 149641 0 None -1 3 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 340 7 0 4 3.5 CCOc1ccccc1N1CCN(CCc2cccc(OC)c2)CC1 10.1016/j.ejmech.2016.06.052
11145007 164093 0 None -2 4 Human 8.5 pKi = 8.5 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 461 9 1 8 3.0 COc1ccc(Cl)cc1N1CCN(CCCCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1 10.1021/jm0009336
CHEMBL420959 164093 0 None -2 4 Human 8.5 pKi = 8.5 Binding
Binding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligandBinding affinity towards human cloned alpha-1A-adrenoceptor using [3H]prazosin as radioligand
ChEMBL 461 9 1 8 3.0 COc1ccc(Cl)cc1N1CCN(CCCCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1 10.1021/jm0009336
19085832 163776 0 None 5 3 Human 7.7 pKi = 7.7 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 483 6 0 7 3.5 Cc1cc(C)c2oc(=O)n(C3CCN(CCCCN4C(=O)c5ccccc5S4(=O)=O)CC3)c2c1 10.1016/s0960-894x(98)00446-6
CHEMBL420578 163776 0 None 5 3 Human 7.7 pKi = 7.7 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 483 6 0 7 3.5 Cc1cc(C)c2oc(=O)n(C3CCN(CCCCN4C(=O)c5ccccc5S4(=O)=O)CC3)c2c1 10.1016/s0960-894x(98)00446-6
2337 3256 77 None -5 62 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
50 3256 77 None -5 62 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
5002 3256 77 None -5 62 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
CHEMBL716 3256 77 None -5 62 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
DB01224 3256 77 None -5 62 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
10578926 118966 0 None 75 3 Human 7.7 pKi = 7.7 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 1 7 4.5 COC(=O)C1=C(C)N=C(C)N(CCC[C@@H](C)CN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL342347 118966 0 None 75 3 Human 7.7 pKi = 7.7 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 1 7 4.5 COC(=O)C1=C(C)N=C(C)N(CCC[C@@H](C)CN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
9890459 16931 0 None 13 3 Human 7.7 pKi = 7.7 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 460 10 1 7 1.3 CCOC(=O)C1CCC(=O)N1CC(=O)NCCN1CCN(c2ccccc2OC(C)C)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL12529 16931 0 None 13 3 Human 7.7 pKi = 7.7 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 460 10 1 7 1.3 CCOC(=O)C1CCC(=O)N1CC(=O)NCCN1CCN(c2ccccc2OC(C)C)CC1 10.1016/s0960-894x(00)00169-4
45560410 1086 0 None -891 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 340 6 1 5 1.6 COc1ccccc1N1CCN(CC1)CCNC(=O)c1ccccn1 10.1021/acs.jmedchem.2c00633
9825 1086 0 None -891 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 340 6 1 5 1.6 COc1ccccc1N1CCN(CC1)CCNC(=O)c1ccccn1 10.1021/acs.jmedchem.2c00633
CHEMBL4205290 1086 0 None -891 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 340 6 1 5 1.6 COc1ccccc1N1CCN(CC1)CCNC(=O)c1ccccn1 10.1021/acs.jmedchem.2c00633
10640907 4912 1 None -21 5 Human 7.7 pKi = 7.7 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 340 6 1 5 1.6 COc1ccccc1N1CCN(CCNC(=O)c2ccncc2)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL104593 4912 1 None -21 5 Human 7.7 pKi = 7.7 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 340 6 1 5 1.6 COc1ccccc1N1CCN(CCNC(=O)c2ccncc2)CC1 10.1021/acs.jmedchem.2c00633
56971026 69242 0 None -12 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 378 7 1 6 2.1 COc1ccccc1N1CCN(CCCN/C(=N\C#N)c2ccccn2)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL1927088 69242 0 None -12 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 378 7 1 6 2.1 COc1ccccc1N1CCN(CCCN/C(=N\C#N)c2ccccn2)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL5172506 69242 0 None -12 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 378 7 1 6 2.1 COc1ccccc1N1CCN(CCCN/C(=N\C#N)c2ccccn2)CC1 10.1021/acs.jmedchem.2c00633
44431553 87486 0 None 1 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 525 7 1 5 4.9 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccc(C(F)(F)F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233416 87486 0 None 1 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 525 7 1 5 4.9 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccc(C(F)(F)F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
44390704 64553 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 445 7 2 10 -0.2 Cn1c(NCCCN2CCN(c3ccc4c(c3)OCC(CO)O4)CC2)cc(=O)n(C)c1=O 10.1016/j.bmcl.2004.11.032
CHEMBL181475 64553 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 445 7 2 10 -0.2 Cn1c(NCCCN2CCN(c3ccc4c(c3)OCC(CO)O4)CC2)cc(=O)n(C)c1=O 10.1016/j.bmcl.2004.11.032
44331090 208393 0 None 6 3 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 464 5 1 5 4.3 CS(=O)(=O)Nc1ccc2c(c1)OC1(CCN(CCc3cccc4ccccc34)CC1)CC2=O 10.1016/s0960-894x(98)00732-x
CHEMBL99614 208393 0 None 6 3 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 464 5 1 5 4.3 CS(=O)(=O)Nc1ccc2c(c1)OC1(CCN(CCc3cccc4ccccc34)CC1)CC2=O 10.1016/s0960-894x(98)00732-x
13141183 161963 1 None 15 2 Bovine 7.7 pKi = 7.7 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 310 0 0 2 4.6 CN1CCC(=C2c3cc(Cl)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
CHEMBL415761 161963 1 None 15 2 Bovine 7.7 pKi = 7.7 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 310 0 0 2 4.6 CN1CCC(=C2c3cc(Cl)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
3251 4072 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assayDisplacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assay
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2011.06.023
5684 4072 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assayDisplacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assay
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2011.06.023
80 4072 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assayDisplacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assay
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2011.06.023
CHEMBL31354 4072 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assayDisplacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assay
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1016/j.ejmech.2011.06.023
10839106 111595 0 None 5 3 Human 7.7 pKi = 7.7 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 500 7 2 3 4.5 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1021/jm990612y
CHEMBL328268 111595 0 None 5 3 Human 7.7 pKi = 7.7 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 500 7 2 3 4.5 CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H](c2ccc(F)c(F)c2)NC(=O)N1C 10.1021/jm990612y
11800744 207331 0 None 10 3 Human 7.7 pKi = 7.7 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 547 7 3 4 4.4 N#Cc1ccccc1C1CCN(CCCNC(=O)C2=C(C(F)(F)F)NC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
CHEMBL93523 207331 0 None 10 3 Human 7.7 pKi = 7.7 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 547 7 3 4 4.4 N#Cc1ccccc1C1CCN(CCCNC(=O)C2=C(C(F)(F)F)NC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
24854106 161061 1 None 2 8 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha-1 receptorInhibition of adrenergic alpha-1 receptor
ChEMBL 367 6 1 3 3.9 O=C1Nc2ccc(F)cc2C1CCCCN1CCN(c2ccccc2)CC1 10.1021/jm070279v
CHEMBL411663 161061 1 None 2 8 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha-1 receptorInhibition of adrenergic alpha-1 receptor
ChEMBL 367 6 1 3 3.9 O=C1Nc2ccc(F)cc2C1CCCCN1CCN(c2ccccc2)CC1 10.1021/jm070279v
3251 4072 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha1A receptorInhibition of adrenergic alpha1A receptor
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1021/jm1009956
5684 4072 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha1A receptorInhibition of adrenergic alpha1A receptor
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1021/jm1009956
80 4072 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha1A receptorInhibition of adrenergic alpha1A receptor
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1021/jm1009956
CHEMBL31354 4072 58 None -64 12 Human 7.7 pKi = 7.7 Binding
Inhibition of adrenergic alpha1A receptorInhibition of adrenergic alpha1A receptor
ChEMBL 422 7 0 5 3.8 COc1ccccc1N1CCN(CC1)CCN(C(=O)C1CCCCC1)c1ccccn1 10.1021/jm1009956
10603951 206516 0 None 11 6 Human 7.7 pKi = 7.7 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 622 10 1 7 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)N(C)CCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL88448 206516 0 None 11 6 Human 7.7 pKi = 7.7 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 622 10 1 7 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)N(C)CCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
10603951 85271 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 622 10 1 7 5.9 COC(=O)C1=C(C)NC(C)=C(C(=O)N(C)CCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL2260148 85271 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 622 10 1 7 5.9 COC(=O)C1=C(C)NC(C)=C(C(=O)N(C)CCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
11097789 102998 1 None -4 6 Human 7.7 pKi = 7.7 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 239 4 2 4 2.0 CSc1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL306792 102998 1 None -4 6 Human 7.7 pKi = 7.7 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 239 4 2 4 2.0 CSc1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
10934575 204486 0 None -1 6 Human 7.7 pKi = 7.7 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 235 4 2 4 2.1 CSc1ccc(C)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL72441 204486 0 None -1 6 Human 7.7 pKi = 7.7 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 235 4 2 4 2.1 CSc1ccc(C)cc1NCC1=NCCN1 10.1021/jm000542r
9894818 98925 0 None 83 7 Human 7.7 pKi = 7.7 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL279436 98925 0 None 83 7 Human 7.7 pKi = 7.7 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
9894818 98925 0 None 83 7 Human 7.7 pKi = 7.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
CHEMBL279436 98925 0 None 83 7 Human 7.7 pKi = 7.7 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 593 10 3 6 4.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
53328684 63398 0 None 2 3 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 480 9 0 7 3.4 COc1ccccc1N1CCN(CCCCN2C(=O)CC(c3ccc([N+](=O)[O-])cc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796043 63398 0 None 2 3 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 480 9 0 7 3.4 COc1ccccc1N1CCN(CCCCN2C(=O)CC(c3ccc([N+](=O)[O-])cc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
46881494 6608 0 None -20 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 421 9 1 5 4.7 COc1ccccc1OCCNCC1CSC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
CHEMBL1083182 6608 0 None -20 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 421 9 1 5 4.7 COc1ccccc1OCCNCC1CSC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
10106205 207137 1 None -12 4 Human 6.7 pKi = 6.7 Binding
Binding affinity towards alpha-1-adrenergic receptorBinding affinity towards alpha-1-adrenergic receptor
ChEMBL 251 2 2 3 3.0 Cc1c(NC2=NCCN2)cccc1-c1ccccc1 10.1021/jm030030n
CHEMBL92221 207137 1 None -12 4 Human 6.7 pKi = 6.7 Binding
Binding affinity towards alpha-1-adrenergic receptorBinding affinity towards alpha-1-adrenergic receptor
ChEMBL 251 2 2 3 3.0 Cc1c(NC2=NCCN2)cccc1-c1ccccc1 10.1021/jm030030n
10183297 93312 0 None -109 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 464 7 1 3 6.7 CC(C)C(=O)Nc1cccc(C2CCN(Cc3ccc(Oc4ccc(F)c(F)c4)cc3)CC2)c1 10.1021/jm060383x
CHEMBL245231 93312 0 None -109 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 464 7 1 3 6.7 CC(C)C(=O)Nc1cccc(C2CCN(Cc3ccc(Oc4ccc(F)c(F)c4)cc3)CC2)c1 10.1021/jm060383x
102 4127 48 None -85 49 Bovine 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00375a017
3659 4127 48 None -85 49 Bovine 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00375a017
8969 4127 48 None -85 49 Bovine 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00375a017
CHEMBL15245 4127 48 None -85 49 Bovine 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00375a017
DB01392 4127 48 None -85 49 Bovine 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00375a017
57393634 69319 0 None -1 5 Pig 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 953 32 2 13 6.2 COc1cc(COCCOCCOCCOCCOCc2ccc(N3CCN(CCCCNC(=O)c4ccccc4)CC3)c(OC)c2)ccc1N1CCN(CCCCNC(=O)c2ccccc2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928248 69319 0 None -1 5 Pig 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 953 32 2 13 6.2 COc1cc(COCCOCCOCCOCCOCc2ccc(N3CCN(CCCCNC(=O)c4ccccc4)CC3)c(OC)c2)ccc1N1CCN(CCCCNC(=O)c2ccccc2)CC1 10.1016/j.bmc.2011.10.063
2737203 183924 83 None -141 2 Bovine 5.7 pKi = 5.7 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 188 1 1 4 0.4 N#Cc1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL48137 183924 83 None -141 2 Bovine 5.7 pKi = 5.7 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 188 1 1 4 0.4 N#Cc1cccnc1N1CCNCC1 10.1021/jm00366a007
1028 291 71 None -48 30 Human 5.7 pKi = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
139148732 291 71 None -48 30 Human 5.7 pKi = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
479 291 71 None -48 30 Human 5.7 pKi = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
5816 291 71 None -48 30 Human 5.7 pKi = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
CHEMBL679 291 71 None -48 30 Human 5.7 pKi = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
DB00668 291 71 None -48 30 Human 5.7 pKi = 5.7 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm00118a019
43260 5482 65 None -1 4 Rat 5.7 pKi = 5.7 Binding
Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (1.6 -2.5)Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (1.6 -2.5)
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1021/jm025550h
CHEMBL1076 5482 65 None -1 4 Rat 5.7 pKi = 5.7 Binding
Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (1.6 -2.5)Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (1.6 -2.5)
ChEMBL 197 4 2 4 0.7 COc1ccc(OC)c(C(O)CN)c1 10.1021/jm025550h
10892762 78821 0 None -52 6 Human 6.7 pKi = 6.7 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 326 7 1 4 3.8 COc1cccc(C2CCC(NCCOc3ccccn3)CC2)c1 10.1021/jm010866v
CHEMBL2112774 78821 0 None -52 6 Human 6.7 pKi = 6.7 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 326 7 1 4 3.8 COc1cccc(C2CCC(NCCOc3ccccn3)CC2)c1 10.1021/jm010866v
12134995 102142 0 None -1 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 318 5 1 5 2.6 COc1ccccc1N1CCN(Cc2ccc(CO)s2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL302495 102142 0 None -1 3 Human 6.7 pKi = 6.7 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 318 5 1 5 2.6 COc1ccccc1N1CCN(Cc2ccc(CO)s2)CC1 10.1016/s0960-894x(02)00347-5
9885114 119604 5 None -47 12 Rat 6.7 pKi = 6.7 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 357 3 1 4 3.0 O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1 10.1021/jm990277d
CHEMBL346389 119604 5 None -47 12 Rat 6.7 pKi = 6.7 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 357 3 1 4 3.0 O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1 10.1021/jm990277d
218362 204800 5 None -75 4 Human 6.7 pKi = 6.7 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 216 1 1 3 2.0 c1ccc2c(c1)CCCC2NC1=NCCO1 10.1016/0960-894X(94)85032-1
CHEMBL75030 204800 5 None -75 4 Human 6.7 pKi = 6.7 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 216 1 1 3 2.0 c1ccc2c(c1)CCCC2NC1=NCCO1 10.1016/0960-894X(94)85032-1
9904606 9386 0 None -2 3 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 305 3 1 3 2.3 CN(c1cccc2c1CCCC2c1c[nH]cn1)S(C)(=O)=O 10.1021/jm030551a
CHEMBL111463 9386 0 None -2 3 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 305 3 1 3 2.3 CN(c1cccc2c1CCCC2c1c[nH]cn1)S(C)(=O)=O 10.1021/jm030551a
11347303 111380 0 None -91 4 Bovine 5.7 pKi = 5.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1ccc2c(c1)C(c1c[nH]cn1)CCC2 10.1021/jm030551a
CHEMBL327116 111380 0 None -91 4 Bovine 5.7 pKi = 5.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1ccc2c(c1)C(c1c[nH]cn1)CCC2 10.1021/jm030551a
1220 187 55 None -1659 44 Rat 5.7 pKi = 5.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm030944+
31 187 55 None -1659 44 Rat 5.7 pKi = 5.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm030944+
7 187 55 None -1659 44 Rat 5.7 pKi = 5.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm030944+
CHEMBL56 187 55 None -1659 44 Rat 5.7 pKi = 5.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 247 5 1 2 3.4 CCCN(C1CCc2c(C1)c(O)ccc2)CCC 10.1021/jm030944+
11857709 85639 0 None 1 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 556 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL228389 85639 0 None 1 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 556 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
11857709 85639 0 None 1 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 556 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL228389 85639 0 None 1 4 Human 7.7 pKi = 7.7 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 556 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
26987 949 33 None -75 21 Rat 7.7 pKi = 7.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
6063 949 33 None -75 21 Rat 7.7 pKi = 7.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
671 949 33 None -75 21 Rat 7.7 pKi = 7.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
CHEMBL1626 949 33 None -75 21 Rat 7.7 pKi = 7.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
DB00283 949 33 None -75 21 Rat 7.7 pKi = 7.7 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 343 6 0 2 5.1 Clc1ccc(cc1)[C@@](c1ccccc1)(OCC[C@H]1CCCN1C)C nan
9798183 13140 0 None -33 3 Rat 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 343 5 1 2 4.4 Fc1ccc2c(C3CCN(CCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
CHEMBL1190579 13140 0 None -33 3 Rat 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 343 5 1 2 4.4 Fc1ccc2c(C3CCN(CCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
CHEMBL541129 13140 0 None -33 3 Rat 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 343 5 1 2 4.4 Fc1ccc2c(C3CCN(CCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
11496213 16074 0 None -35 3 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 454 8 1 4 6.1 Clc1cccc(N2CCN(CCCCNc3ccc(-c4ccccc4)cn3)CC2)c1Cl 10.1016/j.bmcl.2010.07.096
CHEMBL1223800 16074 0 None -35 3 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 454 8 1 4 6.1 Clc1cccc(N2CCN(CCCCNc3ccc(-c4ccccc4)cn3)CC2)c1Cl 10.1016/j.bmcl.2010.07.096
46934789 16691 0 None -2 4 Human 7.7 pKi = 7.7 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 479 7 0 7 2.6 COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3C(=O)CCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242819 16691 0 None -2 4 Human 7.7 pKi = 7.7 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 479 7 0 7 2.6 COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3C(=O)CCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
118716708 115002 0 None 1 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 441 5 0 7 2.5 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)c4ccco4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342861 115002 0 None 1 4 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 441 5 0 7 2.5 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)c4ccco4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
73346042 91834 5 None -213 17 Human 7.7 pKi = 7.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 405 9 0 8 0.9 Cn1c(=O)cnn(CCCCN2CCN(c3ccccc3OCCF)CC2)c1=O 10.1016/j.bmc.2013.05.050
CHEMBL2413153 91834 5 None -213 17 Human 7.7 pKi = 7.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 405 9 0 8 0.9 Cn1c(=O)cnn(CCCCN2CCN(c3ccccc3OCCF)CC2)c1=O 10.1016/j.bmc.2013.05.050
73346042 91834 5 None -213 17 Human 7.7 pKi = 7.7 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 405 9 0 8 0.9 Cn1c(=O)cnn(CCCCN2CCN(c3ccccc3OCCF)CC2)c1=O 10.1021/acs.jmedchem.2c00633
CHEMBL2413153 91834 5 None -213 17 Human 7.7 pKi = 7.7 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 405 9 0 8 0.9 Cn1c(=O)cnn(CCCCN2CCN(c3ccccc3OCCF)CC2)c1=O 10.1021/acs.jmedchem.2c00633
53328316 63391 0 None 1 3 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 449 9 0 5 3.9 COc1ccccc1N1CCN(CCCCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796036 63391 0 None 1 3 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 449 9 0 5 3.9 COc1ccccc1N1CCN(CCCCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
13938356 185078 0 None -154 2 Bovine 6.7 pKi = 6.7 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 364 4 1 5 1.7 CN(C1CCN2CCc3c(oc4ccccc34)C2C1)S(=O)(=O)CCO 10.1021/jm00150a002
CHEMBL48558 185078 0 None -154 2 Bovine 6.7 pKi = 6.7 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 364 4 1 5 1.7 CN(C1CCN2CCc3c(oc4ccccc34)C2C1)S(=O)(=O)CCO 10.1021/jm00150a002
127027079 137776 0 None -416 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 442 7 2 4 3.7 O=C1Cc2c(cccc2N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)N1 10.1016/j.bmcl.2015.12.068
CHEMBL3759441 137776 0 None -416 3 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 442 7 2 4 3.7 O=C1Cc2c(cccc2N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)N1 10.1016/j.bmcl.2015.12.068
145946733 167580 0 None -14 5 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 368 7 0 4 4.2 COc1ccc(N2CCN(CCCOc3c(C)cc(C)cc3C)CC2)cc1 10.1016/j.bmcl.2018.04.059
CHEMBL4205526 167580 0 None -14 5 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 368 7 0 4 4.2 COc1ccc(N2CCN(CCCOc3c(C)cc(C)cc3C)CC2)cc1 10.1016/j.bmcl.2018.04.059
CHEMBL4300710 167580 0 None -14 5 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 368 7 0 4 4.2 COc1ccc(N2CCN(CCCOc3c(C)cc(C)cc3C)CC2)cc1 10.1016/j.bmcl.2018.04.059
11176459 101637 0 None -39 4 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 380 4 0 5 2.4 N#Cc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
CHEMBL299022 101637 0 None -39 4 Rat 6.7 pKi = 6.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 380 4 0 5 2.4 N#Cc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
44312037 204619 1 None -2 6 Human 4.7 pKi = 4.7 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 308 1 1 5 2.9 Brc1c(NC2=NCCS2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL73392 204619 1 None -2 6 Human 4.7 pKi = 4.7 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 308 1 1 5 2.9 Brc1c(NC2=NCCS2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
179268 102166 6 None -4 2 Human 5.7 pKi = 5.7 Binding
Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 454 2 3 1 6.2 Brc1ccc2c(-c3c[nH]c(-c4c[nH]c5cc(Br)ccc45)n3)c[nH]c2c1 10.1016/0960-894X(96)00376-9
CHEMBL302637 102166 6 None -4 2 Human 5.7 pKi = 5.7 Binding
Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 454 2 3 1 6.2 Brc1ccc2c(-c3c[nH]c(-c4c[nH]c5cc(Br)ccc45)n3)c[nH]c2c1 10.1016/0960-894X(96)00376-9
11959098 179536 56 None -79 2 Bovine 6.7 pKi = 6.7 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 211 1 0 3 1.5 CN1CCN(c2ncccc2Cl)CC1 10.1021/jm00366a007
CHEMBL47415 179536 56 None -79 2 Bovine 6.7 pKi = 6.7 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 211 1 0 3 1.5 CN1CCN(c2ncccc2Cl)CC1 10.1021/jm00366a007
10737133 206661 0 None -15 2 Rat 6.7 pKi = 6.7 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 358 6 0 5 2.3 COc1ccccc1N1CCN(CCCN2CC3CCCCN3C2)CC1 10.1021/jm970216k
CHEMBL89380 206661 0 None -15 2 Rat 6.7 pKi = 6.7 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 358 6 0 5 2.3 COc1ccccc1N1CCN(CCCN2CC3CCCCN3C2)CC1 10.1021/jm970216k
10028436 3532 5 None -109 12 Human 6.7 pKi = 6.7 Binding
Compound was tested for its binding affinity for Alpha 1B adrenergic receptorCompound was tested for its binding affinity for Alpha 1B adrenergic receptor
ChEMBL 487 7 1 4 4.9 Clc1ccc(cc1)OC1CCN(CC1)CC[C@H]1CCCN1S(=O)(=O)c1ccc2c(c1)[nH]cc2 10.1016/s0960-894x(02)00690-x
3237 3532 5 None -109 12 Human 6.7 pKi = 6.7 Binding
Compound was tested for its binding affinity for Alpha 1B adrenergic receptorCompound was tested for its binding affinity for Alpha 1B adrenergic receptor
ChEMBL 487 7 1 4 4.9 Clc1ccc(cc1)OC1CCN(CC1)CC[C@H]1CCCN1S(=O)(=O)c1ccc2c(c1)[nH]cc2 10.1016/s0960-894x(02)00690-x
CHEMBL95104 3532 5 None -109 12 Human 6.7 pKi = 6.7 Binding
Compound was tested for its binding affinity for Alpha 1B adrenergic receptorCompound was tested for its binding affinity for Alpha 1B adrenergic receptor
ChEMBL 487 7 1 4 4.9 Clc1ccc(cc1)OC1CCN(CC1)CC[C@H]1CCCN1S(=O)(=O)c1ccc2c(c1)[nH]cc2 10.1016/s0960-894x(02)00690-x
10903226 13770 0 None -2 4 Human 5.7 pKi = 5.7 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 281 6 2 5 1.3 CCCS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1195368 13770 0 None -2 4 Human 5.7 pKi = 5.7 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 281 6 2 5 1.3 CCCS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL554416 13770 0 None -2 4 Human 5.7 pKi = 5.7 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 281 6 2 5 1.3 CCCS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
44314200 102952 0 None -81 4 Human 5.7 pKi = 5.7 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 230 1 1 3 2.4 c1ccc2c(c1)CCCC2NC1=NCCCO1 10.1016/0960-894X(94)85032-1
CHEMBL306377 102952 0 None -81 4 Human 5.7 pKi = 5.7 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 230 1 1 3 2.4 c1ccc2c(c1)CCCC2NC1=NCCCO1 10.1016/0960-894X(94)85032-1
10626453 122015 0 None 72 3 Human 7.7 pKi = 7.7 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 548 9 0 6 6.2 COC(=O)C1=C(C)N=C(C)N(CCC[C@@H](C)CN2CCC(C#N)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL359430 122015 0 None 72 3 Human 7.7 pKi = 7.7 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 548 9 0 6 6.2 COC(=O)C1=C(C)N=C(C)N(CCC[C@@H](C)CN2CCC(C#N)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
135398737 958 93 None -5 89 Rat 7.7 pKi = 7.7 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
38 958 93 None -5 89 Rat 7.7 pKi = 7.7 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
722 958 93 None -5 89 Rat 7.7 pKi = 7.7 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
CHEMBL42 958 93 None -5 89 Rat 7.7 pKi = 7.7 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
DB00363 958 93 None -5 89 Rat 7.7 pKi = 7.7 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1021/jm9810396
10768610 203770 0 None 24 2 Human 7.7 pKi = 7.7 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 532 8 2 7 2.5 COc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
CHEMBL68045 203770 0 None 24 2 Human 7.7 pKi = 7.7 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 532 8 2 7 2.5 COc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
9888164 17951 1 None 25 3 Human 7.7 pKi = 7.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 416 8 1 5 2.1 CC(C)Oc1ccccc1N1CCN(CCNC(=O)CN2CCCCCC2=O)CC1 10.1016/j.bmcl.2004.11.032
CHEMBL12603 17951 1 None 25 3 Human 7.7 pKi = 7.7 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 416 8 1 5 2.1 CC(C)Oc1ccccc1N1CCN(CCNC(=O)CN2CCCCCC2=O)CC1 10.1016/j.bmcl.2004.11.032
16041264 95443 0 None -1 4 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 470 6 2 4 5.4 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cccc(Cl)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL257077 95443 0 None -1 4 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 470 6 2 4 5.4 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cccc(Cl)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
71508710 87055 0 None 50 2 Bovine 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 368 3 0 4 4.9 CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4cccnc4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2325933 87055 0 None 50 2 Bovine 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 368 3 0 4 4.9 CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4cccnc4)cc23)CC1 10.1016/j.bmc.2012.10.049
44289026 166386 0 None 87 3 Human 7.7 pKi = 7.7 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 533 8 1 3 6.5 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C(F)(F)F)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL42763 166386 0 None 87 3 Human 7.7 pKi = 7.7 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 533 8 1 3 6.5 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C(F)(F)F)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
9879119 9446 0 None 4 4 Rat 7.7 pKi = 7.7 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 291 4 2 3 2.2 CCS(=O)(=O)Nc1cccc2c1CCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL111771 9446 0 None 4 4 Rat 7.7 pKi = 7.7 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 291 4 2 3 2.2 CCS(=O)(=O)Nc1cccc2c1CCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
53327991 63401 0 None -9 3 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 449 8 0 5 3.7 COc1ccccc1N1CCN(CCCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796046 63401 0 None -9 3 Human 7.7 pKi = 7.7 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 449 8 0 5 3.7 COc1ccccc1N1CCN(CCCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
145962368 161457 0 None -74 3 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 521 9 0 8 5.1 CCCN(CCC)c1nc(N2CCN(C(=O)c3ccco3)[C@H]3CCCC[C@H]32)nc2cc(OC)c(OC)cc12 10.1016/j.bmc.2018.05.023
CHEMBL4127483 161457 0 None -74 3 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 521 9 0 8 5.1 CCCN(CCC)c1nc(N2CCN(C(=O)c3ccco3)[C@H]3CCCC[C@H]32)nc2cc(OC)c(OC)cc12 10.1016/j.bmc.2018.05.023
9879119 9446 0 None 4 4 Rat 7.7 pKi = 7.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 291 4 2 3 2.2 CCS(=O)(=O)Nc1cccc2c1CCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111771 9446 0 None 4 4 Rat 7.7 pKi = 7.7 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 291 4 2 3 2.2 CCS(=O)(=O)Nc1cccc2c1CCC2c1c[nH]cn1 10.1021/jm030551a
102 4127 48 None -85 49 Bovine 6.7 pKi = 6.7 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
3659 4127 48 None -85 49 Bovine 6.7 pKi = 6.7 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
8969 4127 48 None -85 49 Bovine 6.7 pKi = 6.7 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
CHEMBL15245 4127 48 None -85 49 Bovine 6.7 pKi = 6.7 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
DB01392 4127 48 None -85 49 Bovine 6.7 pKi = 6.7 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
145947545 167694 0 None -199 3 Human 6.7 pKi = 6.7 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 341 4 2 4 3.1 CSc1ccc(Cl)cc1Cn1cc(Cl)cc(C(N)=O)c1=N 10.1016/j.ejmech.2017.07.071
CHEMBL4208816 167694 0 None -199 3 Human 6.7 pKi = 6.7 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 341 4 2 4 3.1 CSc1ccc(Cl)cc1Cn1cc(Cl)cc(C(N)=O)c1=N 10.1016/j.ejmech.2017.07.071
CHEMBL4302269 167694 0 None -199 3 Human 6.7 pKi = 6.7 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 341 4 2 4 3.1 CSc1ccc(Cl)cc1Cn1cc(Cl)cc(C(N)=O)c1=N 10.1016/j.ejmech.2017.07.071
102 4127 48 None -85 49 Bovine 6.7 pKi = 6.7 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00150a002
3659 4127 48 None -85 49 Bovine 6.7 pKi = 6.7 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00150a002
8969 4127 48 None -85 49 Bovine 6.7 pKi = 6.7 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00150a002
CHEMBL15245 4127 48 None -85 49 Bovine 6.7 pKi = 6.7 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00150a002
DB01392 4127 48 None -85 49 Bovine 6.7 pKi = 6.7 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00150a002
44301572 201375 0 None - 1 Human 6.7 pKi = 6.7 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 555 7 0 4 6.8 Cc1ccc(C2(c3ccc(C)cc3)CC(=S)N(CCCN3CCC(C#N)(c4ccccc4Cl)CC3)C2=O)cc1 10.1016/s0960-894x(01)00320-1
CHEMBL60452 201375 0 None - 1 Human 6.7 pKi = 6.7 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 555 7 0 4 6.8 Cc1ccc(C2(c3ccc(C)cc3)CC(=S)N(CCCN3CCC(C#N)(c4ccccc4Cl)CC3)C2=O)cc1 10.1016/s0960-894x(01)00320-1
3303 2244 46 None -3235 15 Human 5.7 pKi = 5.7 Binding
Inhibition of alpha1C adrenergic receptor (unknown origin)Inhibition of alpha1C adrenergic receptor (unknown origin)
ChEMBL 326 3 1 3 3.5 Clc1ccc(cc1)N1CCN(CC1)Cc1c[nH]c2c1cccn2 10.1021/acs.jmedchem.7b00151
5311200 2244 46 None -3235 15 Human 5.7 pKi = 5.7 Binding
Inhibition of alpha1C adrenergic receptor (unknown origin)Inhibition of alpha1C adrenergic receptor (unknown origin)
ChEMBL 326 3 1 3 3.5 Clc1ccc(cc1)N1CCN(CC1)Cc1c[nH]c2c1cccn2 10.1021/acs.jmedchem.7b00151
CHEMBL267014 2244 46 None -3235 15 Human 5.7 pKi = 5.7 Binding
Inhibition of alpha1C adrenergic receptor (unknown origin)Inhibition of alpha1C adrenergic receptor (unknown origin)
ChEMBL 326 3 1 3 3.5 Clc1ccc(cc1)N1CCN(CC1)Cc1c[nH]c2c1cccn2 10.1021/acs.jmedchem.7b00151
76307952 84830 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 375 7 1 4 4.0 c1ccc(OCCNC2COC(c3ccccc3)(c3ccccc3)CO2)cc1 10.1007/s00044-010-9379-1
CHEMBL2234455 84830 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 375 7 1 4 4.0 c1ccc(OCCNC2COC(c3ccccc3)(c3ccccc3)CO2)cc1 10.1007/s00044-010-9379-1
145962817 161519 0 None -74 5 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 385 3 1 7 2.2 COc1cc2nc(N3CCN(C(C)=O)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4128311 161519 0 None -74 5 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 385 3 1 7 2.2 COc1cc2nc(N3CCN(C(C)=O)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
44568818 187705 0 None -6 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNC[C@@H]2COC(c3ccccc3)(c3ccccc3)CO2)cc1 10.1021/jm800461k
CHEMBL495289 187705 0 None -6 4 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNC[C@@H]2COC(c3ccccc3)(c3ccccc3)CO2)cc1 10.1021/jm800461k
6917970 3691 61 None -512 34 Rat 5.7 pKi = 5.7 Binding
Displacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 minsDisplacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 mins
ChEMBL 327 2 2 5 2.8 COc1cc2CCN3[C@H](c2cc1O)Cc1c(C3)c(OC)c(cc1)O 10.1021/acs.jmedchem.6b01217
8370 3691 61 None -512 34 Rat 5.7 pKi = 5.7 Binding
Displacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 minsDisplacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 mins
ChEMBL 327 2 2 5 2.8 COc1cc2CCN3[C@H](c2cc1O)Cc1c(C3)c(OC)c(cc1)O 10.1021/acs.jmedchem.6b01217
CHEMBL487387 3691 61 None -512 34 Rat 5.7 pKi = 5.7 Binding
Displacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 minsDisplacement of [125I]-BE2254 from Wistar rat alpha1A adrenoceptor after 20 mins
ChEMBL 327 2 2 5 2.8 COc1cc2CCN3[C@H](c2cc1O)Cc1c(C3)c(OC)c(cc1)O 10.1021/acs.jmedchem.6b01217
44271903 63284 0 None - 1 Bovine 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 208 1 0 2 2.5 CN1CC=C(c2ncccc2Cl)CC1 10.1021/jm00375a017
CHEMBL17926 63284 0 None - 1 Bovine 5.7 pKi = 5.7 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 208 1 0 2 2.5 CN1CC=C(c2ncccc2Cl)CC1 10.1021/jm00375a017
11655403 16075 0 None -208 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 454 8 1 4 5.8 FC(F)(F)c1cccc(N2CCN(CCCCNc3ccc(-c4ccccc4)cn3)CC2)c1 10.1016/j.bmcl.2010.07.096
CHEMBL1223801 16075 0 None -208 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 454 8 1 4 5.8 FC(F)(F)c1cccc(N2CCN(CCCCNc3ccc(-c4ccccc4)cn3)CC2)c1 10.1016/j.bmcl.2010.07.096
73347826 92542 0 None -1 7 Human 5.6 pKi = 5.6 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin) by PDSP assayInhibition of adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 266 4 1 2 2.4 c1ccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)nc1 10.1016/j.bmc.2013.07.045
CHEMBL2432049 92542 0 None -1 7 Human 5.6 pKi = 5.6 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin) by PDSP assayInhibition of adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 266 4 1 2 2.4 c1ccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)nc1 10.1016/j.bmc.2013.07.045
134157330 153704 0 None -75 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 321 7 1 5 2.7 COc1ccccc1OCCNCC1COC2(CCCCC2)O1 10.1016/j.ejmech.2016.09.050
CHEMBL3981480 153704 0 None -75 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 321 7 1 5 2.7 COc1ccccc1OCCNCC1COC2(CCCCC2)O1 10.1016/j.ejmech.2016.09.050
115 343 71 None -2 6 Bovine 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm00018a001
2092 343 71 None -2 6 Bovine 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm00018a001
7109 343 71 None -2 6 Bovine 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm00018a001
CHEMBL709 343 71 None -2 6 Bovine 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm00018a001
DB00346 343 71 None -2 6 Bovine 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm00018a001
44431560 89164 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL236621 89164 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
44433348 90263 0 None -8 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 545 10 0 7 4.6 CCN([C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1)S(=O)(=O)c1ccc(OC)c(OC)c1 10.1016/j.bmcl.2007.09.051
CHEMBL238401 90263 0 None -8 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 545 10 0 7 4.6 CCN([C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1)S(=O)(=O)c1ccc(OC)c(OC)c1 10.1016/j.bmcl.2007.09.051
44431560 89164 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.008
CHEMBL236621 89164 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.008
11857863 85683 0 None 2 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 534 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccc(F)cc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL228658 85683 0 None 2 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 534 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccc(F)cc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
1531 2266 69 None -3 16 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
3869 2266 69 None -3 16 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
7207 2266 69 None -3 16 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
CHEMBL429 2266 69 None -3 16 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
DB00598 2266 69 None -3 16 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O nan
49865599 16020 0 None -28 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 340 8 1 5 3.1 COc1ccccc1N1CCN(CCCCNc2ccccn2)CC1 10.1016/j.bmcl.2010.07.096
CHEMBL1223615 16020 0 None -28 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 340 8 1 5 3.1 COc1ccccc1N1CCN(CCCCNc2ccccn2)CC1 10.1016/j.bmcl.2010.07.096
11303180 198226 0 None -6 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 369 5 0 4 3.1 COc1ccccc1N1CCN(CCN2C=CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
CHEMBL57540 198226 0 None -6 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 369 5 0 4 3.1 COc1ccccc1N1CCN(CCN2C=CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
11303180 198226 0 None -6 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 369 5 0 4 3.1 COc1ccccc1N1CCN(CCN2C=CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
CHEMBL57540 198226 0 None -6 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 369 5 0 4 3.1 COc1ccccc1N1CCN(CCN2C=CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
76323010 106248 0 None -26 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 451 4 1 8 3.4 COc1cc2nc(N3CCN(C(=O)c4ccc(C)o4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
CHEMBL2261606 106248 0 None -26 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 451 4 1 8 3.4 COc1cc2nc(N3CCN(C(=O)c4ccc(C)o4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
CHEMBL3138929 106248 0 None -26 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 451 4 1 8 3.4 COc1cc2nc(N3CCN(C(=O)c4ccc(C)o4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
16721032 92188 0 None -26 5 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 451 4 1 8 3.4 COc1cc2nc(N3CCN(C(=O)c4ccc(C)o4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
CHEMBL242507 92188 0 None -26 5 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 451 4 1 8 3.4 COc1cc2nc(N3CCN(C(=O)c4ccc(C)o4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
10790988 116100 0 None -2 3 Human 7.6 pKi = 7.6 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 483 8 1 10 2.0 COc1cc2nc(N3CCN(C(=O)COc4c(OC)cccc4OC)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL335731 116100 0 None -2 3 Human 7.6 pKi = 7.6 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 483 8 1 10 2.0 COc1cc2nc(N3CCN(C(=O)COc4c(OC)cccc4OC)CC3)nc(N)c2cc1OC 10.1021/jm9805337
10621592 84571 0 None -1 6 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153559 84571 0 None -1 6 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220898 84571 0 None -1 6 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
4011 82408 49 None -125 24 Rat 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 nan
CHEMBL21731 82408 49 None -125 24 Rat 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 4 1 1 4.2 CNCCCC12CCC(c3ccccc31)c1ccccc12 nan
127025258 137694 0 None -173 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 415 7 1 3 4.8 Cc1cccc(N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)c1C 10.1016/j.bmcl.2015.12.068
CHEMBL3758741 137694 0 None -173 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 415 7 1 3 4.8 Cc1cccc(N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)c1C 10.1016/j.bmcl.2015.12.068
9844022 123061 0 None -32 2 Rat 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 401 6 1 2 5.6 c1ccc(C2CCN(CCCN3CCC(c4c[nH]c5ccccc45)CC3)CC2)cc1 10.1016/j.bmcl.2015.07.046
CHEMBL3609358 123061 0 None -32 2 Rat 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 401 6 1 2 5.6 c1ccc(C2CCN(CCCN3CCC(c4c[nH]c5ccccc45)CC3)CC2)cc1 10.1016/j.bmcl.2015.07.046
12134991 205713 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 412 7 0 6 3.3 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCCC3=O)co2)CC1 10.1016/s0960-894x(02)00436-5
CHEMBL82480 205713 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 412 7 0 6 3.3 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCCC3=O)co2)CC1 10.1016/s0960-894x(02)00436-5
11486511 101584 0 None -691 4 Human 6.6 pKi = 6.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 403 4 0 4 3.6 O=C1CC2(CCCC2)CC(=O)N1CCN1CCCN(c2ccccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL298595 101584 0 None -691 4 Human 6.6 pKi = 6.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 403 4 0 4 3.6 O=C1CC2(CCCC2)CC(=O)N1CCN1CCCN(c2ccccc2Cl)CC1 10.1007/s00044-010-9379-1
11994671 11829 0 None 1 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cc(-c2ccccc2)ccc1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182138 11829 0 None 1 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cc(-c2ccccc2)ccc1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL214506 11829 0 None 1 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cc(-c2ccccc2)ccc1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
2162 41514 100 None -3 6 Human 5.6 pKi = 5.6 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1016/s0960-894x(99)00484-9
CHEMBL1491 41514 100 None -3 6 Human 5.6 pKi = 5.6 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1016/s0960-894x(99)00484-9
11486511 101584 0 None -691 4 Human 6.6 pKi = 6.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 403 4 0 4 3.6 O=C1CC2(CCCC2)CC(=O)N1CCN1CCCN(c2ccccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL298595 101584 0 None -691 4 Human 6.6 pKi = 6.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 403 4 0 4 3.6 O=C1CC2(CCCC2)CC(=O)N1CCN1CCCN(c2ccccc2Cl)CC1 10.1007/s00044-010-9379-1
21509921 104458 0 None -234 24 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 288 0 0 2 3.7 CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1 10.1016/j.bmcl.2013.12.024
CHEMBL3104091 104458 0 None -234 24 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 288 0 0 2 3.7 CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1 10.1016/j.bmcl.2013.12.024
21509921 104458 0 None -234 24 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 288 0 0 2 3.7 CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1 10.1016/j.bmcl.2013.12.024
CHEMBL3104091 104458 0 None -234 24 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 288 0 0 2 3.7 CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1 10.1016/j.bmcl.2013.12.024
14004033 49232 5 None -2 2 Bovine 4.6 pKi = 4.6 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 177 0 1 2 1.5 c1[nH]nc2c1CCN1CCCCC21 10.1021/jm00398a025
CHEMBL156283 49232 5 None -2 2 Bovine 4.6 pKi = 4.6 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 177 0 1 2 1.5 c1[nH]nc2c1CCN1CCCCC21 10.1021/jm00398a025
13151 981 0 None -151 4 Rat 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 391 5 1 2 4.9 FC1=CC=C2C(=CNC2=C1)C3CCN(CC3)CCCN4CC5=CC=CC=C5CC4 10.1016/j.bmcl.2015.07.046
9930376 981 0 None -151 4 Rat 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 391 5 1 2 4.9 FC1=CC=C2C(=CNC2=C1)C3CCN(CC3)CCCN4CC5=CC=CC=C5CC4 10.1016/j.bmcl.2015.07.046
CHEMBL3609360 981 0 None -151 4 Rat 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 391 5 1 2 4.9 FC1=CC=C2C(=CNC2=C1)C3CCN(CC3)CCCN4CC5=CC=CC=C5CC4 10.1016/j.bmcl.2015.07.046
71508686 87053 0 None 10 2 Bovine 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 368 3 0 4 4.9 CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4ccncc4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2325931 87053 0 None 10 2 Bovine 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 368 3 0 4 4.9 CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4ccncc4)cc23)CC1 10.1016/j.bmc.2012.10.049
44288995 162884 0 None 39 3 Human 7.6 pKi = 7.6 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 435 8 1 3 4.9 Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(F)cc2)C(C)C)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL417350 162884 0 None 39 3 Human 7.6 pKi = 7.6 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 435 8 1 3 4.9 Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(F)cc2)C(C)C)CC1 10.1016/s0960-894x(00)00307-3
10962489 11190 0 None -1 2 Human 7.6 pKi = 7.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 8 0 3 4.5 C[N+](C)(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
CHEMBL1178679 11190 0 None -1 2 Human 7.6 pKi = 7.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 8 0 3 4.5 C[N+](C)(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
CHEMBL37212 11190 0 None -1 2 Human 7.6 pKi = 7.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 8 0 3 4.5 C[N+](C)(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
10363912 6538 0 None -36 6 Human 7.6 pKi = 7.6 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
CHEMBL1082862 6538 0 None -36 6 Human 7.6 pKi = 7.6 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
CHEMBL286003 6538 0 None -36 6 Human 7.6 pKi = 7.6 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 405 9 1 5 4.0 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
155532835 176454 0 None -31 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 9 1 5 4.4 COc1ccccc1OCCNCC1CCOC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4467585 176454 0 None -31 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 9 1 5 4.4 COc1ccccc1OCCNCC1CCOC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4596417 176454 0 None -31 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 9 1 5 4.4 COc1ccccc1OCCNCC1CCOC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
10386062 206772 0 None -19 2 Rat 6.6 pKi = 6.6 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 396 6 0 4 3.3 FC(F)(F)c1cccc(N2CCN(CCCCN3CC4CCCN4C3)CC2)c1 10.1021/jm970216k
CHEMBL90165 206772 0 None -19 2 Rat 6.6 pKi = 6.6 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 396 6 0 4 3.3 FC(F)(F)c1cccc(N2CCN(CCCCN3CC4CCCN4C3)CC2)c1 10.1021/jm970216k
9817327 123056 0 None -50 2 Rat 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 285 5 1 2 3.3 CN(C)CCCN1CCC(c2c[nH]c3ccccc23)CC1 10.1016/j.bmcl.2015.07.046
CHEMBL3609353 123056 0 None -50 2 Rat 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 285 5 1 2 3.3 CN(C)CCCN1CCC(c2c[nH]c3ccccc23)CC1 10.1016/j.bmcl.2015.07.046
44289089 164585 0 None 3 3 Human 6.6 pKi = 6.6 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 453 10 1 6 3.2 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)CCc2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL42156 164585 0 None 3 3 Human 6.6 pKi = 6.6 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 453 10 1 6 3.2 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)CCc2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(00)00307-3
94459 64274 127 None -64 2 Bovine 5.6 pKi = 5.6 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 163 1 1 3 0.5 c1ccc(N2CCNCC2)nc1 10.1021/jm00366a007
CHEMBL18094 64274 127 None -64 2 Bovine 5.6 pKi = 5.6 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 163 1 1 3 0.5 c1ccc(N2CCNCC2)nc1 10.1021/jm00366a007
94459 64274 127 None -64 2 Bovine 5.6 pKi = 5.6 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 163 1 1 3 0.5 c1ccc(N2CCNCC2)nc1 10.1021/jm00375a017
CHEMBL18094 64274 127 None -64 2 Bovine 5.6 pKi = 5.6 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 163 1 1 3 0.5 c1ccc(N2CCNCC2)nc1 10.1021/jm00375a017
14004033 49232 5 None -2 2 Bovine 4.6 pKi = 4.6 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 177 0 1 2 1.5 c1[nH]nc2c1CCN1CCCCC21 10.1021/jm00398a025
CHEMBL156283 49232 5 None -2 2 Bovine 4.6 pKi = 4.6 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 177 0 1 2 1.5 c1[nH]nc2c1CCN1CCCCC21 10.1021/jm00398a025
165413025 190367 2 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-prazosin from human adrenergic alpha1A receptor expressed in human HEK293 cellsDisplacement of [3H]-prazosin from human adrenergic alpha1A receptor expressed in human HEK293 cells
ChEMBL 364 6 2 6 1.3 NC(CCOc1ccc(S(N)(=O)=O)cc1)C1COc2ccccc2O1 10.1021/acs.jmedchem.2c01192
CHEMBL5177166 190367 2 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-prazosin from human adrenergic alpha1A receptor expressed in human HEK293 cellsDisplacement of [3H]-prazosin from human adrenergic alpha1A receptor expressed in human HEK293 cells
ChEMBL 364 6 2 6 1.3 NC(CCOc1ccc(S(N)(=O)=O)cc1)C1COc2ccccc2O1 10.1021/acs.jmedchem.2c01192
2291 3184 58 None -446 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
2561 3184 58 None -446 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
4932 3184 58 None -446 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
CHEMBL631 3184 58 None -446 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
DB01182 3184 58 None -446 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 341 11 2 4 3.2 CCCNCC(COc1ccccc1C(=O)CCc1ccccc1)O nan
44431590 87980 0 None -13 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 555 8 1 6 4.9 COc1ccc(C(F)(F)F)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234232 87980 0 None -13 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 555 8 1 6 4.9 COc1ccc(C(F)(F)F)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
44289346 168045 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 466 8 1 4 4.9 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccn3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL432302 168045 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 466 8 1 4 4.9 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccn3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
135398745 2914 112 None -13 65 Rat 7.6 pKi = 7.6 Binding
Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
47 2914 112 None -13 65 Rat 7.6 pKi = 7.6 Binding
Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
CHEMBL715 2914 112 None -13 65 Rat 7.6 pKi = 7.6 Binding
Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
DB00334 2914 112 None -13 65 Rat 7.6 pKi = 7.6 Binding
Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.Receptor Binding Assay: Alpha-1 receptor binding studies were performed according to the methods described by Greengrass and Bremner (Eur. J. Pharmacol., 55:323-326, 1979) on rat cortical membrane preparation using [3H]-prazosine (0.22-0.37 nM) as ligand. The non-specific binding was determined in the presence of 10 μM phentolamine.
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
11281005 11843 0 None 13 5 Human 7.6 pKi = 7.6 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 399 8 1 6 3.4 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1016/j.ejmech.2020.112419
CHEMBL1182191 11843 0 None 13 5 Human 7.6 pKi = 7.6 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 399 8 1 6 3.4 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1016/j.ejmech.2020.112419
CHEMBL218079 11843 0 None 13 5 Human 7.6 pKi = 7.6 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 399 8 1 6 3.4 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1016/j.ejmech.2020.112419
15254720 61301 0 None -204 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 367 4 0 4 3.7 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767136 61301 0 None -204 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 367 4 0 4 3.7 CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
24803483 61332 0 None -63 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 654 15 0 6 8.2 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1021/jm1013874
CHEMBL1767167 61332 0 None -63 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 654 15 0 6 8.2 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1021/jm1013874
132266 1278 12 None -28 9 Human 7.6 pKi = 7.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm960697s
486 1278 12 None -28 9 Human 7.6 pKi = 7.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm960697s
CHEMBL423294 1278 12 None -28 9 Human 7.6 pKi = 7.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm960697s
126225 94976 5 None -13 8 Human 7.6 pKi = 7.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm960697s
CHEMBL25467 94976 5 None -13 8 Human 7.6 pKi = 7.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm960697s
11281005 11843 0 None 13 5 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 399 8 1 6 3.4 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL1182191 11843 0 None 13 5 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 399 8 1 6 3.4 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL218079 11843 0 None 13 5 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 399 8 1 6 3.4 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
76326562 106206 0 None -18 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 479 5 1 9 3.3 COc1cc2nc(N3CCN(C(=O)c4ccc(C(C)=O)o4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
CHEMBL2261608 106206 0 None -18 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 479 5 1 9 3.3 COc1cc2nc(N3CCN(C(=O)c4ccc(C(C)=O)o4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
CHEMBL3138761 106206 0 None -18 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 479 5 1 9 3.3 COc1cc2nc(N3CCN(C(=O)c4ccc(C(C)=O)o4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
44428847 92293 0 None -18 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 479 5 1 9 3.3 COc1cc2nc(N3CCN(C(=O)c4ccc(C(C)=O)o4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
CHEMBL242723 92293 0 None -18 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 479 5 1 9 3.3 COc1cc2nc(N3CCN(C(=O)c4ccc(C(C)=O)o4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
12841596 117460 20 None -3 2 Bovine 6.6 pKi = 6.6 Binding
Binding affinity against alpha-1 adrenergic receptor was determined in calf cerebral cortex homogenates using [3H]prazosin as radioligandBinding affinity against alpha-1 adrenergic receptor was determined in calf cerebral cortex homogenates using [3H]prazosin as radioligand
ChEMBL 237 1 1 5 0.8 Clc1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
CHEMBL2448004 117460 20 None -3 2 Bovine 6.6 pKi = 6.6 Binding
Binding affinity against alpha-1 adrenergic receptor was determined in calf cerebral cortex homogenates using [3H]prazosin as radioligandBinding affinity against alpha-1 adrenergic receptor was determined in calf cerebral cortex homogenates using [3H]prazosin as radioligand
ChEMBL 237 1 1 5 0.8 Clc1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
CHEMBL339883 117460 20 None -3 2 Bovine 6.6 pKi = 6.6 Binding
Binding affinity against alpha-1 adrenergic receptor was determined in calf cerebral cortex homogenates using [3H]prazosin as radioligandBinding affinity against alpha-1 adrenergic receptor was determined in calf cerebral cortex homogenates using [3H]prazosin as radioligand
ChEMBL 237 1 1 5 0.8 Clc1cn2ccnc2c(N2CCNCC2)n1 10.1021/jm00099a012
2419 695 28 None -288 12 Human 6.6 pKi = 6.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.bmcl.2004.11.032
9 695 28 None -288 12 Human 6.6 pKi = 6.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.bmcl.2004.11.032
CHEMBL13647 695 28 None -288 12 Human 6.6 pKi = 6.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.bmcl.2004.11.032
134987 186681 47 None -309 2 Bovine 5.6 pKi = 5.6 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 181 1 1 3 0.6 Fc1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL48833 186681 47 None -309 2 Bovine 5.6 pKi = 5.6 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 181 1 1 3 0.6 Fc1cccnc1N1CCNCC1 10.1021/jm00366a007
3386873 64575 4 None - 1 Human 5.6 pKi = 5.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 338 6 2 3 3.9 N=C(CC(O)COc1ccccc1-c1ccccc1)N1CCCCC1 10.1016/j.bmcl.2004.11.032
CHEMBL181583 64575 4 None - 1 Human 5.6 pKi = 5.6 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 338 6 2 3 3.9 N=C(CC(O)COc1ccccc1-c1ccccc1)N1CCCCC1 10.1016/j.bmcl.2004.11.032
44271616 59676 0 None - 1 Bovine 5.6 pKi = 5.6 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 188 1 0 2 2.1 Cc1cccnc1C1=CCN(C)CC1 10.1021/jm00375a017
CHEMBL17223 59676 0 None - 1 Bovine 5.6 pKi = 5.6 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 188 1 0 2 2.1 Cc1cccnc1C1=CCN(C)CC1 10.1021/jm00375a017
15357024 60679 3 None - 1 Bovine 5.6 pKi = 5.6 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 174 1 0 2 1.8 CN1CC=C(c2ccccn2)CC1 10.1021/jm00375a017
CHEMBL17605 60679 3 None - 1 Bovine 5.6 pKi = 5.6 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 174 1 0 2 1.8 CN1CC=C(c2ccccn2)CC1 10.1021/jm00375a017
3020566 61076 14 None - 1 Bovine 5.6 pKi = 5.6 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 176 1 0 2 1.9 CN1CCC(c2ccccn2)CC1 10.1021/jm00375a017
CHEMBL17648 61076 14 None - 1 Bovine 5.6 pKi = 5.6 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 176 1 0 2 1.9 CN1CCC(c2ccccn2)CC1 10.1021/jm00375a017
2419 695 28 None -288 12 Human 6.6 pKi = 6.6 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm0307741
9 695 28 None -288 12 Human 6.6 pKi = 6.6 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm0307741
CHEMBL13647 695 28 None -288 12 Human 6.6 pKi = 6.6 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm0307741
9950711 109206 0 None 5 3 Rat 6.6 pKi = 6.6 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 359 4 2 3 3.2 O=S(=O)(CC(F)(F)F)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL321644 109206 0 None 5 3 Rat 6.6 pKi = 6.6 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 359 4 2 3 3.2 O=S(=O)(CC(F)(F)F)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
52937527 61303 0 None -1584 4 Human 6.6 pKi = 6.6 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 349 4 1 5 2.8 CN1CCC[C@@H]1Cn1nc(Cc2ccc(O)cc2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767138 61303 0 None -1584 4 Human 6.6 pKi = 6.6 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 349 4 1 5 2.8 CN1CCC[C@@H]1Cn1nc(Cc2ccc(O)cc2)c2ccccc2c1=O 10.1021/jm1013874
2419 695 28 None -288 12 Human 6.6 pKi = 6.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm960697s
9 695 28 None -288 12 Human 6.6 pKi = 6.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm960697s
CHEMBL13647 695 28 None -288 12 Human 6.6 pKi = 6.6 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm960697s
119204 184269 40 None 2 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]-HEAT from human adrenergic alpha1A receptor expressed in rat-1 cellsDisplacement of [125I]-HEAT from human adrenergic alpha1A receptor expressed in rat-1 cells
ChEMBL 279 0 0 3 3.2 CN1CCc2cc3c(c4c2[C@H]1Cc1ccccc1-4)OCO3 10.1039/C7MD00629B
CHEMBL483825 184269 40 None 2 3 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]-HEAT from human adrenergic alpha1A receptor expressed in rat-1 cellsDisplacement of [125I]-HEAT from human adrenergic alpha1A receptor expressed in rat-1 cells
ChEMBL 279 0 0 3 3.2 CN1CCc2cc3c(c4c2[C@H]1Cc1ccccc1-4)OCO3 10.1039/C7MD00629B
10337773 101585 0 None -63 10 Human 4.6 pKi = 4.6 Binding
Binding affinity against Alpha-1A adrenergic receptorBinding affinity against Alpha-1A adrenergic receptor
ChEMBL 311 3 1 4 1.6 Cn1cc(C(=O)C(=O)N[C@@H]2CN3CCC2CC3)c2ccccc21 10.1016/0960-894X(95)00308-G
CHEMBL298612 101585 0 None -63 10 Human 4.6 pKi = 4.6 Binding
Binding affinity against Alpha-1A adrenergic receptorBinding affinity against Alpha-1A adrenergic receptor
ChEMBL 311 3 1 4 1.6 Cn1cc(C(=O)C(=O)N[C@@H]2CN3CCC2CC3)c2ccccc21 10.1016/0960-894X(95)00308-G
11800278 39191 0 None 15 3 Human 5.6 pKi = 5.6 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 527 10 3 8 2.4 CCOC(=O)C1CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)NC)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
CHEMBL146983 39191 0 None 15 3 Human 5.6 pKi = 5.6 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 527 10 3 8 2.4 CCOC(=O)C1CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)NC)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
1599 2341 50 None -3019 16 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 nan
3955 2341 50 None -3019 16 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 nan
7215 2341 50 None -3019 16 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 nan
CHEMBL841 2341 50 None -3019 16 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 nan
DB00836 2341 50 None -3019 16 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 nan
1028 291 71 None -47 30 Rat 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
139148732 291 71 None -47 30 Rat 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
479 291 71 None -47 30 Rat 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
5816 291 71 None -47 30 Rat 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
CHEMBL679 291 71 None -47 30 Rat 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
DB00668 291 71 None -47 30 Rat 6.6 pKi = 6.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O nan
2435 722 100 None -436 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
395 722 100 None -436 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
520 722 100 None -436 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
5386 722 100 None -436 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
CHEMBL844 722 100 None -436 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
DB00484 722 100 None -436 12 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 nan
118717461 115143 0 None -7 4 Human 6.6 pKi = 6.6 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 444 12 2 6 6.3 COc1ccc2c(NCCCCCCCNc3ccnc4cc(OC)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343983 115143 0 None -7 4 Human 6.6 pKi = 6.6 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 444 12 2 6 6.3 COc1ccc2c(NCCCCCCCNc3ccnc4cc(OC)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
118717461 115143 0 None -7 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 444 12 2 6 6.3 COc1ccc2c(NCCCCCCCNc3ccnc4cc(OC)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343983 115143 0 None -7 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 444 12 2 6 6.3 COc1ccc2c(NCCCCCCCNc3ccnc4cc(OC)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
56852956 112043 1 None -66 9 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human adrenergic-alpha1A receptor by PDSP assayDisplacement of [3H]prazosin from human adrenergic-alpha1A receptor by PDSP assay
ChEMBL 339 5 0 6 2.8 c1cnc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1 10.1016/j.bmc.2014.04.026
CHEMBL3289656 112043 1 None -66 9 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human adrenergic-alpha1A receptor by PDSP assayDisplacement of [3H]prazosin from human adrenergic-alpha1A receptor by PDSP assay
ChEMBL 339 5 0 6 2.8 c1cnc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1 10.1016/j.bmc.2014.04.026
137640201 156961 2 None -204 13 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 362 6 0 2 4.3 O=C1CCc2ccccc2N1CCCN1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.8b00265
CHEMBL4072818 156961 2 None -204 13 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 362 6 0 2 4.3 O=C1CCc2ccccc2N1CCCN1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.8b00265
71521479 86259 0 None -831 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNC[C@H]1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm301525w
CHEMBL2312536 86259 0 None -831 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNC[C@H]1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm301525w
11164948 37743 0 None -8 3 Human 5.6 pKi = 5.6 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 382 5 2 6 3.1 COc1cc2nc3c(c(O)c2cc1OC)CCC(CNC(=O)c1ccco1)C3 10.1021/jm030952q
CHEMBL145793 37743 0 None -8 3 Human 5.6 pKi = 5.6 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 382 5 2 6 3.1 COc1cc2nc3c(c(O)c2cc1OC)CCC(CNC(=O)c1ccco1)C3 10.1021/jm030952q
76318763 84824 0 None - 1 Human 5.6 pKi = 5.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 381 5 2 6 3.0 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccoc1)C3 10.1007/s00044-010-9379-1
CHEMBL2234449 84824 0 None - 1 Human 5.6 pKi = 5.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 381 5 2 6 3.0 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccoc1)C3 10.1007/s00044-010-9379-1
56852956 112043 1 None -66 9 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human adrenergic-alpha1A receptor by PDSP assayDisplacement of [3H]prazosin from human adrenergic-alpha1A receptor by PDSP assay
ChEMBL 339 5 0 6 2.8 c1cnc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1 10.1016/j.bmc.2014.04.026
CHEMBL3289656 112043 1 None -66 9 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human adrenergic-alpha1A receptor by PDSP assayDisplacement of [3H]prazosin from human adrenergic-alpha1A receptor by PDSP assay
ChEMBL 339 5 0 6 2.8 c1cnc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1 10.1016/j.bmc.2014.04.026
242 470 124 None -14 51 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl nan
34 470 124 None -14 51 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl nan
60795 470 124 None -14 51 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl nan
CHEMBL1112 470 124 None -14 51 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl nan
DB01238 470 124 None -14 51 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl nan
3584 3777 64 None -3 13 Bovine 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
5401 3777 64 None -3 13 Bovine 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
7302 3777 64 None -3 13 Bovine 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
CHEMBL611 3777 64 None -3 13 Bovine 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
DB01162 3777 64 None -3 13 Bovine 7.6 pKi = 7.6 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
180707 115134 2 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 314 5 2 4 4.3 c1ccc2c(NCCNc3ccnc4ccccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343975 115134 2 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 314 5 2 4 4.3 c1ccc2c(NCCNc3ccnc4ccccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
135398745 2914 112 None -13 65 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
47 2914 112 None -13 65 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
CHEMBL715 2914 112 None -13 65 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
DB00334 2914 112 None -13 65 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
16041629 95446 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cc(F)ccc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL257097 95446 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cc(F)ccc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
180707 115134 2 None 1 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 314 5 2 4 4.3 c1ccc2c(NCCNc3ccnc4ccccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343975 115134 2 None 1 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 314 5 2 4 4.3 c1ccc2c(NCCNc3ccnc4ccccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
9883506 70564 0 None -2 6 Human 7.6 pKi = 7.6 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 282 3 3 5 2.3 Cc1ccc(N(NC2=NCCN2)c2cccc(O)c2)cc1 10.1016/j.bmcl.2005.07.083
CHEMBL194849 70564 0 None -2 6 Human 7.6 pKi = 7.6 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 282 3 3 5 2.3 Cc1ccc(N(NC2=NCCN2)c2cccc(O)c2)cc1 10.1016/j.bmcl.2005.07.083
46934641 16678 0 None -10 4 Human 7.6 pKi = 7.6 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 479 7 0 6 3.5 COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3CCCCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242633 16678 0 None -10 4 Human 7.6 pKi = 7.6 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 479 7 0 6 3.5 COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3CCCCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
56946474 71516 0 None -32 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 403 9 1 4 4.8 COc1ccccc1OCCNCC1CCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm200421e
CHEMBL1946779 71516 0 None -32 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 403 9 1 4 4.8 COc1ccccc1OCCNCC1CCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm200421e
CHEMBL1962769 71516 0 None -32 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 403 9 1 4 4.8 COc1ccccc1OCCNCC1CCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm200421e
44207909 16699 3 None 2 9 Human 6.6 pKi = 6.6 Binding
Binding affinity to human adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to human adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 407 7 1 4 2.6 O=C(Cc1ccccc1)NC1CCN(CCCN2C(=O)COc3ccccc32)CC1 10.1021/jm100697g
CHEMBL1242923 16699 3 None 2 9 Human 6.6 pKi = 6.6 Binding
Binding affinity to human adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to human adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 407 7 1 4 2.6 O=C(Cc1ccccc1)NC1CCN(CCCN2C(=O)COc3ccccc32)CC1 10.1021/jm100697g
44538690 109851 0 None -295 7 Human 6.6 pKi = 6.6 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 380 5 0 4 3.9 O=C(CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCO3)c1ccc(F)cc1 10.1021/jm401958n
CHEMBL3233432 109851 0 None -295 7 Human 6.6 pKi = 6.6 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 380 5 0 4 3.9 O=C(CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCO3)c1ccc(F)cc1 10.1021/jm401958n
CHEMBL4795065 214052 25 None 1 2 Human 5.6 pKi = 5.6 Binding
GPCRScan assay: inhibition of Alpha1AGPCRScan assay: inhibition of Alpha1A
ChEMBL None None None C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1 10.6019/CHEMBL4800730
10219 188796 37 None -467 5 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 nan
CHEMBL493439 188796 37 None -467 5 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 nan
CHEMBL50588 188796 37 None -467 5 Rat 5.6 pKi = 5.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 480 7 1 6 4.9 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 nan
CHEMBL4795065 214052 25 None 1 2 Human 5.6 pKi = 5.6 Binding
GPCRScan assay: inhibition of Alpha1AGPCRScan assay: inhibition of Alpha1A
ChEMBL None None None C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1 10.6019/CHEMBL4800730
12840734 100929 3 None -75 4 Human 5.6 pKi = 5.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 355 4 0 4 2.5 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2)CC1 10.1007/s00044-010-9379-1
CHEMBL293968 100929 3 None -75 4 Human 5.6 pKi = 5.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 355 4 0 4 2.5 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2)CC1 10.1007/s00044-010-9379-1
134133829 143825 0 None -120 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 337 7 1 5 3.5 COc1ccccc1OCCNCC1CSC2(CCCCC2)O1 10.1016/j.ejmech.2016.09.050
CHEMBL3901382 143825 0 None -120 4 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 337 7 1 5 3.5 COc1ccccc1OCCNCC1CSC2(CCCCC2)O1 10.1016/j.ejmech.2016.09.050
10221830 9421 0 None 3 2 Rat 6.6 pKi = 6.6 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 387 5 2 3 4.7 CCS(=O)(=O)Nc1cc(C2CCCCC2)cc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111685 9421 0 None 3 2 Rat 6.6 pKi = 6.6 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 387 5 2 3 4.7 CCS(=O)(=O)Nc1cc(C2CCCCC2)cc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
11811395 204701 0 None -2 4 Human 5.6 pKi = 5.6 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 281 5 2 5 1.3 CC(C)S(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL74071 204701 0 None -2 4 Human 5.6 pKi = 5.6 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 281 5 2 5 1.3 CC(C)S(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
12840734 100929 3 None -75 4 Human 5.6 pKi = 5.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 355 4 0 4 2.5 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2)CC1 10.1007/s00044-010-9379-1
CHEMBL293968 100929 3 None -75 4 Human 5.6 pKi = 5.6 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 355 4 0 4 2.5 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2)CC1 10.1007/s00044-010-9379-1
10721586 119721 0 None 141 3 Human 7.6 pKi = 7.6 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 559 10 3 7 3.4 CC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
CHEMBL347522 119721 0 None 141 3 Human 7.6 pKi = 7.6 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 559 10 3 7 3.4 CC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
11198145 9815 2 None 1 5 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@H]([C@@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
CHEMBL113830 9815 2 None 1 5 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@H]([C@@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
44289047 100383 0 None 25 3 Human 7.6 pKi = 7.6 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 441 8 1 3 5.2 Cc1ccc(C(C(=O)NCCCN2CCC(c3ccccn3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL289916 100383 0 None 25 3 Human 7.6 pKi = 7.6 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 441 8 1 3 5.2 Cc1ccc(C(C(=O)NCCCN2CCC(c3ccccn3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
9822705 100688 0 None -1 3 Rat 7.6 pKi = 7.6 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 407 4 0 3 4.4 O=C1CC2(C=CN1CCN1CCN(c3cc(Cl)ccc3Cl)CC1)CCCC2 10.1021/jm030944+
CHEMBL292366 100688 0 None -1 3 Rat 7.6 pKi = 7.6 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 407 4 0 3 4.4 O=C1CC2(C=CN1CCN1CCN(c3cc(Cl)ccc3Cl)CC1)CCCC2 10.1021/jm030944+
25131876 86192 0 None -41 7 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNCC1COCC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.02.056
CHEMBL2312227 86192 0 None -41 7 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNCC1COCC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.02.056
76308474 106234 0 None -31 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 467 5 1 9 3.1 COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@H]3CCCC[C@@H]32)o1 10.1007/s00044-004-0024-8
CHEMBL2261607 106234 0 None -31 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 467 5 1 9 3.1 COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@H]3CCCC[C@@H]32)o1 10.1007/s00044-004-0024-8
CHEMBL3138856 106234 0 None -31 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 467 5 1 9 3.1 COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@H]3CCCC[C@@H]32)o1 10.1007/s00044-004-0024-8
44428846 92189 0 None -31 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 467 5 1 9 3.1 COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@@H]3CCCC[C@@H]32)o1 10.1016/j.bmc.2007.01.028
CHEMBL242508 92189 0 None -31 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 467 5 1 9 3.1 COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@@H]3CCCC[C@@H]32)o1 10.1016/j.bmc.2007.01.028
25181488 187382 0 None -33 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNC[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm800461k
CHEMBL493486 187382 0 None -33 4 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNC[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm800461k
25131876 86192 0 None -41 7 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNCC1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm301525w
CHEMBL2312227 86192 0 None -41 7 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNCC1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm301525w
10427137 36050 4 None -1 2 Rat 5.6 pKi = 5.6 Binding
Displacement of [3H]prazosin from rat whole brain alpha1 adrenergic receptorDisplacement of [3H]prazosin from rat whole brain alpha1 adrenergic receptor
ChEMBL 336 2 0 2 5.3 Cc1ccc2c(c1)c(-c1ccc(F)cc1)c(C)n2C1CCN(C)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL144362 36050 4 None -1 2 Rat 5.6 pKi = 5.6 Binding
Displacement of [3H]prazosin from rat whole brain alpha1 adrenergic receptorDisplacement of [3H]prazosin from rat whole brain alpha1 adrenergic receptor
ChEMBL 336 2 0 2 5.3 Cc1ccc2c(c1)c(-c1ccc(F)cc1)c(C)n2C1CCN(C)CC1 10.1021/acs.jmedchem.2c00633
11711943 16100 0 None -28 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 444 8 1 5 5.4 FC(F)(F)c1cccc(N2CCN(CCCCNc3ncc(-c4ccccc4)o3)CC2)c1 10.1016/j.bmcl.2010.07.096
CHEMBL1223858 16100 0 None -28 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 444 8 1 5 5.4 FC(F)(F)c1cccc(N2CCN(CCCCNc3ncc(-c4ccccc4)o3)CC2)c1 10.1016/j.bmcl.2010.07.096
71062646 149543 0 None -4466 12 Mouse 5.6 pKi = 5.6 Binding
Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.
ChEMBL 338 6 0 4 2.8 c1ccc(OC[C@@H]2CN(CCN3CCc4ccccc43)CCO2)cc1 nan
CHEMBL3946661 149543 0 None -4466 12 Mouse 5.6 pKi = 5.6 Binding
Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.
ChEMBL 338 6 0 4 2.8 c1ccc(OC[C@@H]2CN(CCN3CCc4ccccc43)CCO2)cc1 nan
9796525 9407 0 None 5 2 Rat 6.6 pKi = 6.6 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 305 3 1 4 2.3 Cn1cnc(C2CCCc3c(NS(C)(=O)=O)cccc32)c1 10.1007/s00044-004-0020-z
CHEMBL111584 9407 0 None 5 2 Rat 6.6 pKi = 6.6 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 305 3 1 4 2.3 Cn1cnc(C2CCCc3c(NS(C)(=O)=O)cccc32)c1 10.1007/s00044-004-0020-z
9796525 9407 0 None 5 2 Rat 6.6 pKi = 6.6 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 305 3 1 4 2.3 Cn1cnc(C2CCCc3c(NS(C)(=O)=O)cccc32)c1 10.1021/jm030551a
CHEMBL111584 9407 0 None 5 2 Rat 6.6 pKi = 6.6 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 305 3 1 4 2.3 Cn1cnc(C2CCCc3c(NS(C)(=O)=O)cccc32)c1 10.1021/jm030551a
10763305 106962 0 None -11 2 Rat 6.6 pKi = 6.6 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 396 5 0 4 3.3 FC(F)(F)c1cccc(N2CCN(CCCN3CC4CCCCN4C3)CC2)c1 10.1021/jm970216k
CHEMBL314997 106962 0 None -11 2 Rat 6.6 pKi = 6.6 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 396 5 0 4 3.3 FC(F)(F)c1cccc(N2CCN(CCCN3CC4CCCCN4C3)CC2)c1 10.1021/jm970216k
18738380 11941 0 None 8 3 Human 7.6 pKi = 7.6 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 417 9 1 6 1.9 CC(C)Oc1ccccc1N1CCN(CC(O)CC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL11828 11941 0 None 8 3 Human 7.6 pKi = 7.6 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 417 9 1 6 1.9 CC(C)Oc1ccccc1N1CCN(CC(O)CC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
11857638 142155 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 516 9 1 6 5.0 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL388361 142155 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 516 9 1 6 5.0 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
11857638 142155 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 516 9 1 6 5.0 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL388361 142155 0 None 1 4 Human 7.6 pKi = 7.6 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 516 9 1 6 5.0 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
1353 1911 93 None -10 83 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
3559 1911 93 None -10 83 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
86 1911 93 None -10 83 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
CHEMBL54 1911 93 None -10 83 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
DB00502 1911 93 None -10 83 Rat 7.6 pKi = 7.6 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl nan
44460477 205407 0 None 1 2 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 432 7 0 6 3.9 O=C1CCCN1Cc1cc(CN2CCN(c3ccccc3Oc3ccccc3)CC2)on1 10.1016/s0960-894x(02)00436-5
CHEMBL80109 205407 0 None 1 2 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 432 7 0 6 3.9 O=C1CCCN1Cc1cc(CN2CCN(c3ccccc3Oc3ccccc3)CC2)on1 10.1016/s0960-894x(02)00436-5
145987771 167089 0 None -8 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting methodDisplacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting method
ChEMBL 431 6 1 2 5.9 Fc1ccc(N2CCN(CCCc3c[nH]c4ccc(F)cc34)CC2)c(-c2ccccc2)c1 10.1016/j.ejmech.2017.12.063
CHEMBL4289783 167089 0 None -8 3 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting methodDisplacement of [3H]prazosin from alpha1-adrenoceptor (unknown origin) in cerebral cortex membranes after 60 mins by TopCount scintillation counting method
ChEMBL 431 6 1 2 5.9 Fc1ccc(N2CCN(CCCc3c[nH]c4ccc(F)cc34)CC2)c(-c2ccccc2)c1 10.1016/j.ejmech.2017.12.063
44288740 101355 0 None 29 3 Human 7.6 pKi = 7.6 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 437 8 1 3 4.9 N#CC1(c2ccccc2)CCN(CCCNC(=O)C(c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL296965 101355 0 None 29 3 Human 7.6 pKi = 7.6 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 437 8 1 3 4.9 N#CC1(c2ccccc2)CCN(CCCNC(=O)C(c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(00)00307-3
53328505 63394 0 None 2 3 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 455 7 0 5 3.8 COc1ccccc1N1CCN(CCCN2C(=O)CC(c3ccc(Cl)cc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796039 63394 0 None 2 3 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 455 7 0 5 3.8 COc1ccccc1N1CCN(CCCN2C(=O)CC(c3ccc(Cl)cc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
76322412 84822 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 354 5 0 5 2.9 COc1ccccc1N1CCN(CC2CO[C@H](c3ccccc3)O2)CC1 10.1007/s00044-010-9379-1
CHEMBL2234447 84822 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 354 5 0 5 2.9 COc1ccccc1N1CCN(CC2CO[C@H](c3ccccc3)O2)CC1 10.1007/s00044-010-9379-1
14004037 53771 2 None -8 2 Bovine 5.6 pKi = 5.6 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 209 0 1 4 1.8 Nc1nc2c(s1)CCN1CCCCC21 10.1021/jm00398a025
CHEMBL160388 53771 2 None -8 2 Bovine 5.6 pKi = 5.6 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 209 0 1 4 1.8 Nc1nc2c(s1)CCN1CCCCC21 10.1021/jm00398a025
1960 2857 67 None -57 26 Rat 6.6 pKi = 6.6 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
439260 2857 67 None -57 26 Rat 6.6 pKi = 6.6 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
505 2857 67 None -57 26 Rat 6.6 pKi = 6.6 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
CHEMBL1437 2857 67 None -57 26 Rat 6.6 pKi = 6.6 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
DB00368 2857 67 None -57 26 Rat 6.6 pKi = 6.6 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
2435 722 100 None -21 12 Human 5.6 pKi = 5.6 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
395 722 100 None -21 12 Human 5.6 pKi = 5.6 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
520 722 100 None -21 12 Human 5.6 pKi = 5.6 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
5386 722 100 None -21 12 Human 5.6 pKi = 5.6 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
CHEMBL844 722 100 None -21 12 Human 5.6 pKi = 5.6 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
DB00484 722 100 None -21 12 Human 5.6 pKi = 5.6 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 10.1016/0960-894X(95)00391-6
14004037 53771 2 None -8 2 Bovine 5.6 pKi = 5.6 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 209 0 1 4 1.8 Nc1nc2c(s1)CCN1CCCCC21 10.1021/jm00398a025
CHEMBL160388 53771 2 None -8 2 Bovine 5.6 pKi = 5.6 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 209 0 1 4 1.8 Nc1nc2c(s1)CCN1CCCCC21 10.1021/jm00398a025
127027076 137687 0 None -257 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 455 7 1 3 5.2 O=C(NCCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
CHEMBL3758711 137687 0 None -257 3 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 455 7 1 3 5.2 O=C(NCCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
2777786 174977 82 None -29 2 Bovine 5.5 pKi = 5.5 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 231 1 1 3 1.5 FC(F)(F)c1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL45663 174977 82 None -29 2 Bovine 5.5 pKi = 5.5 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 231 1 1 3 1.5 FC(F)(F)c1cccnc1N1CCNCC1 10.1021/jm00366a007
73213196 104460 4 None -2 13 Human 6.5 pKi = 6.5 Binding
Binding affinity to adrenergic alpha 1A receptor (unknown origin)Binding affinity to adrenergic alpha 1A receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2014.05.016
CHEMBL3104093 104460 4 None -2 13 Human 6.5 pKi = 6.5 Binding
Binding affinity to adrenergic alpha 1A receptor (unknown origin)Binding affinity to adrenergic alpha 1A receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2014.05.016
73213196 104460 4 None -2 13 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2013.12.024
CHEMBL3104093 104460 4 None -2 13 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2013.12.024
11282574 37732 0 None -38 3 Human 6.5 pKi = 6.5 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 459 5 2 5 4.4 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccccc1C(F)(F)F)C3 10.1021/jm030952q
CHEMBL145785 37732 0 None -38 3 Human 6.5 pKi = 6.5 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 459 5 2 5 4.4 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccccc1C(F)(F)F)C3 10.1021/jm030952q
76319344 85337 0 None 34 2 Rat 6.5 pKi = 6.5 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 289 2 3 5 2.0 COC(=O)Nc1c(O)ccc2c1CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
CHEMBL2261351 85337 0 None 34 2 Rat 6.5 pKi = 6.5 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 289 2 3 5 2.0 COC(=O)Nc1c(O)ccc2c1CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
73213196 104460 4 None -2 13 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2013.12.024
CHEMBL3104093 104460 4 None -2 13 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)Displacement of [125I]HEAT from adrenergic alpha1A receptor (unknown origin)
ChEMBL 288 0 0 2 3.9 CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1 10.1016/j.bmcl.2013.12.024
155552821 176683 0 None -12 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 8 1 4 4.2 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)OC2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4544457 176683 0 None -12 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 8 1 4 4.2 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)OC2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4598345 176683 0 None -12 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 8 1 4 4.2 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)OC2)cc1 10.1016/j.ejmech.2019.05.024
92766 106542 35 None 1 6 Human 7.5 pKi = 7.5 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 10.1016/j.bmcl.2004.11.032
CHEMBL31410 106542 35 None 1 6 Human 7.5 pKi = 7.5 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 10.1016/j.bmcl.2004.11.032
12909385 60429 1 None 7 2 Bovine 7.5 pKi = 7.5 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 276 0 0 2 4.0 CN1CCC(=C2c3ccccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
CHEMBL175154 60429 1 None 7 2 Bovine 7.5 pKi = 7.5 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 276 0 0 2 4.0 CN1CCC(=C2c3ccccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
11303180 198226 0 None -7 4 Rat 7.5 pKi = 7.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 369 5 0 4 3.1 COc1ccccc1N1CCN(CCN2C=CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
CHEMBL57540 198226 0 None -7 4 Rat 7.5 pKi = 7.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 369 5 0 4 3.1 COc1ccccc1N1CCN(CCN2C=CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
122179431 121443 0 None -1 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 585 9 1 13 3.1 CCN(CC)c1ccc2cc(-n3cc(CN4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)nn3)c(=O)oc2c1 10.1021/ml5004298
CHEMBL3582272 121443 0 None -1 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 585 9 1 13 3.1 CCN(CC)c1ccc2cc(-n3cc(CN4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)nn3)c(=O)oc2c1 10.1021/ml5004298
11384664 83112 0 None -35 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 421 7 1 3 4.8 O=C(NCCCCN1CCN(c2ccccc2Cl)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
CHEMBL218203 83112 0 None -35 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 421 7 1 3 4.8 O=C(NCCCCN1CCN(c2ccccc2Cl)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
127026123 137711 0 None -41 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 401 7 1 3 4.5 Cc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2015.12.068
CHEMBL3758881 137711 0 None -41 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 401 7 1 3 4.5 Cc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2015.12.068
2419 695 28 None -288 12 Human 6.5 pKi = 6.5 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm0491391
9 695 28 None -288 12 Human 6.5 pKi = 6.5 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm0491391
CHEMBL13647 695 28 None -288 12 Human 6.5 pKi = 6.5 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm0491391
9845181 208161 3 None -1445 13 Human 6.5 pKi = 6.5 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 423 4 0 4 3.3 C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1016/j.bmcl.2004.11.032
CHEMBL98241 208161 3 None -1445 13 Human 6.5 pKi = 6.5 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 423 4 0 4 3.3 C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1016/j.bmcl.2004.11.032
10643994 77256 0 None -2 2 Rat 5.5 pKi = 5.5 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 388 4 3 8 0.9 COc1cc2nc(N3CCN[C@@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
CHEMBL2079655 77256 0 None -2 2 Rat 5.5 pKi = 5.5 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 388 4 3 8 0.9 COc1cc2nc(N3CCN[C@@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
146025727 171685 0 None -107 27 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting method
ChEMBL 411 3 0 5 6.4 FC(F)(F)c1cc(Oc2nccc3ccsc23)ccc1-c1cccc2nccn12 10.1021/acs.jmedchem.9b00351
CHEMBL4466483 171685 0 None -107 27 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting method
ChEMBL 411 3 0 5 6.4 FC(F)(F)c1cc(Oc2nccc3ccsc23)ccc1-c1cccc2nccn12 10.1021/acs.jmedchem.9b00351
2419 695 28 None -288 12 Human 6.5 pKi = 6.5 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor (n >= 2)Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor (n >= 2)
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm980053f
9 695 28 None -288 12 Human 6.5 pKi = 6.5 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor (n >= 2)Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor (n >= 2)
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm980053f
CHEMBL13647 695 28 None -288 12 Human 6.5 pKi = 6.5 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor (n >= 2)Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor (n >= 2)
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm980053f
9845181 208161 3 None -1445 13 Human 6.5 pKi = 6.5 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 423 4 0 4 3.3 C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1021/jm0307741
CHEMBL98241 208161 3 None -1445 13 Human 6.5 pKi = 6.5 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 423 4 0 4 3.3 C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1021/jm0307741
11191047 201817 0 None -1 2 Rat 6.5 pKi = 6.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 490 7 0 6 3.2 COc1ccccc1N1CCN(CCN2C(=O)CC3(CCN(Cc4ccccc4)CC3)CC2=O)CC1 10.1021/jm030944+
CHEMBL60699 201817 0 None -1 2 Rat 6.5 pKi = 6.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 490 7 0 6 3.2 COc1ccccc1N1CCN(CCN2C(=O)CC3(CCN(Cc4ccccc4)CC3)CC2=O)CC1 10.1021/jm030944+
11486511 101584 0 None -870 4 Rat 6.5 pKi = 6.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 403 4 0 4 3.6 O=C1CC2(CCCC2)CC(=O)N1CCN1CCCN(c2ccccc2Cl)CC1 10.1021/jm030944+
CHEMBL298595 101584 0 None -870 4 Rat 6.5 pKi = 6.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 403 4 0 4 3.6 O=C1CC2(CCCC2)CC(=O)N1CCN1CCCN(c2ccccc2Cl)CC1 10.1021/jm030944+
11346205 9276 0 None - 1 Rat 5.5 pKi = 5.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 268 4 3 5 0.8 CCS(=O)(=O)Nc1cccc(NC2=NCCN2)c1 10.1021/jm030551a
CHEMBL110852 9276 0 None - 1 Rat 5.5 pKi = 5.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 268 4 3 5 0.8 CCS(=O)(=O)Nc1cccc(NC2=NCCN2)c1 10.1021/jm030551a
44460522 205387 0 None 3 2 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 460 7 0 7 3.6 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3C(=O)c4ccccc4C3=O)co2)CC1 10.1016/s0960-894x(02)00436-5
CHEMBL79990 205387 0 None 3 2 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 460 7 0 7 3.6 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3C(=O)c4ccccc4C3=O)co2)CC1 10.1016/s0960-894x(02)00436-5
136680385 207650 0 None 85 3 Human 8.5 pKi = 8.5 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 694 16 4 8 4.9 CCNC(=O)C1=C(COCCN)NC(CC)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
44328824 207650 0 None 85 3 Human 8.5 pKi = 8.5 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 694 16 4 8 4.9 CCNC(=O)C1=C(COCCN)NC(CC)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
CHEMBL95253 207650 0 None 85 3 Human 8.5 pKi = 8.5 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 694 16 4 8 4.9 CCNC(=O)C1=C(COCCN)NC(CC)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
44213782 10540 0 None 309 3 Human 8.5 pKi = 8.5 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 504 8 0 6 3.9 CCOC(=O)C1CN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CCC1c1ccccc1 10.1016/s0960-894x(98)00451-x
CHEMBL1169493 10540 0 None 309 3 Human 8.5 pKi = 8.5 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 504 8 0 6 3.9 CCOC(=O)C1CN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CCC1c1ccccc1 10.1016/s0960-894x(98)00451-x
44431611 87581 0 None 6 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 509 7 1 5 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(Cl)cc3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233582 87581 0 None 6 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 509 7 1 5 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(Cl)cc3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
11857639 143884 1 None 2 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 492 7 1 4 5.2 CC(C)Oc1ccccc1C1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(F)c(F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.098
CHEMBL390184 143884 1 None 2 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 492 7 1 4 5.2 CC(C)Oc1ccccc1C1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(F)c(F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.098
9848303 111580 0 None 1 9 Bovine 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 487 6 1 6 3.8 Cn1cc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)nn1 10.1016/j.bmc.2012.10.049
CHEMBL328187 111580 0 None 1 9 Bovine 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 487 6 1 6 3.8 Cn1cc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)nn1 10.1016/j.bmc.2012.10.049
9848303 111580 0 None 1 9 Bovine 8.5 pKi = 8.5 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 487 6 1 6 3.8 Cn1cc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)nn1 10.1021/jm100652h
CHEMBL328187 111580 0 None 1 9 Bovine 8.5 pKi = 8.5 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
ChEMBL 487 6 1 6 3.8 Cn1cc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)nn1 10.1021/jm100652h
10971791 208318 0 None -7 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 417 5 1 7 3.4 COc1ccccc1N1CCN(CCn2c(C)nc3c4ccccc4nc-3c2O)CC1 10.1016/j.bmcl.2006.09.034
CHEMBL99142 208318 0 None -7 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 417 5 1 7 3.4 COc1ccccc1N1CCN(CCn2c(C)nc3c4ccccc4nc-3c2O)CC1 10.1016/j.bmcl.2006.09.034
118716718 115012 0 None -3 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 532 7 0 9 2.3 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4cccc([N+](=O)[O-])c4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342871 115012 0 None -3 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 532 7 0 9 2.3 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4cccc([N+](=O)[O-])c4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
44447002 94725 0 None -301 4 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 434 6 1 5 4.2 CCC(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
CHEMBL253022 94725 0 None -301 4 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 434 6 1 5 4.2 CCC(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
9960311 203864 0 None 25 2 Human 8.5 pKi = 8.5 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 598 9 2 7 4.5 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(C(C)(C)C)cc2)C3=O)CC1 10.1021/jm9905918
CHEMBL68699 203864 0 None 25 2 Human 8.5 pKi = 8.5 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 598 9 2 7 4.5 CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(C(C)(C)C)cc2)C3=O)CC1 10.1021/jm9905918
19085839 205782 0 None 97 3 Human 8.5 pKi = 8.5 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 469 6 0 7 3.2 Cc1ccc2c(c1)oc(=O)n2C1CCN(CCCCN2C(=O)c3ccccc3S2(=O)=O)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL83041 205782 0 None 97 3 Human 8.5 pKi = 8.5 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 469 6 0 7 3.2 Cc1ccc2c(c1)oc(=O)n2C1CCN(CCCCN2C(=O)c3ccccc3S2(=O)=O)CC1 10.1016/s0960-894x(98)00446-6
4188516 100378 8 None 1 2 Rat 8.5 pKi = 8.5 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 372 6 0 5 1.6 COc1ccccc1N1CCN(CCCN2C(=O)C3CCCN3C2=O)CC1 10.1021/jm970216k
CHEMBL289873 100378 8 None 1 2 Rat 8.5 pKi = 8.5 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 372 6 0 5 1.6 COc1ccccc1N1CCN(CCCN2C(=O)C3CCCN3C2=O)CC1 10.1021/jm970216k
9891166 33612 0 None -7 4 Human 8.5 pKi = 8.5 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 476 6 0 8 3.3 COc1ccccc1N1CCN(CCn2c(=O)c3c(-c4ccccc4)csc3n(C)c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL14213 33612 0 None -7 4 Human 8.5 pKi = 8.5 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 476 6 0 8 3.3 COc1ccccc1N1CCN(CCn2c(=O)c3c(-c4ccccc4)csc3n(C)c2=O)CC1 10.1016/s0960-894x(01)00159-7
16041628 155350 0 None -1 4 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)cc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL403280 155350 0 None -1 4 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)cc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
10841387 99618 0 None 91 6 Human 8.5 pKi = 8.5 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
CHEMBL284103 99618 0 None 91 6 Human 8.5 pKi = 8.5 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
10624665 100332 0 None 19 2 Rat 8.5 pKi = 8.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 482 4 1 7 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5c(Cl)ccnc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL289437 100332 0 None 19 2 Rat 8.5 pKi = 8.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 482 4 1 7 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5c(Cl)ccnc54)c3=O)C[C@@H]21 10.1021/jm990567u
10416624 109650 0 None 263 3 Human 8.5 pKi = 8.5 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 634 14 4 10 2.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(COCCN)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(99)00484-9
136806219 109650 0 None 263 3 Human 8.5 pKi = 8.5 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 634 14 4 10 2.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(COCCN)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(99)00484-9
CHEMBL322405 109650 0 None 263 3 Human 8.5 pKi = 8.5 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 634 14 4 10 2.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(COCCN)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(99)00484-9
2585 803 103 None -5 21 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
522 803 103 None -5 21 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
551 803 103 None -5 21 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
CHEMBL723 803 103 None -5 21 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
DB01136 803 103 None -5 21 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O nan
3157 1470 71 None -2 10 Human 8.5 pKi = 8.5 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm960697s
7170 1470 71 None -2 10 Human 8.5 pKi = 8.5 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm960697s
954 1470 71 None -2 10 Human 8.5 pKi = 8.5 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm960697s
CHEMBL707 1470 71 None -2 10 Human 8.5 pKi = 8.5 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm960697s
DB00590 1470 71 None -2 10 Human 8.5 pKi = 8.5 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1021/jm960697s
10841387 99618 0 None 91 6 Human 8.5 pKi = 8.5 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm960697s
CHEMBL284103 99618 0 None 91 6 Human 8.5 pKi = 8.5 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm960697s
52947579 17050 0 None -17 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 439 13 1 6 5.0 COc1cccc(OC)c1SCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1254582 17050 0 None -17 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 439 13 1 6 5.0 COc1cccc(OC)c1SCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
52945803 17066 0 None -8 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 451 15 1 6 5.1 CCOc1cccc(OCC)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1254742 17066 0 None -8 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 451 15 1 6 5.1 CCOc1cccc(OCC)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
52941624 17092 0 None -1 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 393 12 1 5 4.3 COc1ccccc1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1254915 17092 0 None -1 4 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 393 12 1 5 4.3 COc1ccccc1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
10693026 105953 0 None - 1 Bovine 8.5 pKi = 8.5 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 412 9 1 6 2.8 CCOc1ccccc1OCCNC1CCN(c2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL312935 105953 0 None - 1 Bovine 8.5 pKi = 8.5 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 412 9 1 6 2.8 CCOc1ccccc1OCCNC1CCN(c2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
25032525 94583 0 None -9 4 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 420 5 1 5 3.8 CC(=O)NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21 10.1016/j.bmcl.2007.11.106
CHEMBL252030 94583 0 None -9 4 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 420 5 1 5 3.8 CC(=O)NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21 10.1016/j.bmcl.2007.11.106
10769037 37208 0 None 70 3 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 551 7 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL145332 37208 0 None 70 3 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 551 7 2 6 4.1 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
1043 1582 14 None -35 28 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
149 1582 14 None -35 28 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
8223 1582 14 None -35 28 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
CHEMBL442 1582 14 None -35 28 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
DB00696 1582 14 None -35 28 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 581 4 3 6 2.0 O=C([C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O nan
15853467 208134 0 None 29 6 Human 8.5 pKi = 8.5 Binding
Binding affinity against human Alpha-1A adrenergic receptorBinding affinity against human Alpha-1A adrenergic receptor
ChEMBL 692 16 3 8 5.6 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN=[N+]=[N-])N1 10.1016/s0960-894x(99)00484-9
CHEMBL98063 208134 0 None 29 6 Human 8.5 pKi = 8.5 Binding
Binding affinity against human Alpha-1A adrenergic receptorBinding affinity against human Alpha-1A adrenergic receptor
ChEMBL 692 16 3 8 5.6 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN=[N+]=[N-])N1 10.1016/s0960-894x(99)00484-9
11857864 85684 0 None -2 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 534 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4cc(F)ccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL228659 85684 0 None -2 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 534 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4cc(F)ccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
10553701 100296 0 None 10 2 Rat 8.5 pKi = 8.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 472 4 1 7 3.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccc(C#N)c54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL289166 100296 0 None 10 2 Rat 8.5 pKi = 8.5 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 472 4 1 7 3.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccc(C#N)c54)c3=O)C[C@@H]21 10.1021/jm990567u
9960497 117075 0 None 25 6 Human 8.5 pKi = 8.5 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
CHEMBL3392246 117075 0 None 25 6 Human 8.5 pKi = 8.5 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00019a001
44447015 154241 0 None -3 4 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 483 6 1 6 4.5 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1cccnc1 10.1016/j.bmcl.2007.11.106
CHEMBL398619 154241 0 None -3 4 Rat 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 483 6 1 6 4.5 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1cccnc1 10.1016/j.bmcl.2007.11.106
10071710 84132 0 None -2 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 436 5 1 7 2.7 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccccc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL220781 84132 0 None -2 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 436 5 1 7 2.7 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccccc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
10071710 84132 0 None -2 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 436 5 1 7 2.7 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
CHEMBL220781 84132 0 None -2 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 436 5 1 7 2.7 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
45268939 196660 0 None -4 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to alpha1A adrenergic receptor (unknown origin)Binding affinity to alpha1A adrenergic receptor (unknown origin)
ChEMBL 505 4 1 9 3.0 COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL564481 196660 0 None -4 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to alpha1A adrenergic receptor (unknown origin)Binding affinity to alpha1A adrenergic receptor (unknown origin)
ChEMBL 505 4 1 9 3.0 COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
90645603 112436 0 None -1 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 567 8 1 8 4.9 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)Cc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298021 112436 0 None -1 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 567 8 1 8 4.9 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)Cc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
24894147 195881 0 None -6 3 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 505 4 1 9 3.0 COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1021/jm8016046
CHEMBL558890 195881 0 None -6 3 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 505 4 1 9 3.0 COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1021/jm8016046
11465618 102398 23 None -12 19 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysis
ChEMBL 354 2 0 2 4.9 CN1CCN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CC1(C)C 10.1016/j.bmcl.2022.128879
CHEMBL3039528 102398 23 None -12 19 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysis
ChEMBL 354 2 0 2 4.9 CN1CCN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CC1(C)C 10.1016/j.bmcl.2022.128879
CHEMBL5191141 102398 23 None -12 19 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysisDisplacement of [3H]prazosin from recombinant human alpha1A receptor measured after 60 mins by scintillation counting analysis
ChEMBL 354 2 0 2 4.9 CN1CCN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CC1(C)C 10.1016/j.bmcl.2022.128879
44289034 165953 0 None 199 3 Human 8.5 pKi = 8.5 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 435 8 1 3 4.9 Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2cccc(F)c2)C(C)C)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL42514 165953 0 None 199 3 Human 8.5 pKi = 8.5 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 435 8 1 3 4.9 Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2cccc(F)c2)C(C)C)CC1 10.1016/s0960-894x(00)00307-3
2726 919 68 None -2 72 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
621 919 68 None -2 72 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
83 919 68 None -2 72 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
CHEMBL71 919 68 None -2 72 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
DB00477 919 68 None -2 72 Rat 8.5 pKi = 8.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C nan
44420431 84737 0 None -4 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 468 5 0 7 4.4 COc1ccc(Cl)cc1N1CCN(CCn2c(C)nc3c(sc4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
CHEMBL222896 84737 0 None -4 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 468 5 0 7 4.4 COc1ccc(Cl)cc1N1CCN(CCn2c(C)nc3c(sc4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
76330229 106235 0 None -11 3 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 515 4 1 8 3.9 COc1cc2nc(N3CCN(C(=O)c4ccc(Br)o4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
CHEMBL2261605 106235 0 None -11 3 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 515 4 1 8 3.9 COc1cc2nc(N3CCN(C(=O)c4ccc(Br)o4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
CHEMBL3138857 106235 0 None -11 3 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptorDisplacement of [3H]prazosin from Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 515 4 1 8 3.9 COc1cc2nc(N3CCN(C(=O)c4ccc(Br)o4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1007/s00044-004-0024-8
44428845 142362 0 None -11 3 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 515 4 1 8 3.9 COc1cc2nc(N3CCN(C(=O)c4ccc(Br)o4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
CHEMBL388884 142362 0 None -11 3 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 515 4 1 8 3.9 COc1cc2nc(N3CCN(C(=O)c4ccc(Br)o4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
11638677 84589 0 None -24 5 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 340 5 0 5 2.8 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2016.06.052
CHEMBL2153423 84589 0 None -24 5 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 340 5 0 5 2.8 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2016.06.052
CHEMBL2220978 84589 0 None -24 5 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 340 5 0 5 2.8 COc1ccccc1N1CCN(CCc2ccc3c(c2)OCO3)CC1 10.1016/j.ejmech.2016.06.052
491 192 9 None -22 12 Rat 8.5 pKi = 8.5 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
9891167 192 9 None -22 12 Rat 8.5 pKi = 8.5 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
CHEMBL13856 192 9 None -22 12 Rat 8.5 pKi = 8.5 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
10816832 121504 0 None 234 3 Human 8.5 pKi = 8.5 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 1 7 4.5 COC(=O)C1=C(C)N=C(C)N(CCC[C@H](C)CN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL358313 121504 0 None 234 3 Human 8.5 pKi = 8.5 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 567 10 1 7 4.5 COC(=O)C1=C(C)N=C(C)N(CCC[C@H](C)CN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
44431551 87210 0 None -1 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL232779 87210 0 None -1 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
44431620 87798 0 None 4 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 570 7 1 6 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cnc(Cl)c(Br)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233790 87798 0 None 4 4 Human 8.5 pKi = 8.5 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 570 7 1 6 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cnc(Cl)c(Br)c3)CC2)CC1 10.1016/j.bmcl.2007.04.008
56837635 69308 0 None -11 5 Pig 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1129 44 2 17 6.2 COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928132 69308 0 None -11 5 Pig 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1129 44 2 17 6.2 COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
57398875 69314 0 None 1 5 Pig 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1005 30 2 17 4.7 COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccc(COCCOCCOCCOCCOCc4ccn5ncc(C(=O)NCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928138 69314 0 None 1 5 Pig 8.5 pKi = 8.5 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1005 30 2 17 4.7 COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccc(COCCOCCOCCOCCOCc4ccn5ncc(C(=O)NCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1 10.1016/j.bmc.2011.10.063
11154198 201614 0 None -6 4 Rat 8.5 pKi = 8.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 413 6 0 5 3.3 CC(C)Oc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
CHEMBL60583 201614 0 None -6 4 Rat 8.5 pKi = 8.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 413 6 0 5 3.3 CC(C)Oc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
11801562 85284 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 590 10 2 9 3.7 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL2260362 85284 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 590 10 2 9 3.7 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
90645604 112437 0 None 1 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 652 12 2 9 5.2 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)CCCC(=O)NCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298022 112437 0 None 1 3 Human 8.5 pKi = 8.5 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 652 12 2 9 5.2 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)CCCC(=O)NCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
10582623 101768 0 None 2 2 Rat 8.5 pKi = 8.5 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 392 4 1 6 1.8 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cccnc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL299907 101768 0 None 2 2 Rat 8.5 pKi = 8.5 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 392 4 1 6 1.8 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cccnc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL41844 163232 0 None 194 4 Human 8.5 pKi = 8.5 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 590 10 2 9 4.6 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)N=C(C)/C(=C(/O)OC)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
10745305 37136 0 None 120 3 Human 8.4 pKi = 8.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 553 9 0 7 5.2 COC(=O)C1=C(C)N=C(C)N(CCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL145278 37136 0 None 120 3 Human 8.4 pKi = 8.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 553 9 0 7 5.2 COC(=O)C1=C(C)N=C(C)N(CCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
102 4127 48 None -85 49 Bovine 8.4 pKi = 8.4 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
3659 4127 48 None -85 49 Bovine 8.4 pKi = 8.4 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
8969 4127 48 None -85 49 Bovine 8.4 pKi = 8.4 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
CHEMBL15245 4127 48 None -85 49 Bovine 8.4 pKi = 8.4 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
DB01392 4127 48 None -85 49 Bovine 8.4 pKi = 8.4 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pineal
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00018a001
16041092 95380 0 None -1 4 Human 8.4 pKi = 8.4 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)c(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL256804 95380 0 None -1 4 Human 8.4 pKi = 8.4 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)c(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
136048765 63336 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranesInhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranes
ChEMBL 502 9 3 8 4.9 COc1ccccc1N1CCN(CCCNc2cc(O)nc(Nc3c(Cl)cccc3Cl)n2)CC1 10.1021/jm0491804
CHEMBL179401 63336 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranesInhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranes
ChEMBL 502 9 3 8 4.9 COc1ccccc1N1CCN(CCCNc2cc(O)nc(Nc3c(Cl)cccc3Cl)n2)CC1 10.1021/jm0491804
CHEMBL41844 163232 0 None 194 4 Human 8.4 pKi = 8.4 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 590 10 2 9 4.6 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)N=C(C)/C(=C(/O)OC)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(00)00307-3
44447007 154797 0 None -4 4 Rat 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 448 6 1 5 4.4 CC(C)C(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
CHEMBL400236 154797 0 None -4 4 Rat 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 448 6 1 5 4.4 CC(C)C(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
10817661 85286 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 620 12 3 10 3.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)OCCO)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
CHEMBL2260364 85286 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 620 12 3 10 3.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)OCCO)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
CHEMBL347501 119716 0 None 436 3 Human 8.4 pKi = 8.4 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 620 12 3 10 3.9 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)N=C(C)/C(=C(/O)OCCO)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
4418 34222 85 None -1 6 Human 8.4 pKi = 8.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmcl.2004.11.032
CHEMBL142635 34222 85 None -1 6 Human 8.4 pKi = 8.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmcl.2004.11.032
44316098 169166 0 None 14 3 Human 8.4 pKi = 8.4 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 425 7 0 6 3.0 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)n(C)n2)CC1 10.1016/s0960-894x(00)00472-8
CHEMBL440499 169166 0 None 14 3 Human 8.4 pKi = 8.4 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 425 7 0 6 3.0 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)n(C)n2)CC1 10.1016/s0960-894x(00)00472-8
1443 2028 34 None 1 10 Human 8.4 pKi = 8.4 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
33625 2028 34 None 1 10 Human 8.4 pKi = 8.4 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
501 2028 34 None 1 10 Human 8.4 pKi = 8.4 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
CHEMBL279516 2028 34 None 1 10 Human 8.4 pKi = 8.4 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
DB08950 2028 34 None 1 10 Human 8.4 pKi = 8.4 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm00018a001
10555618 85285 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 604 11 2 9 4.1 CCOC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL2260363 85285 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 604 11 2 9 4.1 CCOC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
4418 34222 85 None -1 6 Human 8.4 pKi = 8.4 Binding
Displacement of [125I-HEAT from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes incubated for 60 minsDisplacement of [125I-HEAT from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes incubated for 60 mins
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmcl.2018.01.068
CHEMBL142635 34222 85 None -1 6 Human 8.4 pKi = 8.4 Binding
Displacement of [125I-HEAT from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes incubated for 60 minsDisplacement of [125I-HEAT from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes incubated for 60 mins
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1016/j.bmcl.2018.01.068
CHEMBL346649 119629 0 None 104 3 Human 8.4 pKi = 8.4 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 604 11 2 9 4.9 CCO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
2284 3182 33 None -1 29 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
4926 3182 33 None -1 29 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
7281 3182 33 None -1 29 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
CHEMBL564 3182 33 None -1 29 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
DB00420 3182 33 None -1 29 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C nan
10526419 199048 0 None 7 2 Rat 8.4 pKi = 8.4 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 425 7 2 6 2.7 COc1cc(N)c(C(=O)NCCN2C[C@@H]3CCc4c(OC)cccc4[C@@H]3C2)cc1OC 10.1021/jm000541z
CHEMBL58612 199048 0 None 7 2 Rat 8.4 pKi = 8.4 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 425 7 2 6 2.7 COc1cc(N)c(C(=O)NCCN2C[C@@H]3CCc4c(OC)cccc4[C@@H]3C2)cc1OC 10.1021/jm000541z
44328654 107185 0 None 47 6 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 663 14 3 6 6.7 CCCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCC)=C(CC)N1 10.1016/s0960-894x(99)00484-9
CHEMBL316495 107185 0 None 47 6 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 663 14 3 6 6.7 CCCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCC)=C(CC)N1 10.1016/s0960-894x(99)00484-9
136806212 207732 0 None 47 3 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 636 13 4 7 4.6 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCN)N1 10.1016/s0960-894x(99)00484-9
44328639 207732 0 None 47 3 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 636 13 4 7 4.6 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL95736 207732 0 None 47 3 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 636 13 4 7 4.6 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCN)N1 10.1016/s0960-894x(99)00484-9
17753379 88063 0 None 2 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 521 8 1 6 4.5 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234607 88063 0 None 2 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 521 8 1 6 4.5 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
11857711 85626 0 None 8 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 506 7 1 4 5.5 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1cc(Cl)ccc1F 10.1016/j.bmcl.2007.04.098
CHEMBL228332 85626 0 None 8 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 506 7 1 4 5.5 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1cc(Cl)ccc1F 10.1016/j.bmcl.2007.04.098
12134986 164394 0 None 70 3 Human 8.4 pKi = 8.4 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 412 7 0 6 3.3 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)on2)CC1 10.1016/s0960-894x(00)00472-8
CHEMBL421324 164394 0 None 70 3 Human 8.4 pKi = 8.4 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 412 7 0 6 3.3 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)on2)CC1 10.1016/s0960-894x(00)00472-8
71817549 102580 0 None -4 6 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
CHEMBL3040803 102580 0 None -4 6 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
CHEMBL3216590 102580 0 None -4 6 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
2894 208071 6 None -8 5 Rat 8.4 pKi = 8.4 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)C4CCCCC43)nc(N)c2cc1OC 10.1021/jm960510x
CHEMBL97698 208071 6 None -8 5 Rat 8.4 pKi = 8.4 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)C4CCCCC43)nc(N)c2cc1OC 10.1021/jm960510x
90645602 112435 0 None 1 3 Human 8.4 pKi = 8.4 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 553 7 1 8 5.0 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)c5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298020 112435 0 None 1 3 Human 8.4 pKi = 8.4 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 553 7 1 8 5.0 COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)c5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
44431616 88077 0 None 3 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 471 8 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234650 88077 0 None 3 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 471 8 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
3584 3777 64 None -2 13 Rat 8.4 pKi = 8.4 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980053f
5401 3777 64 None -2 13 Rat 8.4 pKi = 8.4 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980053f
7302 3777 64 None -2 13 Rat 8.4 pKi = 8.4 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980053f
CHEMBL611 3777 64 None -2 13 Rat 8.4 pKi = 8.4 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980053f
DB01162 3777 64 None -2 13 Rat 8.4 pKi = 8.4 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980053f
44431184 92850 0 None -2 3 Human 8.4 pKi = 8.4 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 515 5 0 5 5.5 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4ccc5ccc(F)cc5c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
CHEMBL243866 92850 0 None -2 3 Human 8.4 pKi = 8.4 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 515 5 0 5 5.5 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4ccc5ccc(F)cc5c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
10310103 107312 0 None 1 8 Bovine 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 425 5 0 5 5.3 N#CCCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ncccn4)cc23)CC1 10.1021/jm020938y
CHEMBL317333 107312 0 None 1 8 Bovine 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 425 5 0 5 5.3 N#CCCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ncccn4)cc23)CC1 10.1021/jm020938y
10602180 168981 0 None 30 2 Rat 8.4 pKi = 8.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 525 5 1 8 4.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ncc(-c6ccccc6)nc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL43909 168981 0 None 30 2 Rat 8.4 pKi = 8.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 525 5 1 8 4.0 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ncc(-c6ccccc6)nc54)c3=O)C[C@@H]21 10.1021/jm990567u
10326069 39296 1 None 23 9 Human 8.4 pKi = 8.4 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 589 10 3 8 3.3 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
CHEMBL147077 39296 1 None 23 9 Human 8.4 pKi = 8.4 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 589 10 3 8 3.3 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
44447003 154796 0 None -8 4 Rat 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 448 7 1 5 4.6 CCCC(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
CHEMBL400235 154796 0 None -8 4 Rat 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 448 7 1 5 4.6 CCCC(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
CHEMBL5275284 194654 0 None -5 3 Human 8.4 pKi = 8.4 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 466 8 1 5 3.9 CC(C)C(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5315872 194654 0 None -5 3 Human 8.4 pKi = 8.4 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 466 8 1 5 3.9 CC(C)C(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
10326069 39296 1 None 23 9 Human 8.4 pKi = 8.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 589 10 3 8 3.3 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL147077 39296 1 None 23 9 Human 8.4 pKi = 8.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 589 10 3 8 3.3 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
1443 2028 34 None 1 10 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm960697s
33625 2028 34 None 1 10 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm960697s
501 2028 34 None 1 10 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm960697s
CHEMBL279516 2028 34 None 1 10 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm960697s
DB08950 2028 34 None 1 10 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10.1021/jm960697s
129211 3749 78 None -1 15 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm960697s
2562 3749 78 None -1 15 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm960697s
488 3749 78 None -1 15 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm960697s
CHEMBL836 3749 78 None -1 15 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm960697s
DB00706 3749 78 None -1 15 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10.1021/jm960697s
9817640 99330 0 None 9 3 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 295 6 1 2 3.6 COc1ccc(CCNCC2CCc3ccccc3C2)cc1 10.1021/jm960697s
CHEMBL282214 99330 0 None 9 3 Human 8.4 pKi = 8.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 295 6 1 2 3.6 COc1ccc(CCNCC2CCc3ccccc3C2)cc1 10.1021/jm960697s
44298644 163127 0 None 31 3 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 454 7 1 6 2.6 Cc1c[nH]c(=O)n(CC(C)(C)CN2CCN(c3ccccc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL417758 163127 0 None 31 3 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 454 7 1 6 2.6 Cc1c[nH]c(=O)n(CC(C)(C)CN2CCN(c3ccccc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
12909387 62637 0 None 33 2 Bovine 7.5 pKi = 7.5 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 301 0 0 3 3.8 CN1CCC(=C2c3cc(C#N)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
CHEMBL178376 62637 0 None 33 2 Bovine 7.5 pKi = 7.5 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 301 0 0 3 3.8 CN1CCC(=C2c3cc(C#N)ccc3C=Cn3cccc32)CC1 10.1021/jm00361a008
102012413 78656 0 None 2 2 Human 7.5 pKi = 7.5 Binding
Tested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assayTested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assay
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H]1c1ccc(F)c(F)c1 10.1016/s0960-894x(00)00524-2
CHEMBL2112365 78656 0 None 2 2 Human 7.5 pKi = 7.5 Binding
Tested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assayTested for binding affinity against recombinant human Alpha-1A adrenergic receptor using [125I]HEAT in competition binding assay
ChEMBL 475 6 1 4 5.0 C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H]1c1ccc(F)c(F)c1 10.1016/s0960-894x(00)00524-2
240 944 43 None -4 24 Rat 7.5 pKi = 7.5 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00086a019
2769 944 43 None -4 24 Rat 7.5 pKi = 7.5 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00086a019
44279790 944 43 None -4 24 Rat 7.5 pKi = 7.5 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00086a019
660 944 43 None -4 24 Rat 7.5 pKi = 7.5 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00086a019
CHEMBL1729 944 43 None -4 24 Rat 7.5 pKi = 7.5 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00086a019
CHEMBL560739 944 43 None -4 24 Rat 7.5 pKi = 7.5 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00086a019
DB00604 944 43 None -4 24 Rat 7.5 pKi = 7.5 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1021/jm00086a019
4038180 204 14 None -2 7 Bovine 7.5 pKi = 7.5 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
480 204 14 None -2 7 Bovine 7.5 pKi = 7.5 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
CHEMBL109783 204 14 None -2 7 Bovine 7.5 pKi = 7.5 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
44420423 84005 0 None -4 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 455 4 1 5 4.3 Cc1nc2c([nH]c3ccccc32)c(=O)n1CCN1CCN(c2ccc(Cl)c(Cl)c2)CC1 10.1016/j.bmcl.2006.09.034
CHEMBL220717 84005 0 None -4 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 455 4 1 5 4.3 Cc1nc2c([nH]c3ccccc32)c(=O)n1CCN1CCN(c2ccc(Cl)c(Cl)c2)CC1 10.1016/j.bmcl.2006.09.034
127040157 136927 0 None -10 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNC[C@@H]2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1039/C4MD00484A
CHEMBL3739897 136927 0 None -10 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNC[C@@H]2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1039/C4MD00484A
CHEMBL3742490 136927 0 None -10 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNC[C@@H]2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1039/C4MD00484A
155563002 176668 0 None -15 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 10 1 5 4.2 COc1ccccc1OCCNC[C@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4570387 176668 0 None -15 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 10 1 5 4.2 COc1ccccc1OCCNC[C@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4598207 176668 0 None -15 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 10 1 5 4.2 COc1ccccc1OCCNC[C@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
118716709 115003 0 None -1 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 457 5 0 6 3.1 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)C4CCCCC4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342862 115003 0 None -1 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 457 5 0 6 3.1 COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)C4CCCCC4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
44388493 63105 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranesInhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranes
ChEMBL 500 8 0 6 4.3 Clc1ccc(C2(Cn3ccnc3)OCC(CN3CCN(CCc4ccccc4)CC3)O2)c(Cl)c1 10.1021/jm0491804
CHEMBL178921 63105 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranesInhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranes
ChEMBL 500 8 0 6 4.3 Clc1ccc(C2(Cn3ccnc3)OCC(CN3CCN(CCc4ccccc4)CC3)O2)c(Cl)c1 10.1021/jm0491804
46882086 5816 0 None 1 2 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 435 10 1 6 4.0 COc1cc(OC)cc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)c1 10.1016/j.bmcl.2010.01.030
CHEMBL1078954 5816 0 None 1 2 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 435 10 1 6 4.0 COc1cc(OC)cc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)c1 10.1016/j.bmcl.2010.01.030
9796667 109466 0 None - 1 Rat 6.5 pKi = 6.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 309 3 2 3 2.4 CS(=O)(=O)Nc1ccc(F)c2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL322042 109466 0 None - 1 Rat 6.5 pKi = 6.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 309 3 2 3 2.4 CS(=O)(=O)Nc1ccc(F)c2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
11857862 85677 0 None 2 4 Human 7.5 pKi = 7.5 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 538 10 1 6 4.8 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL228607 85677 0 None 2 4 Human 7.5 pKi = 7.5 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 538 10 1 6 4.8 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
11857862 85677 0 None 2 4 Human 7.5 pKi = 7.5 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 538 10 1 6 4.8 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL228607 85677 0 None 2 4 Human 7.5 pKi = 7.5 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 538 10 1 6 4.8 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
44331174 4169 0 None 1 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 355 3 0 2 4.9 O=C1c2ccccc2CC12CCN(CCc1cccc3ccccc13)CC2 10.1016/s0960-894x(98)00732-x
CHEMBL100052 4169 0 None 1 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 355 3 0 2 4.9 O=C1c2ccccc2CC12CCN(CCc1cccc3ccccc13)CC2 10.1016/s0960-894x(98)00732-x
CHEMBL5269671 194600 0 None -44 3 Human 7.5 pKi = 7.5 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 466 9 1 5 4.0 CCCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5315170 194600 0 None -44 3 Human 7.5 pKi = 7.5 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 466 9 1 5 4.0 CCCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5284242 194615 0 None -56 3 Human 7.5 pKi = 7.5 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 510 11 0 6 4.0 COCCCC(=O)N(C)CCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5315342 194615 0 None -56 3 Human 7.5 pKi = 7.5 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 510 11 0 6 4.0 COCCCC(=O)N(C)CCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
9981635 36910 0 None -2 3 Human 7.5 pKi = 7.5 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 459 5 2 5 4.4 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1cccc(C(F)(F)F)c1)C3 10.1021/jm030952q
CHEMBL145098 36910 0 None -2 3 Human 7.5 pKi = 7.5 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 459 5 2 5 4.4 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1cccc(C(F)(F)F)c1)C3 10.1021/jm030952q
CHEMBL2112853 36910 0 None -2 3 Human 7.5 pKi = 7.5 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 459 5 2 5 4.4 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1cccc(C(F)(F)F)c1)C3 10.1021/jm030952q
24803797 61080 0 None -7 4 Human 7.5 pKi = 7.5 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 626 11 0 6 7.6 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C1CCCN(CCc2ccc(OCCCN3CCCCCC3)cc2)CC1 10.1021/jm1013874
CHEMBL1765111 61080 0 None -7 4 Human 7.5 pKi = 7.5 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 626 11 0 6 7.6 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C1CCCN(CCc2ccc(OCCCN3CCCCCC3)cc2)CC1 10.1021/jm1013874
24803482 61333 0 None -125 4 Human 7.5 pKi = 7.5 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 640 14 0 6 7.8 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1021/jm1013874
CHEMBL1767168 61333 0 None -125 4 Human 7.5 pKi = 7.5 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 640 14 0 6 7.8 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1021/jm1013874
71817861 102406 0 None 2 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
CHEMBL3039699 102406 0 None 2 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
CHEMBL3217244 102406 0 None 2 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 356 7 2 6 2.5 COc1ccc2c(c1OCCNC[C@@H]1COc3ccccc3O1)NCC2 10.1021/jm400867d
3826471 97478 13 None -17 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 296 5 0 3 3.1 COc1ccccc1N1CCN(CCc2ccccc2)CC1 10.1016/j.ejmech.2016.06.052
CHEMBL27021 97478 13 None -17 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 296 5 0 3 3.1 COc1ccccc1N1CCN(CCc2ccccc2)CC1 10.1016/j.ejmech.2016.06.052
702235 53212 97 None -7 4 Rat 5.5 pKi = 5.5 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 200 1 2 1 2.6 c1ccc2c(C3CCNCC3)c[nH]c2c1 10.1016/j.bmcl.2015.07.046
CHEMBL15988 53212 97 None -7 4 Rat 5.5 pKi = 5.5 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 200 1 2 1 2.6 c1ccc2c(C3CCNCC3)c[nH]c2c1 10.1016/j.bmcl.2015.07.046
CHEMBL2011564 53212 97 None -7 4 Rat 5.5 pKi = 5.5 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 200 1 2 1 2.6 c1ccc2c(C3CCNCC3)c[nH]c2c1 10.1016/j.bmcl.2015.07.046
10397358 174987 44 None -70 2 Bovine 4.5 pKi = 4.5 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 178 1 2 4 0.1 Nc1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL45665 174987 44 None -70 2 Bovine 4.5 pKi = 4.5 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 178 1 2 4 0.1 Nc1cccnc1N1CCNCC1 10.1021/jm00366a007
132060812 162036 0 None -831 10 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by microbeta scintillation counting method
ChEMBL 329 4 0 2 4.9 COc1cccc(-c2ccc3c(c2)CCN(Cc2ccccc2)C3)c1 10.1016/j.ejmech.2018.02.024
CHEMBL4160064 162036 0 None -831 10 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by microbeta scintillation counting method
ChEMBL 329 4 0 2 4.9 COc1cccc(-c2ccc3c(c2)CCN(Cc2ccccc2)C3)c1 10.1016/j.ejmech.2018.02.024
10287924 109833 0 None -95 5 Human 6.5 pKi = 6.5 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 388 4 0 5 3.9 CN1CCN2c3c(cccc31)[C@@H]1CN(CCCc3noc4ccccc34)CC[C@@H]12 10.1021/jm401958n
CHEMBL3233411 109833 0 None -95 5 Human 6.5 pKi = 6.5 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 388 4 0 5 3.9 CN1CCN2c3c(cccc31)[C@@H]1CN(CCCc3noc4ccccc34)CC[C@@H]12 10.1021/jm401958n
155770281 177747 0 None -3 9 Human 5.5 pKi = 5.5 Binding
Binding affinity to alpha1a (unknown origin)Binding affinity to alpha1a (unknown origin)
ChEMBL 517 4 1 2 7.6 CC(=O)N1CCC(c2ccc(-c3cc(C(=O)O)cc4cc(-c5ccc(C(F)(F)F)cc5)ccc34)cc2)CC1 10.1021/acs.jmedchem.1c00164
CHEMBL4642592 177747 0 None -3 9 Human 5.5 pKi = 5.5 Binding
Binding affinity to alpha1a (unknown origin)Binding affinity to alpha1a (unknown origin)
ChEMBL 517 4 1 2 7.6 CC(=O)N1CCC(c2ccc(-c3cc(C(=O)O)cc4cc(-c5ccc(C(F)(F)F)cc5)ccc34)cc2)CC1 10.1021/acs.jmedchem.1c00164
118717459 115141 0 None -2 4 Human 6.5 pKi = 6.5 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 444 12 2 6 6.3 COc1ccc2nccc(NCCCCCCCNc3ccnc4ccc(OC)cc34)c2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343981 115141 0 None -2 4 Human 6.5 pKi = 6.5 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 444 12 2 6 6.3 COc1ccc2nccc(NCCCCCCCNc3ccnc4ccc(OC)cc34)c2c1 10.1016/j.bmc.2014.09.017
10579368 106004 0 None -1 6 Human 6.5 pKi = 6.5 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 593 9 3 6 5.3 CC1=C(C(=O)O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL313251 106004 0 None -1 6 Human 6.5 pKi = 6.5 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 593 9 3 6 5.3 CC1=C(C(=O)O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
10579368 106004 0 None -1 6 Human 6.5 pKi = 6.5 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 593 9 3 6 5.3 CC1=C(C(=O)O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
CHEMBL313251 106004 0 None -1 6 Human 6.5 pKi = 6.5 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 593 9 3 6 5.3 CC1=C(C(=O)O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
52937018 61300 0 None -31 4 Human 6.5 pKi = 6.5 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 355 6 0 4 3.6 CN(C)CCCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767135 61300 0 None -31 4 Human 6.5 pKi = 6.5 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 355 6 0 4 3.6 CN(C)CCCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
52937223 61322 23 None -5 4 Human 6.5 pKi = 6.5 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 381 5 0 4 4.1 CN1CCCC1CCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767157 61322 23 None -5 4 Human 6.5 pKi = 6.5 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 381 5 0 4 4.1 CN1CCCC1CCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
24803316 61327 0 None -794 4 Human 6.5 pKi = 6.5 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 600 15 1 6 6.9 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1CCNCCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1021/jm1013874
CHEMBL1767162 61327 0 None -794 4 Human 6.5 pKi = 6.5 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 600 15 1 6 6.9 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1CCNCCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1021/jm1013874
250 3386 8 None -8912 12 Human 6.5 pKi = 6.5 Binding
Compound was evaluated for binding affinity against Alpha-1C adrenergic receptor using radioligand binding assayCompound was evaluated for binding affinity against Alpha-1C adrenergic receptor using radioligand binding assay
ChEMBL 502 10 1 7 5.0 COc1cc(CCCN2CCC(CC2)CCC(=O)c2cc(Cl)c(c3c2OCCO3)N)ccc1OC 10.1016/0960-894X(95)00358-Z
5311416 3386 8 None -8912 12 Human 6.5 pKi = 6.5 Binding
Compound was evaluated for binding affinity against Alpha-1C adrenergic receptor using radioligand binding assayCompound was evaluated for binding affinity against Alpha-1C adrenergic receptor using radioligand binding assay
ChEMBL 502 10 1 7 5.0 COc1cc(CCCN2CCC(CC2)CCC(=O)c2cc(Cl)c(c3c2OCCO3)N)ccc1OC 10.1016/0960-894X(95)00358-Z
CHEMBL69733 3386 8 None -8912 12 Human 6.5 pKi = 6.5 Binding
Compound was evaluated for binding affinity against Alpha-1C adrenergic receptor using radioligand binding assayCompound was evaluated for binding affinity against Alpha-1C adrenergic receptor using radioligand binding assay
ChEMBL 502 10 1 7 5.0 COc1cc(CCCN2CCC(CC2)CCC(=O)c2cc(Cl)c(c3c2OCCO3)N)ccc1OC 10.1016/0960-894X(95)00358-Z
118717459 115141 0 None -2 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 444 12 2 6 6.3 COc1ccc2nccc(NCCCCCCCNc3ccnc4ccc(OC)cc34)c2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343981 115141 0 None -2 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 444 12 2 6 6.3 COc1ccc2nccc(NCCCCCCCNc3ccnc4ccc(OC)cc34)c2c1 10.1016/j.bmc.2014.09.017
3584 3777 64 None -2 13 Human 7.5 pKi = 7.5 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
5401 3777 64 None -2 13 Human 7.5 pKi = 7.5 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
7302 3777 64 None -2 13 Human 7.5 pKi = 7.5 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
CHEMBL611 3777 64 None -2 13 Human 7.5 pKi = 7.5 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
DB01162 3777 64 None -2 13 Human 7.5 pKi = 7.5 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog prostate tissue preparations
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
2286 3183 51 None -10 30 Rat 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
4927 3183 51 None -10 30 Rat 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
7282 3183 51 None -10 30 Rat 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
CHEMBL643 3183 51 None -10 30 Rat 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
DB01069 3183 51 None -10 30 Rat 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 284 3 0 3 4.2 CN(C(CN1c2ccccc2Sc2c1cccc2)C)C nan
10043148 206540 0 None -26 2 Rat 6.5 pKi = 6.5 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 344 6 0 5 1.9 COc1ccccc1N1CCN(CCCN2CC3CCCN3C2)CC1 10.1021/jm970216k
CHEMBL88594 206540 0 None -26 2 Rat 6.5 pKi = 6.5 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 344 6 0 5 1.9 COc1ccccc1N1CCN(CCCN2CC3CCCN3C2)CC1 10.1021/jm970216k
11995036 11844 0 None 1 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL1182196 11844 0 None 1 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL218732 11844 0 None 1 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
14004032 119834 2 None -1 2 Bovine 5.5 pKi = 5.5 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 188 0 0 2 2.2 c1cnc2c(c1)CCN1CCCCC21 10.1021/jm00398a025
CHEMBL348538 119834 2 None -1 2 Bovine 5.5 pKi = 5.5 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 188 0 0 2 2.2 c1cnc2c(c1)CCN1CCCCC21 10.1021/jm00398a025
53328116 63384 0 None -5 3 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 411 5 0 4 3.4 O=C1CC(c2ccccc2)CC(=O)N1CCN1CCN(c2ccccc2Cl)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796029 63384 0 None -5 3 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 411 5 0 4 3.4 O=C1CC(c2ccccc2)CC(=O)N1CCN1CCN(c2ccccc2Cl)CC1 10.1016/j.ejmech.2011.03.054
14004032 119834 2 None -1 2 Bovine 5.5 pKi = 5.5 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 188 0 0 2 2.2 c1cnc2c(c1)CCN1CCCCC21 10.1021/jm00398a025
CHEMBL348538 119834 2 None -1 2 Bovine 5.5 pKi = 5.5 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 188 0 0 2 2.2 c1cnc2c(c1)CCN1CCCCC21 10.1021/jm00398a025
11732785 163720 0 None -38 6 Rat 7.5 pKi = 7.5 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 432 7 0 5 3.7 COc1ccccc1N1CCN(CCCCN2CCn3c(cc4ccccc43)C2=O)CC1 10.1021/jm0211220
CHEMBL420510 163720 0 None -38 6 Rat 7.5 pKi = 7.5 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 432 7 0 5 3.7 COc1ccccc1N1CCN(CCCCN2CCn3c(cc4ccccc43)C2=O)CC1 10.1021/jm0211220
10020855 78823 0 None -165 6 Human 7.5 pKi = 7.5 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 351 4 0 4 3.9 COc1cccc(C2CCC(N3CCN(c4ccccn4)CC3)CC2)c1 10.1021/jm010866v
CHEMBL2112778 78823 0 None -165 6 Human 7.5 pKi = 7.5 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 351 4 0 4 3.9 COc1cccc(C2CCC(N3CCN(c4ccccn4)CC3)CC2)c1 10.1021/jm010866v
16041265 95337 0 None -1 4 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 504 6 2 4 6.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cccc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL256597 95337 0 None -1 4 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 504 6 2 4 6.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cccc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
49865600 16021 0 None -83 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 378 7 1 4 4.4 Clc1cccc(N2CCN(CCCCNc3ccccn3)CC2)c1Cl 10.1016/j.bmcl.2010.07.096
CHEMBL1223616 16021 0 None -83 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 378 7 1 4 4.4 Clc1cccc(N2CCN(CCCCNc3ccccn3)CC2)c1Cl 10.1016/j.bmcl.2010.07.096
122295 9868 7 None 1 9 Human 7.5 pKi = 7.5 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 10.1021/jm00019a001
CHEMBL114166 9868 7 None 1 9 Human 7.5 pKi = 7.5 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 279 3 0 2 3.7 CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2 10.1021/jm00019a001
11140347 204533 1 None -5 6 Human 7.5 pKi = 7.5 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 239 4 2 4 2.0 CSc1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL72768 204533 1 None -5 6 Human 7.5 pKi = 7.5 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 239 4 2 4 2.0 CSc1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
9824384 118787 1 None -177 7 Bovine 7.5 pKi = 7.5 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1021/jm960510x
CHEMBL342062 118787 1 None -177 7 Bovine 7.5 pKi = 7.5 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1021/jm960510x
145963755 162034 0 None -4 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 465 5 2 9 2.2 COc1cc2nc(N3CCC[C@H](NC(=O)[C@@H]4COc5ccccc5O4)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
CHEMBL4160032 162034 0 None -4 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 465 5 2 9 2.2 COc1cc2nc(N3CCC[C@H](NC(=O)[C@@H]4COc5ccccc5O4)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
10962489 11190 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 404 8 0 3 4.5 C[N+](C)(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
CHEMBL1178679 11190 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 404 8 0 3 4.5 C[N+](C)(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
CHEMBL37212 11190 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 404 8 0 3 4.5 C[N+](C)(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
44417706 11835 0 None 10 6 Human 7.5 pKi = 7.5 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3ccccc3cc2O1 10.1016/j.ejmech.2020.112419
CHEMBL1182152 11835 0 None 10 6 Human 7.5 pKi = 7.5 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3ccccc3cc2O1 10.1016/j.ejmech.2020.112419
CHEMBL215188 11835 0 None 10 6 Human 7.5 pKi = 7.5 Binding
Antagonist activity at human alpha A1 adrenoreceptor expressed in CHO cellsAntagonist activity at human alpha A1 adrenoreceptor expressed in CHO cells
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3ccccc3cc2O1 10.1016/j.ejmech.2020.112419
10962489 11190 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 8 0 3 4.5 C[N+](C)(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
CHEMBL1178679 11190 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 8 0 3 4.5 C[N+](C)(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
CHEMBL37212 11190 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 8 0 3 4.5 C[N+](C)(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
11049096 11196 0 None 1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 389 8 0 4 4.3 CN(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
CHEMBL1178700 11196 0 None 1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 389 8 0 4 4.3 CN(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
CHEMBL37962 11196 0 None 1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 389 8 0 4 4.3 CN(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
9822814 101949 0 None -4 4 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 409 4 0 3 4.3 O=C1CC2(CCCC2)CCN1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL301224 101949 0 None -4 4 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 409 4 0 3 4.3 O=C1CC2(CCCC2)CCN1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
155567201 176228 0 None -20 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 9 1 5 4.2 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)OC1 10.1016/j.ejmech.2019.05.024
CHEMBL4588223 176228 0 None -20 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 9 1 5 4.2 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)OC1 10.1016/j.ejmech.2019.05.024
CHEMBL4594654 176228 0 None -20 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 9 1 5 4.2 COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)OC1 10.1016/j.ejmech.2019.05.024
44417706 11835 0 None 10 6 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3ccccc3cc2O1 10.1021/jm060358r
CHEMBL1182152 11835 0 None 10 6 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3ccccc3cc2O1 10.1021/jm060358r
CHEMBL215188 11835 0 None 10 6 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 395 8 1 6 3.7 COc1cccc(OC)c1OCCNC[C@H]1COc2cc3ccccc3cc2O1 10.1021/jm060358r
9822814 101949 0 None -4 4 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 409 4 0 3 4.3 O=C1CC2(CCCC2)CCN1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL301224 101949 0 None -4 4 Human 7.5 pKi = 7.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 409 4 0 3 4.3 O=C1CC2(CCCC2)CCN1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
44435219 91792 0 None 6 4 Human 6.5 pKi = 6.5 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by PDSP assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 367 2 0 2 6.2 O=C(Cc1ccc2ccccc2c1)N1c2ccccc2Sc2ccccc21 10.1016/j.bmcl.2013.04.082
CHEMBL241115 91792 0 None 6 4 Human 6.5 pKi = 6.5 Binding
Antagonist activity at adrenergic alpha1A receptor (unknown origin) by PDSP assayAntagonist activity at adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 367 2 0 2 6.2 O=C(Cc1ccc2ccccc2c1)N1c2ccccc2Sc2ccccc21 10.1016/j.bmcl.2013.04.082
9932835 100793 0 None -6 3 Rat 6.5 pKi = 6.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 437 4 0 4 4.2 O=C1CC2(CCCCC2)CC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL293111 100793 0 None -6 3 Rat 6.5 pKi = 6.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 437 4 0 4 4.2 O=C1CC2(CCCCC2)CC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
518 3612 1 None -234 6 Human 5.5 pKi = 5.5 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 299 0 0 2 3.8 CN1CCc2c3c(C1)c(Br)oc3ccc2Cl 10.1016/j.bmcl.2004.11.032
9839317 3612 1 None -234 6 Human 5.5 pKi = 5.5 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 299 0 0 2 3.8 CN1CCc2c3c(C1)c(Br)oc3ccc2Cl 10.1016/j.bmcl.2004.11.032
CHEMBL123138 3612 1 None -234 6 Human 5.5 pKi = 5.5 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 299 0 0 2 3.8 CN1CCc2c3c(C1)c(Br)oc3ccc2Cl 10.1016/j.bmcl.2004.11.032
44271624 64775 3 None - 1 Bovine 5.5 pKi = 5.5 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 192 1 0 2 1.9 CN1CC=C(c2ncccc2F)CC1 10.1021/jm00375a017
CHEMBL18194 64775 3 None - 1 Bovine 5.5 pKi = 5.5 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 192 1 0 2 1.9 CN1CC=C(c2ncccc2F)CC1 10.1021/jm00375a017
518 3612 1 None -234 6 Human 5.5 pKi = 5.5 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 299 0 0 2 3.8 CN1CCc2c3c(C1)c(Br)oc3ccc2Cl 10.1021/jm00019a001
9839317 3612 1 None -234 6 Human 5.5 pKi = 5.5 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 299 0 0 2 3.8 CN1CCc2c3c(C1)c(Br)oc3ccc2Cl 10.1021/jm00019a001
CHEMBL123138 3612 1 None -234 6 Human 5.5 pKi = 5.5 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 299 0 0 2 3.8 CN1CCc2c3c(C1)c(Br)oc3ccc2Cl 10.1021/jm00019a001
20750645 102307 0 None 1 2 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 346 6 1 5 3.4 CC(C)Oc1ccccc1N1CCN(Cc2cc(CO)cs2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL303485 102307 0 None 1 2 Human 6.5 pKi = 6.5 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 346 6 1 5 3.4 CC(C)Oc1ccccc1N1CCN(Cc2cc(CO)cs2)CC1 10.1016/s0960-894x(02)00347-5
127035062 136451 0 None -11 19 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A receptor after 90 mins by scintillation counting methodDisplacement of [3H]Prazosin from human recombinant alpha 1A receptor after 90 mins by scintillation counting method
ChEMBL 447 12 0 5 5.2 COc1ccc(CCN(CCCc2ccccc2)CCc2ccc3c(c2)OCO3)cc1OC 10.1039/C4MD00418C
CHEMBL3735756 136451 0 None -11 19 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A receptor after 90 mins by scintillation counting methodDisplacement of [3H]Prazosin from human recombinant alpha 1A receptor after 90 mins by scintillation counting method
ChEMBL 447 12 0 5 5.2 COc1ccc(CCN(CCCc2ccccc2)CCc2ccc3c(c2)OCO3)cc1OC 10.1039/C4MD00418C
44582675 189701 0 None -5 15 Human 6.5 pKi = 6.5 Binding
Inhibition of human cloned alpha1A adrenergic receptor by competitive binding experimentInhibition of human cloned alpha1A adrenergic receptor by competitive binding experiment
ChEMBL 405 9 1 4 4.2 COc1c(OCCF)cccc1[C@H](O)C1CCN(CCc2ccc(F)cc2)CC1 10.1016/j.bmc.2009.03.021
CHEMBL515472 189701 0 None -5 15 Human 6.5 pKi = 6.5 Binding
Inhibition of human cloned alpha1A adrenergic receptor by competitive binding experimentInhibition of human cloned alpha1A adrenergic receptor by competitive binding experiment
ChEMBL 405 9 1 4 4.2 COc1c(OCCF)cccc1[C@H](O)C1CCN(CCc2ccc(F)cc2)CC1 10.1016/j.bmc.2009.03.021
12840734 100929 3 None -95 4 Rat 5.5 pKi = 5.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 355 4 0 4 2.5 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2)CC1 10.1021/jm030944+
CHEMBL293968 100929 3 None -95 4 Rat 5.5 pKi = 5.5 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 355 4 0 4 2.5 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2)CC1 10.1021/jm030944+
76318762 84815 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 435 9 1 6 4.0 COc1cccc(OC)c1OCCNC1COCC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
CHEMBL2234440 84815 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 435 9 1 6 4.0 COc1cccc(OC)c1OCCNC1COCC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
25131193 86190 0 None -239 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 449 10 1 6 4.0 COc1cccc(OC)c1OCCNCC1COCC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.02.056
CHEMBL2312225 86190 0 None -239 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 449 10 1 6 4.0 COc1cccc(OC)c1OCCNCC1COCC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.02.056
24894141 187409 0 None -30 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 449 10 1 6 4.0 COc1cccc(OC)c1OCCNC[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm800461k
CHEMBL493697 187409 0 None -30 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 449 10 1 6 4.0 COc1cccc(OC)c1OCCNC[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm800461k
25131193 86190 0 None -239 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 449 10 1 6 4.0 COc1cccc(OC)c1OCCNCC1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm301525w
CHEMBL2312225 86190 0 None -239 4 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 449 10 1 6 4.0 COc1cccc(OC)c1OCCNCC1COCC(c2ccccc2)(c2ccccc2)O1 10.1021/jm301525w
53328872 63403 0 None -3 3 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 433 5 0 5 2.9 COc1ccccc1N1CCN(CCN2C(=O)CC3(CCc4ccccc43)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796048 63403 0 None -3 3 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 433 5 0 5 2.9 COc1ccccc1N1CCN(CCN2C(=O)CC3(CCc4ccccc43)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
9906978 42711 2 None -2 12 Human 7.5 pKi = 7.5 Binding
Binding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assay
ChEMBL 361 6 1 3 4.0 O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
CHEMBL150161 42711 2 None -2 12 Human 7.5 pKi = 7.5 Binding
Binding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assay
ChEMBL 361 6 1 3 4.0 O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
16041451 97808 0 None -5 4 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 500 7 2 5 5.4 COc1ccc(Cl)cc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL271913 97808 0 None -5 4 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 500 7 2 5 5.4 COc1ccc(Cl)cc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.11.068
168270256 190067 0 None -8 2 Rat 7.5 pKi = 7.5 Binding
Displacement of [3H]-prazosin from rat whole cortex membrane homogenate alpha 1 adrenergic receptorDisplacement of [3H]-prazosin from rat whole cortex membrane homogenate alpha 1 adrenergic receptor
ChEMBL 415 3 0 3 3.7 CCN(CC)C(=O)[C@@H]1C=C2c3cccc4c3c(c(Br)n4C)CC2N(C)C1 10.1021/acs.jmedchem.2c00633
CHEMBL5172469 190067 0 None -8 2 Rat 7.5 pKi = 7.5 Binding
Displacement of [3H]-prazosin from rat whole cortex membrane homogenate alpha 1 adrenergic receptorDisplacement of [3H]-prazosin from rat whole cortex membrane homogenate alpha 1 adrenergic receptor
ChEMBL 415 3 0 3 3.7 CCN(CC)C(=O)[C@@H]1C=C2c3cccc4c3c(c(Br)n4C)CC2N(C)C1 10.1021/acs.jmedchem.2c00633
53328686 63400 0 None 2 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 469 7 0 5 4.0 COc1ccc(Cl)cc1N1CCN(CCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796045 63400 0 None 2 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 469 7 0 5 4.0 COc1ccc(Cl)cc1N1CCN(CCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
2337 3256 77 None -3 62 Rat 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
50 3256 77 None -3 62 Rat 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
5002 3256 77 None -3 62 Rat 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
CHEMBL716 3256 77 None -3 62 Rat 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
DB01224 3256 77 None -3 62 Rat 7.5 pKi = 7.5 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 nan
75201901 166425 19 None -251 24 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting method
ChEMBL 356 3 0 6 4.9 Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12 10.1021/acs.jmedchem.9b00351
CHEMBL4277264 166425 19 None -251 24 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting method
ChEMBL 356 3 0 6 4.9 Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12 10.1021/acs.jmedchem.9b00351
16756752 142591 0 None -4168 3 Human 4.5 pKi = 4.5 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 496 7 1 3 7.8 CC(C)C(=O)Nc1cccc(C2CCN(Cc3ccc(Oc4ccc(Cl)c(Cl)c4)cc3)CC2)c1 10.1021/jm060383x
CHEMBL389129 142591 0 None -4168 3 Human 4.5 pKi = 4.5 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 496 7 1 3 7.8 CC(C)C(=O)Nc1cccc(C2CCN(Cc3ccc(Oc4ccc(Cl)c(Cl)c4)cc3)CC2)c1 10.1021/jm060383x
44460449 205874 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 426 7 0 6 3.7 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCCCC3=O)co2)CC1 10.1016/s0960-894x(02)00436-5
CHEMBL83791 205874 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 426 7 0 6 3.7 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCCCC3=O)co2)CC1 10.1016/s0960-894x(02)00436-5
53328115 63383 0 None -2 3 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 407 6 0 5 2.8 COc1ccccc1N1CCN(CCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796028 63383 0 None -2 3 Human 5.5 pKi = 5.5 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 407 6 0 5 2.8 COc1ccccc1N1CCN(CCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
132060776 162402 0 None -11 16 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by microbeta scintillation counting method
ChEMBL 419 4 0 4 4.4 O=C(OCc1ccccc1)N1CCc2ccc(N3CCN(C4CCCC4)CC3)cc2C1 10.1016/j.ejmech.2018.02.024
CHEMBL4165863 162402 0 None -11 16 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-Prazosin from human adrenergic alpha1A receptor after 90 mins by microbeta scintillation counting method
ChEMBL 419 4 0 4 4.4 O=C(OCc1ccccc1)N1CCc2ccc(N3CCN(C4CCCC4)CC3)cc2C1 10.1016/j.ejmech.2018.02.024
44295193 101778 0 None 11 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 576 7 2 9 2.6 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc3c(c2)OCO3)CC1 10.1016/s0960-894x(99)00653-8
CHEMBL299984 101778 0 None 11 3 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 576 7 2 9 2.6 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc3c(c2)OCO3)CC1 10.1016/s0960-894x(99)00653-8
46881382 7324 0 None -275 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 437 9 1 5 5.4 COc1ccccc1OCCNCC1CSC(c2ccccc2)(c2ccccc2)S1 10.1016/j.bmcl.2010.01.030
CHEMBL1086156 7324 0 None -275 4 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 437 9 1 5 5.4 COc1ccccc1OCCNCC1CSC(c2ccccc2)(c2ccccc2)S1 10.1016/j.bmcl.2010.01.030
49832191 167539 0 None -407 3 Human 6.5 pKi = 6.5 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 382 6 2 5 2.9 CNc1ccc2c(c1)C(NCCOc1cc(F)ccc1F)CCS2(=O)=O 10.1016/j.ejmech.2017.07.071
CHEMBL4218307 167539 0 None -407 3 Human 6.5 pKi = 6.5 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 382 6 2 5 2.9 CNc1ccc2c(c1)C(NCCOc1cc(F)ccc1F)CCS2(=O)=O 10.1016/j.ejmech.2017.07.071
CHEMBL4300210 167539 0 None -407 3 Human 6.5 pKi = 6.5 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 382 6 2 5 2.9 CNc1ccc2c(c1)C(NCCOc1cc(F)ccc1F)CCS2(=O)=O 10.1016/j.ejmech.2017.07.071
1346 83 117 None -2884 9 Rat 5.5 pKi = 5.5 Binding
Binding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranesBinding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranes
ChEMBL 192 2 1 3 1.1 COc1ccccc1N1CCNCC1 10.1021/jm00110a014
280 83 117 None -2884 9 Rat 5.5 pKi = 5.5 Binding
Binding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranesBinding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranes
ChEMBL 192 2 1 3 1.1 COc1ccccc1N1CCNCC1 10.1021/jm00110a014
9899402 83 117 None -2884 9 Rat 5.5 pKi = 5.5 Binding
Binding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranesBinding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranes
ChEMBL 192 2 1 3 1.1 COc1ccccc1N1CCNCC1 10.1021/jm00110a014
CHEMBL9666 83 117 None -2884 9 Rat 5.5 pKi = 5.5 Binding
Binding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranesBinding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranes
ChEMBL 192 2 1 3 1.1 COc1ccccc1N1CCNCC1 10.1021/jm00110a014
155515301 169967 0 None -29 7 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 444 6 0 5 4.2 COc1ccccc1N1CCN(C[C@H]2OCCOC2(c2ccccc2)c2ccccc2)CC1 10.1016/j.ejmech.2019.02.056
CHEMBL4441888 169967 0 None -29 7 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 444 6 0 5 4.2 COc1ccccc1N1CCN(C[C@H]2OCCOC2(c2ccccc2)c2ccccc2)CC1 10.1016/j.ejmech.2019.02.056
10092819 16773 0 None -34 12 Rat 7.4 pKi = 7.4 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 407 8 1 5 3.8 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3o2)CC1 10.1021/jm0211220
CHEMBL124444 16773 0 None -34 12 Rat 7.4 pKi = 7.4 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 407 8 1 5 3.8 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3o2)CC1 10.1021/jm0211220
44431590 87979 0 None -2 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 555 8 1 6 4.9 COc1ccc(C(F)(F)F)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234231 87979 0 None -2 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 555 8 1 6 4.9 COc1ccc(C(F)(F)F)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
44431615 88038 0 None 1 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 521 8 1 5 4.7 O=S(=O)(N[C@H]1CC[C@@H](N2CCN(c3ccccc3OCC3CC3)CC2)CC1)c1cc(Cl)ccc1F 10.1016/j.bmcl.2007.04.008
CHEMBL234476 88038 0 None 1 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 521 8 1 5 4.7 O=S(=O)(N[C@H]1CC[C@@H](N2CCN(c3ccccc3OCC3CC3)CC2)CC1)c1cc(Cl)ccc1F 10.1016/j.bmcl.2007.04.008
13141187 130716 0 None 9 2 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 378 1 0 3 5.2 CN1CCC(=C2c3cc(SC(F)(F)F)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
CHEMBL368475 130716 0 None 9 2 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 378 1 0 3 5.2 CN1CCC(=C2c3cc(SC(F)(F)F)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
56649650 67858 0 None -41 8 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assayDisplacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assay
ChEMBL 466 8 0 5 4.2 COc1ccccc1N1CCN(CCN(C(=O)C23CCC(CF)(CC2)C3)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
CHEMBL1910141 67858 0 None -41 8 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assayDisplacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assay
ChEMBL 466 8 0 5 4.2 COc1ccccc1N1CCN(CCN(C(=O)C23CCC(CF)(CC2)C3)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
145946527 167570 0 None 5 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 382 10 0 4 3.6 Cc1cccc(OCCOCCN2CCN(CCc3ccccc3)CC2)c1C 10.1016/j.bmcl.2018.04.059
CHEMBL4217761 167570 0 None 5 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 382 10 0 4 3.6 Cc1cccc(OCCOCCN2CCN(CCc3ccccc3)CC2)c1C 10.1016/j.bmcl.2018.04.059
CHEMBL4300609 167570 0 None 5 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 382 10 0 4 3.6 Cc1cccc(OCCOCCN2CCN(CCc3ccccc3)CC2)c1C 10.1016/j.bmcl.2018.04.059
126225 94976 5 None -13 8 Human 7.4 pKi = 7.4 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm0307741
CHEMBL25467 94976 5 None -13 8 Human 7.4 pKi = 7.4 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm0307741
126225 94976 5 None -13 8 Human 7.4 pKi = 7.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm00019a001
CHEMBL25467 94976 5 None -13 8 Human 7.4 pKi = 7.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm00019a001
3038603 101865 8 None -48 3 Human 7.4 pKi = 7.4 Binding
The compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligandThe compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligand
ChEMBL 335 1 0 1 5.4 CN(C)C1C=CC2(CC1)c1ccccc1C=Cc1ccc(Cl)cc12 10.1021/jm00109a026
CHEMBL300647 101865 8 None -48 3 Human 7.4 pKi = 7.4 Binding
The compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligandThe compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligand
ChEMBL 335 1 0 1 5.4 CN(C)C1C=CC2(CC1)c1ccccc1C=Cc1ccc(Cl)cc12 10.1021/jm00109a026
10790988 116100 0 None -3 3 Rat 7.4 pKi = 7.4 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 483 8 1 10 2.0 COc1cc2nc(N3CCN(C(=O)COc4c(OC)cccc4OC)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL335731 116100 0 None -3 3 Rat 7.4 pKi = 7.4 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 483 8 1 10 2.0 COc1cc2nc(N3CCN(C(=O)COc4c(OC)cccc4OC)CC3)nc(N)c2cc1OC 10.1021/jm9805337
76307950 84820 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 5 0 5 4.1 COc1ccccc1N1CCN(CC2CO[C@@H](c3cccc4ccccc34)O2)CC1 10.1007/s00044-010-9379-1
CHEMBL2234445 84820 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 5 0 5 4.1 COc1ccccc1N1CCN(CC2CO[C@@H](c3cccc4ccccc34)O2)CC1 10.1007/s00044-010-9379-1
10508016 207156 0 None 3 6 Human 7.4 pKi = 7.4 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 613 9 2 5 7.7 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2ccccc2c1 10.1021/jm980077m
CHEMBL92322 207156 0 None 3 6 Human 7.4 pKi = 7.4 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 613 9 2 5 7.7 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2ccccc2c1 10.1021/jm980077m
10508016 85291 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 613 9 2 5 6.8 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2ccccc2c1 10.1007/s00044-004-0120-9
CHEMBL2260369 85291 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 613 9 2 5 6.8 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2ccccc2c1 10.1007/s00044-004-0120-9
76307950 84820 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 5 0 5 4.1 COc1ccccc1N1CCN(CC2CO[C@@H](c3cccc4ccccc34)O2)CC1 10.1007/s00044-010-9379-1
CHEMBL2234445 84820 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 5 0 5 4.1 COc1ccccc1N1CCN(CC2CO[C@@H](c3cccc4ccccc34)O2)CC1 10.1007/s00044-010-9379-1
9944409 7613 0 None 1 4 Rat 7.4 pKi = 7.4 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 307 3 3 4 2.0 CS(=O)(=O)Nc1c(O)ccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL108804 7613 0 None 1 4 Rat 7.4 pKi = 7.4 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 307 3 3 4 2.0 CS(=O)(=O)Nc1c(O)ccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
53328315 63390 0 None 1 3 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 469 8 0 5 4.2 COc1ccc(Cl)cc1N1CCN(CCCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796035 63390 0 None 1 3 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 469 8 0 5 4.2 COc1ccc(Cl)cc1N1CCN(CCCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
10617200 26434 0 None -6 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 341 5 2 5 2.4 O[C@@H]1[C@H](NC[C@H]2COc3ccccc3O2)CC[C@H]1Oc1ccccc1 10.1021/jm991065j
CHEMBL135973 26434 0 None -6 5 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 341 5 2 5 2.4 O[C@@H]1[C@H](NC[C@H]2COc3ccccc3O2)CC[C@H]1Oc1ccccc1 10.1021/jm991065j
9944409 7613 0 None 1 4 Rat 7.4 pKi = 7.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 307 3 3 4 2.0 CS(=O)(=O)Nc1c(O)ccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL108804 7613 0 None 1 4 Rat 7.4 pKi = 7.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 307 3 3 4 2.0 CS(=O)(=O)Nc1c(O)ccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
71719108 86051 1 None -141 4 Human 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 895 16 6 11 3.5 N=C(N)NCCC[C@@H](NC(=O)CC1(CC(=O)N2CCN(C3c4ccccc4NC(=O)c4ccccc43)CC2)CCCC1)C(=O)NCCn1c(=O)n(-c2ccccc2)n(-c2ccccc2)c1=O 10.1016/j.bmcl.2013.11.061
CHEMBL2307889 86051 1 None -141 4 Human 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 895 16 6 11 3.5 N=C(N)NCCC[C@@H](NC(=O)CC1(CC(=O)N2CCN(C3c4ccccc4NC(=O)c4ccccc43)CC2)CCCC1)C(=O)NCCn1c(=O)n(-c2ccccc2)n(-c2ccccc2)c1=O 10.1016/j.bmcl.2013.11.061
10619916 206738 0 None -12 2 Rat 6.4 pKi = 6.4 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 382 5 0 4 3.0 FC(F)(F)c1cccc(N2CCN(CCCN3CC4CCCN4C3)CC2)c1 10.1021/jm970216k
CHEMBL89950 206738 0 None -12 2 Rat 6.4 pKi = 6.4 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 382 5 0 4 3.0 FC(F)(F)c1cccc(N2CCN(CCCN3CC4CCCN4C3)CC2)c1 10.1021/jm970216k
9909389 165311 6 None -524 2 Human 6.4 pKi = 6.4 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 408 6 1 5 3.5 O=C(C1CCCCC1)N(CCN1CCN(c2ccccc2O)CC1)c1ccccn1 10.1021/acs.jmedchem.2c00633
CHEMBL423361 165311 6 None -524 2 Human 6.4 pKi = 6.4 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 408 6 1 5 3.5 O=C(C1CCCCC1)N(CCN1CCN(c2ccccc2O)CC1)c1ccccn1 10.1021/acs.jmedchem.2c00633
9809007 172564 8 None 134 6 Human 7.4 pKi = 7.4 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
CHEMBL448620 172564 8 None 134 6 Human 7.4 pKi = 7.4 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 608 10 2 7 5.6 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm00010a001
9976756 6607 0 None -10 4 Human 7.4 pKi = 7.4 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm021078o
CHEMBL1083181 6607 0 None -10 4 Human 7.4 pKi = 7.4 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm021078o
CHEMBL37883 6607 0 None -10 4 Human 7.4 pKi = 7.4 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm021078o
9976756 6607 0 None -10 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL1083181 6607 0 None -10 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL37883 6607 0 None -10 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
9976756 6607 0 None -10 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.bmcl.2010.01.030
CHEMBL1083181 6607 0 None -10 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.bmcl.2010.01.030
CHEMBL37883 6607 0 None -10 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.bmcl.2010.01.030
9976756 6607 0 None -10 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1039/C4MD00484A
CHEMBL1083181 6607 0 None -10 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1039/C4MD00484A
CHEMBL37883 6607 0 None -10 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1039/C4MD00484A
9976756 6607 0 None -10 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm200421e
CHEMBL1083181 6607 0 None -10 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm200421e
CHEMBL37883 6607 0 None -10 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 375 8 1 4 4.0 c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm200421e
44431173 92802 0 None -1 3 Human 7.4 pKi = 7.4 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 519 5 0 5 4.8 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4c(F)c(F)c(F)c(F)c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
CHEMBL243690 92802 0 None -1 3 Human 7.4 pKi = 7.4 Binding
Displacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [125]HEAT from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 519 5 0 5 4.8 CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4c(F)c(F)c(F)c(F)c4C3=O)CC2)CC1 10.1016/j.bmcl.2006.12.111
12613159 187326 11 None -1 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@H]([C@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
CHEMBL493054 187326 11 None -1 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@H]([C@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
10084076 97916 0 None -20 9 Human 6.4 pKi = 6.4 Binding
Binding affinity towards alpha-1-adrenergic receptorBinding affinity towards alpha-1-adrenergic receptor
ChEMBL 262 0 1 2 2.8 CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)[C@@H]3N 10.1021/jm030030n
CHEMBL27251 97916 0 None -20 9 Human 6.4 pKi = 6.4 Binding
Binding affinity towards alpha-1-adrenergic receptorBinding affinity towards alpha-1-adrenergic receptor
ChEMBL 262 0 1 2 2.8 CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)[C@@H]3N 10.1021/jm030030n
3024499 175473 73 None -20 2 Bovine 6.4 pKi = 6.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1cccc(N2CCNCC2)n1 10.1021/jm00366a007
CHEMBL45773 175473 73 None -20 2 Bovine 6.4 pKi = 6.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1cccc(N2CCNCC2)n1 10.1021/jm00366a007
11384983 197302 0 None -295 3 Rat 6.4 pKi = 6.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 433 4 0 4 3.3 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2Br)CC1 10.1021/jm030944+
CHEMBL56869 197302 0 None -295 3 Rat 6.4 pKi = 6.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 433 4 0 4 3.3 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2Br)CC1 10.1021/jm030944+
10651027 121063 0 None 11 3 Human 5.4 pKi = 5.4 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 588 11 3 7 3.7 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(CN(C)C)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
CHEMBL356923 121063 0 None 11 3 Human 5.4 pKi = 5.4 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 588 11 3 7 3.7 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(CN(C)C)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
98358 119486 8 None 1 2 Bovine 7.4 pKi = 7.4 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 226 0 1 1 3.3 c1ccc2c3c([nH]c2c1)C1CCCCN1CC3 10.1021/jm00398a025
CHEMBL345349 119486 8 None 1 2 Bovine 7.4 pKi = 7.4 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 226 0 1 1 3.3 c1ccc2c3c([nH]c2c1)C1CCCCN1CC3 10.1021/jm00398a025
44267884 15567 0 None 2 3 Human 7.4 pKi = 7.4 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 403 8 0 6 2.2 CC(C)Oc1ccccc1N1CCN(CCOC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL12202 15567 0 None 2 3 Human 7.4 pKi = 7.4 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 403 8 0 6 2.2 CC(C)Oc1ccccc1N1CCN(CCOC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
44426405 85669 0 None 2 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 562 9 1 5 5.7 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc(OC(F)F)cc1 10.1016/j.bmcl.2007.04.098
CHEMBL228554 85669 0 None 2 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 562 9 1 5 5.7 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc(OC(F)F)cc1 10.1016/j.bmcl.2007.04.098
60785 205893 48 None -309 7 Rat 7.4 pKi = 7.4 Binding
Binding affinity to rat cerebral cortex homogenate alpha 1 adrenergic receptor assessed as inhibition constantBinding affinity to rat cerebral cortex homogenate alpha 1 adrenergic receptor assessed as inhibition constant
ChEMBL 425 5 0 4 3.7 O=S1(=O)c2cccc3cccc(c23)N1CCCN1CCN(c2ccc(F)cc2)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL83894 205893 48 None -309 7 Rat 7.4 pKi = 7.4 Binding
Binding affinity to rat cerebral cortex homogenate alpha 1 adrenergic receptor assessed as inhibition constantBinding affinity to rat cerebral cortex homogenate alpha 1 adrenergic receptor assessed as inhibition constant
ChEMBL 425 5 0 4 3.7 O=S1(=O)c2cccc3cccc(c23)N1CCCN1CCN(c2ccc(F)cc2)CC1 10.1021/acs.jmedchem.2c00633
133 2496 52 None -70 42 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
1723 2496 52 None -70 42 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
28693 2496 52 None -70 42 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
CHEMBL19215 2496 52 None -70 42 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
DB13520 2496 52 None -70 42 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C nan
16040907 97883 0 None -2 4 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 466 7 2 5 4.7 COc1ccccc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL272340 97883 0 None -2 4 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 466 7 2 5 4.7 COc1ccccc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.11.068
71508684 87050 0 None 169 2 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 371 3 0 5 4.2 CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4cnn(C)c4)cc23)CC1 10.1016/j.bmc.2012.10.049
CHEMBL2325929 87050 0 None 169 2 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysisDisplacement of [3H]prazosine from bovine alpha1A adrenoceptor expressed in BHK cells after 20 mins by scintillation counting analysis
ChEMBL 371 3 0 5 4.2 CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4cnn(C)c4)cc23)CC1 10.1016/j.bmc.2012.10.049
2470 3653 50 None -398 59 Rat 7.4 pKi = 7.4 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm960510x
3300 3653 50 None -398 59 Rat 7.4 pKi = 7.4 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm960510x
5265 3653 50 None -398 59 Rat 7.4 pKi = 7.4 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm960510x
99 3653 50 None -398 59 Rat 7.4 pKi = 7.4 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm960510x
CHEMBL267930 3653 50 None -398 59 Rat 7.4 pKi = 7.4 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm960510x
98358 119486 8 None 1 2 Bovine 7.4 pKi = 7.4 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 226 0 1 1 3.3 c1ccc2c3c([nH]c2c1)C1CCCCN1CC3 10.1021/jm00398a025
CHEMBL345349 119486 8 None 1 2 Bovine 7.4 pKi = 7.4 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 226 0 1 1 3.3 c1ccc2c3c([nH]c2c1)C1CCCCN1CC3 10.1021/jm00398a025
44288469 161690 0 None 3 2 Rat 7.4 pKi = 7.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1ccc2c(c1)CCC1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC21 10.1021/jm990567u
CHEMBL41332 161690 0 None 3 2 Rat 7.4 pKi = 7.4 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1ccc2c(c1)CCC1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC21 10.1021/jm990567u
127024959 137801 0 None -30 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 405 7 1 3 4.3 O=C(NCCCCN1CCN(c2ccccc2F)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
CHEMBL3759607 137801 0 None -30 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 405 7 1 3 4.3 O=C(NCCCCN1CCN(c2ccccc2F)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
155562125 176343 0 None -20 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 8 1 4 4.4 c1ccc(OCCNCC2CCOC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4582160 176343 0 None -20 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 8 1 4 4.4 c1ccc(OCCNCC2CCOC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4595563 176343 0 None -20 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 8 1 4 4.4 c1ccc(OCCNCC2CCOC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
56945165 71518 0 None -69 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 442 6 1 4 4.6 COc1ccccc1N1CCN(C[C@H]2CCC(c3ccccc3)(c3ccccc3)[C@H]2O)CC1 10.1021/jm200421e
CHEMBL1946787 71518 0 None -69 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 442 6 1 4 4.6 COc1ccccc1N1CCN(C[C@H]2CCC(c3ccccc3)(c3ccccc3)[C@H]2O)CC1 10.1021/jm200421e
CHEMBL1962770 71518 0 None -69 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 442 6 1 4 4.6 COc1ccccc1N1CCN(C[C@H]2CCC(c3ccccc3)(c3ccccc3)[C@H]2O)CC1 10.1021/jm200421e
44288492 163414 0 None 3 2 Human 6.4 pKi = 6.4 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 439 9 1 6 2.9 COC(=O)C1(c2ccccc2)CCN(CCNC(=O)CCc2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL41959 163414 0 None 3 2 Human 6.4 pKi = 6.4 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 439 9 1 6 2.9 COC(=O)C1(c2ccccc2)CCN(CCNC(=O)CCc2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(00)00307-3
2419 695 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2010.05.023
9 695 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2010.05.023
CHEMBL13647 695 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2010.05.023
2419 695 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2019.02.056
9 695 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2019.02.056
CHEMBL13647 695 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assayDisplacement of [3H]Prazosin from human recombinant alpha 1A adrenergic receptor expressed in CHO cells incubated for 30 mins by radioligand competition binding assay
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2019.02.056
2419 695 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.bmcl.2010.01.030
9 695 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.bmcl.2010.01.030
CHEMBL13647 695 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.bmcl.2010.01.030
2419 695 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm991065j
9 695 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm991065j
CHEMBL13647 695 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm991065j
2419 695 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm800461k
9 695 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm800461k
CHEMBL13647 695 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm800461k
2419 695 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm301525w
9 695 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm301525w
CHEMBL13647 695 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm301525w
2419 695 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm200421e
9 695 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm200421e
CHEMBL13647 695 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm200421e
3778834 101320 78 None -144 2 Bovine 5.4 pKi = 5.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 208 2 1 5 0.4 O=[N+]([O-])c1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL296653 101320 78 None -144 2 Bovine 5.4 pKi = 5.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 208 2 1 5 0.4 O=[N+]([O-])c1cccnc1N1CCNCC1 10.1021/jm00366a007
11338314 171370 0 None -676 4 Human 5.4 pKi = 5.4 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 391 4 0 4 2.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccc(F)cc2F)CC1 10.1021/jm0491391
CHEMBL446180 171370 0 None -676 4 Human 5.4 pKi = 5.4 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 391 4 0 4 2.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccc(F)cc2F)CC1 10.1021/jm0491391
294234 102893 3 None -512 4 Human 5.4 pKi = 5.4 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 182 1 1 3 1.7 C1CCCC(NC2=NCCO2)CC1 10.1016/0960-894X(94)85032-1
CHEMBL305928 102893 3 None -512 4 Human 5.4 pKi = 5.4 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 182 1 1 3 1.7 C1CCCC(NC2=NCCO2)CC1 10.1016/0960-894X(94)85032-1
10640982 26435 0 None -467 5 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 341 5 2 5 2.4 O[C@H]1[C@@H](NC[C@H]2COc3ccccc3O2)CC[C@@H]1Oc1ccccc1 10.1021/jm991065j
CHEMBL135974 26435 0 None -467 5 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 341 5 2 5 2.4 O[C@H]1[C@@H](NC[C@H]2COc3ccccc3O2)CC[C@@H]1Oc1ccccc1 10.1021/jm991065j
2419 695 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2016.09.050
9 695 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2016.09.050
CHEMBL13647 695 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2016.09.050
9796526 109884 0 None - 1 Rat 6.4 pKi = 6.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 305 3 2 3 2.6 Cc1ccc(NS(C)(=O)=O)c2c1C(c1c[nH]cn1)CCC2 10.1021/jm030551a
CHEMBL323440 109884 0 None - 1 Rat 6.4 pKi = 6.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 305 3 2 3 2.6 Cc1ccc(NS(C)(=O)=O)c2c1C(c1c[nH]cn1)CCC2 10.1021/jm030551a
71455083 81830 0 None -64 7 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand binding assayBinding affinity to adrenergic alpha1A receptor by radioligand binding assay
ChEMBL 389 6 0 3 4.8 O=C(C1CCCCC1)N(CCN1CC=C(c2ccccc2)CC1)c1ccccn1 10.1016/j.bmcl.2012.05.119
CHEMBL2164354 81830 0 None -64 7 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand binding assayBinding affinity to adrenergic alpha1A receptor by radioligand binding assay
ChEMBL 389 6 0 3 4.8 O=C(C1CCCCC1)N(CCN1CC=C(c2ccccc2)CC1)c1ccccn1 10.1016/j.bmcl.2012.05.119
3033538 1319 39 None -7 9 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
7155 1319 39 None -7 9 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
781 1319 39 None -7 9 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
CHEMBL1201216 1319 39 None -7 9 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
DB00298 1319 39 None -7 9 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 325 4 0 5 2.3 Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 nan
13091268 78224 0 None -42 14 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assay
ChEMBL 401 6 1 3 5.0 O=C(CCCN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
CHEMBL210578 78224 0 None -42 14 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assayBinding affinity to human cloned adrenergic alpha-1A receptor by radioligand binding assay
ChEMBL 401 6 1 3 5.0 O=C(CCCN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1 10.1016/j.bmcl.2006.03.057
52937830 61319 0 None -125 3 Human 7.4 pKi = 7.4 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 367 4 0 4 3.7 CN1CCC[C@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767154 61319 0 None -125 3 Human 7.4 pKi = 7.4 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 367 4 0 4 3.7 CN1CCC[C@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/jm1013874
17747460 61329 12 None -158 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 640 14 0 6 7.8 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1021/jm1013874
CHEMBL1767164 61329 12 None -158 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 640 14 0 6 7.8 O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1 10.1021/jm1013874
3584 3777 64 None -2 13 Human 7.4 pKi = 7.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm960697s
5401 3777 64 None -2 13 Human 7.4 pKi = 7.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm960697s
7302 3777 64 None -2 13 Human 7.4 pKi = 7.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm960697s
CHEMBL611 3777 64 None -2 13 Human 7.4 pKi = 7.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm960697s
DB01162 3777 64 None -2 13 Human 7.4 pKi = 7.4 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm960697s
56946579 71513 0 None -11 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 440 6 0 4 4.8 COc1ccccc1N1CCN(CC2CCC(c3ccccc3)(c3ccccc3)C2=O)CC1 10.1021/jm200421e
CHEMBL1946783 71513 0 None -11 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 440 6 0 4 4.8 COc1ccccc1N1CCN(CC2CCC(c3ccccc3)(c3ccccc3)C2=O)CC1 10.1021/jm200421e
CHEMBL1962755 71513 0 None -11 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 440 6 0 4 4.8 COc1ccccc1N1CCN(CC2CCC(c3ccccc3)(c3ccccc3)C2=O)CC1 10.1021/jm200421e
52937729 61311 0 None -251 3 Human 6.4 pKi = 6.4 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 367 4 0 4 3.7 CN1CCC[C@@H]1Cn1nc(Cc2cccc(Cl)c2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767146 61311 0 None -251 3 Human 6.4 pKi = 6.4 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 367 4 0 4 3.7 CN1CCC[C@@H]1Cn1nc(Cc2cccc(Cl)c2)c2ccccc2c1=O 10.1021/jm1013874
11857791 168997 0 None -1 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 554 7 1 6 4.9 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc2c(c1)OCCO2 10.1016/j.bmcl.2007.04.098
CHEMBL439197 168997 0 None -1 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 554 7 1 6 4.9 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc2c(c1)OCCO2 10.1016/j.bmcl.2007.04.098
3584 3777 64 None -2 13 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity radioligandIn vitro binding affinity radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990200p
5401 3777 64 None -2 13 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity radioligandIn vitro binding affinity radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990200p
7302 3777 64 None -2 13 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity radioligandIn vitro binding affinity radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990200p
CHEMBL611 3777 64 None -2 13 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity radioligandIn vitro binding affinity radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990200p
DB01162 3777 64 None -2 13 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity radioligandIn vitro binding affinity radioligand
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990200p
44289525 165995 0 None -4 8 Human 8.4 pKi = 8.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNCC1Oc2ccccc2OC1c1ccc(C)cc1 10.1016/j.bmcl.2004.11.032
CHEMBL42539 165995 0 None -4 8 Human 8.4 pKi = 8.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNCC1Oc2ccccc2OC1c1ccc(C)cc1 10.1016/j.bmcl.2004.11.032
57402787 69195 0 None -1 5 Pig 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 977 28 2 17 4.4 COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccc(OCCOCCOCCOCCOc4ccn5ncc(C(=O)NCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1926700 69195 0 None -1 5 Pig 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 977 28 2 17 4.4 COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccc(OCCOCCOCCOCCOc4ccn5ncc(C(=O)NCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1 10.1016/j.bmc.2011.10.063
2142 3096 58 None -2 36 Human 8.4 pKi = 8.4 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
4920903 3096 58 None -2 36 Human 8.4 pKi = 8.4 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
502 3096 58 None -2 36 Human 8.4 pKi = 8.4 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
5775 3096 58 None -2 36 Human 8.4 pKi = 8.4 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
CHEMBL597 3096 58 None -2 36 Human 8.4 pKi = 8.4 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
DB00692 3096 58 None -2 36 Human 8.4 pKi = 8.4 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1016/j.bmcl.2005.07.083
10555134 40797 0 None 173 3 Human 8.4 pKi = 8.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 573 9 2 8 4.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc3c(c2)OCO3)CC1 10.1007/s00044-004-0120-9
CHEMBL148552 40797 0 None 173 3 Human 8.4 pKi = 8.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 573 9 2 8 4.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc3c(c2)OCO3)CC1 10.1007/s00044-004-0120-9
44428851 92318 0 None -8 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 447 4 1 7 3.5 COc1cc2nc(N3CCN(C(=O)c4ccccc4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
CHEMBL242934 92318 0 None -8 4 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 447 4 1 7 3.5 COc1cc2nc(N3CCN(C(=O)c4ccccc4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
491 192 9 None -25 12 Human 8.4 pKi = 8.4 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
9891167 192 9 None -25 12 Human 8.4 pKi = 8.4 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
CHEMBL13856 192 9 None -25 12 Human 8.4 pKi = 8.4 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/s0960-894x(01)00159-7
10555134 40797 0 None 173 3 Human 8.4 pKi = 8.4 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 573 9 2 8 4.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc3c(c2)OCO3)CC1 10.1021/jm980506g
CHEMBL148552 40797 0 None 173 3 Human 8.4 pKi = 8.4 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 573 9 2 8 4.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc3c(c2)OCO3)CC1 10.1021/jm980506g
3584 3777 64 None -2 13 Human 8.4 pKi = 8.4 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
5401 3777 64 None -2 13 Human 8.4 pKi = 8.4 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
7302 3777 64 None -2 13 Human 8.4 pKi = 8.4 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
CHEMBL611 3777 64 None -2 13 Human 8.4 pKi = 8.4 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
DB01162 3777 64 None -2 13 Human 8.4 pKi = 8.4 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1016/s0960-894x(98)00446-6
10554745 37232 0 None 97 3 Human 8.4 pKi = 8.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 552 10 1 6 4.9 COC(=O)C1(c2ccccc2)CCN(CCCCCN2C(C)=NC(C)=C(C(N)=O)C2c2ccc(F)cc2F)CC1 10.1021/jm9902032
CHEMBL145353 37232 0 None 97 3 Human 8.4 pKi = 8.4 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 552 10 1 6 4.9 COC(=O)C1(c2ccccc2)CCN(CCCCCN2C(C)=NC(C)=C(C(N)=O)C2c2ccc(F)cc2F)CC1 10.1021/jm9902032
491 192 9 None -25 12 Human 8.4 pKi = 8.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/j.bmcl.2004.11.032
9891167 192 9 None -25 12 Human 8.4 pKi = 8.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/j.bmcl.2004.11.032
CHEMBL13856 192 9 None -25 12 Human 8.4 pKi = 8.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 10.1016/j.bmcl.2004.11.032
3584 3777 64 None -2 13 Human 8.4 pKi = 8.4 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980053f
5401 3777 64 None -2 13 Human 8.4 pKi = 8.4 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980053f
7302 3777 64 None -2 13 Human 8.4 pKi = 8.4 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980053f
CHEMBL611 3777 64 None -2 13 Human 8.4 pKi = 8.4 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980053f
DB01162 3777 64 None -2 13 Human 8.4 pKi = 8.4 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980053f
57390119 69303 0 None 9 5 Pig 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 969 33 2 14 5.4 COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928127 69303 0 None 9 5 Pig 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 969 33 2 14 5.4 COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
10603030 207463 0 None 47 3 Human 8.4 pKi = 8.4 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 565 7 3 4 4.5 N#Cc1cc(F)ccc1C1CCN(CCCNC(=O)C2=C(C(F)(F)F)NC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
CHEMBL94259 207463 0 None 47 3 Human 8.4 pKi = 8.4 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 565 7 3 4 4.5 N#Cc1cc(F)ccc1C1CCN(CCCNC(=O)C2=C(C(F)(F)F)NC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1 10.1021/jm990612y
44362633 121547 0 None 95 3 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 597 9 3 6 3.9 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCC(C)N2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL358590 121547 0 None 95 3 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 597 9 3 6 3.9 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCC(C)N2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
10674133 163420 0 None 32 2 Human 8.4 pKi = 8.4 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 546 9 2 7 2.9 CCOc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
CHEMBL419624 163420 0 None 32 2 Human 8.4 pKi = 8.4 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 546 9 2 7 2.9 CCOc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
44428848 92294 0 None -17 3 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 453 4 1 8 3.6 COc1cc2nc(N3CCN(C(=O)c4cccs4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
CHEMBL242724 92294 0 None -17 3 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 453 4 1 8 3.6 COc1cc2nc(N3CCN(C(=O)c4cccs4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
134551 358 27 None -3 21 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
271 358 27 None -3 21 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
885 358 27 None -3 21 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
CHEMBL1403281 358 27 None -3 21 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 575 5 3 6 2.4 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)C(C)C)O)C nan
44431594 167410 0 None -1 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 532 9 1 8 3.8 COc1ccc([N+](=O)[O-])cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL429623 167410 0 None -1 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 532 9 1 8 3.8 COc1ccc([N+](=O)[O-])cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
136806211 207683 0 None 61 3 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 650 14 4 7 5.0 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCCN)N1 10.1016/s0960-894x(99)00484-9
44328738 207683 0 None 61 3 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 650 14 4 7 5.0 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL95434 207683 0 None 61 3 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 650 14 4 7 5.0 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCCN)N1 10.1016/s0960-894x(99)00484-9
9817640 99330 0 None 9 3 Human 8.4 pKi = 8.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 295 6 1 2 3.6 COc1ccc(CCNCC2CCc3ccccc3C2)cc1 10.1016/j.bmcl.2004.11.032
CHEMBL282214 99330 0 None 9 3 Human 8.4 pKi = 8.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 295 6 1 2 3.6 COc1ccc(CCNCC2CCc3ccccc3C2)cc1 10.1016/j.bmcl.2004.11.032
489 145 28 None -4 12 Bovine 8.4 pKi = 8.4 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
5640 145 28 None -4 12 Bovine 8.4 pKi = 8.4 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
CHEMBL420060 145 28 None -4 12 Bovine 8.4 pKi = 8.4 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
ChEMBL 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 10.1021/jm00018a001
10841387 99618 0 None 91 6 Human 8.4 pKi = 8.4 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL284103 99618 0 None 91 6 Human 8.4 pKi = 8.4 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
10841387 99618 0 None 91 6 Human 8.4 pKi = 8.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL284103 99618 0 None 91 6 Human 8.4 pKi = 8.4 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 607 10 3 6 5.2 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
73453 29616 24 None -6 17 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 561 4 3 6 2.0 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 nan
CHEMBL1385840 29616 24 None -6 17 Rat 8.4 pKi = 8.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 561 4 3 6 2.0 CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 nan
136680384 207655 0 None 104 6 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 694 16 4 8 4.9 CCNC(=O)C1=C(CC)NC(COCCN)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
44328799 207655 0 None 104 6 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 694 16 4 8 4.9 CCNC(=O)C1=C(CC)NC(COCCN)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
CHEMBL95290 207655 0 None 104 6 Human 8.4 pKi = 8.4 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 694 16 4 8 4.9 CCNC(=O)C1=C(CC)NC(COCCN)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(99)00484-9
44431602 144941 0 None -6 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 525 7 1 5 5.2 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL391035 144941 0 None -6 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 525 7 1 5 5.2 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2007.04.008
11857710 85620 0 None 10 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 518 8 1 5 5.4 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1 10.1016/j.bmcl.2007.04.098
CHEMBL228279 85620 0 None 10 4 Human 8.4 pKi = 8.4 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 518 8 1 5 5.4 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1 10.1016/j.bmcl.2007.04.098
10674791 38171 0 None 10 3 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 582 8 2 7 4.2 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(Cl)cc1 10.1021/jm990200p
CHEMBL146163 38171 0 None 10 3 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 582 8 2 7 4.2 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(Cl)cc1 10.1021/jm990200p
10674544 118791 0 None 331 3 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 568 6 2 7 3.5 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)C(=O)Oc2ccccc23)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL342111 118791 0 None 331 3 Human 8.4 pKi = 8.4 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 568 6 2 7 3.5 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)C(=O)Oc2ccccc23)C1c1ccc(F)c(F)c1 10.1021/jm990201h
44417713 12422 0 None 3 7 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1185884 12422 0 None 3 7 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL439346 12422 0 None 3 7 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 365 7 1 5 3.7 COc1ccc2ccccc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
118716714 115008 0 None 1 4 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 501 6 0 7 2.7 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccc(C)cc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342867 115008 0 None 1 4 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 501 6 0 7 2.7 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccc(C)cc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
56837634 69306 0 None -10 5 Pig 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1041 38 2 15 6.2 COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928130 69306 0 None -10 5 Pig 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1041 38 2 15 6.2 COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
44362867 37647 0 None 165 3 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 658 8 2 5 6.9 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3cc(C)cc(C)c3)(c3cc(C)cc(C)c3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL145719 37647 0 None 165 3 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 658 8 2 5 6.9 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3cc(C)cc(C)c3)(c3cc(C)cc(C)c3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
2142 3096 58 None -2 36 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
4920903 3096 58 None -2 36 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
502 3096 58 None -2 36 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
5775 3096 58 None -2 36 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
CHEMBL597 3096 58 None -2 36 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
DB00692 3096 58 None -2 36 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 nan
44312563 204920 2 None -3 6 Rat 8.3 pKi = 8.3 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampus (+ 10 uM) CES membrane using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampus (+ 10 uM) CES membrane using [3H]prazosin as radioligand
ChEMBL 401 7 1 8 1.0 COc1ccc(C)cc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1021/jm960069a
CHEMBL76168 204920 2 None -3 6 Rat 8.3 pKi = 8.3 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampus (+ 10 uM) CES membrane using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampus (+ 10 uM) CES membrane using [3H]prazosin as radioligand
ChEMBL 401 7 1 8 1.0 COc1ccc(C)cc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 10.1021/jm960069a
463 1405 22 None 5 12 Human 8.3 pKi = 8.3 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
6918097 1405 22 None 5 12 Human 8.3 pKi = 8.3 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
837 1405 22 None 5 12 Human 8.3 pKi = 8.3 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
CHEMBL2051956 1405 22 None 5 12 Human 8.3 pKi = 8.3 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
DB14068 1405 22 None 5 12 Human 8.3 pKi = 8.3 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm00010a001
44299835 198402 0 None 61 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 583 7 2 7 4.0 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccn4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL57691 198402 0 None 61 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 583 7 2 7 4.0 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccn4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
56961507 121442 0 None 1 3 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 678 6 4 11 5.0 COc1cc2nc(N3CCN(C(=S)Nc4ccc(-c5c6ccc(=O)cc-6oc6cc(O)ccc56)c(C(=O)O)c4)CC3)nc(N)c2cc1OC 10.1021/ml5004298
CHEMBL3582271 121442 0 None 1 3 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysisDisplacement of [3H]-Prazosin from human alpha-1A adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis
ChEMBL 678 6 4 11 5.0 COc1cc2nc(N3CCN(C(=S)Nc4ccc(-c5c6ccc(=O)cc-6oc6cc(O)ccc56)c(C(=O)O)c4)CC3)nc(N)c2cc1OC 10.1021/ml5004298
10554492 168567 0 None 3 2 Rat 8.3 pKi = 8.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 505 5 1 8 3.4 COC(=O)c1ccc2sc3c(=O)n(CCN4C[C@@H]5CCc6c(OC)cccc6[C@@H]5C4)c(=O)[nH]c3c2c1 10.1021/jm990567u
CHEMBL43573 168567 0 None 3 2 Rat 8.3 pKi = 8.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 505 5 1 8 3.4 COC(=O)c1ccc2sc3c(=O)n(CCN4C[C@@H]5CCc6c(OC)cccc6[C@@H]5C4)c(=O)[nH]c3c2c1 10.1021/jm990567u
44294569 102019 0 None -5 4 Human 8.3 pKi = 8.3 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 447 7 1 8 2.5 COc1ccccc1N1CCN(CCn2nc(-c3ccccc3)c(C(C)=O)c(N)c2=O)CC1 10.1021/jm981006q
CHEMBL301726 102019 0 None -5 4 Human 8.3 pKi = 8.3 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 447 7 1 8 2.5 COc1ccccc1N1CCN(CCn2nc(-c3ccccc3)c(C(C)=O)c(N)c2=O)CC1 10.1021/jm981006q
10532044 85283 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 629 12 2 10 4.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)OCCC#N)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
136901434 85283 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 629 12 2 10 4.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)OCCC#N)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
CHEMBL2260361 85283 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 629 12 2 10 4.0 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)OCCC#N)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
10603688 121146 0 None 645 3 Human 8.3 pKi = 8.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 603 11 3 8 3.7 CCNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL357681 121146 0 None 645 3 Human 8.3 pKi = 8.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 603 11 3 8 3.7 CCNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL151825 44375 0 None 109 3 Human 8.3 pKi = 8.3 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 629 12 2 10 4.8 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)N=C(C)/C(=C(/O)OCCC#N)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
136680386 207703 0 None 60 6 Human 8.3 pKi = 8.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 680 16 4 8 4.6 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCCN)N1 10.1016/s0960-894x(99)00484-9
44328801 207703 0 None 60 6 Human 8.3 pKi = 8.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 680 16 4 8 4.6 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL95578 207703 0 None 60 6 Human 8.3 pKi = 8.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 680 16 4 8 4.6 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCCN)N1 10.1016/s0960-894x(99)00484-9
44431555 89162 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 535 8 1 7 3.3 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(S(C)(=O)=O)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL236617 89162 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 535 8 1 7 3.3 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(S(C)(=O)=O)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
11857793 85658 0 None 7 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 548 7 1 4 5.9 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cc(Cl)ccc1F 10.1016/j.bmcl.2007.04.098
CHEMBL228494 85658 0 None 7 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 548 7 1 4 5.9 O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cc(Cl)ccc1F 10.1016/j.bmcl.2007.04.098
44273916 98829 0 None 1 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 608 7 2 8 3.4 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL278716 98829 0 None 1 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 608 7 2 8 3.4 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4C#N)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
10603688 121146 0 None 645 3 Human 8.3 pKi = 8.3 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 603 11 3 8 3.7 CCNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
CHEMBL357681 121146 0 None 645 3 Human 8.3 pKi = 8.3 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 603 11 3 8 3.7 CCNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
10154 142129 59 None 58 4 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membraneDisplacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membrane
ChEMBL 327 2 2 5 2.9 COc1cc2c(cc1O)C[C@H]1c3c(cc(O)c(OC)c3-2)CCN1C 10.1021/np990433j
CHEMBL388342 142129 59 None 58 4 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membraneDisplacement of [3H]prazosin from adrenergic alpha1A receptor in rat brain membrane
ChEMBL 327 2 2 5 2.9 COc1cc2c(cc1O)C[C@H]1c3c(cc(O)c(OC)c3-2)CCN1C 10.1021/np990433j
44431618 87066 0 None 1 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 488 8 1 7 3.3 COc1ccncc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL232607 87066 0 None 1 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 488 8 1 7 3.3 COc1ccncc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
10627329 37443 0 None 8 3 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 595 7 2 6 4.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3cccc(C(F)(F)F)c3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145525 37443 0 None 8 3 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 595 7 2 6 4.4 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3cccc(C(F)(F)F)c3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
10091187 78824 1 None -23 6 Human 8.3 pKi = 8.3 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 380 5 0 4 4.6 COc1cccc(C2CCC(N3CCN(c4ccccc4OC)CC3)CC2)c1 10.1021/jm010866v
CHEMBL2112779 78824 1 None -23 6 Human 8.3 pKi = 8.3 Binding
Binding affinity was determined on human cloned Alpha-1A adrenoceptorBinding affinity was determined on human cloned Alpha-1A adrenoceptor
ChEMBL 380 5 0 4 4.6 COc1cccc(C2CCC(N3CCN(c4ccccc4OC)CC3)CC2)c1 10.1021/jm010866v
10430183 205628 0 None -398 7 Human 7.4 pKi = 7.4 Binding
Binding affinity to human alpha 1A adrenergic receptor expressed in CHO cells assessed as inhibition constantBinding affinity to human alpha 1A adrenergic receptor expressed in CHO cells assessed as inhibition constant
ChEMBL 385 5 1 5 2.1 O=C(NCCN1CCN(c2cccc3c2OCCO3)CC1)c1ccc(F)cc1 10.1021/acs.jmedchem.2c00633
CHEMBL81728 205628 0 None -398 7 Human 7.4 pKi = 7.4 Binding
Binding affinity to human alpha 1A adrenergic receptor expressed in CHO cells assessed as inhibition constantBinding affinity to human alpha 1A adrenergic receptor expressed in CHO cells assessed as inhibition constant
ChEMBL 385 5 1 5 2.1 O=C(NCCN1CCN(c2cccc3c2OCCO3)CC1)c1ccc(F)cc1 10.1021/acs.jmedchem.2c00633
2398 954 62 None -4 29 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
2801 954 62 None -4 29 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
701 954 62 None -4 29 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
CHEMBL415 954 62 None -4 29 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
DB01242 954 62 None -4 29 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C nan
12134996 204087 0 None -1 2 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 385 6 0 5 3.2 COc1ccccc1N1CCN(Cc2ccc(CN3CCCC3=O)s2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL70178 204087 0 None -1 2 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 385 6 0 5 3.2 COc1ccccc1N1CCN(Cc2ccc(CN3CCCC3=O)s2)CC1 10.1016/s0960-894x(02)00347-5
11520239 3632 11 None -144 4 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 613 10 3 7 4.0 COCC1=C(C(=O)OC)[C@@H](N(C(=O)N1)C(=O)NCCCN1CCC(CC1)c1cccc(c1)NC(=O)C)c1ccc(c(c1)F)F 10.1021/jm060383x
1313 3632 11 None -144 4 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 613 10 3 7 4.0 COCC1=C(C(=O)OC)[C@@H](N(C(=O)N1)C(=O)NCCCN1CCC(CC1)c1cccc(c1)NC(=O)C)c1ccc(c(c1)F)F 10.1021/jm060383x
CHEMBL185271 3632 11 None -144 4 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha-1A receptor
ChEMBL 613 10 3 7 4.0 COCC1=C(C(=O)OC)[C@@H](N(C(=O)N1)C(=O)NCCCN1CCC(CC1)c1cccc(c1)NC(=O)C)c1ccc(c(c1)F)F 10.1021/jm060383x
49865641 16035 0 None -3 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 338 7 1 4 3.7 Cc1cccc(N2CCN(CCCCNc3ccccn3)CC2)c1C 10.1016/j.bmcl.2010.07.096
CHEMBL1223682 16035 0 None -3 3 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 338 7 1 4 3.7 Cc1cccc(N2CCN(CCCCNc3ccccn3)CC2)c1C 10.1016/j.bmcl.2010.07.096
10320782 99977 0 None -4 6 Rat 7.4 pKi = 7.4 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNC[C@H]1Oc2ccccc2O[C@@H]1c1ccc(C)cc1 10.1021/jm960069a
CHEMBL286565 99977 0 None -4 6 Rat 7.4 pKi = 7.4 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNC[C@H]1Oc2ccccc2O[C@@H]1c1ccc(C)cc1 10.1021/jm960069a
46934645 16687 0 None -2 4 Human 7.4 pKi = 7.4 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 465 7 0 7 2.2 COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3C(=O)CCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242725 16687 0 None -2 4 Human 7.4 pKi = 7.4 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 465 7 0 7 2.2 COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3C(=O)CCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
15166842 98860 23 None - 1 Bovine 5.4 pKi = 5.4 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 160 1 1 2 1.5 C1=C(c2ccccn2)CCNC1 10.1021/jm00375a017
CHEMBL278934 98860 23 None - 1 Bovine 5.4 pKi = 5.4 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 160 1 1 2 1.5 C1=C(c2ccccn2)CCNC1 10.1021/jm00375a017
9823115 198603 0 None -23 4 Human 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 414 4 0 5 3.0 N#Cc1ccc(Cl)cc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
CHEMBL57868 198603 0 None -23 4 Human 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 414 4 0 5 3.0 N#Cc1ccc(Cl)cc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
76311538 84828 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 299 6 1 4 2.8 c1ccc(OCCN[C@H]2COC[C@H](c3ccccc3)O2)cc1 10.1007/s00044-010-9379-1
CHEMBL2234453 84828 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 299 6 1 4 2.8 c1ccc(OCCN[C@H]2COC[C@H](c3ccccc3)O2)cc1 10.1007/s00044-010-9379-1
9823115 198603 0 None -23 4 Human 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 414 4 0 5 3.0 N#Cc1ccc(Cl)cc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
CHEMBL57868 198603 0 None -23 4 Human 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 414 4 0 5 3.0 N#Cc1ccc(Cl)cc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1007/s00044-010-9379-1
25132565 187271 0 None -7 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 313 7 1 4 2.8 c1ccc(OCCNC[C@@H]2COC[C@@H](c3ccccc3)O2)cc1 10.1021/jm800461k
CHEMBL492785 187271 0 None -7 3 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 313 7 1 4 2.8 c1ccc(OCCNC[C@@H]2COC[C@@H](c3ccccc3)O2)cc1 10.1021/jm800461k
22629308 64307 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 425 3 2 5 3.6 N=C(Nc1ccccc1)N1CCN(/C=C2/N=C(c3cccc4ccccc34)OC2=O)CC1 10.1016/j.bmcl.2004.11.032
CHEMBL181071 64307 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 425 3 2 5 3.6 N=C(Nc1ccccc1)N1CCN(/C=C2/N=C(c3cccc4ccccc34)OC2=O)CC1 10.1016/j.bmcl.2004.11.032
9865254 68675 0 None -512 6 Human 5.4 pKi = 5.4 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 391 4 0 4 2.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccc(F)c(F)c2)CC1 10.1021/jm0491391
CHEMBL192099 68675 0 None -512 6 Human 5.4 pKi = 5.4 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 391 4 0 4 2.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccc(F)c(F)c2)CC1 10.1021/jm0491391
11948707 166167 0 None -128 13 Human 6.4 pKi = 6.4 Binding
Binding affinity to alpha 1A adrenergic receptor by radioligand binding assayBinding affinity to alpha 1A adrenergic receptor by radioligand binding assay
ChEMBL 373 7 0 8 0.6 COc1cccc(N2CCN(CCCCn3ncc(=O)n(C)c3=O)CC2)c1 10.1016/j.bmcl.2006.01.052
CHEMBL426317 166167 0 None -128 13 Human 6.4 pKi = 6.4 Binding
Binding affinity to alpha 1A adrenergic receptor by radioligand binding assayBinding affinity to alpha 1A adrenergic receptor by radioligand binding assay
ChEMBL 373 7 0 8 0.6 COc1cccc(N2CCN(CCCCn3ncc(=O)n(C)c3=O)CC2)c1 10.1016/j.bmcl.2006.01.052
11395842 100691 0 None -3 2 Rat 6.4 pKi = 6.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 412 7 0 4 4.0 CN(CCOc1cc(Cl)ccc1Cl)CCN1C(=O)CC2(CCCC2)CC1=O 10.1021/jm030944+
CHEMBL292399 100691 0 None -3 2 Rat 6.4 pKi = 6.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 412 7 0 4 4.0 CN(CCOc1cc(Cl)ccc1Cl)CCN1C(=O)CC2(CCCC2)CC1=O 10.1021/jm030944+
11058166 204705 0 None -1 5 Human 6.4 pKi = 6.4 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cccc(F)c1NCC1=NCCN1 10.1021/jm000542r
CHEMBL74114 204705 0 None -1 5 Human 6.4 pKi = 6.4 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cccc(F)c1NCC1=NCCN1 10.1021/jm000542r
52942591 17612 0 None 4 2 Rat 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 542 9 1 7 2.6 COC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL1258228 17612 0 None 4 2 Rat 6.4 pKi = 6.4 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 542 9 1 7 2.6 COC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
12039032 98262 0 None 14 3 Human 6.4 pKi = 6.4 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 415 9 0 6 2.1 CC(C)Oc1ccccc1N1CCN(CC(=O)CC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL274529 98262 0 None 14 3 Human 6.4 pKi = 6.4 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 415 9 0 6 2.1 CC(C)Oc1ccccc1N1CCN(CC(=O)CC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
127025279 137655 0 None -3 2 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 347 9 1 4 2.8 COc1ccccc1N1CCN(CCCCNC(=O)CC(C)C)CC1 10.1016/j.bmcl.2015.12.068
CHEMBL3758403 137655 0 None -3 2 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 347 9 1 4 2.8 COc1ccccc1N1CCN(CCCCNC(=O)CC(C)C)CC1 10.1016/j.bmcl.2015.12.068
44308654 203584 0 None -3 3 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 401 6 1 6 3.4 COc1ccccc1N1CCN(Cc2ccc(CN3CCCCC3O)s2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL66823 203584 0 None -3 3 Human 6.4 pKi = 6.4 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 401 6 1 6 3.4 COc1ccccc1N1CCN(Cc2ccc(CN3CCCCC3O)s2)CC1 10.1016/s0960-894x(02)00347-5
9822814 101949 0 None -4 4 Human 7.4 pKi = 7.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 409 4 0 3 4.3 O=C1CC2(CCCC2)CCN1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1016/j.bmcl.2004.11.032
CHEMBL301224 101949 0 None -4 4 Human 7.4 pKi = 7.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 409 4 0 3 4.3 O=C1CC2(CCCC2)CCN1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1016/j.bmcl.2004.11.032
11589069 96247 0 None -25 8 Human 7.4 pKi = 7.4 Binding
Inhibition of adrenergic alpha-1 receptorInhibition of adrenergic alpha-1 receptor
ChEMBL 383 6 1 3 4.4 O=C1Nc2ccccc2C1CCCCN1CCN(c2ccc(Cl)cc2)CC1 10.1021/jm070279v
CHEMBL260994 96247 0 None -25 8 Human 7.4 pKi = 7.4 Binding
Inhibition of adrenergic alpha-1 receptorInhibition of adrenergic alpha-1 receptor
ChEMBL 383 6 1 3 4.4 O=C1Nc2ccccc2C1CCCCN1CCN(c2ccc(Cl)cc2)CC1 10.1021/jm070279v
9822814 101949 0 None -5 4 Rat 7.4 pKi = 7.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 409 4 0 3 4.3 O=C1CC2(CCCC2)CCN1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL301224 101949 0 None -5 4 Rat 7.4 pKi = 7.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 409 4 0 3 4.3 O=C1CC2(CCCC2)CCN1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
2419 695 28 None -288 12 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2011.03.054
9 695 28 None -288 12 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2011.03.054
CHEMBL13647 695 28 None -288 12 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/j.ejmech.2011.03.054
506 2252 39 None -81 5 Human 6.4 pKi = 6.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1016/j.bmcl.2004.11.032
6603904 2252 39 None -81 5 Human 6.4 pKi = 6.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1016/j.bmcl.2004.11.032
CHEMBL19476 2252 39 None -81 5 Human 6.4 pKi = 6.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1016/j.bmcl.2004.11.032
506 2252 39 None -81 5 Human 6.4 pKi = 6.4 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
6603904 2252 39 None -81 5 Human 6.4 pKi = 6.4 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
CHEMBL19476 2252 39 None -81 5 Human 6.4 pKi = 6.4 Binding
Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
11315660 167988 0 None -20 3 Rat 6.4 pKi = 6.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 403 4 0 4 3.6 O=C1CC2(CCCCC2)CC(=O)N1CCN1CCN(c2ccccc2Cl)CC1 10.1021/jm030944+
CHEMBL431943 167988 0 None -20 3 Rat 6.4 pKi = 6.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 403 4 0 4 3.6 O=C1CC2(CCCCC2)CC(=O)N1CCN1CCN(c2ccccc2Cl)CC1 10.1021/jm030944+
155529118 176564 0 None -37 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 9 1 4 4.2 c1ccc(OCCNC[C@@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4462768 176564 0 None -37 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 9 1 4 4.2 c1ccc(OCCNC[C@@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4597358 176564 0 None -37 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 9 1 4 4.2 c1ccc(OCCNC[C@@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
44420418 83430 0 None -13 3 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 474 4 1 6 4.0 O=c1[nH]c2c(sc3ccccc32)c(=O)n1CCN1CCN(c2ccc(Cl)c(Cl)c2)CC1 10.1016/j.bmcl.2006.09.034
CHEMBL219718 83430 0 None -13 3 Human 5.4 pKi = 5.4 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 474 4 1 6 4.0 O=c1[nH]c2c(sc3ccccc32)c(=O)n1CCN1CCN(c2ccc(Cl)c(Cl)c2)CC1 10.1016/j.bmcl.2006.09.034
135 2532 43 None -9 58 Bovine 7.4 pKi = 7.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00366a007
1796 2532 43 None -9 58 Bovine 7.4 pKi = 7.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00366a007
4184 2532 43 None -9 58 Bovine 7.4 pKi = 7.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00366a007
CHEMBL6437 2532 43 None -9 58 Bovine 7.4 pKi = 7.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00366a007
DB06148 2532 43 None -9 58 Bovine 7.4 pKi = 7.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00366a007
11857864 144249 0 None 1 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 534 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4cc(F)ccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL390473 144249 0 None 1 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 534 9 1 6 5.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4cc(F)ccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
2419 695 28 None -52 12 Bovine 7.4 pKi = 7.4 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
9 695 28 None -52 12 Bovine 7.4 pKi = 7.4 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
CHEMBL13647 695 28 None -52 12 Bovine 7.4 pKi = 7.4 Binding
Binding affinity towards bovine Alpha-1A adrenergic receptorBinding affinity towards bovine Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1016/s0960-894x(01)00159-7
3158 56267 27 None -295 20 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 nan
CHEMBL1628227 56267 27 None -295 20 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 279 3 0 2 4.0 CN(C)CCC=C1c2ccccc2COc2ccccc21 nan
135 2532 43 None -9 58 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00375a017
1796 2532 43 None -9 58 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00375a017
4184 2532 43 None -9 58 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00375a017
CHEMBL6437 2532 43 None -9 58 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00375a017
DB06148 2532 43 None -9 58 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 10.1021/jm00375a017
11372228 101667 0 None -4 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 373 4 0 3 3.8 O=C1CC2(C=CN1CCN1CCN(c3ccccc3Cl)CC1)CCCC2 10.1007/s00044-010-9379-1
CHEMBL299253 101667 0 None -4 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 373 4 0 3 3.8 O=C1CC2(C=CN1CCN1CCN(c3ccccc3Cl)CC1)CCCC2 10.1007/s00044-010-9379-1
11108001 10872 2 None -3 6 Human 7.4 pKi = 7.4 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL117248 10872 2 None -3 6 Human 7.4 pKi = 7.4 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL540542 10872 2 None -3 6 Human 7.4 pKi = 7.4 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 221 4 2 4 1.8 CSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
11000184 13052 0 None 1 6 Human 7.4 pKi = 7.4 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1190038 13052 0 None 1 6 Human 7.4 pKi = 7.4 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL540035 13052 0 None 1 6 Human 7.4 pKi = 7.4 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 235 5 2 4 2.2 CCSc1ccccc1NCC1=NCCN1 10.1021/jm000542r
11372228 101667 0 None -4 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 373 4 0 3 3.8 O=C1CC2(C=CN1CCN1CCN(c3ccccc3Cl)CC1)CCCC2 10.1007/s00044-010-9379-1
CHEMBL299253 101667 0 None -4 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 373 4 0 3 3.8 O=C1CC2(C=CN1CCN1CCN(c3ccccc3Cl)CC1)CCCC2 10.1007/s00044-010-9379-1
9802999 195674 0 None 18 2 Rat 7.4 pKi = 7.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 434 5 0 6 3.1 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc([N+](=O)[O-])ccc2Cl)CC1 10.1021/jm030944+
CHEMBL55655 195674 0 None 18 2 Rat 7.4 pKi = 7.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 434 5 0 6 3.1 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc([N+](=O)[O-])ccc2Cl)CC1 10.1021/jm030944+
197001 63347 20 None - 1 Human 6.4 pKi = 6.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 339 2 0 5 3.2 COc1cc2c3c(c1OC)-c1cc4c(cc1C[C@@H]3N(C)CC2)OCO4 10.1016/j.bmcl.2004.11.032
CHEMBL179440 63347 20 None - 1 Human 6.4 pKi = 6.4 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 339 2 0 5 3.2 COc1cc2c3c(c1OC)-c1cc4c(cc1C[C@@H]3N(C)CC2)OCO4 10.1016/j.bmcl.2004.11.032
10840781 36933 0 None 3 3 Human 6.4 pKi = 6.4 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 569 8 2 7 3.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccc(C(C)=O)cc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
CHEMBL145122 36933 0 None 3 3 Human 6.4 pKi = 6.4 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 569 8 2 7 3.6 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccc(C(C)=O)cc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990202+
44292470 101635 5 None -57 2 Bovine 5.4 pKi = 5.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 211 1 1 3 1.5 Cc1ccnc(N2CCNCC2)c1Cl 10.1021/jm00366a007
CHEMBL299007 101635 5 None -57 2 Bovine 5.4 pKi = 5.4 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 211 1 1 3 1.5 Cc1ccnc(N2CCNCC2)c1Cl 10.1021/jm00366a007
10646816 43381 0 None 7 3 Human 5.4 pKi = 5.4 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 441 8 3 6 2.3 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCCCC2)=C(C)N1 10.1021/jm980506g
CHEMBL150743 43381 0 None 7 3 Human 5.4 pKi = 5.4 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 441 8 3 6 2.3 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCCCC2)=C(C)N1 10.1021/jm980506g
2419 695 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm9810654
9 695 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm9810654
CHEMBL13647 695 28 None -288 12 Human 6.4 pKi = 6.4 Binding
Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.Binding affinity at human cloned Alpha-1A adrenergic receptor in chinese hamster ovary cells by [3H]-prazosin displacement.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm9810654
71817857 92125 0 None 3 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 354 7 2 5 3.0 COc1ccc2cc[nH]c2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL2419766 92125 0 None 3 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 354 7 2 5 3.0 COc1ccc2cc[nH]c2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm400867d
25130876 192625 0 None -125 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 343 8 1 5 2.8 COc1ccccc1OCCNC[C@@H]1CO[C@H](c2ccccc2)CO1 10.1021/jm800461k
CHEMBL521665 192625 0 None -125 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 343 8 1 5 2.8 COc1ccccc1OCCNC[C@@H]1CO[C@H](c2ccccc2)CO1 10.1021/jm800461k
10236758 115772 5 None -446 13 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 328 7 0 2 4.3 CCCCC1CCN(CCCN2C(=O)CCc3ccccc32)CC1 10.1021/acs.jmedchem.8b00265
CHEMBL3354065 115772 5 None -446 13 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 328 7 0 2 4.3 CCCCC1CCN(CCCN2C(=O)CCc3ccccc32)CC1 10.1021/acs.jmedchem.8b00265
71521480 86261 0 None -1096 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNC[C@H]2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm301525w
CHEMBL2312538 86261 0 None -1096 4 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human recombinant alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins
ChEMBL 389 8 1 4 4.0 c1ccc(OCCNC[C@H]2COCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm301525w
44462130 205332 0 None 45 3 Human 7.4 pKi = 7.4 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 490 7 0 6 3.5 COC(=O)C1(c2ccccc2)CCN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CC1 10.1016/s0960-894x(98)00451-x
CHEMBL79532 205332 0 None 45 3 Human 7.4 pKi = 7.4 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 490 7 0 6 3.5 COC(=O)C1(c2ccccc2)CCN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CC1 10.1016/s0960-894x(98)00451-x
13141185 60488 0 None 9 2 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 356 0 0 2 4.3 CN1CCC(=C2c3cc(Br)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
CHEMBL175508 60488 0 None 9 2 Bovine 7.4 pKi = 7.4 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 356 0 0 2 4.3 CN1CCC(=C2c3cc(Br)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
155533100 176344 0 None -6 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 377 11 1 4 4.5 COc1ccccc1OCCNCCOC(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2019.05.024
CHEMBL4468507 176344 0 None -6 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 377 11 1 4 4.5 COc1ccccc1OCCNCCOC(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2019.05.024
CHEMBL4595564 176344 0 None -6 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 377 11 1 4 4.5 COc1ccccc1OCCNCCOC(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2019.05.024
56945167 71515 0 None -56 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 442 6 1 4 4.6 COc1ccccc1N1CCN(C[C@H]2CCC(c3ccccc3)(c3ccccc3)[C@@H]2O)CC1 10.1021/jm200421e
CHEMBL1946788 71515 0 None -56 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 442 6 1 4 4.6 COc1ccccc1N1CCN(C[C@H]2CCC(c3ccccc3)(c3ccccc3)[C@@H]2O)CC1 10.1021/jm200421e
CHEMBL1962757 71515 0 None -56 4 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 442 6 1 4 4.6 COc1ccccc1N1CCN(C[C@H]2CCC(c3ccccc3)(c3ccccc3)[C@@H]2O)CC1 10.1021/jm200421e
12488 1657 56 None -77 23 Rat 6.4 pKi = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
941361 1657 56 None -77 23 Rat 6.4 pKi = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
CHEMBL30008 1657 56 None -77 23 Rat 6.4 pKi = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
DB04841 1657 56 None -77 23 Rat 6.4 pKi = 6.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 404 6 0 2 5.4 C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F nan
9931327 69810 1 None -2290 6 Human 5.4 pKi = 5.4 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 409 4 0 4 2.9 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)c(F)cc2F)CC1 10.1021/jm0491391
CHEMBL193620 69810 1 None -2290 6 Human 5.4 pKi = 5.4 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 409 4 0 4 2.9 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)c(F)cc2F)CC1 10.1021/jm0491391
136 3292 32 None -6918 15 Human 5.4 pKi = 5.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
223 3292 32 None -6918 15 Human 5.4 pKi = 5.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
643606 3292 32 None -6918 15 Human 5.4 pKi = 5.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
CHEMBL10347 3292 32 None -6918 15 Human 5.4 pKi = 5.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00019a001
1960 2857 67 None -10 26 Bovine 6.4 pKi = 6.4 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
439260 2857 67 None -10 26 Bovine 6.4 pKi = 6.4 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
505 2857 67 None -10 26 Bovine 6.4 pKi = 6.4 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
CHEMBL1437 2857 67 None -10 26 Bovine 6.4 pKi = 6.4 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
DB00368 2857 67 None -10 26 Bovine 6.4 pKi = 6.4 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10.1021/jm960354u
9905391 109486 0 None - 1 Rat 6.4 pKi = 6.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 325 3 2 3 2.9 CS(=O)(=O)Nc1ccc(Cl)c2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL322082 109486 0 None - 1 Rat 6.4 pKi = 6.4 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 325 3 2 3 2.9 CS(=O)(=O)Nc1ccc(Cl)c2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
123981 16459 22 None -245 8 Human 6.4 pKi = 6.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 195 0 0 1 2.4 CN1CCc2cccc(Cl)c2CC1 10.1021/jm00019a001
CHEMBL123349 16459 22 None -245 8 Human 6.4 pKi = 6.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 195 0 0 1 2.4 CN1CCc2cccc(Cl)c2CC1 10.1021/jm00019a001
CHEMBL536803 16459 22 None -245 8 Human 6.4 pKi = 6.4 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 195 0 0 1 2.4 CN1CCc2cccc(Cl)c2CC1 10.1021/jm00019a001
11740041 206559 0 None -8 2 Rat 7.4 pKi = 7.4 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 372 7 0 5 2.7 COc1ccccc1N1CCN(CCCCN2CC3CCCCN3C2)CC1 10.1021/jm970216k
CHEMBL88715 206559 0 None -8 2 Rat 7.4 pKi = 7.4 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 372 7 0 5 2.7 COc1ccccc1N1CCN(CCCCN2CC3CCCCN3C2)CC1 10.1021/jm970216k
44431612 148864 0 None -2 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 509 7 1 5 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cc(Cl)ccc3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL394139 148864 0 None -2 4 Human 7.4 pKi = 7.4 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 509 7 1 5 4.7 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cc(Cl)ccc3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
36811 1454 37 None -2 7 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
535 1454 37 None -2 7 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
937 1454 37 None -2 7 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
CHEMBL926 1454 37 None -2 7 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
DB00841 1454 37 None -2 7 Rat 7.4 pKi = 7.4 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 301 7 4 4 3.0 CC(CCc1ccc(cc1)O)NCCc1ccc(c(c1)O)O nan
44330880 208151 0 None 1 3 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 371 3 0 3 4.6 O=C1OC2(CCN(CCc3cccc4ccccc34)CC2)Cc2ccccc21 10.1016/s0960-894x(98)00732-x
CHEMBL98168 208151 0 None 1 3 Human 7.4 pKi = 7.4 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 371 3 0 3 4.6 O=C1OC2(CCN(CCc3cccc4ccccc34)CC2)Cc2ccccc21 10.1016/s0960-894x(98)00732-x
10132012 109745 0 None - 1 Rat 7.3 pKi = 7.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 339 4 2 3 3.3 CCS(=O)(=O)Nc1cc(Cl)cc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL323004 109745 0 None - 1 Rat 7.3 pKi = 7.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 339 4 2 3 3.3 CCS(=O)(=O)Nc1cc(Cl)cc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
136806214 208129 0 None 60 3 Human 6.3 pKi = 6.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 633 15 4 9 2.4 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(CN(C)C)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
44329028 208129 0 None 60 3 Human 6.3 pKi = 6.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 633 15 4 9 2.4 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(CN(C)C)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL98038 208129 0 None 60 3 Human 6.3 pKi = 6.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 633 15 4 9 2.4 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(CN(C)C)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
10916464 204153 0 None 1 5 Human 6.3 pKi = 6.3 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 287 4 2 5 1.2 CS(=O)(=O)c1cc(Cl)ccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70563 204153 0 None 1 5 Human 6.3 pKi = 6.3 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 287 4 2 5 1.2 CS(=O)(=O)c1cc(Cl)ccc1NCC1=NCCN1 10.1021/jm000542r
11312410 8902 0 None 16 2 Rat 6.3 pKi = 6.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 293 3 2 4 1.5 CS(=O)(=O)Nc1cccc2c1CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
CHEMBL109755 8902 0 None 16 2 Rat 6.3 pKi = 6.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 293 3 2 4 1.5 CS(=O)(=O)Nc1cccc2c1CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
11312410 8902 0 None 16 2 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 293 3 2 4 1.5 CS(=O)(=O)Nc1cccc2c1CCCC2C1=NCCN1 10.1021/jm030551a
CHEMBL109755 8902 0 None 16 2 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 293 3 2 4 1.5 CS(=O)(=O)Nc1cccc2c1CCCC2C1=NCCN1 10.1021/jm030551a
11511026 16036 0 None -75 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 428 7 1 4 5.6 Clc1cccc(N2CCN(CCCCNc3ccc4ccccc4n3)CC2)c1Cl 10.1016/j.bmcl.2010.07.096
CHEMBL1223683 16036 0 None -75 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 428 7 1 4 5.6 Clc1cccc(N2CCN(CCCCNc3ccc4ccccc4n3)CC2)c1Cl 10.1016/j.bmcl.2010.07.096
127024958 137645 0 None -3 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 403 7 2 4 3.9 O=C(NCCCCN1CCN(c2ccccc2O)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
CHEMBL3758330 137645 0 None -3 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 403 7 2 4 3.9 O=C(NCCCCN1CCN(c2ccccc2O)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
76326541 85341 0 None 28 3 Rat 7.3 pKi = 7.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCC[C@H]2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL2261355 85341 0 None 28 3 Rat 7.3 pKi = 7.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCC[C@H]2c1c[nH]cn1 10.1007/s00044-004-0020-z
53328311 63385 0 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 421 7 0 5 3.1 COc1ccccc1N1CCN(CCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796030 63385 0 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 421 7 0 5 3.1 COc1ccccc1N1CCN(CCCN2C(=O)CC(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
9926529 9389 2 None 1 4 Rat 7.3 pKi = 7.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111496 9389 2 None 1 4 Rat 7.3 pKi = 7.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
10698608 43327 0 None 40 3 Human 6.3 pKi = 6.3 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 588 10 3 7 2.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C(=O)N(C)C)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
CHEMBL150696 43327 0 None 40 3 Human 6.3 pKi = 6.3 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 588 10 3 7 2.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C(=O)N(C)C)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
76318764 84829 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 359 8 1 6 2.8 COc1cccc(OC)c1OCCN[C@H]1COC[C@H](c2ccccc2)O1 10.1007/s00044-010-9379-1
CHEMBL2234454 84829 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 359 8 1 6 2.8 COc1cccc(OC)c1OCCN[C@H]1COC[C@H](c2ccccc2)O1 10.1007/s00044-010-9379-1
25131192 187325 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 373 9 1 6 2.8 COc1cccc(OC)c1OCCNC[C@@H]1COC[C@H](c2ccccc2)O1 10.1021/jm800461k
CHEMBL493043 187325 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 373 9 1 6 2.8 COc1cccc(OC)c1OCCNC[C@@H]1COC[C@H](c2ccccc2)O1 10.1021/jm800461k
213 3853 55 None -4 44 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
2717 3853 55 None -4 44 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
5533 3853 55 None -4 44 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
CHEMBL621 3853 55 None -4 44 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
DB00656 3853 55 None -4 44 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 5 0 6 2.4 Clc1cccc(c1)N1CCN(CC1)CCCn1nc2n(c1=O)cccc2 nan
44288754 170516 0 None 36 3 Human 7.3 pKi = 7.3 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 453 9 1 6 3.4 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C(C)c2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL44496 170516 0 None 36 3 Human 7.3 pKi = 7.3 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 453 9 1 6 3.4 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C(C)c2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(00)00307-3
53328312 63386 0 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 425 6 0 4 3.8 O=C1CC(c2ccccc2)CC(=O)N1CCCN1CCN(c2ccccc2Cl)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796031 63386 0 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 425 6 0 4 3.8 O=C1CC(c2ccccc2)CC(=O)N1CCCN1CCN(c2ccccc2Cl)CC1 10.1016/j.ejmech.2011.03.054
118567543 171368 0 None -4 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]-prazosin from human alpha1A adrenoreceptor expressed in enriched membranes incubated for 90 mins by liquid scintillation counting methodDisplacement of [3H]-prazosin from human alpha1A adrenoreceptor expressed in enriched membranes incubated for 90 mins by liquid scintillation counting method
ChEMBL 463 4 0 4 4.2 O=C1N(c2cccnc2C(F)(F)F)CC2(CCN(CCc3ccccc3F)CC2)OC12CC2 10.1021/acs.jmedchem.9b01256
CHEMBL4461774 171368 0 None -4 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]-prazosin from human alpha1A adrenoreceptor expressed in enriched membranes incubated for 90 mins by liquid scintillation counting methodDisplacement of [3H]-prazosin from human alpha1A adrenoreceptor expressed in enriched membranes incubated for 90 mins by liquid scintillation counting method
ChEMBL 463 4 0 4 4.2 O=C1N(c2cccnc2C(F)(F)F)CC2(CCN(CCc3ccccc3F)CC2)OC12CC2 10.1021/acs.jmedchem.9b01256
71450550 83807 0 None 1 16 Human 6.3 pKi = 6.3 Binding
Binding affinity to alpha1A adrenergicBinding affinity to alpha1A adrenergic
ChEMBL 309 4 1 3 2.0 COc1ccccc1CCN1C2C3C4CC5C6C4C2C6C1(O)C53 10.1016/j.bmcl.2012.08.046
CHEMBL2205836 83807 0 None 1 16 Human 6.3 pKi = 6.3 Binding
Binding affinity to alpha1A adrenergicBinding affinity to alpha1A adrenergic
ChEMBL 309 4 1 3 2.0 COc1ccccc1CCN1C2C3C4CC5C6C4C2C6C1(O)C53 10.1016/j.bmcl.2012.08.046
72457 102274 14 None -4 2 Human 5.3 pKi = 5.3 Binding
Compound was tested for its binding affinity towards Rat-1 cells stably expressing hamster alpha-1b adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards Rat-1 cells stably expressing hamster alpha-1b adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 342 3 4 3 4.0 O=C(c1nc(-c2c[nH]c3ccccc23)c[nH]1)c1c[nH]c2cc(O)ccc12 10.1016/0960-894X(96)00376-9
CHEMBL303282 102274 14 None -4 2 Human 5.3 pKi = 5.3 Binding
Compound was tested for its binding affinity towards Rat-1 cells stably expressing hamster alpha-1b adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards Rat-1 cells stably expressing hamster alpha-1b adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 342 3 4 3 4.0 O=C(c1nc(-c2c[nH]c3ccccc23)c[nH]1)c1c[nH]c2cc(O)ccc12 10.1016/0960-894X(96)00376-9
9814617 9334 0 None - 1 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 293 3 2 4 1.7 CS(=O)(=O)Nc1cccc2c1OCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111151 9334 0 None - 1 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 293 3 2 4 1.7 CS(=O)(=O)Nc1cccc2c1OCCC2c1c[nH]cn1 10.1021/jm030551a
9958160 198854 0 None -1 3 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 515 4 0 4 3.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(I)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL58384 198854 0 None -1 3 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 515 4 0 4 3.8 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(I)ccc2Cl)CC1 10.1021/jm030944+
16041263 95447 0 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 470 6 2 4 5.4 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccccc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL257098 95447 0 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 470 6 2 4 5.4 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccccc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
53328506 63395 0 None 1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 459 6 0 4 4.4 O=C1CC(c2ccc(Cl)cc2)CC(=O)N1CCCN1CCN(c2ccccc2Cl)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796040 63395 0 None 1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 459 6 0 4 4.4 O=C1CC(c2ccc(Cl)cc2)CC(=O)N1CCCN1CCN(c2ccccc2Cl)CC1 10.1016/j.ejmech.2011.03.054
44428850 92295 0 None -8 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 448 4 1 8 2.9 COc1cc2nc(N3CCN(C(=O)c4ccccn4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
CHEMBL242725 92295 0 None -8 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha-1a receptor expressed in CHO cells
ChEMBL 448 4 1 8 2.9 COc1cc2nc(N3CCN(C(=O)c4ccccn4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2007.01.028
46881444 7615 0 None -6 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 403 9 1 4 4.5 COc1ccccc1CCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
CHEMBL1088072 7615 0 None -6 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 403 9 1 4 4.5 COc1ccccc1CCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
118716703 114996 0 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 347 4 1 6 1.3 COc1ccccc1N1CCN(CC2COC3(CCNCC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342856 114996 0 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 347 4 1 6 1.3 COc1ccccc1N1CCN(CC2COC3(CCNCC3)O2)CC1 10.1016/j.ejmech.2014.09.070
44414173 12889 0 None -7 2 Rat 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 339 5 0 3 4.2 Cn1cc(C2CCN(CCCN3CCCCC3)CC2)c2ccccc21 10.1016/j.bmcl.2006.05.002
CHEMBL1188901 12889 0 None -7 2 Rat 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 339 5 0 3 4.2 Cn1cc(C2CCN(CCCN3CCCCC3)CC2)c2ccccc21 10.1016/j.bmcl.2006.05.002
CHEMBL537650 12889 0 None -7 2 Rat 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 339 5 0 3 4.2 Cn1cc(C2CCN(CCCN3CCCCC3)CC2)c2ccccc21 10.1016/j.bmcl.2006.05.002
21670271 65239 3 None - 1 Bovine 5.3 pKi = 5.3 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 174 1 0 2 1.8 CN1CC=C(c2cccnc2)CC1 10.1021/jm00375a017
CHEMBL18270 65239 3 None - 1 Bovine 5.3 pKi = 5.3 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 174 1 0 2 1.8 CN1CC=C(c2cccnc2)CC1 10.1021/jm00375a017
46846073 5800 0 None -223 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 451 9 1 4 5.6 c1ccc(-c2ccccc2OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.bmcl.2010.01.030
CHEMBL1078772 5800 0 None -223 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 451 9 1 4 5.6 c1ccc(-c2ccccc2OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.bmcl.2010.01.030
240 944 43 None -4 24 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
2769 944 43 None -4 24 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
44279790 944 43 None -4 24 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
660 944 43 None -4 24 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
CHEMBL1729 944 43 None -4 24 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
CHEMBL560739 944 43 None -4 24 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
DB00604 944 43 None -4 24 Rat 7.3 pKi = 7.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N nan
13298530 99072 20 None -97 2 Bovine 6.3 pKi = 6.3 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 195 1 0 3 1.0 CN1CCN(c2ncccc2F)CC1 10.1021/jm00366a007
CHEMBL280514 99072 20 None -97 2 Bovine 6.3 pKi = 6.3 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 195 1 0 3 1.0 CN1CCN(c2ncccc2F)CC1 10.1021/jm00366a007
6603710 123947 10 None - 1 Human 6.3 pKi = 6.3 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 345 5 2 3 3.9 CCS(=O)(=O)Nc1cccc(C(=C2CCCCC2)c2c[nH]cn2)c1 10.1016/j.bmcl.2004.11.032
CHEMBL362863 123947 10 None - 1 Human 6.3 pKi = 6.3 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 345 5 2 3 3.9 CCS(=O)(=O)Nc1cccc(C(=C2CCCCC2)c2c[nH]cn2)c1 10.1016/j.bmcl.2004.11.032
13298530 99072 20 None -97 2 Bovine 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 195 1 0 3 1.0 CN1CCN(c2ncccc2F)CC1 10.1021/jm00375a017
CHEMBL280514 99072 20 None -97 2 Bovine 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 195 1 0 3 1.0 CN1CCN(c2ncccc2F)CC1 10.1021/jm00375a017
4735 195115 96 None -77 10 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 nan
CHEMBL361506 195115 96 None -77 10 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 nan
CHEMBL55 195115 96 None -77 10 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 340 10 4 4 2.9 N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1 nan
2419 695 28 None -288 12 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm030944+
9 695 28 None -288 12 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm030944+
CHEMBL13647 695 28 None -288 12 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm030944+
19085827 104863 0 None 3 3 Human 6.3 pKi = 6.3 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 485 7 0 8 2.9 COc1ccc2c(c1)oc(=O)n2C1CCN(CCCCN2C(=O)c3ccccc3S2(=O)=O)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL311014 104863 0 None 3 3 Human 6.3 pKi = 6.3 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 485 7 0 8 2.9 COc1ccc2c(c1)oc(=O)n2C1CCN(CCCCN2C(=O)c3ccccc3S2(=O)=O)CC1 10.1016/s0960-894x(98)00446-6
44571938 180073 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 300 3 1 3 3.0 Fc1ccn(Cc2c(F)ccc3c2CC[C@H]3c2ncc[nH]2)n1 10.1016/j.bmcl.2008.10.066
CHEMBL474796 180073 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 300 3 1 3 3.0 Fc1ccn(Cc2c(F)ccc3c2CC[C@H]3c2ncc[nH]2)n1 10.1016/j.bmcl.2008.10.066
44431617 88342 0 None 3 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 458 7 1 6 3.3 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234854 88342 0 None 3 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 458 7 1 6 3.3 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
44390740 122938 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 478 7 3 7 0.9 C[C@@]1(O)C(=O)N(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)C(=O)N[C@@H]1O 10.1016/j.bmcl.2004.11.032
CHEMBL360688 122938 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 478 7 3 7 0.9 C[C@@]1(O)C(=O)N(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)C(=O)N[C@@H]1O 10.1016/j.bmcl.2004.11.032
3033677 202944 40 None -25 9 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]-WB4101 from rat forebrain alpha 1 adrenergic receptorsDisplacement of [3H]-WB4101 from rat forebrain alpha 1 adrenergic receptors
ChEMBL 411 5 1 5 3.8 O=C(c1ccc(F)cc1)C1CCN(CCn2c(=S)[nH]c3ccccc3c2=O)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL2355519 202944 40 None -25 9 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]-WB4101 from rat forebrain alpha 1 adrenergic receptorsDisplacement of [3H]-WB4101 from rat forebrain alpha 1 adrenergic receptors
ChEMBL 411 5 1 5 3.8 O=C(c1ccc(F)cc1)C1CCN(CCn2c(=S)[nH]c3ccccc3c2=O)CC1 10.1021/acs.jmedchem.2c00633
CHEMBL62919 202944 40 None -25 9 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]-WB4101 from rat forebrain alpha 1 adrenergic receptorsDisplacement of [3H]-WB4101 from rat forebrain alpha 1 adrenergic receptors
ChEMBL 411 5 1 5 3.8 O=C(c1ccc(F)cc1)C1CCN(CCn2c(=S)[nH]c3ccccc3c2=O)CC1 10.1021/acs.jmedchem.2c00633
127025276 137727 0 None -3 3 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 416 8 2 4 4.1 COc1ccccc1N1CCN(CCCCNC(=O)Nc2cccc(Cl)c2)CC1 10.1016/j.bmcl.2015.12.068
CHEMBL3758991 137727 0 None -3 3 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 416 8 2 4 4.1 COc1ccccc1N1CCN(CCCCNC(=O)Nc2cccc(Cl)c2)CC1 10.1016/j.bmcl.2015.12.068
10579632 35585 0 None 5 3 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 611 9 2 7 5.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
CHEMBL143940 35585 0 None 5 3 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 611 9 2 7 5.3 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm990200p
52944674 17122 0 None 2 4 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 395 11 3 6 3.7 Oc1cccc(O)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1255085 17122 0 None 2 4 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 395 11 3 6 3.7 Oc1cccc(O)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
134150497 152092 0 None -1 3 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 324 6 0 3 3.8 CC(C)Oc1ccccc1N1CCN(CCc2ccccc2)CC1 10.1016/j.ejmech.2016.06.052
CHEMBL3967641 152092 0 None -1 3 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 minsDisplacement of [3H]prazosin from human alpha1A-adrenoceptor expressed in CHO cell membranes measured after 30 mins
ChEMBL 324 6 0 3 3.8 CC(C)Oc1ccccc1N1CCN(CCc2ccccc2)CC1 10.1016/j.ejmech.2016.06.052
44298780 196548 0 None 25 3 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 478 7 3 7 0.9 C[C@]1(O)C(=O)N(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)C(=O)N[C@H]1O 10.1016/s0960-894x(03)00305-6
CHEMBL56375 196548 0 None 25 3 Human 8.3 pKi = 8.3 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 478 7 3 7 0.9 C[C@]1(O)C(=O)N(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)C(=O)N[C@H]1O 10.1016/s0960-894x(03)00305-6
44329026 208425 0 None 19 6 Human 8.3 pKi = 8.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 679 16 3 7 6.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCCOC)N1 10.1016/s0960-894x(99)00484-9
CHEMBL99864 208425 0 None 19 6 Human 8.3 pKi = 8.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 679 16 3 7 6.1 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCCOC)N1 10.1016/s0960-894x(99)00484-9
16041264 95443 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 470 6 2 4 5.4 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cccc(Cl)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL257077 95443 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 470 6 2 4 5.4 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cccc(Cl)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
2894 208071 6 None -12 5 Bovine 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)C4CCCCC43)nc(N)c2cc1OC 10.1021/jm020938y
CHEMBL97698 208071 6 None -12 5 Bovine 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)C4CCCCC43)nc(N)c2cc1OC 10.1021/jm020938y
44288485 162520 0 None 29 3 Human 8.3 pKi = 8.3 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 498 9 1 4 5.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C(c2ccc(C)cc2)c2ccc(C)cc2)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL41677 162520 0 None 29 3 Human 8.3 pKi = 8.3 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 498 9 1 4 5.1 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C(c2ccc(C)cc2)c2ccc(C)cc2)CC1 10.1016/s0960-894x(00)00307-3
10746137 36954 0 None 138 3 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 599 9 2 7 3.9 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C#N)(c3ccccc3F)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL145134 36954 0 None 138 3 Human 8.3 pKi = 8.3 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 599 9 2 7 3.9 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C#N)(c3ccccc3F)CC2)C(=O)N1 10.1021/jm990201h
90645595 112487 0 None -4 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 611 11 2 8 5.1 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298748 112487 0 None -4 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 611 11 2 8 5.1 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
118716717 115011 0 None 1 4 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 532 7 0 9 2.3 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccc([N+](=O)[O-])cc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342870 115011 0 None 1 4 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 532 7 0 9 2.3 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccc([N+](=O)[O-])cc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
44404321 70292 0 None -1 2 Human 8.3 pKi = 8.3 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 297 4 1 5 3.0 COc1cccc(N(NC2=NCCO2)c2ccc(C)cc2)c1 10.1016/j.bmcl.2005.07.083
CHEMBL194323 70292 0 None -1 2 Human 8.3 pKi = 8.3 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 297 4 1 5 3.0 COc1cccc(N(NC2=NCCO2)c2ccc(C)cc2)c1 10.1016/j.bmcl.2005.07.083
44404326 133524 0 None -1 2 Human 8.3 pKi = 8.3 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 283 3 2 5 2.7 Cc1ccc(N(NC2=NCCO2)c2cccc(O)c2)cc1 10.1016/j.bmcl.2005.07.083
CHEMBL370818 133524 0 None -1 2 Human 8.3 pKi = 8.3 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
ChEMBL 283 3 2 5 2.7 Cc1ccc(N(NC2=NCCO2)c2cccc(O)c2)cc1 10.1016/j.bmcl.2005.07.083
44447018 94864 0 None -131 4 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 496 7 1 5 5.0 O=C(Cc1ccccc1)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
CHEMBL253878 94864 0 None -131 4 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 496 7 1 5 5.0 O=C(Cc1ccccc1)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21 10.1016/j.bmcl.2007.11.106
44288468 168381 0 None 1 2 Rat 8.3 pKi = 8.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1cccc2c1C1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC1CC2 10.1021/jm990567u
CHEMBL434591 168381 0 None 1 2 Rat 8.3 pKi = 8.3 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1cccc2c1C1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC1CC2 10.1021/jm990567u
16041630 97547 0 None -2 4 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(F)cccc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL270589 97547 0 None -2 4 Human 8.3 pKi = 8.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(F)cccc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
44289525 165995 0 None -5 8 Rat 8.3 pKi = 8.3 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampus (+ 10 uM) CES membrane using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampus (+ 10 uM) CES membrane using [3H]prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNCC1Oc2ccccc2OC1c1ccc(C)cc1 10.1021/jm960069a
CHEMBL42539 165995 0 None -5 8 Rat 8.3 pKi = 8.3 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampus (+ 10 uM) CES membrane using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampus (+ 10 uM) CES membrane using [3H]prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNCC1Oc2ccccc2OC1c1ccc(C)cc1 10.1021/jm960069a
44426405 142053 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 562 9 1 5 5.7 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc(OC(F)F)cc1 10.1016/j.bmcl.2007.04.098
CHEMBL387832 142053 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 562 9 1 5 5.7 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc(OC(F)F)cc1 10.1016/j.bmcl.2007.04.098
10746433 121083 0 None 295 3 Human 8.3 pKi = 8.3 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 619 13 3 9 3.0 COCCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
CHEMBL357061 121083 0 None 295 3 Human 8.3 pKi = 8.3 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 619 13 3 9 3.0 COCCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
69781970 161351 0 None -14 4 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 477 5 1 8 4.0 COc1cc2nc(N3CCN(C(=O)OCc4ccccc4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4125981 161351 0 None -14 4 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 477 5 1 8 4.0 COc1cc2nc(N3CCN(C(=O)OCc4ccccc4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
132266 1278 12 None -28 9 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm8016046
486 1278 12 None -28 9 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm8016046
CHEMBL423294 1278 12 None -28 9 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 10.1021/jm8016046
180 401 56 None -10 40 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
200 401 56 None -10 40 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
2160 401 56 None -10 40 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
CHEMBL629 401 56 None -10 40 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
DB00321 401 56 None -10 40 Rat 8.3 pKi = 8.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C nan
44431554 88343 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(F)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234874 88343 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(F)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
44431547 154604 0 None -2 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL399195 154604 0 None -2 4 Human 8.3 pKi = 8.3 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 475 7 1 5 4.0 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3F)CC2)CC1 10.1016/j.bmcl.2007.04.008
11994667 11831 0 None 1 5 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1ccc(-c2ccccc2)cc1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182143 11831 0 None 1 5 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1ccc(-c2ccccc2)cc1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL214694 11831 0 None 1 5 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1ccc(-c2ccccc2)cc1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
71458492 84569 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153556 84569 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220896 84569 0 None -1 4 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 379 8 1 6 3.2 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(Cl)c2O1 10.1016/j.ejmech.2012.09.049
44447012 94799 0 None -56 4 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 516 6 1 5 5.7 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccc(Cl)cc1 10.1016/j.bmcl.2007.11.106
CHEMBL253439 94799 0 None -56 4 Rat 8.3 pKi = 8.3 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
ChEMBL 516 6 1 5 5.7 O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccc(Cl)cc1 10.1016/j.bmcl.2007.11.106
10575494 165747 0 None -1 3 Rat 8.3 pKi = 8.3 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 449 7 1 8 2.5 COc1cc2nc(N3CCN(C(=O)CCC(=O)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL424658 165747 0 None -1 3 Rat 8.3 pKi = 8.3 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 449 7 1 8 2.5 COc1cc2nc(N3CCN(C(=O)CCC(=O)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
44301681 202694 0 None 309 3 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 481 8 2 4 4.6 Cc1ccc(C(O)(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(01)00320-1
CHEMBL61643 202694 0 None 309 3 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 481 8 2 4 4.6 Cc1ccc(C(O)(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(01)00320-1
145953314 161429 0 None -6 3 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 441 7 1 7 3.8 CCCCCC(=O)N1CCN(c2nc(N)c3cc(OC)c(OC)cc3n2)[C@@H]2CCCC[C@@H]21 10.1016/j.bmc.2018.05.023
CHEMBL4127078 161429 0 None -6 3 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 441 7 1 7 3.8 CCCCCC(=O)N1CCN(c2nc(N)c3cc(OC)c(OC)cc3n2)[C@@H]2CCCC[C@@H]21 10.1016/j.bmc.2018.05.023
10895039 18520 0 None -11 8 Rat 8.2 pKi = 8.2 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 418 8 1 5 3.6 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3cn2)CC1 10.1021/jm0211220
CHEMBL127400 18520 0 None -11 8 Rat 8.2 pKi = 8.2 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 418 8 1 5 3.6 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3cn2)CC1 10.1021/jm0211220
CHEMBL129022 18520 0 None -11 8 Rat 8.2 pKi = 8.2 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 418 8 1 5 3.6 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3cn2)CC1 10.1021/jm0211220
44431617 144901 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 458 7 1 6 3.3 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL391016 144901 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 458 7 1 6 3.3 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
44295044 101580 0 None 169 3 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 535 6 2 6 3.5 N#CC1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
CHEMBL298579 101580 0 None 169 3 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 535 6 2 6 3.5 N#CC1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
4418 34222 85 None -1 6 Human 8.2 pKi = 8.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1007/s00044-010-9379-1
CHEMBL142635 34222 85 None -1 6 Human 8.2 pKi = 8.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1007/s00044-010-9379-1
4418 34222 85 None -1 6 Human 8.2 pKi = 8.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1007/s00044-010-9379-1
CHEMBL142635 34222 85 None -1 6 Human 8.2 pKi = 8.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 10.1007/s00044-010-9379-1
10793963 99672 0 None 9 6 Human 8.2 pKi = 8.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 622 11 2 7 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm960697s
CHEMBL284470 99672 0 None 9 6 Human 8.2 pKi = 8.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 622 11 2 7 6.8 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm960697s
10032383 110110 0 None 194 6 Human 8.2 pKi = 8.2 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
136680387 110110 0 None 194 6 Human 8.2 pKi = 8.2 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
CHEMBL323579 110110 0 None 194 6 Human 8.2 pKi = 8.2 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 666 15 4 8 4.2 CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1 10.1016/s0960-894x(99)00484-9
11857793 85650 0 None -6 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 548 7 1 4 5.9 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cc(Cl)ccc1F 10.1016/j.bmcl.2007.04.098
CHEMBL228445 85650 0 None -6 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 548 7 1 4 5.9 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cc(Cl)ccc1F 10.1016/j.bmcl.2007.04.098
10743042 188152 0 None 2 4 Human 8.2 pKi = 8.2 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 471 5 1 8 3.1 Cn1nc(Cl)c2cn3nc(NCCN4CCN(c5ccccc5Cl)CC4)ccc3c2c1=O 10.1021/jm981006q
CHEMBL49851 188152 0 None 2 4 Human 8.2 pKi = 8.2 Binding
The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cellsThe compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 471 5 1 8 3.1 Cn1nc(Cl)c2cn3nc(NCCN4CCN(c5ccccc5Cl)CC4)ccc3c2c1=O 10.1021/jm981006q
10651706 121514 0 None 25 3 Human 8.2 pKi = 8.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 637 11 3 8 4.5 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C(=O)Oc3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
CHEMBL358406 121514 0 None 25 3 Human 8.2 pKi = 8.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 637 11 3 8 4.5 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C(=O)Oc3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
144096985 164094 0 None -5 3 Human 7.3 pKi = 7.3 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 385 9 1 4 3.5 CS(=O)(=O)c1ccccc1CCCNCCOc1cc(F)ccc1Cl 10.1016/j.ejmech.2017.07.071
CHEMBL4209590 164094 0 None -5 3 Human 7.3 pKi = 7.3 Binding
Displacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting methodDisplacement of 7-methoxy-[3H]-prazosin from human alpha1A-adrenoreceptor expressed in CHOK1 cell membranes after 60 mins by TopCount liquid scintillation counting method
ChEMBL 385 9 1 4 3.5 CS(=O)(=O)c1ccccc1CCCNCCOc1cc(F)ccc1Cl 10.1016/j.ejmech.2017.07.071
9841781 123060 0 None -13 2 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 359 5 1 2 4.8 c1ccc2c(c1)CN(CCCN1CCC(c3c[nH]c4ccccc34)CC1)C2 10.1016/j.bmcl.2015.07.046
CHEMBL3609357 123060 0 None -13 2 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 359 5 1 2 4.8 c1ccc2c(c1)CN(CCCN1CCC(c3c[nH]c4ccccc34)CC1)C2 10.1016/j.bmcl.2015.07.046
44288794 162076 0 None 39 3 Human 7.3 pKi = 7.3 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 429 8 1 3 5.0 N#CC1(c2ccccc2)CCN(CCCNC(=O)C(c2ccccc2)C2CCCC2)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL416073 162076 0 None 39 3 Human 7.3 pKi = 7.3 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 429 8 1 3 5.0 N#CC1(c2ccccc2)CCN(CCCNC(=O)C(c2ccccc2)C2CCCC2)CC1 10.1016/s0960-894x(00)00307-3
10026936 163458 0 None 114 3 Human 7.3 pKi = 7.3 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 453 8 1 3 5.1 Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(F)c(F)c2)C(C)C)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL41994 163458 0 None 114 3 Human 7.3 pKi = 7.3 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 453 8 1 3 5.1 Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(F)c(F)c2)C(C)C)CC1 10.1016/s0960-894x(00)00307-3
2267 559 71 None -15 7 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1021/acsmedchemlett.7b00112
271 559 71 None -15 7 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1021/acsmedchemlett.7b00112
7121 559 71 None -15 7 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1021/acsmedchemlett.7b00112
CHEMBL639 559 71 None -15 7 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1021/acsmedchemlett.7b00112
DB00972 559 71 None -15 7 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1021/acsmedchemlett.7b00112
24824726 161109 1 None -64 6 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 496 11 1 6 3.6 COCCCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL4060529 161109 1 None -64 6 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 496 11 1 6 3.6 COCCCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL4117079 161109 1 None -64 6 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 496 11 1 6 3.6 COCCCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5282336 161109 1 None -64 6 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 496 11 1 6 3.6 COCCCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5286389 161109 1 None -64 6 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 496 11 1 6 3.6 COCCCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5273244 194616 0 None -100 3 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 468 9 1 6 2.9 COCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5315364 194616 0 None -100 3 Human 7.3 pKi = 7.3 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 468 9 1 6 2.9 COCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
2267 559 71 None -15 7 Human 7.3 pKi = 7.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1021/jm1013874
271 559 71 None -15 7 Human 7.3 pKi = 7.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1021/jm1013874
7121 559 71 None -15 7 Human 7.3 pKi = 7.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1021/jm1013874
CHEMBL639 559 71 None -15 7 Human 7.3 pKi = 7.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1021/jm1013874
DB00972 559 71 None -15 7 Human 7.3 pKi = 7.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1021/jm1013874
52937728 61310 0 None -100 4 Human 7.3 pKi = 7.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 351 4 0 4 3.2 CN1CCC[C@@H]1Cn1nc(Cc2cccc(F)c2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767145 61310 0 None -100 4 Human 7.3 pKi = 7.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 351 4 0 4 3.2 CN1CCC[C@@H]1Cn1nc(Cc2cccc(F)c2)c2ccccc2c1=O 10.1021/jm1013874
155565449 176331 0 None -3 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 433 11 1 5 4.6 COc1ccccc1OCCNCC[C@@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4579802 176331 0 None -3 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 433 11 1 5 4.6 COc1ccccc1OCCNCC[C@@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4595447 176331 0 None -3 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 433 11 1 5 4.6 COc1ccccc1OCCNCC[C@@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
2267 559 71 None -15 7 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1016/j.bmcl.2017.09.020
271 559 71 None -15 7 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1016/j.bmcl.2017.09.020
7121 559 71 None -15 7 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1016/j.bmcl.2017.09.020
CHEMBL639 559 71 None -15 7 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1016/j.bmcl.2017.09.020
DB00972 559 71 None -15 7 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
ChEMBL 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 10.1016/j.bmcl.2017.09.020
19608536 137782 0 None -10 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 421 7 1 3 4.8 O=C(NCCCCN1CCN(c2cccc(Cl)c2)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
CHEMBL3759513 137782 0 None -10 3 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 421 7 1 3 4.8 O=C(NCCCCN1CCN(c2cccc(Cl)c2)CC1)c1ccc2ccccc2c1 10.1016/j.bmcl.2015.12.068
12575 1988 30 None -331 17 Bovine 6.3 pKi = 6.3 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1021/jm00366a007
54459 1988 30 None -331 17 Bovine 6.3 pKi = 6.3 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1021/jm00366a007
CHEMBL10316 1988 30 None -331 17 Bovine 6.3 pKi = 6.3 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 204 1 1 4 0.8 C1CN=C(N1)C2COC3=CC=CC=C3O2 10.1021/jm00366a007
506 2252 39 None -97 5 Rat 6.3 pKi = 6.3 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
6603904 2252 39 None -97 5 Rat 6.3 pKi = 6.3 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
CHEMBL19476 2252 39 None -97 5 Rat 6.3 pKi = 6.3 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 522 6 2 9 3.0 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H](C1)C(=O)NC(C)(C)C)C(=O)OCc1ccccc1 10.1021/jm980053f
102 4127 48 None -1258 49 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
3659 4127 48 None -1258 49 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
8969 4127 48 None -1258 49 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
CHEMBL15245 4127 48 None -1258 49 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
DB01392 4127 48 None -1258 49 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 nan
10792152 206951 0 None - 1 Human 6.3 pKi = 6.3 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 523 7 3 4 3.9 O=C1NC(C(F)(F)F)=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1021/jm990612y
CHEMBL91179 206951 0 None - 1 Human 6.3 pKi = 6.3 Binding
Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1A adrenergic receptor stably expressed in CHO cells.
ChEMBL 523 7 3 4 3.9 O=C1NC(C(F)(F)F)=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)N1 10.1021/jm990612y
75306277 109254 0 None -251 23 Human 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 308 0 0 3 4.2 CN1CCC2C(C1)c1cccc3c1N2c1ccccc1CS3 10.1039/C2MD00311B
CHEMBL3217984 109254 0 None -251 23 Human 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assayBinding affinity to adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 308 0 0 3 4.2 CN1CCC2C(C1)c1cccc3c1N2c1ccccc1CS3 10.1039/C2MD00311B
52937731 61313 0 None -630 4 Human 6.3 pKi = 6.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 347 4 0 4 3.4 Cc1cccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)c1 10.1021/jm1013874
CHEMBL1767148 61313 0 None -630 4 Human 6.3 pKi = 6.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 347 4 0 4 3.4 Cc1cccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)c1 10.1021/jm1013874
52937829 61318 0 None -316 3 Human 6.3 pKi = 6.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 313 6 0 4 3.2 CCCCCc1nn(C[C@H]2CCCN2C)c(=O)c2ccccc12 10.1021/jm1013874
CHEMBL1767153 61318 0 None -316 3 Human 6.3 pKi = 6.3 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 313 6 0 4 3.2 CCCCCc1nn(C[C@H]2CCCN2C)c(=O)c2ccccc12 10.1021/jm1013874
11736917 9277 2 None - 1 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 254 4 2 3 1.5 CCS(=O)(=O)Nc1cccc(C2CCNC2)c1 10.1021/jm030551a
CHEMBL110859 9277 2 None - 1 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 254 4 2 3 1.5 CCS(=O)(=O)Nc1cccc(C2CCNC2)c1 10.1021/jm030551a
9880162 9302 0 None 3 2 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 321 4 2 4 2.3 COc1ccc2c(c1NS(C)(=O)=O)CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL110976 9302 0 None 3 2 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 321 4 2 4 2.3 COc1ccc2c(c1NS(C)(=O)=O)CCCC2c1c[nH]cn1 10.1021/jm030551a
9823115 198603 0 None -29 4 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 414 4 0 5 3.0 N#Cc1ccc(Cl)cc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
CHEMBL57868 198603 0 None -29 4 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 414 4 0 5 3.0 N#Cc1ccc(Cl)cc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
16041449 95220 0 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 538 6 2 4 6.7 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL256040 95220 0 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 538 6 2 4 6.7 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
16041092 95380 0 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)c(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL256804 95380 0 None -1 4 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)c(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
9820229 123059 0 None -6 2 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 359 5 1 2 4.8 c1ccc2c(c1)CCN2CCCN1CCC(c2c[nH]c3ccccc23)CC1 10.1016/j.bmcl.2015.07.046
CHEMBL3609356 123059 0 None -6 2 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 359 5 1 2 4.8 c1ccc2c(c1)CCN2CCCN1CCC(c2c[nH]c3ccccc23)CC1 10.1016/j.bmcl.2015.07.046
10739024 69833 0 None -20 5 Rat 6.3 pKi = 6.3 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 388 4 3 8 0.9 COc1cc2nc(N3CCN[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
CHEMBL19376 69833 0 None -20 5 Rat 6.3 pKi = 6.3 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 388 4 3 8 0.9 COc1cc2nc(N3CCN[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
10961938 119539 0 None -8511 8 Rat 5.3 pKi = 5.3 Binding
Binding affinity for rat Alpha-1A adrenergic receptor using [11C] radiotracerBinding affinity for rat Alpha-1A adrenergic receptor using [11C] radiotracer
ChEMBL 485 8 1 4 5.5 COc1c(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)ccc2ccccc12 10.1021/jm050171k
CHEMBL345820 119539 0 None -8511 8 Rat 5.3 pKi = 5.3 Binding
Binding affinity for rat Alpha-1A adrenergic receptor using [11C] radiotracerBinding affinity for rat Alpha-1A adrenergic receptor using [11C] radiotracer
ChEMBL 485 8 1 4 5.5 COc1c(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)ccc2ccccc12 10.1021/jm050171k
76322413 84827 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 359 8 1 6 2.8 COc1cccc(OC)c1OCCN[C@H]1CO[C@H](c2ccccc2)CO1 10.1007/s00044-010-9379-1
CHEMBL2234452 84827 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 359 8 1 6 2.8 COc1cccc(OC)c1OCCN[C@H]1CO[C@H](c2ccccc2)CO1 10.1007/s00044-010-9379-1
2803 955 58 None -8 19 Human 6.3 pKi = 6.3 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
516 955 58 None -8 19 Human 6.3 pKi = 6.3 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
704 955 58 None -8 19 Human 6.3 pKi = 6.3 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
CHEMBL134 955 58 None -8 19 Human 6.3 pKi = 6.3 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
DB00575 955 58 None -8 19 Human 6.3 pKi = 6.3 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
25132564 187402 0 None -2 2 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 373 9 1 6 2.8 COc1cccc(OC)c1OCCNC[C@@H]1CO[C@@H](c2ccccc2)CO1 10.1021/jm800461k
CHEMBL493661 187402 0 None -2 2 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 373 9 1 6 2.8 COc1cccc(OC)c1OCCNC[C@@H]1CO[C@@H](c2ccccc2)CO1 10.1021/jm800461k
3086326 204531 22 None -138 6 Human 5.3 pKi = 5.3 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 247 1 2 5 1.7 Clc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL72753 204531 22 None -138 6 Human 5.3 pKi = 5.3 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 247 1 2 5 1.7 Clc1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
16041630 97547 0 None -2 4 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(F)cccc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL270589 97547 0 None -2 4 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 472 6 2 4 5.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(F)cccc3F)CC2)CC1 10.1016/j.bmcl.2007.11.068
49783209 17609 0 None -263 26 Human 6.3 pKi = 6.3 Binding
Binding affinity to human adrenergic alpha1A receptorBinding affinity to human adrenergic alpha1A receptor
ChEMBL 396 7 1 6 3.8 CCCCN1CCC(COC(=O)c2cc(Cl)c(NC)c3c2OCCO3)CC1 10.1021/jm100668r
CHEMBL1258223 17609 0 None -263 26 Human 6.3 pKi = 6.3 Binding
Binding affinity to human adrenergic alpha1A receptorBinding affinity to human adrenergic alpha1A receptor
ChEMBL 396 7 1 6 3.8 CCCCN1CCC(COC(=O)c2cc(Cl)c(NC)c3c2OCCO3)CC1 10.1021/jm100668r
127036932 137348 0 None -17 22 Human 6.3 pKi = 6.3 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 274 7 1 1 4.0 C=CCN(CC=C)CCc1c[nH]c2ccc(Cl)cc12 10.1016/j.bmcl.2015.12.053
CHEMBL3752900 137348 0 None -17 22 Human 6.3 pKi = 6.3 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 274 7 1 1 4.0 C=CCN(CC=C)CCc1c[nH]c2ccc(Cl)cc12 10.1016/j.bmcl.2015.12.053
9813756 9016 0 None 1 3 Rat 6.3 pKi = 6.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 255 2 2 2 2.8 CC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL109848 9016 0 None 1 3 Rat 6.3 pKi = 6.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 255 2 2 2 2.8 CC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
9813756 9016 0 None 1 3 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 255 2 2 2 2.8 CC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL109848 9016 0 None 1 3 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 255 2 2 2 2.8 CC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
15546405 97158 0 None 12 3 Human 7.3 pKi = 7.3 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 416 8 0 5 2.1 CC(C)Oc1ccccc1N1CCN(CCN(C)C(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL268030 97158 0 None 12 3 Human 7.3 pKi = 7.3 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 416 8 0 5 2.1 CC(C)Oc1ccccc1N1CCN(CCN(C)C(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
44331277 4476 0 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 371 3 0 3 4.9 O=C1CC2(CCN(CCc3cccc4ccccc34)CC2)Oc2ccccc21 10.1016/s0960-894x(98)00732-x
CHEMBL101869 4476 0 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 371 3 0 3 4.9 O=C1CC2(CCN(CCc3cccc4ccccc34)CC2)Oc2ccccc21 10.1016/s0960-894x(98)00732-x
9800400 123057 1 None -7 2 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 387 5 1 3 4.0 O=C1c2ccccc2C(=O)N1CCCN1CCC(c2c[nH]c3ccccc23)CC1 10.1016/j.bmcl.2015.07.046
CHEMBL3609354 123057 1 None -7 2 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 387 5 1 3 4.0 O=C1c2ccccc2C(=O)N1CCCN1CCC(c2c[nH]c3ccccc23)CC1 10.1016/j.bmcl.2015.07.046
10818003 106421 0 None 3 6 Human 7.3 pKi = 7.3 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 649 12 3 6 6.2 CC(C)C1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C(C)C)N1 10.1021/jm980077m
CHEMBL313953 106421 0 None 3 6 Human 7.3 pKi = 7.3 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 649 12 3 6 6.2 CC(C)C1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C(C)C)N1 10.1021/jm980077m
10818003 106421 0 None 3 6 Human 7.3 pKi = 7.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 649 12 3 6 6.2 CC(C)C1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C(C)C)N1 10.1007/s00044-004-0120-9
CHEMBL313953 106421 0 None 3 6 Human 7.3 pKi = 7.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 649 12 3 6 6.2 CC(C)C1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C(C)C)N1 10.1007/s00044-004-0120-9
44420412 84796 0 None -3 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 470 5 1 7 3.4 COc1ccc(Cl)cc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
CHEMBL223289 84796 0 None -3 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 470 5 1 7 3.4 COc1ccc(Cl)cc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
14925759 158038 6 None -18 13 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 349 5 0 3 3.2 O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1 10.1021/acs.jmedchem.8b00265
CHEMBL4085780 158038 6 None -18 13 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from human recombinant alpha-1A adrenergic receptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 349 5 0 3 3.2 O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1 10.1021/acs.jmedchem.8b00265
56946472 71511 0 None -26 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 373 8 1 3 4.8 c1ccc(OCCNCC2CCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm200421e
CHEMBL1946778 71511 0 None -26 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 373 8 1 3 4.8 c1ccc(OCCNCC2CCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm200421e
CHEMBL1962753 71511 0 None -26 4 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 373 8 1 3 4.8 c1ccc(OCCNCC2CCC(c3ccccc3)(c3ccccc3)O2)cc1 10.1021/jm200421e
11372228 101667 0 None -5 4 Rat 7.3 pKi = 7.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 373 4 0 3 3.8 O=C1CC2(C=CN1CCN1CCN(c3ccccc3Cl)CC1)CCCC2 10.1021/jm030944+
CHEMBL299253 101667 0 None -5 4 Rat 7.3 pKi = 7.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 373 4 0 3 3.8 O=C1CC2(C=CN1CCN1CCN(c3ccccc3Cl)CC1)CCCC2 10.1021/jm030944+
11771731 108246 2 None -1 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@@H]([C@@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
CHEMBL319706 108246 2 None -1 3 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)Displacement of [3H]prazosin from alpha-1A adrenergic receptor (unknown origin)
ChEMBL 325 5 2 3 3.8 C[C@@H]([C@@H](O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 10.1021/acs.jmedchem.0c01912
9947861 204162 0 None 4 4 Human 6.3 pKi = 6.3 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 287 4 2 5 1.2 CS(=O)(=O)c1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70634 204162 0 None 4 4 Human 6.3 pKi = 6.3 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 287 4 2 5 1.2 CS(=O)(=O)c1ccc(Cl)cc1NCC1=NCCN1 10.1021/jm000542r
76311539 84832 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 299 6 1 4 2.8 c1ccc(OCCN[C@H]2CO[C@H](c3ccccc3)CO2)cc1 10.1007/s00044-010-9379-1
CHEMBL2234457 84832 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 299 6 1 4 2.8 c1ccc(OCCN[C@H]2CO[C@H](c3ccccc3)CO2)cc1 10.1007/s00044-010-9379-1
10267873 110660 0 None - 1 Rat 6.3 pKi = 6.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 317 4 2 3 2.8 O=S(=O)(Nc1cccc2c1CCCC2c1c[nH]cn1)C1CC1 10.1007/s00044-004-0020-z
CHEMBL325897 110660 0 None - 1 Rat 6.3 pKi = 6.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 317 4 2 3 2.8 O=S(=O)(Nc1cccc2c1CCCC2c1c[nH]cn1)C1CC1 10.1007/s00044-004-0020-z
14004035 119519 0 None 1 2 Bovine 6.3 pKi = 6.3 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 227 0 1 2 2.6 c1cnc2[nH]c3c(c2c1)CCN1CCCCC31 10.1021/jm00398a025
CHEMBL345621 119519 0 None 1 2 Bovine 6.3 pKi = 6.3 Binding
Compound was evaluated for log 1/Ki at alpha-1 adrenergic receptorCompound was evaluated for log 1/Ki at alpha-1 adrenergic receptor
ChEMBL 227 0 1 2 2.6 c1cnc2[nH]c3c(c2c1)CCN1CCCCC31 10.1021/jm00398a025
25131196 192632 0 None -3 2 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 313 7 1 4 2.8 c1ccc(OCCNC[C@@H]2CO[C@@H](c3ccccc3)CO2)cc1 10.1021/jm800461k
CHEMBL521694 192632 0 None -3 2 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 313 7 1 4 2.8 c1ccc(OCCNC[C@@H]2CO[C@@H](c3ccccc3)CO2)cc1 10.1021/jm800461k
10267873 110660 0 None - 1 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 317 4 2 3 2.8 O=S(=O)(Nc1cccc2c1CCCC2c1c[nH]cn1)C1CC1 10.1021/jm030551a
CHEMBL325897 110660 0 None - 1 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 317 4 2 3 2.8 O=S(=O)(Nc1cccc2c1CCCC2c1c[nH]cn1)C1CC1 10.1021/jm030551a
441383 20333 57 None -257 16 Rat 5.3 pKi = 5.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
CHEMBL1306 20333 57 None -257 16 Rat 5.3 pKi = 5.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 nan
11505007 90264 0 None -6 4 Human 7.3 pKi = 7.3 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 557 9 1 7 4.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL238402 90264 0 None -6 4 Human 7.3 pKi = 7.3 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 557 9 1 7 4.1 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
11303253 198597 0 None -23 3 Rat 7.3 pKi = 7.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 371 5 0 4 3.0 COc1ccccc1N1CCN(CCN2CCC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
CHEMBL57859 198597 0 None -23 3 Rat 7.3 pKi = 7.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 371 5 0 4 3.0 COc1ccccc1N1CCN(CCN2CCC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
9909471 196906 0 None 1 3 Human 7.3 pKi = 7.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 409 4 0 4 3.4 O=C1CC2(CCCC2)C(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL56620 196906 0 None 1 3 Human 7.3 pKi = 7.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 409 4 0 4 3.4 O=C1CC2(CCCC2)C(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
9909471 196906 0 None 1 3 Human 7.3 pKi = 7.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 409 4 0 4 3.4 O=C1CC2(CCCC2)C(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL56620 196906 0 None 1 3 Human 7.3 pKi = 7.3 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 409 4 0 4 3.4 O=C1CC2(CCCC2)C(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1007/s00044-010-9379-1
14004035 119519 0 None 1 2 Bovine 6.3 pKi = 6.3 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 227 0 1 2 2.6 c1cnc2[nH]c3c(c2c1)CCN1CCCCC31 10.1021/jm00398a025
CHEMBL345621 119519 0 None 1 2 Bovine 6.3 pKi = 6.3 Binding
Affinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranesAffinity to alpha-1 adrenergic receptor by the displacement of [3H]-prazosin from calf cerebral cortex membranes
ChEMBL 227 0 1 2 2.6 c1cnc2[nH]c3c(c2c1)CCN1CCCCC31 10.1021/jm00398a025
1343 1889 62 None -87 9 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
3519 1889 62 None -87 9 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
522 1889 62 None -87 9 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
CHEMBL862 1889 62 None -87 9 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
DB01018 1889 62 None -87 9 Rat 6.3 pKi = 6.3 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 245 2 2 1 1.3 O=C(Cc1c(Cl)cccc1Cl)N=C(N)N nan
10411237 117482 0 None -3019 4 Rat 6.3 pKi = 6.3 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 444 7 2 3 4.8 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2ccccc2[nH]1 10.1021/jm0211220
CHEMBL339960 117482 0 None -3019 4 Rat 6.3 pKi = 6.3 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 444 7 2 3 4.8 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2ccccc2[nH]1 10.1021/jm0211220
CHEMBL4287055 117482 0 None -3019 4 Rat 6.3 pKi = 6.3 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 444 7 2 3 4.8 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2ccccc2[nH]1 10.1021/jm0211220
11090351 163391 0 None -2 4 Human 6.3 pKi = 6.3 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL419448 163391 0 None -2 4 Human 6.3 pKi = 6.3 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1c(F)cccc1NCC1=NCCN1 10.1021/jm000542r
76330200 85340 0 None 2 2 Rat 5.3 pKi = 5.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 323 3 2 5 1.2 CN(c1c(O)ccc2c1CCCC2C1=NCCN1)S(C)(=O)=O 10.1007/s00044-004-0020-z
CHEMBL2261354 85340 0 None 2 2 Rat 5.3 pKi = 5.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 323 3 2 5 1.2 CN(c1c(O)ccc2c1CCCC2C1=NCCN1)S(C)(=O)=O 10.1007/s00044-004-0020-z
135423051 77832 0 None 2 3 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(C[C@@H]2CN=C3c4ccccc4NC(=O)N32)CC1 10.1021/jm970159v
CHEMBL2092926 77832 0 None 2 3 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranesDisplacement of [3H]prazosin from Alpha-1A adrenergic receptor of rat submaxillary gland membranes
ChEMBL 391 4 1 5 2.5 COc1ccccc1N1CCN(C[C@@H]2CN=C3c4ccccc4NC(=O)N32)CC1 10.1021/jm970159v
456386 203003 6 None -3 2 Human 6.3 pKi = 6.3 Binding
Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 376 2 3 1 5.5 Brc1ccc2c(-c3c[nH]c(-c4c[nH]c5ccccc45)n3)c[nH]c2c1 10.1016/0960-894X(96)00376-9
CHEMBL63208 203003 6 None -3 2 Human 6.3 pKi = 6.3 Binding
Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 376 2 3 1 5.5 Brc1ccc2c(-c3c[nH]c(-c4c[nH]c5ccccc45)n3)c[nH]c2c1 10.1016/0960-894X(96)00376-9
44300018 198293 0 None -128 3 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 389 4 0 4 3.2 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2Cl)CC1 10.1021/jm030944+
CHEMBL57593 198293 0 None -128 3 Rat 6.3 pKi = 6.3 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 389 4 0 4 3.2 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2Cl)CC1 10.1021/jm030944+
44331198 4459 0 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 357 3 0 2 5.2 c1ccc2c(c1)CCC1(CCN(CCc3cccc4ccccc34)CC1)O2 10.1016/s0960-894x(98)00732-x
CHEMBL101739 4459 0 None -1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 357 3 0 2 5.2 c1ccc2c(c1)CCC1(CCN(CCc3cccc4ccccc34)CC1)O2 10.1016/s0960-894x(98)00732-x
9797995 13947 0 None -51 2 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 339 6 1 2 4.6 c1ccc2c(C3CCN(CCCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
CHEMBL1196601 13947 0 None -51 2 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 339 6 1 2 4.6 c1ccc2c(C3CCN(CCCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
CHEMBL557584 13947 0 None -51 2 Rat 7.3 pKi = 7.3 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 339 6 1 2 4.6 c1ccc2c(C3CCN(CCCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
10626982 111495 0 None 2 6 Human 7.3 pKi = 7.3 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 575 9 2 6 5.9 CC1=C(C#N)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL327775 111495 0 None 2 6 Human 7.3 pKi = 7.3 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 575 9 2 6 5.9 CC1=C(C#N)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
10626982 111495 0 None 2 6 Human 7.3 pKi = 7.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 575 9 2 6 5.9 CC1=C(C#N)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
CHEMBL327775 111495 0 None 2 6 Human 7.3 pKi = 7.3 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 575 9 2 6 5.9 CC1=C(C#N)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
52941981 17516 0 None 2 2 Rat 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 502 7 1 5 3.1 CN1C(=O)N(CC(O)CN2CCN(c3ccccc3F)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
CHEMBL1257883 17516 0 None 2 2 Rat 6.3 pKi = 6.3 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 502 7 1 5 3.1 CN1C(=O)N(CC(O)CN2CCN(c3ccccc3F)CC2)C(c2ccccc2)(c2ccccc2)C1=O 10.1016/j.bmcl.2010.07.101
44314198 104412 0 None -95 4 Human 6.3 pKi = 6.3 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCCC1NC1=NCCO1 10.1016/0960-894X(94)85032-1
CHEMBL310335 104412 0 None -95 4 Human 6.3 pKi = 6.3 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 210 3 1 3 2.3 CCC[C@H]1CCCCC1NC1=NCCO1 10.1016/0960-894X(94)85032-1
1201549 597 24 None -51 20 Rat 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
333 597 24 None -51 20 Rat 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
7601 597 24 None -51 20 Rat 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
CHEMBL1201203 597 24 None -51 20 Rat 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
CHEMBL438151 597 24 None -51 20 Rat 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
DB00245 597 24 None -51 20 Rat 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 307 4 0 2 4.4 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(c1ccccc1)c1ccccc1 nan
18001206 12786 0 None -4 2 Rat 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 327 5 0 4 3.9 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)noc2c1 10.1016/j.bmcl.2006.05.002
CHEMBL1188049 12786 0 None -4 2 Rat 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 327 5 0 4 3.9 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)noc2c1 10.1016/j.bmcl.2006.05.002
CHEMBL534943 12786 0 None -4 2 Rat 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 327 5 0 4 3.9 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)noc2c1 10.1016/j.bmcl.2006.05.002
9798656 12890 0 None -38 3 Rat 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 353 7 1 2 5.0 c1ccc2c(C3CCN(CCCCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
CHEMBL1188902 12890 0 None -38 3 Rat 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 353 7 1 2 5.0 c1ccc2c(C3CCN(CCCCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
CHEMBL537651 12890 0 None -38 3 Rat 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 353 7 1 2 5.0 c1ccc2c(C3CCN(CCCCCN4CCCCC4)CC3)c[nH]c2c1 10.1016/j.bmcl.2006.05.002
10859076 13682 0 None 1 6 Human 7.2 pKi = 7.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL1194763 13682 0 None 1 6 Human 7.2 pKi = 7.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL553276 13682 0 None 1 6 Human 7.2 pKi = 7.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 249 5 2 4 2.6 CC(C)Sc1ccccc1NCC1=NCCN1 10.1021/jm000542r
134137025 142738 0 None -11 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 362 4 0 5 3.6 COc1ccccc1N1CCN(CC2CSC3(CCCCC3)O2)CC1 10.1016/j.ejmech.2016.09.050
CHEMBL3892434 142738 0 None -11 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 362 4 0 5 3.6 COc1ccccc1N1CCN(CC2CSC3(CCCCC3)O2)CC1 10.1016/j.ejmech.2016.09.050
44288810 169462 0 None 1 3 Human 6.2 pKi = 6.2 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 483 9 2 3 4.5 Cc1ccc(C(C(=O)NCCCN2CCC(C(N)=O)(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL44288 169462 0 None 1 3 Human 6.2 pKi = 6.2 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 483 9 2 3 4.5 Cc1ccc(C(C(=O)NCCCN2CCC(C(N)=O)(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
12134994 163307 0 None -2 3 Human 6.2 pKi = 6.2 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 316 5 0 5 2.9 COc1ccccc1N1CCN(Cc2ccc(C=O)s2)CC1 10.1016/s0960-894x(02)00347-5
CHEMBL418882 163307 0 None -2 3 Human 6.2 pKi = 6.2 Binding
Displacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from COS cell membranes expressing human Alpha-1A adrenergic receptor
ChEMBL 316 5 0 5 2.9 COc1ccccc1N1CCN(Cc2ccc(C=O)s2)CC1 10.1016/s0960-894x(02)00347-5
6075 150108 42 None -11 16 Rat 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 nan
CHEMBL395110 150108 42 None -11 16 Rat 7.2 pKi = 7.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 310 2 0 3 4.6 CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 nan
11568725 16098 0 None -104 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 454 8 1 4 6.1 Clc1cccc(N2CCN(CCCCNc3cc(-c4ccccc4)ccn3)CC2)c1Cl 10.1016/j.bmcl.2010.07.096
CHEMBL1223856 16098 0 None -104 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 454 8 1 4 6.1 Clc1cccc(N2CCN(CCCCNc3cc(-c4ccccc4)ccn3)CC2)c1Cl 10.1016/j.bmcl.2010.07.096
44362633 121547 0 None 95 3 Human 7.2 pKi = 7.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 597 9 3 6 3.9 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCC(C)N2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL358590 121547 0 None 95 3 Human 7.2 pKi = 7.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 597 9 3 6 3.9 CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCC(C)N2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1 10.1021/jm990201h
10946567 16469 0 None -47 6 Human 7.2 pKi = 7.2 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 265 1 0 2 4.1 CCc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm00019a001
CHEMBL123448 16469 0 None -47 6 Human 7.2 pKi = 7.2 Binding
Inhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cellsInhibition of [3H]prazosin binding to human Alpha-1A adrenergic receptor expressed in CHO cells
ChEMBL 265 1 0 2 4.1 CCc1sc2ccc(Cl)c3c2c1CN(C)CC3 10.1021/jm00019a001
10508132 107017 0 None 13 6 Human 7.2 pKi = 7.2 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 621 10 2 6 5.5 CC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)N(C)C)=C(C)N1 10.1021/jm980077m
CHEMBL315392 107017 0 None 13 6 Human 7.2 pKi = 7.2 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 621 10 2 6 5.5 CC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)N(C)C)=C(C)N1 10.1021/jm980077m
10769499 44216 0 None 489 3 Human 7.2 pKi = 7.2 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 576 10 3 8 3.6 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
CHEMBL151668 44216 0 None 489 3 Human 7.2 pKi = 7.2 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 576 10 3 8 3.6 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
10508132 107017 0 None 13 6 Human 7.2 pKi = 7.2 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 621 10 2 6 5.5 CC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)N(C)C)=C(C)N1 10.1007/s00044-004-0120-9
CHEMBL315392 107017 0 None 13 6 Human 7.2 pKi = 7.2 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 621 10 2 6 5.5 CC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)N(C)C)=C(C)N1 10.1007/s00044-004-0120-9
155542075 176619 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 9 1 4 4.4 c1ccc(OCCNCCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4520390 176619 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 9 1 4 4.4 c1ccc(OCCNCCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4597826 176619 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 389 9 1 4 4.4 c1ccc(OCCNCCC2COC(c3ccccc3)(c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
9934955 72276 0 None -165 5 Rat 6.2 pKi = 6.2 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 482 5 2 9 2.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
CHEMBL19826 72276 0 None -165 5 Rat 6.2 pKi = 6.2 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 482 5 2 9 2.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
23290944 81826 0 None -389 7 Human 6.2 pKi = 6.2 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand binding assayBinding affinity to adrenergic alpha1A receptor by radioligand binding assay
ChEMBL 392 6 0 4 3.8 O=C(C1CCCCC1)N(CCN1CCN(c2ccccc2)CC1)c1ccccn1 10.1016/j.bmcl.2012.05.119
CHEMBL2164350 81826 0 None -389 7 Human 6.2 pKi = 6.2 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand binding assayBinding affinity to adrenergic alpha1A receptor by radioligand binding assay
ChEMBL 392 6 0 4 3.8 O=C(C1CCCCC1)N(CCN1CCN(c2ccccc2)CC1)c1ccccn1 10.1016/j.bmcl.2012.05.119
11474152 100621 0 None -23 3 Rat 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 369 4 0 4 2.8 Cc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
CHEMBL291908 100621 0 None -23 3 Rat 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 369 4 0 4 2.8 Cc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1 10.1021/jm030944+
9816461 10719 7 None 2 4 Human 6.2 pKi = 6.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL117094 10719 7 None 2 4 Human 6.2 pKi = 6.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL544290 10719 7 None 2 4 Human 6.2 pKi = 6.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 253 4 2 5 0.5 CS(=O)(=O)c1ccccc1NCC1=NCCN1 10.1021/jm000542r
11034737 204528 0 None -2 6 Human 6.2 pKi = 6.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 289 4 2 4 2.8 CSc1ccc(C(F)(F)F)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL72724 204528 0 None -2 6 Human 6.2 pKi = 6.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 289 4 2 4 2.8 CSc1ccc(C(F)(F)F)cc1NCC1=NCCN1 10.1021/jm000542r
10769499 44216 0 None 489 3 Human 7.2 pKi = 7.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 576 10 3 8 3.6 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
CHEMBL151668 44216 0 None 489 3 Human 7.2 pKi = 7.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 576 10 3 8 3.6 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)O)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
44390756 63857 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 445 10 0 7 2.1 CCOC(=O)C1CCC(=O)N1CC(=O)CCN1CCN(c2ccccc2OC(C)C)CC1 10.1016/j.bmcl.2004.11.032
CHEMBL180312 63857 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 445 10 0 7 2.1 CCOC(=O)C1CCC(=O)N1CC(=O)CCN1CCN(c2ccccc2OC(C)C)CC1 10.1016/j.bmcl.2004.11.032
9822942 197937 0 None -1 3 Rat 7.2 pKi = 7.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 411 5 0 4 3.7 CCC1(C)CC(=O)N(CCN2CCN(c3cc(Cl)ccc3Cl)CC2)C(=O)C1 10.1021/jm030944+
CHEMBL57317 197937 0 None -1 3 Rat 7.2 pKi = 7.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 411 5 0 4 3.7 CCC1(C)CC(=O)N(CCN2CCN(c3cc(Cl)ccc3Cl)CC2)C(=O)C1 10.1021/jm030944+
9845181 208161 3 None -4168 13 Bovine 5.2 pKi = 5.2 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 423 4 0 4 3.3 C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1021/jm020938y
CHEMBL98241 208161 3 None -4168 13 Bovine 5.2 pKi = 5.2 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 423 4 0 4 3.3 C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O 10.1021/jm020938y
49865601 16022 0 None -34 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 378 7 1 4 4.1 FC(F)(F)c1cccc(N2CCN(CCCCNc3ccccn3)CC2)c1 10.1016/j.bmcl.2010.07.096
CHEMBL1223617 16022 0 None -34 3 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 378 7 1 4 4.1 FC(F)(F)c1cccc(N2CCN(CCCCNc3ccccn3)CC2)c1 10.1016/j.bmcl.2010.07.096
2865 4143 73 None -14 53 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 nan
59 4143 73 None -14 53 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 nan
60854 4143 73 None -14 53 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 nan
CHEMBL708 4143 73 None -14 53 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 nan
DB00246 4143 73 None -14 53 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 nan
44431574 87802 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 505 8 1 6 4.0 COc1ccc(F)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL233814 87802 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 505 8 1 6 4.0 COc1ccc(F)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1 10.1016/j.bmcl.2007.04.008
49865668 16051 0 None -6 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 390 8 1 5 4.3 COc1ccccc1N1CCN(CCCCNc2nccc3ccccc23)CC1 10.1016/j.bmcl.2010.07.096
CHEMBL1223748 16051 0 None -6 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 390 8 1 5 4.3 COc1ccccc1N1CCN(CCCCNc2nccc3ccccc23)CC1 10.1016/j.bmcl.2010.07.096
24805674 97818 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 390 8 1 5 4.3 COc1ccccc1N1CCN(CCCCNc2ccc3ccccc3n2)CC1 10.1016/j.bmcl.2010.07.096
CHEMBL271989 97818 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 390 8 1 5 4.3 COc1ccccc1N1CCN(CCCCNc2ccc3ccccc3n2)CC1 10.1016/j.bmcl.2010.07.096
10698880 120868 0 None 630 3 Human 8.2 pKi = 8.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 603 11 3 8 3.7 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)NC)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
CHEMBL355910 120868 0 None 630 3 Human 8.2 pKi = 8.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 603 11 3 8 3.7 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)NC)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1021/jm980506g
10698880 120868 0 None 630 3 Human 8.2 pKi = 8.2 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 603 11 3 8 3.7 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)NC)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
CHEMBL355910 120868 0 None 630 3 Human 8.2 pKi = 8.2 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 603 11 3 8 3.7 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)NC)C2c2ccc([N+](=O)[O-])cc2)CC1 10.1007/s00044-004-0120-9
9893246 121492 0 None 34 3 Human 8.2 pKi = 8.2 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 531 9 3 6 4.0 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL358253 121492 0 None 34 3 Human 8.2 pKi = 8.2 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 531 9 3 6 4.0 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
9893246 121492 0 None 34 3 Human 8.2 pKi = 8.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 531 9 3 6 4.0 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
CHEMBL358253 121492 0 None 34 3 Human 8.2 pKi = 8.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 531 9 3 6 4.0 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
11857792 169369 0 None -3 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 560 8 1 5 5.8 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1 10.1016/j.bmcl.2007.04.098
CHEMBL442059 169369 0 None -3 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 560 8 1 5 5.8 COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1 10.1016/j.bmcl.2007.04.098
16041265 95337 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 504 6 2 4 6.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cccc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL256597 95337 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 504 6 2 4 6.0 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cccc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
44431548 87046 0 None -2 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 502 8 1 7 3.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3[N+](=O)[O-])CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL232592 87046 0 None -2 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 502 8 1 7 3.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3[N+](=O)[O-])CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL5272034 194611 0 None -10 3 Human 8.2 pKi = 8.2 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 496 11 1 6 3.6 COCCNC(=O)CCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5315277 194611 0 None -10 3 Human 8.2 pKi = 8.2 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 496 11 1 6 3.6 COCCNC(=O)CCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
136806218 112678 0 None 75 3 Human 8.2 pKi = 8.2 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 682 15 4 9 3.9 COc1ccc(C2(c3ccccc3)CCN(CCCNC(=O)C3=C(COCCN)NC(C)=C(C(N)=O)C3c3ccc([N+](=O)[O-])cc3)CC2)cc1 10.1016/s0960-894x(99)00484-9
44328754 112678 0 None 75 3 Human 8.2 pKi = 8.2 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 682 15 4 9 3.9 COc1ccc(C2(c3ccccc3)CCN(CCCNC(=O)C3=C(COCCN)NC(C)=C(C(N)=O)C3c3ccc([N+](=O)[O-])cc3)CC2)cc1 10.1016/s0960-894x(99)00484-9
CHEMBL330401 112678 0 None 75 3 Human 8.2 pKi = 8.2 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
ChEMBL 682 15 4 9 3.9 COc1ccc(C2(c3ccccc3)CCN(CCCNC(=O)C3=C(COCCN)NC(C)=C(C(N)=O)C3c3ccc([N+](=O)[O-])cc3)CC2)cc1 10.1016/s0960-894x(99)00484-9
52944615 17109 0 None 1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 431 11 1 4 5.6 Clc1cccc(Cl)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1255002 17109 0 None 1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 431 11 1 4 5.6 Clc1cccc(Cl)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
44298762 100629 0 None 15 3 Human 8.2 pKi = 8.2 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 473 8 1 7 1.9 CN(C)c1c[nH]c(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
CHEMBL291951 100629 0 None 15 3 Human 8.2 pKi = 8.2 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 473 8 1 7 1.9 CN(C)c1c[nH]c(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O 10.1016/s0960-894x(03)00305-6
10839389 100354 0 None 4 2 Rat 8.2 pKi = 8.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 472 4 1 7 3.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5c(C#N)cccc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL289627 100354 0 None 4 2 Rat 8.2 pKi = 8.2 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 472 4 1 7 3.4 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5c(C#N)cccc54)c3=O)C[C@@H]21 10.1021/jm990567u
487 3634 21 None -4 11 Rat 8.2 pKi = 8.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960069a
60602 3634 21 None -4 11 Rat 8.2 pKi = 8.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960069a
CHEMBL405355 3634 21 None -4 11 Rat 8.2 pKi = 8.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960069a
DB09239 3634 21 None -4 11 Rat 8.2 pKi = 8.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
ChEMBL 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10.1021/jm960069a
44288792 100316 0 None 134 3 Human 8.2 pKi = 8.2 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 451 8 1 3 5.5 Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(Cl)cc2)C(C)C)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL289339 100316 0 None 134 3 Human 8.2 pKi = 8.2 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 451 8 1 3 5.5 Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(Cl)cc2)C(C)C)CC1 10.1016/s0960-894x(00)00307-3
124 2981 47 None -13 33 Rat 8.2 pKi = 8.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
2032 2981 47 None -13 33 Rat 8.2 pKi = 8.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
4636 2981 47 None -13 33 Rat 8.2 pKi = 8.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
CHEMBL762 2981 47 None -13 33 Rat 8.2 pKi = 8.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
DB00935 2981 47 None -13 33 Rat 8.2 pKi = 8.2 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10.1021/jm960354u
118716704 114997 0 None 1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 423 5 0 6 3.2 COc1ccccc1N1CCN(CC2COC3(CCN(c4ccccc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342857 114997 0 None 1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 423 5 0 6 3.2 COc1ccccc1N1CCN(CC2COC3(CCN(c4ccccc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
118716715 115009 0 None 1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 521 6 0 7 3.1 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccc(Cl)cc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342868 115009 0 None 1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 521 6 0 7 3.1 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccc(Cl)cc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
44331169 167947 0 None 14 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 444 6 1 6 3.1 COc1ccccc1CCN1CCC2(CC1)CC(=O)c1ccc(NS(C)(=O)=O)cc1O2 10.1016/s0960-894x(98)00732-x
CHEMBL431631 167947 0 None 14 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 444 6 1 6 3.1 COc1ccccc1CCN1CCC2(CC1)CC(=O)c1ccc(NS(C)(=O)=O)cc1O2 10.1016/s0960-894x(98)00732-x
16041449 95220 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 538 6 2 4 6.7 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL256040 95220 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 538 6 2 4 6.7 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2007.11.068
57391896 69305 0 None 1 5 Pig 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1013 36 2 15 5.4 COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928129 69305 0 None 1 5 Pig 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1013 36 2 15 5.4 COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
2894 208071 6 None -12 5 Bovine 8.2 pKi = 8.2 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)C4CCCCC43)nc(N)c2cc1OC 10.1021/jm960510x
CHEMBL97698 208071 6 None -12 5 Bovine 8.2 pKi = 8.2 Binding
Compound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against cloned Alpha-1A adrenergic receptor from bovine brain using radioligand ([3H]prazosin) binding assay
ChEMBL 437 4 1 8 3.1 COc1cc2nc(N3CCN(C(=O)c4ccco4)C4CCCCC43)nc(N)c2cc1OC 10.1021/jm960510x
46934791 16690 0 None -2 4 Human 8.2 pKi = 8.2 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 479 7 0 7 2.6 COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3C(=O)CCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
CHEMBL1242818 16690 0 None -2 4 Human 8.2 pKi = 8.2 Binding
Displacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration techniqueDisplacement [3H]prazosin of human recombinant alpha1A adrenergic receptor expressed in CHO cells by rapid filtration technique
ChEMBL 479 7 0 7 2.6 COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3C(=O)CCCC3=O)(c3ccccc3)O2)CC1 10.1016/j.ejmech.2010.05.023
145960918 161528 0 None -8 3 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 427 3 1 7 3.2 COc1cc2nc(N3CCN(C(=O)C(C)(C)C)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4128460 161528 0 None -8 3 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 427 3 1 7 3.2 COc1cc2nc(N3CCN(C(=O)C(C)(C)C)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
46882085 5815 0 None -7 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 419 10 1 5 4.4 CCOc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
CHEMBL1078953 5815 0 None -7 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 419 10 1 5 4.4 CCOc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.bmcl.2010.01.030
21830793 91835 10 None -44 45 Human 8.2 pKi = 8.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 373 7 0 8 0.6 COc1ccccc1N1CCN(CCCCn2ncc(=O)n(C)c2=O)CC1 10.1016/j.bmc.2013.05.050
CHEMBL2413154 91835 10 None -44 45 Human 8.2 pKi = 8.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 373 7 0 8 0.6 COc1ccccc1N1CCN(CCCCn2ncc(=O)n(C)c2=O)CC1 10.1016/j.bmc.2013.05.050
11948707 166167 0 None -128 13 Human 8.2 pKi = 8.2 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 373 7 0 8 0.6 COc1cccc(N2CCN(CCCCn3ncc(=O)n(C)c3=O)CC2)c1 10.1021/acs.jmedchem.2c00633
CHEMBL426317 166167 0 None -128 13 Human 8.2 pKi = 8.2 Binding
Binding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constantBinding affinity to alpha 1A adrenergic receptor (unknown origin) assessed as inhibition constant
ChEMBL 373 7 0 8 0.6 COc1cccc(N2CCN(CCCCn3ncc(=O)n(C)c3=O)CC2)c1 10.1021/acs.jmedchem.2c00633
118716700 114993 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 437 6 0 6 3.2 COc1ccccc1N1CCN(CC2COC3(CCN(Cc4ccccc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342853 114993 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 437 6 0 6 3.2 COc1ccccc1N1CCN(CC2COC3(CCN(Cc4ccccc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
10841296 36456 0 None 46 3 Human 8.2 pKi = 8.2 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 601 8 0 7 6.1 COC(=O)C1=C(C)N=C(C)N(Cc2cccc(CN3CCC(C(=O)OC)(c4ccccc4)CC3)c2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
CHEMBL144731 36456 0 None 46 3 Human 8.2 pKi = 8.2 Binding
Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.Binding affinity against Alpha-1A adrenergic receptor (recombinant human receptor) using [3H]prazosin.
ChEMBL 601 8 0 7 6.1 COC(=O)C1=C(C)N=C(C)N(Cc2cccc(CN3CCC(C(=O)OC)(c4ccccc4)CC3)c2)C1c1ccc(F)c(F)c1 10.1021/jm9902032
10810527 100573 0 None 1 2 Rat 8.2 pKi = 8.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 392 4 1 6 1.8 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4ccncc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL291588 100573 0 None 1 2 Rat 8.2 pKi = 8.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 392 4 1 6 1.8 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4ccncc4c3=O)C[C@@H]21 10.1021/jm000541z
2142 3096 58 None -1 36 Bovine 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm020938y
4920903 3096 58 None -1 36 Bovine 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm020938y
502 3096 58 None -1 36 Bovine 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm020938y
5775 3096 58 None -1 36 Bovine 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm020938y
CHEMBL597 3096 58 None -1 36 Bovine 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm020938y
DB00692 3096 58 None -1 36 Bovine 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
ChEMBL 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 10.1021/jm020938y
3584 3777 64 None -2 13 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00010a001
5401 3777 64 None -2 13 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00010a001
7302 3777 64 None -2 13 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00010a001
CHEMBL611 3777 64 None -2 13 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00010a001
DB01162 3777 64 None -2 13 Human 8.2 pKi = 8.2 Binding
Ability to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptorAbility to displace [3H]prazosin from cloned human Alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00010a001
10507357 203936 0 None 58 2 Human 8.2 pKi = 8.2 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 574 10 1 7 4.0 COC(CNC(=O)c1ccc2c(c1)C(=O)N(c1cccc(F)c1)C2=O)CN1CCN(c2ccccc2OC(C)C)CC1 10.1021/jm9905918
CHEMBL69245 203936 0 None 58 2 Human 8.2 pKi = 8.2 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 574 10 1 7 4.0 COC(CNC(=O)c1ccc2c(c1)C(=O)N(c1cccc(F)c1)C2=O)CN1CCN(c2ccccc2OC(C)C)CC1 10.1021/jm9905918
3584 3777 64 None -2 13 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990200p
3584 3777 64 None -2 13 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990202+
5401 3777 64 None -2 13 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990200p
5401 3777 64 None -2 13 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990202+
7302 3777 64 None -2 13 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990200p
7302 3777 64 None -2 13 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990202+
CHEMBL611 3777 64 None -2 13 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990200p
CHEMBL611 3777 64 None -2 13 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990202+
DB01162 3777 64 None -2 13 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990200p
DB01162 3777 64 None -2 13 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990202+
3584 3777 64 None -2 13 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990201h
5401 3777 64 None -2 13 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990201h
7302 3777 64 None -2 13 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990201h
CHEMBL611 3777 64 None -2 13 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990201h
DB01162 3777 64 None -2 13 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm990201h
10747021 121020 0 None 12 3 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 670 8 2 5 7.0 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccc(Cl)cc3)(c3ccc(Cl)cc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL356571 121020 0 None 12 3 Human 8.2 pKi = 8.2 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 670 8 2 5 7.0 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccc(Cl)cc3)(c3ccc(Cl)cc3)CC2)C1c1ccc(F)c(F)c1 10.1021/jm990201h
3584 3777 64 None -2 13 Human 8.2 pKi = 8.2 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980077m
5401 3777 64 None -2 13 Human 8.2 pKi = 8.2 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980077m
7302 3777 64 None -2 13 Human 8.2 pKi = 8.2 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980077m
CHEMBL611 3777 64 None -2 13 Human 8.2 pKi = 8.2 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980077m
DB01162 3777 64 None -2 13 Human 8.2 pKi = 8.2 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm980077m
90645600 112433 0 None -1 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 640 12 2 9 4.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCN(C)Cc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298018 112433 0 None -1 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 640 12 2 9 4.6 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCN(C)Cc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
135398745 2914 112 None -39 65 Human 7.2 pKi = 7.2 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
47 2914 112 None -39 65 Human 7.2 pKi = 7.2 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
CHEMBL715 2914 112 None -39 65 Human 7.2 pKi = 7.2 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
DB00334 2914 112 None -39 65 Human 7.2 pKi = 7.2 Binding
Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C nan
3038495 708 37 None -40 19 Rat 7.2 pKi = 7.2 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 417 8 1 4 4.2 COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2 10.1021/jm0211220
7625 708 37 None -40 19 Rat 7.2 pKi = 7.2 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 417 8 1 4 4.2 COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2 10.1021/jm0211220
CHEMBL25236 708 37 None -40 19 Rat 7.2 pKi = 7.2 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 417 8 1 4 4.2 COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2 10.1021/jm0211220
44414264 12788 0 None -7 2 Rat 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 326 5 0 3 4.5 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)coc2c1 10.1016/j.bmcl.2006.05.002
CHEMBL1188050 12788 0 None -7 2 Rat 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 326 5 0 3 4.5 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)coc2c1 10.1016/j.bmcl.2006.05.002
CHEMBL534944 12788 0 None -7 2 Rat 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 326 5 0 3 4.5 c1ccc2c(C3CCN(CCCN4CCCCC4)CC3)coc2c1 10.1016/j.bmcl.2006.05.002
11705395 16052 0 None -19 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 428 7 1 4 5.6 Clc1cccc(N2CCN(CCCCNc3nccc4ccccc34)CC2)c1Cl 10.1016/j.bmcl.2010.07.096
CHEMBL1223749 16052 0 None -19 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 428 7 1 4 5.6 Clc1cccc(N2CCN(CCCCNc3nccc4ccccc34)CC2)c1Cl 10.1016/j.bmcl.2010.07.096
135398745 2914 112 None -39 65 Human 7.2 pKi = 7.2 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1021/jm401958n
47 2914 112 None -39 65 Human 7.2 pKi = 7.2 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1021/jm401958n
CHEMBL715 2914 112 None -39 65 Human 7.2 pKi = 7.2 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1021/jm401958n
DB00334 2914 112 None -39 65 Human 7.2 pKi = 7.2 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1021/jm401958n
197033 199152 64 None -7 8 Human 7.2 pKi = 7.2 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 319 3 0 3 3.9 Cc1ccc2c(c1)c1c(n2CCc2ccc(C)nc2)CCN(C)C1 10.1016/j.bmcl.2009.11.037
CHEMBL589390 199152 64 None -7 8 Human 7.2 pKi = 7.2 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 319 3 0 3 3.9 Cc1ccc2c(c1)c1c(n2CCc2ccc(C)nc2)CCN(C)C1 10.1016/j.bmcl.2009.11.037
76315668 85335 0 None 70 2 Rat 7.2 pKi = 7.2 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 323 4 3 5 1.6 CCS(=O)(=O)Nc1c(O)ccc2c1CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
CHEMBL2261347 85335 0 None 70 2 Rat 7.2 pKi = 7.2 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 323 4 3 5 1.6 CCS(=O)(=O)Nc1c(O)ccc2c1CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
155555859 176227 0 None -3 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 433 11 1 5 4.6 COc1ccccc1OCCNCC[C@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4551941 176227 0 None -3 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 433 11 1 5 4.6 COc1ccccc1OCCNCC[C@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4594653 176227 0 None -3 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 433 11 1 5 4.6 COc1ccccc1OCCNCC[C@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
118716711 115005 0 None 1 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 389 4 0 6 1.6 COc1ccccc1N1CCN(CC2COC3(CCN(C(C)=O)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342864 115005 0 None 1 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 389 4 0 6 1.6 COc1ccccc1N1CCN(CC2COC3(CCN(C(C)=O)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
68712 100338 60 None -8 5 Human 5.2 pKi = 5.2 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1016/0960-894X(94)85032-1
CHEMBL289480 100338 60 None -8 5 Human 5.2 pKi = 5.2 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1016/0960-894X(94)85032-1
10326069 39296 1 None 23 9 Human 6.2 pKi = 6.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 589 10 3 8 3.3 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
CHEMBL147077 39296 1 None 23 9 Human 6.2 pKi = 6.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 589 10 3 8 3.3 CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980506g
73346334 92541 0 None -6 7 Human 5.2 pKi = 5.2 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin) by PDSP assayInhibition of adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 265 4 1 1 3.0 c1ccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)cc1 10.1016/j.bmc.2013.07.045
CHEMBL2432048 92541 0 None -6 7 Human 5.2 pKi = 5.2 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin) by PDSP assayInhibition of adrenergic alpha1A receptor (unknown origin) by PDSP assay
ChEMBL 265 4 1 1 3.0 c1ccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)cc1 10.1016/j.bmc.2013.07.045
44431560 145578 0 None -2 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.008
CHEMBL391530 145578 0 None -2 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.008
44288816 155311 0 None 17 3 Human 7.2 pKi = 7.2 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 443 8 1 3 5.4 N#CC1(c2ccccc2)CCN(CCCNC(=O)C(c2ccccc2)C2CCCCC2)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL40303 155311 0 None 17 3 Human 7.2 pKi = 7.2 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 443 8 1 3 5.4 N#CC1(c2ccccc2)CCN(CCCNC(=O)C(c2ccccc2)C2CCCCC2)CC1 10.1016/s0960-894x(00)00307-3
3038603 101865 8 None -48 3 Human 7.2 pKi = 7.2 Binding
The compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligandThe compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligand
ChEMBL 335 1 0 1 5.4 CN(C)C1C=CC2(CC1)c1ccccc1C=Cc1ccc(Cl)cc12 10.1021/jm00109a026
CHEMBL300647 101865 8 None -48 3 Human 7.2 pKi = 7.2 Binding
The compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligandThe compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligand
ChEMBL 335 1 0 1 5.4 CN(C)C1C=CC2(CC1)c1ccccc1C=Cc1ccc(Cl)cc12 10.1021/jm00109a026
14378574 108587 0 None -24 5 Human 6.2 pKi = 6.2 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 327 2 2 5 2.8 COc1cc2c(cc1O)CCN1Cc3c(ccc(O)c3OC)C[C@@H]21 10.1021/jm0307741
CHEMBL320397 108587 0 None -24 5 Human 6.2 pKi = 6.2 Binding
In vitro binding affinity at human Alpha-1A adrenergic receptor.In vitro binding affinity at human Alpha-1A adrenergic receptor.
ChEMBL 327 2 2 5 2.8 COc1cc2c(cc1O)CCN1Cc3c(ccc(O)c3OC)C[C@@H]21 10.1021/jm0307741
10923927 204178 0 None 1 4 Human 6.2 pKi = 6.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 279 3 2 5 0.8 O=S1(=O)CCCc2cccc(NCC3=NCCN3)c21 10.1021/jm000542r
CHEMBL70740 204178 0 None 1 4 Human 6.2 pKi = 6.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 279 3 2 5 0.8 O=S1(=O)CCCc2cccc(NCC3=NCCN3)c21 10.1021/jm000542r
19968568 85339 0 None 5 2 Rat 6.2 pKi = 6.2 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 323 4 2 5 1.5 COc1ccc2c(c1NS(C)(=O)=O)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
CHEMBL2261353 85339 0 None 5 2 Rat 6.2 pKi = 6.2 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 323 4 2 5 1.5 COc1ccc2c(c1NS(C)(=O)=O)CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
118717458 115140 0 None -4 4 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 412 10 2 4 6.9 Cc1ccc2nccc(NCCCCCCCNc3ccnc4ccc(C)cc34)c2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343980 115140 0 None -4 4 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 412 10 2 4 6.9 Cc1ccc2nccc(NCCCCCCCNc3ccnc4ccc(C)cc34)c2c1 10.1016/j.bmc.2014.09.017
118717458 115140 0 None -4 4 Human 6.2 pKi = 6.2 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 412 10 2 4 6.9 Cc1ccc2nccc(NCCCCCCCNc3ccnc4ccc(C)cc34)c2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343980 115140 0 None -4 4 Human 6.2 pKi = 6.2 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 412 10 2 4 6.9 Cc1ccc2nccc(NCCCCCCCNc3ccnc4ccc(C)cc34)c2c1 10.1016/j.bmc.2014.09.017
44295170 101822 0 None 19 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 554 6 2 7 2.8 COC(=O)C1(c2ccccc2)CCN(CCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
CHEMBL300272 101822 0 None 19 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 554 6 2 7 2.8 COC(=O)C1(c2ccccc2)CCN(CCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1 10.1016/s0960-894x(99)00653-8
10622206 102092 0 None 1 2 Rat 7.2 pKi = 7.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 423 6 1 6 3.6 COc1cc2c(cc1OC)NCN(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)C2 10.1021/jm000541z
CHEMBL302192 102092 0 None 1 2 Rat 7.2 pKi = 7.2 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 423 6 1 6 3.6 COc1cc2c(cc1OC)NCN(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)C2 10.1021/jm000541z
11211017 198234 0 None -43 6 Human 6.2 pKi = 6.2 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 373 4 0 4 2.7 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccc(F)cc2)CC1 10.1021/jm0491391
CHEMBL57546 198234 0 None -43 6 Human 6.2 pKi = 6.2 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 373 4 0 4 2.7 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccc(F)cc2)CC1 10.1021/jm0491391
2419 695 28 None -288 12 Rat 6.2 pKi = 6.2 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm980053f
9 695 28 None -288 12 Rat 6.2 pKi = 6.2 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm980053f
CHEMBL13647 695 28 None -288 12 Rat 6.2 pKi = 6.2 Binding
Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptorCompound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1A adrenergic receptor
ChEMBL 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 10.1021/jm980053f
16785637 181577 80 None -11 2 Bovine 4.2 pKi = 4.2 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 206 2 2 4 -0.4 NC(=O)c1cccnc1N1CCNCC1 10.1021/jm00366a007
CHEMBL47688 181577 80 None -11 2 Bovine 4.2 pKi = 4.2 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 206 2 2 4 -0.4 NC(=O)c1cccnc1N1CCNCC1 10.1021/jm00366a007
5282322 78244 21 None - 1 Rat 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 785 11 4 15 2.4 CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O nan
CHEMBL2106399 78244 21 None - 1 Rat 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 785 11 4 15 2.4 CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O nan
11091738 118092 0 None -954 6 Rat 6.2 pKi = 6.2 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 456 7 1 4 4.9 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2ccccc2cn1 10.1021/jm0211220
CHEMBL340641 118092 0 None -954 6 Rat 6.2 pKi = 6.2 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 456 7 1 4 4.9 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2ccccc2cn1 10.1021/jm0211220
10792347 122006 0 None 8 3 Human 7.2 pKi = 7.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 531 9 3 6 3.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
CHEMBL359375 122006 0 None 8 3 Human 7.2 pKi = 7.2 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 531 9 3 6 3.9 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
52937630 61306 0 None -199 3 Human 7.2 pKi = 7.2 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 351 4 0 4 3.2 CN1CCC[C@@H]1Cn1nc(Cc2ccc(F)cc2)c2ccccc2c1=O 10.1021/jm1013874
CHEMBL1767140 61306 0 None -199 3 Human 7.2 pKi = 7.2 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 351 4 0 4 3.2 CN1CCC[C@@H]1Cn1nc(Cc2ccc(F)cc2)c2ccccc2c1=O 10.1021/jm1013874
24803638 61330 0 None -199 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 636 15 0 7 7.1 COc1ccc(Cc2nn(C[C@H]3CCCN3CCCCc3ccc(OCCCN4CCCCCC4)cc3)c(=O)c3ccccc23)cc1 10.1021/jm1013874
CHEMBL1767165 61330 0 None -199 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 636 15 0 7 7.1 COc1ccc(Cc2nn(C[C@H]3CCCN3CCCCc3ccc(OCCCN4CCCCCC4)cc3)c(=O)c3ccccc23)cc1 10.1021/jm1013874
53328873 63404 0 None 1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 447 6 0 5 3.2 COc1ccccc1N1CCN(CCCN2C(=O)CC3(CCc4ccccc43)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796049 63404 0 None 1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 447 6 0 5 3.2 COc1ccccc1N1CCN(CCCN2C(=O)CC3(CCc4ccccc43)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
9864325 101738 1 None -758 6 Human 6.2 pKi = 6.2 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 373 4 0 4 2.7 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2F)CC1 10.1021/jm0491391
CHEMBL299691 101738 1 None -758 6 Human 6.2 pKi = 6.2 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 373 4 0 4 2.7 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2F)CC1 10.1021/jm0491391
14378574 108587 0 None -24 5 Human 6.2 pKi = 6.2 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 327 2 2 5 2.8 COc1cc2c(cc1O)CCN1Cc3c(ccc(O)c3OC)C[C@@H]21 10.1016/j.bmcl.2004.11.032
CHEMBL320397 108587 0 None -24 5 Human 6.2 pKi = 6.2 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactiveBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +:inactive
ChEMBL 327 2 2 5 2.8 COc1cc2c(cc1O)CCN1Cc3c(ccc(O)c3OC)C[C@@H]21 10.1016/j.bmcl.2004.11.032
11440979 197660 0 None - 1 Rat 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 400 5 1 6 1.3 COc1ccccc1N1CCN(CCN2C(=O)CC3(CCNCC3)CC2=O)CC1 10.1021/jm030944+
CHEMBL57098 197660 0 None - 1 Rat 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 400 5 1 6 1.3 COc1ccccc1N1CCN(CCN2C(=O)CC3(CCNCC3)CC2=O)CC1 10.1021/jm030944+
127036953 137515 0 None -63 22 Human 6.2 pKi = 6.2 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 318 7 1 1 4.1 C=CCN(CC=C)CCc1c[nH]c2ccc(Br)cc12 10.1016/j.bmcl.2015.12.053
CHEMBL3754166 137515 0 None -63 22 Human 6.2 pKi = 6.2 Binding
Binding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assayBinding affinity to alpha-1A adrenergic receptor (unknown origin) by competition binding assay
ChEMBL 318 7 1 1 4.1 C=CCN(CC=C)CCc1c[nH]c2ccc(Br)cc12 10.1016/j.bmcl.2015.12.053
10571609 206697 0 None -2 2 Rat 7.2 pKi = 7.2 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 376 6 0 4 3.4 Clc1cccc(N2CCN(CCCCN3CC4CCCCN4C3)CC2)c1 10.1021/jm970216k
CHEMBL89677 206697 0 None -2 2 Rat 7.2 pKi = 7.2 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 376 6 0 4 3.4 Clc1cccc(N2CCN(CCCCN3CC4CCCCN4C3)CC2)c1 10.1021/jm970216k
10594858 165655 0 None -2 2 Rat 7.2 pKi = 7.2 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 362 6 0 4 3.0 Clc1cccc(N2CCN(CCCCN3CC4CCCN4C3)CC2)c1 10.1021/jm970216k
CHEMBL424432 165655 0 None -2 2 Rat 7.2 pKi = 7.2 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 362 6 0 4 3.0 Clc1cccc(N2CCN(CCCCN3CC4CCCN4C3)CC2)c1 10.1021/jm970216k
3565378 178817 8 None -26 2 Rat 7.2 pKi = 7.2 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 424 6 0 4 3.0 O=C1C2CCCN2C(=O)N1CCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1021/jm970216k
CHEMBL46918 178817 8 None -26 2 Rat 7.2 pKi = 7.2 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 424 6 0 4 3.0 O=C1C2CCCN2C(=O)N1CCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1021/jm970216k
44361064 31615 0 None -23 5 Rat 6.2 pKi = 6.2 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 338 7 2 4 4.5 N=CCC(O)CC1CCN(c2ccccc2Oc2ccccc2)CC1 10.1021/jm960510x
CHEMBL140450 31615 0 None -23 5 Rat 6.2 pKi = 6.2 Binding
Binding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assayBinding affinity against native Alpha-1A adrenergic receptor from rat hippocampus pretreated with chloroethylclonidine using radioligand ([3H]prazosin) binding assay
ChEMBL 338 7 2 4 4.5 N=CCC(O)CC1CCN(c2ccccc2Oc2ccccc2)CC1 10.1021/jm960510x
127025278 137714 0 None -33 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 387 9 1 4 3.7 COc1ccccc1N1CCN(CCCCNC(=O)CC2CCCCC2)CC1 10.1016/j.bmcl.2015.12.068
CHEMBL3758913 137714 0 None -33 3 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 387 9 1 4 3.7 COc1ccccc1N1CCN(CCCCNC(=O)CC2CCCCC2)CC1 10.1016/j.bmcl.2015.12.068
11994673 12316 0 None -3 5 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL1185036 12316 0 None -3 5 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
CHEMBL385371 12316 0 None -3 5 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 419 7 1 5 4.5 COc1ccc2ccccc2c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3 10.1021/jm060358r
71449516 84604 0 None -3 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153552 84604 0 None -3 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2221146 84604 0 None -3 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 361 8 2 7 2.2 COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(O)c2O1 10.1016/j.ejmech.2012.09.049
11079593 204115 0 None -1 4 Human 6.2 pKi = 6.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL70326 204115 0 None -1 4 Human 6.2 pKi = 6.2 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1cc(F)ccc1NCC1=NCCN1 10.1021/jm000542r
10454026 17907 0 None -2041 9 Rat 6.2 pKi = 6.2 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 406 8 2 4 3.5 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3[nH]2)CC1 10.1021/jm0211220
CHEMBL125916 17907 0 None -2041 9 Rat 6.2 pKi = 6.2 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 406 8 2 4 3.5 COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3[nH]2)CC1 10.1021/jm0211220
49800167 17681 0 None -1 2 Rat 7.2 pKi = 7.2 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 514 9 2 6 3.1 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)NC(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL1258457 17681 0 None -1 2 Rat 7.2 pKi = 7.2 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 514 9 2 6 3.1 CCOc1ccccc1N1CCN(CC(O)CN2C(=O)NC(=O)C2(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
53328507 63396 0 None 1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 469 8 0 5 4.2 COc1ccccc1N1CCN(CCCCN2C(=O)CC(c3ccc(Cl)cc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796041 63396 0 None 1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 469 8 0 5 4.2 COc1ccccc1N1CCN(CCCCN2C(=O)CC(c3ccc(Cl)cc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
11554490 16053 0 None -67 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 428 7 1 4 5.3 FC(F)(F)c1cccc(N2CCN(CCCCNc3nccc4ccccc34)CC2)c1 10.1016/j.bmcl.2010.07.096
CHEMBL1223750 16053 0 None -67 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 428 7 1 4 5.3 FC(F)(F)c1cccc(N2CCN(CCCCNc3nccc4ccccc34)CC2)c1 10.1016/j.bmcl.2010.07.096
9909471 196906 0 None -1 3 Rat 7.2 pKi = 7.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 409 4 0 4 3.4 O=C1CC2(CCCC2)C(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL56620 196906 0 None -1 3 Rat 7.2 pKi = 7.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 409 4 0 4 3.4 O=C1CC2(CCCC2)C(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
3039881 174257 10 None -19 3 Human 6.2 pKi = 6.2 Binding
The compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligandThe compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligand
ChEMBL 337 1 0 1 5.0 CN(C)C1C=CC2(CC1)c1ccccc1CCc1ccc(Cl)cc12 10.1021/jm00109a026
CHEMBL45491 174257 10 None -19 3 Human 6.2 pKi = 6.2 Binding
The compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligandThe compound was tested for binding affinity against Alpha-1 adrenergic receptor using WB-4101 as radioligand
ChEMBL 337 1 0 1 5.0 CN(C)C1C=CC2(CC1)c1ccccc1CCc1ccc(Cl)cc12 10.1021/jm00109a026
11651319 181628 27 None -17 2 Bovine 5.2 pKi = 5.2 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1cnccc1N1CCNCC1 10.1021/jm00366a007
CHEMBL47740 181628 27 None -17 2 Bovine 5.2 pKi = 5.2 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1cnccc1N1CCNCC1 10.1021/jm00366a007
118717457 115137 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 374 7 2 6 4.3 COc1ccc2c(NCCNc3ccnc4cc(OC)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343978 115137 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 374 7 2 6 4.3 COc1ccc2c(NCCNc3ccnc4cc(OC)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
11857861 85676 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 520 10 1 6 4.5 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
CHEMBL228606 85676 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to human cloned adrenergic Alpha-1A receptorBinding affinity to human cloned adrenergic Alpha-1A receptor
ChEMBL 520 10 1 6 4.5 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.09.051
11857861 85676 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 520 10 1 6 4.5 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL228606 85676 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 520 10 1 6 4.5 COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
44275526 98866 0 None 2 3 Human 7.2 pKi = 7.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 621 11 2 6 7.3 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(OC(C)C)cc1 10.1021/jm960697s
CHEMBL27899 98866 0 None 2 3 Human 7.2 pKi = 7.2 Binding
Binding affinity was tested on human Alpha-1A adrenergic receptorBinding affinity was tested on human Alpha-1A adrenergic receptor
ChEMBL 621 11 2 6 7.3 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(OC(C)C)cc1 10.1021/jm960697s
118717457 115137 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 374 7 2 6 4.3 COc1ccc2c(NCCNc3ccnc4cc(OC)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
CHEMBL3343978 115137 0 None -1 4 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 374 7 2 6 4.3 COc1ccc2c(NCCNc3ccnc4cc(OC)ccc34)ccnc2c1 10.1016/j.bmc.2014.09.017
9884513 13027 0 None -43 2 Rat 6.2 pKi = 6.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 343 5 1 2 4.4 Fc1ccc2[nH]cc(C3CCN(CCCN4CCCCC4)CC3)c2c1 10.1016/j.bmcl.2006.05.002
CHEMBL1189871 13027 0 None -43 2 Rat 6.2 pKi = 6.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 343 5 1 2 4.4 Fc1ccc2[nH]cc(C3CCN(CCCN4CCCCC4)CC3)c2c1 10.1016/j.bmcl.2006.05.002
CHEMBL539601 13027 0 None -43 2 Rat 6.2 pKi = 6.2 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 343 5 1 2 4.4 Fc1ccc2[nH]cc(C3CCN(CCCN4CCCCC4)CC3)c2c1 10.1016/j.bmcl.2006.05.002
11338630 9657 0 None -3 2 Bovine 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 403 4 2 3 4.8 O=S(=O)(Nc1cccc2c1CCCC2c1c[nH]cn1)c1ccc2ccccc2c1 10.1021/jm030551a
CHEMBL112814 9657 0 None -3 2 Bovine 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 403 4 2 3 4.8 O=S(=O)(Nc1cccc2c1CCCC2c1c[nH]cn1)c1ccc2ccccc2c1 10.1021/jm030551a
53328504 63393 0 None -4 3 Human 5.2 pKi = 5.2 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 445 5 0 4 4.0 O=C1CC(c2ccc(Cl)cc2)CC(=O)N1CCN1CCN(c2ccccc2Cl)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796038 63393 0 None -4 3 Human 5.2 pKi = 5.2 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 445 5 0 4 4.0 O=C1CC(c2ccc(Cl)cc2)CC(=O)N1CCN1CCN(c2ccccc2Cl)CC1 10.1016/j.ejmech.2011.03.054
101876962 115138 0 None 5 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 342 5 2 4 4.9 Cc1cccc2c(NCCNc3ccnc4c(C)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
CHEMBL3343979 115138 0 None 5 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 342 5 2 4 4.9 Cc1cccc2c(NCCNc3ccnc4c(C)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
11857794 85659 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 562 9 1 5 5.7 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cccc(OC(F)F)c1 10.1016/j.bmcl.2007.04.098
CHEMBL228496 85659 0 None -1 4 Human 8.2 pKi = 8.2 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 562 9 1 5 5.7 O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cccc(OC(F)F)c1 10.1016/j.bmcl.2007.04.098
57390115 69296 0 None -1 5 Pig 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 455 13 1 6 3.4 CCOCCOc1cccc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)c1 10.1016/j.bmc.2011.10.063
CHEMBL1928120 69296 0 None -1 5 Pig 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 455 13 1 6 3.4 CCOCCOc1cccc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)c1 10.1016/j.bmc.2011.10.063
10841190 107042 0 None 28 6 Human 8.2 pKi = 8.2 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 593 10 2 6 6.5 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(OC)cc1 10.1021/jm980077m
CHEMBL315538 107042 0 None 28 6 Human 8.2 pKi = 8.2 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 593 10 2 6 6.5 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(OC)cc1 10.1021/jm980077m
10841190 85273 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 593 10 2 6 5.7 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(OC)cc1 10.1007/s00044-004-0120-9
CHEMBL2260150 85273 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 593 10 2 6 5.7 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(OC)cc1 10.1007/s00044-004-0120-9
44126269 201484 5 None -18 6 Human 8.2 pKi = 8.2 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 318 3 0 2 4.5 Cc1ccc(CCn2c3c(c4cc(C)ccc42)CN(C)CC3)cc1 10.1016/j.bmcl.2009.11.037
CHEMBL605081 201484 5 None -18 6 Human 8.2 pKi = 8.2 Binding
Binding affinity to adrenergic alpha1A receptor by radioligand displacement assayBinding affinity to adrenergic alpha1A receptor by radioligand displacement assay
ChEMBL 318 3 0 2 4.5 Cc1ccc(CCn2c3c(c4cc(C)ccc42)CN(C)CC3)cc1 10.1016/j.bmcl.2009.11.037
90645594 112486 0 None -2 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 597 10 2 8 4.7 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
CHEMBL3298747 112486 0 None -2 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human alpha1a receptor expressed in HEK293 cells
ChEMBL 597 10 2 8 4.7 COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCc5ccccc5)cc43)c2=O)CC1 10.1016/j.ejmech.2014.06.057
145962478 162249 0 None -13 3 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 459 5 2 9 2.8 COc1cc2nc(N3CCC[C@H](NC4=CC(=O)c5ccccc5C4=O)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
CHEMBL4163587 162249 0 None -13 3 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 minsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins
ChEMBL 459 5 2 9 2.8 COc1cc2nc(N3CCC[C@H](NC4=CC(=O)c5ccccc5C4=O)C3)nc(N)c2cc1OC 10.1016/j.ejmech.2017.05.003
2470 3653 50 None -398 59 Rat 8.1 pKi = 8.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm00018a001
3300 3653 50 None -398 59 Rat 8.1 pKi = 8.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm00018a001
5265 3653 50 None -398 59 Rat 8.1 pKi = 8.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm00018a001
99 3653 50 None -398 59 Rat 8.1 pKi = 8.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm00018a001
CHEMBL267930 3653 50 None -398 59 Rat 8.1 pKi = 8.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1021/jm00018a001
155526629 176398 0 None -14 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 10 1 5 4.4 COc1ccccc1OCCNCCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4458714 176398 0 None -14 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 10 1 5 4.4 COc1ccccc1OCCNCCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4595984 176398 0 None -14 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 10 1 5 4.4 COc1ccccc1OCCNCCC1COC(c2ccccc2)(c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
3584 3777 64 None -2 13 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
5401 3777 64 None -2 13 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
7302 3777 64 None -2 13 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
CHEMBL611 3777 64 None -2 13 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
DB01162 3777 64 None -2 13 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 10.1021/jm00018a001
21712258 169263 0 None 194 2 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 465 8 1 3 5.5 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(01)00320-1
CHEMBL44124 169263 0 None 194 2 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 465 8 1 3 5.5 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(01)00320-1
21712258 169263 0 None 194 2 Human 8.1 pKi = 8.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 465 8 1 3 5.5 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL44124 169263 0 None 194 2 Human 8.1 pKi = 8.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 465 8 1 3 5.5 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
44288815 101454 0 None 87 3 Human 8.1 pKi = 8.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 431 8 1 3 5.1 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C)CC2)C(C)C)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL297667 101454 0 None 87 3 Human 8.1 pKi = 8.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 431 8 1 3 5.1 Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C)CC2)C(C)C)cc1 10.1016/s0960-894x(00)00307-3
101876962 115138 0 None 5 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 342 5 2 4 4.9 Cc1cccc2c(NCCNc3ccnc4c(C)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
CHEMBL3343979 115138 0 None 5 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 342 5 2 4 4.9 Cc1cccc2c(NCCNc3ccnc4c(C)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
44288392 100369 0 None 1 2 Rat 8.1 pKi = 8.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 475 6 1 6 4.4 COc1cccc2c1CCC1CN(CCCCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC21 10.1021/jm990567u
CHEMBL289758 100369 0 None 1 2 Rat 8.1 pKi = 8.1 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 475 6 1 6 4.4 COc1cccc2c1CCC1CN(CCCCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC21 10.1021/jm990567u
44431555 89163 0 None 1 4 Human 8.1 pKi = 8.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 535 8 1 7 3.3 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(S(C)(=O)=O)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL236618 89163 0 None 1 4 Human 8.1 pKi = 8.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 535 8 1 7 3.3 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(S(C)(=O)=O)cc3)CC2)CC1 10.1016/j.bmcl.2007.04.008
10841819 118754 0 None 346 3 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 640 7 1 8 3.9 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)N2CCC(N3CCC(C(=O)OC)(c4ccccc4)CC3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL341838 118754 0 None 346 3 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 640 7 1 8 3.9 COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)N2CCC(N3CCC(C(=O)OC)(c4ccccc4)CC3)CC2)C(=O)N1 10.1021/jm990201h
44289112 164897 0 None 75 3 Human 8.1 pKi = 8.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 495 9 1 4 5.5 COc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(C)cc2)c2ccc(C)cc2)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL42220 164897 0 None 75 3 Human 8.1 pKi = 8.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 495 9 1 4 5.5 COc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(C)cc2)c2ccc(C)cc2)CC1 10.1016/s0960-894x(00)00307-3
8459 3298 4 None -7 3 Rat 8.1 pKi = 8.1 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 495 8 1 9 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)COc1c(OC)cccc1C(C)C 10.1021/jm9805337
9891980 3298 4 None -7 3 Rat 8.1 pKi = 8.1 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 495 8 1 9 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)COc1c(OC)cccc1C(C)C 10.1021/jm9805337
CHEMBL430717 3298 4 None -7 3 Rat 8.1 pKi = 8.1 Binding
The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1A adrenergic receptor in the COS cell line.
ChEMBL 495 8 1 9 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)COc1c(OC)cccc1C(C)C 10.1021/jm9805337
10793504 41740 0 None 436 3 Human 8.1 pKi = 8.1 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 588 10 3 8 3.2 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc3c(c2)OCO3)CC1 10.1021/jm980506g
CHEMBL149263 41740 0 None 436 3 Human 8.1 pKi = 8.1 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 588 10 3 8 3.2 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc3c(c2)OCO3)CC1 10.1021/jm980506g
10721049 43722 0 None 245 3 Human 8.1 pKi = 8.1 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 533 9 4 7 2.8 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(O)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
CHEMBL151045 43722 0 None 245 3 Human 8.1 pKi = 8.1 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 533 9 4 7 2.8 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(O)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
10743111 198695 0 None 1 2 Rat 8.1 pKi = 8.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 473 5 1 6 4.1 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(-c5ccccc5)sc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL58105 198695 0 None 1 2 Rat 8.1 pKi = 8.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 473 5 1 6 4.1 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(-c5ccccc5)sc4c3=O)C[C@@H]21 10.1021/jm000541z
10793504 41740 0 None 436 3 Human 8.1 pKi = 8.1 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 588 10 3 8 3.2 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc3c(c2)OCO3)CC1 10.1007/s00044-004-0120-9
CHEMBL149263 41740 0 None 436 3 Human 8.1 pKi = 8.1 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 588 10 3 8 3.2 CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc3c(c2)OCO3)CC1 10.1007/s00044-004-0120-9
10606659 100534 0 None 7 2 Rat 8.1 pKi = 8.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 436 6 0 5 3.4 COc1cc2c(cc1OC)C(=O)N(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)CC2 10.1021/jm000541z
CHEMBL291305 100534 0 None 7 2 Rat 8.1 pKi = 8.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 436 6 0 5 3.4 COc1cc2c(cc1OC)C(=O)N(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)CC2 10.1021/jm000541z
2470 3653 50 None -208 59 Human 8.1 pKi = 8.1 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1016/j.bmcl.2004.11.032
3300 3653 50 None -208 59 Human 8.1 pKi = 8.1 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1016/j.bmcl.2004.11.032
5265 3653 50 None -208 59 Human 8.1 pKi = 8.1 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1016/j.bmcl.2004.11.032
99 3653 50 None -208 59 Human 8.1 pKi = 8.1 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1016/j.bmcl.2004.11.032
CHEMBL267930 3653 50 None -208 59 Human 8.1 pKi = 8.1 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1016/j.bmcl.2004.11.032
10721730 37493 0 None 245 3 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 568 6 2 7 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)OC(=O)c2ccccc23)C1c1ccc(F)c(F)c1 10.1021/jm990201h
CHEMBL145571 37493 0 None 245 3 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 568 6 2 7 3.7 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)OC(=O)c2ccccc23)C1c1ccc(F)c(F)c1 10.1021/jm990201h
76326030 84821 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 5 0 5 4.1 COc1ccccc1N1CCN(CC2CO[C@H](c3cccc4ccccc34)O2)CC1 10.1007/s00044-010-9379-1
CHEMBL2234446 84821 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 5 0 5 4.1 COc1ccccc1N1CCN(CC2CO[C@H](c3cccc4ccccc34)O2)CC1 10.1007/s00044-010-9379-1
CHEMBL5286701 194629 0 None -12 3 Human 8.1 pKi = 8.1 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 482 10 1 6 3.3 COCCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
CHEMBL5315483 194629 0 None -12 3 Human 8.1 pKi = 8.1 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 482 10 1 6 3.3 COCCC(=O)NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O 10.1021/acsmedchemlett.7b00112
76326030 84821 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 5 0 5 4.1 COc1ccccc1N1CCN(CC2CO[C@H](c3cccc4ccccc34)O2)CC1 10.1007/s00044-010-9379-1
CHEMBL2234446 84821 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 404 5 0 5 4.1 COc1ccccc1N1CCN(CC2CO[C@H](c3cccc4ccccc34)O2)CC1 10.1007/s00044-010-9379-1
11619713 72817 0 None -8 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 468 14 1 8 4.2 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1[N+](=O)[O-] 10.1021/jm0580398
CHEMBL200136 72817 0 None -8 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cellsDisplacement of [3H]prazosin from cloned human ADRA1A expressed in CHO cells
ChEMBL 468 14 1 8 4.2 COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1[N+](=O)[O-] 10.1021/jm0580398
52947088 17110 0 None 1 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 391 11 1 4 4.9 Cc1cccc(C)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1255003 17110 0 None 1 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 391 11 1 4 4.9 Cc1cccc(C)c1OCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
118716713 115007 0 None 1 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 487 6 0 7 2.4 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccccc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342866 115007 0 None 1 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 487 6 0 7 2.4 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccccc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
118716719 115013 0 None 1 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 493 6 0 8 2.5 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4cccs4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342872 115013 0 None 1 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 493 6 0 8 2.5 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4cccs4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
10572794 207114 0 None - 1 Bovine 8.1 pKi = 8.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 395 7 1 5 3.0 Cc1cccc(C)c1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
CHEMBL92109 207114 0 None - 1 Bovine 8.1 pKi = 8.1 Binding
In vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptorIn vitro for the displacement of [3H]prazosin binding to bovine Alpha-1A adrenergic receptor
ChEMBL 395 7 1 5 3.0 Cc1cccc(C)c1N1CCN(CCCNc2ncccc2C(=O)N(C)C)CC1 10.1021/jm970166j
44213730 195656 0 None 7 3 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 460 8 2 7 1.3 O=c1[nH]cc(CO)c(=O)n1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
CHEMBL55645 195656 0 None 7 3 Human 8.1 pKi = 8.1 Binding
Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptorInhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1A adrenergic receptor
ChEMBL 460 8 2 7 1.3 O=c1[nH]cc(CO)c(=O)n1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1 10.1016/s0960-894x(03)00305-6
11234230 101701 0 None -64 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 375 4 0 3 3.6 O=C1CC2(CCCC2)CCN1CCN1CCN(c2ccccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL299454 101701 0 None -64 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 375 4 0 3 3.6 O=C1CC2(CCCC2)CCN1CCN1CCN(c2ccccc2Cl)CC1 10.1007/s00044-010-9379-1
11234230 101701 0 None -64 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 375 4 0 3 3.6 O=C1CC2(CCCC2)CCN1CCN1CCN(c2ccccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL299454 101701 0 None -64 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 375 4 0 3 3.6 O=C1CC2(CCCC2)CCN1CCN1CCN(c2ccccc2Cl)CC1 10.1007/s00044-010-9379-1
44292196 180006 2 None -5 2 Bovine 6.2 pKi = 6.2 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 287 3 0 3 3.1 Clc1cccnc1N1CCN(Cc2ccccc2)CC1 10.1021/jm00366a007
CHEMBL47471 180006 2 None -5 2 Bovine 6.2 pKi = 6.2 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 287 3 0 3 3.1 Clc1cccnc1N1CCN(Cc2ccccc2)CC1 10.1021/jm00366a007
541604 165339 10 None 72 4 Human 6.2 pKi = 6.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 201 3 4 4 0.5 CNCC(O)c1cc(O)c(O)cc1F 10.1021/jm00118a019
CHEMBL42359 165339 10 None 72 4 Human 6.2 pKi = 6.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
ChEMBL 201 3 4 4 0.5 CNCC(O)c1cc(O)c(O)cc1F 10.1021/jm00118a019
130442572 171908 0 None -147 24 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting method
ChEMBL 395 3 0 5 6.0 FC(F)(F)c1cc(Oc2nccc3occc23)ccc1-c1cccc2nccn12 10.1021/acs.jmedchem.9b00351
CHEMBL4469848 171908 0 None -147 24 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting method
ChEMBL 395 3 0 5 6.0 FC(F)(F)c1cc(Oc2nccc3occc23)ccc1-c1cccc2nccn12 10.1021/acs.jmedchem.9b00351
9796594 9373 0 None - 1 Rat 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 307 3 3 4 2.0 CS(=O)(=O)Nc1ccc(O)c2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL111372 9373 0 None - 1 Rat 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 307 3 3 4 2.0 CS(=O)(=O)Nc1ccc(O)c2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
11196451 168065 0 None - 1 Rat 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 268 5 2 3 1.7 CCS(=O)(=O)Nc1cccc(CC2CCCN2)c1 10.1021/jm030551a
CHEMBL432451 168065 0 None - 1 Rat 6.2 pKi = 6.2 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 268 5 2 3 1.7 CCS(=O)(=O)Nc1cccc(CC2CCCN2)c1 10.1021/jm030551a
76326540 85338 0 None 1 2 Rat 5.2 pKi = 5.2 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 274 2 4 4 1.3 NC(=O)Nc1c(O)ccc2c1CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
CHEMBL2261352 85338 0 None 1 2 Rat 5.2 pKi = 5.2 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 274 2 4 4 1.3 NC(=O)Nc1c(O)ccc2c1CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
44331079 4318 0 None -1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 355 3 0 2 5.3 C1=CC2(CCN(CCc3cccc4ccccc34)CC2)Oc2ccccc21 10.1016/s0960-894x(98)00732-x
CHEMBL100878 4318 0 None -1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 355 3 0 2 5.3 C1=CC2(CCN(CCc3cccc4ccccc34)CC2)Oc2ccccc21 10.1016/s0960-894x(98)00732-x
24829343 159021 0 None -89 9 Human 7.2 pKi = 7.2 Binding
Inhibition of adrenergic alpha-1 receptorInhibition of adrenergic alpha-1 receptor
ChEMBL 429 7 1 3 5.1 CCC1(CCCCN2CCN(c3ccc(Cl)cc3)CC2)C(=O)Nc2cc(F)ccc21 10.1021/jm070279v
CHEMBL409662 159021 0 None -89 9 Human 7.2 pKi = 7.2 Binding
Inhibition of adrenergic alpha-1 receptorInhibition of adrenergic alpha-1 receptor
ChEMBL 429 7 1 3 5.1 CCC1(CCCCN2CCN(c3ccc(Cl)cc3)CC2)C(=O)Nc2cc(F)ccc21 10.1021/jm070279v
415628 208192 95 None -60 5 Rat 6.2 pKi = 6.2 Binding
Binding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranesBinding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranes
ChEMBL 196 1 1 2 1.8 Clc1ccccc1N1CCNCC1 10.1021/jm00110a014
CHEMBL9841 208192 95 None -60 5 Rat 6.2 pKi = 6.2 Binding
Binding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranesBinding affinity measured for alpha-1 adrenergic receptor by displacement of [3H]prazosin from rat cortical membranes
ChEMBL 196 1 1 2 1.8 Clc1ccccc1N1CCNCC1 10.1021/jm00110a014
2771 195017 74 None -8 27 Rat 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 nan
CHEMBL1200781 195017 74 None -8 27 Rat 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 nan
CHEMBL549 195017 74 None -8 27 Rat 6.2 pKi = 6.2 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 324 5 0 3 3.8 CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 nan
11633992 16101 0 None -5 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 460 8 1 5 5.8 FC(F)(F)c1cccc(N2CCN(CCCCNc3nc(-c4ccccc4)cs3)CC2)c1 10.1016/j.bmcl.2010.07.096
CHEMBL1223859 16101 0 None -5 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 460 8 1 5 5.8 FC(F)(F)c1cccc(N2CCN(CCCCNc3nc(-c4ccccc4)cs3)CC2)c1 10.1016/j.bmcl.2010.07.096
44289058 165345 0 None 16 3 Human 7.1 pKi = 7.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 403 8 1 3 4.5 CC(C)C(C(=O)NCCCN1CCC(C#N)(c2ccccc2)CC1)c1ccccc1 10.1016/s0960-894x(00)00307-3
CHEMBL42361 165345 0 None 16 3 Human 7.1 pKi = 7.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 403 8 1 3 4.5 CC(C)C(C(=O)NCCCN1CCC(C#N)(c2ccccc2)CC1)c1ccccc1 10.1016/s0960-894x(00)00307-3
4384568 163103 8 None -7 3 Rat 7.1 pKi = 7.1 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 438 6 0 4 3.4 O=C1C2CCCCN2C(=O)N1CCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1021/jm970216k
CHEMBL417709 163103 8 None -7 3 Rat 7.1 pKi = 7.1 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 438 6 0 4 3.4 O=C1C2CCCCN2C(=O)N1CCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1021/jm970216k
10713438 107031 0 None -4 2 Rat 7.1 pKi = 7.1 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 358 7 0 5 2.3 COc1ccccc1N1CCN(CCCCN2CC3CCCN3C2)CC1 10.1021/jm970216k
CHEMBL315472 107031 0 None -4 2 Rat 7.1 pKi = 7.1 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 358 7 0 5 2.3 COc1ccccc1N1CCN(CCCCN2CC3CCCN3C2)CC1 10.1021/jm970216k
21302490 112805 32 None -10 9 Human 7.1 pKi = 7.1 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 393 5 0 4 3.9 CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12 10.1021/jm401958n
CHEMBL3233142 112805 32 None -10 9 Human 7.1 pKi = 7.1 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 393 5 0 4 3.9 CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12 10.1021/jm401958n
CHEMBL3306803 112805 32 None -10 9 Human 7.1 pKi = 7.1 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
ChEMBL 393 5 0 4 3.9 CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12 10.1021/jm401958n
44309199 204051 0 None - 1 Human 5.1 pKi = 5.1 Binding
In vitro binding affinity towards Alpha-1 adrenergic receptor by displacing [3H]prazosin radioligandIn vitro binding affinity towards Alpha-1 adrenergic receptor by displacing [3H]prazosin radioligand
ChEMBL 355 6 3 4 2.7 Cc1ccc(CC2(O)CCN(C[C@@H](O)Cc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(01)00392-4
CHEMBL69967 204051 0 None - 1 Human 5.1 pKi = 5.1 Binding
In vitro binding affinity towards Alpha-1 adrenergic receptor by displacing [3H]prazosin radioligandIn vitro binding affinity towards Alpha-1 adrenergic receptor by displacing [3H]prazosin radioligand
ChEMBL 355 6 3 4 2.7 Cc1ccc(CC2(O)CCN(C[C@@H](O)Cc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(01)00392-4
10473406 204220 0 None - 1 Human 5.1 pKi = 5.1 Binding
In vitro binding affinity towards Alpha-1 adrenergic receptor by displacing [3H]prazosin radioligandIn vitro binding affinity towards Alpha-1 adrenergic receptor by displacing [3H]prazosin radioligand
ChEMBL 355 6 3 4 2.7 Cc1ccc(CC2(O)CCN(C[C@H](O)Cc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(01)00392-4
CHEMBL70918 204220 0 None - 1 Human 5.1 pKi = 5.1 Binding
In vitro binding affinity towards Alpha-1 adrenergic receptor by displacing [3H]prazosin radioligandIn vitro binding affinity towards Alpha-1 adrenergic receptor by displacing [3H]prazosin radioligand
ChEMBL 355 6 3 4 2.7 Cc1ccc(CC2(O)CCN(C[C@H](O)Cc3ccc(O)cc3)CC2)cc1 10.1016/s0960-894x(01)00392-4
118717462 115144 0 None 2 4 Human 7.1 pKi = 7.1 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 444 12 2 6 6.3 COc1cccc2c(NCCCCCCCNc3ccnc4c(OC)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
CHEMBL3343984 115144 0 None 2 4 Human 7.1 pKi = 7.1 Binding
Binding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptorBinding affinity to human alpha1A adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor
ChEMBL 444 12 2 6 6.3 COc1cccc2c(NCCCCCCCNc3ccnc4c(OC)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
9913449 106452 1 None 13 3 Human 7.1 pKi = 7.1 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparations
ChEMBL 489 6 0 7 3.5 O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL313990 106452 1 None 13 3 Human 7.1 pKi = 7.1 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in dog aorta preparations
ChEMBL 489 6 0 7 3.5 O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
16041090 95393 0 None -1 4 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 496 8 2 6 4.7 COc1ccc(NC(=O)NC2CCC(N3CCN(c4ccccc4OC(C)C)CC3)CC2)c(OC)c1 10.1016/j.bmcl.2007.11.068
CHEMBL256853 95393 0 None -1 4 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 496 8 2 6 4.7 COc1ccc(NC(=O)NC2CCC(N3CCN(c4ccccc4OC(C)C)CC3)CC2)c(OC)c1 10.1016/j.bmcl.2007.11.068
56649649 67857 0 None -87 8 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assayDisplacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assay
ChEMBL 480 8 0 5 4.6 COc1ccccc1N1CCN(CCN(C(=O)C23CCC(CF)(CC2)CC3)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
CHEMBL1910140 67857 0 None -87 8 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assayDisplacement of [3H]prazosin from alpha1A receptor expressed in HEK293 EBNA cells by radioligand binding assay
ChEMBL 480 8 0 5 4.6 COc1ccccc1N1CCN(CCN(C(=O)C23CCC(CF)(CC2)CC3)c2ccccn2)CC1 10.1016/j.ejmech.2011.06.023
44288741 168847 0 None 45 2 Human 7.1 pKi = 7.1 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 408 8 1 4 3.3 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)Cc2ccc(C)cc2)CC1 10.1016/s0960-894x(01)00320-1
CHEMBL43799 168847 0 None 45 2 Human 7.1 pKi = 7.1 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 408 8 1 4 3.3 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)Cc2ccc(C)cc2)CC1 10.1016/s0960-894x(01)00320-1
44288741 168847 0 None 45 2 Human 7.1 pKi = 7.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 408 8 1 4 3.3 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)Cc2ccc(C)cc2)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL43799 168847 0 None 45 2 Human 7.1 pKi = 7.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 408 8 1 4 3.3 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)Cc2ccc(C)cc2)CC1 10.1016/s0960-894x(00)00307-3
76333282 84831 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 405 8 1 5 4.0 COc1ccccc1OCCNC1COC(c2ccccc2)(c2ccccc2)CO1 10.1007/s00044-010-9379-1
CHEMBL2234456 84831 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 405 8 1 5 4.0 COc1ccccc1OCCNC1COC(c2ccccc2)(c2ccccc2)CO1 10.1007/s00044-010-9379-1
118717462 115144 0 None 2 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 444 12 2 6 6.3 COc1cccc2c(NCCCCCCCNc3ccnc4c(OC)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
CHEMBL3343984 115144 0 None 2 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cellsDisplacement of [3H]-prazosin from human alpha1A adrenergic receptor transfected in COS1 cells
ChEMBL 444 12 2 6 6.3 COc1cccc2c(NCCCCCCCNc3ccnc4c(OC)cccc34)ccnc12 10.1016/j.bmc.2014.09.017
44568917 187355 0 None -9 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNC[C@@H]1COC(c2ccccc2)(c2ccccc2)CO1 10.1021/jm800461k
CHEMBL493283 187355 0 None -9 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 419 9 1 5 4.0 COc1ccccc1OCCNC[C@@H]1COC(c2ccccc2)(c2ccccc2)CO1 10.1021/jm800461k
52945071 17643 0 None -1 2 Rat 6.1 pKi = 6.1 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 470 7 2 5 2.7 O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1CC(O)CN1CCN(c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
CHEMBL1258344 17643 0 None -1 2 Rat 6.1 pKi = 6.1 Binding
Binding affinity to adrenergic alpha1A receptor in rat brainBinding affinity to adrenergic alpha1A receptor in rat brain
ChEMBL 470 7 2 5 2.7 O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1CC(O)CN1CCN(c2ccccc2)CC1 10.1016/j.bmcl.2010.07.101
44288857 168783 0 None 43 3 Human 7.1 pKi = 7.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 439 9 1 6 2.9 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)Cc2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(00)00307-3
CHEMBL43749 168783 0 None 43 3 Human 7.1 pKi = 7.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 439 9 1 6 2.9 COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)Cc2ccc([N+](=O)[O-])cc2)CC1 10.1016/s0960-894x(00)00307-3
49862238 15008 16 None 1 2 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic Alpha-1A receptorBinding affinity to adrenergic Alpha-1A receptor
ChEMBL 367 6 0 5 3.6 COc1cccc(F)c1OC1CN(Cc2cnn(-c3ccccc3)c2C)C1 10.1016/j.bmcl.2010.06.033
CHEMBL1209158 15008 16 None 1 2 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic Alpha-1A receptorBinding affinity to adrenergic Alpha-1A receptor
ChEMBL 367 6 0 5 3.6 COc1cccc(F)c1OC1CN(Cc2cnn(-c3ccccc3)c2C)C1 10.1016/j.bmcl.2010.06.033
44301680 101970 0 None - 1 Human 7.1 pKi = 7.1 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 521 7 0 5 5.8 Cc1ccc(C2(c3ccc(C)cc3)OC(=O)N(CCCN3CCC(C#N)(c4ccccc4C)CC3)C2=O)cc1 10.1016/s0960-894x(01)00320-1
CHEMBL301416 101970 0 None - 1 Human 7.1 pKi = 7.1 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 521 7 0 5 5.8 Cc1ccc(C2(c3ccc(C)cc3)OC(=O)N(CCCN3CCC(C#N)(c4ccccc4C)CC3)C2=O)cc1 10.1016/s0960-894x(01)00320-1
10688604 24752 0 None -4 5 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 341 5 2 5 2.4 O[C@@H]1[C@H](NC[C@@H]2COc3ccccc3O2)CC[C@H]1Oc1ccccc1 10.1021/jm991065j
CHEMBL134428 24752 0 None -4 5 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 341 5 2 5 2.4 O[C@@H]1[C@H](NC[C@@H]2COc3ccccc3O2)CC[C@H]1Oc1ccccc1 10.1021/jm991065j
9929277 100978 0 None -1 3 Rat 7.1 pKi = 7.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 369 4 0 4 2.7 O=C1CCCC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL294235 100978 0 None -1 3 Rat 7.1 pKi = 7.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 369 4 0 4 2.7 O=C1CCCC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
456387 100757 5 None -6 2 Human 6.1 pKi = 6.1 Binding
Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 376 2 3 1 5.5 Brc1ccc2c(-c3nc(-c4c[nH]c5ccccc45)c[nH]3)c[nH]c2c1 10.1016/0960-894X(96)00376-9
CHEMBL292801 100757 5 None -6 2 Human 6.1 pKi = 6.1 Binding
Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)Compound was tested for its binding affinity towards CHO cells expressing human Alpha-1a adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone)
ChEMBL 376 2 3 1 5.5 Brc1ccc2c(-c3nc(-c4c[nH]c5ccccc45)c[nH]3)c[nH]c2c1 10.1016/0960-894X(96)00376-9
44271701 65513 0 None - 1 Bovine 5.1 pKi = 5.1 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 192 1 0 2 1.9 CN1CC=C(c2ccncc2F)CC1 10.1021/jm00375a017
CHEMBL18306 65513 0 None - 1 Bovine 5.1 pKi = 5.1 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 192 1 0 2 1.9 CN1CC=C(c2ccncc2F)CC1 10.1021/jm00375a017
145946265 167514 0 None -1 5 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 396 10 0 4 3.9 Cc1cc(C)c(OCCOCCN2CCN(CCc3ccccc3)CC2)c(C)c1 10.1016/j.bmcl.2018.04.059
CHEMBL4203310 167514 0 None -1 5 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 396 10 0 4 3.9 Cc1cc(C)c(OCCOCCN2CCN(CCc3ccccc3)CC2)c(C)c1 10.1016/j.bmcl.2018.04.059
CHEMBL4299892 167514 0 None -1 5 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 396 10 0 4 3.9 Cc1cc(C)c(OCCOCCN2CCN(CCc3ccccc3)CC2)c(C)c1 10.1016/j.bmcl.2018.04.059
10221005 204322 0 None 4 4 Human 6.1 pKi = 6.1 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 267 4 2 5 0.8 Cc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
CHEMBL71479 204322 0 None 4 4 Human 6.1 pKi = 6.1 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 267 4 2 5 0.8 Cc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1 10.1021/jm000542r
76330198 85336 0 None 3 2 Rat 6.1 pKi = 6.1 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 337 5 3 5 2.0 CCCS(=O)(=O)Nc1c(O)ccc2c1CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
CHEMBL2261348 85336 0 None 3 2 Rat 6.1 pKi = 6.1 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 337 5 3 5 2.0 CCCS(=O)(=O)Nc1c(O)ccc2c1CCCC2C1=NCCN1 10.1007/s00044-004-0020-z
1547484 940 74 None -125 20 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
654 940 74 None -125 20 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
9072 940 74 None -125 20 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
CHEMBL43064 940 74 None -125 20 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
DB00568 940 74 None -125 20 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 368 6 0 2 5.1 c1ccc(cc1)/C=C/CN1CCN(CC1)C(c1ccccc1)c1ccccc1 nan
10873978 168486 0 None -1905 6 Rat 6.1 pKi = 6.1 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 445 7 1 4 5.1 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2ccccc2o1 10.1021/jm0211220
CHEMBL435218 168486 0 None -1905 6 Rat 6.1 pKi = 6.1 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 445 7 1 4 5.1 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2ccccc2o1 10.1021/jm0211220
11698643 3630 11 None -15 4 Human 7.1 pKi = 7.1 Binding
Binding affinity to human adrenergic alpha-1A receptorBinding affinity to human adrenergic alpha-1A receptor
ChEMBL 479 6 0 4 6.0 O=C1C(=Nc2cccc(c2)C(F)(F)F)c2c(N1c1cccc(c1)OCCN1CCCC1)cccc2 10.1016/j.bmcl.2006.05.025
6125 3630 11 None -15 4 Human 7.1 pKi = 7.1 Binding
Binding affinity to human adrenergic alpha-1A receptorBinding affinity to human adrenergic alpha-1A receptor
ChEMBL 479 6 0 4 6.0 O=C1C(=Nc2cccc(c2)C(F)(F)F)c2c(N1c1cccc(c1)OCCN1CCCC1)cccc2 10.1016/j.bmcl.2006.05.025
CHEMBL209497 3630 11 None -15 4 Human 7.1 pKi = 7.1 Binding
Binding affinity to human adrenergic alpha-1A receptorBinding affinity to human adrenergic alpha-1A receptor
ChEMBL 479 6 0 4 6.0 O=C1C(=Nc2cccc(c2)C(F)(F)F)c2c(N1c1cccc(c1)OCCN1CCCC1)cccc2 10.1016/j.bmcl.2006.05.025
53248361 62082 0 None -50 7 Human 7.1 pKi = 7.1 Binding
Inhibition of adrenergic alpha1A receptorInhibition of adrenergic alpha1A receptor
ChEMBL 568 7 0 5 3.2 COc1ccccc1N1CCN(CCN(C(=O)C23C4C5C2C2C3C4C52I)c2ccccn2)CC1 10.1021/jm1009956
CHEMBL1774991 62082 0 None -50 7 Human 7.1 pKi = 7.1 Binding
Inhibition of adrenergic alpha1A receptorInhibition of adrenergic alpha1A receptor
ChEMBL 568 7 0 5 3.2 COc1ccccc1N1CCN(CCN(C(=O)C23C4C5C2C2C3C4C52I)c2ccccn2)CC1 10.1021/jm1009956
2105 3054 37 None -1258 33 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
47811 3054 37 None -1258 33 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
48 3054 37 None -1258 33 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
CHEMBL531 3054 37 None -1258 33 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
DB01186 3054 37 None -1258 33 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 nan
9867138 195792 0 None -1 3 Rat 6.1 pKi = 6.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 425 7 0 4 4.1 CN(CCN1C(=O)CC2(CCCC2)CC1=O)CCN(C)c1cc(Cl)ccc1Cl 10.1021/jm030944+
CHEMBL55790 195792 0 None -1 3 Rat 6.1 pKi = 6.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 425 7 0 4 4.1 CN(CCN1C(=O)CC2(CCCC2)CC1=O)CCN(C)c1cc(Cl)ccc1Cl 10.1021/jm030944+
448537 160250 89 None -1584 25 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
CHEMBL411 160250 89 None -1584 25 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 nan
12134985 204878 0 None - 1 Human 7.1 pKi = 7.1 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 438 7 1 7 2.7 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)nc(N)n2)CC1 10.1016/s0960-894x(00)00472-8
CHEMBL75808 204878 0 None - 1 Human 7.1 pKi = 7.1 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 438 7 1 7 2.7 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)nc(N)n2)CC1 10.1016/s0960-894x(00)00472-8
CHEMBL5276489 194643 0 None -70 3 Human 7.1 pKi = 7.1 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 492 8 1 5 4.4 O=C(NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O)C1CCCC1 10.1021/acsmedchemlett.7b00112
CHEMBL5315725 194643 0 None -70 3 Human 7.1 pKi = 7.1 Binding
Antagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysisAntagonist activity against recombinant human adrenergic alpha1A receptor expressed in Rat1 cells incubated for 30 mins by FLIPR analysis
ChEMBL 492 8 1 5 4.4 O=C(NCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O)C1CCCC1 10.1021/acsmedchemlett.7b00112
10314056 208150 1 None 1 3 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 322 3 0 4 3.1 O=C1CC2(CCN(CCc3ccccn3)CC2)Oc2ccccc21 10.1016/s0960-894x(98)00732-x
CHEMBL98167 208150 1 None 1 3 Human 6.1 pKi = 6.1 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 322 3 0 4 3.1 O=C1CC2(CCN(CCc3ccccn3)CC2)Oc2ccccc21 10.1016/s0960-894x(98)00732-x
9923051 108669 0 None - 1 Rat 6.1 pKi = 6.1 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 319 4 2 3 2.9 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]c(C)n1 10.1007/s00044-004-0020-z
CHEMBL320765 108669 0 None - 1 Rat 6.1 pKi = 6.1 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 319 4 2 3 2.9 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]c(C)n1 10.1007/s00044-004-0020-z
52937629 61304 0 None -158 3 Human 6.1 pKi = 6.1 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 377 6 0 5 3.5 CCOc1ccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)cc1 10.1021/jm1013874
CHEMBL1767139 61304 0 None -158 3 Human 6.1 pKi = 6.1 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
ChEMBL 377 6 0 5 3.5 CCOc1ccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)cc1 10.1021/jm1013874
11288646 8674 0 None - 1 Rat 6.1 pKi = 6.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 268 4 2 3 1.8 CCS(=O)(=O)Nc1cccc2c1CCCC2CN 10.1021/jm030551a
CHEMBL109553 8674 0 None - 1 Rat 6.1 pKi = 6.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 268 4 2 3 1.8 CCS(=O)(=O)Nc1cccc2c1CCCC2CN 10.1021/jm030551a
9923051 108669 0 None - 1 Rat 6.1 pKi = 6.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 319 4 2 3 2.9 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]c(C)n1 10.1021/jm030551a
CHEMBL320765 108669 0 None - 1 Rat 6.1 pKi = 6.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 319 4 2 3 2.9 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]c(C)n1 10.1021/jm030551a
10626686 204319 0 None 7 2 Human 8.1 pKi = 8.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 560 9 2 7 3.3 CC(C)Oc1ccccc1N1CCN(C[C@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
CHEMBL71473 204319 0 None 7 2 Human 8.1 pKi = 8.1 Binding
Binding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligandBinding affinity towards cloned human alpha-1A adrenergic receptor was determined using [125]-HEAT as radioligand
ChEMBL 560 9 2 7 3.3 CC(C)Oc1ccccc1N1CCN(C[C@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1 10.1021/jm9905918
44331150 4430 0 None 3 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 530 6 1 7 4.4 Cn1cnc(S(=O)(=O)Nc2ccc3c(c2)C(=O)CC2(CCN(CCc4cccc5ccccc45)CC2)O3)c1 10.1016/s0960-894x(98)00732-x
CHEMBL101579 4430 0 None 3 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 530 6 1 7 4.4 Cn1cnc(S(=O)(=O)Nc2ccc3c(c2)C(=O)CC2(CCN(CCc4cccc5ccccc45)CC2)O3)c1 10.1016/s0960-894x(98)00732-x
9847419 208194 0 None 14 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 467 5 2 5 3.9 Cc1[nH]c2ccccc2c1CCN1CCC2(CC1)CC(=O)c1ccc(NS(C)(=O)=O)cc1O2 10.1016/s0960-894x(98)00732-x
CHEMBL98430 208194 0 None 14 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1C adrenergic receptor expressed in CHO cells
ChEMBL 467 5 2 5 3.9 Cc1[nH]c2ccccc2c1CCN1CCC2(CC1)CC(=O)c1ccc(NS(C)(=O)=O)cc1O2 10.1016/s0960-894x(98)00732-x
10507129 121973 0 None 9 3 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 562 8 2 7 3.8 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(C)cc1 10.1021/jm990200p
CHEMBL359173 121973 0 None 9 3 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.In vitro binding affinity against Alpha-1A adrenergic receptor of human liver microsomes.
ChEMBL 562 8 2 7 3.8 COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(C)cc1 10.1021/jm990200p
9867616 168326 0 None -1 3 Human 8.1 pKi = 8.1 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 435 6 1 8 2.2 COc1cc2nc(N3CCN(C(=O)CC(=O)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
CHEMBL434228 168326 0 None -1 3 Human 8.1 pKi = 8.1 Binding
The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.The binding affinity towards Alpha-1C adrenergic receptor in the COS cell line.
ChEMBL 435 6 1 8 2.2 COc1cc2nc(N3CCN(C(=O)CC(=O)c4ccccc4)CC3)nc(N)c2cc1OC 10.1021/jm9805337
115 343 71 None -3 6 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm00018a001
2092 343 71 None -3 6 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm00018a001
7109 343 71 None -3 6 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm00018a001
CHEMBL709 343 71 None -3 6 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm00018a001
DB00346 343 71 None -3 6 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
ChEMBL 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10.1021/jm00018a001
4149971 166632 7 None -1 4 Rat 8.1 pKi = 8.1 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 386 7 0 5 2.0 COc1ccccc1N1CCN(CCCCN2C(=O)C3CCCN3C2=O)CC1 10.1021/jm970216k
CHEMBL42810 166632 7 None -1 4 Rat 8.1 pKi = 8.1 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 386 7 0 5 2.0 COc1ccccc1N1CCN(CCCCN2C(=O)C3CCCN3C2=O)CC1 10.1021/jm970216k
44300166 196353 0 None 15 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 583 7 2 7 4.0 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@H](N3CCC(c4ccccn4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
CHEMBL56248 196353 0 None 15 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cellsDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor stably expressed in CHO cells
ChEMBL 583 7 2 7 4.0 COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@H](N3CCC(c4ccccn4)CC3)C2)C(=O)N1 10.1016/s0960-894x(00)00374-7
44420408 141758 0 None -5 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 453 5 2 6 2.7 COc1ccc(Cl)cc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
CHEMBL386005 141758 0 None -5 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cellsDisplacement of [125I]BE2254 from human cloned adrenergic alpha 1A receptor expressed in HEK293 cells
ChEMBL 453 5 2 6 2.7 COc1ccc(Cl)cc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1 10.1016/j.bmcl.2006.09.034
10320782 99977 0 None 4 6 Bovine 8.1 pKi = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNC[C@H]1Oc2ccccc2O[C@@H]1c1ccc(C)cc1 10.1021/jm960069a
CHEMBL286565 99977 0 None 4 6 Bovine 8.1 pKi = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
ChEMBL 435 9 1 6 4.6 COc1cccc(OC)c1OCCNC[C@H]1Oc2ccccc2O[C@@H]1c1ccc(C)cc1 10.1021/jm960069a
10811627 205550 0 None 11 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 412 7 0 6 3.3 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)no2)CC1 10.1016/s0960-894x(02)00436-5
CHEMBL538529 205550 0 None 11 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 412 7 0 6 3.3 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)no2)CC1 10.1016/s0960-894x(02)00436-5
CHEMBL81093 205550 0 None 11 3 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 412 7 0 6 3.3 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)no2)CC1 10.1016/s0960-894x(02)00436-5
44268966 33437 0 None -6 5 Human 8.1 pKi = 8.1 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 476 7 1 7 3.6 COc1ccccc1N1CCN(CCCn2c(=O)[nH]c3scc(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL14199 33437 0 None -6 5 Human 8.1 pKi = 8.1 Binding
Binding affinity for human Alpha-1A adrenergic receptorBinding affinity for human Alpha-1A adrenergic receptor
ChEMBL 476 7 1 7 3.6 COc1ccccc1N1CCN(CCCn2c(=O)[nH]c3scc(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
11857861 194780 0 None -1 4 Human 8.1 pKi = 8.1 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 520 10 1 6 4.5 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
CHEMBL538397 194780 0 None -1 4 Human 8.1 pKi = 8.1 Binding
Binding affinity to human cloned adrenergic alpha-1a receptorBinding affinity to human cloned adrenergic alpha-1a receptor
ChEMBL 520 10 1 6 4.5 COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC 10.1016/j.bmcl.2007.04.098
118716698 114992 0 None 1 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 364 4 0 6 2.5 COc1ccccc1N1CCN(CC2COC3(CCSCC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342852 114992 0 None 1 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 364 4 0 6 2.5 COc1ccccc1N1CCN(CC2COC3(CCSCC3)O2)CC1 10.1016/j.ejmech.2014.09.070
4165402 178768 8 None 1 2 Rat 8.1 pKi = 8.1 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 400 7 0 5 2.4 COc1ccccc1N1CCN(CCCCN2C(=O)C3CCCCN3C2=O)CC1 10.1021/jm970216k
CHEMBL46881 178768 8 None 1 2 Rat 8.1 pKi = 8.1 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 400 7 0 5 2.4 COc1ccccc1N1CCN(CCCCN2C(=O)C3CCCCN3C2=O)CC1 10.1021/jm970216k
9887378 98405 4 None 40 3 Human 8.1 pKi = 8.1 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 402 8 1 5 1.7 CC(C)Oc1ccccc1N1CCN(CCNC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL275469 98405 4 None 40 3 Human 8.1 pKi = 8.1 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 402 8 1 5 1.7 CC(C)Oc1ccccc1N1CCN(CCNC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
10790430 84819 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 431 9 1 5 4.5 COc1cccc(OC)c1OCCNC[C@@H]1C(=O)c2ccccc2C[C@H]1c1ccccc1 10.1007/s00044-010-9379-1
CHEMBL2234444 84819 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 431 9 1 5 4.5 COc1cccc(OC)c1OCCNC[C@@H]1C(=O)c2ccccc2C[C@H]1c1ccccc1 10.1007/s00044-010-9379-1
44431562 89283 0 None -1 4 Human 8.1 pKi = 8.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(OC)c(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)c1 10.1016/j.bmcl.2007.04.008
CHEMBL236832 89283 0 None -1 4 Human 8.1 pKi = 8.1 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 517 9 1 7 3.9 COc1ccc(OC)c(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)c1 10.1016/j.bmcl.2007.04.008
10651080 105942 0 None 23 6 Human 8.1 pKi = 8.1 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 592 9 3 6 4.7 CC1=C(C(N)=O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
CHEMBL312871 105942 0 None 23 6 Human 8.1 pKi = 8.1 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 592 9 3 6 4.7 CC1=C(C(N)=O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980077m
10531532 207094 0 None 8 6 Human 8.1 pKi = 8.1 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 594 9 2 7 6.0 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
CHEMBL91956 207094 0 None 8 6 Human 8.1 pKi = 8.1 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 594 9 2 7 6.0 CO/C(O)=C1\C(C)=NC(C)=C(C(=O)NCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1021/jm980077m
10531532 85293 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 594 9 2 7 5.2 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
CHEMBL2260371 85293 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 594 9 2 7 5.2 COC(=O)C1=C(C)NC(C)=C(C(=O)NCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1 10.1007/s00044-004-0120-9
10651080 105942 0 None 23 6 Human 8.1 pKi = 8.1 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 592 9 3 6 4.7 CC1=C(C(N)=O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
CHEMBL312871 105942 0 None 23 6 Human 8.1 pKi = 8.1 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 592 9 3 6 4.7 CC1=C(C(N)=O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1 10.1007/s00044-004-0120-9
10790430 84819 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 431 9 1 5 4.5 COc1cccc(OC)c1OCCNC[C@@H]1C(=O)c2ccccc2C[C@H]1c1ccccc1 10.1007/s00044-010-9379-1
CHEMBL2234444 84819 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 431 9 1 5 4.5 COc1cccc(OC)c1OCCNC[C@@H]1C(=O)c2ccccc2C[C@H]1c1ccccc1 10.1007/s00044-010-9379-1
44288841 101139 0 None 3 3 Human 8.1 pKi = 8.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 440 8 1 2 5.8 Cc1ccc(C(C(=O)NCCCN2CCC(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
CHEMBL295304 101139 0 None 3 3 Human 8.1 pKi = 8.1 Binding
Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.Inhibition of binding of [125I]HEAT to cloned human alpha-1A adrenergic receptor.
ChEMBL 440 8 1 2 5.8 Cc1ccc(C(C(=O)NCCCN2CCC(c3ccccc3)CC2)c2ccc(C)cc2)cc1 10.1016/s0960-894x(00)00307-3
57393627 69307 0 None 11 5 Pig 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1101 42 2 17 5.4 COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
CHEMBL1928131 69307 0 None 11 5 Pig 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 1101 42 2 17 5.4 COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1 10.1016/j.bmc.2011.10.063
10507651 206507 0 None 42 6 Human 8.1 pKi = 8.1 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 591 9 2 6 5.8 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
CHEMBL88388 206507 0 None 42 6 Human 8.1 pKi = 8.1 Binding
Binding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptorBinding affinity determined by displacement of [3H]prazosin from alpha-1A adrenergic receptor
ChEMBL 591 9 2 6 5.8 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1021/jm980077m
10507651 206507 0 None 42 6 Human 8.1 pKi = 8.1 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 591 9 2 6 5.8 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1007/s00044-004-0120-9
CHEMBL88388 206507 0 None 42 6 Human 8.1 pKi = 8.1 Binding
Binding affinity to Homo sapiens (human) alpha1A adrenergic receptorBinding affinity to Homo sapiens (human) alpha1A adrenergic receptor
ChEMBL 591 9 2 6 5.8 CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2 10.1007/s00044-004-0120-9
4038180 204 14 None 2 7 Rat 8.1 pKi = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
480 204 14 None 2 7 Rat 8.1 pKi = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
CHEMBL109783 204 14 None 2 7 Rat 8.1 pKi = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 10.1021/jm960354u
118716716 115010 0 None 2 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 571 7 0 8 3.3 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccc(OC(F)(F)F)cc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342869 115010 0 None 2 4 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 571 7 0 8 3.3 COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccc(OC(F)(F)F)cc4)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
73350823 102530 0 None -5 9 Human 7.1 pKi = 7.1 Binding
Binding affinity to human adrenergic alpha-1A receptor by competitive binding assayBinding affinity to human adrenergic alpha-1A receptor by competitive binding assay
ChEMBL 509 8 1 5 3.7 O=C(Cc1ccc(OC2CCNCC2)cc1OCCF)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1016/j.bmcl.2013.07.045
CHEMBL2424668 102530 0 None -5 9 Human 7.1 pKi = 7.1 Binding
Binding affinity to human adrenergic alpha-1A receptor by competitive binding assayBinding affinity to human adrenergic alpha-1A receptor by competitive binding assay
ChEMBL 509 8 1 5 3.7 O=C(Cc1ccc(OC2CCNCC2)cc1OCCF)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1016/j.bmcl.2013.07.045
CHEMBL3040578 102530 0 None -5 9 Human 7.1 pKi = 7.1 Binding
Binding affinity to human adrenergic alpha-1A receptor by competitive binding assayBinding affinity to human adrenergic alpha-1A receptor by competitive binding assay
ChEMBL 509 8 1 5 3.7 O=C(Cc1ccc(OC2CCNCC2)cc1OCCF)N1CCC(N2C(=O)CCc3ccccc32)CC1 10.1016/j.bmcl.2013.07.045
13141186 130691 0 None 7 2 Bovine 7.1 pKi = 7.1 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 312 0 0 2 4.2 CN1CCC(=C2c3cc(Cl)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
CHEMBL368357 130691 0 None 7 2 Bovine 7.1 pKi = 7.1 Binding
Displacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortexDisplacement of [3H]- prazosin radioligand binding at the alpha 1-adrenergic binding site of calf cerebral cortex
ChEMBL 312 0 0 2 4.2 CN1CCC(=C2c3cc(Cl)ccc3CCn3cccc32)CC1 10.1021/jm00361a008
10622156 200068 0 None 1 2 Rat 7.1 pKi = 7.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 422 6 0 5 3.7 COc1cc2c(cc1OC)CN(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)CC2 10.1021/jm000541z
CHEMBL59575 200068 0 None 1 2 Rat 7.1 pKi = 7.1 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 422 6 0 5 3.7 COc1cc2c(cc1OC)CN(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)CC2 10.1021/jm000541z
2771431 188282 52 None -1 2 Bovine 6.1 pKi = 6.1 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 231 1 1 3 1.8 Clc1cnc(N2CCNCC2)c(Cl)c1 10.1021/jm00366a007
CHEMBL50016 188282 52 None -1 2 Bovine 6.1 pKi = 6.1 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 231 1 1 3 1.8 Clc1cnc(N2CCNCC2)c(Cl)c1 10.1021/jm00366a007
13938357 101730 0 None -79 2 Bovine 5.1 pKi = 5.1 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 364 4 1 5 1.7 CN([C@H]1CCN2CCc3c(oc4ccccc34)[C@H]2C1)S(=O)(=O)CCO 10.1021/jm00150a002
CHEMBL299595 101730 0 None -79 2 Bovine 5.1 pKi = 5.1 Binding
Evaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortexEvaluated for its ability to displace [3H]prazosin from alpha-1-Adrenoceptor of calf cerebral cortex
ChEMBL 364 4 1 5 1.7 CN([C@H]1CCN2CCc3c(oc4ccccc34)[C@H]2C1)S(=O)(=O)CCO 10.1021/jm00150a002
127025277 137851 0 None -44 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 376 7 1 5 1.6 COc1ccccc1N1CCN(CCCCNC(=O)N2CCOCC2)CC1 10.1016/j.bmcl.2015.12.068
CHEMBL3760063 137851 0 None -44 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 376 7 1 5 1.6 COc1ccccc1N1CCN(CCCCNC(=O)N2CCOCC2)CC1 10.1016/j.bmcl.2015.12.068
11801861 118788 0 None 181 3 Human 7.1 pKi = 7.1 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 609 6 2 6 4.0 CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)N2CCC(N3CCC(C(=O)OC)(c4ccccc4)CC3)CC2)C(=O)N1 10.1021/jm990201h
CHEMBL342064 118788 0 None 181 3 Human 7.1 pKi = 7.1 Binding
In vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomesIn vitro binding affinity against alpha-1A adrenergic receptor of human liver microsomes
ChEMBL 609 6 2 6 4.0 CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)N2CCC(N3CCC(C(=O)OC)(c4ccccc4)CC3)CC2)C(=O)N1 10.1021/jm990201h
44222842 195092 0 None -3 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 505 4 1 9 3.0 COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1021/jm8016046
CHEMBL549764 195092 0 None -3 3 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenoceptor expressed in CHO cells
ChEMBL 505 4 1 9 3.0 COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1021/jm8016046
10367857 18112 0 None -21379 4 Rat 5.1 pKi = 5.1 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 478 7 2 3 5.5 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2cc(Cl)ccc2[nH]1 10.1021/jm0211220
CHEMBL126889 18112 0 None -21379 4 Rat 5.1 pKi = 5.1 Binding
Binding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin bindingBinding affinity for rat cortex alpha-1 adrenergic receptor by inhibition of [3H]prazosin binding
ChEMBL 478 7 2 3 5.5 O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1cc2cc(Cl)ccc2[nH]1 10.1021/jm0211220
10199335 204747 0 None 1 4 Human 6.1 pKi = 6.1 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
CHEMBL74467 204747 0 None 1 4 Human 6.1 pKi = 6.1 Binding
Affinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranesAffinity to Alpha-1 adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes
ChEMBL 271 4 2 5 0.6 CS(=O)(=O)c1ccc(F)cc1NCC1=NCCN1 10.1021/jm000542r
10764133 84572 0 None -6 4 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2153560 84572 0 None -6 4 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
CHEMBL2220899 84572 0 None -6 4 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counterDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter
ChEMBL 375 9 1 7 2.5 COc1cccc(OC)c1OCCNC[C@@H]1COc2c(OC)cccc2O1 10.1016/j.ejmech.2012.09.049
44318000 205397 0 None 51 2 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 480 7 0 7 4.0 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3C(=O)CC4(CCCC4)CC3=O)co2)CC1 10.1016/s0960-894x(02)00436-5
CHEMBL80036 205397 0 None 51 2 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 480 7 0 7 4.0 CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3C(=O)CC4(CCCC4)CC3=O)co2)CC1 10.1016/s0960-894x(02)00436-5
16041091 95221 0 None 1 4 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 468 7 2 4 4.5 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)NCc3cccc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
CHEMBL256041 95221 0 None 1 4 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]HEAT from human recombinant adrenergic alpha1A receptorDisplacement of [125I]HEAT from human recombinant adrenergic alpha1A receptor
ChEMBL 468 7 2 4 4.5 CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)NCc3cccc(F)c3)CC2)CC1 10.1016/j.bmcl.2007.11.068
44267817 163250 0 None 53 3 Human 7.1 pKi = 7.1 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 420 8 1 5 1.9 CC(C)Oc1cc(F)ccc1N1CCN(CCNC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL418531 163250 0 None 53 3 Human 7.1 pKi = 7.1 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 420 8 1 5 1.9 CC(C)Oc1cc(F)ccc1N1CCN(CCNC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
44593557 183918 11 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 262 3 1 2 3.3 COCc1c(Cl)ccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
CHEMBL481322 183918 11 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 262 3 1 2 3.3 COCc1c(Cl)ccc2c1CC[C@H]2c1ncc[nH]1 10.1016/j.bmcl.2008.10.066
155513941 176278 0 None -53 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 407 12 2 5 3.8 COc1ccccc1OCCNCC(CO)OC(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2019.05.024
CHEMBL4439658 176278 0 None -53 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 407 12 2 5 3.8 COc1ccccc1OCCNCC(CO)OC(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2019.05.024
CHEMBL4595078 176278 0 None -53 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 407 12 2 5 3.8 COc1ccccc1OCCNCC(CO)OC(c1ccccc1)c1ccccc1 10.1016/j.ejmech.2019.05.024
9880254 9301 0 None - 1 Rat 7.1 pKi = 7.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 323 4 2 3 2.8 CCS(=O)(=O)Nc1cc(F)cc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL110975 9301 0 None - 1 Rat 7.1 pKi = 7.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 323 4 2 3 2.8 CCS(=O)(=O)Nc1cc(F)cc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
10739024 69833 0 None -33 5 Human 6.1 pKi = 6.1 Binding
Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 388 4 3 8 0.9 COc1cc2nc(N3CCN[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
CHEMBL19376 69833 0 None -33 5 Human 6.1 pKi = 6.1 Binding
Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptorCompound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1A adrenergic receptor
ChEMBL 388 4 3 8 0.9 COc1cc2nc(N3CCN[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC 10.1021/jm980053f
11049096 11196 0 None 1 2 Human 6.1 pKi = 6.1 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 389 8 0 4 4.3 CN(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
CHEMBL1178700 11196 0 None 1 2 Human 6.1 pKi = 6.1 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 389 8 0 4 4.3 CN(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
CHEMBL37962 11196 0 None 1 2 Human 6.1 pKi = 6.1 Binding
Affinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assayAffinity constant towards human recombinant Alpha-1A adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay
ChEMBL 389 8 0 4 4.3 CN(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1021/jm021078o
11049096 11196 0 None 1 2 Human 6.1 pKi = 6.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 389 8 0 4 4.3 CN(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
CHEMBL1178700 11196 0 None 1 2 Human 6.1 pKi = 6.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 389 8 0 4 4.3 CN(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
CHEMBL37962 11196 0 None 1 2 Human 6.1 pKi = 6.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 389 8 0 4 4.3 CN(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1 10.1007/s00044-010-9379-1
11334596 9420 1 None - 1 Rat 6.1 pKi = 6.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 265 4 2 3 1.9 CC(c1cccc(NS(C)(=O)=O)c1)c1c[nH]cn1 10.1021/jm030551a
CHEMBL111682 9420 1 None - 1 Rat 6.1 pKi = 6.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 265 4 2 3 1.9 CC(c1cccc(NS(C)(=O)=O)c1)c1c[nH]cn1 10.1021/jm030551a
9922027 115410 0 None 10 2 Rat 6.1 pKi = 6.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 289 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCC=C2c1c[nH]cn1 10.1021/jm030551a
CHEMBL3350265 115410 0 None 10 2 Rat 6.1 pKi = 6.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 289 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCC=C2c1c[nH]cn1 10.1021/jm030551a
71062708 154306 0 None -47 12 Mouse 5.1 pKi = 5.1 Binding
Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.
ChEMBL 368 7 0 5 2.8 COc1cccc(OC[C@@H]2CN(CCN3CCc4ccccc43)CCO2)c1 nan
CHEMBL3986651 154306 0 None -47 12 Mouse 5.1 pKi = 5.1 Binding
Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.
ChEMBL 368 7 0 5 2.8 COc1cccc(OC[C@@H]2CN(CCN3CCc4ccccc43)CCO2)c1 nan
2520 204008 70 None -147 12 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC nan
CHEMBL1280 204008 70 None -147 12 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC nan
CHEMBL6966 204008 70 None -147 12 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC nan
10479323 34693 0 None -9 3 Human 7.1 pKi = 7.1 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 459 5 2 5 4.4 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccc(C(F)(F)F)cc1)C3 10.1021/jm030952q
CHEMBL143026 34693 0 None -9 3 Human 7.1 pKi = 7.1 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 459 5 2 5 4.4 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccc(C(F)(F)F)cc1)C3 10.1021/jm030952q
10479323 34693 0 None -9 3 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 459 5 2 5 4.4 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccc(C(F)(F)F)cc1)C3 10.1007/s00044-010-9379-1
CHEMBL143026 34693 0 None -9 3 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 459 5 2 5 4.4 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccc(C(F)(F)F)cc1)C3 10.1007/s00044-010-9379-1
46882088 5827 0 None -11 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 435 10 1 6 4.0 COc1cccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)c1OC 10.1016/j.bmcl.2010.01.030
CHEMBL1079066 5827 0 None -11 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 435 10 1 6 4.0 COc1cccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)c1OC 10.1016/j.bmcl.2010.01.030
3198 205513 76 None -1698 34 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL1201049 205513 76 None -1698 34 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
CHEMBL808 205513 76 None -1698 34 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 380 6 0 3 5.8 Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 nan
44318075 205366 0 None 3 2 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 460 7 0 6 4.7 O=C1CCCCCN1Cc1cc(CN2CCN(c3ccccc3Oc3ccccc3)CC2)on1 10.1016/s0960-894x(02)00436-5
CHEMBL79817 205366 0 None 3 2 Human 7.1 pKi = 7.1 Binding
Displacement of [125I]HEAT from human Alpha-1A adrenergic receptorDisplacement of [125I]HEAT from human Alpha-1A adrenergic receptor
ChEMBL 460 7 0 6 4.7 O=C1CCCCCN1Cc1cc(CN2CCN(c3ccccc3Oc3ccccc3)CC2)on1 10.1016/s0960-894x(02)00436-5
122187556 123058 0 None -7 2 Rat 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 307 5 1 2 4.2 c1ccc2c(C3CCN(CCCn4cccc4)CC3)c[nH]c2c1 10.1016/j.bmcl.2015.07.046
CHEMBL3609355 123058 0 None -7 2 Rat 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membraneDisplacement of [3H]prazosin from alpha1A adrenoceptor in rat submaxillary gland membrane
ChEMBL 307 5 1 2 4.2 c1ccc2c(C3CCN(CCCn4cccc4)CC3)c[nH]c2c1 10.1016/j.bmcl.2015.07.046
9844321 100861 0 None -8 4 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 407 4 0 4 3.3 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL293539 100861 0 None -8 4 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 407 4 0 4 3.3 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2Cl)CC1 10.1007/s00044-010-9379-1
42 2063 57 None -15 18 Human 7.1 pKi = 7.1 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 401 6 0 7 1.2 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1016/s0960-894x(98)00451-x
56971 2063 57 None -15 18 Human 7.1 pKi = 7.1 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 401 6 0 7 1.2 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1016/s0960-894x(98)00451-x
CHEMBL8412 2063 57 None -15 18 Human 7.1 pKi = 7.1 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 401 6 0 7 1.2 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(CC1)c1ncccn1 10.1016/s0960-894x(98)00451-x
9844321 100861 0 None -8 4 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 407 4 0 4 3.3 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2Cl)CC1 10.1007/s00044-010-9379-1
CHEMBL293539 100861 0 None -8 4 Human 7.1 pKi = 7.1 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 407 4 0 4 3.3 O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2Cl)CC1 10.1007/s00044-010-9379-1
11994915 11832 0 None -1 6 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cc(-c2ccccc2)ccc1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182145 11832 0 None -1 6 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cc(-c2ccccc2)ccc1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL214762 11832 0 None -1 6 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cc(-c2ccccc2)ccc1OCCNC[C@H]1COc2ccccc2O1 10.1021/jm060358r
25132566 187323 0 None -14 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 343 8 1 5 2.8 COc1ccccc1OCCNC[C@@H]1COC[C@@H](c2ccccc2)O1 10.1021/jm800461k
CHEMBL493041 187323 0 None -14 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 343 8 1 5 2.8 COc1ccccc1OCCNC[C@@H]1COC[C@@H](c2ccccc2)O1 10.1021/jm800461k
11234230 101701 0 None -81 4 Rat 7.1 pKi = 7.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 375 4 0 3 3.6 O=C1CC2(CCCC2)CCN1CCN1CCN(c2ccccc2Cl)CC1 10.1021/jm030944+
CHEMBL299454 101701 0 None -81 4 Rat 7.1 pKi = 7.1 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 375 4 0 3 3.6 O=C1CC2(CCCC2)CCN1CCN1CCN(c2ccccc2Cl)CC1 10.1021/jm030944+
49783419 17749 0 None -41 12 Human 7.1 pKi = 7.1 Binding
Binding affinity to human adrenergic alpha1A receptorBinding affinity to human adrenergic alpha1A receptor
ChEMBL 366 6 1 6 2.8 CCCCN1CCC(COC(=O)c2cc(F)c(N)c3c2OCCO3)CC1 10.1021/jm100668r
CHEMBL1258671 17749 0 None -41 12 Human 7.1 pKi = 7.1 Binding
Binding affinity to human adrenergic alpha1A receptorBinding affinity to human adrenergic alpha1A receptor
ChEMBL 366 6 1 6 2.8 CCCCN1CCC(COC(=O)c2cc(F)c(N)c3c2OCCO3)CC1 10.1021/jm100668r
130442480 175270 0 None -107 24 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting method
ChEMBL 410 3 0 6 5.7 Cc1ncc2nccn2c1-c1ccc(Oc2nccc3occc23)cc1C(F)(F)F 10.1021/acs.jmedchem.9b00351
CHEMBL4572614 175270 0 None -107 24 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting methodDisplacement of [3H]-prazosin from recombinant human alpha1A adrenergic receptor measured after 90 mins by microbeta scintillation counting method
ChEMBL 410 3 0 6 5.7 Cc1ncc2nccn2c1-c1ccc(Oc2nccc3occc23)cc1C(F)(F)F 10.1021/acs.jmedchem.9b00351
46915370 54967 0 None -1 6 Human 6.1 pKi = 6.1 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 195 0 3 5 -1.6 Cn1c(=O)[nH]c2c([nH]c(=O)n2C)c1=N 10.1021/jm100490m
CHEMBL1241328 54967 0 None -1 6 Human 6.1 pKi = 6.1 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 195 0 3 5 -1.6 Cn1c(=O)[nH]c2c([nH]c(=O)n2C)c1=N 10.1021/jm100490m
CHEMBL1615596 54967 0 None -1 6 Human 6.1 pKi = 6.1 Binding
Binding affinity to adrenergic alpha1A receptorBinding affinity to adrenergic alpha1A receptor
ChEMBL 195 0 3 5 -1.6 Cn1c(=O)[nH]c2c([nH]c(=O)n2C)c1=N 10.1021/jm100490m
12134987 204988 0 None 16 2 Human 7.1 pKi = 7.1 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 414 7 0 6 2.8 CC(C)Oc1ccccc1N1CCN(CC2=NOC(CN3CCCCC3=O)C2)CC1 10.1016/s0960-894x(00)00472-8
CHEMBL76643 204988 0 None 16 2 Human 7.1 pKi = 7.1 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 414 7 0 6 2.8 CC(C)Oc1ccccc1N1CCN(CC2=NOC(CN3CCCCC3=O)C2)CC1 10.1016/s0960-894x(00)00472-8
155565219 176565 0 None -1 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 403 10 1 4 4.6 c1ccc(OCCNCC[C@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4580335 176565 0 None -1 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 403 10 1 4 4.6 c1ccc(OCCNCC[C@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
CHEMBL4597359 176565 0 None -1 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 403 10 1 4 4.6 c1ccc(OCCNCC[C@H]2CO[C@H](C(c3ccccc3)c3ccccc3)O2)cc1 10.1016/j.ejmech.2019.05.024
44568918 187356 0 None 1 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 449 10 1 6 4.0 COc1cccc(OC)c1OCCNC[C@@H]1COC(c2ccccc2)(c2ccccc2)CO1 10.1021/jm800461k
CHEMBL493284 187356 0 None 1 4 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human cloned alpha1A adrenoceptor expressed in CHO cells
ChEMBL 449 10 1 6 4.0 COc1cccc(OC)c1OCCNC[C@@H]1COC(c2ccccc2)(c2ccccc2)CO1 10.1021/jm800461k
68712 100338 60 None -8 5 Human 5.1 pKi = 5.1 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1016/0960-894X(94)85032-1
CHEMBL289480 100338 60 None -8 5 Human 5.1 pKi = 5.1 Binding
Binding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1A adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 10.1016/0960-894X(94)85032-1
2351 3286 64 None -138 21 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
2820 3286 64 None -138 21 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
5035 3286 64 None -138 21 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
CHEMBL81 3286 64 None -138 21 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
DB00481 3286 64 None -138 21 Rat 6.1 pKi = 6.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 473 7 2 6 6.1 Oc1ccc2c(c1)sc(c2C(=O)c1ccc(cc1)OCCN1CCCCC1)c1ccc(cc1)O nan
1016 3747 78 None -1737 35 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2561 3747 78 None -1737 35 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
2733526 3747 78 None -1737 35 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
5384 3747 78 None -1737 35 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
CHEMBL83 3747 78 None -1737 35 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
DB00675 3747 78 None -1737 35 Rat 5.1 pKi = 5.1 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 371 8 0 2 6.0 CC/C(=C(\c1ccccc1)/c1ccc(cc1)OCCN(C)C)/c1ccccc1 nan
44316072 205016 0 None 4 3 Human 8.1 pKi = 8.1 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 425 7 0 6 3.0 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)nn2C)CC1 10.1016/s0960-894x(00)00472-8
CHEMBL76867 205016 0 None 4 3 Human 8.1 pKi = 8.1 Binding
Compound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptorCompound was evaluated for its binding affinity to COS cell membrane expressing the human Alpha-1A adrenergic receptor
ChEMBL 425 7 0 6 3.0 CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)nn2C)CC1 10.1016/s0960-894x(00)00472-8
11567620 16076 0 None -5 3 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 404 8 1 4 4.9 Fc1ccccc1N1CCN(CCCCNc2cc(-c3ccccc3)ccn2)CC1 10.1016/j.bmcl.2010.07.096
CHEMBL1223802 16076 0 None -5 3 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A receptorDisplacement of [3H]prazosin from human adrenergic alpha1A receptor
ChEMBL 404 8 1 4 4.9 Fc1ccccc1N1CCN(CCCCNc2cc(-c3ccccc3)ccn2)CC1 10.1016/j.bmcl.2010.07.096
57395340 69300 0 None 1 5 Pig 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 469 14 1 6 3.6 CCOCCOCc1ccc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)cc1 10.1016/j.bmc.2011.10.063
CHEMBL1928124 69300 0 None 1 5 Pig 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 469 14 1 6 3.6 CCOCCOCc1ccc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)cc1 10.1016/j.bmc.2011.10.063
10095156 78543 0 None 2 2 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL2112073 78543 0 None 2 2 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 447 4 1 6 3.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)C[C@@H]21 10.1021/jm990567u
10698907 121031 0 None 602 3 Human 8.0 pKi = 8.0 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 605 12 4 9 2.4 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C(=O)OCCO)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
CHEMBL356623 121031 0 None 602 3 Human 8.0 pKi = 8.0 Binding
Binding affinity was determined for the alpha-1A adrenergic receptorBinding affinity was determined for the alpha-1A adrenergic receptor
ChEMBL 605 12 4 9 2.4 CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C(=O)OCCO)(c3ccccc3)CC2)=C(C)N1 10.1021/jm980506g
44295133 188728 0 None 13 3 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 586 7 2 5 5.0 O=C1OCC2=C1C(c1ccc(F)c(F)c1)N(C(=O)NCCCN1CCC(c3ccccc3)(c3ccccc3)CC1)C(=O)N2 10.1016/s0960-894x(99)00653-8
CHEMBL50490 188728 0 None 13 3 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptorDisplacement of [3H]- prazosin from human recombinant Alpha-1A adrenergic receptor
ChEMBL 586 7 2 5 5.0 O=C1OCC2=C1C(c1ccc(F)c(F)c1)N(C(=O)NCCCN1CCC(c3ccccc3)(c3ccccc3)CC1)C(=O)N2 10.1016/s0960-894x(99)00653-8
71817710 102407 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL2419770 102407 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm400867d
CHEMBL3039705 102407 0 None 1 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 minsDisplacement of [3H]prazosin from human alpha-1A adrenoreceptor expressed in CHO cells after 30 mins
ChEMBL 355 7 1 6 3.3 COc1ccc2ccoc2c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm400867d
10430193 161598 0 None -60 5 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 385 3 1 7 2.2 COc1cc2nc(N3CCN(C(C)=O)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
CHEMBL4129461 161598 0 None -60 5 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration methodDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cell membranes after 30 mins by rapid filtration method
ChEMBL 385 3 1 7 2.2 COc1cc2nc(N3CCN(C(C)=O)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC 10.1016/j.bmc.2018.05.023
3038495 708 37 None -6 19 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 417 8 1 4 4.2 COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2 10.1016/j.bmcl.2015.12.068
7625 708 37 None -6 19 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 417 8 1 4 4.2 COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2 10.1016/j.bmcl.2015.12.068
CHEMBL25236 708 37 None -6 19 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 417 8 1 4 4.2 COc1ccccc1N1CCN(CC1)CCCCNC(=O)c1ccc2c(c1)cccc2 10.1016/j.bmcl.2015.12.068
1588 2325 27 None -26 44 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
28864 2325 27 None -26 44 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
43 2325 27 None -26 44 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
CHEMBL157138 2325 27 None -26 44 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
DB00589 2325 27 None -26 44 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC nan
10582624 202792 0 None 1 2 Rat 8.0 pKi = 8.0 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 393 4 1 7 1.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4nccnc4c3=O)C[C@@H]21 10.1021/jm000541z
CHEMBL62206 202792 0 None 1 2 Rat 8.0 pKi = 8.0 Binding
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary glandBinding affinity to alpha-1A adrenergic receptor in rat submaxillary gland
ChEMBL 393 4 1 7 1.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4nccnc4c3=O)C[C@@H]21 10.1021/jm000541z
10530732 168051 0 None 2 2 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 515 4 1 6 4.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cc(C(F)(F)F)ccc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL43234 168051 0 None 2 2 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 515 4 1 6 4.6 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cc(C(F)(F)F)ccc54)c3=O)C[C@@H]21 10.1021/jm990567u
9887378 98405 4 None 40 3 Human 8.0 pKi = 8.0 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 402 8 1 5 1.7 CC(C)Oc1ccccc1N1CCN(CCNC(=O)CN2CCCCC2=O)CC1 10.1016/j.bmcl.2004.11.032
CHEMBL275469 98405 4 None 40 3 Human 8.0 pKi = 8.0 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
ChEMBL 402 8 1 5 1.7 CC(C)Oc1ccccc1N1CCN(CCNC(=O)CN2CCCCC2=O)CC1 10.1016/j.bmcl.2004.11.032
11995034 11833 0 None 3 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cccc(-c2ccccc2)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL1182148 11833 0 None 3 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cccc(-c2ccccc2)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
CHEMBL214952 11833 0 None 3 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cellsDisplacement of [3H]prazosin from cloned human adrenergic alpha 1A receptor expressed in CHO cells
ChEMBL 391 8 1 5 4.2 COc1cccc(-c2ccccc2)c1OCCNC[C@@H]1COc2ccccc2O1 10.1021/jm060358r
44388495 63424 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranesInhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranes
ChEMBL 362 5 3 3 3.4 Nc1ccc(C(=O)NCCN2CCC(c3cccc4[nH]ccc34)CC2)cc1 10.1021/jm0491804
CHEMBL179721 63424 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranesInhibition of [3H]prazosin binding to human adrenergic alpha-1A receptor expressed in CHO-K1 cell membranes
ChEMBL 362 5 3 3 3.4 Nc1ccc(C(=O)NCCN2CCC(c3cccc4[nH]ccc34)CC2)cc1 10.1021/jm0491804
1212 1662 50 None -19 65 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
204 1662 50 None -19 65 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
3372 1662 50 None -19 65 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
CHEMBL726 1662 50 None -19 65 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
DB00623 1662 50 None -19 65 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F nan
44268966 33437 0 None -7 5 Rat 8.0 pKi = 8.0 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 476 7 1 7 3.6 COc1ccccc1N1CCN(CCCn2c(=O)[nH]c3scc(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
CHEMBL14199 33437 0 None -7 5 Rat 8.0 pKi = 8.0 Binding
Binding affinity towards rat Alpha-1A adrenergic receptorBinding affinity towards rat Alpha-1A adrenergic receptor
ChEMBL 476 7 1 7 3.6 COc1ccccc1N1CCN(CCCn2c(=O)[nH]c3scc(-c4ccccc4)c3c2=O)CC1 10.1016/s0960-894x(01)00159-7
3584 3777 64 None -2 13 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
5401 3777 64 None -2 13 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
7302 3777 64 None -2 13 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
CHEMBL611 3777 64 None -2 13 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
DB01162 3777 64 None -2 13 Rat 8.0 pKi = 8.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 nan
10644152 100395 7 None 1 3 Rat 8.0 pKi = 8.0 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 390 6 0 4 2.7 O=C1C2CCCN2C(=O)N1CCCCN1CCN(c2cccc(Cl)c2)CC1 10.1021/jm970216k
CHEMBL290039 100395 7 None 1 3 Rat 8.0 pKi = 8.0 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 390 6 0 4 2.7 O=C1C2CCCN2C(=O)N1CCCCN1CCN(c2cccc(Cl)c2)CC1 10.1021/jm970216k
44431546 88141 0 None -1 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 482 7 1 6 3.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3C#N)CC2)CC1 10.1016/j.bmcl.2007.04.008
CHEMBL234679 88141 0 None -1 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to human cloned adrenergic alpha-1A receptorBinding affinity to human cloned adrenergic alpha-1A receptor
ChEMBL 482 7 1 6 3.8 CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3C#N)CC2)CC1 10.1016/j.bmcl.2007.04.008
57391897 69309 0 None 1 5 Pig 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 481 12 1 8 2.7 CCOCCOc1ccn2ncc(C(=O)NCCCN3CCN(c4ccccc4OC)CC3)c2c1 10.1016/j.bmc.2011.10.063
CHEMBL1928133 69309 0 None 1 5 Pig 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenateDisplacement of [3H]prazosin from pig adrenergic alpha1 receptor in cerebral cortex homogenate
ChEMBL 481 12 1 8 2.7 CCOCCOc1ccn2ncc(C(=O)NCCCN3CCN(c4ccccc4OC)CC3)c2c1 10.1016/j.bmc.2011.10.063
44301573 202797 0 None 154 3 Human 8.0 pKi = 8.0 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 535 7 1 5 4.6 Cc1ccc(C2(c3ccc(C)cc3)CC(=O)N(CC(O)CN3CCC(C#N)(c4ccccc4C)CC3)C2=O)cc1 10.1016/s0960-894x(01)00320-1
CHEMBL62249 202797 0 None 154 3 Human 8.0 pKi = 8.0 Binding
In vitro binding affinity towards cloned human Alpha-1A adrenergic receptorIn vitro binding affinity towards cloned human Alpha-1A adrenergic receptor
ChEMBL 535 7 1 5 4.6 Cc1ccc(C2(c3ccc(C)cc3)CC(=O)N(CC(O)CN3CCC(C#N)(c4ccccc4C)CC3)C2=O)cc1 10.1016/s0960-894x(01)00320-1
53327992 63405 0 None -1 3 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 461 7 0 5 3.6 COc1ccccc1N1CCN(CCCCN2C(=O)CC3(CCc4ccccc43)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796050 63405 0 None -1 3 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 461 7 0 5 3.6 COc1ccccc1N1CCN(CCCCN2C(=O)CC3(CCc4ccccc43)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
52948823 17057 0 None -8 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 421 13 1 5 4.9 COc1cccc(OC)c1CCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
CHEMBL1254659 17057 0 None -8 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cellsDisplacement of [3H]prazosin from human adrenergic alpha1A expressed in CHO cells
ChEMBL 421 13 1 5 4.9 COc1cccc(OC)c1CCCNCCOc1ccccc1OCc1ccccc1 10.1016/j.bmc.2010.08.002
118716702 114995 0 None 5 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 396 4 0 7 1.1 COc1ccccc1N1CCN(CC2COC3(CCS(=O)(=O)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL3342855 114995 0 None 5 4 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 396 4 0 7 1.1 COc1ccccc1N1CCN(CC2COC3(CCS(=O)(=O)CC3)O2)CC1 10.1016/j.ejmech.2014.09.070
4110501 169094 8 None -2 2 Rat 8.0 pKi = 8 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 386 6 0 5 2.0 COc1ccccc1N1CCN(CCCN2C(=O)C3CCCCN3C2=O)CC1 10.1021/jm970216k
CHEMBL43992 169094 8 None -2 2 Rat 8.0 pKi = 8 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 386 6 0 5 2.0 COc1ccccc1N1CCN(CCCN2C(=O)C3CCCCN3C2=O)CC1 10.1021/jm970216k
9805944 56227 37 None -16 9 Human 8.0 pKi = 8 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptorDisplacement of [125I]HEAT from adrenergic alpha1A receptor
ChEMBL 462 7 2 3 4.7 CNC(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm800510m
CHEMBL1627 56227 37 None -16 9 Human 8.0 pKi = 8 Binding
Displacement of [125I]HEAT from adrenergic alpha1A receptorDisplacement of [125I]HEAT from adrenergic alpha1A receptor
ChEMBL 462 7 2 3 4.7 CNC(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm800510m
2247 505 81 None -5 42 Rat 8.0 pKi = 8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
249 505 81 None -5 42 Rat 8.0 pKi = 8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
2603 505 81 None -5 42 Rat 8.0 pKi = 8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
CHEMBL296419 505 81 None -5 42 Rat 8.0 pKi = 8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
DB00637 505 81 None -5 42 Rat 8.0 pKi = 8 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 nan
44461012 104273 0 None 7 3 Human 7.1 pKi = 7.1 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 509 6 0 7 3.7 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3cc4c(cc32)CCCC4)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL309949 104273 0 None 7 3 Human 7.1 pKi = 7.1 Binding
Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cellsAbility to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1a adrenergic receptor stably expressed in Chinese Hamster Ovary (CHO) cells
ChEMBL 509 6 0 7 3.7 O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3cc4c(cc32)CCCC4)CC1 10.1016/s0960-894x(98)00446-6
9913449 106452 1 None 13 3 Human 7.1 pKi = 7.1 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparations
ChEMBL 489 6 0 7 3.5 O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
CHEMBL313990 106452 1 None 13 3 Human 7.1 pKi = 7.1 Binding
Compound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparationsCompound was evaluated for its affinity for Alpha-1a adrenergic receptor in human aorta preparations
ChEMBL 489 6 0 7 3.5 O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1 10.1016/s0960-894x(98)00446-6
5019971 173271 4 None -15 2 Rat 7.0 pKi = 7.0 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 424 5 0 4 3.0 O=C1C2CCCCN2C(=O)N1CCCN1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1021/jm970216k
CHEMBL45253 173271 4 None -15 2 Rat 7.0 pKi = 7.0 Binding
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membraneBinding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]prazosin as radioligand in rat cerebral cortex membrane
ChEMBL 424 5 0 4 3.0 O=C1C2CCCCN2C(=O)N1CCCN1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1021/jm970216k
3805301 101337 83 None 1 2 Bovine 6.1 pKi = 6.1 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1ccc(N2CCNCC2)nc1 10.1021/jm00366a007
CHEMBL296787 101337 83 None 1 2 Bovine 6.1 pKi = 6.1 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 197 1 1 3 1.1 Clc1ccc(N2CCNCC2)nc1 10.1021/jm00366a007
44414189 12814 0 None -12 2 Rat 6.1 pKi = 6.1 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 342 5 1 5 3.3 Oc1nc2ccccc2n1C1CCN(CCCN2CCCCC2)CC1 10.1016/j.bmcl.2006.05.002
CHEMBL1188266 12814 0 None -12 2 Rat 6.1 pKi = 6.1 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 342 5 1 5 3.3 Oc1nc2ccccc2n1C1CCN(CCCN2CCCCC2)CC1 10.1016/j.bmcl.2006.05.002
CHEMBL535838 12814 0 None -12 2 Rat 6.1 pKi = 6.1 Binding
Displacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranesDisplacement of [3H]prazosin from adrenergic alpha-1A receptor in rat submaxillary gland membranes
ChEMBL 342 5 1 5 3.3 Oc1nc2ccccc2n1C1CCN(CCCN2CCCCC2)CC1 10.1016/j.bmcl.2006.05.002
71061709 149527 0 None -63 11 Mouse 5.0 pKi = 5.0 Binding
Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.
ChEMBL 372 6 0 4 3.5 Clc1cccc(OC[C@@H]2CN(CCN3CCc4ccccc43)CCO2)c1 nan
CHEMBL3946540 149527 0 None -63 11 Mouse 5.0 pKi = 5.0 Binding
Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.Radioligand Binding Assay: The detailed experimental protocols for the radioligand and functional receptor assays are available on the NIMH PDSP website at http://pdsp.med.unc.edu/UNC-CH %20Protocol %20Book.pdf. A. Serotonin receptors: 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT5A, 5-HT6 and 5-HT7. Assay Buffer: Standard Binding Buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM EDTA, pH 7.4) Membrane Fraction Source: Transiently or stably transfected cell lines (e.g., HEK293, COS, CHO, NIH3T3). Protocol adapted from Roth et al. (1986), J. Pharmacol. Exp. Ther., 238(2): 480-485; and Roth et al. (1994), J. Pharmacol. Exp. Ther., 268(3): 1403-1410. Adrenergic Receptors: alpha1A, alpha1B, alpha2A, alpha2B, alpha2C, beta1, beta2, beta3 Assay Buffers: For alpha1 receptors, alpha1 Binding Buffer (20 mM Tris-HCl, 145 mM NaCl, pH 7.4); for alpha2 receptors, alpha2 Binding Buffer (50 mM Tris-HCl, 5 mM MgCl2, pH 7.7); for beta receptors.
ChEMBL 372 6 0 4 3.5 Clc1cccc(OC[C@@H]2CN(CCN3CCc4ccccc43)CCO2)c1 nan
3658 4107 53 None -9 8 Human 7.0 pKi = 7.0 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1016/j.bmcl.2004.06.085
517 4107 53 None -9 8 Human 7.0 pKi = 7.0 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1016/j.bmcl.2004.06.085
5709 4107 53 None -9 8 Human 7.0 pKi = 7.0 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1016/j.bmcl.2004.06.085
CHEMBL312448 4107 53 None -9 8 Human 7.0 pKi = 7.0 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1016/j.bmcl.2004.06.085
DB06694 4107 53 None -9 8 Human 7.0 pKi = 7.0 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
ChEMBL 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C 10.1016/j.bmcl.2004.06.085
44269078 98597 7 None 1 2 Human 7.0 pKi = 7.0 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
ChEMBL 202 1 1 2 2.3 CC(C)(C)c1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.06.085
CHEMBL276868 98597 7 None 1 2 Human 7.0 pKi = 7.0 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
ChEMBL 202 1 1 2 2.3 CC(C)(C)c1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.06.085
135 2532 43 None -46 58 Rat 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
1796 2532 43 None -46 58 Rat 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
4184 2532 43 None -46 58 Rat 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
CHEMBL6437 2532 43 None -46 58 Rat 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
DB06148 2532 43 None -46 58 Rat 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 nan
44123711 84823 0 None -17 3 Human 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 346 4 0 5 2.9 COc1ccccc1N1CCN(CC2COC3(CCCCC3)O2)CC1 10.1007/s00044-010-9379-1
CHEMBL2234448 84823 0 None -17 3 Human 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 346 4 0 5 2.9 COc1ccccc1N1CCN(CC2COC3(CCCCC3)O2)CC1 10.1007/s00044-010-9379-1
9900133 8985 0 None 1 3 Rat 7.0 pKi = 7.0 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 271 2 2 3 3.1 COC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL109827 8985 0 None 1 3 Rat 7.0 pKi = 7.0 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 271 2 2 3 3.1 COC(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
46881443 5590 0 None -34 4 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 405 9 1 5 4.0 COc1cccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)c1 10.1016/j.bmcl.2010.01.030
CHEMBL1077168 5590 0 None -34 4 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cellsDisplacement of [3H]prazosin from human alpha1A adrenergic receptor expressed in CHO cells
ChEMBL 405 9 1 5 4.0 COc1cccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)c1 10.1016/j.bmcl.2010.01.030
44123711 84823 0 None -17 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 346 4 0 5 2.9 COc1ccccc1N1CCN(CC2COC3(CCCCC3)O2)CC1 10.1016/j.ejmech.2014.09.070
CHEMBL2234448 84823 0 None -17 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 346 4 0 5 2.9 COc1ccccc1N1CCN(CC2COC3(CCCCC3)O2)CC1 10.1016/j.ejmech.2014.09.070
44123711 84823 0 None -17 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 346 4 0 5 2.9 COc1ccccc1N1CCN(CC2COC3(CCCCC3)O2)CC1 10.1016/j.ejmech.2016.09.050
CHEMBL2234448 84823 0 None -17 3 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1a adrenergic receptor expressed in CHO cell membranes after 30 mins by TopCount liquid scintillation counting method
ChEMBL 346 4 0 5 2.9 COc1ccccc1N1CCN(CC2COC3(CCCCC3)O2)CC1 10.1016/j.ejmech.2016.09.050
11449200 78461 0 None 21 2 Rat 7.0 pKi = 7.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCC[C@H]2c1c[nH]cn1 10.1021/jm030551a
CHEMBL2111710 78461 0 None 21 2 Rat 7.0 pKi = 7.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 291 3 2 3 2.2 CS(=O)(=O)Nc1cccc2c1CCC[C@H]2c1c[nH]cn1 10.1021/jm030551a
9906677 101045 0 None -1 2 Rat 7.0 pKi = 7.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 355 4 0 4 2.3 O=C1CCC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
CHEMBL294646 101045 0 None -1 2 Rat 7.0 pKi = 7.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.In vitro binding affinity towards alpha-1A adrenergic receptor through displacement of [3H]prazosin in epididymal rat vas deferens.
ChEMBL 355 4 0 4 2.3 O=C1CCC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1 10.1021/jm030944+
44312198 204589 0 None -3 4 Human 4.0 pKi = 4.0 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 292 1 1 5 2.2 Brc1c(NC2=NCCO2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL73164 204589 0 None -3 4 Human 4.0 pKi = 4.0 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 292 1 1 5 2.2 Brc1c(NC2=NCCO2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
145947560 167708 0 None -4 5 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 344 6 0 3 4.2 Cc1cc(OCCCN2CCN(c3ccccc3)CC2)ccc1Cl 10.1016/j.bmcl.2018.04.059
CHEMBL4212812 167708 0 None -4 5 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 344 6 0 3 4.2 Cc1cc(OCCCN2CCN(c3ccccc3)CC2)ccc1Cl 10.1016/j.bmcl.2018.04.059
CHEMBL4302457 167708 0 None -4 5 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting methodDisplacement of [3H]prazosin from recombinant human alpha1 adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counting method
ChEMBL 344 6 0 3 4.2 Cc1cc(OCCCN2CCN(c3ccccc3)CC2)ccc1Cl 10.1016/j.bmcl.2018.04.059
2146 3100 67 None 1 9 Bovine 6.0 pKi = 6.0 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
485 3100 67 None 1 9 Bovine 6.0 pKi = 6.0 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
6041 3100 67 None 1 9 Bovine 6.0 pKi = 6.0 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
CHEMBL1215 3100 67 None 1 9 Bovine 6.0 pKi = 6.0 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
DB00388 3100 67 None 1 9 Bovine 6.0 pKi = 6.0 Binding
Binding affinity towards bovine clonal Alpha-1A adrenergic receptorBinding affinity towards bovine clonal Alpha-1A adrenergic receptor
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
9965896 110374 0 None - 1 Rat 6.0 pKi = 6.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 293 4 2 4 1.8 CCS(=O)(=O)Nc1cccc2c1COC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL324238 110374 0 None - 1 Rat 6.0 pKi = 6.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 293 4 2 4 1.8 CCS(=O)(=O)Nc1cccc2c1COC2c1c[nH]cn1 10.1021/jm030551a
136 3292 32 None -1479 15 Bovine 6.0 pKi = 6.0 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
223 3292 32 None -1479 15 Bovine 6.0 pKi = 6.0 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
643606 3292 32 None -1479 15 Bovine 6.0 pKi = 6.0 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
CHEMBL10347 3292 32 None -1479 15 Bovine 6.0 pKi = 6.0 Binding
Binding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligandBinding activity against alpha-1 adrenergic receptor from calf cerebral cortex, using [3H]-prazosin as the radioligand
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00366a007
136 3292 32 None -1479 15 Bovine 6.0 pKi = 6.0 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00375a017
223 3292 32 None -1479 15 Bovine 6.0 pKi = 6.0 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00375a017
643606 3292 32 None -1479 15 Bovine 6.0 pKi = 6.0 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00375a017
CHEMBL10347 3292 32 None -1479 15 Bovine 6.0 pKi = 6.0 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
ChEMBL 354 1 2 4 2.6 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 10.1021/jm00375a017
9929936 167912 0 None 1 4 Human 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 0 4 3.1 Cc1ccc(C)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1007/s00044-010-9379-1
CHEMBL431354 167912 0 None 1 4 Human 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 0 4 3.1 Cc1ccc(C)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1007/s00044-010-9379-1
76318763 84824 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 381 5 2 6 3.0 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccoc1)C3 10.1007/s00044-010-9379-1
CHEMBL2234449 84824 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 381 5 2 6 3.0 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccoc1)C3 10.1007/s00044-010-9379-1
11338016 35976 0 None -7 3 Human 7.0 pKi = 7.0 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 381 5 2 6 3.0 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccco1)C3 10.1021/jm030952q
CHEMBL144286 35976 0 None -7 3 Human 7.0 pKi = 7.0 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 381 5 2 6 3.0 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccco1)C3 10.1021/jm030952q
9929936 167912 0 None 1 4 Human 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 0 4 3.1 Cc1ccc(C)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1007/s00044-010-9379-1
CHEMBL431354 167912 0 None 1 4 Human 7.0 pKi = 7.0 Binding
Binding affinity to adrenergic alpha1A receptor (unknown origin)Binding affinity to adrenergic alpha1A receptor (unknown origin)
ChEMBL 383 4 0 4 3.1 Cc1ccc(C)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1 10.1007/s00044-010-9379-1
9926529 9389 2 None 1 4 Rat 7.0 pKi = 7.0 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
CHEMBL111496 9389 2 None 1 4 Rat 7.0 pKi = 7.0 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 305 4 2 3 2.6 CCS(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1007/s00044-004-0020-z
44361064 31615 0 None -3 5 Human 7.0 pKi = 7.0 Binding
Compound was tested for binding affinity against human hippocampus Alpha-1A adrenergic receptor using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against human hippocampus Alpha-1A adrenergic receptor using radioligand ([3H]prazosin) binding assay
ChEMBL 338 7 2 4 4.5 N=CCC(O)CC1CCN(c2ccccc2Oc2ccccc2)CC1 10.1021/jm960510x
CHEMBL140450 31615 0 None -3 5 Human 7.0 pKi = 7.0 Binding
Compound was tested for binding affinity against human hippocampus Alpha-1A adrenergic receptor using radioligand ([3H]prazosin) binding assayCompound was tested for binding affinity against human hippocampus Alpha-1A adrenergic receptor using radioligand ([3H]prazosin) binding assay
ChEMBL 338 7 2 4 4.5 N=CCC(O)CC1CCN(c2ccccc2Oc2ccccc2)CC1 10.1021/jm960510x
53328687 63402 0 None -1 3 Human 7.0 pKi = 7.0 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 483 8 0 5 4.4 COc1ccc(Cl)cc1N1CCN(CCCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
CHEMBL1796047 63402 0 None -1 3 Human 7.0 pKi = 7.0 Binding
Displacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cellsDisplacement of [125I]BE-2254 from human adrenergic alpha1A receptor expressed in HEK293 cells
ChEMBL 483 8 0 5 4.4 COc1ccc(Cl)cc1N1CCN(CCCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1 10.1016/j.ejmech.2011.03.054
10804826 23615 2 None 1 3 Rat 6.0 pKi = 6.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@@H]2C1=NCCN1 10.1021/jm960354u
CHEMBL133451 23615 2 None 1 3 Rat 6.0 pKi = 6.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 309 3 3 5 1.2 CS(=O)(=O)Nc1c(O)ccc2c1CCC[C@@H]2C1=NCCN1 10.1021/jm960354u
10065903 22302 0 None -257 4 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 341 5 2 5 2.4 O[C@H]1[C@@H](NC[C@@H]2COc3ccccc3O2)CC[C@@H]1Oc1ccccc1 10.1021/jm991065j
CHEMBL132378 22302 0 None -257 4 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptorDisplacement of [3H]prazosin from human cloned Alpha-1A adrenergic receptor
ChEMBL 341 5 2 5 2.4 O[C@H]1[C@@H](NC[C@@H]2COc3ccccc3O2)CC[C@@H]1Oc1ccccc1 10.1021/jm991065j
44276536 97369 0 None -1584 4 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 373 8 1 4 3.3 COc1ccccc1N1CCN(CCCCNC(=O)C2CCCCC2)CC1 10.1016/j.bmcl.2015.12.068
CHEMBL26962 97369 0 None -1584 4 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]-prazosin from human ADRA1A receptorDisplacement of [3H]-prazosin from human ADRA1A receptor
ChEMBL 373 8 1 4 3.3 COc1ccccc1N1CCN(CCCCNC(=O)C2CCCCC2)CC1 10.1016/j.bmcl.2015.12.068
10382537 204166 12 None -144 6 Human 6.0 pKi = 6.0 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 339 1 2 5 1.6 Ic1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
CHEMBL70676 204166 12 None -144 6 Human 6.0 pKi = 6.0 Binding
Binding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosinBinding affinity for human Alpha-1A adrenergic receptor from cultured LM(tk-) cells using [3H]-prazosin
ChEMBL 339 1 2 5 1.6 Ic1c(NC2=NCCN2)ccc2nccnc12 10.1016/0960-894X(95)00391-6
11488170 35230 0 None -24 3 Human 6.0 pKi = 6.0 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 467 10 2 8 3.6 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNCCOc1c(OC)cccc1OC)C3 10.1021/jm030952q
CHEMBL143558 35230 0 None -24 3 Human 6.0 pKi = 6.0 Binding
Binding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKiBinding affinity measured in CHO cells expressing human cloned Alpha-1A adrenergic receptor expressed as pKi
ChEMBL 467 10 2 8 3.6 COc1cc2nc3c(c(N)c2cc1OC)CCC(CNCCOc1c(OC)cccc1OC)C3 10.1021/jm030952q
2146 3100 67 None -12 9 Rat 6.0 pKi = 6.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
485 3100 67 None -12 9 Rat 6.0 pKi = 6.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
6041 3100 67 None -12 9 Rat 6.0 pKi = 6.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
CHEMBL1215 3100 67 None -12 9 Rat 6.0 pKi = 6.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
DB00388 3100 67 None -12 9 Rat 6.0 pKi = 6.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glandsBinding affinity towards Alpha-1A adrenergic receptor in rat submaxillary glands
ChEMBL 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10.1021/jm960354u
2803 955 58 None -8 19 Human 6.0 pKi = 6.0 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
516 955 58 None -8 19 Human 6.0 pKi = 6.0 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
704 955 58 None -8 19 Human 6.0 pKi = 6.0 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
CHEMBL134 955 58 None -8 19 Human 6.0 pKi = 6.0 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
DB00575 955 58 None -8 19 Human 6.0 pKi = 6.0 Binding
Binding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosinBinding affinity towards human Alpha-1C adrenergic receptor by the displacement of [3H]prazosin
ChEMBL 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl 10.1016/0960-894X(94)85032-1
155544514 176355 0 None -309 4 Human 6.0 pKi = 6.0 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 10 1 5 4.2 COc1ccccc1OCCNC[C@@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4526865 176355 0 None -309 4 Human 6.0 pKi = 6.0 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 10 1 5 4.2 COc1ccccc1OCCNC[C@@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
CHEMBL4595671 176355 0 None -309 4 Human 6.0 pKi = 6.0 Binding
Displacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation countingDisplacement of [3H] prazosin from human cloned adrenoceptor alpha 1A expressed in CHO cell membrane incubated for 30 mins by liquid scintillation counting
ChEMBL 419 10 1 5 4.2 COc1ccccc1OCCNC[C@@H]1CO[C@H](C(c2ccccc2)c2ccccc2)O1 10.1016/j.ejmech.2019.05.024
9944937 111338 0 None - 1 Bovine 6.0 pKi = 6.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 320 4 2 3 2.1 CN(C)S(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
CHEMBL326862 111338 0 None - 1 Bovine 6.0 pKi = 6.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of bovine clone in radioligand binding assay
ChEMBL 320 4 2 3 2.1 CN(C)S(=O)(=O)Nc1cccc2c1CCCC2c1c[nH]cn1 10.1021/jm030551a
162265 202274 22 None -5 43 Rat 5.0 pKi = 5.0 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 10.1007/s00044-004-0020-z
4786 202274 22 None -5 43 Rat 5.0 pKi = 5.0 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 10.1007/s00044-004-0020-z
CHEMBL61006 202274 22 None -5 43 Rat 5.0 pKi = 5.0 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
ChEMBL 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 10.1007/s00044-004-0020-z
162265 202274 22 None -5 43 Rat 5.0 pKi = 5.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 10.1021/jm030551a
4786 202274 22 None -5 43 Rat 5.0 pKi = 5.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 10.1021/jm030551a
CHEMBL61006 202274 22 None -5 43 Rat 5.0 pKi = 5.0 Binding
In vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assayIn vitro binding affinity towards alpha-1A adrenergic receptor of rat submaxillary gland in radioligand binding assay
ChEMBL 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 10.1021/jm030551a
118718431 115354 0 None 11 2 Human 7.0 pKi = 7.0 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 504 8 0 6 3.9 CCOC(=O)[C@H]1CN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CC[C@H]1c1ccccc1 10.1016/s0960-894x(98)00451-x
CHEMBL3349545 115354 0 None 11 2 Human 7.0 pKi = 7.0 Binding
Binding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assayBinding affinity against human Alpha-1a adrenergic receptor was evaluated by cloned receptor binding assay
ChEMBL 504 8 0 6 3.9 CCOC(=O)[C@H]1CN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CC[C@H]1c1ccccc1 10.1016/s0960-894x(98)00451-x
44267912 16883 0 None 102 3 Human 7.0 pKi = 7.0 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 388 8 1 5 1.3 COc1ccccc1N1CCN(CCCNC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
CHEMBL12501 16883 0 None 102 3 Human 7.0 pKi = 7.0 Binding
Binding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranesBinding affinity for human Alpha-1A adrenergic receptor expressed in COS cell membranes
ChEMBL 388 8 1 5 1.3 COc1ccccc1N1CCN(CCCNC(=O)CN2CCCCC2=O)CC1 10.1016/s0960-894x(00)00169-4
277 1301 62 None -117 50 Rat 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
2913 1301 62 None -117 50 Rat 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
765 1301 62 None -117 50 Rat 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
CHEMBL516 1301 62 None -117 50 Rat 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
DB00434 1301 62 None -117 50 Rat 7.0 pKi = 7.0 Binding
DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 nan
10673466 161764 0 None 12 2 Rat 7.0 pKi = 7 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 481 4 1 6 4.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5c(Cl)cccc54)c3=O)C[C@@H]21 10.1021/jm990567u
CHEMBL41396 161764 0 None 12 2 Rat 7.0 pKi = 7 Binding
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptorIn vitro binding affinity using [3H]prazosin as radioligand against alpha-1A adrenergic receptor
ChEMBL 481 4 1 6 4.2 COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5c(Cl)cccc54)c3=O)C[C@@H]21 10.1021/jm990567u
10297 27112 30 None -37 42 Rat 5.0 pKi = 5.0 Binding
Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (6.2 - 15)Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (6.2 - 15)
ChEMBL 151 2 2 2 1.1 C[C@H](N)[C@H](O)c1ccccc1 10.1021/jm025550h
CHEMBL136560 27112 30 None -37 42 Rat 5.0 pKi = 5.0 Binding
Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (6.2 - 15)Binding affinity towards rat submaxillary gland Alpha-1 adrenergic receptor; value ranges from (6.2 - 15)
ChEMBL 151 2 2 2 1.1 C[C@H](N)[C@H](O)c1ccccc1 10.1021/jm025550h
25070031 65385 18 None -4897 4 Human 5.0 pKi = 5.0 Binding
Inhibition of adrenergic alpha 1A receptorInhibition of adrenergic alpha 1A receptor
ChEMBL 313 6 1 4 2.7 C[C@@H]1CCCN1CCCOc1ccc(-c2ccc(=O)[nH]n2)cc1 10.1021/jm200401v
CHEMBL1829335 65385 18 None -4897 4 Human 5.0 pKi = 5.0 Binding
Inhibition of adrenergic alpha 1A receptorInhibition of adrenergic alpha 1A receptor
ChEMBL 313 6 1 4 2.7 C[C@@H]1CCCN1CCCOc1ccc(-c2ccc(=O)[nH]n2)cc1 10.1021/jm200401v
2477 745 59 None - 29 Bovine 8.3 pIC50 = 8.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
36 745 59 None - 29 Bovine 8.3 pIC50 = 8.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
437 745 59 None - 29 Bovine 8.3 pIC50 = 8.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
CHEMBL49 745 59 None - 29 Bovine 8.3 pIC50 = 8.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
DB00490 745 59 None - 29 Bovine 8.3 pIC50 = 8.3 Binding
Binding affinity against alpha-1 adrenergic receptor in calf frontal cortexBinding affinity against alpha-1 adrenergic receptor in calf frontal cortex
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
1816 2540 102 None - 18 Human 8.3 pIC50 = 8.3 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
Drug Central 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
4205 2540 102 None - 18 Human 8.3 pIC50 = 8.3 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
Drug Central 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
7241 2540 102 None - 18 Human 8.3 pIC50 = 8.3 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
Drug Central 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
CHEMBL654 2540 102 None - 18 Human 8.3 pIC50 = 8.3 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
Drug Central 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
DB00370 2540 102 None - 18 Human 8.3 pIC50 = 8.3 Binding
Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.
Drug Central 265 0 0 3 2.5 CN1CCN2C(C1)c1ccccc1Cc1c2nccc1 None
9952220 98256 6 None - 4 Rat 8.2 pIC50 = 8.2 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
Drug Central 387 6 2 4 3.8 CNc1cc(OC)c(C(=O)N[C@H]2CCN(Cc3ccccc3)[C@H]2C)cc1Cl None
CHEMBL274491 98256 6 None - 4 Rat 8.2 pIC50 = 8.2 Binding
Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranesBinding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes
Drug Central 387 6 2 4 3.8 CNc1cc(OC)c(C(=O)N[C@H]2CCN(Cc3ccccc3)[C@H]2C)cc1Cl None
135 2532 43 None -40 58 Human 8.2 pIC50 = 8.2 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
1796 2532 43 None -40 58 Human 8.2 pIC50 = 8.2 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
4184 2532 43 None -40 58 Human 8.2 pIC50 = 8.2 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
CHEMBL6437 2532 43 None -40 58 Human 8.2 pIC50 = 8.2 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
DB06148 2532 43 None -40 58 Human 8.2 pIC50 = 8.2 Binding
Binding affinity for human cloned Alpha-1A adrenergic receptorBinding affinity for human cloned Alpha-1A adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
135398737 958 93 None - 89 Bovine 8.2 pIC50 = 8.2 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 958 93 None - 89 Bovine 8.2 pIC50 = 8.2 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 958 93 None - 89 Bovine 8.2 pIC50 = 8.2 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 958 93 None - 89 Bovine 8.2 pIC50 = 8.2 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 958 93 None - 89 Bovine 8.2 pIC50 = 8.2 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
5656 203066 87 None - 40 Rat 8.2 pIC50 = 8.2 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
Drug Central 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 None
CHEMBL637 203066 87 None - 40 Rat 8.2 pIC50 = 8.2 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
Drug Central 277 5 1 3 3.0 COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 None
125017 9451 99 None - 0 Rat 8.1 pIC50 = 8.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
Drug Central 263 4 2 3 2.7 CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1 None
CHEMBL1118 9451 99 None - 0 Rat 8.1 pIC50 = 8.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
Drug Central 263 4 2 3 2.7 CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1 None
1353 1911 93 None - 83 Bovine 8.1 pIC50 = 8.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
3559 1911 93 None - 83 Bovine 8.1 pIC50 = 8.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
86 1911 93 None - 83 Bovine 8.1 pIC50 = 8.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
CHEMBL54 1911 93 None - 83 Bovine 8.1 pIC50 = 8.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
DB00502 1911 93 None - 83 Bovine 8.1 pIC50 = 8.1 Binding
Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosinAffinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
2435 3590 83 None - 48 Rat 8.1 pIC50 = 8.1 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
60149 3590 83 None - 48 Rat 8.1 pIC50 = 8.1 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
98 3590 83 None - 48 Rat 8.1 pIC50 = 8.1 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
CHEMBL12713 3590 83 None - 48 Rat 8.1 pIC50 = 8.1 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
DB06144 3590 83 None - 48 Rat 8.1 pIC50 = 8.1 Binding
Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranesDisplacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
1427 2013 54 None - 27 Rat 8.1 pIC50 = 8.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
357 2013 54 None - 27 Rat 8.1 pIC50 = 8.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
3696 2013 54 None - 27 Rat 8.1 pIC50 = 8.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
CHEMBL11 2013 54 None - 27 Rat 8.1 pIC50 = 8.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
DB00458 2013 54 None - 27 Rat 8.1 pIC50 = 8.1 Binding
Inhibition of binding of [3H]imipramine to imipramine receptor in rat brainInhibition of binding of [3H]imipramine to imipramine receptor in rat brain
Drug Central 280 4 0 2 3.9 CN(CCCN1c2ccccc2CCc2c1cccc2)C None
102 4127 48 None -346 49 Human 8.2 pKd = 8.2 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4127 48 None -346 49 Human 8.2 pKd = 8.2 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4127 48 None -346 49 Human 8.2 pKd = 8.2 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4127 48 None -346 49 Human 8.2 pKd = 8.2 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4127 48 None -346 49 Human 8.2 pKd = 8.2 Binding
Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptorInhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
2803 955 58 None -3 19 Rat 8.2 pKd = 8.2 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 955 58 None -3 19 Rat 8.2 pKd = 8.2 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 955 58 None -3 19 Rat 8.2 pKd = 8.2 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 955 58 None -3 19 Rat 8.2 pKd = 8.2 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 955 58 None -3 19 Rat 8.2 pKd = 8.2 Binding
The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
1353 1911 93 None -10 83 Rat 8.1 pKd = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
3559 1911 93 None -10 83 Rat 8.1 pKd = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
86 1911 93 None -10 83 Rat 8.1 pKd = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
CHEMBL54 1911 93 None -10 83 Rat 8.1 pKd = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
DB00502 1911 93 None -10 83 Rat 8.1 pKd = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aortaBinding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
4209 3163 75 None -3 33 Human 9.1 pKd = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
4893 3163 75 None -3 33 Human 9.1 pKd = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
503 3163 75 None -3 33 Human 9.1 pKd = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
5385 3163 75 None -3 33 Human 9.1 pKd = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
CHEMBL2 3163 75 None -3 33 Human 9.1 pKd = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
DB00457 3163 75 None -3 33 Human 9.1 pKd = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
4106 2502 22 3H-PRAZOSIN -1 34 Pig 10.2 pKi = 10.2 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
5358812 2502 22 3H-PRAZOSIN -1 34 Pig 10.2 pKi = 10.2 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
89 2502 22 3H-PRAZOSIN -1 34 Pig 10.2 pKi = 10.2 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
CHEMBL93240 2502 22 3H-PRAZOSIN -1 34 Pig 10.2 pKi = 10.2 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
None 215958 0 3H-PRAZOSIN -5 19 Pig 10.1 pKi = 10.1 Binding
NoneNone
PDSP KiDatabase 421 9 1 6 4.3 COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3O2)C4=CC=CC=C4 None
4209 3163 75 3H-PRAZOSIN -2 33 Pig 9.6 pKi = 9.6 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3163 75 3H-PRAZOSIN -2 33 Pig 9.6 pKi = 9.6 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3163 75 3H-PRAZOSIN -2 33 Pig 9.6 pKi = 9.6 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3163 75 3H-PRAZOSIN -2 33 Pig 9.6 pKi = 9.6 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3163 75 3H-PRAZOSIN -2 33 Pig 9.6 pKi = 9.6 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3163 75 3H-PRAZOSIN -2 33 Pig 9.6 pKi = 9.6 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4106 2502 22 3H-PRAZOSIN -1 34 Pig 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
5358812 2502 22 3H-PRAZOSIN -1 34 Pig 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
89 2502 22 3H-PRAZOSIN -1 34 Pig 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
CHEMBL93240 2502 22 3H-PRAZOSIN -1 34 Pig 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
2389 3331 118 3H-PRAZOSIN -5 67 Pig 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 3331 118 3H-PRAZOSIN -5 67 Pig 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 3331 118 3H-PRAZOSIN -5 67 Pig 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 3331 118 3H-PRAZOSIN -5 67 Pig 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 3331 118 3H-PRAZOSIN -5 67 Pig 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
None 215958 0 3H-PRAZOSIN -5 19 Pig 9.3 pKi = 9.3 Binding
NoneNone
PDSP KiDatabase 421 9 1 6 4.3 COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3O2)C4=CC=CC=C4 None
4209 3163 75 3H-PRAZOSIN -2 33 Pig 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3163 75 3H-PRAZOSIN -2 33 Pig 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3163 75 3H-PRAZOSIN -2 33 Pig 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3163 75 3H-PRAZOSIN -2 33 Pig 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3163 75 3H-PRAZOSIN -2 33 Pig 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3163 75 3H-PRAZOSIN -2 33 Pig 9.2 pKi = 9.2 Binding
NoneNone
PDSP KiDatabase 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
489 145 28 3H-PRAZOSIN -8 12 Pig 9.1 pKi = 9.1 Binding
NoneNone
PDSP KiDatabase 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C None
5640 145 28 3H-PRAZOSIN -8 12 Pig 9.1 pKi = 9.1 Binding
NoneNone
PDSP KiDatabase 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C None
CHEMBL420060 145 28 3H-PRAZOSIN -8 12 Pig 9.1 pKi = 9.1 Binding
NoneNone
PDSP KiDatabase 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C None
489 145 28 3H-PRAZOSIN -8 12 Pig 9.0 pKi = 9 Binding
NoneNone
PDSP KiDatabase 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C None
5640 145 28 3H-PRAZOSIN -8 12 Pig 9.0 pKi = 9 Binding
NoneNone
PDSP KiDatabase 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C None
CHEMBL420060 145 28 3H-PRAZOSIN -8 12 Pig 9.0 pKi = 9 Binding
NoneNone
PDSP KiDatabase 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C None
2389 3331 118 3H-PRAZOSIN -5 67 Pig 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 3331 118 3H-PRAZOSIN -5 67 Pig 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 3331 118 3H-PRAZOSIN -5 67 Pig 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 3331 118 3H-PRAZOSIN -5 67 Pig 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 3331 118 3H-PRAZOSIN -5 67 Pig 8.9 pKi = 8.9 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
463 1405 22 None 5 12 Human 8.0 pKi = 8 Binding
GRAC: human a1A selective antagonistGRAC: human a1A selective antagonist
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
6918097 1405 22 None 5 12 Human 8.0 pKi = 8 Binding
GRAC: human a1A selective antagonistGRAC: human a1A selective antagonist
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
837 1405 22 None 5 12 Human 8.0 pKi = 8 Binding
GRAC: human a1A selective antagonistGRAC: human a1A selective antagonist
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
CHEMBL2051956 1405 22 None 5 12 Human 8.0 pKi = 8 Binding
GRAC: human a1A selective antagonistGRAC: human a1A selective antagonist
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
DB14068 1405 22 None 5 12 Human 8.0 pKi = 8 Binding
GRAC: human a1A selective antagonistGRAC: human a1A selective antagonist
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
4209 3163 75 None -3 33 Rat 8.0 pKi = 8.0 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3163 75 None -3 33 Rat 8.0 pKi = 8.0 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3163 75 None -3 33 Rat 8.0 pKi = 8.0 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3163 75 None -3 33 Rat 8.0 pKi = 8.0 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3163 75 None -3 33 Rat 8.0 pKi = 8.0 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3163 75 None -3 33 Rat 8.0 pKi = 8.0 Binding
Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary glandInhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4209 3163 75 None -3 33 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3163 75 None -3 33 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3163 75 None -3 33 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3163 75 None -3 33 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3163 75 None -3 33 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3163 75 None -3 33 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cellsDisplacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4151 3607 89 None 33 3 Human 8.0 pKi = 8.0 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
Drug Central 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N None
493 3607 89 None 33 3 Human 8.0 pKi = 8.0 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
Drug Central 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N None
5312125 3607 89 None 33 3 Human 8.0 pKi = 8.0 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
Drug Central 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N None
CHEMBL24778 3607 89 None 33 3 Human 8.0 pKi = 8.0 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
Drug Central 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N None
DB06207 3607 89 None 33 3 Human 8.0 pKi = 8.0 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active
Drug Central 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N None
129211 3749 78 None -2 15 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
2562 3749 78 None -2 15 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
488 3749 78 None -2 15 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
CHEMBL836 3749 78 None -2 15 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
DB00706 3749 78 None -2 15 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
129211 3749 78 None -1 15 Human 8.0 pKi = 8.0 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
2562 3749 78 None -1 15 Human 8.0 pKi = 8.0 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
488 3749 78 None -1 15 Human 8.0 pKi = 8.0 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
CHEMBL836 3749 78 None -1 15 Human 8.0 pKi = 8.0 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
DB00706 3749 78 None -1 15 Human 8.0 pKi = 8.0 Binding
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligandBinding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
484 2858 51 3H-PRAZOSIN -16 35 Pig 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
951 2858 51 3H-PRAZOSIN -16 35 Pig 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
CHEMBL432 2858 51 3H-PRAZOSIN -16 35 Pig 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
2470 3653 50 3H-PRAZOSIN -478 59 Pig 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
3300 3653 50 3H-PRAZOSIN -478 59 Pig 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
5265 3653 50 3H-PRAZOSIN -478 59 Pig 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
99 3653 50 3H-PRAZOSIN -478 59 Pig 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
CHEMBL267930 3653 50 3H-PRAZOSIN -478 59 Pig 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
100 3805 58 3H-PRAZOSIN -20 55 Pig 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
2637 3805 58 3H-PRAZOSIN -20 55 Pig 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
5452 3805 58 3H-PRAZOSIN -20 55 Pig 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
CHEMBL479 3805 58 3H-PRAZOSIN -20 55 Pig 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
DB00679 3805 58 3H-PRAZOSIN -20 55 Pig 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
2389 3331 118 3H-PRAZOSIN -5 67 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 3331 118 3H-PRAZOSIN -5 67 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 3331 118 3H-PRAZOSIN -5 67 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 3331 118 3H-PRAZOSIN -5 67 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 3331 118 3H-PRAZOSIN -5 67 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
100 3805 58 3H-PRAZOSIN -20 55 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
2637 3805 58 3H-PRAZOSIN -20 55 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
5452 3805 58 3H-PRAZOSIN -20 55 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
CHEMBL479 3805 58 3H-PRAZOSIN -20 55 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
DB00679 3805 58 3H-PRAZOSIN -20 55 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
None 215958 0 3H-PRAZOSIN -5 19 Pig 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 421 9 1 6 4.3 COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3O2)C4=CC=CC=C4 None
2726 919 68 3H-PRAZOSIN -20 72 Pig 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 919 68 3H-PRAZOSIN -20 72 Pig 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 919 68 3H-PRAZOSIN -20 72 Pig 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 919 68 3H-PRAZOSIN -20 72 Pig 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 919 68 3H-PRAZOSIN -20 72 Pig 6.8 pKi = 6.8 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
124 2981 47 3H-PRAZOSIN -36 33 Pig 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2981 47 3H-PRAZOSIN -36 33 Pig 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2981 47 3H-PRAZOSIN -36 33 Pig 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2981 47 3H-PRAZOSIN -36 33 Pig 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2981 47 3H-PRAZOSIN -36 33 Pig 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
None 216241 0 3H-PRAZOSIN -2 4 Pig 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 609 10 1 8 6.0 CC1=C(C(C(=C(N1)C)C(=O)OCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC None
126225 94976 5 3H-PRAZOSIN -41 8 Pig 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 None
CHEMBL25467 94976 5 3H-PRAZOSIN -41 8 Pig 6.6 pKi = 6.6 Binding
NoneNone
PDSP KiDatabase 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 None
None 216241 0 3H-PRAZOSIN -2 4 Pig 5.6 pKi = 5.6 Binding
NoneNone
PDSP KiDatabase 609 10 1 8 6.0 CC1=C(C(C(=C(N1)C)C(=O)OCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC None
135398737 958 93 3H-PRAZOSIN -9 89 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 958 93 3H-PRAZOSIN -9 89 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 958 93 3H-PRAZOSIN -9 89 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 958 93 3H-PRAZOSIN -9 89 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 958 93 3H-PRAZOSIN -9 89 Pig 8.5 pKi = 8.5 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
489 145 28 3H-PRAZOSIN -8 12 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C None
5640 145 28 3H-PRAZOSIN -8 12 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C None
CHEMBL420060 145 28 3H-PRAZOSIN -8 12 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C None
124 2981 47 3H-PRAZOSIN -36 33 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2981 47 3H-PRAZOSIN -36 33 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2981 47 3H-PRAZOSIN -36 33 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2981 47 3H-PRAZOSIN -36 33 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2981 47 3H-PRAZOSIN -36 33 Pig 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
None 216241 0 3H-PRAZOSIN -2 4 Pig 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 609 10 1 8 6.0 CC1=C(C(C(=C(N1)C)C(=O)OCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC None
100 3805 58 3H-PRAZOSIN -20 55 Pig 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
2637 3805 58 3H-PRAZOSIN -20 55 Pig 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
5452 3805 58 3H-PRAZOSIN -20 55 Pig 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
CHEMBL479 3805 58 3H-PRAZOSIN -20 55 Pig 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
DB00679 3805 58 3H-PRAZOSIN -20 55 Pig 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 370 4 0 4 5.9 CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1 None
1028 291 71 3H-PRAZOSIN -741 30 Pig 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
139148732 291 71 3H-PRAZOSIN -741 30 Pig 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
479 291 71 3H-PRAZOSIN -741 30 Pig 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
5816 291 71 3H-PRAZOSIN -741 30 Pig 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL679 291 71 3H-PRAZOSIN -741 30 Pig 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
DB00668 291 71 3H-PRAZOSIN -741 30 Pig 5.4 pKi = 5.4 Binding
NoneNone
PDSP KiDatabase 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
3016 1412 48 None 46 5 Human 8.4 pKi = 8.4 Binding
NoneNone
Drug Central 284 1 0 2 3.2 Clc1ccc2c(c1)C(=NCC(=O)N2C)c1ccccc1 None
3364 1412 48 None 46 5 Human 8.4 pKi = 8.4 Binding
NoneNone
Drug Central 284 1 0 2 3.2 Clc1ccc2c(c1)C(=NCC(=O)N2C)c1ccccc1 None
852 1412 48 None 46 5 Human 8.4 pKi = 8.4 Binding
NoneNone
Drug Central 284 1 0 2 3.2 Clc1ccc2c(c1)C(=NCC(=O)N2C)c1ccccc1 None
CHEMBL12 1412 48 None 46 5 Human 8.4 pKi = 8.4 Binding
NoneNone
Drug Central 284 1 0 2 3.2 Clc1ccc2c(c1)C(=NCC(=O)N2C)c1ccccc1 None
DB00829 1412 48 None 46 5 Human 8.4 pKi = 8.4 Binding
NoneNone
Drug Central 284 1 0 2 3.2 Clc1ccc2c(c1)C(=NCC(=O)N2C)c1ccccc1 None
4508 3139 98 None 1 12 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 183 3 4 4 0.4 CNCC(c1ccc(c(c1)O)O)O None
4866774 3139 98 None 1 12 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 183 3 4 4 0.4 CNCC(c1ccc(c(c1)O)O)O None
509 3139 98 None 1 12 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 183 3 4 4 0.4 CNCC(c1ccc(c(c1)O)O)O None
838 3139 98 None 1 12 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 183 3 4 4 0.4 CNCC(c1ccc(c(c1)O)O)O None
CHEMBL1740 3139 98 None 1 12 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 183 3 4 4 0.4 CNCC(c1ccc(c(c1)O)O)O None
162265 202274 22 None -5 43 Rat 8.3 pKi = 8.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
Drug Central 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
4786 202274 22 None -5 43 Rat 8.3 pKi = 8.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
Drug Central 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
CHEMBL61006 202274 22 None -5 43 Rat 8.3 pKi = 8.3 Binding
Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assayBinding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay
Drug Central 151 2 2 2 1.1 CC(N)C(O)c1ccccc1 None
2470 3653 50 3H-PRAZOSIN -478 59 Pig 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
3300 3653 50 3H-PRAZOSIN -478 59 Pig 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
5265 3653 50 3H-PRAZOSIN -478 59 Pig 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
99 3653 50 3H-PRAZOSIN -478 59 Pig 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
CHEMBL267930 3653 50 3H-PRAZOSIN -478 59 Pig 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
68712 100338 60 None -8 5 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 None
CHEMBL289480 100338 60 None -8 5 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 180 3 1 3 1.2 C1COC(NC(C2CC2)C2CC2)=N1 None
2146 3100 67 None -2 9 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
485 3100 67 None -2 9 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
6041 3100 67 None -2 9 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
CHEMBL1215 3100 67 None -2 9 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
DB00388 3100 67 None -2 9 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
2695 3841 81 None 9 6 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
5504 3841 81 None 9 6 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
7310 3841 81 None 9 6 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
CHEMBL770 3841 81 None 9 6 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
DB00797 3841 81 None 9 6 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 160 2 1 2 1.2 c1ccc(cc1)CC1=NCCN1 None
2435 722 100 None -21 12 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
395 722 100 None -21 12 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
520 722 100 None -21 12 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
5386 722 100 None -21 12 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
CHEMBL844 722 100 None -21 12 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
DB00484 722 100 None -21 12 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 291 1 2 5 1.8 Brc1c(ccc2c1nccn2)NC1=NCCN1 None
1830 2590 44 None 1 28 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
207 2590 44 None 1 28 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
23897 2590 44 None 1 28 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
CHEMBL460 2590 44 None 1 28 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
DB01618 2590 44 None 1 28 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 276 3 1 3 2.0 CCc1c(C)[nH]c2c1C(=O)C(CC2)CN1CCOCC1 None
2162 41514 100 None -3 6 Human 8.3 pKi = 8.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
Drug Central 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl None
CHEMBL1491 41514 100 None -3 6 Human 8.3 pKi = 8.3 Binding
Binding affinity against human Alpha-1a adrenergic receptorBinding affinity against human Alpha-1a adrenergic receptor
Drug Central 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl None
446220 133521 14 None 19 45 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 303 3 0 5 1.9 COC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2C None
CHEMBL370805 133521 14 None 19 45 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 303 3 0 5 1.9 COC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2C None
1028 291 71 None -48 30 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
139148732 291 71 None -48 30 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
479 291 71 None -48 30 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
5816 291 71 None -48 30 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL679 291 71 None -48 30 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
DB00668 291 71 None -48 30 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O None
1960 2857 67 None -57 26 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
439260 2857 67 None -57 26 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
505 2857 67 None -57 26 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL1437 2857 67 None -57 26 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
DB00368 2857 67 None -57 26 Human 8.2 pKi = 8.2 Binding
Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
126225 94976 5 3H-PRAZOSIN -41 8 Pig 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 None
CHEMBL25467 94976 5 3H-PRAZOSIN -41 8 Pig 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 None
484 2858 51 3H-PRAZOSIN -16 35 Pig 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
951 2858 51 3H-PRAZOSIN -16 35 Pig 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
CHEMBL432 2858 51 3H-PRAZOSIN -16 35 Pig 5.3 pKi = 5.3 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
2146 3100 67 None 1 9 Bovine 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
485 3100 67 None 1 9 Bovine 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
6041 3100 67 None 1 9 Bovine 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
CHEMBL1215 3100 67 None 1 9 Bovine 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
DB00388 3100 67 None 1 9 Bovine 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O None
2202 3132 96 None -2 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
4850 3132 96 None -2 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
49 3132 96 None -2 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
CHEMBL1371770 3132 96 None -2 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
DB12478 3132 96 None -2 21 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 None
135398737 958 93 3H-PRAZOSIN -9 89 Pig 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 958 93 3H-PRAZOSIN -9 89 Pig 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 958 93 3H-PRAZOSIN -9 89 Pig 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 958 93 3H-PRAZOSIN -9 89 Pig 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 958 93 3H-PRAZOSIN -9 89 Pig 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
1960 2857 67 None -10 26 Bovine 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
439260 2857 67 None -10 26 Bovine 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
505 2857 67 None -10 26 Bovine 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
CHEMBL1437 2857 67 None -10 26 Bovine 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
DB00368 2857 67 None -10 26 Bovine 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O None
5284550 41721 15 None 1 9 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 295 3 0 2 4.7 CN(C)CC/C=C1\c2ccccc2CSc2ccccc21 None
CHEMBL1492500 41721 15 None 1 9 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 295 3 0 2 4.7 CN(C)CC/C=C1\c2ccccc2CSc2ccccc21 None
2477 745 59 None 1 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
36 745 59 None 1 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
437 745 59 None 1 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
CHEMBL49 745 59 None 1 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
DB00490 745 59 None 1 29 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 385 6 0 6 2.1 O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1 None
37 778 60 None -18 17 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C None
460 778 60 None -18 17 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C None
54746 778 60 None -18 17 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C None
CHEMBL1201087 778 60 None -18 17 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C None
DB00248 778 60 None -18 17 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C None
66265 94013 15 None -1 19 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1 None
CHEMBL248702 94013 15 None -1 19 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1 None
3151 1462 97 None -8 27 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
945 1462 97 None -8 27 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
965 1462 97 None -8 27 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
CHEMBL219916 1462 97 None -8 27 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
DB01184 1462 97 None -8 27 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 425 5 2 5 3.4 Clc1ccc2c(c1)[nH]c(=O)n2C1CCN(CC1)CCCn1c(=O)[nH]c2c1cccc2 None
16362 3125 71 None -35 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
2172 3125 71 None -35 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
90 3125 71 None -35 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
CHEMBL1423 3125 71 None -35 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
DB01100 3125 71 None -35 30 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 None
15387 45822 55 None 1 24 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 263 5 0 2 3.5 CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1 None
CHEMBL1531134 45822 55 None 1 24 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 263 5 0 2 3.5 CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1 None
68617 205527 62 None 3 26 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 None
CHEMBL1709 205527 62 None 3 26 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 None
CHEMBL809 205527 62 None 3 26 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 305 2 1 1 5.2 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 None
2470 3653 50 3H-PRAZOSIN -478 59 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
3300 3653 50 3H-PRAZOSIN -478 59 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
5265 3653 50 3H-PRAZOSIN -478 59 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
99 3653 50 3H-PRAZOSIN -478 59 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
CHEMBL267930 3653 50 3H-PRAZOSIN -478 59 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
126225 94976 5 3H-PRAZOSIN -41 8 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 None
CHEMBL25467 94976 5 3H-PRAZOSIN -41 8 Pig 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 263 1 0 2 4.2 C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3 None
135398737 958 93 3H-PRAZOSIN -9 89 Pig 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 958 93 3H-PRAZOSIN -9 89 Pig 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 958 93 3H-PRAZOSIN -9 89 Pig 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 958 93 3H-PRAZOSIN -9 89 Pig 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 958 93 3H-PRAZOSIN -9 89 Pig 6.2 pKi = 6.2 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
484 2858 51 3H-PRAZOSIN -16 35 Pig 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
951 2858 51 3H-PRAZOSIN -16 35 Pig 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
CHEMBL432 2858 51 3H-PRAZOSIN -16 35 Pig 5.2 pKi = 5.2 Binding
NoneNone
PDSP KiDatabase 169 2 4 4 0.1 NCC(c1ccc(c(c1)O)O)O None
2995 204405 53 None 3 23 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
CHEMBL1696 204405 53 None 3 23 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
CHEMBL72 204405 53 None 3 23 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 266 4 1 2 3.5 CNCCCN1c2ccccc2CCc2ccccc21 None
3947 206395 53 None -1 16 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 418 7 0 3 5.8 CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1 None
CHEMBL87708 206395 53 None -1 16 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 418 7 0 3 5.8 CN(CCCN1c2ccccc2CCc2ccccc21)CC(=O)c1ccc(Cl)cc1 None
3658 4107 53 None -9 8 Human 8.2 pKi = 8.2 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
Drug Central 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
517 4107 53 None -9 8 Human 8.2 pKi = 8.2 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
Drug Central 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
5709 4107 53 None -9 8 Human 8.2 pKi = 8.2 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
Drug Central 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
CHEMBL312448 4107 53 None -9 8 Human 8.2 pKi = 8.2 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
Drug Central 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
DB06694 4107 53 None -9 8 Human 8.2 pKi = 8.2 Binding
Binding affinity towards human Alpha-1 adrenergic receptorBinding affinity towards human Alpha-1 adrenergic receptor
Drug Central 244 2 1 2 3.1 Cc1cc(cc(c1CC1=NCCN1)C)C(C)(C)C None
2448 99323 70 None -5 18 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 419 6 1 3 4.5 O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1 None
CHEMBL28218 99323 70 None -5 18 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 419 6 1 3 4.5 O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1 None
21302490 112805 32 None -10 9 Human 8.2 pKi = 8.2 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
Drug Central 393 5 0 4 3.9 CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12 None
CHEMBL3233142 112805 32 None -10 9 Human 8.2 pKi = 8.2 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
Drug Central 393 5 0 4 3.9 CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12 None
CHEMBL3306803 112805 32 None -10 9 Human 8.2 pKi = 8.2 Binding
Inhibition of adrenergic alpha1A receptor (unknown origin)Inhibition of adrenergic alpha1A receptor (unknown origin)
Drug Central 393 5 0 4 3.9 CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12 None
242 470 124 None -14 51 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
34 470 124 None -14 51 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
60795 470 124 None -14 51 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
CHEMBL1112 470 124 None -14 51 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
DB01238 470 124 None -14 51 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl None
125564 666 97 None -12 7 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 367 3 0 3 4.7 CCN1CCN(CC1)c1nc2CCCCCCc2c(c1)c1ccc(cc1)F None
388 666 97 None -12 7 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 367 3 0 3 4.7 CCN1CCN(CC1)c1nc2CCCCCCc2c(c1)c1ccc(cc1)F None
7670 666 97 None -12 7 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 367 3 0 3 4.7 CCN1CCN(CC1)c1nc2CCCCCCc2c(c1)c1ccc(cc1)F None
CHEMBL178803 666 97 None -12 7 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 367 3 0 3 4.7 CCN1CCN(CC1)c1nc2CCCCCCc2c(c1)c1ccc(cc1)F None
DB09223 666 97 None -12 7 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 367 3 0 3 4.7 CCN1CCN(CC1)c1nc2CCCCCCc2c(c1)c1ccc(cc1)F None
1971 2866 38 None -1 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
2404 2866 38 None -1 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
4543 2866 38 None -1 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
CHEMBL445 2866 38 None -1 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
DB00540 2866 38 None -1 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 None
2267 559 71 None -15 7 Human 8.1 pKi = 8.1 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
Drug Central 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 None
271 559 71 None -15 7 Human 8.1 pKi = 8.1 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
Drug Central 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 None
7121 559 71 None -15 7 Human 8.1 pKi = 8.1 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
Drug Central 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 None
CHEMBL639 559 71 None -15 7 Human 8.1 pKi = 8.1 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
Drug Central 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 None
DB00972 559 71 None -15 7 Human 8.1 pKi = 8.1 Binding
Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblastsBinding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts
Drug Central 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 None
2267 559 71 None -15 7 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
Drug Central 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 None
271 559 71 None -15 7 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
Drug Central 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 None
7121 559 71 None -15 7 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
Drug Central 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 None
CHEMBL639 559 71 None -15 7 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
Drug Central 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 None
DB00972 559 71 None -15 7 Rat 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptorDisplacement of [3H]prazosin from rat salivary gland adrenergic alpha1a receptor
Drug Central 381 3 0 4 4.3 CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2 None
135 2532 43 None -9 58 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
1796 2532 43 None -9 58 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
4184 2532 43 None -9 58 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
CHEMBL6437 2532 43 None -9 58 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
DB06148 2532 43 None -9 58 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptorDisplacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor
Drug Central 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 None
277 1301 62 None -20 50 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
2913 1301 62 None -20 50 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
765 1301 62 None -20 50 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
CHEMBL516 1301 62 None -20 50 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
DB00434 1301 62 None -20 50 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 None
3294 2006 111 None -10 45 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
71360 2006 111 None -10 45 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
87 2006 111 None -10 45 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
CHEMBL14376 2006 111 None -10 45 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
DB04946 2006 111 None -10 45 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 426 8 0 6 4.8 COc1cc(ccc1OCCCN1CCC(CC1)c1noc2c1ccc(c2)F)C(=O)C None
1613 2348 53 None -2 44 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
205 2348 53 None -2 44 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
3964 2348 53 None -2 44 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
CHEMBL831 2348 53 None -2 44 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
DB00408 2348 53 None -2 44 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 None
240 944 43 None -4 24 Rat 8.1 pKi = 8.1 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
2769 944 43 None -4 24 Rat 8.1 pKi = 8.1 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
44279790 944 43 None -4 24 Rat 8.1 pKi = 8.1 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
660 944 43 None -4 24 Rat 8.1 pKi = 8.1 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
CHEMBL1729 944 43 None -4 24 Rat 8.1 pKi = 8.1 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
CHEMBL560739 944 43 None -4 24 Rat 8.1 pKi = 8.1 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
DB00604 944 43 None -4 24 Rat 8.1 pKi = 8.1 Binding
The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brainThe ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain
Drug Central 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N None
3584 3777 64 None -3 13 Bovine 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
5401 3777 64 None -3 13 Bovine 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
7302 3777 64 None -3 13 Bovine 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
CHEMBL611 3777 64 None -3 13 Bovine 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
DB01162 3777 64 None -3 13 Bovine 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
2274 3173 58 None -3 31 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
4917 3173 58 None -3 31 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
7279 3173 58 None -3 31 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
CHEMBL728 3173 58 None -3 31 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
DB00433 3173 58 None -3 31 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 373 4 0 4 4.6 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
214 3860 58 None -9 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
2740 3860 58 None -9 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
5566 3860 58 None -9 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
66064 3860 58 None -9 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
CHEMBL422 3860 58 None -9 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
DB00831 3860 58 None -9 30 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 407 4 0 4 4.9 CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
1225 1471 26 None -26 22 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
3958 1471 26 None -26 22 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
667477 1471 26 None -26 22 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
CHEMBL860 1471 26 None -26 22 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
DB01142 1471 26 None -26 22 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 279 3 0 2 4.0 CN(CC/C=C\1/c2ccccc2OCc2c1cccc2)C None
115 343 71 None -2 6 Bovine 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C None
2092 343 71 None -2 6 Bovine 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C None
7109 343 71 None -2 6 Bovine 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C None
CHEMBL709 343 71 None -2 6 Bovine 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C None
DB00346 343 71 None -2 6 Bovine 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C None
135398737 958 93 None -5 89 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 958 93 None -5 89 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 958 93 None -5 89 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 958 93 None -5 89 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 958 93 None -5 89 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
135398745 2914 112 None -39 65 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
47 2914 112 None -39 65 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
CHEMBL715 2914 112 None -39 65 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
DB00334 2914 112 None -39 65 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
1890 2759 49 None -1 16 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl None
4449 2759 49 None -1 16 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl None
7247 2759 49 None -1 16 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl None
CHEMBL623 2759 49 None -1 16 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl None
DB01149 2759 49 None -1 16 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl None
2470 3653 50 None -316 59 Bovine 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
3300 3653 50 None -316 59 Bovine 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
5265 3653 50 None -316 59 Bovine 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
99 3653 50 None -316 59 Bovine 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
CHEMBL267930 3653 50 None -316 59 Bovine 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
124 2981 47 None -14 33 Bovine 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2981 47 None -14 33 Bovine 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2981 47 None -14 33 Bovine 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2981 47 None -14 33 Bovine 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2981 47 None -14 33 Bovine 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2389 3331 118 None -6 67 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 3331 118 None -6 67 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 3331 118 None -6 67 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 3331 118 None -6 67 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 3331 118 None -6 67 Rat 8.1 pKi = 8.1 Binding
Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
1353 1911 93 None -6 83 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
3559 1911 93 None -6 83 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
86 1911 93 None -6 83 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
CHEMBL54 1911 93 None -6 83 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
DB00502 1911 93 None -6 83 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
1443 2028 34 None -2 10 Bovine 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
33625 2028 34 None -2 10 Bovine 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
501 2028 34 None -2 10 Bovine 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
CHEMBL279516 2028 34 None -2 10 Bovine 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
DB08950 2028 34 None -2 10 Bovine 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
212 3806 47 None -7 25 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C None
2639 3806 47 None -7 25 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C None
941651 3806 47 None -7 25 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C None
CHEMBL1201 3806 47 None -7 25 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C None
DB01623 3806 47 None -7 25 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 443 5 0 5 3.5 CN1CCN(CC1)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C None
2726 919 68 3H-PRAZOSIN -20 72 Pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 919 68 3H-PRAZOSIN -20 72 Pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 919 68 3H-PRAZOSIN -20 72 Pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 919 68 3H-PRAZOSIN -20 72 Pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 919 68 3H-PRAZOSIN -20 72 Pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
4106 2502 22 3H-PRAZOSIN -1 34 Pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
5358812 2502 22 3H-PRAZOSIN -1 34 Pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
89 2502 22 3H-PRAZOSIN -1 34 Pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
CHEMBL93240 2502 22 3H-PRAZOSIN -1 34 Pig 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 356 2 0 4 4.4 CSc1ccc2c(c1)C(Cc1c(S2)cccc1)N1CCN(CC1)C None
209 3057 97 None -11 23 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
2113 3057 97 None -11 23 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
4748 3057 97 None -11 23 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
CHEMBL567 3057 97 None -11 23 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
DB00850 3057 97 None -11 23 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 403 6 1 5 3.9 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(Cl)cc2 None
2865 4143 73 None -14 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
59 4143 73 None -14 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
60854 4143 73 None -14 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
CHEMBL708 4143 73 None -14 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
DB00246 4143 73 None -14 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
115 343 71 None -3 6 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
Drug Central 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C None
2092 343 71 None -3 6 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
Drug Central 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C None
7109 343 71 None -3 6 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
Drug Central 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C None
CHEMBL709 343 71 None -3 6 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
Drug Central 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C None
DB00346 343 71 None -3 6 Human 8.1 pKi = 8.1 Binding
Binding affinity against Alpha-1A adrenergic receptor from human cloneBinding affinity against Alpha-1A adrenergic receptor from human clone
Drug Central 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C None
2470 3653 50 None -208 59 Human 8.1 pKi = 8.1 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
3300 3653 50 None -208 59 Human 8.1 pKi = 8.1 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
5265 3653 50 None -208 59 Human 8.1 pKi = 8.1 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
99 3653 50 None -208 59 Human 8.1 pKi = 8.1 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
CHEMBL267930 3653 50 None -208 59 Human 8.1 pKi = 8.1 Binding
Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately activeBinding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
135398737 958 93 None -5 89 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 958 93 None -5 89 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 958 93 None -5 89 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 958 93 None -5 89 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 958 93 None -5 89 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
2470 3653 50 None -398 59 Rat 8.1 pKi = 8.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
3300 3653 50 None -398 59 Rat 8.1 pKi = 8.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
5265 3653 50 None -398 59 Rat 8.1 pKi = 8.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
99 3653 50 None -398 59 Rat 8.1 pKi = 8.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
CHEMBL267930 3653 50 None -398 59 Rat 8.1 pKi = 8.1 Binding
Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary glandOverall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland
Drug Central 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
103 4153 61 None -6 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
2875 4153 61 None -6 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
5736 4153 61 None -6 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL285802 4153 61 None -6 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
DB09225 4153 61 None -6 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
2142 3096 58 None -1 36 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3096 58 None -1 36 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3096 58 None -1 36 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3096 58 None -1 36 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3096 58 None -1 36 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3096 58 None -1 36 Bovine 8.1 pKi = 8.1 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
1212 1662 50 None -16 65 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
204 1662 50 None -16 65 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
3372 1662 50 None -16 65 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
CHEMBL726 1662 50 None -16 65 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
DB00623 1662 50 None -16 65 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 437 6 1 5 4.3 OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F None
124 2981 47 None -13 33 Rat 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2981 47 None -13 33 Rat 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2981 47 None -13 33 Rat 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2981 47 None -13 33 Rat 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2981 47 None -13 33 Rat 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
3389 217711 0 None -1 26 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 549 12 0 6 6.8 CCCCCCC(=O)OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1 None
463 1405 22 None -7 12 Rat 8.1 pKi = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
6918097 1405 22 None -7 12 Rat 8.1 pKi = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
837 1405 22 None -7 12 Rat 8.1 pKi = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
CHEMBL2051956 1405 22 None -7 12 Rat 8.1 pKi = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
DB14068 1405 22 None -7 12 Rat 8.1 pKi = 8.1 Binding
Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
1524 2181 96 None -5 52 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
197 2181 96 None -5 52 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
3822 2181 96 None -5 52 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
88 2181 96 None -5 52 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
CHEMBL51 2181 96 None -5 52 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
DB12465 2181 96 None -5 52 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 None
124 2981 47 None -19 33 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2032 2981 47 None -19 33 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
4636 2981 47 None -19 33 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
CHEMBL762 2981 47 None -19 33 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
DB00935 2981 47 None -19 33 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C None
2284 3182 33 None -3 29 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
4926 3182 33 None -3 29 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
7281 3182 33 None -3 29 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
CHEMBL564 3182 33 None -3 29 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
DB00420 3182 33 None -3 29 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 284 4 0 3 4.2 CN(CCCN1c2ccccc2Sc2c1cccc2)C None
1588 2325 27 None -23 44 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
28864 2325 27 None -23 44 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
43 2325 27 None -23 44 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL157138 2325 27 None -23 44 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
DB00589 2325 27 None -23 44 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC None
31101 729 40 None -12 36 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
35 729 40 None -12 36 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
403 729 40 None -12 36 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
CHEMBL493 729 40 None -12 36 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
DB01200 729 40 None -12 36 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C None
2142 3096 58 None -2 36 Human 8.1 pKi = 8.1 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
4920903 3096 58 None -2 36 Human 8.1 pKi = 8.1 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
502 3096 58 None -2 36 Human 8.1 pKi = 8.1 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
5775 3096 58 None -2 36 Human 8.1 pKi = 8.1 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
CHEMBL597 3096 58 None -2 36 Human 8.1 pKi = 8.1 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
DB00692 3096 58 None -2 36 Human 8.1 pKi = 8.1 Binding
Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cellsBinding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells
Drug Central 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 None
11978813 721 79 None -10 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
5014 721 79 None -10 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
7672 721 79 None -10 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
CHEMBL2105760 721 79 None -10 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
DB09128 721 79 None -10 24 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 433 7 1 5 4.7 O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2 None
4418 34222 85 None -1 6 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 None
CHEMBL142635 34222 85 None -1 6 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 392 7 1 5 3.4 COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1 None
1443 2028 34 None 1 10 Human 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
33625 2028 34 None 1 10 Human 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
501 2028 34 None 1 10 Human 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
CHEMBL279516 2028 34 None 1 10 Human 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
DB08950 2028 34 None 1 10 Human 8.1 pKi = 8.1 Binding
The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.
Drug Central 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 None
102 4127 48 None -85 49 Bovine 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
3659 4127 48 None -85 49 Bovine 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
8969 4127 48 None -85 49 Bovine 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
CHEMBL15245 4127 48 None -85 49 Bovine 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
DB01392 4127 48 None -85 49 Bovine 8.1 pKi = 8.1 Binding
Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pinealCompound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pineal
Drug Central 354 1 2 4 2.6 COC(=O)[C@H]1[C@@H](O)CC[C@@H]2[C@@H]1C[C@@H]1N(C2)CCc2c1[nH]c1c2cccc1 None
2398 954 62 None 1 29 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
2801 954 62 None 1 29 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
701 954 62 None 1 29 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
CHEMBL415 954 62 None 1 29 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
DB01242 954 62 None 1 29 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C None
2601 3780 33 None -5 21 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
443951 3780 33 None -5 21 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
56 3780 33 None -5 21 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
CHEMBL73151 3780 33 None -5 21 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
DB13399 3780 33 None -5 21 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC None
2389 3331 118 None -11 67 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 3331 118 None -11 67 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 3331 118 None -11 67 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 3331 118 None -11 67 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 3331 118 None -11 67 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
115237 55585 119 None -36 54 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
CHEMBL1621 55585 119 None -36 54 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
2585 803 103 None -9 21 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
522 803 103 None -9 21 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
551 803 103 None -9 21 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
CHEMBL723 803 103 None -9 21 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
DB01136 803 103 None -9 21 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O None
5440 28724 37 None -1 9 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 399 6 0 5 5.0 CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2 None
CHEMBL1378 28724 37 None -1 9 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 399 6 0 5 5.0 CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2 None
2435 3590 83 None -16 48 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
60149 3590 83 None -16 48 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
98 3590 83 None -16 48 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
CHEMBL12713 3590 83 None -16 48 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
DB06144 3590 83 None -16 48 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
3157 1470 71 None -2 10 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
7170 1470 71 None -2 10 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
954 1470 71 None -2 10 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
CHEMBL707 1470 71 None -2 10 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
DB00590 1470 71 None -2 10 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 None
5639 98895 75 None -1 5 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 387 7 1 8 0.7 COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 None
CHEMBL279229 98895 75 None -1 5 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 387 7 1 8 0.7 COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 None
46780481 107531 20 None -52 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
9903970 107531 20 None -52 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3187365 107531 20 None -52 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3544974 107531 20 None -52 53 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
3584 3777 64 None -2 13 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
5401 3777 64 None -2 13 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
7302 3777 64 None -2 13 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
CHEMBL611 3777 64 None -2 13 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
DB01162 3777 64 None -2 13 Human 8.1 pKi = 8.1 Binding
NoneNone
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
3584 3777 64 None -2 13 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
5401 3777 64 None -2 13 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
7302 3777 64 None -2 13 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
CHEMBL611 3777 64 None -2 13 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
DB01162 3777 64 None -2 13 Rat 8.0 pKi = 8.0 Binding
In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1AIn vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A
Drug Central 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 None
1238 203174 24 None -3 16 Bovine 8.0 pKi = 8.0 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
Drug Central 344 1 0 3 4.3 CN1CCN(C2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 None
CHEMBL64249 203174 24 None -3 16 Bovine 8.0 pKi = 8.0 Binding
Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cellsDisplacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells
Drug Central 344 1 0 3 4.3 CN1CCN(C2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 None
2865 4143 73 None -4 53 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
59 4143 73 None -4 53 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
60854 4143 73 None -4 53 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
CHEMBL708 4143 73 None -4 53 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
DB00246 4143 73 None -4 53 Rat 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cellsDisplacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells
Drug Central 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
463 1405 22 None -8 12 Bovine 8.0 pKi = 8.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
6918097 1405 22 None -8 12 Bovine 8.0 pKi = 8.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
837 1405 22 None -8 12 Bovine 8.0 pKi = 8.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
CHEMBL2051956 1405 22 None -8 12 Bovine 8.0 pKi = 8.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
DB14068 1405 22 None -8 12 Bovine 8.0 pKi = 8.0 Binding
Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligandBinding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand
Drug Central 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C None
2435 3590 83 None -3 48 Bovine 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
60149 3590 83 None -3 48 Bovine 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
98 3590 83 None -3 48 Bovine 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
CHEMBL12713 3590 83 None -3 48 Bovine 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
DB06144 3590 83 None -3 48 Bovine 8.0 pKi = 8.0 Binding
Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cellsDisplacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells
Drug Central 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
4209 3163 75 None -4 33 Bovine 8.0 pKi = 8.0 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
4893 3163 75 None -4 33 Bovine 8.0 pKi = 8.0 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
503 3163 75 None -4 33 Bovine 8.0 pKi = 8.0 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
5385 3163 75 None -4 33 Bovine 8.0 pKi = 8.0 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
CHEMBL2 3163 75 None -4 33 Bovine 8.0 pKi = 8.0 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
DB00457 3163 75 None -4 33 Bovine 8.0 pKi = 8.0 Binding
Binding affinity against Alpha-1A adrenergic receptor from bovine cloneBinding affinity against Alpha-1A adrenergic receptor from bovine clone
Drug Central 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 None
129211 3749 78 None -7 15 Bovine 8.0 pKi = 8 Binding
NoneNone
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
2562 3749 78 None -7 15 Bovine 8.0 pKi = 8 Binding
NoneNone
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
488 3749 78 None -7 15 Bovine 8.0 pKi = 8 Binding
NoneNone
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
CHEMBL836 3749 78 None -7 15 Bovine 8.0 pKi = 8 Binding
NoneNone
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
DB00706 3749 78 None -7 15 Bovine 8.0 pKi = 8 Binding
NoneNone
Drug Central 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C None
4151 3607 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 31285236
4151 3607 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 32608144
4151 3607 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 7651358
493 3607 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 31285236
493 3607 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 32608144
493 3607 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 7651358
5312125 3607 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 31285236
5312125 3607 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 32608144
5312125 3607 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 7651358
CHEMBL24778 3607 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 31285236
CHEMBL24778 3607 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 32608144
CHEMBL24778 3607 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 7651358
DB06207 3607 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 31285236
DB06207 3607 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 32608144
DB06207 3607 89 None 33 3 Human 10.0 pKi = 10 Binding
UnclassifiedUnclassified
Guide to Pharmacology 495 13 3 6 3.1 OCCCN1CCc2c1c(cc(c2)C[C@H](NCCOc1ccccc1OCC(F)(F)F)C)C(=O)N 7651358
129211 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10334511
129211 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10369480
129211 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 31285236
129211 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 32608144
129211 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 7651358
129211 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 7815325
129211 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 9249248
129211 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 9490024
2562 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10334511
2562 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10369480
2562 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 31285236
2562 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 32608144
2562 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 7651358
2562 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 7815325
2562 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 9249248
2562 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 9490024
488 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10334511
488 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10369480
488 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 31285236
488 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 32608144
488 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 7651358
488 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 7815325
488 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 9249248
488 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 9490024
CHEMBL836 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10334511
CHEMBL836 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10369480
CHEMBL836 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 31285236
CHEMBL836 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 32608144
CHEMBL836 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 7651358
CHEMBL836 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 7815325
CHEMBL836 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 9249248
CHEMBL836 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 9490024
DB00706 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10334511
DB00706 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 10369480
DB00706 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 31285236
DB00706 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 32608144
DB00706 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 7651358
DB00706 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 7815325
DB00706 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 9249248
DB00706 3749 78 None -1 15 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 408 11 2 6 2.3 CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C 9490024
4431 2729 25 None 1 12 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 393 7 0 5 2.9 COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2 11459121
73 2729 25 None 1 12 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 393 7 0 5 2.9 COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2 11459121
CHEMBL8618 2729 25 None 1 12 Human 10.1 pKi = 10.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 393 7 0 5 2.9 COc1ccccc1N1CCN(CC1)CCCCN1C(=O)c2c(C1=O)cccc2 11459121
1753 2504 28 None -7 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10433504
1753 2504 28 None -7 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 20978120
1753 2504 28 None -7 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 28444738
1753 2504 28 None -7 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 34355529
1753 2504 28 None -7 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 7651358
1753 2504 28 None -7 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 7815325
483 2504 28 None -7 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10433504
483 2504 28 None -7 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 20978120
483 2504 28 None -7 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 28444738
483 2504 28 None -7 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 34355529
483 2504 28 None -7 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 7651358
483 2504 28 None -7 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 7815325
6082 2504 28 None -7 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10433504
6082 2504 28 None -7 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 20978120
6082 2504 28 None -7 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 28444738
6082 2504 28 None -7 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 34355529
6082 2504 28 None -7 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 7651358
6082 2504 28 None -7 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 7815325
CHEMBL524 2504 28 None -7 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10433504
CHEMBL524 2504 28 None -7 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 20978120
CHEMBL524 2504 28 None -7 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 28444738
CHEMBL524 2504 28 None -7 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 34355529
CHEMBL524 2504 28 None -7 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 7651358
CHEMBL524 2504 28 None -7 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 7815325
DB00723 2504 28 None -7 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 10433504
DB00723 2504 28 None -7 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 20978120
DB00723 2504 28 None -7 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 28444738
DB00723 2504 28 None -7 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 34355529
DB00723 2504 28 None -7 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 7651358
DB00723 2504 28 None -7 5 Human 4.9 pKi = 4.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 211 4 2 4 1.1 COc1ccc(c(c1)C(C(N)C)O)OC 7815325
247704 290 31 None -10 5 Human 5.0 pKi = 5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@H](c1ccc(c(c1)O)O)O 7815325
4450 290 31 None -10 5 Human 5.0 pKi = 5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@H](c1ccc(c(c1)O)O)O 7815325
CHEMBL42280 290 31 None -10 5 Human 5.0 pKi = 5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@H](c1ccc(c(c1)O)O)O 7815325
507 3328 0 None -2511 2 Rat 5.0 pKi = 5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12824165
2146 3100 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10433504
2146 3100 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 20978120
2146 3100 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 28444738
2146 3100 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 34355529
485 3100 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10433504
485 3100 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 20978120
485 3100 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 28444738
485 3100 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 34355529
6041 3100 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10433504
6041 3100 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 20978120
6041 3100 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 28444738
6041 3100 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 34355529
CHEMBL1215 3100 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10433504
CHEMBL1215 3100 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 20978120
CHEMBL1215 3100 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 28444738
CHEMBL1215 3100 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 34355529
DB00388 3100 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 10433504
DB00388 3100 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 20978120
DB00388 3100 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 28444738
DB00388 3100 67 None -2 9 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 167 3 3 3 0.6 CNC[C@@H](c1cccc(c1)O)O 34355529
1960 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10433504
1960 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20978120
1960 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 28444738
1960 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 34355529
1960 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 7651358
1960 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 7815325
1960 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 8564227
439260 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10433504
439260 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20978120
439260 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 28444738
439260 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 34355529
439260 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 7651358
439260 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 7815325
439260 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 8564227
505 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10433504
505 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20978120
505 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 28444738
505 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 34355529
505 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 7651358
505 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 7815325
505 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 8564227
CHEMBL1437 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10433504
CHEMBL1437 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20978120
CHEMBL1437 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 28444738
CHEMBL1437 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 34355529
CHEMBL1437 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 7651358
CHEMBL1437 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 7815325
CHEMBL1437 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 8564227
DB00368 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 10433504
DB00368 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 20978120
DB00368 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 28444738
DB00368 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 34355529
DB00368 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 7651358
DB00368 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 7815325
DB00368 2857 67 None -57 26 Human 5.6 pKi = 5.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 169 2 4 4 0.1 NC[C@@H](c1ccc(c(c1)O)O)O 8564227
1028 291 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
1028 291 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7651358
1028 291 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7815325
1028 291 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 8564227
139148732 291 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
139148732 291 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7651358
139148732 291 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7815325
139148732 291 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 8564227
479 291 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
479 291 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7651358
479 291 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7815325
479 291 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 8564227
5816 291 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
5816 291 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7651358
5816 291 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7815325
5816 291 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 8564227
CHEMBL679 291 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
CHEMBL679 291 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7651358
CHEMBL679 291 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7815325
CHEMBL679 291 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 8564227
DB00668 291 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 34355529
DB00668 291 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7651358
DB00668 291 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 7815325
DB00668 291 71 None -48 30 Human 5.8 pKi = 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 183 3 4 4 0.4 CNC[C@@H](c1ccc(c(c1)O)O)O 8564227
481 2892 7 None 4 3 Human 6.2 pKi = 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 8719417
9838763 2892 7 None 4 3 Human 6.2 pKi = 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 8719417
CHEMBL72958 2892 7 None 4 3 Human 6.2 pKi = 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 248 4 3 4 0.2 NC[C@@H](c1cc(ccc1F)NS(=O)(=O)C)O 8719417
2765 943 19 None -10 9 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 20978120
2765 943 19 None -10 9 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 34355529
515 943 19 None -10 9 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 20978120
515 943 19 None -10 9 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 34355529
CHEMBL13852 943 19 None -10 9 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 20978120
CHEMBL13852 943 19 None -10 9 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 34355529
DB09202 943 19 None -10 9 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 20978120
DB09202 943 19 None -10 9 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 216 4 1 3 1.9 C1CN=C(N1)COc1ccccc1C1CC1 34355529
11079 2733 63 None -22 5 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
3369 2733 63 None -22 5 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
4436 2733 63 None -22 5 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
5509 2733 63 None -22 5 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
CHEMBL761 2733 63 None -22 5 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
DB06711 2733 63 None -22 5 Human 6.5 pKi = 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 210 2 1 2 2.4 C1CN=C(N1)Cc1cccc2c1cccc2 34355529
2419 695 28 None -288 12 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 11354357
2419 695 28 None -288 12 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 11459121
2419 695 28 None -288 12 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 32608144
9 695 28 None -288 12 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 11354357
9 695 28 None -288 12 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 11459121
9 695 28 None -288 12 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 32608144
CHEMBL13647 695 28 None -288 12 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 11354357
CHEMBL13647 695 28 None -288 12 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 11459121
CHEMBL13647 695 28 None -288 12 Human 6.8 pKi = 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 32608144
2419 695 28 None -288 12 Rat 7.0 pKi = 7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 11354357
9 695 28 None -288 12 Rat 7.0 pKi = 7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 11354357
CHEMBL13647 695 28 None -288 12 Rat 7.0 pKi = 7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 385 5 0 5 2.5 COc1ccccc1N1CCN(CC1)CCN1C(=O)CC2(CC1=O)CCCC2 11354357
5268 3656 40 None -251 18 Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 11459121
5268 3656 40 None -251 18 Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 32608144
53 3656 40 None -251 18 Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 11459121
53 3656 40 None -251 18 Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 32608144
CHEMBL300555 3656 40 None -251 18 Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 11459121
CHEMBL300555 3656 40 None -251 18 Human 7.1 pKi = 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 379 3 1 5 2.3 O=C1NCN(C21CCN(CC2)CC1COc2c(O1)cccc2)c1ccccc1 32608144
4038180 204 14 None -6 7 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 20978120
4038180 204 14 None -6 7 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 28444738
4038180 204 14 None -6 7 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 34355529
4038180 204 14 None -6 7 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 7616455
4038180 204 14 None -6 7 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 9249248
480 204 14 None -6 7 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 20978120
480 204 14 None -6 7 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 28444738
480 204 14 None -6 7 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 34355529
480 204 14 None -6 7 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 7616455
480 204 14 None -6 7 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 9249248
CHEMBL109783 204 14 None -6 7 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 20978120
CHEMBL109783 204 14 None -6 7 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 28444738
CHEMBL109783 204 14 None -6 7 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 34355529
CHEMBL109783 204 14 None -6 7 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 7616455
CHEMBL109783 204 14 None -6 7 Human 7.2 pKi = 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 309 3 3 5 1.2 Oc1ccc2c(c1NS(=O)(=O)C)CCCC2C1=NCCN1 9249248
1531 2266 69 None -7 16 Human 7.3 pKi = 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 34355529
3869 2266 69 None -7 16 Human 7.3 pKi = 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 34355529
7207 2266 69 None -7 16 Human 7.3 pKi = 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 34355529
CHEMBL429 2266 69 None -7 16 Human 7.3 pKi = 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 34355529
DB00598 2266 69 None -7 16 Human 7.3 pKi = 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 328 8 5 4 2.9 CC(CCc1ccccc1)NCC(c1ccc(c(c1)C(=N)O)O)O 34355529
216249 1305 51 None - 1 Human 7.4 pKi = 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 5 2 5 1.4 Clc1ccc(c(c1NS(=O)(=O)C)C)OCC1=NCCN1 14678390
3469 1305 51 None - 1 Human 7.4 pKi = 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 5 2 5 1.4 Clc1ccc(c(c1NS(=O)(=O)C)C)OCC1=NCCN1 14678390
CHEMBL257978 1305 51 None - 1 Human 7.4 pKi = 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 317 5 2 5 1.4 Clc1ccc(c(c1NS(=O)(=O)C)C)OCC1=NCCN1 14678390
10453764 2198 0 None 1 3 Rat 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 402 4 0 8 0.9 Clc1ccccc1N1CCN(CC1)CCn1cnc2c1c(=O)n(C)c(=O)n2C 17639498
8896 2198 0 None 1 3 Rat 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 402 4 0 8 0.9 Clc1ccccc1N1CCN(CC1)CCn1cnc2c1c(=O)n(C)c(=O)n2C 17639498
124 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10433504
124 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 20978120
124 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 28444738
124 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 34355529
124 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7651358
124 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7815325
124 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 8564227
124 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 8719417
2032 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10433504
2032 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 20978120
2032 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 28444738
2032 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 34355529
2032 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7651358
2032 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7815325
2032 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 8564227
2032 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 8719417
4636 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10433504
4636 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 20978120
4636 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 28444738
4636 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 34355529
4636 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7651358
4636 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7815325
4636 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 8564227
4636 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 8719417
CHEMBL762 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10433504
CHEMBL762 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 20978120
CHEMBL762 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 28444738
CHEMBL762 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 34355529
CHEMBL762 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7651358
CHEMBL762 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7815325
CHEMBL762 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 8564227
CHEMBL762 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 8719417
DB00935 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 10433504
DB00935 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 20978120
DB00935 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 28444738
DB00935 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 34355529
DB00935 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7651358
DB00935 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 7815325
DB00935 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 8564227
DB00935 2981 47 None -19 33 Human 7.7 pKi = 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 260 2 2 3 2.9 Cc1cc(c(c(c1CC1=NCCN1)C)O)C(C)(C)C 8719417
115 343 71 None -3 6 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10812954
115 343 71 None -3 6 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 31285236
115 343 71 None -3 6 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 32608144
2092 343 71 None -3 6 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10812954
2092 343 71 None -3 6 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 31285236
2092 343 71 None -3 6 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 32608144
7109 343 71 None -3 6 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10812954
7109 343 71 None -3 6 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 31285236
7109 343 71 None -3 6 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 32608144
CHEMBL709 343 71 None -3 6 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10812954
CHEMBL709 343 71 None -3 6 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 31285236
CHEMBL709 343 71 None -3 6 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 32608144
DB00346 343 71 None -3 6 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 10812954
DB00346 343 71 None -3 6 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 31285236
DB00346 343 71 None -3 6 Human 8.0 pKi = 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology 389 8 3 7 2.0 COc1cc2nc([nH]c(=N)c2cc1OC)N(CCCN=C(C1CCCO1)O)C 32608144
1588 2325 27 None -23 44 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
1588 2325 27 None -23 44 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 32608144
28864 2325 27 None -23 44 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
28864 2325 27 None -23 44 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 32608144
43 2325 27 None -23 44 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
43 2325 27 None -23 44 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 32608144
CHEMBL157138 2325 27 None -23 44 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
CHEMBL157138 2325 27 None -23 44 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 32608144
DB00589 2325 27 None -23 44 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
DB00589 2325 27 None -23 44 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 338 3 2 2 2.8 CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC 32608144
2398 954 62 None 1 29 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 32608144
2801 954 62 None 1 29 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 32608144
701 954 62 None 1 29 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 32608144
CHEMBL415 954 62 None 1 29 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 32608144
DB01242 954 62 None 1 29 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 32608144
2142 3096 58 None -2 36 Rat 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 11331292
4920903 3096 58 None -2 36 Rat 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 11331292
502 3096 58 None -2 36 Rat 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 11331292
5775 3096 58 None -2 36 Rat 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 11331292
CHEMBL597 3096 58 None -2 36 Rat 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 11331292
DB00692 3096 58 None -2 36 Rat 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 11331292
135398737 958 93 None -5 89 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 11459121
135398737 958 93 None -5 89 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 32608144
38 958 93 None -5 89 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 11459121
38 958 93 None -5 89 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 32608144
722 958 93 None -5 89 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 11459121
722 958 93 None -5 89 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 32608144
CHEMBL42 958 93 None -5 89 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 11459121
CHEMBL42 958 93 None -5 89 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 32608144
DB00363 958 93 None -5 89 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 11459121
DB00363 958 93 None -5 89 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 32608144
180 401 56 None -12 40 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 32608144
200 401 56 None -12 40 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 32608144
2160 401 56 None -12 40 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 32608144
CHEMBL629 401 56 None -12 40 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 32608144
DB00321 401 56 None -12 40 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 32608144
1971 2866 38 None -1 30 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 32608144
2404 2866 38 None -1 30 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 32608144
4543 2866 38 None -1 30 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 32608144
CHEMBL445 2866 38 None -1 30 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 32608144
DB00540 2866 38 None -1 30 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 263 3 1 1 3.8 CNCCC=C1c2ccccc2CCc2c1cccc2 32608144
3584 3777 64 None -2 13 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 31285236
3584 3777 64 None -2 13 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 32608144
3584 3777 64 None -2 13 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 9379432
5401 3777 64 None -2 13 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 31285236
5401 3777 64 None -2 13 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 32608144
5401 3777 64 None -2 13 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 9379432
7302 3777 64 None -2 13 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 31285236
7302 3777 64 None -2 13 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 32608144
7302 3777 64 None -2 13 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 9379432
CHEMBL611 3777 64 None -2 13 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 31285236
CHEMBL611 3777 64 None -2 13 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 32608144
CHEMBL611 3777 64 None -2 13 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 9379432
DB01162 3777 64 None -2 13 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 31285236
DB01162 3777 64 None -2 13 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 32608144
DB01162 3777 64 None -2 13 Human 8.3 pKi = 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 4 2 7 0.9 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1CCCO1 9379432
132266 1278 12 None -28 9 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 32608144
132266 1278 12 None -28 9 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 8917649
486 1278 12 None -28 9 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 32608144
486 1278 12 None -28 9 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 8917649
CHEMBL423294 1278 12 None -28 9 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 32608144
CHEMBL423294 1278 12 None -28 9 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 437 4 1 8 3.1 COc1cc2nc(nc(c2cc1OC)N)N1CCN([C@@H]2[C@H]1CCCC2)C(=O)c1ccco1 8917649
2142 3096 58 None -2 36 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 32608144
2142 3096 58 None -2 36 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7651358
4920903 3096 58 None -2 36 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 32608144
4920903 3096 58 None -2 36 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7651358
502 3096 58 None -2 36 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 32608144
502 3096 58 None -2 36 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7651358
5775 3096 58 None -2 36 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 32608144
5775 3096 58 None -2 36 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7651358
CHEMBL597 3096 58 None -2 36 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 32608144
CHEMBL597 3096 58 None -2 36 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7651358
DB00692 3096 58 None -2 36 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 32608144
DB00692 3096 58 None -2 36 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 281 4 2 4 2.8 Cc1ccc(cc1)N(c1cccc(c1)O)CC1=NCCN1 7651358
2585 803 103 None -9 21 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 32608144
522 803 103 None -9 21 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 32608144
551 803 103 None -9 21 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 32608144
CHEMBL723 803 103 None -9 21 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 32608144
DB01136 803 103 None -9 21 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 406 10 3 5 3.7 COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O 32608144
1443 2028 34 None 1 10 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10334511
1443 2028 34 None 1 10 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 32608144
1443 2028 34 None 1 10 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 9249248
33625 2028 34 None 1 10 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10334511
33625 2028 34 None 1 10 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 32608144
33625 2028 34 None 1 10 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 9249248
501 2028 34 None 1 10 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10334511
501 2028 34 None 1 10 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 32608144
501 2028 34 None 1 10 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 9249248
CHEMBL279516 2028 34 None 1 10 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10334511
CHEMBL279516 2028 34 None 1 10 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 32608144
CHEMBL279516 2028 34 None 1 10 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 9249248
DB08950 2028 34 None 1 10 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 10334511
DB08950 2028 34 None 1 10 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 32608144
DB08950 2028 34 None 1 10 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 347 5 2 2 3.6 O=C(c1ccccc1)NC1CCN(CC1)CCc1c[nH]c2c1cccc2 9249248
2389 3331 118 None -11 67 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 11459121
2389 3331 118 None -11 67 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 32608144
5073 3331 118 None -11 67 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 11459121
5073 3331 118 None -11 67 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 32608144
96 3331 118 None -11 67 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 11459121
96 3331 118 None -11 67 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 32608144
CHEMBL85 3331 118 None -11 67 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 11459121
CHEMBL85 3331 118 None -11 67 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 32608144
DB00734 3331 118 None -11 67 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 11459121
DB00734 3331 118 None -11 67 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 32608144
490 191 8 None -12 12 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 11354357
9890547 191 8 None -12 12 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 11354357
CHEMBL268758 191 8 None -12 12 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 11354357
219050 3373 25 None -15 21 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 346 6 2 2 5.0 Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2 12388666
52 3373 25 None -15 21 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 346 6 2 2 5.0 Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2 12388666
CHEMBL431367 3373 25 None -15 21 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 346 6 2 2 5.0 Oc1ccc2c(c1)c(CCCCN1CCC(=CC1)c1ccccc1)c[nH]2 12388666
13134 701 0 None - 1 Human 8.7 pKi = 8.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None O=C(CCC1=CC=C2C=C3C(C)=CC(C)=[N]3[B+3]([F-])([N-]21)[F-])N4CCN(CC4)C5=NC6=C(C=C(C(OC)=C6)OC)C(N)=N5 19572943
3894573 3393 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10334511
3894573 3393 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 32608144
3894573 3393 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 8632751
3894573 3393 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 9249248
3894573 3393 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 9490024
495 3393 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10334511
495 3393 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 32608144
495 3393 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 8632751
495 3393 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 9249248
495 3393 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 9490024
CHEMBL88272 3393 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 10334511
CHEMBL88272 3393 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 32608144
CHEMBL88272 3393 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 8632751
CHEMBL88272 3393 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 9249248
CHEMBL88272 3393 6 None -1 5 Human 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 412 10 2 3 5.6 Clc1ccc2c(c1)c(c[nH]2)CC(NCCOc1ccccc1OCC1CC1)(C)C 9490024
3157 1470 71 None -2 10 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 31285236
3157 1470 71 None -2 10 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 32608144
7170 1470 71 None -2 10 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 31285236
7170 1470 71 None -2 10 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 32608144
954 1470 71 None -2 10 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 31285236
954 1470 71 None -2 10 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 32608144
CHEMBL707 1470 71 None -2 10 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 31285236
CHEMBL707 1470 71 None -2 10 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 32608144
DB00590 1470 71 None -2 10 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 31285236
DB00590 1470 71 None -2 10 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 32608144
497 3365 8 None 61 3 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10369480
9872515 3365 8 None 61 3 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10369480
CHEMBL24777 3365 8 None 61 3 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 444 7 1 6 2.1 Fc1ccc(c(c1)OCC(F)(F)F)N1CCN(CC1)CCCn1c(=O)[nH]cc(c1=O)C 10369480
489 145 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 11459121
489 145 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 32608144
489 145 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 7651358
489 145 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 8764344
489 145 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 9190863
489 145 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 9249248
489 145 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 9490024
5640 145 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 11459121
5640 145 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 32608144
5640 145 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 7651358
5640 145 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 8764344
5640 145 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 9190863
5640 145 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 9249248
5640 145 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 9490024
CHEMBL420060 145 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 11459121
CHEMBL420060 145 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 32608144
CHEMBL420060 145 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 7651358
CHEMBL420060 145 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 8764344
CHEMBL420060 145 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 9190863
CHEMBL420060 145 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 9249248
CHEMBL420060 145 28 None -3 12 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 9490024
498 3631 0 None 2511 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 608 10 2 7 5.6 COC(=O)C1=C(C)NC(=C([C@H]1c1ccc(cc1)[N+](=O)[O-])C(=O)NCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10812954
498 3631 0 None 2511 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 608 10 2 7 5.6 COC(=O)C1=C(C)NC(=C([C@H]1c1ccc(cc1)[N+](=O)[O-])C(=O)NCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 32608144
498 3631 0 None 2511 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 608 10 2 7 5.6 COC(=O)C1=C(C)NC(=C([C@H]1c1ccc(cc1)[N+](=O)[O-])C(=O)NCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 7752182
498 3631 0 None 2511 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 608 10 2 7 5.6 COC(=O)C1=C(C)NC(=C([C@H]1c1ccc(cc1)[N+](=O)[O-])C(=O)NCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 9190863
5311437 3631 0 None 2511 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 608 10 2 7 5.6 COC(=O)C1=C(C)NC(=C([C@H]1c1ccc(cc1)[N+](=O)[O-])C(=O)NCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 10812954
5311437 3631 0 None 2511 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 608 10 2 7 5.6 COC(=O)C1=C(C)NC(=C([C@H]1c1ccc(cc1)[N+](=O)[O-])C(=O)NCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 32608144
5311437 3631 0 None 2511 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 608 10 2 7 5.6 COC(=O)C1=C(C)NC(=C([C@H]1c1ccc(cc1)[N+](=O)[O-])C(=O)NCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 7752182
5311437 3631 0 None 2511 2 Human 9.1 pKi = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 608 10 2 7 5.6 COC(=O)C1=C(C)NC(=C([C@H]1c1ccc(cc1)[N+](=O)[O-])C(=O)NCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 9190863
178103275 3326 0 None - 1 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 20015090
178103275 3326 0 None - 1 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 23935897
6663 3326 0 None - 1 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 20015090
6663 3326 0 None - 1 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 23935897
499 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10334511
499 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 32608144
499 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 7651358
499 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 9249248
499 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 9490024
5685 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10334511
5685 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 32608144
5685 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 7651358
5685 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 9249248
5685 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 9490024
CHEMBL25554 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 10334511
CHEMBL25554 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 32608144
CHEMBL25554 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 7651358
CHEMBL25554 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 9249248
CHEMBL25554 4077 18 None 1 14 Human 9.4 pKi = 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 9490024
4209 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10334511
4209 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10369480
4209 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
4209 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7651358
4209 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9249248
4209 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9490024
4893 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10334511
4893 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10369480
4893 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
4893 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7651358
4893 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9249248
4893 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9490024
503 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10334511
503 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10369480
503 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
503 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7651358
503 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9249248
503 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9490024
5385 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10334511
5385 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10369480
5385 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
5385 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7651358
5385 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9249248
5385 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9490024
CHEMBL2 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10334511
CHEMBL2 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10369480
CHEMBL2 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
CHEMBL2 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7651358
CHEMBL2 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9249248
CHEMBL2 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9490024
DB00457 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10334511
DB00457 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 10369480
DB00457 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 32608144
DB00457 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 7651358
DB00457 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9249248
DB00457 3163 75 None -3 33 Human 9.5 pKi = 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 9490024
487 3634 21 None -1 11 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 32608144
487 3634 21 None -1 11 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 7651358
487 3634 21 None -1 11 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 9249248
60602 3634 21 None -1 11 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 32608144
60602 3634 21 None -1 11 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 7651358
60602 3634 21 None -1 11 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 9249248
CHEMBL405355 3634 21 None -1 11 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 32608144
CHEMBL405355 3634 21 None -1 11 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 7651358
CHEMBL405355 3634 21 None -1 11 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 9249248
DB09239 3634 21 None -1 11 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 32608144
DB09239 3634 21 None -1 11 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 7651358
DB09239 3634 21 None -1 11 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 9249248
3567002 3387 9 None 58 3 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 10369480
3567002 3387 9 None 58 3 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 32608144
7381 3387 9 None 58 3 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 10369480
7381 3387 9 None 58 3 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 32608144
CHEMBL56331 3387 9 None 58 3 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 10369480
CHEMBL56331 3387 9 None 58 3 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 426 7 1 6 2.0 O=c1[nH]cc(c(=O)n1CCCN1CCN(CC1)c1ccccc1OCC(F)(F)F)C 32608144
148842 3946 27 None 8 5 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 9249248
496 3946 27 None 8 5 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 9249248
CHEMBL278865 3946 27 None 8 5 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 511 8 1 6 4.7 COc1ccccc1N1CCN(CC1)CCCNC(=O)c1cccc2c1oc(c1ccccc1)c(c2=O)C 9249248
499 4077 18 None -1 14 Rat 9.9 pKi = 9.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 11331292
499 4077 18 None -1 14 Rat 9.9 pKi = 9.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 9384500
5685 4077 18 None -1 14 Rat 9.9 pKi = 9.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 11331292
5685 4077 18 None -1 14 Rat 9.9 pKi = 9.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 9384500
CHEMBL25554 4077 18 None -1 14 Rat 9.9 pKi = 9.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 11331292
CHEMBL25554 4077 18 None -1 14 Rat 9.9 pKi = 9.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 345 8 1 6 2.5 COc1cccc(c1OCCNCC1COc2c(O1)cccc2)OC 9384500
444 206666 53 None 6 18 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 239 3 1 2 3.3 CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1 None
CHEMBL894 206666 53 None 6 18 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 239 3 1 2 3.3 CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1 None
146570 43454 67 None 1 4 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 324 5 0 3 3.8 CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 None
CHEMBL1508 43454 67 None 1 4 Human 8.3 pKi None 8.3 Binding
NoneNone
Drug Central 324 5 0 3 3.8 CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21 None
228 445 28 None -1 24 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O None
33 445 28 None -1 24 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O None
6005 445 28 None -1 24 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O None
CHEMBL53 445 28 None -1 24 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O None
DB00714 445 28 None -1 24 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 267 0 2 3 2.9 CN1CCc2c3[C@H]1Cc1ccc(c(c1c3ccc2)O)O None
1209 1658 75 None -1 32 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
203 1658 75 None -1 32 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
3386 1658 75 None -1 32 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
CHEMBL41 1658 75 None -1 32 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
DB00472 1658 75 None -1 32 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 309 6 1 2 4.4 CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F None
2105 3054 37 None -9 33 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
47811 3054 37 None -9 33 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
48 3054 37 None -9 33 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
CHEMBL531 3054 37 None -9 33 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
DB01186 3054 37 None -9 33 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 314 4 1 2 4.3 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3 None
2803 955 58 None -8 19 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
516 955 58 None -8 19 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
704 955 58 None -8 19 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
CHEMBL134 955 58 None -8 19 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
DB00575 955 58 None -8 19 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 229 1 2 3 2.4 Clc1cccc(c1NC1=NCCN1)Cl None
3337 206367 27 None 13 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
65801 206367 27 None 13 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
66264 206367 27 None 13 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
91452 206367 27 None 13 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
CHEMBL87493 206367 27 None 13 40 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 231 4 1 1 3.2 CCNC(C)Cc1cccc(C(F)(F)F)c1 None
521 1404 69 None -16 7 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
5311068 1404 69 None -16 7 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
835 1404 69 None -16 7 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
CHEMBL778 1404 69 None -16 7 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
DB00633 1404 69 None -16 7 Human 8.2 pKi None 8.2 Binding
NoneNone
Drug Central 200 2 1 1 3.2 Cc1cccc(c1C)[C@@H](c1c[nH]cn1)C None
2726 919 68 None -5 72 Human 8.0 pKi None 8.0 Binding
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
621 919 68 None -5 72 Human 8.0 pKi None 8.0 Binding
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
83 919 68 None -5 72 Human 8.0 pKi None 8.0 Binding
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL71 919 68 None -5 72 Human 8.0 pKi None 8.0 Binding
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
DB00477 919 68 None -5 72 Human 8.0 pKi None 8.0 Binding
NoneNone
Drug Central 318 4 0 3 4.9 CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C None
2202 3132 96 None -2 21 Human 6.1 pKi None 6.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 12388666
4850 3132 96 None -2 21 Human 6.1 pKi None 6.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 12388666
49 3132 96 None -2 21 Human 6.1 pKi None 6.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 12388666
CHEMBL1371770 3132 96 None -2 21 Human 6.1 pKi None 6.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 12388666
DB12478 3132 96 None -2 21 Human 6.1 pKi None 6.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 298 3 0 6 1.5 c1cnc(nc1)N1CCN(CC1)Cc1ccc2c(c1)OCO2 12388666
37 778 60 None -18 17 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 12388666
460 778 60 None -18 17 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 12388666
54746 778 60 None -18 17 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 12388666
CHEMBL1201087 778 60 None -18 17 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 12388666
DB00248 778 60 None -18 17 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 8 2 4 3.2 C=CCN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N(C(=O)NCC)CCCN(C)C 12388666
277 1301 62 None -20 50 Human 7.4 pKi None 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 11459121
2913 1301 62 None -20 50 Human 7.4 pKi None 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 11459121
765 1301 62 None -20 50 Human 7.4 pKi None 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 11459121
CHEMBL516 1301 62 None -20 50 Human 7.4 pKi None 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 11459121
DB00434 1301 62 None -20 50 Human 7.4 pKi None 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 11459121
135 2532 43 None -40 58 Human 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 11459121
1796 2532 43 None -40 58 Human 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 11459121
4184 2532 43 None -40 58 Human 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 11459121
CHEMBL6437 2532 43 None -40 58 Human 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 11459121
DB06148 2532 43 None -40 58 Human 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 264 0 0 2 3.1 CN1CCN2C(C1)c1ccccc1Cc1c2cccc1 11459121
1524 2181 96 None -5 52 Human 8.2 pKi None 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 11459121
197 2181 96 None -5 52 Human 8.2 pKi None 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 11459121
3822 2181 96 None -5 52 Human 8.2 pKi None 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 11459121
88 2181 96 None -5 52 Human 8.2 pKi None 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 11459121
CHEMBL51 2181 96 None -5 52 Human 8.2 pKi None 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 11459121
DB12465 2181 96 None -5 52 Human 8.2 pKi None 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 5 1 5 2.4 Fc1ccc(cc1)C(=O)C1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)cccc2 11459121
2470 3653 50 None -208 59 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 11459121
3300 3653 50 None -208 59 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 11459121
5265 3653 50 None -208 59 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 11459121
99 3653 50 None -208 59 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 11459121
CHEMBL267930 3653 50 None -208 59 Human 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 395 6 1 4 3.2 Fc1ccc(cc1)C(=O)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 11459121
491 192 9 None -25 12 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 11354357
9891167 192 9 None -25 12 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 11354357
CHEMBL13856 192 9 None -25 12 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 11354357
5074 3332 80 None -6 30 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 11459121
97 3332 80 None -6 30 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 11459121
CHEMBL267777 3332 80 None -6 30 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 11459121
DB12693 3332 80 None -6 30 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 5 0 5 5.5 Fc1ccc(cc1)C(=C1CCN(CC1)CCc1c(C)nc2n(c1=O)ccs2)c1ccc(cc1)F 11459121
491 192 9 None -22 12 Rat 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 11354357
9891167 192 9 None -22 12 Rat 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 11354357
CHEMBL13856 192 9 None -22 12 Rat 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 476 6 1 7 3.6 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1cccc(c1)C 11354357
2601 3780 33 None -5 21 Human 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
443951 3780 33 None -5 21 Human 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
56 3780 33 None -5 21 Human 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
CHEMBL73151 3780 33 None -5 21 Human 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
DB13399 3780 33 None -5 21 Human 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 340 3 2 2 2.9 CCN(C(=O)N[C@@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)c[nH]3)CC 12388666
490 191 8 None -18 12 Rat 8.6 pKi None 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 11354357
9890547 191 8 None -18 12 Rat 8.6 pKi None 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 11354357
CHEMBL268758 191 8 None -18 12 Rat 8.6 pKi None 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 462 6 1 7 3.2 COc1ccccc1N1CCN(CC1)CCn1c(=O)[nH]c2c(c1=O)c(cs2)c1ccccc1 11354357
489 145 28 None -2 12 Rat 9.0 pKi None 9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 11331292
5640 145 28 None -2 12 Rat 9.0 pKi None 9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 11331292
CHEMBL420060 145 28 None -2 12 Rat 9.0 pKi None 9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 401 7 1 8 1.0 COc1ccccc1N1CCN(CC1)CCCNc1c(C)c(=O)n(c(=O)n1C)C 11331292
487 3634 21 None -4 11 Rat 9.3 pKi None 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 11331292
60602 3634 21 None -4 11 Rat 9.3 pKi None 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 11331292
CHEMBL405355 3634 21 None -4 11 Rat 9.3 pKi None 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 11331292
DB09239 3634 21 None -4 11 Rat 9.3 pKi None 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 10 1 8 6.0 COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C 11331292
4209 3163 75 None -3 33 Rat 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 11331292
4893 3163 75 None -3 33 Rat 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 11331292
503 3163 75 None -3 33 Rat 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 11331292
5385 3163 75 None -3 33 Rat 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 11331292
CHEMBL2 3163 75 None -3 33 Rat 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 11331292
DB00457 3163 75 None -3 33 Rat 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 383 4 1 8 1.8 COc1cc2nc(nc(c2cc1OC)N)N1CCN(CC1)C(=O)c1ccco1 11331292